Citrus Sinensis ID: 022794
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 292 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.784 | 0.587 | 0.353 | 8e-41 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.828 | 0.294 | 0.383 | 3e-39 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.856 | 0.272 | 0.323 | 3e-37 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.736 | 0.230 | 0.376 | 3e-33 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.732 | 0.088 | 0.336 | 6e-33 | |
| Q54R58 | 918 | Probable tyrosine-protein | no | no | 0.739 | 0.235 | 0.354 | 7e-33 | |
| Q54U31 | 744 | Dual specificity protein | no | no | 0.691 | 0.271 | 0.365 | 2e-32 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.736 | 0.166 | 0.356 | 3e-32 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.75 | 0.132 | 0.311 | 1e-31 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.743 | 0.428 | 0.346 | 2e-31 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 167 bits (423), Expect = 8e-41, Method: Compositional matrix adjust.
Identities = 88/249 (35%), Positives = 137/249 (55%), Gaps = 20/249 (8%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
K +R++W + S+L I + A G ++RG+Y VAVK++ T A+ L
Sbjct: 73 KGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAK---LE 129
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F EVA+ +L HPN+ +FI A + C++ EY+ G L+
Sbjct: 130 QQFKSEVALLSRLFHPNIVQFIAACKKPP----------------VYCIITEYMSQGNLR 173
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL K L+ + V++LALD++RG+ YLHSQ ++HRD+K+ N+LL+ VK+ADFG
Sbjct: 174 MYLNKKEPYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGT 233
Query: 219 ARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
+ +E + + G GT +MAPE++ PY RK DVYSFGI LWE+ +P+ ++
Sbjct: 234 SCLE-TQCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPV 292
Query: 279 EVTSAVVRQ 287
+ AV +
Sbjct: 293 QAAFAVAEK 301
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (409), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 104/271 (38%), Positives = 152/271 (56%), Gaps = 29/271 (10%)
Query: 19 AAAASANATATPI-GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVA 77
AA +A + P+ +A+ L D +I L IK I G+FGTVHR + G DVA
Sbjct: 517 AAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVA 576
Query: 78 VKLLDWGEEGHRTEAEIAALR-SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENG 136
VK+L E + A R + F +EVA+ +L HPN+ F+GA
Sbjct: 577 VKIL--------MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA-------------- 614
Query: 137 QVAMPSNICCVVVEYLPGGALKTYLIKN-RRRKLAFKVVVQLALDLARGLSYLHSQK--I 193
V P N+ +V EYL G+L L K+ R +L + + +A D+A+G++YLH++ I
Sbjct: 615 -VTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 672
Query: 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKC 253
VHRD+K+ N+L+DK TVK+ DFG++R++AS GT +MAPEVL P N K
Sbjct: 673 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 732
Query: 254 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
DVYSFG+ LWE+ P+ +L+ ++V +AV
Sbjct: 733 DVYSFGVILWELATLQQPWGNLNPAQVVAAV 763
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 3e-37, Method: Composition-based stats.
Identities = 92/284 (32%), Positives = 152/284 (53%), Gaps = 34/284 (11%)
Query: 4 SKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTF 63
S Q N+ NIL ++ + P + + D EI S+L I S + GTF
Sbjct: 624 SPNQYNNQGNIL------KNSGSVVEPPSQQQQYF----SDIEISFSELKISSKLGEGTF 673
Query: 64 GTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123
G V++GL+ G VA+K + E+ + E F +E+ + +L HPN+ + A
Sbjct: 674 GVVYKGLWRGSSVAIKQIKINEDVNNQVLE------EFRKELTILSRLRHPNIVLLMAAC 727
Query: 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR 183
P N+C + EYLPGG+L L +++ K+ ++ +LA+ +A+
Sbjct: 728 TA---------------PPNLC-FITEYLPGGSLYDAL-HSKKIKMNMQLYKKLAIQIAQ 770
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEV 243
G++YLH ++HRD+K+ N+LLD++ VKI DFG+++++ S +MT G+ +M+PE+
Sbjct: 771 GMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLK-SKSTEMTKSIGSPIWMSPEL 829
Query: 244 LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
L G Y K DVY+FGI LWE+ ++PY L ++ AV +
Sbjct: 830 LMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (357), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 96/255 (37%), Positives = 135/255 (52%), Gaps = 40/255 (15%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVK-LLDWGEEGHRTEAEIAALRSAFTQE 104
EI + LVI I G++G V+ + G +VAVK LD G A +A RS E
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSG----AALAEFRS----E 714
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL--- 161
V + +L HPNV F+GA V P N+ +V E+LP G+L L
Sbjct: 715 VRIMRRLRHPNVVFFLGA---------------VTRPPNLS-IVTEFLPRGSLYRILHRP 758
Query: 162 ---IKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADF 216
I RRR +++ALD+A G++ LH+ IVHRD+KT N+L+D N VK+ DF
Sbjct: 759 KSHIDERRR-------IKMALDVAMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDF 811
Query: 217 GVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
G++R++ + GT +MAPEVL P N KCDVYSFG+ LWE+ +P+ ++
Sbjct: 812 GLSRLKHNTFLSSKSTAGTPEWMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPWRGMN 871
Query: 277 FSEVTSAVVRQVQYL 291
+V AV Q + L
Sbjct: 872 PMQVVGAVGFQNRRL 886
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 6e-33, Method: Composition-based stats.
Identities = 84/250 (33%), Positives = 135/250 (54%), Gaps = 36/250 (14%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
R ++EI+ ++L I +G FG V RG + DVA+K++ +R + + + F
Sbjct: 2105 RSEYEIDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKII------YRDQFKTKSSLVMF 2158
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
EV + KL HPNV +F+GA E H C+V E++ GG+L+ +L
Sbjct: 2159 QNEVGILSKLRHPNVVQFLGACTAGGEDH--------------HCIVTEWMGGGSLRQFL 2204
Query: 162 IKN-RRRKLAFKVVVQLALDLARGLSYLH--SQKIVHRDVKTENMLLD-----KNRTV-- 211
+ + + ++LALD+A+G++YLH + I+HRD+ + N+LLD KN V
Sbjct: 2205 TDHFNLLEQNPHIRLKLALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSS 2264
Query: 212 ------KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
KI+DFG++R++ + MT G + YMAPEV G+ + K DVYS+G+ L+E+
Sbjct: 2265 RQDIKCKISDFGLSRLKMEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFEL 2324
Query: 266 YCCDMPYPDL 275
D P D+
Sbjct: 2325 LTSDEPQQDM 2334
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum GN=DDB_G0283397 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 7e-33, Method: Composition-based stats.
Identities = 85/240 (35%), Positives = 125/240 (52%), Gaps = 24/240 (10%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAAL 97
LK + EI +L ++ I +G FG V++ + G VA+K + + TE EI
Sbjct: 163 LKSTLKKHEIPSRELTVEKEIGQGFFGKVYKARWRGKSVALKKITLIKFRDLTETEI--- 219
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F +EV++ KL HP FIGA + PSN +++EY+ GG+L
Sbjct: 220 ---FDKEVSIMSKLCHPTCVMFIGAC-------------SLDGPSNDRSIIMEYMEGGSL 263
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ----KIVHRDVKTENMLLDKNRTV-K 212
+ L + L + + +A D+A G++YLH+ IVHRD+ + N+LL+ + TV K
Sbjct: 264 RRLLDEKSSYHLPPSLQLSIARDIAEGMNYLHTNFKEGPIVHRDLTSSNILLNSSYTVAK 323
Query: 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
I DFG+++ P +MT G+L +MAPE Y K DVYSF I LWEI C PY
Sbjct: 324 INDFGLSKEMKPGPTEMTAAMGSLAWMAPECFKAENYTEKVDVYSFAIILWEIVTCRDPY 383
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (350), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 84/230 (36%), Positives = 125/230 (54%), Gaps = 28/230 (12%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
EI P ++ + +G+FG+V++G G +VAVK+ + + + L ++F EV
Sbjct: 271 EILPEEIDRTDFLGQGSFGSVYKGKCRGQEVAVKI------PRKQKLSLYEL-TSFRHEV 323
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ K+ HPNV F+GA S ++ I TE +C +E L + N
Sbjct: 324 KIMSKIFHPNVVLFLGACTQSGKMQIVTE---------LCQTDLEKL---------LHND 365
Query: 166 RRKLAFKVV--VQLALDLARGLSYLHS-QKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
R K F + +Q+A D A G+++LH +IVH D+KT N+L+D N VK+ DFG ++++
Sbjct: 366 RTKKEFSLFRRMQMAKDAALGMNWLHGITRIVHNDLKTANLLVDINLRVKVTDFGFSQIK 425
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT +MAPEV+ GNPYN K DVYSFGI LWEI + PY
Sbjct: 426 EGEEFQDKAAKGTPLWMAPEVMMGNPYNEKADVYSFGIILWEILTKEAPY 475
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (349), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 88/247 (35%), Positives = 134/247 (54%), Gaps = 32/247 (12%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+WE+ S++ I + I RG +G V RG + G +VAVK+L + L S +
Sbjct: 843 EWEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKML-------FNDNVNLKLISDLRK 895
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV + KL HPN+ F+GA S C+V EYL G+L L+
Sbjct: 896 EVDLLCKLRHPNIVLFMGACTEPSS----------------PCIVTEYLSRGSLANILL- 938
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ ++ + + +QL D ARG++YLHS+ I+HRD+KT+N+L+D + VK+ADFG+A V
Sbjct: 939 DESIEMDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATV 998
Query: 222 EASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
++ +T GT G++APEVL Y K DVYS+ I LWE+ +PY + +
Sbjct: 999 KSH----TFAKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQ 1054
Query: 280 VTSAVVR 286
V ++ R
Sbjct: 1055 VVRSIDR 1061
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 137 bits (344), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 77/247 (31%), Positives = 132/247 (53%), Gaps = 28/247 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W I ++ + I G++G V+RG + DVA+K + E + +R +E
Sbjct: 1392 WVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKF---IKQKIDENHLLGIR----EE 1444
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+A KL HPN+ +GA++ + C+V EY+ G L+ + +
Sbjct: 1445 IAFLKKLHHPNIITMVGASLKKPNI----------------CIVTEYMAKGNLRDAM-RT 1487
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHS--QKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
KL + +++ +++A+G+SYLHS I+HRD+K N+L+D+N VKIADFG AR++
Sbjct: 1488 CTPKLEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIK 1547
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
N + GT + APE++ + Y+ K DV+SFGI +WE+ C P+ +F ++T
Sbjct: 1548 EENA--IMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITM 1605
Query: 283 AVVRQVQ 289
++ V+
Sbjct: 1606 DILEDVR 1612
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 136 bits (342), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 85/245 (34%), Positives = 134/245 (54%), Gaps = 28/245 (11%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTE 91
G S++ +++ EI P ++ + +I G+FG V++G VAVKLL H+
Sbjct: 4 GLGSSYPEERSGPPEIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLL------HKQN 57
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
+ A L SAF +EV + K+ HPN+ F+GA +P C +V E
Sbjct: 58 FDAATL-SAFRKEVHLMSKIYHPNICLFMGAC---------------TIPGR-CVIVTEL 100
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNR 209
+P G L+T L+ +++ +L + +++A D A G+++LH VHRD+K+ N+L+D+N
Sbjct: 101 VPKGNLET-LLHDQKIQLPLYLRMRMARDAALGINWLHESNPVFVHRDIKSSNLLVDENM 159
Query: 210 TVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
VKI DFG++ ++ + D + GT YMAPEV+ +N DVYSFGI LWEI
Sbjct: 160 RVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEVMMFKEFNESSDVYSFGIVLWEILT 219
Query: 268 CDMPY 272
P+
Sbjct: 220 RKEPF 224
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 292 | ||||||
| 449440684 | 379 | PREDICTED: serine/threonine-protein kina | 0.955 | 0.736 | 0.836 | 1e-140 | |
| 225457064 | 381 | PREDICTED: serine/threonine-protein kina | 0.962 | 0.737 | 0.829 | 1e-139 | |
| 147768303 | 381 | hypothetical protein VITISV_010542 [Viti | 0.962 | 0.737 | 0.825 | 1e-139 | |
| 297733801 | 349 | unnamed protein product [Vitis vinifera] | 0.962 | 0.805 | 0.829 | 1e-139 | |
| 356508671 | 386 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.738 | 0.821 | 1e-139 | |
| 255540709 | 393 | protein kinase atmrk1, putative [Ricinus | 0.982 | 0.730 | 0.815 | 1e-139 | |
| 356516684 | 386 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.738 | 0.821 | 1e-138 | |
| 356513267 | 391 | PREDICTED: dual specificity protein kina | 0.979 | 0.731 | 0.815 | 1e-138 | |
| 449446652 | 385 | PREDICTED: serine/threonine-protein kina | 0.842 | 0.638 | 0.930 | 1e-138 | |
| 449489453 | 395 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.842 | 0.622 | 0.930 | 1e-138 |
| >gi|449440684|ref|XP_004138114.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449477402|ref|XP_004155013.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1293), Expect = e-140, Method: Compositional matrix adjust.
Identities = 240/287 (83%), Positives = 256/287 (89%), Gaps = 8/287 (2%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
MEK+KK+ N +T+A A + +T K RQ+WEI+PSKL+IKSVIAR
Sbjct: 33 MEKNKKKDEDTGNSFLTSAPIARSRST--------KVAAKDRQEWEIDPSKLIIKSVIAR 84
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AF QEVAVWHKL+HPNVTKFI
Sbjct: 85 GTFGTVHRGVYDGLDVAVKLLDWGEEGHRTEAEIASLRAAFKQEVAVWHKLEHPNVTKFI 144
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL IQTENG + MPSNICCVVVEYL GGALK+YLIKNRRRKLAFKVVVQLALD
Sbjct: 145 GATMGSAELQIQTENGLIGMPSNICCVVVEYLAGGALKSYLIKNRRRKLAFKVVVQLALD 204
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 205 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 264
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ
Sbjct: 265 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 311
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225457064|ref|XP_002283021.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 500 bits (1288), Expect = e-139, Method: Compositional matrix adjust.
Identities = 238/287 (82%), Positives = 260/287 (90%), Gaps = 6/287 (2%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M+K+KK+ + +++AAA+ A ++ RQDWEI+PSKL+IK+VIAR
Sbjct: 33 MDKNKKKEDD------SSSAAAAIPTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVIAR 86
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFI
Sbjct: 87 GTFGTVHRGVYDGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 146
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL+IQTENG + MPSNICCVVVEYLPGGALK+YLIKNRRRKLAFKVV+QLALD
Sbjct: 147 GATMGSAELNIQTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALD 206
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 207 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 266
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
PEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ
Sbjct: 267 PEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 313
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147768303|emb|CAN64754.1| hypothetical protein VITISV_010542 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1286), Expect = e-139, Method: Compositional matrix adjust.
Identities = 237/287 (82%), Positives = 260/287 (90%), Gaps = 6/287 (2%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M+K+KK+ + +++AAA+ A ++ RQDWEI+PSKL+IK+VJAR
Sbjct: 33 MDKNKKKEDD------SSSAAAAIPTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVJAR 86
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFI
Sbjct: 87 GTFGTVHRGVYDGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 146
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL+IQTENG + MPSNICCVVVEYLPGGALK+YLIKNRRRKLAFKVV+QLALD
Sbjct: 147 GATMGSAELNIQTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALD 206
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 207 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 266
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
PEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ
Sbjct: 267 PEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 313
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733801|emb|CBI15048.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1285), Expect = e-139, Method: Compositional matrix adjust.
Identities = 238/287 (82%), Positives = 260/287 (90%), Gaps = 6/287 (2%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M+K+KK+ + +++AAA+ A ++ RQDWEI+PSKL+IK+VIAR
Sbjct: 1 MDKNKKKEDD------SSSAAAAIPTLAPSTTASTTAPTTARQDWEIDPSKLIIKTVIAR 54
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA+LR+AFTQEVAVWHKLDHPNVTKFI
Sbjct: 55 GTFGTVHRGVYDGQDVAVKLLDWGEEGHRTEAEIASLRAAFTQEVAVWHKLDHPNVTKFI 114
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMGS+EL+IQTENG + MPSNICCVVVEYLPGGALK+YLIKNRRRKLAFKVV+QLALD
Sbjct: 115 GATMGSAELNIQTENGHIGMPSNICCVVVEYLPGGALKSYLIKNRRRKLAFKVVIQLALD 174
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 175 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 234
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
PEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ
Sbjct: 235 PEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 281
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508671|ref|XP_003523078.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1284), Expect = e-139, Method: Compositional matrix adjust.
Identities = 235/286 (82%), Positives = 257/286 (89%), Gaps = 1/286 (0%)
Query: 2 EKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARG 61
+K + SD + ++ A A+ + A+ F KKQRQ+WEI+PS L+IKSVIARG
Sbjct: 34 QKEEDDAGSDHSRHSSSFATATKFKSVAGSAGATTF-KKQRQEWEIDPSNLIIKSVIARG 92
Query: 62 TFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121
TFGTVHRG+YDG DVAVK+LDWGEEGHRTEAEIAALRSAFTQEVAVWHKL+HPNVTKFIG
Sbjct: 93 TFGTVHRGIYDGQDVAVKMLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLEHPNVTKFIG 152
Query: 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDL 181
ATMGSSEL IQT+NG ++MPSNICCVVVEYL GG LK++LIKNRRRKLAFKVV+QLALDL
Sbjct: 153 ATMGSSELQIQTDNGLISMPSNICCVVVEYLAGGTLKSFLIKNRRRKLAFKVVIQLALDL 212
Query: 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 241
ARGLSYLHSQK+VHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMAP
Sbjct: 213 ARGLSYLHSQKVVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 272
Query: 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQ
Sbjct: 273 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQ 318
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540709|ref|XP_002511419.1| protein kinase atmrk1, putative [Ricinus communis] gi|223550534|gb|EEF52021.1| protein kinase atmrk1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1284), Expect = e-139, Method: Compositional matrix adjust.
Identities = 239/293 (81%), Positives = 259/293 (88%), Gaps = 6/293 (2%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKK------QRQDWEIEPSKLVI 54
M+K+K+ N +N++ A SA+ +A + F K RQ+WEI+PSKL+I
Sbjct: 33 MDKNKRADNHHNNLIARPPLAFSADDSAISATTTATFTKTTTALKKDRQEWEIDPSKLII 92
Query: 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
K+VIARGTFGTVHRG+YDG DVAVKLLDWGEEGHRTEAEIA LR+AFTQEV VWHKLDHP
Sbjct: 93 KTVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRTEAEIATLRAAFTQEVVVWHKLDHP 152
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
NVTKFIGATMGSSEL IQTENG + MPSNICCV+VEYLPGGALK+YLIKNRR+KLAFKVV
Sbjct: 153 NVTKFIGATMGSSELQIQTENGYIGMPSNICCVIVEYLPGGALKSYLIKNRRKKLAFKVV 212
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
V+LALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETG
Sbjct: 213 VELALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETG 272
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ
Sbjct: 273 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 325
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516684|ref|XP_003527023.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1283), Expect = e-138, Method: Compositional matrix adjust.
Identities = 235/286 (82%), Positives = 257/286 (89%), Gaps = 1/286 (0%)
Query: 2 EKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARG 61
+K + SD + ++ A A+ + A+ F KKQRQ+WEI+PS L+IKSVIARG
Sbjct: 34 QKEEDDAGSDHSRHSSSFATATKFKSVAGSAGATTF-KKQRQEWEIDPSNLIIKSVIARG 92
Query: 62 TFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121
TFGTVHRG+YDG DVAVK+LDWGEEGHRTEAEIAALRSAFTQEVAVWH+L+HPNVTKFIG
Sbjct: 93 TFGTVHRGIYDGQDVAVKMLDWGEEGHRTEAEIAALRSAFTQEVAVWHRLEHPNVTKFIG 152
Query: 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDL 181
ATMGSSEL IQT+NG ++MPSNICCVVVEYL GG LK++LIKNRRRKLAFKVVVQLALDL
Sbjct: 153 ATMGSSELQIQTDNGLISMPSNICCVVVEYLAGGTLKSFLIKNRRRKLAFKVVVQLALDL 212
Query: 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 241
ARGLSYLHSQK+VHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMAP
Sbjct: 213 ARGLSYLHSQKVVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAP 272
Query: 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQ
Sbjct: 273 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQ 318
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513267|ref|XP_003525335.1| PREDICTED: dual specificity protein kinase zakA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1278), Expect = e-138, Method: Compositional matrix adjust.
Identities = 238/292 (81%), Positives = 256/292 (87%), Gaps = 6/292 (2%)
Query: 1 MEKSKKQRNSDDNILV-----TTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIK 55
+EK K+ +D V TT+A AS + NF KK++QDWEI+PSKL+IK
Sbjct: 33 IEKKKRSEGEEDADHVHLHVHTTSATASPKFSHASSAARVNF-KKKKQDWEIDPSKLIIK 91
Query: 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+VIARGTFGTVHRG+YD DVAVKLLDWGEEG RTEAEIA+LR+AFTQEVAVWHKLDHPN
Sbjct: 92 TVIARGTFGTVHRGVYDTQDVAVKLLDWGEEGQRTEAEIASLRAAFTQEVAVWHKLDHPN 151
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
VTKFIGATMGSSEL IQT+NG + MPSN+CCVVVEYL GG LK YLIKNRRRKLAFKVV+
Sbjct: 152 VTKFIGATMGSSELQIQTDNGLIGMPSNVCCVVVEYLAGGNLKQYLIKNRRRKLAFKVVI 211
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
QLALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGT
Sbjct: 212 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGT 271
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE+TSAVVRQ
Sbjct: 272 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEITSAVVRQ 323
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446652|ref|XP_004141085.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1277), Expect = e-138, Method: Compositional matrix adjust.
Identities = 229/246 (93%), Positives = 242/246 (98%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
RQ+WEI+PSKL+IK+VIARGTFGTVHRG+YDG DVAVKLLDWGEEGHR+EAEIA+LR+AF
Sbjct: 72 RQEWEIDPSKLIIKAVIARGTFGTVHRGVYDGQDVAVKLLDWGEEGHRSEAEIASLRAAF 131
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
TQEVAVWHKLDHPNVTKFIGAT+GSS+LHIQTENGQ+ MPSNICCVVVEY PGGALK+YL
Sbjct: 132 TQEVAVWHKLDHPNVTKFIGATIGSSDLHIQTENGQIGMPSNICCVVVEYCPGGALKSYL 191
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
IKNRR+KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARV
Sbjct: 192 IKNRRKKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARV 251
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT
Sbjct: 252 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 311
Query: 282 SAVVRQ 287
SAVVRQ
Sbjct: 312 SAVVRQ 317
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449489453|ref|XP_004158316.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 496 bits (1276), Expect = e-138, Method: Compositional matrix adjust.
Identities = 229/246 (93%), Positives = 242/246 (98%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
RQ+WEI+PSKL+IK+VIARGTFGTVHRG+YDG DVAVKLLDWGEEGHR+EAEIA+LR+AF
Sbjct: 72 RQEWEIDPSKLIIKAVIARGTFGTVHRGVYDGQDVAVKLLDWGEEGHRSEAEIASLRAAF 131
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
TQEVAVWHKLDHPNVTKFIGAT+GSS+LHIQTENGQ+ MPSNICCVVVEY PGGALK+YL
Sbjct: 132 TQEVAVWHKLDHPNVTKFIGATIGSSDLHIQTENGQIGMPSNICCVVVEYCPGGALKSYL 191
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
IKNRR+KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARV
Sbjct: 192 IKNRRKKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARV 251
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT
Sbjct: 252 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 311
Query: 282 SAVVRQ 287
SAVVRQ
Sbjct: 312 SAVVRQ 317
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 292 | ||||||
| TAIR|locus:2084193 | 411 | AT3G01490 [Arabidopsis thalian | 0.866 | 0.615 | 0.873 | 1.9e-122 | |
| TAIR|locus:2170106 | 385 | AT5G50000 [Arabidopsis thalian | 0.976 | 0.740 | 0.790 | 1.9e-122 | |
| TAIR|locus:2094329 | 378 | AT3G22750 [Arabidopsis thalian | 0.839 | 0.648 | 0.730 | 2.3e-101 | |
| TAIR|locus:2130230 | 364 | AT4G14780 [Arabidopsis thalian | 0.842 | 0.675 | 0.691 | 4.7e-96 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.839 | 0.626 | 0.696 | 1.1e-92 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.472 | 0.252 | 0.458 | 3.6e-43 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.472 | 0.242 | 0.416 | 6.5e-41 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.472 | 0.290 | 0.443 | 3.6e-40 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.441 | 0.362 | 0.446 | 3.5e-36 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.452 | 0.381 | 0.450 | 4.4e-36 |
| TAIR|locus:2084193 AT3G01490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
Identities = 221/253 (87%), Positives = 244/253 (96%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEI 94
S ++K R++WEI+PSKL+IKSVIARGTFGTVHRG+YDG DVAVKLLDWGEEGHR++AEI
Sbjct: 91 STEVEKSRREWEIDPSKLIIKSVIARGTFGTVHRGIYDGQDVAVKLLDWGEEGHRSDAEI 150
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
A+LR+AFTQEVAVWHKLDHPNVTKFIGA MG+SE+ IQTENGQ+ MPSN+CCVVVEY PG
Sbjct: 151 ASLRAAFTQEVAVWHKLDHPNVTKFIGAAMGTSEMSIQTENGQMGMPSNVCCVVVEYCPG 210
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
GALK++LIK RRRKLAFKVV+QL+LDLARGLSYLHSQKIVHRDVKTENMLLDK+RT+KIA
Sbjct: 211 GALKSFLIKTRRRKLAFKVVIQLSLDLARGLSYLHSQKIVHRDVKTENMLLDKSRTLKIA 270
Query: 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
DFGVAR+EASNPNDMTGETGTLGYMAPEVLNG+PYNRKCDVYSFGICLWEIYCCDMPYPD
Sbjct: 271 DFGVARLEASNPNDMTGETGTLGYMAPEVLNGSPYNRKCDVYSFGICLWEIYCCDMPYPD 330
Query: 275 LSFSEVTSAVVRQ 287
LSFSEVTSAVVRQ
Sbjct: 331 LSFSEVTSAVVRQ 343
|
|
| TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
Identities = 227/287 (79%), Positives = 249/287 (86%)
Query: 1 MEKSKKQRNSDDNILVXXXXXXXXXXXXXPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
+EK+KK+ D + G +KQR +WEI+PSKL+IK+V+AR
Sbjct: 33 LEKNKKKDEEDTTAVAIGGSASSSPVTLNGGGFVGK--RKQRLEWEIDPSKLIIKTVLAR 90
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
GTFGTVHRG+YDG DVAVKLLDWGEEGHR+EAEI +LR+ F QEVAVWHKLDHPNVTKFI
Sbjct: 91 GTFGTVHRGIYDGQDVAVKLLDWGEEGHRSEAEIVSLRADFAQEVAVWHKLDHPNVTKFI 150
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180
GATMG+S L +QTE+G +AMP+NICCVVVEYLPGGALK+YLIKNRRRKL FK+VVQLALD
Sbjct: 151 GATMGASGLQLQTESGPLAMPNNICCVVVEYLPGGALKSYLIKNRRRKLTFKIVVQLALD 210
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
LARGLSYLHSQKIVHRDVKTENMLLDK RTVKIADFGVARVEASNPNDMTGETGTLGYMA
Sbjct: 211 LARGLSYLHSQKIVHRDVKTENMLLDKTRTVKIADFGVARVEASNPNDMTGETGTLGYMA 270
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL+FSEVTSAVVRQ
Sbjct: 271 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLTFSEVTSAVVRQ 317
|
|
| TAIR|locus:2094329 AT3G22750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
Identities = 184/252 (73%), Positives = 221/252 (87%)
Query: 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
K +++WEIE +KL +++VIARG +G V++G+YDG DVAVK+LDWGE+G+ T AE +ALR+
Sbjct: 62 KPKEEWEIELAKLEMRNVIARGAYGIVYKGIYDGQDVAVKVLDWGEDGYATTAETSALRA 121
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHI----QTENGQVAMPSNICCVVVEYLPGG 155
+F QEVAVWHKLDHPNVT+F+GA+MG++ L I +TEN ++P CCVVVEY+PGG
Sbjct: 122 SFRQEVAVWHKLDHPNVTRFVGASMGTANLKIPSSAETEN---SLPQRACCVVVEYIPGG 178
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
LK YL +NRR+KLAFKVVVQLALDL+RGLSYLHS++IVHRDVKTENMLLD R +KIAD
Sbjct: 179 TLKQYLFRNRRKKLAFKVVVQLALDLSRGLSYLHSERIVHRDVKTENMLLDYQRNLKIAD 238
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
FGVARVEA NP DMTGETGTLGYMAPEVL+G PYNR+CDVYSFGICLWEIYCCDMPYPDL
Sbjct: 239 FGVARVEAQNPKDMTGETGTLGYMAPEVLDGKPYNRRCDVYSFGICLWEIYCCDMPYPDL 298
Query: 276 SFSEVTSAVVRQ 287
SF++V+SAVVRQ
Sbjct: 299 SFADVSSAVVRQ 310
|
|
| TAIR|locus:2130230 AT4G14780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 4.7e-96, P = 4.7e-96
Identities = 170/246 (69%), Positives = 213/246 (86%)
Query: 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
K +++WEI+ +KL +VIARGT+GTV++G+YDG DVAVK+LDW ++G+ T A+ A R+
Sbjct: 49 KAKEEWEIDLAKLETSNVIARGTYGTVYKGIYDGQDVAVKVLDWEDDGNETTAKTATNRA 108
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F QEV VWHKL+HPNVTKF+GA+MG++ L+I++ + + ++P CCVVVEYLPGG LK
Sbjct: 109 LFRQEVTVWHKLNHPNVTKFVGASMGTTNLNIRSADSKGSLPQQACCVVVEYLPGGTLKQ 168
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+LI+++ +KLAFK V++LALDLARGLSYLHS+KIVHRDVKTENMLLD + +KIADFGVA
Sbjct: 169 HLIRHKSKKLAFKAVIKLALDLARGLSYLHSEKIVHRDVKTENMLLDAQKNLKIADFGVA 228
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
RVEA NP DMTGETGTLGYMAPEV++G PYNR+CDVYSFGICLWEIYCCDMPYPDLSF +
Sbjct: 229 RVEALNPKDMTGETGTLGYMAPEVIDGKPYNRRCDVYSFGICLWEIYCCDMPYPDLSFVD 288
Query: 280 VTSAVV 285
V+SAVV
Sbjct: 289 VSSAVV 294
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
Identities = 174/250 (69%), Positives = 203/250 (81%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
Q+WEI+ SKL +K V+A GT+GTV+RG+Y G +VAVK+LDWGE+G+ T AE ALR++F
Sbjct: 74 QEWEIDLSKLDMKHVLAHGTYGTVYRGVYAGQEVAVKVLDWGEDGYATPAETTALRASFE 133
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN-----GQVAMPSNICCVVVEYLPGGAL 157
QEVAVW KLDHPNVTKFIGA+MG+S+L I G A P+ CCVVVEY+ GG L
Sbjct: 134 QEVAVWQKLDHPNVTKFIGASMGTSDLRIPPAGDTGGRGNGAHPARACCVVVEYVAGGTL 193
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
K +LIK R KL K V+QLALDLARGLSYLHS+ IVHRDVK+ENMLL N+T+KIADFG
Sbjct: 194 KKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLLQPNKTLKIADFG 253
Query: 218 VARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
VARVEA NP DMTGETGTLGYMAPEVL G PYNRKCDVYSFG+CLWEIYCCDMPY D SF
Sbjct: 254 VARVEAQNPQDMTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEIYCCDMPYADCSF 313
Query: 278 SEVTSAVVRQ 287
+E++ AVV +
Sbjct: 314 AEISHAVVHR 323
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 3.6e-43, Sum P(2) = 3.6e-43
Identities = 66/144 (45%), Positives = 100/144 (69%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKV--VVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V E++ G++ +L K +K AFK+ ++++ALD+A+G+SYLH I+HRD+KT N+
Sbjct: 357 CIVTEFMARGSIYDFLHK---QKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANL 413
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+D++ VK+ADFGVARV+ + MT ETGT +MAPEV+ PYN K DV+S+ I LW
Sbjct: 414 LMDEHGLVKVADFGVARVQIES-GVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLW 472
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQ 287
E+ D+PY L+ + VV++
Sbjct: 473 ELLTGDIPYAFLTPLQAAVGVVQK 496
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 315 (115.9 bits), Expect = 6.5e-41, Sum P(2) = 6.5e-41
Identities = 60/144 (41%), Positives = 99/144 (68%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKV--VVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V E++ G++ +L K+ K FK+ ++++ALD+++G++YLH I+HRD+KT N+
Sbjct: 363 CIVTEFMTRGSIYDFLHKH---KGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANL 419
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+D++ VK+ADFGVARV+ + MT ETGT +MAPEV+ PY+ + DV+S+ I LW
Sbjct: 420 LMDEHEVVKVADFGVARVQTES-GVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLW 478
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQ 287
E+ ++PY L+ + VV++
Sbjct: 479 ELLTGELPYSYLTPLQAAVGVVQK 502
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 335 (123.0 bits), Expect = 3.6e-40, Sum P(2) = 3.6e-40
Identities = 63/142 (44%), Positives = 99/142 (69%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C++ EY+P G+L++YL K ++ L + ++ LD+A+G+ Y+HS++IVH+D+K EN+L+
Sbjct: 235 CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLI 294
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
D + +KIADFG+A E D+ G+ GT +MAPEVL P+ RKCDVYSFG+ LWE
Sbjct: 295 DNDFHLKIADFGIACEEEYC--DVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWE 352
Query: 265 IYCCDMPYPDLSFSE-VTSAVV 285
+ +PY ++ F+E + AV+
Sbjct: 353 MVAGALPYEEMKFAEQIAYAVI 374
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 278 (102.9 bits), Expect = 3.5e-36, Sum P(2) = 3.5e-36
Identities = 62/139 (44%), Positives = 86/139 (61%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V E L GG L+ YL+ R ++L ++ V ALD+AR + LHS I+HRD+K EN++L
Sbjct: 100 IVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIARAMECLHSHGIIHRDLKPENLILS 159
Query: 207 KN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN------GNP--YNRKCDVYS 257
+ +TVK+ADFG+AR E S MT ETGT +MAPE+ + G YN K D YS
Sbjct: 160 ADHKTVKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYS 218
Query: 258 FGICLWEIYCCDMPYPDLS 276
F I LWE+ +P+ +S
Sbjct: 219 FAIVLWELILNKLPFEGMS 237
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 278 (102.9 bits), Expect = 4.4e-36, Sum P(2) = 4.4e-36
Identities = 64/142 (45%), Positives = 86/142 (60%)
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+ +V E L GG L+ YL+ R L +V + ALD+ARG+ LHS I+HRD+K EN+
Sbjct: 91 VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIARGMECLHSHGIIHRDLKPENL 150
Query: 204 LLDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN------GNP--YNRKCD 254
LL + +TVK+ADFG+AR E S MT ETGT +MAPE+ + G YN K D
Sbjct: 151 LLTADHKTVKLADFGLAR-EESLTEMMTAETGTYRWMAPELYSTVTLRLGEKKHYNHKVD 209
Query: 255 VYSFGICLWEIYCCDMPYPDLS 276
YSF I LWE+ +P+ +S
Sbjct: 210 AYSFAIVLWELLHNKLPFEGMS 231
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00016112001 | SubName- Full=Chromosome chr17 scaffold_12, whole genome shotgun sequence; (349 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 292 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-62 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-62 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-61 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-60 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-40 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-39 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-37 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-35 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-34 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-33 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-33 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-31 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-31 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-31 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-31 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-30 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-30 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-29 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-29 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-28 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-27 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-27 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-26 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-25 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-24 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-24 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-23 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-22 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-21 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-20 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-17 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-17 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-17 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-16 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-15 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-13 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 8e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 2e-62
Identities = 81/238 (34%), Positives = 116/238 (48%), Gaps = 34/238 (14%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
L + + G FG V++G G VAVK L EG E R F +E
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEE-----REEFLEEA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
++ KL HPN+ + +G L +V EY+PGG L +L +
Sbjct: 53 SIMKKLSHPNIVRLLGVCTQGEPL----------------YIVTEYMPGGDLLDFL-RKH 95
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
KL K ++Q+AL +A+G+ YL S+ VHRD+ N L+ +N VKI+DFG++R +
Sbjct: 96 GEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
Query: 226 PNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280
G L +MAPE L + K DV+SFG+ LWEI+ + PYP +S EV
Sbjct: 156 DYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 213
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 7e-62
Identities = 71/223 (31%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G+FG V+ G VA+K++ + +I R +E+ + KL
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--------KKKIKKDRERILREIKILKKL 54
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ + +L++ V+EY GG L L K R L+
Sbjct: 55 KHPNIVRLYDVFEDEDKLYL----------------VMEYCEGGDLFDLLKKRGR--LSE 96
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ L YLHS+ IVHRD+K EN+LLD++ VK+ADFG+AR + +T
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTT 155
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
GT YMAPEVL G Y + D++S G+ L+E+ P+P
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPG 198
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 2e-61
Identities = 80/241 (33%), Positives = 121/241 (50%), Gaps = 32/241 (13%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
L + + G FG V++G G +VAVK L + +A F +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-------KEDASEQQ-IEEFLREA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ KLDHPN+ K +G L +V+EY+PGG L YL KNR
Sbjct: 53 RIMRKLDHPNIVKLLGVCTEEEPL----------------MIVMEYMPGGDLLDYLRKNR 96
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++L+ ++ AL +ARG+ YL S+ +HRD+ N L+ +N VKI+DFG++R +
Sbjct: 97 PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156
Query: 226 P-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSA 283
+ G + +MAPE L + K DV+SFG+ LWEI+ + PYP +S +EV
Sbjct: 157 DYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY 216
Query: 284 V 284
+
Sbjct: 217 L 217
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (489), Expect = 2e-60
Identities = 79/243 (32%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
L + + G FG V++G G +VAVK L +E +I +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFL----REA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ KLDHPNV K +G L +V+EY+ GG L +YL +
Sbjct: 53 RIMRKLDHPNVVKLLGVCTEEEPL----------------YIVMEYMEGGDLLSYL-RKN 95
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
R KL+ ++ AL +ARG+ YL S+ +HRD+ N L+ +N VKI+DFG++R +
Sbjct: 96 RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 155
Query: 226 P-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSA 283
G + +MAPE L + K DV+SFG+ LWEI+ + PYP +S EV
Sbjct: 156 DYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY 215
Query: 284 VVR 286
+
Sbjct: 216 LKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-59
Identities = 81/239 (33%), Positives = 114/239 (47%), Gaps = 39/239 (16%)
Query: 57 VIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G FG V++G G +VAVK L E E R F +E V KL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEE-----RKDFLKEARVMKKL 53
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------ 165
HPNV + +G L +V+EY+ GG L YL K+R
Sbjct: 54 GHPNVVRLLGVCTEEEPL----------------YLVLEYMEGGDLLDYLRKSRPVFPSP 97
Query: 166 -RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ L+ K ++ A+ +A+G+ YL S+K VHRD+ N L+ ++ VKI+DFG++R
Sbjct: 98 EKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
Query: 225 NPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280
+ G L +MAPE L + K DV+SFG+ LWEI+ PYP LS EV
Sbjct: 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 3e-57
Identities = 72/212 (33%), Positives = 114/212 (53%), Gaps = 29/212 (13%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G FGTV+ G VA+K++ + + ++L +E+ + KL+HPN
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK--------KEDSSSLLEELLREIEILKKLNHPN 52
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K G + EN +V+EY GG+LK +K KL+ ++
Sbjct: 53 IVKLYGV--------FEDENH--------LYLVMEYCEGGSLKDL-LKENEGKLSEDEIL 95
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIADFGVARVEASNPNDMTGETG 234
++ L + GL YLHS I+HRD+K EN+LLD N VK+ADFG++++ S+ + + G
Sbjct: 96 RILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155
Query: 235 TLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
T YMAPEVL G Y+ K D++S G+ L+E+
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 4e-54
Identities = 78/226 (34%), Positives = 115/226 (50%), Gaps = 28/226 (12%)
Query: 52 LVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ + G+FGTV++ G VAVK+L + +E + +E+ +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKIL-------KKRSEKSKKDQTARREIRILR 53
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+L HPN+ + I A L++ V+EY GG L YL + L
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYL----------------VMEYCEGGDLFDYLSRGGP--L 95
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
+ ++AL + RGL YLHS I+HRD+K EN+LLD+N VKIADFG+A+ + + +
Sbjct: 96 SEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL 155
Query: 230 TGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
T GT YMAPEVL GN Y K DV+S G+ L+E+ P+
Sbjct: 156 TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-47
Identities = 72/223 (32%), Positives = 114/223 (51%), Gaps = 27/223 (12%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
++ RG+FG+V+ L G +AVK + E +E E+ AL +E+ + L HP
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSV---ELSGDSEEELEALE----REIRILSSLQHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ ++ G SE + N + +EY+ GG+L + L+K + KL V+
Sbjct: 60 NIVRYYG-----SERDEEK---------NTLNIFLEYVSGGSL-SSLLK-KFGKLPEPVI 103
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET- 233
+ + GL+YLHS IVHRD+K N+L+D + VK+ADFG A+ +
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ G Y R D++S G + E+ P+ +L
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-44
Identities = 69/227 (30%), Positives = 115/227 (50%), Gaps = 31/227 (13%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I I +G FG V++ + G +VA+K++ ++ + + E+ + K
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-----LESKEK----KEKIINEIQILKKC 54
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ K+ G+ + EL I V+E+ GG+LK L+K+ + L
Sbjct: 55 KHPNIVKYYGSYLKKDELWI----------------VMEFCSGGSLKD-LLKSTNQTLTE 97
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMT 230
+ + +L +GL YLHS I+HRD+K N+LL + VK+ DFG++ ++ + +
Sbjct: 98 SQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
GT +MAPEV+NG PY+ K D++S GI E+ PY +L
Sbjct: 158 --VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 7e-40
Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 41/225 (18%)
Query: 51 KLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K I I +G+FG V+ R DG +K +D + +E E EV +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS---NMSEKEREDAL----NEVKIL 53
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
KL+HPN+ K+ + +L I V+EY GG L IK ++++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCI----------------VMEYADGGDLS-QKIKKQKKE 96
Query: 169 LAF-------KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
VQL L L YLHS+KI+HRD+K +N+ L N VK+ DFG+++V
Sbjct: 97 GKPFPEEQILDWFVQLCL----ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152
Query: 222 EASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
S+ D+ +T GT Y++PE+ PYN K D++S G L+E
Sbjct: 153 -LSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYE 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-40
Identities = 77/245 (31%), Positives = 117/245 (47%), Gaps = 34/245 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W I +L + + I +G FG V G Y G VAVK L + T A+ AF E
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCL----KDDSTAAQ------AFLAE 50
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+V L HPN+ + +G + + L+I V EY+ G+L YL
Sbjct: 51 ASVMTTLRHPNLVQLLGVVLQGNPLYI----------------VTEYMAKGSLVDYLRSR 94
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R + + ALD+ G+ YL + VHRD+ N+L+ ++ K++DFG+A+ +
Sbjct: 95 GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154
Query: 225 NPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 281
++G L + APE L ++ K DV+SFGI LWEIY +PYP + +V
Sbjct: 155 GQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
Query: 282 SAVVR 286
V +
Sbjct: 210 PHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-39
Identities = 75/226 (33%), Positives = 115/226 (50%), Gaps = 29/226 (12%)
Query: 58 IARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
I +G FG V++G L +VAVK L+ F QE + + DHPN+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTC--------RSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
K IG + ++I V+E +PGG+L T+L K + R L K ++Q
Sbjct: 55 VKLIGVCVQKQPIYI----------------VMELVPGGSLLTFLRKKKNR-LTVKKLLQ 97
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
++LD A G+ YL S+ +HRD+ N L+ +N +KI+DFG++R E ++ +
Sbjct: 98 MSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157
Query: 237 --GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
+ APE LN Y + DV+S+GI LWE + D PYP +S +
Sbjct: 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-38
Identities = 76/245 (31%), Positives = 122/245 (49%), Gaps = 34/245 (13%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+PS+L + G FG VH G + G DVA+K++ EG +E + F +E
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDD-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HPN+ + G + T+ + +V EY+ G L YL + R
Sbjct: 51 KVMMKLSHPNLVQLYG---------VCTKQRPI-------FIVTEYMANGCLLNYL-RER 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ KL + ++ + D+ + YL S +HRD+ N L+ ++ VK++DFG+AR
Sbjct: 94 KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD- 152
Query: 226 PNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 281
+ T GT + + PEV + + ++ K DV+SFG+ +WE++ MPY S SEV
Sbjct: 153 -DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
Query: 282 SAVVR 286
+V
Sbjct: 212 ESVSA 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 69/223 (30%), Positives = 113/223 (50%), Gaps = 38/223 (17%)
Query: 58 IARGTFGTVHRGLYD------GHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ G FG V YD G VAVK L+ GEE HR++ F +E+ +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---------FEREIEILRT 62
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
LDH N+ K+ G + + G +++EYLP G+L+ YL ++R +
Sbjct: 63 LDHENIVKYKG---------VCEKPGG-----RSLRLIMEYLPSGSLRDYLQRHRDQINL 108
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
K ++ + + +G+ YL SQ+ +HRD+ N+L++ VKI+DFG+A+V + +
Sbjct: 109 -KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 231 ----GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YC 267
GE+ Y APE L + ++ DV+SFG+ L+E+ Y
Sbjct: 168 VKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYG 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-37
Identities = 73/230 (31%), Positives = 111/230 (48%), Gaps = 33/230 (14%)
Query: 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
+ +I RG FG V++GL G VA+K + + + AL+S QE+ +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQIS------LEKIKEEALKS-IMQEIDLL 53
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR- 167
L HPN+ K+IG+ S L+I ++EY G+L+ +IK
Sbjct: 54 KNLKHPNIVKYIGSIETSDSLYI----------------ILEYAENGSLRQ-IIKKFGPF 96
Query: 168 --KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
L V Q+ +GL+YLH Q ++HRD+K N+L K+ VK+ADFGVA
Sbjct: 97 PESLVAVYVYQVL----QGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
D GT +MAPEV+ + + D++S G + E+ + PY DL
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-35
Identities = 75/241 (31%), Positives = 121/241 (50%), Gaps = 32/241 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W + KL + +I G FG V +G Y G VAVK + + ++ A AF +E
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNI---------KCDVTA--QAFLEE 49
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
AV KL H N+ + +G + + L+I V+E + G L +L
Sbjct: 50 TAVMTKLHHKNLVRLLGVILHNG-LYI----------------VMELMSKGNLVNFLRTR 92
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R ++ ++Q +LD+A G+ YL S+K+VHRD+ N+L+ ++ K++DFG+ARV
Sbjct: 93 GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--- 149
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 283
+ + + APE L ++ K DV+S+G+ LWE++ PYP +S EV
Sbjct: 150 GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209
Query: 284 V 284
V
Sbjct: 210 V 210
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 29/228 (12%)
Query: 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
+ I +G+FG V++ + VA+K++D E E EI + QE+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDI----QQEIQF 52
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ P +TK+ G+ + S+L I ++EY GG+ L +
Sbjct: 53 LSQCRSPYITKYYGSFLKGSKLWI----------------IMEYCGGGSCLDLL---KPG 93
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
KL + + ++ GL YLH + +HRD+K N+LL + VK+ADFGV+ S +
Sbjct: 94 KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ + Y+ K D++S GI E+ + P DL
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 72/247 (29%), Positives = 122/247 (49%), Gaps = 44/247 (17%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFT 102
WE+E + + +K + G +G V+ G++ + VAVK L E+ E F
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEE--------FL 50
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E AV ++ HPN+ + +G +I + E++ G L YL
Sbjct: 51 KEAAVMKEIKHPNLVQLLGVCTREPPFYI----------------ITEFMTYGNLLDYLR 94
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ R+++ V++ +A ++ + YL + +HRD+ N L+ +N VK+ADFG++R+
Sbjct: 95 ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL- 153
Query: 223 ASNPNDMTGETGT--------LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYP 273
MTG+T T + + APE L N ++ K DV++FG+ LWEI M PYP
Sbjct: 154 ------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207
Query: 274 DLSFSEV 280
+ S+V
Sbjct: 208 GIDLSQV 214
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 69/250 (27%), Positives = 115/250 (46%), Gaps = 34/250 (13%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
S L V+ +G+ G V++ + G A+K + R +E+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--------HVDGDEEFRKQLLRELKT 52
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ P V K GA + G++ +V+EY+ GG+L L+K +
Sbjct: 53 LRSCESPYVVKCYGAFY---------KEGEI-------SIVLEYMDGGSLAD-LLK-KVG 94
Query: 168 KLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARV-EASN 225
K+ V+ +A + +GL YLH++ I+HRD+K N+L++ VKIADFG+++V E +
Sbjct: 95 KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL---SFSEVTS 282
T GT+ YM+PE + G Y+ D++S G+ L E P+ SF E+
Sbjct: 155 DQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213
Query: 283 AVVRQVQYLL 292
A+ L
Sbjct: 214 AICDGPPPSL 223
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 76/260 (29%), Positives = 123/260 (47%), Gaps = 46/260 (17%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAAL 97
WE+ K+ + + +G+FG V+ GL G VA+K ++ E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--------ENASMRE 52
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
R F E +V + + +V + +G GQ + VV+E + G L
Sbjct: 53 RIEFLNEASVMKEFNCHHVVRLLGVV----------STGQPTL------VVMELMAKGDL 96
Query: 158 KTYLIKNRRRKLAFKVVV---------QLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
K+YL ++RR + + Q+A ++A G++YL ++K VHRD+ N ++ ++
Sbjct: 97 KSYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED 155
Query: 209 RTVKIADFGVAR-VEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEI 265
TVKI DFG+ R + ++ G+ G L +MAPE L + K DV+SFG+ LWE+
Sbjct: 156 LTVKIGDFGMTRDIYETDYYRKGGK-GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
Query: 266 YC-CDMPYPDLSFSEVTSAV 284
+ PY LS EV V
Sbjct: 215 ATLAEQPYQGLSNEEVLKFV 234
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-34
Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 36/234 (15%)
Query: 58 IARGTFGTVHRGLY---DGH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G FG+V +G+Y G +VAVK L + IAA + F +E +V +LD
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
HP + + IG G +V+E P G L YL K R ++
Sbjct: 55 HPCIVRLIGVCKGEP-----------------LMLVMELAPLGPLLKYLKKRR--EIPVS 95
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ +LA +A G++YL S+ VHRD+ N+LL KI+DFG++R + +
Sbjct: 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 233 TG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTS 282
T L + APE +N ++ K DV+S+G+ LWE + PY ++ +EV +
Sbjct: 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-33
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 27/222 (12%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + I +G+FG V + + D A+K +D + R E A+ E V KL
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE--AID-----EARVLAKL 56
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
D + ++ + + +L +V+EY G L L R R L
Sbjct: 57 DSSYIIRYYESFLDKGKL----------------NIVMEYAENGDLHKLLKMQRGRPLPE 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
V + + + GL++LHS+KI+HRD+K+ N+ LD VKI D GVA++ + N N
Sbjct: 101 DQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
GT Y++PE+ PYN K DV++ G+ L+E CC +P
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE--CCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 35/215 (16%)
Query: 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I G G V++ G +VA+K + ++ + E+ + H
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN----------KELIINEILIMKDCKH 74
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ + + + EL VV+EY+ GG+L T +I ++
Sbjct: 75 PNIVDYYDSYLVGDELW----------------VVMEYMDGGSL-TDIITQNFVRMNEPQ 117
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA---RVEASNPNDMT 230
+ + ++ +GL YLHSQ ++HRD+K++N+LL K+ +VK+ADFG A E S N +
Sbjct: 118 IAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV- 176
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
GT +MAPEV+ Y K D++S GI E+
Sbjct: 177 --VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 75/239 (31%), Positives = 122/239 (51%), Gaps = 34/239 (14%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I PS+L + I G FG V G + VA+K + EG +E + F +E
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEED-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HP + + G + TE + C+V E++ G L YL + +
Sbjct: 51 QVMMKLSHPKLVQLYG---------VCTERSPI-------CLVFEFMEHGCLSDYL-RAQ 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
R K + + ++ + LD+ G++YL S ++HRD+ N L+ +N+ VK++DFG+ R
Sbjct: 94 RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD- 152
Query: 226 PNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280
+ T TGT + + +PEV + + Y+ K DV+SFG+ +WE++ PY + S SEV
Sbjct: 153 -DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 3e-33
Identities = 74/251 (29%), Positives = 116/251 (46%), Gaps = 37/251 (14%)
Query: 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I + G+FG V+ D VA+K+L + + F +E+ + L+H
Sbjct: 4 ILRKLGEGSFGEVYLA-RDRKLVALKVL------AKKLESKSKEVERFLREIQILASLNH 56
Query: 114 P-NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF- 171
P N+ K Q E +V+EY+ GG+L+ L+K RK
Sbjct: 57 PPNIVKLYD--------FFQDEGS--------LYLVMEYVDGGSLE-DLLKKIGRKGPLS 99
Query: 172 -KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-VKIADFGVARV------EA 223
+ + + L YLHS+ I+HRD+K EN+LLD++ VK+ DFG+A++ +
Sbjct: 100 ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159
Query: 224 SNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
S P + GT GYMAPEVL G + D++S GI L+E+ P+ S
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 281 TSAVVRQVQYL 291
TS ++ + L
Sbjct: 220 TSQTLKIILEL 230
|
Length = 384 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 64/229 (27%), Positives = 123/229 (53%), Gaps = 26/229 (11%)
Query: 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
++I G+FG+V+ G+ G +AVK ++ ++ ++ A +E+A+ +L H
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ +++G+++ + L+I +EY+PGG++ L N +
Sbjct: 66 ENIVQYLGSSLDADHLNI----------------FLEYVPGGSVAALL--NNYGAFEETL 107
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGE 232
V + +GL+YLH++ I+HRD+K N+L+D +KI+DFG++ ++EA++ + T
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167
Query: 233 T-----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
G++ +MAPEV+ Y RK D++S G + E+ P+PD +
Sbjct: 168 ARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-33
Identities = 73/212 (34%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GTFG V+ L G +AVK + + +T EIA E+ V L HPN
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-------DEMKVLELLKHPN 60
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K+ G ++ +V + +EY GG L+ L R L V+
Sbjct: 61 LVKYYG---------VEVHREKV-------YIFMEYCSGGTLEELL--EHGRILDEHVIR 102
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE--- 232
L L GL+YLHS IVHRD+K N+ LD N +K+ DFG A V+ N GE
Sbjct: 103 VYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA-VKLKNNTTTMGEEVQ 161
Query: 233 --TGTLGYMAPEVLNGNP---YNRKCDVYSFG 259
GT YMAPEV+ G + R D++S G
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLG 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 77/256 (30%), Positives = 114/256 (44%), Gaps = 53/256 (20%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
WE+ +L + + G FG V + G D VAVK+L + TE +++ L
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDL 62
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
S E+ + + H N+ +G L+ VVVEY G
Sbjct: 63 VS----EMEMMKMIGKHKNIINLLGVCTQEGPLY----------------VVVEYAAHGN 102
Query: 157 LKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
L+ +L R L K +V A +ARG+ +L S+K +HRD+ N
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGY--MAPEVLNGNPYNRKCDVYSF 258
+L+ ++ +KIADFG+AR + D +T G L MAPE L Y + DV+SF
Sbjct: 163 VLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220
Query: 259 GICLWEIYCC-DMPYP 273
G+ LWEI+ PYP
Sbjct: 221 GVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-32
Identities = 63/183 (34%), Positives = 94/183 (51%), Gaps = 33/183 (18%)
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
A +E+ + +L+HP++ + +GAT S ++ VE++ GG++
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNL----------------FVEWMAGGSVSH 92
Query: 160 YLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTVKIADF 216
L K AFK V++ L RGLSYLH +I+HRDVK N+L+D + ++IADF
Sbjct: 93 LLSKYG----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF 148
Query: 217 GVARVEASNPNDMTGE-------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269
G A A+ TG GT+ +MAPEVL G Y R CDV+S G + E+
Sbjct: 149 GAAARLAA---KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
Query: 270 MPY 272
P+
Sbjct: 206 PPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ GT+G V++ G VA+K LD EEG ALR E+++ +L H
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----IPSTALR-----EISLLKELKH 57
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ K L + ++ + V EY LK YL R L+ +
Sbjct: 58 PNIVKL---------LDVIHTERKLYL-------VFEYCDMD-LKKYL-DKRPGPLSPNL 99
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+ + L RGL+Y HS +I+HRD+K +N+L++++ +K+ADFG+AR T E
Sbjct: 100 IKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TL Y APE+L G YS + +W + C
Sbjct: 160 VTLWYRAPEILLG------SKHYSTAVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-32
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
V+ RG FG VH R D V +K + E R A E V L HP
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIP-------VEQMTKDERLAAQNECQVLKLLSHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ ++ + L I V+EY PGG L Y+ K L +
Sbjct: 60 NIIEYYENFLEDKALMI----------------VMEYAPGGTLAEYIQKRCNSLLDEDTI 103
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIADFGVARVEASNPNDMTGET 233
+ + + L ++H++ I+HRD+KT+N+LLDK++ V KI DFG++++ +S T
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VV 162
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
GT Y++PE+ G PYN+K D+++ G L+E+
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-32
Identities = 76/247 (30%), Positives = 114/247 (46%), Gaps = 33/247 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L ++ + G FG V G ++G VAVK L + G + AF Q
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPE-------AFLQ 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL H + + ++I V EY+ G+L +L
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYI----------------VTEYMSKGSLLDFLKS 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+KL +V +A +A G++YL S+ +HRD+ N+L+ +N KIADFG+AR+
Sbjct: 95 GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279
++ T G + + APE N + K DV+SFGI L EI +PYP ++ E
Sbjct: 155 D--DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212
Query: 280 VTSAVVR 286
V V R
Sbjct: 213 VLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 38/228 (16%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G++G+V++ ++ G VA+K++ E+ EI+ L+ +
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILK-----------QC 55
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA- 170
D P + K+ G+ +++L I V+EY G++ ++K + L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWI----------------VMEYCGAGSVSD-IMKITNKTLTE 98
Query: 171 --FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
++ L +GL YLHS K +HRD+K N+LL++ K+ADFGV+ + ++
Sbjct: 99 EEIAAILYQTL---KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMA 154
Query: 229 MTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ YN K D++S GI E+ PY D+
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 72/233 (30%), Positives = 117/233 (50%), Gaps = 28/233 (12%)
Query: 57 VIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
++ +G FG V +G L D VAVK E L+ F E + + DHPN
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTC--------KEDLPQELKIKFLSEARILKQYDHPN 53
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K IG ++I V+E +PGG ++L + ++ +L K +V
Sbjct: 54 IVKLIGVCTQRQPIYI----------------VMELVPGGDFLSFL-RKKKDELKTKQLV 96
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG-ETG 234
+ ALD A G++YL S+ +HRD+ N L+ +N +KI+DFG++R E +G +
Sbjct: 97 KFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVR 286
+ + APE LN Y+ + DV+S+GI LWE + + PYP ++ + V +
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 69/245 (28%), Positives = 118/245 (48%), Gaps = 34/245 (13%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+P L + G FG V G + G +DVA+K++ +EG +E E F +E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDE-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL H + + G ++I V EY+ G L YL +
Sbjct: 51 KVMMKLSHEKLVQLYGVCTKQRPIYI----------------VTEYMSNGCLLNYL-REH 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++ ++++ D+ G++YL S++ +HRD+ N L+D VK++DFG++R
Sbjct: 94 GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD- 152
Query: 226 PNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVT 281
++ T G+ + + PEVL + ++ K DV++FG+ +WE+Y MPY + SE
Sbjct: 153 -DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211
Query: 282 SAVVR 286
V +
Sbjct: 212 EKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-31
Identities = 77/243 (31%), Positives = 118/243 (48%), Gaps = 34/243 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W + +L + I +G FG V G Y G+ VAVK + + A+ AF E
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-----NDATAQ------AFLAE 49
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+V +L H N+ + +G I E G + +V EY+ G+L YL
Sbjct: 50 ASVMTQLRHSNLVQLLGV--------IVEEKGGLY-------IVTEYMAKGSLVDYLRSR 94
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R L +++ +LD+ + YL + VHRD+ N+L+ ++ K++DFG+ + EAS
Sbjct: 95 GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 153
Query: 225 NPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVT 281
+ D TG L + APE L ++ K DV+SFGI LWEIY +PYP + +V
Sbjct: 154 STQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
Query: 282 SAV 284
V
Sbjct: 210 PRV 212
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 72/231 (31%), Positives = 110/231 (47%), Gaps = 39/231 (16%)
Query: 48 EPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
E L + +G FG+V YD G VAVK L H LR F
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--------LRD-F 52
Query: 102 TQEVAVWHKLDHPNVTKFIGA--TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
+E+ + L H N+ K+ G + G L + V+EYLP G+L+
Sbjct: 53 EREIEILKSLQHDNIVKYKGVCYSAGRRNLRL----------------VMEYLPYGSLRD 96
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
YL K+R R L + ++ A + +G+ YL S++ VHRD+ T N+L++ VKI DFG+
Sbjct: 97 YLQKHRER-LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
Query: 220 RVEASNPNDMT----GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+V + GE+ Y APE L + ++ DV+SFG+ L+E++
Sbjct: 156 KVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 34/228 (14%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRS 99
+EI+ + + I G FG V++G+Y + VAVK + ++R
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-------KNCTS-PSVRE 52
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F QE + + DHP++ K IG + TEN P I V+E P G L++
Sbjct: 53 KFLQEAYIMRQFDHPHIVKLIG---------VITEN-----PVWI---VMELAPLGELRS 95
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
YL N+ L ++ + L+ L+YL S++ VHRD+ N+L+ VK+ DFG++
Sbjct: 96 YLQVNKYS-LDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
Query: 220 RVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
R + + G L +MAPE +N + DV+ FG+C+WEI
Sbjct: 155 RY-LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 78/259 (30%), Positives = 113/259 (43%), Gaps = 42/259 (16%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAALR 98
E+ + + + G FG V+ GLY G D VAVK L E+
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--------PESCSEQDE 53
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
S F E + K +H N+ + IG V+ +++E + GG LK
Sbjct: 54 SDFLMEALIMSKFNHQNIVRLIG----------------VSFERLPRFILLELMAGGDLK 97
Query: 159 TYLIKNRRR-----KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD---KNRT 210
++L +NR R L K ++ A D+A+G YL +HRD+ N LL R
Sbjct: 98 SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157
Query: 211 VKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
KIADFG+AR + ++ G + +M PE + K DV+SFG+ LWEI+
Sbjct: 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 269 D-MPYPDLSFSEVTSAVVR 286
MPYP + EV V
Sbjct: 218 GYMPYPGRTNQEVMEFVTG 236
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 22/163 (13%)
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E + +++HP + K LH QTE +V+EY PGG L ++L
Sbjct: 43 ERNILSRINHPFIVK----------LHYAFQTEEK--------LYLVLEYAPGGELFSHL 84
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
++ + + + A ++ L YLHS I++RD+K EN+LLD + +K+ DFG+A+
Sbjct: 85 --SKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKE 142
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
+S + GT Y+APEVL G Y + D +S G+ L+E
Sbjct: 143 LSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-30
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 28/224 (12%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G+FG+V+ G L DG AVK + ++G + + L QE+A+ KL HPN
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE----QEIALLSKLQHPN 63
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ +++G L + +E +PGG+L L ++ + V+
Sbjct: 64 IVQYLGTEREEDNL----------------YIFLELVPGGSLAKLL---KKYGSFPEPVI 104
Query: 176 QL-ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+L + GL YLH + VHRD+K N+L+D N VK+ADFG+A+ + G
Sbjct: 105 RLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF-SFAKSFKG 163
Query: 235 TLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
+ +MAPEV+ Y D++S G + E+ P+ L
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 72/245 (29%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI+ + + + + G FG V GL++ VAVK L G F
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG----------TMDPKDFLA 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL HP + + ++I V E + G+L YL
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYI----------------VTELMKYGSLLEYLQG 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
R L ++ +A +A G++YL +Q +HRD+ N+L+ +N K+ADFG+ARV
Sbjct: 95 GAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279
+ G + + APE N ++ K DV+SFGI L EI MPYP ++ +E
Sbjct: 155 E--DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
Query: 280 VTSAV 284
V V
Sbjct: 213 VLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I +G+FGTV R DG + K +D+G + TE E + EV + +L
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG---NMTEKE----KQQLVSEVNILREL 56
Query: 112 DHPNVTKFIG--ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR-- 167
HPN+ ++ + L+I V+EY GG L LI+ ++
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYI----------------VMEYCEGGDLAQ-LIQKCKKER 99
Query: 168 -KLAFKVVVQLALDLARGLSYLH-----SQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ + + ++ L L H ++HRD+K N+ LD N VK+ DFG+A++
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+ + GT YM+PE LN Y+ K D++S G ++E+
Sbjct: 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-30
Identities = 66/230 (28%), Positives = 110/230 (47%), Gaps = 41/230 (17%)
Query: 58 IARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ +G FG V+ YD G ++AVK + + + T+ E+ AL E+ + L H
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALE----CEIQLLKNLQHE 64
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY------LIKNRRRK 168
+ ++ G ++ + + +EY+PGG++K L + RK
Sbjct: 65 RIVQYYGC---------LRDDETL-------SIFMEYMPGGSVKDQLKAYGALTETVTRK 108
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEA--SN 225
+++ G+ YLHS IVHRD+K N+L D VK+ DFG + R++ S+
Sbjct: 109 YTRQIL--------EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
M TGT +M+PEV++G Y RK DV+S G + E+ P+ +
Sbjct: 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-30
Identities = 70/242 (28%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGH-RTEAEIAALRSAFTQEV 105
L + ++ G FG+V G D VAVK + + H +E E F E
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL--DIHTYSEIE------EFLSEA 52
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
A DHPNV K IG +S L ++ P V++ ++ G L ++L+ +R
Sbjct: 53 ACMKDFDHPNVMKLIGVCFEASSL------QKIPKP----MVILPFMKHGDLHSFLLYSR 102
Query: 166 RRKLAFKVVVQ----LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
L K+ +Q +D+A G+ YL ++ +HRD+ N +L ++ TV +ADFG+++
Sbjct: 103 LGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 222 EASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFS 278
S G + ++A E L Y K DV++FG+ +WEI PYP +
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
Query: 279 EV 280
E+
Sbjct: 223 EI 224
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 66/243 (27%), Positives = 111/243 (45%), Gaps = 34/243 (13%)
Query: 58 IARGTFGTVHRGLYD---GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G+FG V RG + G VAVK L +++ +++ + F +E A+ H LD
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-------KSD-KLSDIMDDFLKEAAIMHSLD 54
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H N+ + G + M +V E P G+L L K+
Sbjct: 55 HENLIRLYGVVLTHP-----------LM------MVTELAPLGSLLDRLRKDALGHFLIS 97
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ A+ +A G+ YL S++ +HRD+ N+LL + VKI DFG+ R N + E
Sbjct: 98 TLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
Query: 233 TGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQV 288
+ APE L ++ DV+ FG+ LWE++ + P+ LS S++ + ++
Sbjct: 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217
Query: 289 QYL 291
+ L
Sbjct: 218 ERL 220
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-29
Identities = 73/242 (30%), Positives = 116/242 (47%), Gaps = 39/242 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWG----EEGHRTEAEIAALRSAFTQEVAV 107
+ + +G++G+V++ L D A+K +D G +E EI L S
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILAS-------- 55
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
++HPN+ + A + N C+V+EY P G L + K +++
Sbjct: 56 ---VNHPNIISYKEAFL----------------DGNKLCIVMEYAPFGDLSKAISKRKKK 96
Query: 168 KLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ + ++ + L RGL LH QKI+HRD+K+ N+LL N VKI D G+++V N
Sbjct: 97 RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156
Query: 226 PNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
M + GT YMAPEV G PY+ K D++S G L+E+ P+ S ++ V
Sbjct: 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
Query: 285 VR 286
R
Sbjct: 214 QR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-29
Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 57 VIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
VI +G FG V+ G D AVK L+ + E F +E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--------FLKEGIIMKDF 53
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPNV +G + S + VV+ Y+ G L+ + I++
Sbjct: 54 SHPNVLSLLGICLPSEGSPL---------------VVLPYMKHGDLRNF-IRSETHNPTV 97
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR----VEASNPN 227
K ++ L +A+G+ YL S+K VHRD+ N +LD++ TVK+ADFG+AR E + +
Sbjct: 98 KDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVT 281
+ TG + +MA E L + K DV+SFG+ LWE+ PYPD+ ++T
Sbjct: 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-29
Identities = 71/243 (29%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I PS+L + G FG VH G + VA+K ++ EG +E + F +E
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEED-------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HP + + G L+I V E++ G L YL + R
Sbjct: 51 KVMMKLSHPKLVQLYGVCTQQKPLYI----------------VTEFMENGCLLNYL-RQR 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEAS 224
+ KL+ +++ + D+ G+ YL +HRD+ N L+ VK++DFG+ R V
Sbjct: 94 QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283
+G + + PEV N + Y+ K DV+SFG+ +WE++ MP+ S EV
Sbjct: 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213
Query: 284 VVR 286
+ R
Sbjct: 214 ISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 63/173 (36%), Positives = 94/173 (54%), Gaps = 18/173 (10%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E+ + P + K+ GA + S I +AM EY GG+L +
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIG-----IAM---------EYCEGGSLDSIYK 93
Query: 163 KNRRR--KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
K ++R ++ KV+ ++A + +GLSYLHS+KI+HRD+K N+LL + VK+ DFGV+
Sbjct: 94 KVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
E N T TGT YMAPE + G PY+ DV+S G+ L E+ P+P
Sbjct: 154 -ELVNSLAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 61/246 (24%), Positives = 115/246 (46%), Gaps = 35/246 (14%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
++L V+ G FGTV++G++ +G VA+K+L E
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--------EETSPKANKEILD 58
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V +DHP+V + +G + S ++ + +P G L Y+ +
Sbjct: 59 EAYVMASVDHPHVVRLLGICLSSQ-----------------VQLITQLMPLGCLLDYV-R 100
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
N + + + ++ + +A+G+SYL +++VHRD+ N+L+ + VKI DFG+A++
Sbjct: 101 NHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 224 SNPNDMTGETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEV 280
+ + E G + +MA E + Y K DV+S+G+ +WE+ PY + E+
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
Query: 281 TSAVVR 286
+ +
Sbjct: 221 PDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 78/249 (31%), Positives = 114/249 (45%), Gaps = 47/249 (18%)
Query: 58 IARGTFGTVHRG-----LYDGHD---VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ G FG V+ G L G VAVK L G T+ E + F +E +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQE----KKEFLKEAHLMS 54
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK- 168
+HPN+ K +G + + +I ++E + GG L +YL R +
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYI----------------IMELMEGGDLLSYLRDARVERF 98
Query: 169 ----LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVA 219
L K ++ + LD+A+G YL +HRD+ N L+ D +R VKI DFG+A
Sbjct: 99 GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
Query: 220 R-VEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
R + S+ GE G L +MAPE L + + DV+SFG+ +WEI PYP L
Sbjct: 159 RDIYKSDYYRKEGE-GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217
Query: 276 SFSEVTSAV 284
+ EV V
Sbjct: 218 NNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-28
Identities = 72/239 (30%), Positives = 112/239 (46%), Gaps = 30/239 (12%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I RG FG V G D VAVK E L++ F QE + + HPN
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC--------RETLPPDLKAKFLQEARILKQYSHPN 54
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + IG ++I V+E + GG T+L + +L K ++
Sbjct: 55 IVRLIGVCTQKQPIYI----------------VMELVQGGDFLTFL-RTEGPRLKVKELI 97
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG--ET 233
Q+ + A G+ YL S+ +HRD+ N L+ + +KI+DFG++R E TG +
Sbjct: 98 QMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQVQYL 291
+ + APE LN Y+ + DV+SFGI LWE + +PY +LS + A+ + V+
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP 216
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 63/225 (28%), Positives = 116/225 (51%), Gaps = 33/225 (14%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH- 113
+I RG +G V+RG + G VA+K+++ + +++ ++ +EVA+ +L
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQ----REVALLSQLRQS 59
Query: 114 --PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
PN+TK+ G+ + L +++EY GG+++T + + +A
Sbjct: 60 QPPNITKYYGSYLKGPRL----------------WIIMEYAEGGSVRTLM---KAGPIAE 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
K + + ++ L Y+H ++HRD+K N+L+ VK+ DFGVA + N + +
Sbjct: 101 KYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
Query: 232 ETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV G Y+ K D++S GI ++E+ + PY D+
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 63/248 (25%), Positives = 99/248 (39%), Gaps = 59/248 (23%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLD----WGEEGHRTEAEIAALRSAFTQEVAV 107
+I G+F TV + A+K+LD E + + E V
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE---KKVKYV-------KIEKEV 54
Query: 108 WHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
+L+ HP + K L+ V+EY P G L Y+ +
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYF----------------VLEYAPNGELLQYI--RKY 96
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP 226
L K A ++ L YLHS+ I+HRD+K EN+LLDK+ +KI DFG A+V +P
Sbjct: 97 GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL--DP 154
Query: 227 NDMTGET----------------------GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
N GT Y++PE+LN P + D+++ G +++
Sbjct: 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQ 214
Query: 265 IYCCDMPY 272
+ P+
Sbjct: 215 MLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 33/246 (13%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
I+PS + I+ VI G FG V RG DVA+K L G ++ + R F
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQ----RLDF 52
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + DHPN+ + G S + I + EY+ G+L +L
Sbjct: 53 LTEASIMGQFDHPNIIRLEGVVTKSRPVMI----------------ITEYMENGSLDKFL 96
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ K +V + +A G+ YL VHRD+ N+L++ N K++DFG++R
Sbjct: 97 -RENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155
Query: 222 -EASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278
E S T G + + APE + + DV+SFGI +WE+ + PY D+S
Sbjct: 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ 215
Query: 279 EVTSAV 284
+V AV
Sbjct: 216 DVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 71/231 (30%), Positives = 107/231 (46%), Gaps = 50/231 (21%)
Query: 56 SVIARGTFGTV----HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G G V HR G +AVK + E A++ +E+ + HK
Sbjct: 7 GELGAGNSGVVSKVLHRP--TGKIMAVKTI------RLEINE--AIQKQILRELDILHKC 56
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR---- 167
+ P + F GA NG + +IC +EY+ GG+L L + + R
Sbjct: 57 NSPYIVGFYGAFY---------NNGDI----SIC---MEYMDGGSLDKILKEVQGRIPER 100
Query: 168 ---KLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
K+A V+ +GL+YLH + KI+HRDVK N+L++ +K+ DFGV+
Sbjct: 101 ILGKIAVAVL--------KGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152
Query: 224 SNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
N + GT YMAPE + GN Y+ K D++S G+ L E+ PYP
Sbjct: 153 ---NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 72/232 (31%), Positives = 117/232 (50%), Gaps = 32/232 (13%)
Query: 48 EPSKLVIK-SVIARGTFGTVHRGLYDGHD---VAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+P +L K I +G+FG V++G+ D VA+K++D E E EI ++ Q
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEE----AEDEIEDIQ----Q 51
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ V + D P +T++ G+ + ++L I ++EYL GG+ L
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWI----------------IMEYLGGGSALDLL-- 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ L + + ++ +GL YLHS++ +HRD+K N+LL + VK+ADFGVA
Sbjct: 94 -KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ + Y+ K D++S GI E+ + P DL
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 69/241 (28%), Positives = 120/241 (49%), Gaps = 29/241 (12%)
Query: 57 VIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
++ +G FG+V D VAVK+L + + ++ F +E A +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML-------KADIFSSSDIEEFLREAACMKEF 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK--- 168
DHPNV K IG ++ S G++ +P V++ ++ G L T+L+ +R +
Sbjct: 59 DHPNVIKLIGVSLRSRA------KGRLPIP----MVILPFMKHGDLHTFLLMSRIGEEPF 108
Query: 169 -LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
L + +V+ +D+A G+ YL S+ +HRD+ N +L++N TV +ADFG+++ S
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168
Query: 228 DMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284
G L ++A E L N Y DV++FG+ +WEI PY + SE+ + +
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
Query: 285 V 285
+
Sbjct: 229 I 229
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD- 112
I G +GTV++ L G VA+K + EEG ++ LR E+A+ +L+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG----IPLSTLR-----EIALLKQLES 57
Query: 113 --HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
HPN+ + + G +T+ +V E++ L TYL K + L
Sbjct: 58 FEHPNIVRLLDVCHGP-----RTDRELKLT------LVFEHVDQD-LATYLSKCPKPGLP 105
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + L L RG+ +LHS +IVHRD+K +N+L+ + VKIADFG+AR+ S +T
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI-YSFEMALT 164
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TL Y APEVL + Y D++S G E++
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 61/241 (25%)
Query: 54 IKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGE------EGHRTEAEIAALRSAFTQEV 105
+ G+FG V + G A+K+L + H E L+S
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-VLNEKRILQS------ 57
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ HP + G+ S L++ V+EY+PGG L ++L K+
Sbjct: 58 -----IRHPFLVNLYGSFQDDSNLYL----------------VMEYVPGGELFSHLRKSG 96
Query: 166 R------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
R R A +VV LAL+ YLHS IV+RD+K EN+LLD + +KI DFG A
Sbjct: 97 RFPEPVARFYAAQVV--LALE------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA 148
Query: 220 RVEASNPNDMTGET----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ T GT Y+APE++ Y + D ++ GI ++E+ P+ D
Sbjct: 149 KRVKGR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201
Query: 276 S 276
+
Sbjct: 202 N 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-27
Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 28/224 (12%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I+ I +G F V++ L DG VA+K + E A R +E+ + +L
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQI------FEMMDAKARQDCLKEIDLLKQL 59
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRK 168
DHPNV K++ + + ++EL+I V+E G L +IK+ ++R
Sbjct: 60 DHPNVIKYLASFIENNELNI----------------VLELADAGDLSR-MIKHFKKQKRL 102
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
+ + + + + L L ++HS++I+HRD+K N+ + VK+ D G+ R +S
Sbjct: 103 IPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT YM+PE ++ N YN K D++S G L+E+ P+
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-27
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 43/233 (18%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ I GT+G V+ R + G VA+K+ L+ G++ + EI+ L+
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC--------- 57
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--- 166
HPN+ + G+ + +L I V+EY GG+L+ R
Sbjct: 58 --RHPNIVAYFGSYLRRDKLWI----------------VMEYCGGGSLQDIYQVTRGPLS 99
Query: 167 -RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++A+ V + L +GL+YLH +HRD+K N+LL ++ VK+ADFGV+ +
Sbjct: 100 ELQIAY--VCRETL---KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154
Query: 226 PNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV Y+ KCD+++ GI E+ P DL
Sbjct: 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-27
Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 35/242 (14%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAAL 97
WE + L + G FG V G VAVK+L H +E E
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSERE---- 83
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
A E+ + L +H N+ +GA + + TE CC G
Sbjct: 84 --ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE---------YCCY-------GD 125
Query: 157 LKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
L +L + R L + ++ + +A+G+++L S+ +HRD+ N+LL + VKI DF
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185
Query: 217 GVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYP 273
G+AR ++ N + L +MAPE + Y + DV+S+GI LWEI+ PYP
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245
Query: 274 DL 275
+
Sbjct: 246 GM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEA--EIAALRSAFTQEVAVWHKL 111
I GT+G V+ R G VA+K L + EG A EI L+ +L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLK-----------EL 55
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+HPN+ K + +L++ E M +++ LIK+R+R L
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFE----FMDTDLY--------------KLIKDRQRGLPE 97
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
++ L +GL++ HS I+HRD+K EN+L++ +K+ADFG+AR S T
Sbjct: 98 SLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T Y APE+L G YS + +W + C
Sbjct: 158 YVVTRWYRAPELLLG------DKGYSTPVDIWSVGC 187
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 65/217 (29%), Positives = 97/217 (44%), Gaps = 35/217 (16%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V++ G VA+K + E + I A+R E+ + KL HPN
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIR-----EIKLLQKLRHPN 59
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP----GGALKTYLIKNRRRKLAF 171
+ + E+ G + M V EY+ G L+ + K
Sbjct: 60 IVRLK-------EIVTSKGKGSIYM-------VFEYMDHDLTG------LLDSPEVKFTE 99
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMT 230
+ L GL YLHS I+HRD+K N+L++ + +K+ADFG+AR N D T
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 231 GETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIY 266
TL Y PE+L G Y + D++S G L E++
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 25/202 (12%)
Query: 61 GTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118
GT+ V++ G VA+K + + G R EA+ +A +E+ + +L HPN+
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTAL-REIKLLQELKHPNIIG 66
Query: 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLA 178
+ S +++ V E++ K +IK++ L +
Sbjct: 67 LLDVFGHKSNINL----------------VFEFMETDLEK--VIKDKSIVLTPADIKSYM 108
Query: 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGY 238
L RGL YLHS I+HRD+K N+L+ + +K+ADFG+AR S MT + T Y
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 239 MAPEVLNG-NPYNRKCDVYSFG 259
APE+L G Y D++S G
Sbjct: 169 RAPELLFGARHYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
V+ +G++G V R DG +K L+ R R A QE + +L HP
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE-------RKAAEQEAQLLSQLKHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ + + G E+G + +V+ + GG L L + + + L V
Sbjct: 60 NIVAYRESWEG--------EDGLLY-------IVMGFCEGGDLYHKLKEQKGKLLPENQV 104
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE-T 233
V+ + +A L YLH + I+HRD+KT+N+ L + +K+ D G+ARV N DM
Sbjct: 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMASTLI 163
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
GT YM+PE+ + PYN K DV++ G C++E+
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 49/237 (20%)
Query: 50 SKLVIKSVIARGTFGTV----HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
S+L + I G GTV HR G A+K++ E +R +E+
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRP--TGRLYALKVIYGNHED--------TVRRQICREI 123
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ ++HPNV K ++ NG++ V++E++ GG+L+ I +
Sbjct: 124 EILRDVNHPNVVK-------CHDMFDH--NGEIQ-------VLLEFMDGGSLEGTHIADE 167
Query: 166 RRKLAFKVVVQLALDLAR----GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ LA D+AR G++YLH + IVHRD+K N+L++ + VKIADFGV+R+
Sbjct: 168 Q---------FLA-DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 222 EASNPNDMTGETGTLGYMAPEV----LNGNPYNRKC-DVYSFGICLWEIYCCDMPYP 273
A + GT+ YM+PE LN Y+ D++S G+ + E Y P+
Sbjct: 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 43/129 (33%), Positives = 70/129 (54%), Gaps = 14/129 (10%)
Query: 146 CVVVEYLPGGALKTYL--IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+V+EYLPGG L + L + + +A + ++ L L YLHS I+HRD+K +N+
Sbjct: 69 YLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVL----ALEYLHSNGIIHRDLKPDNI 124
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGET--------GTLGYMAPEVLNGNPYNRKCDV 255
L+D N +K+ DFG+++V + GT Y+APEV+ G +++ D
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDW 184
Query: 256 YSFGICLWE 264
+S G L+E
Sbjct: 185 WSLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 63/229 (27%), Positives = 115/229 (50%), Gaps = 31/229 (13%)
Query: 57 VIARGTFGTVHRGL--YDGHDVAVKLLDWGE-EGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+I +GT+G V+ L G +AVK ++ R ++ + A E+ LDH
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK- 172
N+ +++G E + + +EY+PGG++ + L R F+
Sbjct: 68 LNIVQYLGF-----------ETTE-----EYLSIFLEYVPGGSIGSCL----RTYGRFEE 107
Query: 173 -VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA---SNPND 228
+V + GL+YLHS+ I+HRD+K +N+L+D + KI+DFG+++ N +
Sbjct: 108 QLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167
Query: 229 MTGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
M+ + G++ +MAPEV++ Y+ K D++S G + E++ P+ D
Sbjct: 168 MSMQ-GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 77/267 (28%), Positives = 114/267 (42%), Gaps = 55/267 (20%)
Query: 37 FLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRT 90
+LKK R V+ G FG V YD G VAVK L
Sbjct: 5 YLKKIR--------------VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ-- 48
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
S + +E+ + L H N+ K+ G +Q +++E
Sbjct: 49 ------NTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ--------------LIME 88
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+P G+L+ YL K+ KL ++ A + G++YLHSQ +HRD+ N+LLD +R
Sbjct: 89 YVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL 145
Query: 211 VKIADFGVAR-VEASNPNDMTGETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
VKI DFG+A+ V + E G + + A E L N ++ DV+SFG+ L+E+
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
Query: 268 -CDMPY--PDLSFSE---VTSAVVRQV 288
CD P F E + V
Sbjct: 206 HCD-SKQSPPKKFEEMIGPKQGQMTVV 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 29/245 (11%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WE + ++ + G FG V GL+ VA+K+L + + + F +
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD---------FQK 51
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV +L H ++ ++I + E + G+L +L
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYI----------------ITELMEKGSLLAFLRS 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ L ++ +A +A G++YL Q +HRD+ N+L+ ++ K+ADFG+AR+
Sbjct: 96 PEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL-I 154
Query: 224 SNPNDMTGETGT-LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
++ + + APE + ++ K DV+SFGI L+E++ +PYP ++ EV
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 282 SAVVR 286
+
Sbjct: 215 DQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 75/261 (28%), Positives = 115/261 (44%), Gaps = 62/261 (23%)
Query: 58 IARGTFGTVHR----GLYDGHD---VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
I +G FG V + GL VAVK+L + EA A +++ F +E A+ +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML-------KEEAS-ADMQADFQREAALMAE 64
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN------ 164
DHPN+ K +G V C++ EY+ G L +L
Sbjct: 65 FDHPNIVKLLG----------------VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQC 108
Query: 165 --------------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
L+ + +A +A G++YL +K VHRD+ T N L+ +N
Sbjct: 109 SLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV 168
Query: 211 VKIADFGVARVEAS------NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
VKIADFG++R S + ND + +M PE + N Y + DV+++G+ LWE
Sbjct: 169 VKIADFGLSRNIYSADYYKASENDAI----PIRWMPPESIFYNRYTTESDVWAYGVVLWE 224
Query: 265 IYCCDM-PYPDLSFSEVTSAV 284
I+ M PY ++ EV V
Sbjct: 225 IFSYGMQPYYGMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 45/127 (35%), Positives = 66/127 (51%), Gaps = 5/127 (3%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQL-ALDLARGLSYLHSQKIVHRDVKTENMLLD 206
VV+ L GG L+ +L + + V+ ++ L YLHS+ I+HRD+K +N+LLD
Sbjct: 78 VVDLLLGGDLRYHLSQKVKFSEE---QVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ V I DF +A + T +GT GYMAPEVL Y+ D +S G+ +E
Sbjct: 135 EQGHVHITDFNIATKVTPDTL-TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193
Query: 267 CCDMPYP 273
PY
Sbjct: 194 RGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 36/234 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
VI G V+ + + VA+K +D + + + LR +EV + +HP
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELR----KEVQAMSQCNHP 59
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF--K 172
NV K+ + + EL + V+ YL GG+L ++K+ +
Sbjct: 60 NVVKYYTSFVVGDELWL----------------VMPYLSGGSL-LDIMKSSYPRGGLDEA 102
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
++ + ++ +GL YLHS +HRD+K N+LL ++ +VKIADFGV+ A D T +
Sbjct: 103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD-GGDRTRK 161
Query: 233 T-----GTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
GT +MAPEV+ + Y+ K D++SFGI E+ PY +V
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 34/219 (15%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ VI GT+G V++ + G VA+K++D +E + E LR
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILR----------KY 59
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---R 167
+HPN+ F GA + + + Q+ + V+E GG++ T L+K R +
Sbjct: 60 SNHPNIATFYGAFIKKNP---PGNDDQLWL-------VMELCGGGSV-TDLVKGLRKKGK 108
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+L + + + + RGL+YLH K++HRD+K +N+LL KN VK+ DFGV+ + +
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTL 167
Query: 228 DMTGE-TGTLGYMAPEVL--NGNP---YNRKCDVYSFGI 260
GT +MAPEV+ + P Y+ + DV+S GI
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 72/231 (31%), Positives = 118/231 (51%), Gaps = 30/231 (12%)
Query: 48 EPSKLVIK-SVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
+P +L K I +G+FG V +G+ + VA+K++D E E EI ++ QE
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQ----QE 52
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ V + D P VTK+ G+ + ++L I ++EYL GG+ L
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKDTKLWI----------------IMEYLGGGSALDLLEPG 96
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ +++ ++ +GL YLHS+K +HRD+K N+LL ++ VK+ADFGVA
Sbjct: 97 PLDETQIATILR---EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ + Y+ K D++S GI E+ + P+ +L
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 74/257 (28%), Positives = 106/257 (41%), Gaps = 46/257 (17%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRG-LY------DGHDVAVKLLDWGEEGHRTEAEIAALR 98
++ +V+K + G FG V G Y D VAVK L E R
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL--------KETASNDAR 52
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E + H N+ KF G TE M V EY+ G L
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVC---------TEGDPPIM-------VFEYMEHGDLN 96
Query: 159 TYL------------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+L + +L ++Q+A+ +A G+ YL SQ VHRD+ T N L+
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWE 264
+ VKI DFG++R + G L +M PE + + + DV+SFG+ LWE
Sbjct: 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216
Query: 265 IYCC-DMPYPDLSFSEV 280
I+ P+ LS EV
Sbjct: 217 IFTYGKQPWYGLSNEEV 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-25
Identities = 74/231 (32%), Positives = 117/231 (50%), Gaps = 30/231 (12%)
Query: 48 EPSKLVIK-SVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
+P +L K I +G+FG V +G+ + VA+K++D E E EI ++ QE
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQ----QE 52
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ V + D P VTK+ G+ + ++L I ++EYL GG+ L
Sbjct: 53 ITVLSQCDSPYVTKYYGSYLKGTKLWI----------------IMEYLGGGSALDLLRAG 96
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ F++ L ++ +GL YLHS+K +HRD+K N+LL + VK+ADFGVA
Sbjct: 97 PFDE--FQIATMLK-EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ + Y+ K D++S GI E+ + P D+
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 79/266 (29%), Positives = 124/266 (46%), Gaps = 55/266 (20%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEI 94
WE +LV+ + G FG V R G D VAVK+L + + T+ ++
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML----KDNATDKDL 61
Query: 95 AALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
A L S E+ + + H N+ +G + T+ G + V+VEY
Sbjct: 62 ADLIS----EMELMKLIGKHKNIINLLG---------VCTQEGPLY-------VIVEYAA 101
Query: 154 GGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
G L+ +L R +L+FK +V A +ARG+ YL S++ +HRD+
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT----LGYMAPEVLNGNPYNRKCDV 255
N+L+ ++ +KIADFG+AR + D +T + +MAPE L Y + DV
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR--GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219
Query: 256 YSFGICLWEIYCC-DMPYPDLSFSEV 280
+SFGI +WEI+ PYP + E+
Sbjct: 220 WSFGILMWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 69/241 (28%), Positives = 115/241 (47%), Gaps = 34/241 (14%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WE+ L + + G FG V G Y+GH VA+K L ++G + AF
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSP-------EAFLA 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + +L HP + + + A + ++I + EY+ G+L +L
Sbjct: 51 EANLMKQLQHPRLVR-LYAVVTQEPIYI----------------ITEYMENGSLVDFLKT 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
KL ++ +A +A G++++ + +HRD++ N+L+ + KIADFG+AR+
Sbjct: 94 PEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-- 151
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSE 279
N+ T G + + APE +N + K DV+SFGI L EI +PYP ++ E
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
Query: 280 V 280
V
Sbjct: 212 V 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-25
Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 49/255 (19%)
Query: 61 GTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
G FG V++G VA+K L + AE ++ F QE + L H
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTL-------KENAEPK-VQQEFRQEAELMSDLQH 67
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------- 165
PN+ +G C++ EYL G L +L++N
Sbjct: 68 PNIVCLLGVCTKEQPT----------------CMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 166 ------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ L + +A+ +A G+ YL S VHRD+ N L+ + TVKI+DFG++
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 220 R-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 276
R + +++ + ++ + +M PE + + + D++SFG+ LWEI+ + PY S
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 277 FSEVTSAVVRQVQYL 291
EV ++R Q L
Sbjct: 232 NQEVIE-MIRSRQLL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-25
Identities = 69/240 (28%), Positives = 114/240 (47%), Gaps = 28/240 (11%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
L + + G FG+V G + D VAVK + R+E E F E
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEME------DFLSEAVC 53
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-- 165
+ DHPNV + IG + + E PS + V++ ++ G L ++L+ +R
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVE--------SEGYPSPV--VILPFMKHGDLHSFLLYSRLG 103
Query: 166 --RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ L +++V+ D+A G+ YL S+ +HRD+ N +L++N V +ADFG+++
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163
Query: 224 SNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280
+ G + ++A E L Y K DV+SFG+ +WEI PYP + SE+
Sbjct: 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 78/263 (29%), Positives = 115/263 (43%), Gaps = 51/263 (19%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEIA 95
WE KL + + G FG V G D VAVK+L + TE +++
Sbjct: 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML----KDDATEKDLS 65
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
L S + H N+ +GA L+ V+VEY G
Sbjct: 66 DLVSEMEMMKMIGK---HKNIINLLGACTQDGPLY----------------VIVEYASKG 106
Query: 156 ALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
L+ YL R ++ FK +V +ARG+ YL SQK +HRD+
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSF 258
N+L+ +N +KIADFG+AR + +N + T + +MAPE L Y + DV+SF
Sbjct: 167 NVLVTENNVMKIADFGLAR-DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 259 GICLWEIYCC-DMPYPDLSFSEV 280
G+ +WEI+ PYP + E+
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-24
Identities = 74/250 (29%), Positives = 117/250 (46%), Gaps = 38/250 (15%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
I+ S + I+ VI G FG V RG VA+K L G TE + R F
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQ----RRDF 52
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + DHPN+ G S + I TE ++ GAL ++L
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE----------------FMENGALDSFL 96
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+N + ++V L +A G+ YL VHRD+ N+L++ N K++DFG++R
Sbjct: 97 RQNDGQFTVIQLVGMLR-GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155
Query: 222 EASNPNDMTGETGTLG------YMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
+ +D T T +LG + APE + + DV+S+GI +WE+ + PY D
Sbjct: 156 LEDDTSDPT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214
Query: 275 LSFSEVTSAV 284
+S +V +A+
Sbjct: 215 MSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-24
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 57 VIARGTFG--TVHRGLYDGHDVAVKLLDWGE--EGHRTEAEIAALRSAFTQEVAVWHKLD 112
V+ +G FG T++R D V K ++ E R +A E+ + L
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---------LNEIVILSLLQ 57
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF- 171
HPN+ + M + L I+ +EY GG L Y R++ F
Sbjct: 58 HPNIIAYYNHFMDDNTLLIE----------------MEYANGGTL--YDKIVRQKGQLFE 99
Query: 172 -KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++V+ + +SY+H I+HRD+KT N+ L K +K+ DFG++++ S +
Sbjct: 100 EEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
GT YM+PE+ G YN K D+++ G L+E+
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-24
Identities = 70/230 (30%), Positives = 110/230 (47%), Gaps = 41/230 (17%)
Query: 53 VIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+IK I G+FG ++ + D +K +D + E E A +EV + K
Sbjct: 4 IIK-KIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKE------ASKKEVILLAK 55
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ HPN+ F + + L I V+EY GG L + NR+R +
Sbjct: 56 MKHPNIVTFFASFQENGRLFI----------------VMEYCDGGDLMKRI--NRQRGVL 97
Query: 171 FKV------VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIADFGVARVEA 223
F VQ++L GL ++H +KI+HRD+K++N+ L KN V K+ DFG+AR
Sbjct: 98 FSEDQILSWFVQISL----GLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
+ GT Y++PE+ PYN K D++S G L+E+ C + +P
Sbjct: 154 DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL--CTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-24
Identities = 72/249 (28%), Positives = 114/249 (45%), Gaps = 38/249 (15%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRG---LYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAF 101
I+ S + I+ VI G FG V G L + VA+K L G TE + R F
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQ----RRDF 52
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + DHPN+ G S + I V EY+ G+L +L
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMI----------------VTEYMENGSLDAFL 96
Query: 162 IKNRRRKLAFKVV--VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
K+ + F V+ V + +A G+ YL VHRD+ N+L++ N K++DFG++
Sbjct: 97 RKHDGQ---FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153
Query: 220 RVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
RV +P G + + APE + + DV+S+GI +WE+ + PY ++
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213
Query: 276 SFSEVTSAV 284
S +V A+
Sbjct: 214 SNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 3e-24
Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 34/230 (14%)
Query: 61 GTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
G FG V +G+Y DVA+K+L E ++R +E + H+LD+P +
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYI 57
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ IG + + +V+E GG L +L ++ ++ VV+
Sbjct: 58 VRMIGVCEAEALM-----------------LVMEMASGGPLNKFLS-GKKDEITVSNVVE 99
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG-- 234
L ++ G+ YL + VHRD+ N+LL KI+DFG+++ ++ + +
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159
Query: 235 -TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTS 282
L + APE +N ++ + DV+S+GI +WE + PY + EV S
Sbjct: 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS 209
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-24
Identities = 70/247 (28%), Positives = 114/247 (46%), Gaps = 33/247 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI + + + G FG V G Y+ VAVK L G + AF +
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ----------AFLE 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + L H + + ++I + EY+ G+L +L
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYI----------------ITEYMAKGSLLDFLKS 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ K+ ++ + +A G++Y+ + +HRD++ N+L+ ++ KIADFG+ARV
Sbjct: 95 DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV-- 152
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
N+ T G + + APE +N + K DV+SFGI L+EI +PYP +S S+
Sbjct: 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
Query: 280 VTSAVVR 286
V SA+ R
Sbjct: 213 VMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-24
Identities = 70/223 (31%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V R G A+K+L + E IA A T E V H
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLQNTRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKL 169
P +T + + QT + C V+EY GG L +L + R R
Sbjct: 55 PFLT--------ALKYSFQTHDR--------LCFVMEYANGGELFFHLSRERVFSEDRAR 98
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
+ + AL YLHS +V+RD+K EN++LDK+ +KI DFG+ + S+ M
Sbjct: 99 FYGAEIVSALG------YLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL N Y R D + G+ ++E+ C +P+
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 9e-24
Identities = 70/219 (31%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V R G A+K+L R E IA A T E V H
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P +T A L C V+EY GG L +L +R R +
Sbjct: 55 PFLTALKYAFQTHDRL----------------CFVMEYANGGELFFHL--SRERVFTEER 96
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
++ L YLHS+ +V+RD+K EN++LDK+ +KI DFG+ + S+ M
Sbjct: 97 ARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC 156
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL N Y R D + G+ ++E+ C +P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 78/262 (29%), Positives = 115/262 (43%), Gaps = 49/262 (18%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEIA 95
WE+ +LV+ + G FG V G D VAVK+L + TE +++
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML----KSDATEKDLS 68
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
L S + H N+ +GA L+ V+VEY G
Sbjct: 69 DLISEMEMMKMIG---KHKNIINLLGACTQDGPLY----------------VIVEYASKG 109
Query: 156 ALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
L+ YL R +L+FK +V A +ARG+ YL S+K +HRD+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169
Query: 202 NMLLDKNRTVKIADFGVAR--VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
N+L+ ++ +KIADFG+AR T + +MAPE L Y + DV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229
Query: 260 ICLWEIYCC-DMPYPDLSFSEV 280
+ LWEI+ PYP + E+
Sbjct: 230 VLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-23
Identities = 69/255 (27%), Positives = 112/255 (43%), Gaps = 56/255 (21%)
Query: 51 KLVIKSVIARGTFGTVHR-------GLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
LV+ + G FG V + G VAVK+L + +E+ L S F
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFN- 55
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
+ +++HP+V K GA L + +VEY G+L+++L +
Sbjct: 56 ---LLKQVNHPHVIKLYGACSQDGPLLL----------------IVEYAKYGSLRSFLRE 96
Query: 164 NRR----------------------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
+R+ R L ++ A ++RG+ YL K+VHRD+
Sbjct: 97 SRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFG 259
N+L+ + R +KI+DFG++R + + G + +MA E L + Y + DV+SFG
Sbjct: 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216
Query: 260 ICLWEIYCCDM-PYP 273
+ LWEI PYP
Sbjct: 217 VLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-23
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 53/233 (22%)
Query: 61 GTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSA----------FTQEVAVWHK 110
G FG V++ H+ AA + F E+ + +
Sbjct: 16 GAFGKVYKAQ-----------------HKETGLFAAAKIIQIESEEELEDFMVEIDILSE 58
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RK 168
HPN+ A ++L I ++E+ GGAL + +++ R +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWI----------------LIEFCDGGALDSIMLELERGLTE 102
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
+ V + L+ L++LHS K++HRD+K N+LL + VK+ADFGV+ S
Sbjct: 103 PQIRYVCRQMLE---ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159
Query: 229 MTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
GT +MAPEV+ NPY+ K D++S GI L E+ + P+ +L+
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 78/263 (29%), Positives = 117/263 (44%), Gaps = 51/263 (19%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEIA 95
WE+ ++L + + G FG V G D VAVK+L + T+ +++
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML----KDDATDKDLS 62
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
L S + H N+ +GA L+ V+VEY G
Sbjct: 63 DLVSEMEMMKMIG---KHKNIINLLGACTQDGPLY----------------VLVEYASKG 103
Query: 156 ALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
L+ YL R +L FK +V A +ARG+ YL SQK +HRD+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSF 258
N+L+ ++ +KIADFG+AR + N + T + +MAPE L Y + DV+SF
Sbjct: 164 NVLVTEDNVMKIADFGLAR-DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 259 GICLWEIYCCD-MPYPDLSFSEV 280
G+ LWEI+ PYP + E+
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-23
Identities = 73/248 (29%), Positives = 112/248 (45%), Gaps = 34/248 (13%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--GHD---VAVKLLDWGEEGHRTEAEIAALRSA 100
EI PS + + VI G FG V RG+ G VA+K L G TE + R
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG----YTEKQ----RQD 52
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F E ++ + H N+ + G I + EY+ GAL Y
Sbjct: 53 FLSEASIMGQFSHHNIIRLEGVVTKFKPAMI----------------ITEYMENGALDKY 96
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L + ++++V L +A G+ YL VHRD+ N+L++ N K++DFG++R
Sbjct: 97 LRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155
Query: 221 VEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLS 276
V +P +G + + APE + + DV+SFGI +WE+ + PY D+S
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215
Query: 277 FSEVTSAV 284
EV A+
Sbjct: 216 NHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-23
Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 32/218 (14%)
Query: 57 VIARGTFGTVHRGLYD-GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
V+ +G +GTV+ GL + G +AVK LD E E L+ +EV + L H
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV-LAAEKEYEKLQ----EEVDLLKSLKH 61
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ +++G + N + +E++PGG++ + L NR L V
Sbjct: 62 VNIVQYLGT----------------CLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPV 103
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR------VEASNPN 227
+ + G++YLH+ +VHRD+K N++L N +K+ DFG AR + ++ N
Sbjct: 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+ GT +MAPEV+N + Y RK D++S G ++E+
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 50/129 (38%), Positives = 68/129 (52%), Gaps = 12/129 (9%)
Query: 157 LKTYLIKNRRR---KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213
L TYL K R A + Q+ GL YLH+Q+I+HRDVKTEN+ ++ V I
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQIL----EGLRYLHAQRIIHRDVKTENIFINDVDQVCI 198
Query: 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
D G A+ P + G GT+ APEVL + YN K D++S GI L+E+ + YP
Sbjct: 199 GDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM----LAYP 253
Query: 274 DLSFSEVTS 282
F + S
Sbjct: 254 STIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-23
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 58 IARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ G FGTV +G+Y VAVK+L + + AL+ +E V +LD+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-------KNDNNDPALKDELLREANVMQQLDN 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + + IG S + +V+E G L +L KN+ + K
Sbjct: 56 PYIVRMIGICEAESWM-----------------LVMELAELGPLNKFLQKNKH--VTEKN 96
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+ +L ++ G+ YL VHRD+ N+LL KI+DFG+++ ++ N +T
Sbjct: 97 ITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156
Query: 234 G---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVR 286
+ + APE +N ++ K DV+SFG+ +WE + PY + +EVT +
Sbjct: 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-23
Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 31/242 (12%)
Query: 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGH-RTEAEIAALRSAFT----QEV 105
+ +++ + +G+FGTV+ V K E E + L T QE
Sbjct: 1 RYILQQRLGKGSFGTVYL-------VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA 53
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL--KTYLIK 163
+ KLDHP + KF + + C++ EY G L K +K
Sbjct: 54 QLLSKLDHPAIVKFHASFLERDAF----------------CIITEYCEGRDLDCKLEELK 97
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ + L+ V + + L G+ Y+H ++I+HRD+K +N+ L KN +KI DFGV+R+
Sbjct: 98 HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLM 156
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
+ + T TGT YM+PE L Y+ K D++S G L+E+ C + +F V
Sbjct: 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216
Query: 284 VV 285
+V
Sbjct: 217 IV 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-23
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 38/233 (16%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVK------LLDWGEEGHRTEAEIAALRSAF 101
+ I+ I RG F V+R DG VA+K L+D A R+
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD------------AKARADC 49
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+E+ + +L+HPNV K+ + + +EL+I V+E G L +
Sbjct: 50 IKEIDLLKQLNHPNVIKYYASFIEDNELNI----------------VLELADAGDLSRMI 93
Query: 162 --IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
K ++R + K V + + L L ++HS++++HRD+K N+ + VK+ D G+
Sbjct: 94 KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
R +S GT YM+PE ++ N YN K D++S G L+E+ P+
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 72/265 (27%), Positives = 121/265 (45%), Gaps = 54/265 (20%)
Query: 46 EIEPSKLVIKSVIARGTFGTVH----RGL----------YDGHD--VAVKLLDWGEEGHR 89
E +L +K + G FG VH GL +DG VAVK+L R
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-------R 53
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
+ A R+ F +E+ + +L +PN+ + +G + L C++
Sbjct: 54 ADVTKTA-RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL----------------CMIT 96
Query: 150 EYLPGGALKTYL----------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
EY+ G L +L N ++ ++ +A+ +A G+ YL S VHRD+
Sbjct: 97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156
Query: 200 TENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYS 257
T N L+ + T+KIADFG++R + + + + G + +MA E + + DV++
Sbjct: 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216
Query: 258 FGICLWEIY--CCDMPYPDLSFSEV 280
FG+ LWE++ C + PY LS +V
Sbjct: 217 FGVTLWEMFTLCKEQPYSLLSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-23
Identities = 71/219 (32%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V R G A+K+L + E IA A T E V H
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKIL-------KKEVIIAKDEVAHTLTESRVLKNTRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P +T S + QT++ C V+EY+ GG L +L +R R +
Sbjct: 55 PFLT--------SLKYSFQTKDR--------LCFVMEYVNGGELFFHL--SRERVFSEDR 96
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
++ L YLHS KIV+RD+K EN++LDK+ +KI DFG+ + ++ M
Sbjct: 97 TRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC 156
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL N Y R D + G+ ++E+ C +P+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 37/218 (16%)
Query: 76 VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135
VAVK+L R +A A R F +EV + +L PN+ + +G
Sbjct: 49 VAVKVL-------RPDASDNA-REDFLKEVKILSRLSDPNIARLLGVCTVD--------- 91
Query: 136 GQVAMPSNICCVVVEYLPGGALKTYL---------IKNRRRKLAFKVVVQLALDLARGLS 186
C+++EY+ G L +L + + L+F ++ +A +A G+
Sbjct: 92 -------PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMR 144
Query: 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETGT-LGYMAPEVL 244
YL S VHRD+ T N L+ KN T+KIADFG++R + +S+ + G + +MA E +
Sbjct: 145 YLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204
Query: 245 NGNPYNRKCDVYSFGICLWEIY--CCDMPYPDLSFSEV 280
+ K DV++FG+ LWEI C + PY L+ +V
Sbjct: 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-23
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIA--ALRSAFTQEVAVWHKLDH 113
I G G V + G VA+K + R E I ALR E+ H
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALR-----EIKALQACQH 58
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV-EYLPGGALKTYLIKNRRRKLAFK 172
P V K + P V+V EY+P + ++++ R L
Sbjct: 59 PYVVKLLDVF-----------------PHGSGFVLVMEYMPSDL--SEVLRDEERPLPEA 99
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN-PNDMTG 231
V L +G++Y+H+ I+HRD+K N+L+ + +KIADFG+AR+ + P +
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ T Y APE+L G RK Y G+ LW + C
Sbjct: 160 QVATRWYRAPELLYG---ARK---YDPGVDLWAVGC 189
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 7e-23
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 27/224 (12%)
Query: 57 VIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
++ +G FG V+ YD G ++A K + + E T E++AL E+ + L H
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQH 63
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ ++ G +E + + +EY+PGG++K L L V
Sbjct: 64 ERIVQYYGCLRDRAEKTLT--------------IFMEYMPGGSVKDQL--KAYGALTESV 107
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS---NPNDMT 230
+ + G+SYLHS IVHRD+K N+L D VK+ DFG ++ + + +
Sbjct: 108 TRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
TGT +M+PEV++G Y RK DV+S G + E+ P+ +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-23
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 26/227 (11%)
Query: 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
+ I+ I RG F V+R L D VA+K + E A R +E+ +
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKV------QIFEMMDAKARQDCVKEIDL 55
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL--IKNR 165
+L+HPNV K++ + + +EL+I V+E G L + K +
Sbjct: 56 LKQLNHPNVIKYLDSFIEDNELNI----------------VLELADAGDLSQMIKYFKKQ 99
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+R + + V + + L + ++HS++++HRD+K N+ + VK+ D G+ R +S
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT YM+PE ++ N YN K D++S G L+E+ P+
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-23
Identities = 79/258 (30%), Positives = 115/258 (44%), Gaps = 53/258 (20%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGH--DVAVKLLD--WGEEGHRTEAEIAALR 98
WE + + VI G FG V R + DG + A+K+L E HR
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-------- 48
Query: 99 SAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F E+ V KL HPN+ +GA L+I +EY P G L
Sbjct: 49 --FAGELEVLCKLGHHPNIINLLGACENRGYLYI----------------AIEYAPYGNL 90
Query: 158 KTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+L K+R L + ++Q A D+A G+ YL ++ +HRD+ N+
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNV 150
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
L+ +N KIADFG++R E G + +MA E LN + Y K DV+SFG+ LW
Sbjct: 151 LVGENLASKIADFGLSRGEEVYVKKTMGRL-PVRWMAIESLNYSVYTTKSDVWSFGVLLW 209
Query: 264 EIYCC-DMPYPDLSFSEV 280
EI PY ++ +E+
Sbjct: 210 EIVSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 9e-23
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 38/225 (16%)
Query: 55 KSVIARGTFGTVHRGLY--DGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ ++ G GTV++ + +AVK+ LD E L+ E+ + +K
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE----------LQKQIMSELEILYK 55
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
D P + F GA + + I TE ++ GG+L Y RK+
Sbjct: 56 CDSPYIIGFYGAFFVENRISICTE----------------FMDGGSLDVY------RKIP 93
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
V+ ++A+ + +GL+YL S KI+HRDVK NML++ VK+ DFGV+ + N T
Sbjct: 94 EHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIAKT 152
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT YMAPE ++G Y DV+S GI E+ PYP +
Sbjct: 153 -YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 58 IARGTFGTVHRGLYDGHDV--AVKLL------DWGEEGH-RTEAEIAALRSAFTQEVAVW 108
+ G FG V + A+K + + G++ H +E EI +E
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI-------LEEC--- 50
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
+HP + K T + +I +++EY GG L T L R R
Sbjct: 51 ---NHPFIVKLY-RTF-KDKKYIY--------------MLMEYCLGGELWTIL---RDR- 87
Query: 169 LAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
AR YLH++ I++RD+K EN+LLD N VK+ DFG A+
Sbjct: 88 ------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
S T GT Y+APE++ Y+ D +S GI L+E+ P+
Sbjct: 142 KLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 56 SVIARGTFGTVH--RGLYDGHDVAVKLL---DWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G +G V R G VA+K + E+ +T ALR EV V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT-----ALR-----EVKVLRQ 56
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
L H N+ A L++ V EY+ L+ L++ L
Sbjct: 57 LRHENIVNLKEAFRRKGRLYL----------------VFEYVERTLLE--LLEASPGGLP 98
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DM 229
V L + ++Y HS I+HRD+K EN+L+ ++ +K+ DFG AR + P +
Sbjct: 99 PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158
Query: 230 TGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
T T Y APE+L G+ Y + DV++ G + E+
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-22
Identities = 72/255 (28%), Positives = 123/255 (48%), Gaps = 34/255 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS--AFT 102
WE+ K+ + + +G+FG V+ G+ G VK +T E A++R F
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKG---VVKDEPETRVAIKTVNEAASMRERIEFL 57
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
E +V + + +V + +G GQ + V++E + G LK+YL
Sbjct: 58 NEASVMKEFNCHHVVRLLGVV----------SQGQPTL------VIMELMTRGDLKSYL- 100
Query: 163 KNRRRKL---------AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213
++ R ++ + K ++Q+A ++A G++YL++ K VHRD+ N ++ ++ TVKI
Sbjct: 101 RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160
Query: 214 ADFGVARVEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDM 270
DFG+ R G G L +M+PE L + DV+SFG+ LWEI +
Sbjct: 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 220
Query: 271 PYPDLSFSEVTSAVV 285
PY +S +V V+
Sbjct: 221 PYQGMSNEQVLRFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-22
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 34/221 (15%)
Query: 58 IARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G FG V YD G VAVK L G+ IA L+ +E+ + L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN----HIADLK----KEIEILRNL 63
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H N+ K+ G I TE+G + +++E+LP G+LK YL +N+ K+
Sbjct: 64 YHENIVKYKG---------ICTEDGGNGIK-----LIMEFLPSGSLKEYLPRNKN-KINL 108
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
K ++ A+ + +G+ YL S++ VHRD+ N+L++ VKI DFG+ + ++ T
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 232 E---TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YC 267
+ + + APE L + + DV+SFG+ L+E+ YC
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-22
Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 27/232 (11%)
Query: 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
P + ++ RG FG V+ YD G ++AVK + + + T E+ AL E+
Sbjct: 1 PVNWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EI 55
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ L H + ++ G E + + VEY+PGG++K L
Sbjct: 56 QLLKNLRHDRIVQYYGCLRDPEEKKLS--------------IFVEYMPGGSIKDQL--KA 99
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
L V + + +G+SYLHS IVHRD+K N+L D VK+ DFG ++ +
Sbjct: 100 YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159
Query: 226 PNDMTG---ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
TG TGT +M+PEV++G Y RK DV+S + E+ P+ +
Sbjct: 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 2/128 (1%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L ++ ++ R A ++ GL +LH + I++RD+K +N+LL
Sbjct: 72 FFVMEYVNGGDLMFHIQRSGRFDEP--RARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D +KIADFG+ + + GT Y+APE+L+ PY D ++ G+ L+E+
Sbjct: 130 DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
Query: 266 YCCDMPYP 273
P+
Sbjct: 190 LAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-22
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 58 IARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I G+ G V G VAVK +D ++ R EV + HPN
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---------ELLFNEVVIMRDYQHPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + + + EL VV+E+L GGAL + R + V
Sbjct: 78 IVEMYSSYLVGDEL----------------WVVMEFLEGGALTDIVTHTRMNEEQIATVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG-VARVEASNPNDMTGETG 234
L + LS+LH+Q ++HRD+K++++LL + VK++DFG A+V P + G
Sbjct: 122 LAVL---KALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-LVG 177
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
T +MAPEV++ PY + D++S GI + E+ + PY
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-22
Identities = 55/174 (31%), Positives = 88/174 (50%), Gaps = 28/174 (16%)
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
R +EVAV + HPN+ ++ + + L+I V++Y GG L
Sbjct: 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYI----------------VMDYCEGGDL 86
Query: 158 KTYLIKNRRRKLAFKV------VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
Y N +R + F VQ+ L L ++H +KI+HRD+K++N+ L K+ T+
Sbjct: 87 --YKKINAQRGVLFPEDQILDWFVQICL----ALKHVHDRKILHRDIKSQNIFLTKDGTI 140
Query: 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
K+ DFG+ARV S GT Y++PE+ PYN K D+++ G L+E+
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-22
Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 27/233 (11%)
Query: 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
P+ + ++ +G FG V+ YD G ++AVK + + E T E+ AL E+
Sbjct: 1 PTNWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALEC----EI 55
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ L H + ++ G E + + +E++PGG++K L
Sbjct: 56 QLLKNLLHERIVQYYGCLRDPMERTLS--------------IFMEHMPGGSIKDQL--KS 99
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS- 224
L V + + G+SYLHS IVHRD+K N+L D VK+ DFG ++ +
Sbjct: 100 YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159
Query: 225 --NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ M TGT +M+PEV++G Y RK D++S G + E+ P+ +
Sbjct: 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 76/244 (31%), Positives = 107/244 (43%), Gaps = 48/244 (19%)
Query: 56 SVIARGTFGTV-------HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRS---AFTQEV 105
+V+ RG FG V LY A+K L G+ R E E +L F E
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELY-----AIKALKKGDIIARDEVE--SLMCEKRIF--ET 55
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN- 164
A + HP + QTE+ C V+EY GG L ++ +
Sbjct: 56 A--NSERHPFLVNLFAC--------FQTEDH--------VCFVMEYAAGGDLMMHIHTDV 97
Query: 165 --RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
R + + V L GL YLH KIV+RD+K +N+LLD VKIADFG+ + E
Sbjct: 98 FSEPRAVFYAACVVL------GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-E 150
Query: 223 ASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
D T GT ++APEVL Y R D + G+ ++E+ + P+P EV
Sbjct: 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 282 SAVV 285
++V
Sbjct: 211 DSIV 214
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V+ R G VA+K + R + E + S +E+++ +L+HPN
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ K + I TEN +V E+L LK ++ + + ++
Sbjct: 61 IVKLLDV--------IHTENKLY--------LVFEFL-HQDLKKFMDASPLSGIPLPLIK 103
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L +GL++ HS +++HRD+K +N+L++ +K+ADFG+AR T E T
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT 163
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
L Y APE+L G C YS + +W + C
Sbjct: 164 LWYRAPEILLG------CKYYSTAVDIWSLGC 189
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-22
Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 40/240 (16%)
Query: 57 VIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+ RG FG V G + V VK L ++ + L+S F +E+ ++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN--------LQSEFRRELDMFR 63
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK- 168
KL H NV + +G +E H +++EY G LK +L + +
Sbjct: 64 KLSHKNVVRLLGLCR-EAEPH---------------YMILEYTDLGDLKQFLRATKSKDE 107
Query: 169 ------LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-V 221
L+ K V L +A G+ +L + + VHRD+ N L+ R VK++ +++ V
Sbjct: 108 KLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEV 280
S + L ++APE + + ++ K DV+SFG+ +WE++ ++P+ LS EV
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-22
Identities = 65/252 (25%), Positives = 115/252 (45%), Gaps = 42/252 (16%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
I ++ + ++ GTFG + G+ +V VK + + H +E ++ L
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLL--- 55
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
QE + + L H N+ LH+ E+G+ V+ Y+ G LK +
Sbjct: 56 -LQESCLLYGLSHQNI---------LPILHVCIEDGEPPF------VLYPYMNWGNLKLF 99
Query: 161 LIKNR------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
L + R + L+ + +V +A+ +A G+SYLH + ++H+D+ N ++D+ VKI
Sbjct: 100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159
Query: 215 DFGVARVEASNPNDM----TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-D 269
D ++R P D E + +MA E L Y+ DV+SFG+ LWE+
Sbjct: 160 DNALSR--DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217
Query: 270 MPYPDLSFSEVT 281
PY ++ E+
Sbjct: 218 TPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-22
Identities = 77/258 (29%), Positives = 119/258 (46%), Gaps = 40/258 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHR----TEAEIAALRS- 99
WE+ K+ + + +G+FG V+ G D+ +K GE R T E A+LR
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGN--ARDI-IK----GEAETRVAVKTVNESASLRER 53
Query: 100 -AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E +V +V + +G GQ + VV+E + G LK
Sbjct: 54 IEFLNEASVMKGFTCHHVVRLLGVV----------SKGQPTL------VVMELMAHGDLK 97
Query: 159 TYLIKNR--------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
+YL R R + ++Q+A ++A G++YL+++K VHRD+ N ++ + T
Sbjct: 98 SYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157
Query: 211 VKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267
VKI DFG+ R G G L +MAPE L + D++SFG+ LWEI
Sbjct: 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217
Query: 268 CDMPYPDLSFSEVTSAVV 285
+ PY LS +V V+
Sbjct: 218 AEQPYQGLSNEQVLKFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-22
Identities = 70/245 (28%), Positives = 109/245 (44%), Gaps = 30/245 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L + + G FG V G ++G+ VAVK L G +F +
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLE 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL H + + A + ++I V EY+ G+L +L
Sbjct: 51 EAQIMKKLRHDKLVQLY-AVVSEEPIYI----------------VTEYMSKGSLLDFLKD 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VE 222
R L +V +A +A G++Y+ +HRD+++ N+L+ KIADFG+AR +E
Sbjct: 94 GEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G + + APE + K DV+SFGI L E+ +PYP ++ EV
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213
Query: 282 SAVVR 286
V R
Sbjct: 214 EQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V+ R G VA+K + R E E + S +E+++ +L+HPN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + + ++L++ V E+L LK Y+ + L ++
Sbjct: 60 IVRLLDVVHSENKLYL----------------VFEFLDLD-LKKYMDSSPLTGLDPPLIK 102
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L +G++Y HS +++HRD+K +N+L+D+ +K+ADFG+AR T E T
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT 162
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
L Y APE+L G+ YS + +W I C
Sbjct: 163 LWYRAPEILLGSRQ------YSTPVDIWSIGC 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-22
Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 43/233 (18%)
Query: 55 KSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ V+ +GT+G V+ R L +A+K E R + L +E+A+ L
Sbjct: 13 RVVLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLH----EEIALHSYLK 63
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL------IKNRR 166
H N+ +++G+ +ENG + +E +PGG+L L +K+
Sbjct: 64 HRNIVQYLGSD---------SENGFFK-------IFMEQVPGGSLSALLRSKWGPLKDNE 107
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIADFGVA-RVEAS 224
+ + F + GL YLH +IVHRD+K +N+L++ + VKI+DFG + R+
Sbjct: 108 QTIIF-----YTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162
Query: 225 NPNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDL 275
NP T TGTL YMAPEV++ P Y D++S G + E+ P+ +L
Sbjct: 163 NPCTETF-TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-22
Identities = 72/245 (29%), Positives = 110/245 (44%), Gaps = 30/245 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L ++ + +G FG V G ++G VA+K L G AF Q
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQ 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V KL H + + A + ++I V EY+ G+L +L
Sbjct: 51 EAQVMKKLRHEKLVQLY-AVVSEEPIYI----------------VTEYMSKGSLLDFLKG 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VE 222
+ L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+AR +E
Sbjct: 94 EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G + + APE + K DV+SFGI L E+ +PYP + EV
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213
Query: 282 SAVVR 286
V R
Sbjct: 214 DQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-22
Identities = 70/247 (28%), Positives = 111/247 (44%), Gaps = 34/247 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L ++ + G FG V Y+ H VAVK + G AF
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----------VEAFLA 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V L H + K + A + ++I + E++ G+L +L
Sbjct: 51 EANVMKTLQHDKLVK-LHAVVTKEPIYI----------------ITEFMAKGSLLDFLKS 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ K ++ + +A G++++ + +HRD++ N+L+ + KIADFG+ARV
Sbjct: 94 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-- 151
Query: 224 SNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSE 279
N+ T G + + APE +N + K DV+SFGI L EI +PYP +S E
Sbjct: 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
Query: 280 VTSAVVR 286
V A+ R
Sbjct: 212 VIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-22
Identities = 72/270 (26%), Positives = 118/270 (43%), Gaps = 63/270 (23%)
Query: 50 SKLVIKSVIARGTFGTVHR----------------GLYDGHD--VAVKLLDWGEEGHRTE 91
L+ K + G FG VH + G VAVK+L R +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-------RPD 57
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
A A R+ F +EV + +L PN+ + +G + L C++ EY
Sbjct: 58 ANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL----------------CMITEY 100
Query: 152 LPGGALKTYLIKNRRRK-----------------LAFKVVVQLALDLARGLSYLHSQKIV 194
+ G L +L + +++ ++ +AL +A G+ YL S V
Sbjct: 101 MENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160
Query: 195 HRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRK 252
HRD+ T N L+ +N T+KIADFG++R + A + + G + +MA E + +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 253 CDVYSFGICLWEIY--CCDMPYPDLSFSEV 280
DV++FG+ LWEI C + PY +L+ +V
Sbjct: 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 73/272 (26%), Positives = 118/272 (43%), Gaps = 67/272 (24%)
Query: 46 EIEPSKLVIKSVIARGTFGTVH----RGLYDGHD--------------VAVKLLDWGEEG 87
E +L K + G FG VH G+ D VAVK+L
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML------ 54
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
R +A A R+ F +E+ + +L PN+ + + + S L C+
Sbjct: 55 -REDANKNA-RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL----------------CM 96
Query: 148 VVEYLPGGALKTYLIKNR---------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198
+ EY+ G L +L ++ +++ ++ +A +A G+ YL S VHRD+
Sbjct: 97 ITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156
Query: 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGE--------TGTLGYMAPEVLNGNPYN 250
T N L+ KN T+KIADFG++R N +G+ + +M+ E + +
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSR------NLYSGDYYRIQGRAVLPIRWMSWESILLGKFT 210
Query: 251 RKCDVYSFGICLWEI--YCCDMPYPDLSFSEV 280
DV++FG+ LWEI C + PY LS +V
Sbjct: 211 TASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 45/144 (31%), Positives = 72/144 (50%), Gaps = 10/144 (6%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+V+EYL GG + LIK L Q ++ G+ LH + I+HRD+K EN+L+
Sbjct: 73 YLVMEYLNGGDCAS-LIK-TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D+ +K+ DFG++R N + GT Y+APE + G ++ D +S G ++E
Sbjct: 131 DQTGHLKLTDFGLSRNGLENKKFV----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 266 YCCDMPY----PDLSFSEVTSAVV 285
P+ PD F + S +
Sbjct: 187 LFGYPPFHAETPDAVFDNILSRRI 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-21
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 30/207 (14%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V+R G VA+K L E + I +LR E+ + KL HPN
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLR-----EINILLKLQHPN 65
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCV--VVEYLPGGALKTYLIKNRRRKLAFKV 173
+ + ++ +V + SN+ + V+EY+ LK+ L++ ++
Sbjct: 66 I------------VTVK----EVVVGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSE 107
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L L L G+++LH I+HRD+KT N+LL+ +KI DFG+AR S T
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 234 GTLGYMAPEVLNGNP-YNRKCDVYSFG 259
TL Y APE+L G Y+ D++S G
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 49/246 (19%)
Query: 57 VIARGTFGTVHRGLY--DG--HDVAVKLLD--WGEEGHRTEAEIAALRSAFTQEVAVWHK 110
VI G FG V + DG D A+K + ++ HR F E+ V K
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----------FAGELEVLCK 51
Query: 111 L-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---- 165
L HPN+ +GA L++ +EY P G L +L K+R
Sbjct: 52 LGHHPNIINLLGACEHRGYLYL----------------AIEYAPHGNLLDFLRKSRVLET 95
Query: 166 ----------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
L+ + ++ A D+ARG+ YL ++ +HRD+ N+L+ +N KIAD
Sbjct: 96 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
FG++R + G + +MA E LN + Y DV+S+G+ LWEI PY
Sbjct: 156 FGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214
Query: 275 LSFSEV 280
++ +E+
Sbjct: 215 MTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 72/234 (30%), Positives = 104/234 (44%), Gaps = 40/234 (17%)
Query: 48 EPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQ 103
E SK + I +GTFG V R VA+K L++ +EG I ALR
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF----PITALR----- 60
Query: 104 EVAVWHKLDHPNVTKFI-----GATMGSSELHIQTENGQVAMPSNICCVVVEY-LPGGAL 157
E+ + L H NV I AT + G + C E+ L G
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRY------KGSFYLVFEFC----EHDLAG--- 107
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
L+ N+ K + ++ L GL Y+H KI+HRD+K N+L+ K+ +K+ADFG
Sbjct: 108 ---LLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164
Query: 218 VARV----EASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIY 266
+AR + S PN T TL Y PE+L G Y D++ G + E++
Sbjct: 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-21
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 37/214 (17%)
Query: 61 GTFGTVHRGL--YDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+ TV++G G VA+K LD EEG A+R E+++ +L H N+
Sbjct: 11 GTYATVYKGRNRTTGEIVALKEIHLD-AEEG----TPSTAIR-----EISLMKELKHENI 60
Query: 117 TKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYL-IKNRRRKLAFKV 173
+ LH I TEN + +V EY+ LK Y+ R L
Sbjct: 61 VR----------LHDVIHTENKLM--------LVFEYMDKD-LKKYMDTHGVRGALDPNT 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L +G+++ H +++HRD+K +N+L++K +K+ADFG+AR N + E
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161
Query: 234 GTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIY 266
TL Y AP+VL G+ Y+ D++S G + E+
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-21
Identities = 61/235 (25%), Positives = 117/235 (49%), Gaps = 35/235 (14%)
Query: 57 VIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G FGTV++GL+ +G VA+K L EA E V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKEILDEAYVMAS 65
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+D+P+V + +G + S+ +Q ++ + +P G L Y+ +++ +
Sbjct: 66 VDNPHVCRLLGICLTST---VQ--------------LITQLMPFGCLLDYVREHKDN-IG 107
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A++ ++ +
Sbjct: 108 SQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167
Query: 231 GETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTS 282
E G + +MA E + Y + DV+S+G+ +WE+ PY + SE++S
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 222
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 74/233 (31%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 54 IKSVIARGTFGTVHR--GLYDGHDVAVKLLD-WGEEGHRTEAEIAALRSAFTQEVAVWHK 110
I I +GT+G V++ DG AVK+LD + EAE L+S
Sbjct: 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL---------- 75
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRR 167
+HPNV KF G + +L GQ+ + V+E GG++ T L+K +
Sbjct: 76 PNHPNVVKFYGMFYKADKL----VGGQLWL-------VLELCNGGSV-TELVKGLLICGQ 123
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+L ++ + GL +LH+ +I+HRDVK N+LL VK+ DFGV+ S
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 228 DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ Y+ +CDV+S GI E+ D P D+
Sbjct: 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-21
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 18/171 (10%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E + K+ HPN+ F + L+I V+EY GG L +
Sbjct: 47 KEAVLLAKMKHPNIVAFKESFEADGHLYI----------------VMEYCDGGDLMQKIK 90
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
R + ++Q + + G+ ++H ++++HRD+K++N+ L +N VK+ DFG AR+
Sbjct: 91 LQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
S GT Y+ PE+ PYN K D++S G L+E+ C + +P
Sbjct: 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYEL--CTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 50/227 (22%), Positives = 106/227 (46%), Gaps = 34/227 (14%)
Query: 66 VHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125
+++G+++ +V ++ +GH+ +I E+ ++D N+ K G +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDI------TENEIKNLRRIDSNNILKIYGFIID 89
Query: 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGL 185
+P +++EY G L+ L K + L+FK + +A+D +GL
Sbjct: 90 IV----------DDLPRLS--LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGL 135
Query: 186 SYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP----NDMTGETGTLGYMA 240
L+ ++++ + + L+ +N +KI G+ ++ +S P N M Y +
Sbjct: 136 YNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-------YFS 188
Query: 241 PEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285
++LN + Y K D+YS G+ LWEI+ +P+ +L+ E+ ++
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII 235
|
Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-21
Identities = 58/184 (31%), Positives = 96/184 (52%), Gaps = 24/184 (13%)
Query: 93 EI-AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
EI A+R+ +E+ V H+ + P + F GA E+ +IC +E+
Sbjct: 37 EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI-------------SIC---MEH 80
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRT 210
+ GG+L L K R + ++ ++++ + RGL+YL + KI+HRDVK N+L++
Sbjct: 81 MDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE 138
Query: 211 VKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269
+K+ DFGV+ ++ S N GT YM+PE L G Y + D++S G+ L E+
Sbjct: 139 IKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
Query: 270 MPYP 273
P P
Sbjct: 196 YPIP 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 39/150 (26%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLA-FKVV-VQLALDLARGLSYLHSQKIVHRDVKTENM 203
V+EY+PGG L LI+ + A F + + LALD +H +HRD+K +N+
Sbjct: 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD------SVHKLGFIHRDIKPDNI 132
Query: 204 LLDKNRTVKIADFGVA------------RVEASNPNDMTGET-----------------G 234
L+D + +K+ADFG+ ++ N G
Sbjct: 133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
T Y+APEVL G PY +CD +S G+ L+E
Sbjct: 193 TPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-20
Identities = 70/245 (28%), Positives = 109/245 (44%), Gaps = 30/245 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
WEI L + + +G FG V G ++G VA+K L G + AF Q
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG----------TMMPEAFLQ 50
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E + KL H + A + ++I V E++ G+L +L +
Sbjct: 51 EAQIMKKLRHDKLVPLY-AVVSEEPIYI----------------VTEFMGKGSLLDFLKE 93
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VE 222
+ L +V +A +A G++Y+ +HRD++ N+L+ N KIADFG+AR +E
Sbjct: 94 GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281
+ G + + APE + K DV+SFGI L E+ +PYP + EV
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213
Query: 282 SAVVR 286
V R
Sbjct: 214 EQVER 218
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 46/125 (36%), Positives = 72/125 (57%), Gaps = 2/125 (1%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EYL GG L ++ + R A A ++ GL +LH + I++RD+K +N+LLDK
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDEARARF--YAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ +KIADFG+ + + + GT Y+APE+L G YN D +SFG+ L+E+
Sbjct: 132 DGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191
Query: 268 CDMPY 272
P+
Sbjct: 192 GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 41/246 (16%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD----VAVKLL-DWGEEGHRTEAEIAALRS 99
++ ++L ++ G FGTVH+G++ +G VA+K + D G +T EI
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEI----- 56
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
T + LDH + + +G G+S +Q +V + P G+L
Sbjct: 57 --TDHMLAMGSLDHAYIVRLLGICPGAS---LQ--------------LVTQLSPLGSLLD 97
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ ++ R L + ++ + +A+G+ YL ++VHR++ N+LL + V+IADFGVA
Sbjct: 98 H-VRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
Query: 220 RVEASNPND---MTGETGT-LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPD 274
+ P+D E T + +MA E + Y + DV+S+G+ +WE+ PY
Sbjct: 157 --DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 275 LSFSEV 280
+ EV
Sbjct: 215 MRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 78/305 (25%), Positives = 118/305 (38%), Gaps = 92/305 (30%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
WE +L + V+ G FG V G D VAVK+L G T +E AL
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKAL 57
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
S + H +H NV +GA P+ V+VE+ G L
Sbjct: 58 MSELKILI---HIGNHLNVVNLLGA---------------CTKPNGPLMVIVEFCKYGNL 99
Query: 158 KTYLIKNR-----------RRKLAFKVVVQLA---------------------------- 178
+L R +++ F+ +V+ +
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159
Query: 179 ---------------------LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
+ARG+ +L S+K +HRD+ N+LL +N VKI DFG
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219
Query: 218 VARVEASNPNDMTGETG--TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPD 274
+AR +P+ + + L +MAPE + Y + DV+SFG+ LWEI+ PYP
Sbjct: 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279
Query: 275 LSFSE 279
+ +E
Sbjct: 280 VQINE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 68/217 (31%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAE-----IAALRSAFTQEVAVWHK 110
I GT+G V+R G VA+K + R + E I++LR E+ +
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-------RMDNERDGIPISSLR-----EITLLLN 62
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
L HPN+ + +G I +V+EY L+ N +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSI--------------FLVMEYCEQDLAS--LLDNMPTPFS 106
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
V L L L RGL YLH I+HRD+K N+LL +KIADFG+AR MT
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ TL Y APE+L G C Y+ I +W + C
Sbjct: 167 PKVVTLWYRAPELLLG------CTTYTTAIDMWAVGC 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-20
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V++G G VA+K + R E+E + S +E+++ +L HPN
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ M S L++ + E+L LK YL + + +V
Sbjct: 61 IVCLQDVLMQESRLYL----------------IFEFLSMD-LKKYLDSLPKGQYMDAELV 103
Query: 176 QLAL-DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ L + +G+ + HS++++HRD+K +N+L+D +K+ADFG+AR T E
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV 163
Query: 235 TLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
TL Y APEVL G+P Y+ D++S G E+
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-20
Identities = 55/217 (25%), Positives = 109/217 (50%), Gaps = 34/217 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDV----AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G FGTV++G++ +G V A+K+L+ G + E F E +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVE-------FMDEALIMAS 65
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+DHP++ + +G + + IQ +V + +P G L Y + + +
Sbjct: 66 MDHPHLVRLLGVCLSPT---IQ--------------LVTQLMPHGCLLDY-VHEHKDNIG 107
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++++ + +A+G+ YL +++VHRD+ N+L+ VKI DFG+AR+ + +
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167
Query: 231 GETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+ G + +MA E ++ + + DV+S+G+ +WE+
Sbjct: 168 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT-QEVAVWHKLDH 113
++ +GTFG V + G A+K+L + E +A A T E V H
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKIL-------KKEVIVAKDEVAHTLTENRVLQNSRH 54
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P F+ A S + H + C V+EY GG L +L +R R +
Sbjct: 55 P----FLTALKYSFQTH------------DRLCFVMEYANGGELFFHL--SRERVFSEDR 96
Query: 174 VVQLALDLARGLSYLHSQK-IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
++ L YLHS+K +V+RD+K EN++LDK+ +KI DFG+ + + M
Sbjct: 97 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF 156
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL N Y R D + G+ ++E+ C +P+
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-20
Identities = 45/129 (34%), Positives = 73/129 (56%), Gaps = 1/129 (0%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V+ + GG LK ++ R L + V+ + + G+ +LHS IV+RD+K EN+LL
Sbjct: 69 CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL 128
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D +++D G+A VE + +T GT GYMAPE+L PY+ D ++ G ++E+
Sbjct: 129 DDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
Query: 266 YCCDMPYPD 274
P+ D
Sbjct: 188 VAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-20
Identities = 76/233 (32%), Positives = 108/233 (46%), Gaps = 33/233 (14%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I I +GT+G V + L +G AVK+LD H + EI A E + L
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILD---PIHDIDEEIEA-------EYNILKAL 71
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK---NRRR 167
DHPNV KF G +NG + +V+E GG++ T L+K R
Sbjct: 72 SDHPNVVKFYGMYYKKD-----VKNG------DQLWLVLELCNGGSV-TDLVKGFLKRGE 119
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
++ ++ + + GL +LH K +HRDVK N+LL VK+ DFGV+ S
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 228 DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ + Y+ +CDV+S GI E+ D P DL
Sbjct: 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 67/229 (29%), Positives = 100/229 (43%), Gaps = 53/229 (23%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVK-----LLDWGEEGHRTEAEIAALRSAFTQEV 105
VIK + GTFG+V+ G VA+K W E LR EV
Sbjct: 3 VIKQ-LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--------EECMNLR-----EV 48
Query: 106 AVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
KL +HPN+ K + EL+ V EY+ G + L+K+
Sbjct: 49 KSLRKLNEHPNIVKLKEVFRENDELYF----------------VFEYMEGNLYQ--LMKD 90
Query: 165 RRRKL-----AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
R+ K ++ Q+ GL+++H HRD+K EN+L+ VKIADFG+A
Sbjct: 91 RKGKPFSESVIRSIIYQILQ----GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
Query: 220 R-VEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIY 266
R + + P T T Y APE+L + Y+ D+++ G + E+Y
Sbjct: 147 REIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-20
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 34/224 (15%)
Query: 58 IARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I G+ G V R + G VAVK++D ++ R EV + H N
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---------ELLFNEVVIMRDYQHQN 79
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
V + + + EL V++E+L GGAL + + R + V
Sbjct: 80 VVEMYKSYLVGEEL----------------WVLMEFLQGGALTDIVSQTRLNEEQIATVC 123
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L YLHSQ ++HRD+K++++LL + VK++DFG + + GT
Sbjct: 124 ESVL---QALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT 180
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
+MAPEV++ PY + D++S GI + E+ + PY FS+
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY----FSD 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-20
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 30/164 (18%)
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+L HPN+ ++ + + L+I V++ + G L + + +K
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYI----------------VMDLIEGAPLGEHFNSLKEKKQ 108
Query: 170 AF------KVVVQLALDLARGLSYLHSQK-IVHRDVKTENMLLDKNRTVKIADFGVARVE 222
F + VQ+ L L YLH +K IVHRD+ N++L ++ V I DFG+A+
Sbjct: 109 RFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-- 162
Query: 223 ASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
P +T GT+ Y PE++ PY K DV++FG L+++
Sbjct: 163 QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-20
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA+K ++ ++ + E+ V + HPN
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---------ELIINEILVMRENKHPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL VV+EYL GG+L + + + V
Sbjct: 78 IVNYLDSYLVGDELW----------------VVMEYLAGGSLTDVVTETCMDEGQIAAVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 122 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
+MAPEV+ Y K D++S GI E+ + PY
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-20
Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 71 YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130
+ G VAVK +D ++ R EV + H NV + + EL
Sbjct: 45 HTGKQVAVKKMDLRKQQRR---------ELLFNEVVIMRDYHHENVVDMYNSYLVGDEL- 94
Query: 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190
VV+E+L GGAL + R + + + + L + R LSYLH+
Sbjct: 95 ---------------WVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHN 136
Query: 191 QKIVHRDVKTENMLLDKNRTVKIADFG-VARVEASNPNDMTGETGTLGYMAPEVLNGNPY 249
Q ++HRD+K++++LL + +K++DFG A+V P + GT +MAPEV++ PY
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPY 195
Query: 250 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQVQ 289
+ D++S GI + E+ + PY F+E +R+++
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY----FNEPPLQAMRRIR 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 15/193 (7%)
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC------- 145
E+ A + T ++ KLD + K G M +E I +V+ +
Sbjct: 8 EVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE---KVSSRFIVSLAYAFET 64
Query: 146 ----CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201
C+V+ + GG LK ++ + A + GL +LH ++IV+RD+K E
Sbjct: 65 KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPE 124
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
N+LLD + V+I+D G+A VE + G GT GYMAPEVL G Y+ D ++ G
Sbjct: 125 NVLLDDHGNVRISDLGLA-VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCT 183
Query: 262 LWEIYCCDMPYPD 274
L+E+ P+
Sbjct: 184 LYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---D 112
I G +GTV+ R + GH VA+K + R + L + +EVA+ +L D
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-------RVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
HPN+ + + +S +T+ +V E++ L+TYL K L +
Sbjct: 61 HPNIVRLMDVC-ATSRTDRETK----------VTLVFEHVDQD-LRTYLDKVPPPGLPAE 108
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ L RGL +LH+ IVHRD+K EN+L+ VK+ADFG+AR+ S +T
Sbjct: 109 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPV 167
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TL Y APEVL + Y D++S G E++
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 70/226 (30%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 61 GTFGTVHRGLY--DGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GTFG V++ G VA+K L+ ++G I ALR E+ + KL HPNV
Sbjct: 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDG----FPITALR-----EIKILKKLKHPNV 69
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY----LPGGALKTYLIKNRRRKLAFK 172
I + + + + G V M V Y L G L++N KL
Sbjct: 70 VPLIDMAVERPDKS-KRKRGSVYM-------VTPYMDHDLSG------LLENPSVKLTES 115
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV-EASNPNDMTG 231
+ L L G++YLH I+HRD+K N+L+D +KIADFG+AR + PN G
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 232 ETG----------TLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIY 266
G T Y PE+L G Y D++ G E++
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 57/195 (29%), Positives = 102/195 (52%), Gaps = 23/195 (11%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
A+R+ +E+ V H+ + P + F GA E+ +IC +E++ GG
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-------------SIC---MEHMDGG 88
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIA 214
+L L + +R + +++ ++++ + RGL+YL + +I+HRDVK N+L++ +K+
Sbjct: 89 SLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLC 146
Query: 215 DFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFGV+ ++ S N G T YM+PE L G Y+ + D++S G+ L E+ P P
Sbjct: 147 DFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203
Query: 274 DLSFSEVTSAVVRQV 288
E+ + R V
Sbjct: 204 PPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 41/105 (39%), Positives = 61/105 (58%), Gaps = 3/105 (2%)
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL- 236
+ +ARG+ +L S+K +HRD+ N+LL +N VKI DFG+AR +P+ + L
Sbjct: 179 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 237 -GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSE 279
+MAPE + Y + DV+SFG+ LWEI+ PYP + E
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 48/131 (36%), Positives = 73/131 (55%), Gaps = 14/131 (10%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EYL GG L ++ + L A ++ GL +LHS+ IV+RD+K +N+LLD
Sbjct: 74 VMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGET------GTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
+ +KIADFG+ + +M G+ GT Y+APE+L G YN D +SFG+
Sbjct: 132 DGHIKIADFGMCK------ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVL 185
Query: 262 LWEIYCCDMPY 272
L+E+ P+
Sbjct: 186 LYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 68/256 (26%), Positives = 112/256 (43%), Gaps = 51/256 (19%)
Query: 31 IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTV----HRGLYDGHDVAVKLLDWGEE 86
+ A F K W++ S + + G+FG V H+G G A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKL--SDFEMGETLGTGSFGRVRIAKHKG--TGEYYAIKCL----- 51
Query: 87 GHRTEAEIAALRSA--FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNI 144
+ EI ++ QE ++ +L HP + + + + ++
Sbjct: 52 ---KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF------------- 95
Query: 145 CCVVVEYLPGGALKTYLIK-----NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
++E++ GG L T+L K N K +V LA + YLHS+ I++RD+K
Sbjct: 96 ---LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV-LAFE------YLHSKDIIYRDLK 145
Query: 200 TENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258
EN+LLD VK+ DFG A +V P+ GT Y+APEV+ + + D ++
Sbjct: 146 PENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTM 201
Query: 259 GICLWEIYCCDMPYPD 274
G+ L+E P+ D
Sbjct: 202 GVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 73/259 (28%), Positives = 117/259 (45%), Gaps = 53/259 (20%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTV--HRGLYDG--HDVAVKLL-DWG-EEGHRTEAEIAAL 97
+W + + + VI G FG V R DG D A+K + ++ ++ HR
Sbjct: 5 EW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD------- 53
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
F E+ V KL HPN+ +GA L++ +EY P G
Sbjct: 54 ---FAGELEVLCKLGHHPNIINLLGACEHRGYLYL----------------AIEYAPHGN 94
Query: 157 LKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
L +L K+R L+ + ++ A D+ARG+ YL ++ +HRD+ N
Sbjct: 95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+L+ +N KIADFG++R + G + +MA E LN + Y DV+S+G+ L
Sbjct: 155 ILVGENYVAKIADFGLSRGQEVYVKKTMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLL 213
Query: 263 WEIYCC-DMPYPDLSFSEV 280
WEI PY ++ +E+
Sbjct: 214 WEIVSLGGTPYCGMTCAEL 232
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-19
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 29/202 (14%)
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F QEV + +L+HPNV + +G + S +V+E+ P G LK Y
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPY----------------LLVLEFCPLGDLKNY 85
Query: 161 LIKNR--RRKLAFKVVVQ-LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
L NR ++A K V+Q +A ++A GL +LH +H D+ N L + +VKI D+G
Sbjct: 86 LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYG 145
Query: 218 VARVEASNPNDMTGETGT--LGYMAPEVLNGNPYN-------RKCDVYSFGICLWEIY-C 267
+A + +T + L ++APE++ + +K +++S G+ +WE++
Sbjct: 146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
Query: 268 CDMPYPDLSFSEVTSAVVRQVQ 289
D PYPDLS +V VVR+
Sbjct: 206 ADQPYPDLSDEQVLKQVVREQD 227
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 70/243 (28%), Positives = 118/243 (48%), Gaps = 35/243 (14%)
Query: 51 KLVIKSVIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K I V+ G GTV + + DG AVK++D EG +EA+ ++ EV
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDM--EGM-SEADKNRAQA----EVCCL 85
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV--VVEYLPGGALKTYLIKNRR 166
D ++ K H P N+ + V++Y G L+ IK+R
Sbjct: 86 LNCDFFSIVK----------CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQE-IKSRA 134
Query: 167 R-KLAFK------VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ F+ + +Q+ L + ++HS+ ++HRD+K+ N+LL N VK+ DFG +
Sbjct: 135 KTNRTFREHEAGLLFIQVLL----AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
Query: 220 RVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
++ A+ +D G T GT Y+APE+ PY++K D++S G+ L+E+ P+ +
Sbjct: 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250
Query: 278 SEV 280
EV
Sbjct: 251 EEV 253
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-19
Identities = 44/125 (35%), Positives = 75/125 (60%), Gaps = 2/125 (1%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+E+L GG L + I+++ R ++ A ++ GL +LHS+ I++RD+K +N++LD+
Sbjct: 74 VMEFLNGGDL-MFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ +KIADFG+ + N + GT Y+APE+L G Y D +SFG+ L+E+
Sbjct: 132 DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191
Query: 268 CDMPY 272
P+
Sbjct: 192 GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-19
Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 26/180 (14%)
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ + +HP + K +GA +L I ++E+ PGGA+ +++
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWI----------------MIEFCPGGAVDAIMLE 102
Query: 164 NRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
R + +V+ + L+ L YLHS KI+HRD+K N+LL + +K+ADFGV+
Sbjct: 103 LDRGLTEPQIQVICRQMLE---ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
Query: 222 EASNPNDMTGETGTLGYMAPEV-----LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
GT +MAPEV + PY+ K D++S GI L E+ + P+ +L+
Sbjct: 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 48/144 (33%), Positives = 79/144 (54%), Gaps = 8/144 (5%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L Y I+ + FK V A ++A GL +LHS+ I++RD+K +N++L
Sbjct: 79 VMEYVNGGDL-MYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
D +KIADFG+ + E T GT Y+APE++ PY + D ++FG+ L+E
Sbjct: 135 DAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
Query: 265 IYCCDMPYPDLSFSEVTSAVVRQV 288
+ P+ E+ +++
Sbjct: 194 MLAGQPPFDGEDEDELFQSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-19
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 43/219 (19%)
Query: 56 SVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV----AVWH 109
+ GTFG VH R H A+K++ E+ L+ Q V V
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAI--------PEVIRLKQ--EQHVHNEKRVLK 56
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
++ HP + + L++ ++EY+PGG L +YL +N R
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYM----------------LMEYVPGGELFSYL-RNSGR-- 97
Query: 170 AFKVVVQL--ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
F L A ++ L YLHS++IV+RD+K EN+LLDK +K+ DFG A+
Sbjct: 98 -FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLR 152
Query: 228 DMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D T GT Y+APEV+ +N+ D ++ GI ++E+
Sbjct: 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-19
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I GT+GTV + VA+K LD +EG + +ALR E+ + +L H
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALR-----EICLLKELKH 58
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ + +L + V EY LK Y + + ++
Sbjct: 59 KNIVRLYDVLHSDKKLTL----------------VFEYCDQD-LKKYF-DSCNGDIDPEI 100
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L +GL++ HS ++HRD+K +N+L++KN +K+ADFG+AR + E
Sbjct: 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160
Query: 234 GTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
TL Y P+VL G Y+ D++S G E+
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-19
Identities = 70/235 (29%), Positives = 104/235 (44%), Gaps = 44/235 (18%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDW----GEEGHRTEAEI 94
+ WE+ P + S + G +G V G VA+K L RT E+
Sbjct: 7 NKTVWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL 65
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVE 150
L+ H +DH NV IG T SS Q V + V
Sbjct: 66 RLLK----------H-MDHENV---IGLLDVFTPASSLEDFQ----DVYL--------VT 99
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
+L G L + + +KL+ + L + RGL Y+HS I+HRD+K N+ ++++
Sbjct: 100 HLMGADLNNIV---KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE 156
Query: 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWE 264
+KI DFG+AR ++MTG T Y APE+ LN YN+ D++S G + E
Sbjct: 157 LKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 54/180 (30%), Positives = 96/180 (53%), Gaps = 23/180 (12%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
A+R+ +E+ V H+ + P + F GA E+ +IC +E++ GG
Sbjct: 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-------------SIC---MEHMDGG 88
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIA 214
+L L K ++ +++ ++++ + +GL+YL + KI+HRDVK N+L++ +K+
Sbjct: 89 SLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 146
Query: 215 DFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFGV+ ++ S N G T YM+PE L G Y+ + D++S G+ L E+ P P
Sbjct: 147 DFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 42/120 (35%), Positives = 66/120 (55%), Gaps = 1/120 (0%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V+ + GG LK ++ + V A ++ GL LH ++IV+RD+K EN+LL
Sbjct: 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
D ++I+D G+A VE + G GT+GYMAPEV+ Y D + G ++E+
Sbjct: 136 DDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I GT+G V+ R G VA+K L+ EEG ALR E+++ L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----IPPTALR-----EISLLQMLSE 59
Query: 114 -PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---RKL 169
+ + + H++ +NG+ ++ +V EYL LK ++ N R R L
Sbjct: 60 SIYIVRLLDVE------HVEEKNGKPSL-----YLVFEYLDSD-LKKFMDSNGRGPGRPL 107
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIADFGVARVEASNPND 228
K + L +G+++ H ++HRD+K +N+L+DK + + KIAD G+ R +
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 229 MTGETGTLGYMAPEVLNGNP-YNRKCDVYSFG 259
T E TL Y APEVL G+ Y+ D++S G
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG 199
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 49/130 (37%), Positives = 73/130 (56%), Gaps = 4/130 (3%)
Query: 153 PGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
P + LI N L++ +V + +A G+ +L S+ VHRD+ N+L+ + + VK
Sbjct: 221 PERTRRDTLI-NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVK 279
Query: 213 IADFGVARVEASNPNDMT-GETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-D 269
I DFG+AR + N ++ G T L +MAPE + N Y DV+SFGI LWEI+
Sbjct: 280 ICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339
Query: 270 MPYPDLSFSE 279
PYP+L +E
Sbjct: 340 TPYPELPMNE 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 71/255 (27%), Positives = 113/255 (44%), Gaps = 53/255 (20%)
Query: 63 FGTVHRG-LY-DGHD----VAVKLL-DWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
FG +++G LY G D VA+K L D E F QE ++ +L HPN
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE---------FQQEASLMAELHHPN 68
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------- 165
+ +G T+ V C++ EYL G L +LI
Sbjct: 69 IVCLLGVV---------TQEQPV-------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 166 -----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ L + +A+ +A G+ YL S VH+D+ N+L+ + VKI+D G++R
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 221 VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 276
E + + + +L +M PE + ++ D++SFG+ LWEI+ + PY S
Sbjct: 173 -EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231
Query: 277 FSEVTSAVVRQVQYL 291
EV +VR+ Q L
Sbjct: 232 NQEVIE-MVRKRQLL 245
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 68/228 (29%), Positives = 114/228 (50%), Gaps = 35/228 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH- 113
V+ GT+G V++G + G A+K++D E+ E EI E+ + K H
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED---EEEEI-------KLEINMLKKYSHH 72
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFK 172
N+ + GA + S + Q+ + V+E+ G++ T L+KN + L
Sbjct: 73 RNIATYYGAFIKKSP---PGHDDQLWL-------VMEFCGAGSV-TDLVKNTKGNALKED 121
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ + ++ RGL++LH+ K++HRD+K +N+LL +N VK+ DFGV+
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 233 TGTLGYMAPEVL--NGNP---YNRKCDVYSFGICLWEIY-----CCDM 270
GT +MAPEV+ + NP Y+ + D++S GI E+ CDM
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 61 GTFGTVHRGLYDGHDV--AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118
G FG V++ V A K++D ++E E+ + E+ + DHPN+ K
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVID-----TKSEEEL----EDYMVEIDILASCDHPNIVK 66
Query: 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQ 176
+ A + L I ++E+ GGA+ +++ R + +VV +
Sbjct: 67 LLDAFYYENNLWI----------------LIEFCAGGAVDAVMLELERPLTEPQIRVVCK 110
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L+ L+YLH KI+HRD+K N+L + +K+ADFGV+ GT
Sbjct: 111 QTLE---ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 167
Query: 237 GYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
+MAPEV+ PY+ K DV+S GI L E+ + P+ +L+
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 4e-18
Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 35/228 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLD-WGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
++ GT+G V++G + G A+K++D G+E + EI L+ H
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----------HH 62
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFK 172
N+ + GA + + + + +V+E+ G++ T LIKN + L +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQ----------LWLVMEFCGAGSV-TDLIKNTKGNTLKEE 111
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ + ++ RGLS+LH K++HRD+K +N+LL +N VK+ DFGV+
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 233 TGTLGYMAPEVL--NGNP---YNRKCDVYSFGICLWEIY-----CCDM 270
GT +MAPEV+ + NP Y+ K D++S GI E+ CDM
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 38/79 (48%), Positives = 51/79 (64%), Gaps = 2/79 (2%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAP 241
RGL YLHS I+HRD+K N+L++ N +KI DFG+ARVE + + MT E T Y AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 242 EVLNGNP-YNRKCDVYSFG 259
E+L G+ Y D++S G
Sbjct: 174 EILMGSRHYTSAVDIWSVG 192
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 41/224 (18%)
Query: 58 IARGTFGTVHRGL--YDGHDVA---VKLLDWGEEGHRTEAEIAALRSAFT--QEVAVWHK 110
+ GT+G V + G VA VK+++ + + + FT +E+ + ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ H N+ MG +++++ + +V++ + K + +R+ +L
Sbjct: 77 IKHENI-------MGLVDVYVEGD---------FINLVMDIMASDLKK---VVDRKIRLT 117
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP---- 226
V + L + GL+ LH +HRD+ N+ ++ KIADFG+AR P
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 227 ----------NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFG 259
+MT + TL Y APE+L G Y+ D++S G
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 49/264 (18%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
I+ +V+K + G FG V D VAVK L + +AA R
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--------KDPTLAA-RK 52
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F +E + L H ++ KF G L +V EY+ G L
Sbjct: 53 DFQREAELLTNLQHEHIVKFYGVCGDGDPL----------------IMVFEYMKHGDLNK 96
Query: 160 YL--------------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+L + + +L ++ +A +A G+ YL SQ VHRD+ T N L+
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156
Query: 206 DKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
N VKI DFG++R V +++ + G T + +M PE + + + DV+SFG+ LW
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216
Query: 264 EIYCC-DMPYPDLSFSEVTSAVVR 286
EI+ P+ LS +EV + +
Sbjct: 217 EIFTYGKQPWFQLSNTEVIECITQ 240
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-18
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 47/248 (18%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA+K ++ ++ + E+ V + +PN
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---------ELIINEILVMRENKNPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL VV+EYL GG+L + + + V
Sbjct: 78 IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 122 RECL---QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY-----------------PDLSFS 278
+MAPEV+ Y K D++S GI E+ + PY P+L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 279 EVTSAVVR 286
E SAV R
Sbjct: 239 ERLSAVFR 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-17
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 53/225 (23%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVK--------LLDWGEEGHRTEAEIAALRSAFTQ 103
+ I G +G V + G VA+K L+D R EI LR
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID----AKRILREIKLLRH---- 55
Query: 104 EVAVWHKLDHPNVTKFI-----GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
L H N+ + + ++++I TE M +++
Sbjct: 56 -------LRHENIIGLLDILRPPSPEDFNDVYIVTE----LMETDLH------------- 91
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
+IK+ + L + + RGL YLHS ++HRD+K N+L++ N +KI DFG+
Sbjct: 92 -KVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL 149
Query: 219 ARV---EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFG 259
AR + +T T Y APE+ L+ + Y + D++S G
Sbjct: 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG 194
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV + G +VA+K ++ ++ + E+ V +L +PN
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---------ELIINEILVMKELKNPN 77
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ F+ + + EL VV+EYL GG+L + + + V
Sbjct: 78 IVNFLDSFLVGDELF----------------VVMEYLAGGSLTDVVTETCMDEAQIAAVC 121
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LH+ +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 122 RECL---QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
+MAPEV+ Y K D++S GI E+ + PY
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 41/117 (35%), Positives = 67/117 (57%), Gaps = 3/117 (2%)
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
++ L + ++ + +A+G+ +L S+K +HRD+ N+LL +N VKI DFG+AR +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 226 PNDMTGETG--TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSE 279
P+ + L +MAPE + Y + DV+SFG+ LWEI+ PYP + E
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 34/89 (38%), Positives = 55/89 (61%)
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEV 243
GL +LH ++I++RD+K EN+LLD + V+I+D G+A + G GT G+MAPE+
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 244 LNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
L G Y+ D ++ G+ L+E+ P+
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 52/141 (36%), Positives = 75/141 (53%), Gaps = 16/141 (11%)
Query: 147 VVVEYLPGGALKT----YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
+V+EY+PGG L Y I + + VV LALD +HS +HRDVK +N
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVV-LALDA------IHSMGFIHRDVKPDN 172
Query: 203 MLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNG----NPYNRKCDVYS 257
MLLDK+ +K+ADFG +++A+ GT Y++PEVL Y R+CD +S
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 258 FGICLWEIYCCDMPYPDLSFS 278
G+ L+E+ D P+ S
Sbjct: 233 VGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 30/201 (14%)
Query: 73 GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132
G VAVK +D ++ R EV + H NV + + + EL
Sbjct: 45 GKLVAVKKMDLRKQQRR---------ELLFNEVVIMRDYQHENVVEMYNSYLVGDEL--- 92
Query: 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192
VV+E+L GGAL + R + + + + L + + LS LH+Q
Sbjct: 93 -------------WVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQG 136
Query: 193 IVHRDVKTENMLLDKNRTVKIADFG-VARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR 251
++HRD+K++++LL + VK++DFG A+V P + GT +MAPE+++ PY
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGP 195
Query: 252 KCDVYSFGICLWEIYCCDMPY 272
+ D++S GI + E+ + PY
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHKLDH 113
VI +G+FG V + DG AVK+L + E I A R+ + + H
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK------H 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + + + +L+ V++Y+ GG L +L R R
Sbjct: 56 PFLVGLHYSFQTAEKLYF----------------VLDYVNGGELFFHL--QRERCFLEPR 97
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE- 232
A ++A + YLHS I++RD+K EN+LLD V + DFG+ + E P + T
Sbjct: 98 ARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTF 156
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
GT Y+APEVL PY+R D + G L+E+
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI-QTENGQVAM-------PSN 143
E+ A + T ++ +L+ + K G +M +E I + N Q + +
Sbjct: 14 GEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD 73
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V+ + GG LK ++ + + A ++ GL LH + V+RD+K EN+
Sbjct: 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD ++I+D G+A V+ + G GT+GYMAPEVLN Y D + G ++
Sbjct: 134 LLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIY 192
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 193 EMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLL 205
+V+EY PGG L + L NR + + Q L +L + +H VHRD+K EN+L+
Sbjct: 78 LVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135
Query: 206 DKNRTVKIADFG-VARVEASNPNDMTGETGTLGYMAPEVL---NGNP---YNRKCDVYSF 258
D+ +K+ADFG AR+ A+ + GT Y+APEVL NG+ Y +CD +S
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 259 GICLWEIYCCDMPYPDLSFSEVTSAV 284
G+ +E+ P F E TSA
Sbjct: 196 GVIAYEMIYGRSP-----FHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 62/233 (26%), Positives = 114/233 (48%), Gaps = 35/233 (15%)
Query: 57 VIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+ G FGTV++G++ DG + VA+K+L E +A L A+ V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RENTSPKANKEILDEAY-----VMAG 65
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ P V + +G + S+ +Q +V + +P G L Y+ +N+ R +
Sbjct: 66 VGSPYVCRLLGICLTST---VQ--------------LVTQLMPYGCLLDYVRENKDR-IG 107
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ ++ + +A+G+SYL ++VHRD+ N+L+ VKI DFG+AR+ + +
Sbjct: 108 SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167
Query: 231 GETGT--LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEV 280
+ G + +MA E + + + DV+S+G+ +WE+ PY + E+
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 45/146 (30%), Positives = 81/146 (55%), Gaps = 10/146 (6%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+EY+ GG L ++ R+RKL + A ++ L++LH + I++RD+K +N+LLD
Sbjct: 73 LVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 207 KNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+ +K+ D+G+ + E P D T GT Y+APE+L G Y D ++ G+ ++E+
Sbjct: 131 ADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 266 YCCDMPY------PDLSFSEVTSAVV 285
P+ PD++ + V+
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 42/115 (36%), Positives = 63/115 (54%), Gaps = 15/115 (13%)
Query: 149 VEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
+E P G L ++R RK F+++ RG+ + HS I+HRD+K EN+L+ ++
Sbjct: 90 LEKYPNG-----LDESRVRKYLFQIL--------RGIEFCHSHNIIHRDIKPENILVSQS 136
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICL 262
VK+ DFG AR A+ T T Y APE+L G+ Y R D+++ G CL
Sbjct: 137 GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG-CL 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 9/189 (4%)
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI-QTENGQVAMP-------SN 143
E+ A + T ++ KL+ + K G +M +E I + N + + +
Sbjct: 14 GEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD 73
Query: 144 ICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
C+V+ + GG LK ++ V A ++ GL LH ++IV+RD+K EN+
Sbjct: 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD + ++I+D G+A V + G GT+GYMAPEV+ Y D ++ G L+
Sbjct: 134 LLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 192
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 193 EMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114
I GTF V + G A+K + ++ ++ ++ LR E+ +L HP
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM---KKHFKSLEQVNNLR-----EIQALRRLSPHP 58
Query: 115 NVTKFIGATMGSSELHIQTENGQVA-----MPSNICCVVVEYLPGGALKTY-LIKNRRRK 168
N+ + I E+ + G++A M N+ Y LIK R+R
Sbjct: 59 NILRLI-------EVLFDRKTGRLALVFELMDMNL---------------YELIKGRKRP 96
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
L K V L + L ++H I HRD+K EN+L+ + +K+ADFG R S P
Sbjct: 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP-P 154
Query: 229 MTGETGTLGYMAPE-VLNGNPYNRKCDVYSFGICLWEI 265
T T Y APE +L Y K D+++ G +EI
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 35/89 (39%), Positives = 53/89 (59%), Gaps = 5/89 (5%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND----MTGETGTL 236
L RGL Y+HS ++HRD+K N+L++++ ++I DFG+AR +S+P + MT T
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
Query: 237 GYMAPEVLNGNP-YNRKCDVYSFGICLWE 264
Y APE+L P Y D++S G E
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 42/126 (33%), Positives = 73/126 (57%), Gaps = 4/126 (3%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ GG L ++ R+RKL + + +++ L+YLH + I++RD+K +N+LLD
Sbjct: 74 VIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+K+ D+G+ + E P D T GT Y+APE+L G Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 267 CCDMPY 272
P+
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 36/225 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ GT+G V+ R L+ G AVK++ E G S QE+ + + H N
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDF--------SLIQQEIFMVKECKHCN 67
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK-TYLIKNRRRKLAFKVV 174
+ + G+ + +L I +EY GG+L+ Y + +L V
Sbjct: 68 IVAYFGSYLSREKLWI----------------CMEYCGGGSLQDIYHVTGPLSELQIAYV 111
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ L +GL+YLHS+ +HRD+K N+LL N VK+ADFGVA + G
Sbjct: 112 CRETL---QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIG 168
Query: 235 TLGYMAPEVL----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
T +MAPEV NG YN+ CD+++ GI E+ P DL
Sbjct: 169 TPYWMAPEVAAVEKNGG-YNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 42/126 (33%), Positives = 60/126 (47%), Gaps = 21/126 (16%)
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTE 201
EY+PGG +T L L+ D AR + LH +HRD+K E
Sbjct: 81 EYVPGGDFRTLLNNLG----------VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPE 130
Query: 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
N L+D + +K+ DFG+++ + N + G YMAPEVL G Y+ D +S G
Sbjct: 131 NFLIDASGHIKLTDFGLSKGIVTYANSVVGSP---DYMAPEVLRGKGYDFTVDYWSLGCM 187
Query: 262 LWEIYC 267
L+E C
Sbjct: 188 LYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 38/107 (35%), Positives = 63/107 (58%), Gaps = 10/107 (9%)
Query: 173 VVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM-- 229
++ ++A+ + + L YLHS+ ++HRDVK N+L+++N VK+ DFG++ + +
Sbjct: 104 ILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS---GYLVDSVAK 160
Query: 230 TGETGTLGYMAPEVLN--GNP--YNRKCDVYSFGICLWEIYCCDMPY 272
T + G YMAPE +N N Y+ K DV+S GI + E+ PY
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-17
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA++ ++ ++ + E+ V + +PN
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---------ELIINEILVMRENKNPN 78
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL VV+EYL GG+L + + + V
Sbjct: 79 IVNYLDSYLVGDEL----------------WVVMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG + + GT
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
+MAPEV+ Y K D++S GI E+ + PY
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 37/86 (43%), Positives = 51/86 (59%), Gaps = 1/86 (1%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
L RGL Y+HS ++HRD+K N+LL+ N +KI DFG+AR + + MT T Y A
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRA 176
Query: 241 PEV-LNGNPYNRKCDVYSFGICLWEI 265
PE+ LN + Y DV+S G E+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-17
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 35/214 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ R + VA+K + + G++ + +I +EV +L HP
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------IKEVRFLQQLRHP 75
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + +V+EY G A + +++ ++ L +
Sbjct: 76 NTIEYKGCYLREH----------------TAWLVMEYCLGSA--SDILEVHKKPLQEVEI 117
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS + +HRD+K N+LL + TVK+ADFG A + S N G
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL-VSPANSF---VG 173
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEI 265
T +MAPEV ++ Y+ K DV+S GI E+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-17
Identities = 45/129 (34%), Positives = 76/129 (58%), Gaps = 8/129 (6%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFK---VVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+++++L GG L T L K ++ F V LA +LA L +LHS I++RD+K EN+
Sbjct: 75 LILDFLRGGDLFTRLSK----EVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENI 129
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD+ +K+ DFG+++ + GT+ YMAPEV+N + + D +SFG+ ++
Sbjct: 130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMF 189
Query: 264 EIYCCDMPY 272
E+ +P+
Sbjct: 190 EMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAE-IAALRSAFTQEVAVWHKLDH 113
VI +G+FG V + DG AVK+L + E + I A R+ + V H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK------H 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + LH + V++Y+ GG L +L R R
Sbjct: 56 PFLVG----------LHYSFQTADKLY------FVLDYVNGGELFFHL--QRERSFPEPR 97
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE- 232
A ++A L YLHS I++RD+K EN+LLD V + DFG+ + E + T
Sbjct: 98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTF 156
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
GT Y+APEVL PY+R D + G L+E+
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 57 VIARGTFGTV--HRGLYDGHDVAVKLLDWGEEGHRTEAE-IAALRSAFTQEVAVWHKLDH 113
VI +G+FG V + DG AVK+L +R E + I A R+ + V H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV------KH 55
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
P + + + +L+ V++++ GG L +L R R
Sbjct: 56 PFLVGLHYSFQTTEKLYF----------------VLDFVNGGELFFHL--QRERSFPEPR 97
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
A ++A L YLHS IV+RD+K EN+LLD V + DFG+ + + + T
Sbjct: 98 ARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
GT Y+APEV+ PY+ D + G L+E+
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 9e-17
Identities = 71/231 (30%), Positives = 106/231 (45%), Gaps = 41/231 (17%)
Query: 53 VIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V+K VI RG FG V R A+KLL E R+++ F +E +
Sbjct: 47 VVK-VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF------FWEERDIMAF 99
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL----KTYLIKNRR 166
+ P V + A L++ V+EY+PGG L Y + +
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYM----------------VMEYMPGGDLVNLMSNYDVPEKW 143
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASN 225
K + V LALD +HS ++HRDVK +NMLLDK+ +K+ADFG +++ +
Sbjct: 144 AKF-YTAEVVLALDA------IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196
Query: 226 PNDMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPY 272
GT Y++PEVL Y R+CD +S G+ L+E+ D P+
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 43/125 (34%), Positives = 71/125 (56%), Gaps = 2/125 (1%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ GG L + + R K V A ++A GL +LHS+ I++RD+K +N++LD
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAVF--YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+KIADFG+ + + GT Y+APE++ PY + D ++FG+ L+E+
Sbjct: 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
Query: 268 CDMPY 272
P+
Sbjct: 197 GQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-17
Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 46/261 (17%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRG----LYDGHD---VAVKLLDWGEEGHRTEAEIAALRS 99
I+ +V+K + G FG V L D VAVK L + R +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD-------- 53
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F +E + L H ++ KF G V + + +V EY+ G L
Sbjct: 54 -FHREAELLTNLQHEHIVKFYG----------------VCVEGDPLIMVFEYMKHGDLNK 96
Query: 160 YLIK-----------NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
+L NR +L ++ +A +A G+ YL SQ VHRD+ T N L+ +N
Sbjct: 97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156
Query: 209 RTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VKI DFG++R V +++ + G T + +M PE + + + DV+S G+ LWEI+
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
Query: 267 CC-DMPYPDLSFSEVTSAVVR 286
P+ LS +EV + +
Sbjct: 217 TYGKQPWYQLSNNEVIECITQ 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-17
Identities = 46/119 (38%), Positives = 65/119 (54%), Gaps = 4/119 (3%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V++Y+ GG L +L R R A ++A L YLHS IV+RD+K EN+LLD
Sbjct: 74 VLDYINGGELFYHL--QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+ + DFG+ + E N T GT Y+APEVL+ PY+R D + G L+E+
Sbjct: 132 QGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 43/127 (33%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
+K L + L ++ +ARG+ +L S+ VHRD+ N+LL + + V
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276
Query: 212 KIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC- 268
KI DFG+AR + N ++ + L +MAPE + N Y DV+S+GI LWEI+
Sbjct: 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG 336
Query: 269 DMPYPDL 275
PYP +
Sbjct: 337 GTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 74/256 (28%), Positives = 110/256 (42%), Gaps = 50/256 (19%)
Query: 36 NFLKKQR------QDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEG 87
NFL + + +D ++ + VI RG FG V R A+KLL E
Sbjct: 23 NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
R+++ F +E + + P V + A L++
Sbjct: 83 KRSDSAF------FWEERDIMAFANSPWVVQLFYAFQDDRYLYM---------------- 120
Query: 148 VVEYLPGGAL----KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
V+EY+PGG L Y + + + + V LALD +HS +HRDVK +NM
Sbjct: 121 VMEYMPGGDLVNLMSNYDVPEKWARF-YTAEVVLALD------AIHSMGFIHRDVKPDNM 173
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMT---GETGTLGYMAPEVLNGNP----YNRKCDVY 256
LLDK+ +K+ADFG N M GT Y++PEVL Y R+CD +
Sbjct: 174 LLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 257 SFGICLWEIYCCDMPY 272
S G+ L+E+ D P+
Sbjct: 232 SVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 40/126 (31%), Positives = 73/126 (57%), Gaps = 4/126 (3%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+E++ GG L ++ R+RKL + + +++ L++LH + I++RD+K +N+LLD
Sbjct: 74 VIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 208 NRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+K+ D+G+ + E P D T GT Y+APE+L G Y D ++ G+ ++E+
Sbjct: 132 EGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 267 CCDMPY 272
P+
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 38/122 (31%), Positives = 70/122 (57%), Gaps = 5/122 (4%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
++++Y+ GG L T+L + + +V V +A ++ L +LH I++RD+K EN+LLD
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 207 KNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNP--YNRKCDVYSFGICLW 263
V + DFG+++ + + GT+ YMAPEV+ G +++ D +S G+ +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 264 EI 265
E+
Sbjct: 200 EL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ GT+ TV +G + V L + E H A A+R EV++ L H N+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIR-----EVSLLKNLKHANIV 66
Query: 118 KFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
LH I TE +V EYL LK YL N ++ V
Sbjct: 67 T----------LHDIIHTERC--------LTLVFEYLDSD-LKQYL-DNCGNLMSMHNVK 106
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L RGLSY H +KI+HRD+K +N+L+++ +K+ADFG+AR ++ + E T
Sbjct: 107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVT 166
Query: 236 LGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
L Y P+VL G+ Y+ D++ G L+E+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 9/188 (4%)
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI-QTENGQVAMP-------SNI 144
E+ A + T ++ KL+ + K G M +E I + N + + +
Sbjct: 15 EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
C+V+ + GG LK ++ + + A +L GL L ++IV+RD+K EN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
LD ++I+D G+A V+ + G GT+GYMAPEV+N Y D + G ++E
Sbjct: 135 LDDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193
Query: 265 IYCCDMPY 272
+ P+
Sbjct: 194 MIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 20/175 (11%)
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
A R E + ++HP++ + G + C++ LP
Sbjct: 124 AGQRGGTATEAHILRAINHPSIIQLKGTFTYNK----------------FTCLI---LPR 164
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
Y +R +A ++ + + R + YLH +I+HRD+K EN+ ++ V +
Sbjct: 165 YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLG 224
Query: 215 DFGVARVEAS-NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
DFG A N N G GT+ APE+L +PY D++S GI L+E+ C
Sbjct: 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-16
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKL--LDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I GT+G V+ R + G A+K+ L+ GE+ + EI ++ H
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----------KH 65
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK-TYLIKNRRRKLAFK 172
N+ + G+ + +L I +E+ GG+L+ Y + +
Sbjct: 66 SNIVAYFGSYLRRDKLWIC----------------MEFCGGGSLQDIYHVTGPLSESQIA 109
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
V + L +GL YLHS+ +HRD+K N+LL N VK+ADFGV+ +
Sbjct: 110 YVSRETL---QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166
Query: 233 TGTLGYMAPEVL---NGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV YN+ CD+++ GI E+ P DL
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-16
Identities = 35/84 (41%), Positives = 52/84 (61%), Gaps = 4/84 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242
RGL Y+HS +VHRD+K N+L+++N +KI DFG+AR++ MTG T Y APE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPE 175
Query: 243 V-LNGNPYNRKCDVYSFGICLWEI 265
+ L Y+ + D++S G E+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV---EASNPNDMTGETGTLGYM 239
RGL Y+HS ++HRD+K N+LL+ N +KI DFG+AR+ E + +T T Y
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 240 APEV-LNGNPYNRKCDVYSFGICLWEIYCC 268
APE+ LN Y + D++S G L E+
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-16
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 34/247 (13%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRG---LYDGHD--VAVKLLDWGEEGHRTEAEIAALRSA 100
E++ + I+ ++ G FG + RG L + VA+ L G R
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------DKQRRG 52
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F E + DH N+ + G V N +V EY+ GAL ++
Sbjct: 53 FLAEALTLGQFDHSNIVRLEG----------------VITRGNTMMIVTEYMSNGALDSF 96
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L K+ + +A +++ L LA G+ YL VH+ + +L++ + KI+ F +
Sbjct: 97 LRKHEGQLVAGQLMGMLP-GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155
Query: 221 VEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
+ S M+G++ L + APE + + ++ DV+SFGI +WE+ + PY D+S
Sbjct: 156 EDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214
Query: 278 SEVTSAV 284
+V AV
Sbjct: 215 QDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 7e-16
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 31/225 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRT-EAEIAALRSAF 101
WE+ P + + G +G+V + G VA+K L R ++EI A R A+
Sbjct: 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL------SRPFQSEIFAKR-AY 62
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+E+ + + H NV + + + ++ + MP ++T L
Sbjct: 63 -RELTLLKHMQHENVIGLLDVFTSAVSGD-EFQDFYLVMPY--------------MQTDL 106
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
K L+ V L + GL Y+HS I+HRD+K N+ ++++ +KI DFG+AR
Sbjct: 107 QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 165
Query: 222 EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
+MTG T Y APEV LN YN+ D++S G + E+
Sbjct: 166 --HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 58 IARGTFGTVH--RGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-- 112
I G +G V R L +G VA+K + R + + + +EVAV L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 113 -HPNVTK-FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
HPNV + F T+ ++ + +V E++ L TYL K +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLT------------LVFEHVDQD-LTTYLDKVPEPGVP 108
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + + L RGL +LHS ++VHRD+K +N+L+ + +K+ADFG+AR+ S +T
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALT 167
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TL Y APEVL + Y D++S G E++
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 1e-15
Identities = 81/297 (27%), Positives = 121/297 (40%), Gaps = 76/297 (25%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHR----GLYDGHD---VAVKLLDWGEEGHRTEAEIAAL 97
WE ++L + G FG V GL+ VAVK+L H TE
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLK--PSAHLTE------ 81
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGA-TMGSSELHI------------------------ 131
R A E+ V L +H N+ +GA T+G L I
Sbjct: 82 REALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPK 141
Query: 132 QTENGQVAMPSNI-------CCVVVEYLPGGALKTYLI--KNRRRKLAF-------KVVV 175
++ + A+ N+ C + EY+ +Y++ K +R+ V
Sbjct: 142 HEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTS 201
Query: 176 ------QLALDL----------ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+LALD A+G+S+L S+ +HRD+ N+LL R KI DFG+A
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261
Query: 220 RVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYP 273
R ++ N + L +MAPE + Y + DV+S+GI LWEI+ PYP
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 41/127 (32%), Positives = 73/127 (57%), Gaps = 6/127 (4%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ GG L ++ + K V A +++ GL +LH + I++RD+K +N++LD
Sbjct: 79 VMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 208 NRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+KIADFG+ + + +T T GT Y+APE++ PY + D +++G+ L+E+
Sbjct: 137 EGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
Query: 266 YCCDMPY 272
P+
Sbjct: 195 LAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 21/180 (11%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
++R +E+ + H+ P + F GA EN NIC + +E++ G
Sbjct: 45 SVRKQILRELQIMHECRSPYIVSFYGA--------FLNEN-------NIC-MCMEFMDCG 88
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLDKNRTVKIA 214
+L I + + +++ ++A+ + GL+YL++ +I+HRD+K N+L++ +K+
Sbjct: 89 SLDR--IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLC 146
Query: 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
DFGV+ E N T GT YM+PE + G Y K DV+S GI + E+ P+
Sbjct: 147 DFGVSG-ELINSIADTF-VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 58 IARGTFGTVHRG----LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I RGT+G V++ DG + A+K G++ T +A R E+A+ +L H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACR-----EIALLRELKH 61
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY----LPGGALKTYLIKNRRRKL 169
NV + E+ ++ + V + + +Y L + + + +R +
Sbjct: 62 ENVVSLV-------EVFLEHADKSVYL-------LFDYAEHDL--WQIIKFHRQAKRVSI 105
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASN 225
+V L + G+ YLHS ++HRD+K N+L+ + VKI D G+AR+ +
Sbjct: 106 PPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 226 PNDMTGETG---TLGYMAPEVLNG-NPYNRKCDVYSFG 259
+ T+ Y APE+L G Y + D+++ G
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ GT+ TV++G D V L + E H A A+R EV++ L H N+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLE-HEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 118 KFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
LH I TE +V EYL LK YL + + V
Sbjct: 68 T----------LHDIIHTEKS--------LTLVFEYLDKD-LKQYL-DDCGNSINMHNVK 107
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L RGL+Y H +K++HRD+K +N+L+++ +K+ADFG+AR ++ + E T
Sbjct: 108 LFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVT 167
Query: 236 LGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
L Y P++L G+ Y+ + D++ G +E+
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 59/271 (21%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTE 91
+R+D +V+K + G FG V L + H+ VAVK L E R +
Sbjct: 3 KRRD-------IVLKWELGEGAFGKVF--LAECHNLLPEQDKMLVAVKALKEASESARQD 53
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
F +E + L H ++ +F G + TE + M V EY
Sbjct: 54 ---------FQREAELLTVLQHQHIVRFYG---------VCTEGRPLLM-------VFEY 88
Query: 152 LPGGALKTYLIKNRRR-------------KLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198
+ G L +L + +L ++ +A +A G+ YL S VHRD+
Sbjct: 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDL 148
Query: 199 KTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVY 256
T N L+ + VKI DFG++R + +++ + G T + +M PE + + + D++
Sbjct: 149 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208
Query: 257 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVR 286
SFG+ LWEI+ P+ LS +E + +
Sbjct: 209 SFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ R + + VA+K + + G++ + +I +EV KL HP
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-------IKEVRFLQKLRHP 75
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + +V+EY G A + L++ ++ L +
Sbjct: 76 NTIQYRGCYL----------------REHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 117
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRDVK N+LL + VK+ DFG A + A G
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVG 173
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEI 265
T +MAPEV ++ Y+ K DV+S GI E+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 38/227 (16%)
Query: 58 IARGTFGTVHRGLYD--GHDVAVK---LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
I RG FGTV++ L+ G +AVK +E R ++ + + D
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS----------SD 61
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI--KNRRRKLA 170
P + KF GA + C + +E + K Y + + +
Sbjct: 62 CPYIVKFYGALFREGD----------------CWICMELMDISLDKFYKYVYEVLKSVIP 105
Query: 171 FKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
+++ ++A+ + L+YL + KI+HRDVK N+LLD+N +K+ DFG++ + +
Sbjct: 106 EEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVDSIAK 164
Query: 230 TGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYP 273
T + G YMAPE ++ + Y+ + DV+S GI L+E+ PYP
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 3/105 (2%)
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+++ + +A+G+ +L S+ +HRDV N+LL R KI DFG+AR ++ N +
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273
Query: 234 GTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDL 275
L +MAPE + Y + DV+S+GI LWEI+ PYP +
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I GT+G V++ +A+K + R E E + S +E+++ ++ H N
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ + L++ V EYL LK ++ + +++
Sbjct: 63 IVRLQDVVHSEKRLYL----------------VFEYLDLD-LKKHMDSSPDFAKNPRLIK 105
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETG 234
+ RG++Y HS +++HRD+K +N+L+D+ +K+ADFG+AR T E
Sbjct: 106 TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 235 TLGYMAPEVLNGN-PYNRKCDVYSFG 259
TL Y APE+L G+ Y+ D++S G
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVG 191
|
Length = 294 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 49/271 (18%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALR 98
EI S + + FG V++G G VA+K L + +AE LR
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-------KDKAEGP-LR 52
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E + +L HPN+ +G + T+ ++M + Y L
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLG---------VVTKEQPLSM-------IFSYCSHSDLH 96
Query: 159 TYLI--------------KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+L+ K + L V + +A G+ +L S +VH+D+ T N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 205 LDKNRTVKIADFGVAR-VEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+ VKI+D G+ R V A++ + G + + +M+PE + ++ D++S+G+ L
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216
Query: 263 WEIYCCDM-PYPDLSFSEVTSAVVRQVQYLL 292
WE++ + PY S +V ++R Q L
Sbjct: 217 WEVFSYGLQPYCGYSNQDVIE-MIRNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-15
Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 11/92 (11%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-----VEASNPNDMTGETGT 235
L + L Y+HS ++HRD+K N+LL+ + VK+ADFG+AR E +T T
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y APE+L G+ Y+ G+ +W + C
Sbjct: 176 RWYRAPEILLGSTR------YTKGVDMWSVGC 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 46/123 (37%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
C V+ +Y L TYL R R L V +A L + Y+H + I+HRD+KTEN+L
Sbjct: 236 CLVLPKY--RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 205 LDKNRTVKIADFGVA---RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
++ + + DFG A R S P G GT+ APEVL G+PY D++S G+
Sbjct: 293 VNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 262 LWE 264
++E
Sbjct: 352 IFE 354
|
Length = 461 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ + VAVK + + G++ + +I +EV +L HP
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-------IKEVKFLQQLKHP 81
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + +V+EY G A + L++ ++ L +
Sbjct: 82 NTIEYKGCYL----------------KEHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 123
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRD+K N+LL + VK+ADFG A +S N G
Sbjct: 124 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK-SSPANSF---VG 179
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEI 265
T +MAPEV ++ Y+ K DV+S GI E+
Sbjct: 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-15
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ +G +G+V++ L+ V + + + R E + + E+ + HK P +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-----RLELDESKFNQ-IIMELDILHKAVSPYIV 62
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL-KTYLIKNRRRKLAFKVVVQ 176
F GA G V M C+ EY+ G+L K Y + V+ +
Sbjct: 63 DFYGAF---------FIEGAVYM-----CM--EYMDAGSLDKLYAGGVATEGIPEDVLRR 106
Query: 177 LALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETG 234
+ + +GL +L + I+HRDVK N+L++ N VK+ DFGV+ + AS G
Sbjct: 107 ITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT---NIG 163
Query: 235 TLGYMAPE-VLNGNP-----YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
YMAPE + +G P Y + DV+S G+ + E+ PYP +++ + +
Sbjct: 164 CQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-15
Identities = 41/128 (32%), Positives = 69/128 (53%), Gaps = 8/128 (6%)
Query: 148 VVEYLPGGALKTYLIKNRR---RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
V+E++ GG L ++ K+RR + F A ++ L +LH + I++RD+K +N+L
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARF-----YAAEITSALMFLHDKGIIYRDLKLDNVL 128
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
LD K+ADFG+ + N + GT Y+APE+L Y D ++ G+ L+E
Sbjct: 129 LDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYE 188
Query: 265 IYCCDMPY 272
+ C P+
Sbjct: 189 MLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 48/159 (30%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLA---FKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+V+E+ P G LK YL R+ +L + ++A ++A GL +LH +H D+ N
Sbjct: 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNC 131
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETG--TLGYMAPEVLN---GN----PYNRKCD 254
LL + TVKI D+G++ + +T + L ++APE+++ GN ++ +
Sbjct: 132 LLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESN 191
Query: 255 VYSFGICLWEIY-CCDMPYPDLSFSEVTSAVVRQVQYLL 292
V+S G+ +WE++ PY LS +V + VR+ Q L
Sbjct: 192 VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 35/214 (16%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ R + VA+K + + G++ + +I +EV ++ HP
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------IKEVKFLQRIKHP 85
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + +V+EY G A + L++ ++ L +
Sbjct: 86 NSIEYKGCYL----------------REHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEI 127
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRD+K N+LL + VK+ADFG A + AS N G
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI-ASPANSF---VG 183
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEI 265
T +MAPEV ++ Y+ K DV+S GI E+
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 13/148 (8%)
Query: 147 VVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+V +Y+ GG L +L K R A + +L L L +LH IV+RD+K EN+L
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL----ALEHLHKYDIVYRDLKPENIL 128
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEV-LNGNPYNRKCDVYSFGICL 262
LD + + DFG+++ ++ N T GT Y+APEV L+ Y + D +S G+ +
Sbjct: 129 LDATGHIALCDFGLSKANLTD-NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187
Query: 263 WEIYCCDMPYPDLSFSEVTSAVVRQVQY 290
+E+ C P+ ++E T + R + +
Sbjct: 188 FEMCCGWSPF----YAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-14
Identities = 42/112 (37%), Positives = 65/112 (58%), Gaps = 6/112 (5%)
Query: 157 LKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
L TY+ +R L + + + L L+YLH + I+HRDVKTEN+ LD+ + DF
Sbjct: 172 LFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229
Query: 217 GVA-RVEAS--NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
G A +++A P G +GTL +PE+L +PY K D++S G+ L+E+
Sbjct: 230 GAACKLDAHPDTPQCY-GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 40/121 (33%), Positives = 70/121 (57%), Gaps = 6/121 (4%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLL 205
+++EYL GG L +L R + + L +++ L +LH Q I++RD+K EN+LL
Sbjct: 77 LILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
D VK+ DFG+ + E+ + +T GT+ YMAPE+L + + + D +S G +++
Sbjct: 134 DAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYD 192
Query: 265 I 265
+
Sbjct: 193 M 193
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 37/204 (18%)
Query: 73 GHDVAVKLL--DWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130
GH+VA+KLL D EE H+ R+ F +E A+ +L HPN+ +
Sbjct: 3 GHEVAIKLLRTDAPEEEHQ--------RARFRRETALCARLYHPNIVALL---------- 44
Query: 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190
++G+ P + V EY+PG L+ L + L +L L + L+ H+
Sbjct: 45 ---DSGEA--PPGLLFAVFEYVPGRTLREVLAADG--ALPAGETGRLMLQVLDALACAHN 97
Query: 191 QKIVHRDVKTENMLL---DKNRTVKIADFGVAR----VEASNPNDMTGETGTLG---YMA 240
Q IVHRD+K +N+++ K+ DFG+ V ++ +T T LG Y A
Sbjct: 98 QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCA 157
Query: 241 PEVLNGNPYNRKCDVYSFGICLWE 264
PE L G P D+Y++G+ E
Sbjct: 158 PEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 41/218 (18%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDW-GEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ G++ TV++G+ +G VA+K++ EEG A+R E ++ L H
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIR-----EASLLKGLKHA 63
Query: 115 NVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYL---PGGALKTYLIKNRRRKL 169
N+ LH I T+ + + + +Y+ PGG L Y + R
Sbjct: 64 NIVL----------LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-LHPYNV----RLF 108
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM 229
F+ L RGL+Y+H Q I+HRD+K +N+L+ +K+ADFG+AR ++
Sbjct: 109 MFQ--------LLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160
Query: 230 TGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIY 266
+ E TL Y P+VL G Y+ D++ G E+
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 37/164 (22%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRD 197
C+V+EY+ GG T L+KN + L +D+AR L YLH+ IVHRD
Sbjct: 77 CMVMEYVEGGDCAT-LLKN---------IGALPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASN------PNDMTGET---------GTLGYMAPE 242
+K +N+L+ +K+ DFG++++ + + +T GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 243 VLNGNPYNRKCDVYSFGICLWEIYCCDMPY----PDLSFSEVTS 282
V+ Y + D ++ GI L+E +P+ P+ F +V S
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 41/125 (32%), Positives = 64/125 (51%), Gaps = 11/125 (8%)
Query: 174 VVQLALDLAR----------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
V+Q+ LD R G+ +LHS I+HRD+K N+++ + T+KI DFG+AR A
Sbjct: 118 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 176
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
MT T Y APEV+ G Y D++S G + E+ + +P + +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 284 VVRQV 288
V+ Q+
Sbjct: 237 VIEQL 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 4e-14
Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 13/129 (10%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
+++Y+ G L L+K KL+ V ++ L L+ LH I+H D+K EN+L D+
Sbjct: 87 IMDYIKDGDLFD-LLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144
Query: 208 NRT-VKIADFGVARVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
+ + + D+G+ ++ + + GTL Y +PE + G+ Y+ D ++ G+ +
Sbjct: 145 AKDRIYLCDYGLCKIIGT-------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTY 197
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 198 ELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ GT+ TV +G + V L + E H A A+R EV++ L H N+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLE-HEEGAPCTAIR-----EVSLLKDLKHANIV 67
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQL 177
LH + +V EYL LK Y+ + ++ V
Sbjct: 68 T----------LH------DIVHTDKSLTLVFEYLDKD-LKQYM-DDCGNIMSMHNVKIF 109
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
+ RGL+Y H +K++HRD+K +N+L+++ +K+ADFG+AR ++ + E TL
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 238 YMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
Y P+VL G+ Y+ + D++ G +E+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+E++ GG T+L +N+R V A + YL S IV+RD+K EN+LLD
Sbjct: 108 LVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
K+ +K+ DFG A+V + + GT Y+APE+L + + D ++ GI ++EI
Sbjct: 166 KDGFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
Query: 267 CCDMPY----PDLSFSEVTSAVVRQVQYL 291
P+ P L + ++ ++ ++L
Sbjct: 223 VGCPPFYANEPLLIYQKILEGIIYFPKFL 251
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 61/253 (24%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWH 109
I +I +G G V+ YD VA+K + R + +E L+ F +E +
Sbjct: 6 IIRLIGKGGMGEVYLA-YDPVCSRRVALKKI-------REDLSENPLLKKRFLREAKIAA 57
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQV--AMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L HP + I ++ V MP Y+ G LK+ L+K+ +
Sbjct: 58 DLIHPGIVPVYS---------ICSDGDPVYYTMP---------YIEGYTLKS-LLKSVWQ 98
Query: 168 K------LAFKVVVQLALDL----ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
K LA K V L + + Y+HS+ ++HRD+K +N+LL V I D+G
Sbjct: 99 KESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158
Query: 218 VAR-----------VEASNPNDMTGE-------TGTLGYMAPEVLNGNPYNRKCDVYSFG 259
A ++ N GT YMAPE L G P + D+Y+ G
Sbjct: 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218
Query: 260 ICLWEIYCCDMPY 272
+ L+++ PY
Sbjct: 219 VILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 174 VVQLALDLAR----------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
V+Q+ LD R G+ +LHS I+HRD+K N+++ + T+KI DFG+AR A
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 168
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
MT T Y APEV+ G Y D++S G
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 54 IKSVIARGTFG--TVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I VI RG FG V + G A+K+L+ E R E + F +E V
Sbjct: 5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET------ACFREERDVLVNG 58
Query: 112 DHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
D +T LH Q EN +V++Y GG L T L K R
Sbjct: 59 DRRWIT----------NLHYAFQDENNLY--------LVMDYYVGGDLLTLLSKFEDR-- 98
Query: 170 AFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-R 220
L D+AR + +H VHRD+K +N+LLDKN +++ADFG R
Sbjct: 99 -------LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPY 272
+ A GT Y++PE+L Y +CD +S G+C++E+ + P+
Sbjct: 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-14
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 185 LSYL-HSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPE 242
L YL ++HRDVK N+LLD + VK+ DFG++ R+ S T G YMAPE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184
Query: 243 VL---NGNP-YNRKCDVYSFGICLWEIYCCDMPYP 273
+ + NP Y+ + DV+S GI L E+ PY
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-14
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 10/129 (7%)
Query: 148 VVEYLPGGALKTYLIKNRR----RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
V+EY+ GG L + ++R+ R + V LAL +LH +++RD+K +N+
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHRHGVIYRDLKLDNI 127
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
LLD K+ADFG+ + N T GT Y+APE+L Y D ++ G+ ++
Sbjct: 128 LLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMY 187
Query: 264 EIYCCDMPY 272
E+ P+
Sbjct: 188 EMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 39/100 (39%), Positives = 59/100 (59%), Gaps = 4/100 (4%)
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP 226
+KL V L + RGL Y+HS I+HRD+K N+ ++++ +KI DFG+AR
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 171
Query: 227 NDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
++MTG T Y APE+ LN YN+ D++S G + E+
Sbjct: 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 36/90 (40%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L L RGL Y+HS I+HRD+K N+ ++++ ++I DFG+AR ++MTG T
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATR 179
Query: 237 GYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
Y APE+ LN YN+ D++S G + E+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR----VEASNPNDMTGETGTLGY 238
GL Y+HS ++HRD+K N+L++ + +KI DFG+AR N MT T Y
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 239 MAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
APE+ L+ Y + DV+S G L E+
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 38/211 (18%)
Query: 61 GTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118
G++ TV++G G VA+K + R E E A +A +E ++ L H N+
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEI-------RLEHEEGAPFTAI-REASLLKDLKHANIVT 67
Query: 119 FIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
LH I T+ +V EYL LK Y+ + L+ V
Sbjct: 68 ----------LHDIIHTKKTLT--------LVFEYLDTD-LKQYM-DDCGGGLSMHNVRL 107
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L RGL+Y H ++++HRD+K +N+L+ + +K+ADFG+AR ++ + E TL
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 237 GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y P+VL G+ YS + +W + C
Sbjct: 168 WYRPPDVLLGS------TEYSTSLDMWGVGC 192
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY-DGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
+K + V+ G +G V + + + + VA+K EE E + LR E+ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE--EVKETTLR-----ELKM 53
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L N+ + A +L++ E + M ++E +P G + R
Sbjct: 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-----LLEEMPNGVPP-----EKVR 103
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR--VEASN 225
++++ + + + H IVHRD+K EN+L+ N +K+ DFG AR E SN
Sbjct: 104 SYIYQLI--------KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
N T T Y +PE+L G PY + D++S G L E+
Sbjct: 156 AN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 32/207 (15%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIA--ALRSAFTQEVAVWHKLDH 113
I G++G V R G VA+K E+ + I ALR E+ + +L H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESED----DPVIKKIALR-----EIRMLKQLKH 59
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ I +LH+ V EY L ++ R + +
Sbjct: 60 PNLVNLIEVFRRKRKLHL----------------VFEYCDHTVLNE--LEKNPRGVPEHL 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
+ ++ + +++ H +HRDVK EN+L+ K +K+ DFG AR+ +D T
Sbjct: 102 IKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 234 GTLGYMAPEVLNGN-PYNRKCDVYSFG 259
T Y APE+L G+ Y DV++ G
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 39/130 (30%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLL 205
++++Y+ GG L T+L + R K + VQ+ ++ L +LH I++RD+K EN+LL
Sbjct: 82 LILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNP--YNRKCDVYSFGICL 262
D N V + DFG+++ + + GT+ YMAP+++ G +++ D +S G+ +
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198
Query: 263 WEIYCCDMPY 272
+E+ P+
Sbjct: 199 YELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-13
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F Q+ + L HPN+ + +G + A+P +V EY G LK+Y
Sbjct: 42 FLQQGDPYRILQHPNILQCLGQCVE-------------AIPY---LLVFEYCELGDLKSY 85
Query: 161 LIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
L + RR ++ ++A ++A G++++H +H D+ N L + TVK+ D+G+
Sbjct: 86 LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
Query: 219 ARVEASNPNDMTGET--GTLGYMAPEV-------LNGNPYNRKCDVYSFGICLWEIY-CC 268
T + L ++APE+ L + +V++ G+ LWE++
Sbjct: 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205
Query: 269 DMPYPDLSFSEVTSAVVRQVQYLL 292
PY LS EV + V++ Q L
Sbjct: 206 AQPYSHLSDREVLNHVIKDQQVKL 229
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 66/259 (25%), Positives = 105/259 (40%), Gaps = 69/259 (26%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHKLDH 113
VI RG FG V + GH A+K+L + + + I A R + ++W
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW----- 62
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
V K + L++ ++E+LPGG + T L+K + L +
Sbjct: 63 --VVKMFYSFQDKLNLYL----------------IMEFLPGGDMMTLLMK--KDTLTEEE 102
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-------RVE---- 222
+ + +H +HRD+K +N+LLD VK++DFG+ R E
Sbjct: 103 TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 223 --ASNPNDMT---------GET-------------GTLGYMAPEVLNGNPYNRKCDVYSF 258
S P+D T ET GT Y+APEV YN+ CD +S
Sbjct: 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
Query: 259 GICLWEI------YCCDMP 271
G+ ++E+ +C + P
Sbjct: 223 GVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
ALR E+ + +LDH N+ K + +G S TE+ N +V EY+
Sbjct: 49 ALR-----EIKIIRRLDHDNIVK-VYEVLGPSG-SDLTEDVGSLTELNSVYIVQEYMETD 101
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV-KIA 214
L L + L+ + L RGL Y+HS ++HRD+K N+ ++ V KI
Sbjct: 102 -LANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157
Query: 215 DFGVARV---EASNPNDMTGETGTLGYMAPE-VLNGNPYNRKCDVYSFGICLWEI 265
DFG+AR+ S+ ++ T Y +P +L+ N Y + D+++ G E+
Sbjct: 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 49/170 (28%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V++Y+PGG + + LI+ LA + +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTC----AIESVHKMGFIHRDIKPDNILI 134
Query: 206 DKNRTVKIADFGV------------------ARVEASNPNDMTGE--------------- 232
D++ +K+ DFG+ R ++ P++ E
Sbjct: 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKR 194
Query: 233 ----------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL Y + CD +S G+ L+E+ P+
Sbjct: 195 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 4/103 (3%)
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ KL+ + L + +GL Y+H+ I+HRD+K N+ ++++ +KI DFG+AR S
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170
Query: 225 NPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
+MTG T Y APEV LN Y + D++S G + E+
Sbjct: 171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 23/144 (15%)
Query: 143 NICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIV 194
N +V++Y GG L T L K R L D+AR + +H V
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDR---------LPEDMARFYIAEMVLAIHSIHQLHYV 124
Query: 195 HRDVKTENMLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNG-----NP 248
HRD+K +N+LLD N +++ADFG ++ + GT Y++PE+L
Sbjct: 125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK 184
Query: 249 YNRKCDVYSFGICLWEIYCCDMPY 272
Y +CD +S G+C++E+ + P+
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 39/141 (27%), Positives = 75/141 (53%), Gaps = 2/141 (1%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+ ++ GG L +L + R L+ L A L LH +++RD+K EN+LLD
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCA--LENLHKFNVIYRDLKPENILLD 127
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ + DFG+ ++ + + GT Y+APE+L G+ Y + D ++ G+ L+E+
Sbjct: 128 YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
Query: 267 CCDMPYPDLSFSEVTSAVVRQ 287
P+ D + +E+ ++++
Sbjct: 188 TGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
I I GT+G V+ R G VA+K LD +EG I A+R E+ +
Sbjct: 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF----PITAIR-----EIKILR 61
Query: 110 KLDHPNVTKFIG-ATMGSSELHIQTENGQVAMPSNICCVVVEYLPG---GALKTYLIKNR 165
+L+H N+ T L + + G + V EY+ G L++ L+
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL-------VFEYMDHDLMGLLESGLVHFS 114
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV-EAS 224
+ L GL+Y H + +HRD+K N+LL+ +K+ADFG+AR+ +
Sbjct: 115 EDHIK-----SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 225 NPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIY 266
T + TL Y PE+L G Y DV+S G L E++
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 68/251 (27%)
Query: 53 VIKSVIARGTFGTVH----RGLYDGHDVAVKLLDWGE-----EGHRTEAEIAALRSAFTQ 103
IK ++ +G G V +G G A+K+LD E + R E L +
Sbjct: 5 KIK-LLGKGDVGRVFLVRLKG--TGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT---- 57
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
LDHP F+ T+ +S QTE C+V++Y PGG L L +
Sbjct: 58 -------LDHP----FL-PTLYAS---FQTET--------YLCLVMDYCPGGELFRLLQR 94
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF------- 216
+ L+ +V A ++ L YLH IV+RD+K EN+LL ++ + ++DF
Sbjct: 95 QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
Query: 217 --GVARVEA-------SNPNDMTGET-------------GTLGYMAPEVLNGNPYNRKCD 254
+A S+ N + ET GT Y+APEV++G+ + D
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVD 214
Query: 255 VYSFGICLWEI 265
++ GI L+E+
Sbjct: 215 WWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 47/250 (18%)
Query: 54 IKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I VI RG FG V D A+K+L+ E R E + F +E V
Sbjct: 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET------ACFREERDVLVNG 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
D+ +T A + L++ V++Y GG L T L K R
Sbjct: 59 DNQWITTLHYAFQDENNLYL----------------VMDYYVGGDLLTLLSKFEDR---- 98
Query: 172 KVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-RVE 222
L D+AR + +H VHRD+K +N+L+D N +++ADFG ++
Sbjct: 99 -----LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
+ GT Y++PE+L Y +CD +S G+C++E+ + P+ S
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 278 SEVTSAVVRQ 287
E ++
Sbjct: 214 VETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G++ TV++G +G VA+K++ EE A+R E ++ L H N
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIR-----EASLLKGLKHAN 64
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ L + E + C ++ PGG L + F+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDL-----CQYMDKHPGG-----LHPENVKLFLFQ--- 111
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGT 235
L RGLSY+H + I+HRD+K +N+L+ +K+ADFG+AR ++ + + E T
Sbjct: 112 -----LLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVT 166
Query: 236 LGYMAPEVLNGNPYNRKC-DVYSFGICLWEI 265
L Y P+VL G+ C D++ G E+
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 40/143 (27%), Positives = 75/143 (52%), Gaps = 4/143 (2%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKV--VVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+++EY GG L + + + L F+ V L + L +HS+K++HRD+K+ N+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
L +K+ DFG ++ + + + + GT Y+APE+ Y++K D++S G+ L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 263 WEIYCCDMPYPDLSFSEVTSAVV 285
+E+ P+ S E+ V+
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 41/132 (31%), Positives = 73/132 (55%), Gaps = 13/132 (9%)
Query: 146 CVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
C +++ + GG L +L ++ +++ F A ++ GL ++H++ +V+RD+K N
Sbjct: 73 CFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHNRFVVYRDLKPAN 127
Query: 203 MLLDKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGI 260
+LLD++ V+I+D G+A P+ GT GYMAPEVL G Y+ D +S G
Sbjct: 128 ILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184
Query: 261 CLWEIYCCDMPY 272
L+++ P+
Sbjct: 185 MLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 41/125 (32%), Positives = 65/125 (52%), Gaps = 11/125 (8%)
Query: 174 VVQLALDLAR----------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
V+Q+ LD R G+ +LHS I+HRD+K N+++ + T+KI DFG+AR A
Sbjct: 111 VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-A 169
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283
MT T Y APEV+ G Y D++S G + E+ + +P + + +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229
Query: 284 VVRQV 288
V+ Q+
Sbjct: 230 VIEQL 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 69/259 (26%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQEVAVWHKLDH 113
VI RG FG V + GH A+K+L + + + A I A R + W
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW----- 62
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
V K + L++ ++E+LPGG + T L+K + L+ +
Sbjct: 63 --VVKMFYSFQDKRNLYL----------------IMEFLPGGDMMTLLMK--KDTLSEEA 102
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA-------RVE---- 222
+ + +H +HRD+K +N+LLD VK++DFG+ R E
Sbjct: 103 TQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162
Query: 223 --ASNPNDMT---------GET-------------GTLGYMAPEVLNGNPYNRKCDVYSF 258
+ P+D + ET GT Y+APEV YN+ CD +S
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
Query: 259 GICLWEI------YCCDMP 271
G+ ++E+ +C + P
Sbjct: 223 GVIMYEMLIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 38/122 (31%), Positives = 68/122 (55%), Gaps = 7/122 (5%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+++ + GG L +L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 73 SFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130
Query: 206 DKNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLW 263
D++ V+I+D G+A P+ GT GYMAPEVL G Y+ D +S G L+
Sbjct: 131 DEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 187
Query: 264 EI 265
++
Sbjct: 188 KL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-12
Identities = 60/249 (24%), Positives = 99/249 (39%), Gaps = 68/249 (27%)
Query: 60 RGTFGTVHRGLY----------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
+GTF +++G+ G +V+V L G + + A F + ++
Sbjct: 5 QGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--------FFETASLMS 56
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR-K 168
+L H ++ K G + NI +V EY+ G L +L + +
Sbjct: 57 QLSHKHLVKLYGVCVR---------------DENI--MVEEYVKFGPLDVFLHREKNNVS 99
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-------VKIADFGVA-- 219
L +K+ V A LA L YL +K+VH +V +N+L+ + +K++D G+
Sbjct: 100 LHWKLDV--AKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157
Query: 220 ------RVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYC-CDM 270
RVE P ++APE + D +SFG L EI +
Sbjct: 158 VLSREERVERI-P-----------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
Query: 271 PYPDLSFSE 279
P LS SE
Sbjct: 206 PLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 69/270 (25%), Positives = 106/270 (39%), Gaps = 88/270 (32%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGE--EGHRTEAEIAALRSAFTQEVAVWHKLD 112
VI RG FG V + GH A+K L E E + A + A R + D
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQV-AHVRAERDILAEA-------D 59
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-------R 165
+P V K + + L++ ++EYLPGG + T L+K
Sbjct: 60 NPWVVKLYYSFQDENYLYL----------------IMEYLPGGDMMTLLMKKDTFTEEET 103
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG-------- 217
R +A + LA+D +H +HRD+K +N+LLD +K++DFG
Sbjct: 104 RFYIAETI---LAID------SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 218 --------VARVEASNPNDMTGET----------------------GTLGYMAPEVLNGN 247
++ SN D + GT Y+APEV
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 248 PYNRKCDVYSFGICLWEI------YCCDMP 271
YN++CD +S G+ ++E+ +C D P
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 40/128 (31%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
++++Y+ GG + T+L + R + V + ++ L +LH IV+RD+K EN+LLD
Sbjct: 82 LILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 207 KNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWE 264
V + DFG+++ S + T GT+ YMAPE++ G + + D +S GI ++E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 265 IYCCDMPY 272
+ P+
Sbjct: 200 LLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 33/82 (40%), Positives = 49/82 (59%), Gaps = 1/82 (1%)
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEV 243
G+ +LHS I+HRD+K N+++ + T+KI DFG+AR +N MT T Y APEV
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM-MTPYVVTRYYRAPEV 193
Query: 244 LNGNPYNRKCDVYSFGICLWEI 265
+ G Y D++S G + E+
Sbjct: 194 ILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 48/154 (31%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 147 VVVEYLPGGALK--TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
VV+E++P K + +N L +V + L R L+Y+HS+ I HRD+K +N+L
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNH-ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202
Query: 205 LDKN-RTVKIADFGVARVEASNPNDMTGETG-----TLGYMAPEVLNGNP-YNRKCDVYS 257
+D N T+K+ DFG A+ N + G+ + Y APE++ G Y D++S
Sbjct: 203 IDPNTHTLKLCDFGSAK------NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWS 256
Query: 258 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQVQYL 291
G + E+ + YP S +VR +Q L
Sbjct: 257 LGCIIAEMI---LGYPIFSGQSSVDQLVRIIQVL 287
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 8/90 (8%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN-PNDM--TGETGTLG 237
L R L Y+H+ + HRD+K +N+L + + +KI DFG+ARV ++ P + T T
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 238 YMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y APE L G+ +++ Y+ I +W I C
Sbjct: 172 YRAPE-LCGSFFSK----YTPAIDIWSIGC 196
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-10
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+ +GTF + +G+ +V D+GE H+TE + L + H N +
Sbjct: 3 LGQGTFTKIFKGIR--REVG----DYGE-LHKTEVLLKVLDKS------------HRNYS 43
Query: 118 K--FIGATMGS--SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ F A+M S S H+ G V + + +V EY+ G+L TYL KN+ +
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYG-VCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISW 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRT---VKIADFGVARVEASN 225
+++A LA L +L + + H +V +N+LL K +K++D G++
Sbjct: 102 KLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVL 159
Query: 226 PNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYC-CDMP 271
P ++ E + ++ PE + N + D +SFG LWEI+ D P
Sbjct: 160 PKEILLE--RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 29/77 (37%), Positives = 47/77 (61%), Gaps = 6/77 (7%)
Query: 147 VVVEYLPGGALKTYL--IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+V+EYL GG +K+ L ++A K + ++AL L YLH I+HRD+K +NML
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL----ALDYLHRHGIIHRDLKPDNML 136
Query: 205 LDKNRTVKIADFGVARV 221
+ +K+ DFG+++V
Sbjct: 137 ISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 53/174 (30%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V++Y+PGG + + LI+ LA + +L L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIESVHKMGFIHRDIKPDNILI 134
Query: 206 DKNRTVKIADFGVA------------------RVEASNPND--------------MTGE- 232
D + +K+ DFG+ R ++ P+D T E
Sbjct: 135 DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ 194
Query: 233 --------------TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT Y+APEVL Y + CD +S G+ L+E+ P+
Sbjct: 195 RATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT--GETGTLGY 238
L + Y+H +K++HRD+K EN+ L+ + + + DFG A + + G GT+
Sbjct: 276 LLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVAT 334
Query: 239 MAPEVLNGNPYNRKCDVYSFGICLWEI 265
+PE+L G+ Y D++S G+ L ++
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 45/192 (23%), Positives = 79/192 (41%), Gaps = 47/192 (24%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
QE+ +L HPN+ ++ + + SEL+ VV + G+ + L+
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELY----------------VVSPLMAYGSCED-LL 90
Query: 163 KNRRRKLAFK------VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
K F + + D+ L Y+HS+ +HR VK ++LL + V ++
Sbjct: 91 KTH-----FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
Query: 217 GVAR--VEASN----PNDMT-GETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYC 267
+ ++ +D L +++PEVL N YN K D+YS GI
Sbjct: 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT-----A 200
Query: 268 CDM-----PYPD 274
C++ P+ D
Sbjct: 201 CELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 43/226 (19%)
Query: 58 IARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
+ RGT+G V++ DG D +E + E + + +E+A+ +L HPNV
Sbjct: 9 VGRGTYGHVYKAKRKDGKD--------EKEYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ S+ + ++ +Y ++IK R A K +Q
Sbjct: 61 IALQKVFLSHSDRKVW--------------LLFDYAEHDLW--HIIKFHRASKANKKPMQ 104
Query: 177 LALDLAR--------GLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVARVEA 223
L + + G+ YLH+ ++HRD+K N+L+ ++ R VKIAD G AR+
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFARLFN 163
Query: 224 S--NP-NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEI 265
S P D+ T Y APE+L G Y + D+++ G E+
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 49/229 (21%)
Query: 58 IARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ RGT+G V++ D D A+K + EG T ++A R E+A+ +L H
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EG--TGISMSACR-----EIALLRELKH 57
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PNV + ++ + ++ +Y ++IK R A K
Sbjct: 58 PNVISLQKVFLSHADRKVW--------------LLFDYAEHDLW--HIIKFHRASKANKK 101
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVAR 220
VQL + + G+ YLH+ ++HRD+K N+L+ ++ R VKIAD G AR
Sbjct: 102 PVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR-VKIADMGFAR 160
Query: 221 VEAS--NP-NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEI 265
+ S P D+ T Y APE+L G Y + D+++ G E+
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 63/175 (36%)
Query: 147 VVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
+++E+LPGG L T LIK R +A V LA++ L + +HRD+K
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV---LAIEAVHKLGF------IHRDIK 128
Query: 200 TENMLLDKNRTVKIADFGV---------------------ARVEASNPNDMTGET----- 233
+N+L+D+ +K++DFG+ + N N + ++
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188
Query: 234 ---------------------GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
GT Y+APE+ Y ++CD +S G ++E
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 18/145 (12%)
Query: 138 VAMPSNICCVVVEYLPGGALKTYLIKNRRR-KLAFKVVVQLALDLARGLSYLHSQKIVHR 196
V NI +V E++ G L L K + R +A+K+ V A LA LSYL + +VH
Sbjct: 86 VRGSENI--MVEEFVEHGPLDVCLRKEKGRVPVAWKITV--AQQLASALSYLEDKNLVHG 141
Query: 197 DVKTENMLLDKNRT-------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVL-NGNP 248
+V +N+LL + +K++D GV+ S + + ++APE + GN
Sbjct: 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVE----RIPWIAPECVPGGNS 197
Query: 249 YNRKCDVYSFGICLWEIYCCDMPYP 273
+ D +SFG L EI C D P
Sbjct: 198 LSTAADKWSFGTTLLEI-CFDGEVP 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 7/120 (5%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+++ GG L +++ K + + V + A ++ L LH + IV RD+ N+LLD
Sbjct: 62 LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 207 KNRTVKIADFGVAR-VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+++ F VE S + Y APEV + CD +S G L+E+
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFEL 175
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA--------RVEA 223
K++ + D+ L Y+H I H D+K EN+++D N I D+G+A +E
Sbjct: 126 KLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEY 185
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
S GTL Y + NG R+ D+ S G C+
Sbjct: 186 SK-EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 26/195 (13%)
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICC------VVVEYLPGGA 156
+E+ V K+ P+ A ++ + Q + + + +C +V E++ G
Sbjct: 31 KEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 157 LKTYLIKNRRRK---LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT--- 210
L ++ RK L ++A LA LSYL + +VH +V T+N+LL +
Sbjct: 91 LDLFM----HRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146
Query: 211 ----VKIADFGVARVEASNPNDMTGETGTLGYMAPE-VLNGNPYNRKCDVYSFGICLWEI 265
+K++D G+ S + + ++APE V + + D +SFG LWEI
Sbjct: 147 CGPFIKLSDPGIPITVLSRQECVE----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
Query: 266 -YCCDMPYPDLSFSE 279
Y ++P D + +E
Sbjct: 203 CYNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 15/105 (14%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG----------VARVEASNPNDMTGE 232
RGL+YLH +HR++K ++L+ + V ++ A+V P
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ---FS 168
Query: 233 TGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDL 275
T L +++PE+L + YN K D+YS GI E+ +P+ D+
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 24/72 (33%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 155 GALKTYLIKNRR-------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
G L+ +++ ++ K V+ + + GL LH IVHRD+K EN+L+
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344
Query: 208 NRTVKIADFGVA 219
+ VKI DFG A
Sbjct: 345 DGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 17/36 (47%), Positives = 22/36 (61%), Gaps = 1/36 (2%)
Query: 185 LSYLHSQKIVHRDVKTENMLLD-KNRTVKIADFGVA 219
L LHS IVHRDVK +N++ + + KI D G A
Sbjct: 268 LDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 22/73 (30%), Positives = 42/73 (57%), Gaps = 6/73 (8%)
Query: 148 VVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V++Y+PGG + + LI+ LA + +L + +H +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC----AVESVHKMGFIHRDIKPDNILI 134
Query: 206 DKNRTVKIADFGV 218
D++ +K+ DFG+
Sbjct: 135 DRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+EY+ G LK L + R L +V + LH IVH D+ T N++L
Sbjct: 76 IVMEYIEGELLKDALEEARP-DLLREVGRLVGK--------LHKAGIVHGDLTTSNIILS 126
Query: 207 KNRTVKIADFGVARVEAS 224
R I DFG+
Sbjct: 127 GGRIYFI-DFGLGEFSDE 143
|
Length = 204 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 54/250 (21%)
Query: 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109
S L ++VI+RG G ++G + + EI + S + E+A
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGM-----------QFVVKEINDVNSIPSSEIADMG 738
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK---NRR 166
KL HPN+ K IG + SE + A ++ EY+ G L L RR
Sbjct: 739 KLQHPNIVKLIG--LCRSE--------KGAY------LIHEYIEGKNLSEVLRNLSWERR 782
Query: 167 RKLAFKVVVQLALDLARGLSYLH---SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
RK+A + +A+ L +LH S +V ++ E +++D +
Sbjct: 783 RKIA--------IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK--------DEPHLRL 826
Query: 224 SNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
S P + +T Y+APE K D+Y FG+ L E+ P D F V
Sbjct: 827 SLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEF-GV 884
Query: 281 TSAVVRQVQY 290
++V +Y
Sbjct: 885 HGSIVEWARY 894
|
Length = 968 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 7/73 (9%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ G LK + N ++L+ ++ R + LHS I+H D+ T NM+L
Sbjct: 77 VMEYIEGEPLKDLINSNGME------ELELSREIGRLVGKLHSAGIIHGDLTTSNMIL-S 129
Query: 208 NRTVKIADFGVAR 220
+ + DFG+A
Sbjct: 130 GGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 21/75 (28%), Positives = 33/75 (44%), Gaps = 11/75 (14%)
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206
+V+EY+ G LK L N + ++ LH IVH D+ T N ++
Sbjct: 413 IVMEYIGGKDLKDVLEGNPEL----------VRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462
Query: 207 KNRTVKIADFGVARV 221
+R I DFG+ +
Sbjct: 463 DDRLYLI-DFGLGKY 476
|
Length = 535 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 7e-04
Identities = 58/266 (21%), Positives = 108/266 (40%), Gaps = 56/266 (21%)
Query: 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
VIK I G FG V H + W +R E +S EV V +L
Sbjct: 17 VIKK-IGNGRFGEV---FLVKHKRTQEFFCWKAISYRGLKERE--KSQLVIEVNVMRELK 70
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR--KLA 170
H N+ ++I + + + +++E+ G L + K + K+
Sbjct: 71 HKNIVRYIDRFLNKANQKLY--------------ILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 171 FKVVVQLALDLARGLSYLHS-------QKIVHRDVKTENML-----------------LD 206
+V + L L+Y H+ ++++HRD+K +N+ L+
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 207 KNRTVKIADFGVAR---VEASNPNDMTGETGTLGYMAPEVL--NGNPYNRKCDVYSFGIC 261
KI DFG+++ +E+ + + GT Y +PE+L Y+ K D+++ G
Sbjct: 177 GRPIAKIGDFGLSKNIGIESMAHSCV----GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 262 LWEIYCCDMPYPDL-SFSEVTSAVVR 286
++E+ P+ +FS++ S + R
Sbjct: 233 IYELCSGKTPFHKANNFSQLISELKR 258
|
Length = 1021 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 10/74 (13%)
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
V+EY+ G LK +I+ +L ++ + LH IVH D+ T N+++
Sbjct: 75 VMEYIEGKPLK-DVIEEGNDELLREIGRLVGK--------LHKAGIVHGDLTTSNIIVRD 125
Query: 208 NRTVKIADFGVARV 221
++ I DFG+ +
Sbjct: 126 DKLYLI-DFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 9e-04
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 36/163 (22%)
Query: 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLS 186
+ Q E G ++C V+ +Y P L +++K+ R LA Q+ L
Sbjct: 199 YFQNETG------HMCIVMPKYGP--CLLDWIMKHGPFSHRHLA-----QIIFQTGVALD 245
Query: 187 YLHSQ-KIVHRDVKTENMLLDKNRT----------------VKIADFGVARVEASNPNDM 229
Y H++ ++H D+K EN+L++ + T V+I D G E +
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSR 302
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
T T Y +PEV+ G + D++S G ++E+Y + Y
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 42/193 (21%), Positives = 78/193 (40%), Gaps = 32/193 (16%)
Query: 101 FTQ-EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F Q E+ V +HPN+ + + +EL VV ++ G+ K
Sbjct: 45 FLQGELHVSKLFNHPNIVPYRATFIADNEL----------------WVVTSFMAYGSAKD 88
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV- 218
+ + ++ + + + + L Y+H VHR VK ++L+ + V ++
Sbjct: 89 LICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 148
Query: 219 ---------ARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYC 267
RV P L +++PEVL N Y+ K D+YS GI E+
Sbjct: 149 LSMINHGQRLRVVHDFPKY---SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205
Query: 268 CDMPYPDLSFSEV 280
+P+ D+ +++
Sbjct: 206 GHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.001
Identities = 28/89 (31%), Positives = 40/89 (44%), Gaps = 15/89 (16%)
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEASNPNDMTGETGT 235
+ L L LH Q K+ N+LL + +K+ + E S P+
Sbjct: 22 VCLQCLGALRELHRQA------KSGNILLTWDGLLKLDGSVAFKTPEQSRPDPY------ 69
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
+MAPEV+ G Y K D+YS GI L+E
Sbjct: 70 --FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 292 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.61 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.56 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.35 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.31 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.16 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.14 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.12 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.9 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.86 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.74 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.55 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.27 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.14 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.93 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.84 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.63 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.48 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.35 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.27 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.27 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.24 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.24 | |
| PLN02236 | 344 | choline kinase | 97.05 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.0 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.98 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.87 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.8 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.52 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.42 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.26 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.15 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.04 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.78 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.57 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.99 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=321.90 Aligned_cols=218 Identities=28% Similarity=0.457 Sum_probs=195.3
Q ss_pred ecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
...++|+++++||+|+||.||++ +++++.+|+|+++....... .-.+....|..+|.+++||.||+++-.|+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~------~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK------KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh------hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 44689999999999999999999 45799999999975443222 12344778999999999999999999999
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+...+ |+|+||+.||.|...+++ ...+++..++.++.+|+.||.|||++||+||||||+|||
T Consensus 96 t~~kL----------------ylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 96 TEEKL----------------YLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL 157 (357)
T ss_pred cCCeE----------------EEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence 98877 999999999999999964 457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++++|+++|+|||++.............+||+.|||||++.+..|+.+.|.||||+++|+|++|.+||.+.+..+++++|
T Consensus 158 Ld~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I 237 (357)
T KOG0598|consen 158 LDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI 237 (357)
T ss_pred ecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH
Confidence 99999999999999986655555556689999999999999999999999999999999999999999999999999999
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 238 ~~~k 241 (357)
T KOG0598|consen 238 LKGK 241 (357)
T ss_pred hcCc
Confidence 9886
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=322.48 Aligned_cols=214 Identities=28% Similarity=0.462 Sum_probs=189.0
Q ss_pred CCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||.|.|++||+|. .++..||||.+....- .....+.+..|+.+|+.++|||||++++++.+.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-------~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-------NKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-------CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 4689999999999999999995 4689999998854321 233455678899999999999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ |+|||||.||+|.+|+++. +.+++.+++.++.||+.||++||+++|+||||||.|||++
T Consensus 82 ~~i----------------~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs 143 (429)
T KOG0595|consen 82 DFI----------------YLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLS 143 (429)
T ss_pred CeE----------------EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEec
Confidence 765 9999999999999999653 4799999999999999999999999999999999999997
Q ss_pred CC------CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 KN------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 ~~------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.. -.+||.|||+++... .........|++-|||||++..+.|+.++|+||+|+++|+|++|..||...+..|+
T Consensus 144 ~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 144 TTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred cCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 64 458999999998766 33455568899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhh
Q 022794 281 TSAVVRQV 288 (292)
Q Consensus 281 ~~~i~~~~ 288 (292)
...+.++.
T Consensus 223 ~~~~~k~~ 230 (429)
T KOG0595|consen 223 LLYIKKGN 230 (429)
T ss_pred HHHHhccc
Confidence 99887764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=314.61 Aligned_cols=216 Identities=29% Similarity=0.491 Sum_probs=192.7
Q ss_pred CceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec-eecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG-ATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~ 126 (292)
.+|+|+++||.|.||.||++ ..+|+.||.|.++...- ....++.+..|+.+|++|+||||+++++ .|.+.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-------d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-------DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-------cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 57999999999999999999 45899999998864432 2334566888999999999999999998 44444
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLHS--QK--IVHRDVKT 200 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~--~~--i~h~di~p 200 (292)
++. ++|+||+|..|+|...++. ...+.+++..+|+++.|++.||.++|. .+ +.||||||
T Consensus 92 ~ev---------------lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP 156 (375)
T KOG0591|consen 92 NEV---------------LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP 156 (375)
T ss_pred chh---------------hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc
Confidence 432 2799999999999999964 345679999999999999999999999 45 99999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.|||++..|.+||+|||+++...+........+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+-+-.++
T Consensus 157 aNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L 236 (375)
T KOG0591|consen 157 ANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL 236 (375)
T ss_pred hheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH
Confidence 99999999999999999999988888888889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
.++|.++
T Consensus 237 ~~KI~qg 243 (375)
T KOG0591|consen 237 CKKIEQG 243 (375)
T ss_pred HHHHHcC
Confidence 9999887
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=331.78 Aligned_cols=214 Identities=27% Similarity=0.412 Sum_probs=196.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|...+.||+|||..||.+++ +|+.||+|++... .......++++.+|+++.+.|+|||||+++++|.+.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~------~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKK------LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehH------HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 5799999999999999999955 7999999999532 2222344667899999999999999999999999988
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ ||++|+|+.++|.++++ +++.++|.+++.+++||+.+|.|||+++|+|||||..|+|+++
T Consensus 92 nV----------------YivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~ 153 (592)
T KOG0575|consen 92 NV----------------YIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE 153 (592)
T ss_pred ce----------------EEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC
Confidence 77 89999999999999886 5678999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++||+|||+|+............+|||.|.|||++.....+..+||||+||+||.||.|++||...+..+.+.+|+..
T Consensus 154 ~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~ 233 (592)
T KOG0575|consen 154 NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN 233 (592)
T ss_pred cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence 99999999999999887777778899999999999999999999999999999999999999999999999999998865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=310.77 Aligned_cols=213 Identities=32% Similarity=0.529 Sum_probs=188.7
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+...+.+.++.||+|..|+||++.+ +++.+|+|++.... ....++.+.+|+++++.++||+||.+|+.|.
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--------~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--------DPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--------CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 3345788899999999999999965 59999999984322 2344667899999999999999999999999
Q ss_pred CCcc-cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q 022794 125 GSSE-LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTEN 202 (292)
Q Consensus 125 ~~~~-~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~N 202 (292)
.... + +|+||||++|+|++++... +.++|..+..++.+++++|.|||. ++|+||||||+|
T Consensus 148 ~~~~~i----------------sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsN 209 (364)
T KOG0581|consen 148 SNGEEI----------------SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSN 209 (364)
T ss_pred eCCceE----------------EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHH
Confidence 8874 5 8999999999999998654 569999999999999999999995 999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-----SF 277 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~-----~~ 277 (292)
+|++..|++||||||.+..+... ......||..|||||.+.+..|+.++||||||+.++|+..|+.||... +.
T Consensus 210 lLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~ 287 (364)
T KOG0581|consen 210 LLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI 287 (364)
T ss_pred eeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH
Confidence 99999999999999999876654 556789999999999999999999999999999999999999999874 78
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
-+++..|+.+
T Consensus 288 ~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 288 FELLCAIVDE 297 (364)
T ss_pred HHHHHHHhcC
Confidence 8888888764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=321.29 Aligned_cols=217 Identities=27% Similarity=0.437 Sum_probs=189.2
Q ss_pred eecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 122 (292)
.....+|.+++.||.|+|++|++|+ .+++.||||++.... .-.+...+.+..|-..|.+| +||.|++++-.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~------Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T 142 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY------IIKEKKVKYVTREKEALTQLSGHPGIVKLYFT 142 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH------HHhhcccchhhHHHHHHHHhhCCCCeEEEEEE
Confidence 4456899999999999999999995 479999999984321 11122234577899999999 99999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
|++...+ |+|+||+++|+|.++|.+. +.+++...+.++.+|+.||+|||++|||||||||+|
T Consensus 143 FQD~~sL----------------YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 143 FQDEESL----------------YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred eecccce----------------EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 9998877 8999999999999999765 569999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC-------------CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND-------------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~ 269 (292)
||++.+|+++|+|||.|..+...... ....+||-.|.+||++.....++.+|||+|||++|+|+.|.
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~ 284 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ 284 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC
Confidence 99999999999999999865432111 13478999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 022794 270 MPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 270 ~pf~~~~~~~~~~~i~~ 286 (292)
+||.+.++--+.++|++
T Consensus 285 PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 285 PPFRAANEYLIFQKIQA 301 (604)
T ss_pred CCCccccHHHHHHHHHH
Confidence 99999999999999876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=316.26 Aligned_cols=220 Identities=29% Similarity=0.450 Sum_probs=186.2
Q ss_pred cCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
....|.+.+.||+|+||.|-+|. .+|+.||||+++......... ..+. ...+.+|+++|++++|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~-~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAK-TRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccc-hhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 45679999999999999999994 579999999997655433222 1111 1226789999999999999999999998
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. |+||||++||.|.+++-.+ +.+.+..-..+++|++.|+.|||+.||+||||||+|||+
T Consensus 248 ~ds~----------------YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl 309 (475)
T KOG0615|consen 248 PDSS----------------YMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILL 309 (475)
T ss_pred CCce----------------EEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEe
Confidence 8877 8999999999999999654 568888889999999999999999999999999999999
Q ss_pred cCC---CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 206 DKN---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY---NRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 206 ~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
..+ ..+||.|||+|.... ........+||+.|.|||++.+... ..+.|+|||||++|-+++|.+||.+.....
T Consensus 310 ~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 310 SNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 765 779999999998765 4455666899999999999987643 347799999999999999999999887777
Q ss_pred -HHHHHHHhh
Q 022794 280 -VTSAVVRQV 288 (292)
Q Consensus 280 -~~~~i~~~~ 288 (292)
+.++|.+|.
T Consensus 389 sl~eQI~~G~ 398 (475)
T KOG0615|consen 389 SLKEQILKGR 398 (475)
T ss_pred cHHHHHhcCc
Confidence 888888774
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=296.96 Aligned_cols=217 Identities=24% Similarity=0.389 Sum_probs=190.5
Q ss_pred CceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|..++++|+|+||+||+++ ++|+.||||.+....++ ...++-..+|+++|++++|+|+|.++++|...+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-------~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-------PVVKKIALREIRMLKQLKHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-------HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc
Confidence 578899999999999999994 57999999999654432 333455788999999999999999999999888
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ ++|+|||+..-|. -+.++. ..++...+..++.|++.|+.++|+++++||||||+||||+.
T Consensus 75 kl----------------hLVFE~~dhTvL~-eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~ 136 (396)
T KOG0593|consen 75 KL----------------HLVFEYCDHTVLH-ELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ 136 (396)
T ss_pred ee----------------EEEeeecchHHHH-HHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec
Confidence 77 8999999764444 465544 45889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.|.+||||||.|+.+..+...++..+.|..|+|||.+.| ..|.++.|||++||++.||++|.+.|++.+.-+.+-.|.+
T Consensus 137 ~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 137 NGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred CCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 999999999999988777778888899999999999998 5799999999999999999999999999999998888887
Q ss_pred hhhcc
Q 022794 287 QVQYL 291 (292)
Q Consensus 287 ~~~~~ 291 (292)
-+=.|
T Consensus 217 tLG~L 221 (396)
T KOG0593|consen 217 TLGNL 221 (396)
T ss_pred HHccc
Confidence 65444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=290.76 Aligned_cols=215 Identities=29% Similarity=0.455 Sum_probs=193.0
Q ss_pred ecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
...++|++++.||.|+||.|.+++ .+|..+|+|+++.. ......+.+...+|.++|+.+.||.++++++.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~------~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ------KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH------HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 344689999999999999999995 46899999999532 2233445567889999999999999999999999
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.+.+ ++||||++||.|..++++. +++++..++.++.||+.||+|||+++|++||+||+|||
T Consensus 115 d~~~l----------------ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiL 176 (355)
T KOG0616|consen 115 DNSNL----------------YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLL 176 (355)
T ss_pred cCCeE----------------EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHee
Confidence 88776 9999999999999999654 56999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.+|.+||+|||.|...... .-..+||+.|+|||.+....+..+.|-|+||+++|||+.|.+||..-++-+++++|
T Consensus 177 lD~~G~iKitDFGFAK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI 253 (355)
T KOG0616|consen 177 LDQNGHIKITDFGFAKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI 253 (355)
T ss_pred eccCCcEEEEeccceEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence 999999999999999876644 33478999999999999999999999999999999999999999999999999999
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
+++.
T Consensus 254 ~~~~ 257 (355)
T KOG0616|consen 254 LEGK 257 (355)
T ss_pred HhCc
Confidence 9874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=310.17 Aligned_cols=229 Identities=45% Similarity=0.780 Sum_probs=197.8
Q ss_pred hhcccceecCCceeEeeeeccCcceEEEEEEECCce-eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
.....+.+......+.+.||+|+||+||++.+.|+. ||+|++......... .+.|.+|+.+|++++|||||+
T Consensus 31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-------~~~f~~E~~il~~l~HpNIV~ 103 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-------RKAFRREASLLSRLRHPNIVQ 103 (362)
T ss_pred ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-------HHHHHHHHHHHHhCCCCCeee
Confidence 344556677778888888999999999999999999 999999755433221 566999999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC-ccccC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK-IVHRD 197 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-i~h~d 197 (292)
+++++..... .+++||||+++|+|.+++.......++...+..++.||+.++.|||+++ |+|||
T Consensus 104 f~G~~~~~~~---------------~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrD 168 (362)
T KOG0192|consen 104 FYGACTSPPG---------------SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRD 168 (362)
T ss_pred EEEEEcCCCC---------------ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecc
Confidence 9999987652 1289999999999999997655678999999999999999999999999 99999
Q ss_pred CCCCCeeEcCCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 198 VKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 198 i~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|||.|+|++.++ ++||+|||+++.............||..|||||+++ ...++.++||||||+++|||+||..||.+
T Consensus 169 LK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 169 LKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred cChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 999999999997 999999999986654333344468999999999999 56899999999999999999999999999
Q ss_pred CCHHHHHHHHHHhhhc
Q 022794 275 LSFSEVTSAVVRQVQY 290 (292)
Q Consensus 275 ~~~~~~~~~i~~~~~~ 290 (292)
....++...+..+..+
T Consensus 249 ~~~~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 249 LAPVQVASAVVVGGLR 264 (362)
T ss_pred CCHHHHHHHHHhcCCC
Confidence 9998888888766543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=309.15 Aligned_cols=220 Identities=27% Similarity=0.437 Sum_probs=190.0
Q ss_pred cCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|.+++.||+|+||.||+| +++|+.+|+|+++.. ..-.......+..|-.+|.....|.||+++-.|.+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS------~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS------EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHH------HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 4578999999999999999999 468999999999632 23333344557789999999999999999999998
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.+ ||+|||++||++...|.+ ...+++..++.++.+++.||..||++|++||||||+|+||
T Consensus 213 ~~~L----------------YLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi 274 (550)
T KOG0605|consen 213 KEYL----------------YLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI 274 (550)
T ss_pred CCee----------------EEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee
Confidence 8877 999999999999999954 4679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccC--------------------CCCC---------------------------CCCCCCcccc
Q 022794 206 DKNRTVKIADFGVARVEAS--------------------NPND---------------------------MTGETGTLGY 238 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~--------------------~~~~---------------------------~~~~~~~~~y 238 (292)
+..|++||+|||++.-... .+.. ....+|||.|
T Consensus 275 D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 275 DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 9999999999998742110 0000 1123599999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc
Q 022794 239 MAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQVQYL 291 (292)
Q Consensus 239 ~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 291 (292)
+|||++.+..|+..+|.||||||+||||.|.+||.+.++.+.+.+|++....|
T Consensus 355 iAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l 407 (550)
T KOG0605|consen 355 IAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL 407 (550)
T ss_pred cchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999999999999999999999987554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=309.50 Aligned_cols=212 Identities=36% Similarity=0.603 Sum_probs=190.3
Q ss_pred CceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|.||+||+| +++.+.||+|.+..... .+.+ .+.+.+|+++++.++||||+.++++|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr---~~k~----l~~l~~ev~i~r~lkHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR---NEKE----LKNLRQEVRILRSLKHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC---chHH----HHHHHHHHHHHHhcCCcchhhHHHhhcccc
Confidence 68999999999999999999 45788999998854433 2222 234778999999999999999999999887
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
++ |+|.||+.| +|..++.. +..++++.+..++.+++.||.|||+++|+|||+||.|||+..
T Consensus 75 ~~----------------~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~ 135 (808)
T KOG0597|consen 75 HL----------------WVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK 135 (808)
T ss_pred eE----------------EEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC
Confidence 76 899999965 99999954 467999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|.+|+||||+++.+...........||+-|||||+..++.|+..+|+|||||++||++.|++||...+..++++.|.+.
T Consensus 136 ~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d 215 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD 215 (808)
T ss_pred CCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC
Confidence 99999999999998877766667778999999999999999999999999999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=303.62 Aligned_cols=221 Identities=28% Similarity=0.561 Sum_probs=190.6
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~ 122 (292)
....++|.+.+.||+|.||.|++|.+ +|..||+|++......... ......+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~----~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS----QKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc----cccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 34568999999999999999999955 6899999977543211111 112334568999999998 9999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.....+ ++||||+.||.|.+++.. ..++.+..++.++.|++.|++|||++||+||||||+|
T Consensus 89 ~~t~~~~----------------~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~EN 150 (370)
T KOG0583|consen 89 FATPTKI----------------YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPEN 150 (370)
T ss_pred EecCCeE----------------EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHH
Confidence 9988775 899999999999999976 4679999999999999999999999999999999999
Q ss_pred eeEcCC-CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 203 MLLDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YN-RKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 203 ili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
++++.+ +++||+|||++..............|++.|+|||++.+.. |+ .++|+||+|++||.|++|..||...+...
T Consensus 151 illd~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~ 230 (370)
T KOG0583|consen 151 ILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN 230 (370)
T ss_pred EEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH
Confidence 999999 9999999999987643445566688999999999999987 86 78999999999999999999999999999
Q ss_pred HHHHHHHhh
Q 022794 280 VTSAVVRQV 288 (292)
Q Consensus 280 ~~~~i~~~~ 288 (292)
++.+|.++.
T Consensus 231 l~~ki~~~~ 239 (370)
T KOG0583|consen 231 LYRKIRKGE 239 (370)
T ss_pred HHHHHhcCC
Confidence 999987763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=306.89 Aligned_cols=218 Identities=28% Similarity=0.460 Sum_probs=192.9
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 121 (292)
..+..++|.++++||+|.||.|+++.. +++.+|||+++....-.+++. +..+.|.+++... +||.+++++.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~V------e~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEV------ESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccH------HHHHHHHHHHHHhccCCeEeeccc
Confidence 356668999999999999999999954 688999999987654444332 2356788888888 6999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
+|...+.+ |+||||+.||++..++ ....+++..++.++..++.||.|||++||+|||||.+
T Consensus 437 ~fQT~~~l----------------~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd 497 (694)
T KOG0694|consen 437 CFQTKEHL----------------FFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD 497 (694)
T ss_pred ccccCCeE----------------EEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh
Confidence 99998877 8999999999955443 4467999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|||++.+|++||.|||+++.............||+.|+|||++.+..|+.+.|-|+||++||+|+.|..||++.+++|+.
T Consensus 498 NiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 498 NLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred heEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 99999999999999999987765666777799999999999999999999999999999999999999999999999999
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
.+|++.
T Consensus 578 dsI~~d 583 (694)
T KOG0694|consen 578 DSIVND 583 (694)
T ss_pred HHHhcC
Confidence 999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=299.17 Aligned_cols=216 Identities=28% Similarity=0.390 Sum_probs=186.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
...|..+++||+|.||.||+|++ +|+.||+|.++........ .....+|+.||++|+||||+++.+...+.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~-------~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGF-------PITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcc-------hHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 45789999999999999999965 7999999999876643332 23367899999999999999999988776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
..- .+|+|+|||+ .+|.-.+. +..-.+++.++.-++.||+++|.|+|.+|++|||||.+||||+
T Consensus 189 ~~~--------------siYlVFeYMd-hDL~GLl~-~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid 252 (560)
T KOG0600|consen 189 LSG--------------SIYLVFEYMD-HDLSGLLS-SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID 252 (560)
T ss_pred CCc--------------eEEEEEeccc-chhhhhhc-CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc
Confidence 322 2399999995 58988774 3455799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.+|.+||.|||+|++...... ..+..+.|.-|.|||++.|. .|+.+.|+||.||||.||+.|++.|++.+.-+.+++|
T Consensus 253 n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI 332 (560)
T KOG0600|consen 253 NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI 332 (560)
T ss_pred CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH
Confidence 999999999999996554433 36778899999999999886 5999999999999999999999999999999999998
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.+-
T Consensus 333 fkl 335 (560)
T KOG0600|consen 333 FKL 335 (560)
T ss_pred HHH
Confidence 763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=272.38 Aligned_cols=213 Identities=28% Similarity=0.416 Sum_probs=188.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|...+.||+|.||+||+|++ +|+.||||.++........ .....+|+..|+.++|+||+.++++|...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-------~~talREIK~Lqel~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-------NRTALREIKLLQELKHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-------cHHHHHHHHHHHHccCcchhhhhhhccCCC
Confidence 4788899999999999999976 6999999999876443222 223668999999999999999999998887
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ .+|+||++ .+|...++. ....++...+..++.+++.+|+|||.+.|+||||||.|+||+.
T Consensus 75 ~l----------------~lVfEfm~-tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 75 NL----------------SLVFEFMP-TDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS 136 (318)
T ss_pred ce----------------EEEEEecc-ccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC
Confidence 77 78999995 599998864 5567999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+|.+||.|||+++....+.......+.|.-|+|||.+.|. .|+...|+||.|||+.||+-+.+-|++.+.-+.+..|.+
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~ 216 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR 216 (318)
T ss_pred CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence 9999999999999888776666666889999999999886 589999999999999999999999999999998888875
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
-
T Consensus 217 ~ 217 (318)
T KOG0659|consen 217 A 217 (318)
T ss_pred H
Confidence 3
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=282.69 Aligned_cols=215 Identities=31% Similarity=0.401 Sum_probs=189.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|+.+..|++|.||.||+|++ +++.||+|.++...+...-. -.-.+|+.+|.+++|||||.+-++....+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-------ItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-------ITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-------chhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 4799999999999999999966 68899999998766432211 12567999999999999999988876543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
- +..|+|||||+ .+|...+... .+++...++.-+..|++.+++|||.+.|+||||||+|+|++.
T Consensus 149 ~--------------d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~ 212 (419)
T KOG0663|consen 149 M--------------DKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH 212 (419)
T ss_pred c--------------ceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc
Confidence 3 23499999995 4999988654 468999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.|.+|++|||+|+...++....+..+.|.-|+|||.+.|. .|+.+.|+||+|||+.||+++.+.|++.+.-+.+.+|.+
T Consensus 213 ~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 213 KGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred CCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 9999999999999988888888888999999999999886 599999999999999999999999999999999999876
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 293 l 293 (419)
T KOG0663|consen 293 L 293 (419)
T ss_pred H
Confidence 4
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=286.05 Aligned_cols=223 Identities=25% Similarity=0.364 Sum_probs=191.8
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
+...+....|++++.||+|..|+||++... +..+|+|++... .........+...|.+||+.+.||.++.+|
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~------~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY 143 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKE------SLASRKKLKRAQTEREILSLLDHPFLPTLY 143 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHH------HHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence 445566678999999999999999999765 479999999532 223334456678899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
..|...... |++||||+||+|...++++.++.+++..++.++.+++.||+|||.+|||+|||||
T Consensus 144 a~fet~~~~----------------cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP 207 (459)
T KOG0610|consen 144 ASFETDKYS----------------CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP 207 (459)
T ss_pred heeecccee----------------EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence 999876655 9999999999999999999999999999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceecc-------C--------------------------CCC--------------------
Q 022794 201 ENMLLDKNRTVKIADFGVARVEA-------S--------------------------NPN-------------------- 227 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~-------~--------------------------~~~-------------------- 227 (292)
+||||.++|+++|.||+++.... . ...
T Consensus 208 ENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep 287 (459)
T KOG0610|consen 208 ENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEP 287 (459)
T ss_pred ceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCC
Confidence 99999999999999999763210 0 000
Q ss_pred ---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 228 ---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 228 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
.....+||-.|.|||+++|...+.+.|-|+||+++|||+.|.-||.+.+..+.+.+|+.+
T Consensus 288 ~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~ 350 (459)
T KOG0610|consen 288 TGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ 350 (459)
T ss_pred CCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC
Confidence 011245889999999999999999999999999999999999999999999999998865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=298.78 Aligned_cols=221 Identities=34% Similarity=0.622 Sum_probs=196.8
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEECCc-eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...|.+....+++++.||+|.||.||+|.++|. +||+|.++...-. ...|.+|+.++++|+|++||+++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----------~~~f~~Ea~iMk~L~H~~lV~l~ 267 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----------PEAFLREAQIMKKLRHEKLVKLY 267 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----------hhHHHHHHHHHHhCcccCeEEEE
Confidence 677889999999999999999999999999887 9999999754321 23377999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.....+ +|||||++.|+|.+|++...+..++....+.++.||+++.+||+++++|||||..
T Consensus 268 gV~~~~~pi----------------yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA 331 (468)
T KOG0197|consen 268 GVCTKQEPI----------------YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA 331 (468)
T ss_pred EEEecCCce----------------EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhh
Confidence 999887755 8999999999999999876677899999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
.|||++++..+||+|||+++...+... ......-+..|.|||.+..+.++.++||||||++|+||+| |+.||.+++..
T Consensus 332 RNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ 411 (468)
T KOG0197|consen 332 RNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE 411 (468)
T ss_pred hheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence 999999999999999999985443322 2233445679999999999999999999999999999999 99999999999
Q ss_pred HHHHHHHHhh
Q 022794 279 EVTSAVVRQV 288 (292)
Q Consensus 279 ~~~~~i~~~~ 288 (292)
++++.+.+|-
T Consensus 412 ev~~~le~Gy 421 (468)
T KOG0197|consen 412 EVLELLERGY 421 (468)
T ss_pred HHHHHHhccC
Confidence 9999999873
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=282.77 Aligned_cols=223 Identities=27% Similarity=0.431 Sum_probs=192.1
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
....|....+.|.+.+.||.|..++||+|+ ..++.||||+++..+.+.. .+.+.+|+..++.++||||+.
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--------ld~l~kE~~~msl~~HPNIv~ 88 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--------LDALRKEVQTMSLIDHPNIVT 88 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--------HHHHHHHHHHhhhcCCCCcce
Confidence 345677788999999999999999999995 4789999999975443211 445788999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
++..|.....+ |+||.|+.+|++.+.++......++|..+..+++++++||.|||++|.|||||
T Consensus 89 ~~~sFvv~~~L----------------WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdv 152 (516)
T KOG0582|consen 89 YHCSFVVDSEL----------------WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDV 152 (516)
T ss_pred EEEEEEeccee----------------EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceeccc
Confidence 99999988877 89999999999999998777778999999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCCCC----CCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPNDM----TGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
|+.||||+.+|.|+|.|||.+..+....... ....+++.|||||++.. ..|+.++||||||+...||.+|+.||
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 9999999999999999999876554443322 44589999999999643 46999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHh
Q 022794 273 PDLSFSEVTSAVVRQ 287 (292)
Q Consensus 273 ~~~~~~~~~~~i~~~ 287 (292)
....+-+++..-+++
T Consensus 233 ~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQN 247 (516)
T ss_pred ccCChHHHHHHHhcC
Confidence 998887776554443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=298.96 Aligned_cols=217 Identities=29% Similarity=0.531 Sum_probs=191.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+-|++++.||.|+.|.|-+|++ +|+.+|||++....... ......+.+|+-+++.+.|||++++++++.+..
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s------~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS------SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc------cccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 5689999999999999999965 89999999986432111 112334778999999999999999999999887
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |+++||+++|-|++++.+ .+++++.++.+++.||+.++.|+|..+|||||+||+|+|++.
T Consensus 86 ~l----------------ylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~ 147 (786)
T KOG0588|consen 86 HL----------------YLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV 147 (786)
T ss_pred eE----------------EEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence 77 899999999999999965 367999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.+++||.|||+|.... ...-....+|.+.|++||.+.|..|. .++||||.|+|||.||+|++||++-+...++.+|.+
T Consensus 148 ~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~ 226 (786)
T KOG0588|consen 148 KNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR 226 (786)
T ss_pred ccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 9999999999998543 44556668899999999999999885 789999999999999999999999999999999999
Q ss_pred hhhcc
Q 022794 287 QVQYL 291 (292)
Q Consensus 287 ~~~~~ 291 (292)
|+.+|
T Consensus 227 G~f~M 231 (786)
T KOG0588|consen 227 GVFEM 231 (786)
T ss_pred CcccC
Confidence 98654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.59 Aligned_cols=214 Identities=27% Similarity=0.392 Sum_probs=181.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +++.||+|+++... .........+.+|..++.+++|++|+++++.+.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~ 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD------MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4789999999999999999965 58899999985321 111223445778999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~ 136 (363)
T cd05628 75 NL----------------YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS 136 (363)
T ss_pred eE----------------EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 55 8999999999999998643 56899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-----------------------------------CCCCCCCcccccCCcccCCCCCCch
Q 022794 208 NRTVKIADFGVARVEASNPN-----------------------------------DMTGETGTLGYMAPEVLNGNPYNRK 252 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 252 (292)
++.++|+|||++........ ......|++.|+|||++.+..++.+
T Consensus 137 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~ 216 (363)
T cd05628 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216 (363)
T ss_pred CCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc
Confidence 99999999999864321100 0122468999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 253 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 253 ~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|+|||||++|+|++|..||.+.+..+...++.+.
T Consensus 217 ~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 251 (363)
T cd05628 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251 (363)
T ss_pred hhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999999999999988888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=289.79 Aligned_cols=222 Identities=28% Similarity=0.425 Sum_probs=181.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCc-----cHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHR-----TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
.+.|++.+.||+|.||.|-+|.+ +++.||||++........ .......-.++..+|+.++++|.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 46899999999999999999965 689999999954321110 00000001246889999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccc-cCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK-LAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+..+...-.+ |||+|||..|.+...- .... +++.+++.++.+++.+|.|||..||+||||||
T Consensus 176 vLDDP~s~~~--------------YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKP 238 (576)
T KOG0585|consen 176 VLDDPESDKL--------------YLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKP 238 (576)
T ss_pred eecCcccCce--------------EEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccch
Confidence 9988765544 9999999988876532 3344 89999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCC-----CCCCCCCCCcccccCCcccCCCC----CCchhhHHHHHHHHHHHHhCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASN-----PNDMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMP 271 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwslg~il~~l~~g~~p 271 (292)
+|+|++++|++||.|||.+...... ........||++|+|||...++. -+.+.||||+|++||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 9999999999999999998754222 11223467999999999987732 35789999999999999999999
Q ss_pred CCCCCHHHHHHHHHHh
Q 022794 272 YPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 272 f~~~~~~~~~~~i~~~ 287 (292)
|.+...-+++.+|++.
T Consensus 319 F~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 319 FFDDFELELFDKIVND 334 (576)
T ss_pred cccchHHHHHHHHhcC
Confidence 9999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=266.73 Aligned_cols=219 Identities=27% Similarity=0.457 Sum_probs=195.5
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
..|.+ ++|.+.+.||+|-||.||+|.. ++..||+|++.. ...........+.+|+++-+.|+||||++++
T Consensus 17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfK------sqi~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFK------SQILKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeH------HHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence 44444 7899999999999999999955 577899999842 2333444556688999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
++|.+...+ |+++||..+|.|...+...+...+++...+.+..|++.||.|+|..+++||||||
T Consensus 89 ~~fhd~~ri----------------yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKp 152 (281)
T KOG0580|consen 89 GYFHDSKRI----------------YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKP 152 (281)
T ss_pred hheecccee----------------EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCH
Confidence 999998887 9999999999999999877778899999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+|+|++..+.+++.|||.+...+ .......+||..|.|||...+..++...|+|++|++.|+++.|.+||...+.++.
T Consensus 153 enlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et 230 (281)
T KOG0580|consen 153 ENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET 230 (281)
T ss_pred HHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH
Confidence 99999999999999999986544 4555668899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+++|.+-
T Consensus 231 YkrI~k~ 237 (281)
T KOG0580|consen 231 YKRIRKV 237 (281)
T ss_pred HHHHHHc
Confidence 9998763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=291.75 Aligned_cols=213 Identities=27% Similarity=0.361 Sum_probs=185.1
Q ss_pred cCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 124 (292)
...+|.++++||.|.||.||+|+ .+|+.||||.++..-. .-++.. =.+|+..|++++ ||||+++.+++.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~---s~ee~~-----nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY---SWEECM-----NLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc---cHHHHH-----HHHHHHHHHhcCCCCcchhhHHHhh
Confidence 45799999999999999999994 5799999998853322 122222 246999999997 999999999999
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.+. . +++||||+ ..+|.+.++.. ++.+++..++.|+.||+++|+|+|++|+.|||+||+|||
T Consensus 80 d~~~-~--------------L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiL 142 (538)
T KOG0661|consen 80 DNDR-I--------------LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENIL 142 (538)
T ss_pred ccCc-e--------------EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheE
Confidence 8873 1 28999999 56999988764 889999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
|.....+||+|||+|+...+. +.++..+.|.-|+|||++. ..-|+.+.|+|++|||++|+++-++.|++.++-+.+-+
T Consensus 143 i~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K 221 (538)
T KOG0661|consen 143 ISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK 221 (538)
T ss_pred ecccceeEecccccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH
Confidence 998889999999999876654 5567788999999999975 45689999999999999999999999999999999998
Q ss_pred HHH
Q 022794 284 VVR 286 (292)
Q Consensus 284 i~~ 286 (292)
|+.
T Consensus 222 Ic~ 224 (538)
T KOG0661|consen 222 ICE 224 (538)
T ss_pred HHH
Confidence 875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=281.69 Aligned_cols=210 Identities=27% Similarity=0.426 Sum_probs=178.3
Q ss_pred ceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|.-.+++|.|+||+||+|. .+++.||||....+... -.+|+.+++.+.|||||++.-+|....+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------------knrEl~im~~l~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------------KNRELQIMRKLDHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------------CcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence 57888999999999999994 45789999987543321 3469999999999999999988876543
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
. +.....+||||++. +|.++++.. .+..++.-.++-+..||++||+|||..|||||||||.|+|++
T Consensus 92 ~-----------d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD 159 (364)
T KOG0658|consen 92 S-----------DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD 159 (364)
T ss_pred C-----------chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc
Confidence 3 12233799999965 999988642 356788888999999999999999999999999999999998
Q ss_pred CC-CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.+ |.+||||||+|..+...... ....++..|+|||.+.|. .|+.+.||||.|||+.||+.|++.|++.+..+.+..|
T Consensus 160 ~~tg~LKicDFGSAK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eI 238 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEI 238 (364)
T ss_pred CCCCeEEeccCCcceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHH
Confidence 76 99999999999876654443 557899999999999886 5999999999999999999999999999999999888
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
++
T Consensus 239 ik 240 (364)
T KOG0658|consen 239 IK 240 (364)
T ss_pred HH
Confidence 76
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=284.03 Aligned_cols=212 Identities=28% Similarity=0.423 Sum_probs=181.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|+||.||+|.+ +|+.||+|++.... .........+.+|+.++++++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE------VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH------HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 3789999999999999999976 48999999985321 111123445788999999999999999998877665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ..+++..++.++.|++.||++||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~ 136 (291)
T cd05612 75 FL----------------YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK 136 (291)
T ss_pred eE----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC
Confidence 44 8999999999999998643 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..++++.+..+
T Consensus 137 ~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 137 EGHIKLTDFGFAKKLRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred CCCEEEEecCcchhccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 999999999998754322 22346889999999999988999999999999999999999999999998888888765
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 214 ~ 214 (291)
T cd05612 214 K 214 (291)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.25 Aligned_cols=207 Identities=27% Similarity=0.440 Sum_probs=183.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-C-----Ccccceec
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-H-----PNVTKFIG 121 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~ 121 (292)
.+|.|.+.||+|.||.|.+|.+ +++.||||+++.... ..+....|+.+|.+++ | -|+|++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----------FLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----------HHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 3789999999999999999976 689999999974432 2334567999999996 3 49999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
+|...++. |||+|.+ ..+|.++++.++-.+++...++.++.||+.+|..||..||||+||||+
T Consensus 256 ~F~fr~Hl----------------ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPE 318 (586)
T KOG0667|consen 256 YFYFRNHL----------------CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPE 318 (586)
T ss_pred ccccccce----------------eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChh
Confidence 99887776 9999999 569999999988889999999999999999999999999999999999
Q ss_pred CeeEcCC--CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 202 NMLLDKN--RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 202 Nili~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
|||+.+. ..+|++|||+++....... ...-+..|+|||++.|.+|+.+.||||||||++||++|.+.|++.++.+
T Consensus 319 NILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 319 NILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred heeeccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 9999655 4699999999997665443 4677889999999999999999999999999999999999999999999
Q ss_pred HHHHHHH
Q 022794 280 VTSAVVR 286 (292)
Q Consensus 280 ~~~~i~~ 286 (292)
.+..|+.
T Consensus 396 Ql~~I~e 402 (586)
T KOG0667|consen 396 QLARIIE 402 (586)
T ss_pred HHHHHHH
Confidence 9998875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=283.66 Aligned_cols=216 Identities=26% Similarity=0.506 Sum_probs=191.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
+.++|.+.+.||+|.||.|-+|.. .|+.||||.++.+.. +..+..-.+.+|++|++.|+||||++++++|..
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI------kdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN 124 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI------KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN 124 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc------ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence 457999999999999999999954 699999999865432 122223347899999999999999999999998
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.+ .|||||..+|.|.+|+.+ .+.+++.+++.+++||+.|+.|+|+++++|||||.+|||+
T Consensus 125 kdKI----------------vivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL 186 (668)
T KOG0611|consen 125 KDKI----------------VIVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL 186 (668)
T ss_pred CceE----------------EEEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee
Confidence 8877 889999999999999965 3569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++++||.|||++.... .....+.++|++-|.+||...|..|. +..|-||||++||.|..|.+||++.+...++.+|
T Consensus 187 D~N~NiKIADFGLSNly~-~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYA-DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred cCCCCeeeeccchhhhhc-cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 999999999999987544 34566778999999999999999875 7899999999999999999999999999999999
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.+|.
T Consensus 266 s~Ga 269 (668)
T KOG0611|consen 266 SRGA 269 (668)
T ss_pred hccc
Confidence 8874
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=289.96 Aligned_cols=218 Identities=26% Similarity=0.487 Sum_probs=197.9
Q ss_pred CCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+++.+|+|+||.++++. .+++.+++|.+.......+.. +...+|+.+++++.||||+.+.+.|...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-------~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-------RSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-------HHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 4689999999999999999874 467899999998766544432 2467899999999999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ ++|+|+||+||++.+.+.+.++..++++.++.|+.|++.|+.|||+++|+|||||+.|||++
T Consensus 76 ~~~---------------l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 76 GQL---------------LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred Cce---------------EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 662 38999999999999999888888899999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.|+|+|||+++.+...........||+.|+.||.+.+.+|..++|||||||++|||++-+++|...+...++.+|.+
T Consensus 141 k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~ 220 (426)
T KOG0589|consen 141 KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR 220 (426)
T ss_pred ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence 99999999999999887766567778999999999999999999999999999999999999999999999999999998
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
+.
T Consensus 221 ~~ 222 (426)
T KOG0589|consen 221 GL 222 (426)
T ss_pred cc
Confidence 76
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=288.03 Aligned_cols=217 Identities=26% Similarity=0.379 Sum_probs=183.7
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
..+...+|.+.+.||+|+||.||+|.+. +..||+|++..... ........+.+|+.+++.++||||+++++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 98 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI------IKQKQVDHVFSERKILNYINHPFCVNLYG 98 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence 3345578999999999999999999653 35799998853221 11122345778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+.+.. +++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+
T Consensus 99 ~~~~~~~~----------------~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 160 (340)
T PTZ00426 99 SFKDESYL----------------YLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPE 160 (340)
T ss_pred EEEeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHH
Confidence 98776554 8999999999999999653 46899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|||++.++.++|+|||++...... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+...+.
T Consensus 161 NILl~~~~~ikL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 237 (340)
T PTZ00426 161 NLLLDKDGFIKMTDFGFAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237 (340)
T ss_pred HEEECCCCCEEEecCCCCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999998754322 22356889999999999888999999999999999999999999999988888
Q ss_pred HHHHHhh
Q 022794 282 SAVVRQV 288 (292)
Q Consensus 282 ~~i~~~~ 288 (292)
..+.++.
T Consensus 238 ~~i~~~~ 244 (340)
T PTZ00426 238 QKILEGI 244 (340)
T ss_pred HHHhcCC
Confidence 8877654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=291.62 Aligned_cols=214 Identities=27% Similarity=0.403 Sum_probs=180.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+ +|+.||||++.... .........+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE------MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 4799999999999999999966 58899999985321 111223345778999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 136 (364)
T cd05599 75 YL----------------YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA 136 (364)
T ss_pred eE----------------EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 55 8999999999999998643 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC--------------------------------------CCCCCCCcccccCCcccCCCCC
Q 022794 208 NRTVKIADFGVARVEASNPN--------------------------------------DMTGETGTLGYMAPEVLNGNPY 249 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 249 (292)
++.++|+|||++........ ......||+.|+|||++.+..+
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (364)
T cd05599 137 KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216 (364)
T ss_pred CCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC
Confidence 99999999998864322110 0012358999999999999899
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 250 NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 250 ~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||||++|+|++|..||...+..+.+..+.+.
T Consensus 217 ~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~ 254 (364)
T cd05599 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW 254 (364)
T ss_pred CCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999999999999999998888888777654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=273.07 Aligned_cols=220 Identities=28% Similarity=0.412 Sum_probs=187.4
Q ss_pred CCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc-ccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN-VTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~ 125 (292)
...|..+++||+|.||+||+|+ .+|+.||+|.++.....+... ....+|+.+++.++|+| |+.+++++..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P-------~taiREisllk~L~~~~~iv~L~dv~~~ 82 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVP-------STAIREISLLKRLSHANHIVRLHDVIHT 82 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCC-------chhhHHHHHHHHhCCCcceEEEEeeeee
Confidence 3568888899999999999995 479999999998765532221 12567999999999999 9999999988
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+... .....++++||+ ..+|..++..... ..++...+..++.||+.||+|||+++|+||||||.|+
T Consensus 83 ~~~~~----------~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNl 151 (323)
T KOG0594|consen 83 SNNHR----------GIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNL 151 (323)
T ss_pred ccccc----------ccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceE
Confidence 76310 122348999999 5699999976543 4677789999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+|++.|.+||+|||+|+....+.......++|.-|+|||++.|. .|+...||||+||+++||+++++.|.+.+..+.+.
T Consensus 152 Li~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~ 231 (323)
T KOG0594|consen 152 LISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF 231 (323)
T ss_pred EECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999999999998766666667888899999999999987 69999999999999999999999999999988877
Q ss_pred HHHH
Q 022794 283 AVVR 286 (292)
Q Consensus 283 ~i~~ 286 (292)
.|.+
T Consensus 232 ~If~ 235 (323)
T KOG0594|consen 232 RIFR 235 (323)
T ss_pred HHHH
Confidence 7765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=280.07 Aligned_cols=202 Identities=31% Similarity=0.542 Sum_probs=169.7
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|...+.||+|+||+||++.+. |...|||......... .+.+.+|+.+|++++|||||++++.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---------SESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---------HHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 467888999999999999999664 7999999886442111 34478899999999999999999974433
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .+++.|||+++|+|.+++.+..+ .+++..++.+.+|++++|.|||++|++|+||||+|||++
T Consensus 87 ~~~--------------~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 87 END--------------EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred cCe--------------eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 321 23899999999999999987766 799999999999999999999999999999999999999
Q ss_pred C-CCcEEEeecCcceeccC---CCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 207 K-NRTVKIADFGVARVEAS---NPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 207 ~-~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
. ++.+||.|||++..... .........||+.|||||++..+ ...+++|||||||++.||+||..||..
T Consensus 152 ~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 152 PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 9 69999999999876553 11223346799999999999953 344699999999999999999999998
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=277.48 Aligned_cols=207 Identities=27% Similarity=0.381 Sum_probs=173.8
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|++.+.||+|+||.||+|.+ +|+.||+|.+..... ........+.+|+.++++++|++++++++.+.+.+.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~ 74 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhh------hhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence 378899999999999999954 689999998853221 111122346789999999999999999998877665
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++||||||+||+++++
T Consensus 75 ~----------------~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 75 L----------------CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred E----------------EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4 899999999999988865555578999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+.++|+|||++...... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||...+....
T Consensus 139 ~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 139 GHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred CCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 99999999998764322 222345689999999999999999999999999999999999999987665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=286.23 Aligned_cols=213 Identities=26% Similarity=0.394 Sum_probs=183.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.++++++||||+++++++.+.
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE------ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 37899999999999999999976 57899999985321 11122345578899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 91 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~ 152 (329)
T PTZ00263 91 NRV----------------YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD 152 (329)
T ss_pred CEE----------------EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC
Confidence 655 8999999999999998643 4688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+..+++.+
T Consensus 153 ~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 229 (329)
T PTZ00263 153 NKGHVKVTDFGFAKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229 (329)
T ss_pred CCCCEEEeeccCceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 9999999999998765332 2235688999999999999899999999999999999999999999888888887766
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
+.
T Consensus 230 ~~ 231 (329)
T PTZ00263 230 GR 231 (329)
T ss_pred CC
Confidence 53
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.32 Aligned_cols=211 Identities=25% Similarity=0.355 Sum_probs=181.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+ +++.||+|+++... .........+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL------LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH------HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence 4699999999999999999976 58899999986321 111222345778999999999999999999887765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. ...+++..++.++.|++.||.+||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 136 (333)
T cd05600 75 YL----------------YLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA 136 (333)
T ss_pred EE----------------EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 54 899999999999999854 346889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||++..... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+.+.
T Consensus 137 ~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 137 SGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred CCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999865432 233456899999999999999999999999999999999999999998888887777653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=292.28 Aligned_cols=213 Identities=25% Similarity=0.373 Sum_probs=178.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+++.||+|+||.||+|.+ +|+.||||++.... .........+.+|+.++++++||||+++++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE------MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4789999999999999999965 68899999985321 111223455788999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. |++|||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~ 136 (377)
T cd05629 75 YL----------------YLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR 136 (377)
T ss_pred ee----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC
Confidence 54 899999999999999864 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-----------------------------------------------CCCCCCCcccccC
Q 022794 208 NRTVKIADFGVARVEASNPN-----------------------------------------------DMTGETGTLGYMA 240 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-----------------------------------------------~~~~~~~~~~y~a 240 (292)
++.++|+|||++........ ......|++.|+|
T Consensus 137 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 216 (377)
T cd05629 137 GGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIA 216 (377)
T ss_pred CCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccC
Confidence 99999999998852211000 0012358899999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 241 PEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 241 PE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
||++.+..++.++|+|||||++|+|++|..||...+..+.+..+.+
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 217 PEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred HHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 9999998999999999999999999999999998888888877765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=289.59 Aligned_cols=221 Identities=29% Similarity=0.421 Sum_probs=184.0
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.....+..++|++.+.||+|+||.||+|.+ +++.||+|++.... .........+.+|+.+++.++||||+++
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE------MIKRSDSAFFWEERDIMAFANSPWVVQL 108 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH------hhhhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence 344566678999999999999999999976 57899999985321 1111223447789999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++.+.+.... ++||||+++++|.+++.. ..+++..+..++.||+.||++||++|++|||||
T Consensus 109 ~~~~~~~~~~----------------~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK 169 (370)
T cd05621 109 FCAFQDDKYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169 (370)
T ss_pred EEEEEcCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 9998776554 899999999999998853 358899999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCC----CCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|+||+++.++.++|+|||.+........ ......|++.|+|||++.+.. ++.++|+||+||++|+|++|..||..
T Consensus 170 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred HHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9999999999999999999876533221 223456899999999987643 77899999999999999999999999
Q ss_pred CCHHHHHHHHHHh
Q 022794 275 LSFSEVTSAVVRQ 287 (292)
Q Consensus 275 ~~~~~~~~~i~~~ 287 (292)
.+..+.+.++.+.
T Consensus 250 ~~~~~~~~~i~~~ 262 (370)
T cd05621 250 DSLVGTYSKIMDH 262 (370)
T ss_pred CCHHHHHHHHHhC
Confidence 8888888887764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=284.87 Aligned_cols=208 Identities=29% Similarity=0.462 Sum_probs=175.3
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||+|.+ +|+.||+|+++.... ........+.+|+.++++++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~---- 70 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL---- 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE----
Confidence 4689999999999965 688999999863211 1112234467899999999999999999988776655
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
+++|||+++++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|
T Consensus 71 ------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl 136 (323)
T cd05571 71 ------------CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKI 136 (323)
T ss_pred ------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEE
Confidence 899999999999998864 356899999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+...+...+..+
T Consensus 137 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05571 137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210 (323)
T ss_pred eeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999865433333333456899999999999999999999999999999999999999998888877776544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=290.01 Aligned_cols=212 Identities=24% Similarity=0.364 Sum_probs=177.7
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+++.||+|+||.||+|.+ +++.||+|++... ..........+.+|+.++++++|+||+++++.+.+.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~------~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~ 75 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK------DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH------HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence 689999999999999999965 6789999998522 11122334567889999999999999999999987665
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++||||+++|+|.+++.+. ..+++..++.++.||+.||.+||++||+||||||+|||++.+
T Consensus 76 ~----------------~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 76 L----------------YFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred E----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 4 8999999999999998643 468899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCC-----------------------------------------------CCCCCCCCCcccccCC
Q 022794 209 RTVKIADFGVARVEASN-----------------------------------------------PNDMTGETGTLGYMAP 241 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~-----------------------------------------------~~~~~~~~~~~~y~aP 241 (292)
+.++|+|||++...... ........|++.|+||
T Consensus 138 g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 217 (382)
T cd05625 138 GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217 (382)
T ss_pred CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCH
Confidence 99999999986421100 0001123588999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 242 E~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
|++.+..++.++|+|||||++|+|++|+.||...+..+...++.+
T Consensus 218 E~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred HHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 999999999999999999999999999999999888877777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=290.98 Aligned_cols=213 Identities=25% Similarity=0.369 Sum_probs=177.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +++.||+|++.... .........+.+|+.+++++.|+||+++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD------VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH------HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence 4799999999999999999965 58899999985221 111223455778999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~ 136 (376)
T cd05598 75 NL----------------YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136 (376)
T ss_pred EE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC
Confidence 55 8999999999999998643 46889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCC-------------------------------------------CCCCCCCCCcccccCCccc
Q 022794 208 NRTVKIADFGVARVEASN-------------------------------------------PNDMTGETGTLGYMAPEVL 244 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~-------------------------------------------~~~~~~~~~~~~y~aPE~~ 244 (292)
++.++|+|||++...... ........|++.|+|||++
T Consensus 137 ~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 216 (376)
T cd05598 137 DGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL 216 (376)
T ss_pred CCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHH
Confidence 999999999987421100 0001123689999999999
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 245 NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 245 ~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 217 ~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 258 (376)
T cd05598 217 LRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVIN 258 (376)
T ss_pred cCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhc
Confidence 999999999999999999999999999999888877766654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.14 Aligned_cols=212 Identities=24% Similarity=0.353 Sum_probs=177.3
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|.+++.||+|+||.||+|.+ +++.||+|++.... .........+.+|+.++++++|+||+++++.+.+.+.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~ 75 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD------VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence 689999999999999999965 67899999985321 1112234558889999999999999999999987665
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++... ..+++..++.++.|++.||.+||+.||+||||||+||+++.+
T Consensus 76 ~----------------~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 76 L----------------YFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred E----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 4 8999999999999998643 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCC-----------------------------------------------CCCCCCCCcccccCC
Q 022794 209 RTVKIADFGVARVEASNP-----------------------------------------------NDMTGETGTLGYMAP 241 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~-----------------------------------------------~~~~~~~~~~~y~aP 241 (292)
+.++|+|||++....... .......|++.|+||
T Consensus 138 ~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 217 (381)
T cd05626 138 GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217 (381)
T ss_pred CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCH
Confidence 999999999864221000 001124689999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 242 EVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 242 E~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
|.+.+..++.++|||||||++|+|++|..||...+..+....+..
T Consensus 218 E~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred HHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 999988899999999999999999999999998888777766654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=281.65 Aligned_cols=208 Identities=30% Similarity=0.473 Sum_probs=175.0
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||++.+ +|+.||+|+++.... ........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~---- 70 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL---- 70 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE----
Confidence 4689999999999965 688999999863211 1112234466799999999999999999998776654
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
+++|||+++++|..++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus 71 ------------~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 136 (323)
T cd05595 71 ------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKI 136 (323)
T ss_pred ------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEe
Confidence 8999999999999888543 46899999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+..+
T Consensus 137 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05595 137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210 (323)
T ss_pred cccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 99998864333323333456899999999999999999999999999999999999999998888888777643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=285.45 Aligned_cols=207 Identities=29% Similarity=0.508 Sum_probs=183.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|....+||+|..|.||.|.. +++.||+|.+.......+ +.+.+|+.+++..+|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---------eLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---------ELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---------hhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 4688999999999999999954 688999999876554332 34789999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
++ |+||||++||+|.+.+... .++|.++..++++++.||.|||..||+|||||.+|||++.
T Consensus 344 eL----------------WVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~ 404 (550)
T KOG0578|consen 344 EL----------------WVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM 404 (550)
T ss_pred ee----------------EEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc
Confidence 66 8999999999999998553 4999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+|.+||+|||++..+...........||+.|||||+.....|+++.||||||++++||+.|.+||-+.++..-+.-|
T Consensus 405 ~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 405 DGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred CCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 99999999999987776666777789999999999999999999999999999999999999999865555444333
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.19 Aligned_cols=220 Identities=30% Similarity=0.422 Sum_probs=183.4
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
.+.+..++|++.+.||+|+||.||+|.+ +++.||+|++.... .........+.+|..+++.++||||+++++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~------~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE------MIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH------hhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4556668999999999999999999966 58899999985321 111222345778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
.+.+.+.. +++|||+++++|.+++.. ..+++..+..++.||+.||.+||++|++||||||+
T Consensus 111 ~~~~~~~~----------------~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 171 (371)
T cd05622 111 AFQDDRYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 171 (371)
T ss_pred EEEcCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 98766544 899999999999998853 35889999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||+++.++.++|+|||.+........ ......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+
T Consensus 172 NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred HEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999876543221 223456899999999987543 7889999999999999999999999989
Q ss_pred HHHHHHHHHHhh
Q 022794 277 FSEVTSAVVRQV 288 (292)
Q Consensus 277 ~~~~~~~i~~~~ 288 (292)
....+.++.++.
T Consensus 252 ~~~~~~~i~~~~ 263 (371)
T cd05622 252 LVGTYSKIMNHK 263 (371)
T ss_pred HHHHHHHHHcCC
Confidence 888888887643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=289.14 Aligned_cols=223 Identities=35% Similarity=0.638 Sum_probs=190.9
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
+...+.|++..+.+.+...||+|.||+||+|.|.|. ||||+++....... ..+.|++|+..+++-+|.||+-
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~-------qlqaFKnEVa~lkkTRH~NIlL 452 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPE-------QLQAFKNEVAVLKKTRHENILL 452 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHH-------HHHHHHHHHHHHhhcchhhhee
Confidence 444578999999999999999999999999999885 89999987654322 4567999999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
|.+++..... .||..+|+|-+|+.++.-. ...+.....+.|++|+++++.|||.++|+|+||
T Consensus 453 FMG~~~~p~~-----------------AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDL 514 (678)
T KOG0193|consen 453 FMGACMNPPL-----------------AIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDL 514 (678)
T ss_pred eehhhcCCce-----------------eeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhc
Confidence 9999876654 5899999999999998643 356899999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceecc--CCCCCCCCCCCcccccCCcccCCC---CCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEA--SNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|..|||+.+++.|+|+|||++..-. ..........+..-|+|||+++.+ +|++.+||||||+|+|||++|.+||.
T Consensus 515 KSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 515 KSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 9999999999999999999986421 223333445688899999999754 68999999999999999999999999
Q ss_pred CCCHHHHHHHHHHh
Q 022794 274 DLSFSEVTSAVVRQ 287 (292)
Q Consensus 274 ~~~~~~~~~~i~~~ 287 (292)
....++++-.+-+|
T Consensus 595 i~~~dqIifmVGrG 608 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRG 608 (678)
T ss_pred CCChhheEEEeccc
Confidence 88888777666555
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.90 Aligned_cols=213 Identities=28% Similarity=0.467 Sum_probs=182.6
Q ss_pred CceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+. |+.||+|+++.... ........+.+|+.++..++|+||+++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM------IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH------hhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence 47999999999999999999764 89999999863211 11122345788999999999999999999887765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~ 136 (350)
T cd05573 75 HL----------------YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA 136 (350)
T ss_pred eE----------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 54 8999999999999999654 56899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC-----------------------------CCCCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 208 NRTVKIADFGVARVEASNP-----------------------------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
++.++|+|||.+....... .......+++.|+|||.+.+..++.++|||||
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 216 (350)
T cd05573 137 DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSL 216 (350)
T ss_pred CCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEec
Confidence 9999999999987544332 12234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 259 GICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 259 g~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
||++|+|++|..||...+..+...++.+
T Consensus 217 G~il~ell~g~~Pf~~~~~~~~~~~i~~ 244 (350)
T cd05573 217 GVILYEMLYGFPPFYSDTLQETYNKIIN 244 (350)
T ss_pred chhhhhhccCCCCCCCCCHHHHHHHHhc
Confidence 9999999999999999888888887776
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=280.51 Aligned_cols=211 Identities=24% Similarity=0.369 Sum_probs=176.1
Q ss_pred eeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 55 KSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
++.||+|+||.||++.. +++.||+|+++.... .........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-----VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH-----HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence 36799999999999864 578899999863211 11112234467899999999999999999998776554
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 76 ----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 137 (323)
T cd05584 76 ----------------YLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG 137 (323)
T ss_pred ----------------EEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC
Confidence 899999999999999854 34688889999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022794 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 288 (292)
.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.+..+.++.
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 216 (323)
T cd05584 138 HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216 (323)
T ss_pred CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999998643333333334568999999999998889999999999999999999999999988888887776653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=280.05 Aligned_cols=214 Identities=26% Similarity=0.378 Sum_probs=177.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-cccceeceecCCc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP-NVTKFIGATMGSS 127 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~ 127 (292)
+|++.+.||+|+||.||+|.+ +++.||+|+++..... .....+.+..|.+++..+.|+ +|+.+++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence 588999999999999999966 4678999998632210 111234467789999999664 5788888877665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 136 (324)
T cd05587 75 RL----------------YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA 136 (324)
T ss_pred EE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC
Confidence 54 8999999999999988543 46889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||++..............|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+..+++..+.+.
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05587 137 EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (324)
T ss_pred CCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999999998864332233333456899999999999999999999999999999999999999999998888887765
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 217 ~ 217 (324)
T cd05587 217 N 217 (324)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=279.58 Aligned_cols=213 Identities=26% Similarity=0.384 Sum_probs=178.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSS 127 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 127 (292)
+|.+.+.||+|+||.||+|.+ +++.||+|+++..... .......+..|..++..+ .|++|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence 588999999999999999966 4679999998643211 111223356677888777 6889999999887766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.
T Consensus 75 ~~----------------~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 75 RL----------------YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred EE----------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 54 8999999999999988543 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..++...+.+.
T Consensus 137 ~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 216 (323)
T cd05616 137 EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216 (323)
T ss_pred CCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999875433333334456899999999999999999999999999999999999999999988888877654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=273.64 Aligned_cols=213 Identities=30% Similarity=0.458 Sum_probs=178.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||.|+||.||+|.+ +++.||+|+++....... ...+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------PCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc--------chhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 36799999999999999999965 588999999864432211 12356799999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||++ ++|.+++... ...+++..+..++.|++.||++||++|++||||||+||+++
T Consensus 76 ~~~----------------~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~ 137 (288)
T cd07871 76 RCL----------------TLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN 137 (288)
T ss_pred CeE----------------EEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 544 89999996 4999988643 34578999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+..............+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||.+.+..+.+..+.
T Consensus 138 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 138 EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998755433333444567899999999876 468899999999999999999999999988888877766
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 218 ~~ 219 (288)
T cd07871 218 RL 219 (288)
T ss_pred HH
Confidence 53
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=280.10 Aligned_cols=206 Identities=23% Similarity=0.382 Sum_probs=174.8
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||+|+||.||+|.+ +++.||+|+++.... ........+.+|+.++++++||||+++++.+...+..
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL------ 68 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE------
Confidence 69999999999966 578999999853211 1112234567899999999999999999988766554
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~D 136 (312)
T cd05585 69 ----------YLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCD 136 (312)
T ss_pred ----------EEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEE
Confidence 899999999999999864 34689999999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 216 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
||++..............|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..++...+.++
T Consensus 137 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 208 (312)
T cd05585 137 FGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208 (312)
T ss_pred CcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 999875433333334456899999999999999999999999999999999999999998988888877654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=281.47 Aligned_cols=207 Identities=30% Similarity=0.475 Sum_probs=174.1
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||++.+ +|+.||+|++...... .......+.+|+.+++.+.||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---- 70 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL---- 70 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE----
Confidence 3689999999999965 6889999998632211 112234567899999999999999999988776655
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|
T Consensus 71 ------------~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL 136 (328)
T cd05593 71 ------------CFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKI 136 (328)
T ss_pred ------------EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEE
Confidence 899999999999988854 346899999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..++...+..
T Consensus 137 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~ 209 (328)
T cd05593 137 TDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (328)
T ss_pred ecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc
Confidence 9999986533332333345689999999999988999999999999999999999999998888887776653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=285.47 Aligned_cols=220 Identities=29% Similarity=0.412 Sum_probs=182.8
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
....+..++|++.+.||+|+||.||+|.+ +++.||+|++..... ........+.+|+.+++.++||||++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~h~~iv~~~ 109 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM------IKRSDSAFFWEERDIMAHANSEWIVQLH 109 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence 34455667999999999999999999965 588999999853211 1111233467899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.+.. +++|||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||
T Consensus 110 ~~~~~~~~~----------------~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp 170 (370)
T cd05596 110 YAFQDDKYL----------------YMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170 (370)
T ss_pred EEEecCCEE----------------EEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 988776654 899999999999998843 3588999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+|||++.++.++|+|||.+........ ......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...
T Consensus 171 ~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 999999999999999999875433221 22345689999999998654 3788999999999999999999999999
Q ss_pred CHHHHHHHHHHh
Q 022794 276 SFSEVTSAVVRQ 287 (292)
Q Consensus 276 ~~~~~~~~i~~~ 287 (292)
+..+.+.++.++
T Consensus 251 ~~~~~~~~i~~~ 262 (370)
T cd05596 251 SLVGTYSKIMDH 262 (370)
T ss_pred CHHHHHHHHHcC
Confidence 988888888764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=286.43 Aligned_cols=213 Identities=27% Similarity=0.410 Sum_probs=179.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.. +++.||+|+++... .........+.+|..++.+++|++|+++++.+.+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD------MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3689999999999999999965 58899999986321 111223455778999999999999999999987766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.+ ...+++..++.++.|++.+|++||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~ 136 (360)
T cd05627 75 NL----------------YLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA 136 (360)
T ss_pred EE----------------EEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC
Confidence 54 899999999999999854 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC-----------------------------------CCCCCCCCcccccCCcccCCCCCCch
Q 022794 208 NRTVKIADFGVARVEASNP-----------------------------------NDMTGETGTLGYMAPEVLNGNPYNRK 252 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~-----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~ 252 (292)
++.++|+|||++....... .......|++.|+|||++.+..++.+
T Consensus 137 ~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~ 216 (360)
T cd05627 137 KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL 216 (360)
T ss_pred CCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc
Confidence 9999999999876432110 00112468999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 253 CDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 253 ~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+|+|||||++|+|++|..||.+.+..+...++.+
T Consensus 217 ~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~ 250 (360)
T cd05627 217 CDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMN 250 (360)
T ss_pred ceeccccceeeecccCCCCCCCCCHHHHHHHHHc
Confidence 9999999999999999999999998888877765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=279.05 Aligned_cols=211 Identities=30% Similarity=0.470 Sum_probs=175.6
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH---HhCCCCcccceeceecCC
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW---HKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~ 126 (292)
|.+.+.||+|++|.||+|.+ +|+.||||+++..... .....+.+.+|.+++ +.++||||+++++++...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII------ARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 67899999999999999965 5889999998632211 111123455565554 566899999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. |++|||+++++|..++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++
T Consensus 75 ~~~----------------~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~ 135 (324)
T cd05589 75 DHV----------------CFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135 (324)
T ss_pred CEE----------------EEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 654 899999999999988743 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..++...+.+
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05589 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN 215 (324)
T ss_pred CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999999886433333333446689999999999998999999999999999999999999999998888887766
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 216 ~ 216 (324)
T cd05589 216 D 216 (324)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=280.69 Aligned_cols=214 Identities=33% Similarity=0.590 Sum_probs=172.9
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
.|.+..++|++.+.||+|+||.||+|.+ +++.||+|+++.... . .....+.+|+.+++.+ +|||
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~n 72 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT----A----SEHKALMSELKILIHIGNHLN 72 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc----h----HHHHHHHHHHHHHHHhccCcc
Confidence 3677788999999999999999999963 246799999863221 1 1124578899999999 8999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc------------------------------
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------ 165 (292)
|+++++++...+. .++++|||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~~~---------------~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (338)
T cd05102 73 VVNLLGACTKPNG---------------PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRI 137 (338)
T ss_pred eeeEEeEecCCCC---------------ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccccc
Confidence 9999998765432 2389999999999999986532
Q ss_pred ------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 166 ------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 166 ------------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
...+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~D 217 (338)
T cd05102 138 EAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 217 (338)
T ss_pred ccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEee
Confidence 12477888999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 216 FGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 216 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
||++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+.
T Consensus 218 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~ 285 (338)
T cd05102 218 FGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285 (338)
T ss_pred cccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 9998754322211 112345678999999998889999999999999999997 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=278.75 Aligned_cols=209 Identities=28% Similarity=0.441 Sum_probs=171.8
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||+|.+ +|+.||+|++...... ........+..+..+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~---- 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-----KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL---- 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE----
Confidence 4689999999999976 6899999998532110 1111122223334456788999999999988776554
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
+++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.++|
T Consensus 72 ------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl 137 (323)
T cd05575 72 ------------YFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVL 137 (323)
T ss_pred ------------EEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEE
Confidence 899999999999998864 346899999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..++...+.++
T Consensus 138 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 138 TDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred eccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999865433333334456899999999999999999999999999999999999999999998888887765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=266.58 Aligned_cols=219 Identities=26% Similarity=0.367 Sum_probs=183.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
....|..++.||+|+||.|..|.+ +|+.||||.+. ...+.....++..+|+.+|+.++|+||+.+.+++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-------~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-------NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhh-------hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 346677789999999999999965 68999999874 223334456678899999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... .+.+..|+|+|++ +.+|...++. ++.+++..+..++.|++.+|.|+|+.|++|||+||+|+|+
T Consensus 93 ~~~-----------~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~ 158 (359)
T KOG0660|consen 93 PSR-----------DKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL 158 (359)
T ss_pred ccc-----------cccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee
Confidence 211 1345669999999 6699998854 3459999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCC--CCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.+..+|++|||+|+..... ....+..+.|..|.|||.+.. ..|+.+.||||+|||+.||++|++.|++.+.-+.+.
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 99999999999999876432 233456778999999999754 579999999999999999999999999999988888
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.|..-
T Consensus 239 lI~~~ 243 (359)
T KOG0660|consen 239 LILEL 243 (359)
T ss_pred HHHHh
Confidence 77653
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.76 Aligned_cols=213 Identities=25% Similarity=0.387 Sum_probs=176.5
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCCc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSS 127 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 127 (292)
+|.+.+.||+|+||.||+|.+ +|+.||+|+++.... ........+..|..+++.+. |++|+++++++...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV------IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence 477889999999999999965 588999999863211 11112234667888888884 577888888887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 75 RL----------------YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred EE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 54 8999999999999998543 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||++..............|++.|+|||++.+..++.++|+||+|+++|+|++|..||.+.+..++++.+.+.
T Consensus 137 ~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (323)
T cd05615 137 EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (323)
T ss_pred CCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999865333322333456899999999999988999999999999999999999999999988888887654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=262.44 Aligned_cols=216 Identities=27% Similarity=0.438 Sum_probs=186.2
Q ss_pred ecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
...+.|.+.+.||+|.|++|+++ ..+|+.+++|+++...-... ..+.+.+|++|-+.|+||||+++.+.+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-------~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-------DFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-------cHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 44578999999999999999988 45799999998864332222 2344788999999999999999998876
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
.... .|+|+|++.|++|..-|-. +..+++..+-..++||++||.|+|.+||+|||+||+|++
T Consensus 81 ~~~~----------------~ylvFe~m~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nll 142 (355)
T KOG0033|consen 81 EESF----------------HYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLL 142 (355)
T ss_pred ccce----------------eEEEEecccchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 5443 4899999999999876643 256899999999999999999999999999999999999
Q ss_pred Ec---CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 205 LD---KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 205 i~---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+. ...-+||+|||++..+. .....-...|++.|+|||+++..+|+...|||+.|++||-|+.|.+||.+.+...++
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly 221 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 221 (355)
T ss_pred eeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH
Confidence 94 33459999999998776 556666788999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhh
Q 022794 282 SAVVRQV 288 (292)
Q Consensus 282 ~~i~~~~ 288 (292)
++|+++.
T Consensus 222 e~I~~g~ 228 (355)
T KOG0033|consen 222 EQIKAGA 228 (355)
T ss_pred HHHhccc
Confidence 9999874
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.02 Aligned_cols=208 Identities=26% Similarity=0.420 Sum_probs=174.6
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++.... ........+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~--- 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL--- 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE---
Confidence 3689999999999965 578999999853211 1111233466788888877 799999999998776655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~k 136 (320)
T cd05590 72 -------------FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCK 136 (320)
T ss_pred -------------EEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence 8999999999999988643 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+++..+.++
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 137 LADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred EeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 999999865433333334456899999999999888999999999999999999999999999999888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.11 Aligned_cols=208 Identities=28% Similarity=0.438 Sum_probs=171.6
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++...... ......+..|..++..+ +||||+++++++......
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~--- 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE------DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL--- 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh------hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence 3689999999999966 57789999986432111 11122244566666654 899999999988766554
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~k 136 (316)
T cd05592 72 -------------FFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIK 136 (316)
T ss_pred -------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEE
Confidence 8999999999999988543 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+++..+.+.
T Consensus 137 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 137 IADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred EccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 999999875443333344456899999999999988999999999999999999999999999988888877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=269.25 Aligned_cols=218 Identities=28% Similarity=0.398 Sum_probs=176.1
Q ss_pred CceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceecee
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGAT 123 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~ 123 (292)
.+|++.+.||+|+||.||+|.+ .++.||+|.++......... ..+.+|+.+++.+ .||||+++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~hpniv~~~~~~ 73 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-------LSTIREVAVLRHLETFEHPNVVRLFDVC 73 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch-------HHHHHHHHHHHhhcccCCCCcceEEEEE
Confidence 4799999999999999999975 36789999986543322111 1234566666555 799999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...... .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 74 ~~~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Ni 141 (290)
T cd07862 74 TVSRTD-----------RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 141 (290)
T ss_pred ecccCC-----------CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 532210 1223489999995 6999999765556789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+++.++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.+.+..+.+.+
T Consensus 142 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~ 220 (290)
T cd07862 142 LVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 220 (290)
T ss_pred EEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 9999999999999998754433 233345688999999999888899999999999999999999999999998888888
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.+.
T Consensus 221 i~~~ 224 (290)
T cd07862 221 ILDV 224 (290)
T ss_pred HHHH
Confidence 7754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=276.81 Aligned_cols=208 Identities=25% Similarity=0.370 Sum_probs=174.7
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++.... ......+.+..|.++++.+ +||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~--- 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL--- 71 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE---
Confidence 3689999999999966 477999999863211 1112234466788888876 899999999999876655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~k 136 (321)
T cd05591 72 -------------FFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK 136 (321)
T ss_pred -------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence 8999999999999988543 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..++++.+.++
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 137 LADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred EeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999875433333334456899999999999889999999999999999999999999999999888887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.41 Aligned_cols=209 Identities=27% Similarity=0.426 Sum_probs=171.0
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||+|.+ +++.||+|++..... .........+..+..+++.++||||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~---- 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL---- 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE----
Confidence 3689999999999976 577899999853211 01111122233344457788999999999998776655
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
+++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus 72 ------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl 137 (325)
T cd05602 72 ------------YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 137 (325)
T ss_pred ------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEE
Confidence 899999999999998854 346888999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+++..+.+.
T Consensus 138 ~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 138 TDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred ccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 99999865433333334456899999999999999999999999999999999999999999988888877654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=276.18 Aligned_cols=214 Identities=29% Similarity=0.452 Sum_probs=178.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||++.. +++.||+|+++.. ..........+.+|..+++.++|+||+++++++.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW------EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH------HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4799999999999999999965 5889999998521 1111222445778999999999999999999987766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.+. ...+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 137 (331)
T cd05597 75 NL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK 137 (331)
T ss_pred eE----------------EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC
Confidence 54 8999999999999998653 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
++.++|+|||.+........ ......+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||...+..+..
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~ 217 (331)
T cd05597 138 NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217 (331)
T ss_pred CCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH
Confidence 99999999999865433222 2222458999999999863 35788999999999999999999999988888877
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
..+..
T Consensus 218 ~~i~~ 222 (331)
T cd05597 218 GKIMN 222 (331)
T ss_pred HHHHc
Confidence 77654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=276.20 Aligned_cols=208 Identities=29% Similarity=0.432 Sum_probs=170.7
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH-HHHHhCCCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV-AVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +|+.||+|++..... ........+..|. .+++.++||||+++++.+.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~--- 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI------LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL--- 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH------HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE---
Confidence 4689999999999976 588999999853211 1111122233444 467888999999999988776655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~k 136 (321)
T cd05603 72 -------------YFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV 136 (321)
T ss_pred -------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 899999999999988854 35688999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||++..............+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..++...+..+
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 137 LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred EccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 999999865333333334456899999999999888999999999999999999999999998888888777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.30 Aligned_cols=208 Identities=29% Similarity=0.464 Sum_probs=173.5
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||++.+ +|+.||+|+++.... ........+.+|+++++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~---- 70 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL---- 70 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE----
Confidence 3689999999999965 688999999863211 1111233466799999999999999999988776654
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeEcCCCcEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nili~~~~~~~ 212 (292)
++||||+++++|..++.. ...+++..++.++.||+.||.|||+ .|++||||||+||+++.++.++
T Consensus 71 ------------~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~k 136 (325)
T cd05594 71 ------------CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 136 (325)
T ss_pred ------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEE
Confidence 899999999999988854 3468999999999999999999997 7999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||++..............+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+..+
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 137 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211 (325)
T ss_pred EecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC
Confidence 999999865333333333456899999999999989999999999999999999999999988888777766543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.58 Aligned_cols=201 Identities=28% Similarity=0.448 Sum_probs=168.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +++.||+|+++....... ...+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--------PFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--------chhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 6899999999999999999976 688999999864432111 123567999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+. ++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||++++
T Consensus 77 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 138 (303)
T cd07869 77 TL----------------TLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD 138 (303)
T ss_pred eE----------------EEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 54 89999994 6888887653 345889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
++.++|+|||.+..............+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+..
T Consensus 139 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 139 TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred CCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999987544333334446678999999998654 57889999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=267.99 Aligned_cols=211 Identities=27% Similarity=0.378 Sum_probs=175.9
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|+||.||++.+ +++.||+|++..... ........+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI------KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh------hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence 488999999999999999965 588999999853221 111223446789999999999999999998876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||+++++
T Consensus 75 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 75 L----------------CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred E----------------EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 4 899999999999998865545579999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.....+.+
T Consensus 139 ~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 139 GHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213 (285)
T ss_pred CCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence 99999999998754322 2223356889999999999888999999999999999999999999987665444444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=275.56 Aligned_cols=215 Identities=29% Similarity=0.462 Sum_probs=189.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 124 (292)
....|.+.+.||+|.||+||+++. +|+.+|+|++......... ....+.+|+.+|+++. ||||+.+++.|.
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~------~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE------DREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc------cHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 346899999999999999999955 5899999999654432221 2345789999999997 999999999999
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+...+ ++|||++.||.|.+.+.+. .+++..+..++.|++++++|||..|++|||+||+|+|
T Consensus 107 ~~~~~----------------~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L 167 (382)
T KOG0032|consen 107 DPDSV----------------YLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL 167 (382)
T ss_pred cCCeE----------------EEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence 88866 8999999999999999765 3999999999999999999999999999999999999
Q ss_pred EcCC----CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 205 LDKN----RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 205 i~~~----~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+... +.++++|||++..... ........|++.|+|||++....|+...|+||+|+++|.|++|.+||.+.+..+.
T Consensus 168 ~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~ 246 (382)
T KOG0032|consen 168 LASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI 246 (382)
T ss_pred eccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence 9533 4799999999987765 5566778899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhh
Q 022794 281 TSAVVRQV 288 (292)
Q Consensus 281 ~~~i~~~~ 288 (292)
..+|.++.
T Consensus 247 ~~~i~~~~ 254 (382)
T KOG0032|consen 247 FLAILRGD 254 (382)
T ss_pred HHHHHcCC
Confidence 99888774
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=276.46 Aligned_cols=214 Identities=28% Similarity=0.430 Sum_probs=178.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||++.+ +++.||+|++.... .........+.+|..++..++|++|+++++.+.+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE------MLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4799999999999999999965 57889999985311 111222344778999999999999999999987766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. |++|||+++|+|.+++.+. ...+++..+..++.|++.||++||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~ 137 (331)
T cd05624 75 YL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM 137 (331)
T ss_pred EE----------------EEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC
Confidence 54 8999999999999999653 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
++.++|+|||++........ ......|++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...+..+.+
T Consensus 138 ~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~ 217 (331)
T cd05624 138 NGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217 (331)
T ss_pred CCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH
Confidence 99999999999875443222 1223468999999999875 45788999999999999999999999988887777
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
.++..
T Consensus 218 ~~i~~ 222 (331)
T cd05624 218 GKIMN 222 (331)
T ss_pred HHHHc
Confidence 77654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.76 Aligned_cols=208 Identities=28% Similarity=0.425 Sum_probs=171.6
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH-HHHHhCCCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV-AVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +|+.||+|++...... .......+..|. .+++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~--- 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL------NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL--- 71 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE---
Confidence 3689999999999965 6889999998532110 111122234444 456778999999999988776655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~k 136 (325)
T cd05604 72 -------------YFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136 (325)
T ss_pred -------------EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence 899999999999988854 35689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||++..............+++.|+|||++.+..++.++|+|||||++|+|++|..||...+..++...+.++
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred EeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999864333333334456899999999999999999999999999999999999999999988888877654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.93 Aligned_cols=211 Identities=26% Similarity=0.391 Sum_probs=174.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +++.||+|+++...... .....+.+|+.++++++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-------EVKETTLRELKMLRTLKQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-------cchhhHHHHHHHHHhCCCccccchhhhEecCC
Confidence 3799999999999999999976 57889999986543221 12344678999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||++++.+..+. . ....+++..++.++.|++.||.+||+.|++|+||||+||+++.
T Consensus 74 ~~----------------~lv~e~~~~~~l~~~~-~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 74 KL----------------YLVFEYVEKNMLELLE-E-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred EE----------------EEEEecCCCCHHHHHH-h-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 44 8999999887666543 2 2346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+........ ......+++.|+|||++.+..++.++|+||+|+++|+|++|++||.+.+..+....+.
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 136 NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred CCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999876433222 2233468889999999998889999999999999999999999999887766655544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=275.65 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=167.1
Q ss_pred ceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
+|++++.||+|+||.||++.. +++.||+|++..... .........+.+|+.+++++ +|++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL-----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe
Confidence 588999999999999999854 578999999853211 11222344577899999999 6999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+.. +++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||
T Consensus 76 ~~~~~----------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil 137 (332)
T cd05614 76 TEAKL----------------HLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL 137 (332)
T ss_pred cCCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence 66554 899999999999999854 346899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 205 LDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.++.++|+|||++........ ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 138 i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 99999999999999875432221 22235689999999999875 478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.02 Aligned_cols=207 Identities=29% Similarity=0.431 Sum_probs=175.2
Q ss_pred eeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 56 SVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
+.||+|+||.||++.+ +|+.||+|++..... .......+.+|+.++++++||||+++++.+...+..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKL- 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEE-
Confidence 5799999999998853 578999999863221 111233467899999999999999999998776554
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
|++|||+++++|.+++.+ ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 74 ---------------~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 136 (318)
T cd05582 74 ---------------YLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 136 (318)
T ss_pred ---------------EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc
Confidence 899999999999999854 346899999999999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.+.
T Consensus 137 ~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 137 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875443323333456899999999999888999999999999999999999999998888888777654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=274.47 Aligned_cols=215 Identities=27% Similarity=0.437 Sum_probs=178.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||++.. +++.+|+|++... ..........+.+|..++..++|++|+++++.+.+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW------EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH------HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4799999999999999999966 4678999998421 1111222344778999999999999999999887766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+++|+|.+++.+. ...+++..++.++.|++.||.+||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~ 137 (332)
T cd05623 75 NL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM 137 (332)
T ss_pred EE----------------EEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC
Confidence 54 8999999999999999653 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
++.++|+|||++........ ......|++.|+|||++. ...++.++|+||||+++|+|++|+.||...+..+.+
T Consensus 138 ~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~ 217 (332)
T cd05623 138 NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217 (332)
T ss_pred CCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999865432222 222356899999999986 345788999999999999999999999998888888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
.++.+.
T Consensus 218 ~~i~~~ 223 (332)
T cd05623 218 GKIMNH 223 (332)
T ss_pred HHHhCC
Confidence 877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=272.25 Aligned_cols=208 Identities=28% Similarity=0.425 Sum_probs=172.1
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +|+.||+|+++..... .......+..|..++..+ .||+|+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~--- 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL--- 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE---
Confidence 4689999999999966 5789999998642110 011123355677777765 899999999998776654
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~k 136 (316)
T cd05620 72 -------------FFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK 136 (316)
T ss_pred -------------EEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 8999999999999988543 4688999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+..............++..|+|||++.+..++.++|+||||+++|+|++|..||.+.+..++.+.+...
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (316)
T cd05620 137 IADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211 (316)
T ss_pred eCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 999998864332233334456899999999999999999999999999999999999999998888888776544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=276.80 Aligned_cols=215 Identities=27% Similarity=0.405 Sum_probs=179.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|.+.+.||+|+||.||+|.+ +|+.||+|+++... .........+.+|+.+++.++|+||+++++.+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV------LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 3689999999999999999965 68899999986321 111223455788999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.+. ...+++..++.++.|++.||.+||+.|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~ 137 (330)
T cd05601 75 NL----------------YLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR 137 (330)
T ss_pred eE----------------EEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC
Confidence 54 8999999999999998654 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 208 NRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLN------GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~------~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
++.++|+|||.+......... .....+++.|+|||++. +..++.++|+||||+++|+|++|..||...+..+.
T Consensus 138 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 217 (330)
T cd05601 138 TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217 (330)
T ss_pred CCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH
Confidence 999999999998765433221 22346889999999986 45678899999999999999999999998888888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+.++.+.
T Consensus 218 ~~~i~~~ 224 (330)
T cd05601 218 YNNIMNF 224 (330)
T ss_pred HHHHHcC
Confidence 7777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=269.43 Aligned_cols=210 Identities=28% Similarity=0.489 Sum_probs=178.3
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+..++|++.+.||+|+||.||++.+ +|..+|+|++..... ......+.+|+.++++++||||+++++++.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 3457899999999999999999976 478899999864211 123456888999999999999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCe
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENM 203 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~p~Ni 203 (292)
..+.. +++|||+++++|.+++... ..+++..+..++.|++.+|.|||+. +++|+||||+||
T Consensus 74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni 135 (331)
T cd06649 74 SDGEI----------------SICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135 (331)
T ss_pred ECCEE----------------EEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence 76554 8999999999999998643 4589999999999999999999986 699999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+++.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..++...
T Consensus 136 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 213 (331)
T cd06649 136 LVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213 (331)
T ss_pred EEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999998654322 22335688999999999998999999999999999999999999998887776544
Q ss_pred H
Q 022794 284 V 284 (292)
Q Consensus 284 i 284 (292)
+
T Consensus 214 ~ 214 (331)
T cd06649 214 F 214 (331)
T ss_pred h
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=264.44 Aligned_cols=197 Identities=26% Similarity=0.427 Sum_probs=165.5
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||+|+||+||++.+ +|+.||+|.+.... .........+..|+.+++.++|+||+++.+.+......
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~------ 68 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR------LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL------ 68 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH------HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE------
Confidence 69999999999965 68899999985321 11112234567899999999999999999888766554
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
+++|||+++++|..++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 69 ----------~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l 138 (280)
T cd05608 69 ----------CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRI 138 (280)
T ss_pred ----------EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 8999999999999887432 3356899999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+|||.+..............+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 139 ~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 139 SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred eeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998765444333344578899999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=270.97 Aligned_cols=211 Identities=25% Similarity=0.377 Sum_probs=170.1
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|+||.||+|.+ +|+.||+|.++..... ......+.+|+.++++++||||+++++++.....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 589999999999999999965 5889999988532111 1112347789999999999999999998754432
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. .....+++|||+ +++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+
T Consensus 74 ~-----------~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 74 R-----------EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred C-----------CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 1 112348999999 56899988543 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.++|+|||.+........ ......++..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+...
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~ 218 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 9999999999864322211 1233568899999999876 578899999999999999999999998877655443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.77 Aligned_cols=208 Identities=29% Similarity=0.428 Sum_probs=171.4
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++..... ..........|..+++.+ .||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~--- 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL------MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL--- 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh------hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE---
Confidence 4689999999999976 4778999998642210 011122345677777765 999999999998876654
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~k 136 (316)
T cd05619 72 -------------FFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIK 136 (316)
T ss_pred -------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence 8999999999999998543 4688999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+..............++..|+|||++.+..++.++|+||+||++|+|++|..||...+..++.+.+...
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 211 (316)
T cd05619 137 IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211 (316)
T ss_pred EccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 999999865333333333456899999999999989999999999999999999999999998888887776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=275.71 Aligned_cols=202 Identities=35% Similarity=0.614 Sum_probs=170.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.++|.-...||+|+||.||+|.. +|..||||.+....... ...|.+|+.++.+++|||+++++|+|.+.+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---------EREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---------hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 36777788999999999999965 55899999775443221 122889999999999999999999999877
Q ss_pred c-cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCCe
Q 022794 128 E-LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTENM 203 (292)
Q Consensus 128 ~-~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~h~di~p~Ni 203 (292)
. . +||+||+++|+|.+++.......++|..+.+|+.+++.||+|||... |+|||||++||
T Consensus 145 ~~~----------------~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 145 EHR----------------LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred ceE----------------EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 4 4 89999999999999996543327899999999999999999999864 99999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCC-CCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGE-TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|++++.+.||+|||++............. .||.+|++||++..+..+.++||||||+++.|+++|+.|....
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred eECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99999999999999996554311122222 7999999999999888999999999999999999999888754
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.05 Aligned_cols=208 Identities=26% Similarity=0.398 Sum_probs=173.6
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++.... ........+.+|..+++.+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~--- 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL--- 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE---
Confidence 4689999999999966 577999999863211 1112233466788888888 799999999998776654
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~k 136 (318)
T cd05570 72 -------------FFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK 136 (318)
T ss_pred -------------EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEE
Confidence 8999999999999988543 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+..............++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..++...+.+.
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 137 IADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211 (318)
T ss_pred ecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 999998864333333333356889999999999999999999999999999999999999998888888777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=261.56 Aligned_cols=214 Identities=27% Similarity=0.378 Sum_probs=177.5
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|+..+.||+|+||.||+|.+ +++.||+|.+..... ........+.+|+.++++++|++++.+.+.+...+.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI------KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA 74 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh------hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence 477889999999999999966 588999999853211 111122346779999999999999999988876655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++++
T Consensus 75 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 75 L----------------CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred E----------------EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 4 899999999999998865555579999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.+.
T Consensus 139 ~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~ 216 (285)
T cd05632 139 GHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR 216 (285)
T ss_pred CCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999988654322 2223356889999999999888999999999999999999999999987766555555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=281.25 Aligned_cols=230 Identities=25% Similarity=0.365 Sum_probs=185.7
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
........+|.+.+.||+|+||.||+|.+ +|+.||||++...... . .....+.+|+.++..++|+|+++++
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~---~----~~~~~~~~Ei~~l~~~~h~~iv~~~ 97 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS---E----ADKNRAQAEVCCLLNCDFFSIVKCH 97 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC---H----HHHHHHHHHHHHHhcCCCCcEEEee
Confidence 33444567999999999999999999965 6899999998644321 1 1133467899999999999999988
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+.+...+... .......+++|||+++|+|.+++... ....+++..++.++.|++.+|.|||+.|++||||
T Consensus 98 ~~~~~~~~~~--------~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDL 169 (496)
T PTZ00283 98 EDFAKKDPRN--------PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDI 169 (496)
T ss_pred cceecccccC--------cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 7765433210 00112347999999999999998643 2356899999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||+||+++.++.++|+|||+++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+
T Consensus 170 KP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 170 KSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred CHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999987543221 12233568999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
..+++..+..+
T Consensus 250 ~~~~~~~~~~~ 260 (496)
T PTZ00283 250 MEEVMHKTLAG 260 (496)
T ss_pred HHHHHHHHhcC
Confidence 88888877654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=272.93 Aligned_cols=194 Identities=26% Similarity=0.468 Sum_probs=165.0
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+...+|.+++.||+|+||.||+|.+ +++.||+|... ...+.+|+.++++++||||+++++++.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------------~~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------------RGGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------------hhhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 4457899999999999999999966 58899999642 122568999999999999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..... ++++|++ .++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 154 ~~~~~----------------~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl 214 (391)
T PHA03212 154 YNKFT----------------CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF 214 (391)
T ss_pred ECCee----------------EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence 65544 8999999 56898888543 45889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCC-CCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 205 LDKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.++.++|+|||++...... ........|++.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 999999999999998643221 1223345789999999999998999999999999999999999988753
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=275.37 Aligned_cols=216 Identities=24% Similarity=0.361 Sum_probs=172.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|.+.+.||+|+||.||+|.+ +++.||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 346899999999999999999965 68899999874321 113469999999999999999987754
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.... ......+++++|||++ ++|.+++... ....+++..++.++.||+.||+|||+.||+||||||+||
T Consensus 131 ~~~~--------~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NI 201 (440)
T PTZ00036 131 ECFK--------KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL 201 (440)
T ss_pred cccc--------cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHE
Confidence 3210 0001224579999996 4787777532 345689999999999999999999999999999999999
Q ss_pred eEcCCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 204 LLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|++.++ .++|+|||++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 202 Ll~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 280 (440)
T PTZ00036 202 LIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280 (440)
T ss_pred EEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 998664 6999999999754432 223345678999999998764 6899999999999999999999999998887777
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
.++++
T Consensus 281 ~~i~~ 285 (440)
T PTZ00036 281 VRIIQ 285 (440)
T ss_pred HHHHH
Confidence 77654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=259.45 Aligned_cols=217 Identities=31% Similarity=0.576 Sum_probs=182.1
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|.+..++|++++.||+|++|.||+|.. ++..|++|.+..... . .+.+.+|+.++++++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~------~----~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM------S----VQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch------h----HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 556778999999999999999999965 567899998753211 1 23478899999999999999999888
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++.......+++..++.++.|++.+|++||+.+++|+||+|+||
T Consensus 71 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 71 TKEEPI----------------YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred cCCCCc----------------EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 765544 8999999999999999765556788999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+..
T Consensus 135 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05072 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214 (261)
T ss_pred EecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence 999999999999999976543221 1122335668999999988889999999999999999998 99999988888877
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 215 ~~~~~~ 220 (261)
T cd05072 215 SALQRG 220 (261)
T ss_pred HHHHcC
Confidence 776644
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=263.83 Aligned_cols=209 Identities=22% Similarity=0.442 Sum_probs=174.6
Q ss_pred eeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
..||+|++|.||+|.++|+.||+|+++..... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~------- 92 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKG------HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD------- 92 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccc------cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc-------
Confidence 57899999999999999999999998643221 12223557899999999999999999998866111
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeEcCCCcEEEe
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIA 214 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~p~Nili~~~~~~~l~ 214 (292)
.....+++|||+++|+|.+++... ..+++.....++.|++.+|.+||+. +++||||||+||+++.++.++|+
T Consensus 93 -----~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 93 -----DLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred -----CCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEc
Confidence 012238999999999999999653 4688999999999999999999984 99999999999999999999999
Q ss_pred ecCcceeccCCCCCCCCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..++...+.++
T Consensus 166 dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~ 237 (283)
T PHA02988 166 CHGLEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK 237 (283)
T ss_pred ccchHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999987543321 23567889999999976 67899999999999999999999999999998888887654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=260.85 Aligned_cols=216 Identities=26% Similarity=0.472 Sum_probs=178.0
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+...+|++.+.||+|+||.||+|.+ .+..|++|.++.... . .....+.+|+..+++++||||+++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~----~----~~~~~~~~e~~~l~~l~h~~iv~~~~ 73 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS----D----KQRRGFLAEALTLGQFDHSNIVRLEG 73 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC----H----HHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 3457899999999999999999964 356899999864321 1 11245778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...+.. +++|||+++++|.+++... ...+++..++.++.|++.||++||+.|++|+||+|+
T Consensus 74 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ 136 (266)
T cd05064 74 VITRGNTM----------------MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAH 136 (266)
T ss_pred EEecCCCc----------------EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHh
Confidence 98765544 8999999999999998653 346899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..+
T Consensus 137 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~ 216 (266)
T cd05064 137 KVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD 216 (266)
T ss_pred hEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 999999999999999977543221111 111234568999999998899999999999999999775 999999999988
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
+++.+.++
T Consensus 217 ~~~~~~~~ 224 (266)
T cd05064 217 VIKAVEDG 224 (266)
T ss_pred HHHHHHCC
Confidence 88877654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=274.92 Aligned_cols=222 Identities=30% Similarity=0.513 Sum_probs=178.7
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
....|.+...+|++.+.||+|+||.||+|++ ++..||+|.++..... .....+.+|+.+++.+ +
T Consensus 29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~~ 100 (374)
T cd05106 29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--------DEREALMSELKILSHLGQ 100 (374)
T ss_pred ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--------HHHHHHHHHHHHHHhhcc
Confidence 3456777788999999999999999999864 2357999998643211 1134577899999999 8
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---------------------------
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------------------- 165 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------- 165 (292)
|+||+++++.+...... +++|||+++|+|.+++....
T Consensus 101 h~nIv~~~~~~~~~~~~----------------~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 101 HKNIVNLLGACTHGGPV----------------LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred CCceeeEeeEecCCCCe----------------EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 99999999998776654 89999999999999986432
Q ss_pred -----------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 166 -----------------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 166 -----------------------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..++++..++.++.|++.||.|||++|++||||||+||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 124778889999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
+++++.++|+|||++......... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||......+..
T Consensus 245 ~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 245 LTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred EeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 999999999999998754332211 111234567999999998889999999999999999997 99999887665554
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
.++.+
T Consensus 325 ~~~~~ 329 (374)
T cd05106 325 YKMVK 329 (374)
T ss_pred HHHHH
Confidence 44443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=265.39 Aligned_cols=214 Identities=30% Similarity=0.526 Sum_probs=173.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC------------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHH
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD------------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~------------------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 109 (292)
..++|++.+.||+|+||.||+|.+. +..||+|++..... ......+.+|+.++.
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~ 74 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--------KNARNDFLKEVKILS 74 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--------HHHHHHHHHHHHHHh
Confidence 4578999999999999999999642 34699998864221 112345788999999
Q ss_pred hCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-----------------ccccCHH
Q 022794 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----------------RRKLAFK 172 (292)
Q Consensus 110 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~ 172 (292)
+++||||+++++++.+.+.. +++|||+++++|.+++.... ...+++.
T Consensus 75 ~l~h~niv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPL----------------CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS 138 (304)
T ss_pred hcCCCCeeEEEEEEecCCce----------------EEEEecCCCCcHHHHHHhccccccccccccccccccccccccHH
Confidence 99999999999998776554 89999999999999985421 1246778
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCC
Q 022794 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYN 250 (292)
Q Consensus 173 ~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 250 (292)
.++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||++.+..++
T Consensus 139 ~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (304)
T cd05096 139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218 (304)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC
Confidence 8999999999999999999999999999999999999999999999875432211 11123456789999999888899
Q ss_pred chhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHH
Q 022794 251 RKCDVYSFGICLWEIYC--CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 251 ~~~Diwslg~il~~l~~--g~~pf~~~~~~~~~~~i~ 285 (292)
.++|+||||+++|+|++ +..||...+..++...+.
T Consensus 219 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 255 (304)
T cd05096 219 TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAG 255 (304)
T ss_pred chhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHH
Confidence 99999999999999986 678999888877766554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.48 Aligned_cols=211 Identities=27% Similarity=0.459 Sum_probs=176.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +++.||+|.++....... ...+.+|+.++++++||||+++++++...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--------chhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 6799999999999999999965 578899999865432211 122567999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||++ ++|.+++... ...+++..++.++.|++.||.+||+.|++||||||+||+++.
T Consensus 78 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~ 139 (309)
T cd07872 78 SL----------------TLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE 139 (309)
T ss_pred eE----------------EEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 54 89999996 4888887553 345889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|++||.+.+..+....+.+
T Consensus 140 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 219 (309)
T cd07872 140 RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219 (309)
T ss_pred CCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999998754443333344567889999999865 4588999999999999999999999999888887777655
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=270.68 Aligned_cols=194 Identities=25% Similarity=0.411 Sum_probs=164.1
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++.... ......+.+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~------~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~--- 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV------NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL--- 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE---
Confidence 3689999999999965 588999999963221 1112234567899999888 799999999998876655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~k 136 (329)
T cd05588 72 -------------FFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK 136 (329)
T ss_pred -------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 8999999999999988543 5699999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|+.||.
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 9999988643322233344568999999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=280.99 Aligned_cols=213 Identities=23% Similarity=0.367 Sum_probs=179.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--C-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--D-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..|.+.+.||+|++|.||+|.. + +..||+|...... . .....+.+|+.+++.++||||+++++.+...
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-----~----~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-----E----RQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-----H----HHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 4599999999999999999954 3 6778888763211 1 1223467899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.. +++|||+++++|.+++... ...++++..+..++.|++.||.|||++|++||||||+||+
T Consensus 138 ~~~----------------~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIl 201 (478)
T PTZ00267 138 DKL----------------LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201 (478)
T ss_pred CEE----------------EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEE
Confidence 655 8999999999999988542 2346889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++.++.++|+|||++........ ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+++.
T Consensus 202 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~ 281 (478)
T PTZ00267 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ 281 (478)
T ss_pred ECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999976543221 1233468999999999999999999999999999999999999999988888888
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+..+
T Consensus 282 ~~~~~ 286 (478)
T PTZ00267 282 QVLYG 286 (478)
T ss_pred HHHhC
Confidence 77654
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=256.17 Aligned_cols=214 Identities=31% Similarity=0.495 Sum_probs=183.1
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||+|.+ +++.|++|.+...... ......+.+|+.++++++|||++++++.+...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-------RREREEAIDEARVLAKLDSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-------HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE
Confidence 478899999999999999965 6899999988543221 1223457789999999999999999998876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 74 L----------------NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred E----------------EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 4 899999999999999976555679999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............++..|+|||++.+..++.++|+||||+++++|++|..||...+..+...++.++
T Consensus 138 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08529 138 DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG 216 (256)
T ss_pred CCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999876554433334456788999999999888999999999999999999999999988888877776654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=272.30 Aligned_cols=217 Identities=30% Similarity=0.511 Sum_probs=174.8
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
.|.+..++|++.+.||+|+||.||+|++ ++..||||+++..... .....+.+|+.+++.+ +|||
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~Ei~il~~l~~Hpn 100 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--------TEREALMSELKVLSYLGNHIN 100 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--------HHHHHHHHHHHHHHHhcCCcc
Confidence 4555667899999999999999999863 3568999998633211 1123577899999999 8999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc------------------------------
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------ 165 (292)
|+++++++...+.. +++|||+++|+|.+++....
T Consensus 101 Iv~l~~~~~~~~~~----------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (375)
T cd05104 101 IVNLLGACTVGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDS 164 (375)
T ss_pred eeeeeeeeccCCcc----------------eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchh
Confidence 99999998776655 89999999999999986432
Q ss_pred -------------------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 166 -------------------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 166 -------------------------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
...+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 165 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 244 (375)
T cd05104 165 LNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARN 244 (375)
T ss_pred hhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhh
Confidence 1246788899999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
|+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 245 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 245 ILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred EEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 99999999999999998754432221 111234567999999999999999999999999999998 899998766554
Q ss_pred HHHHH
Q 022794 280 VTSAV 284 (292)
Q Consensus 280 ~~~~i 284 (292)
...++
T Consensus 325 ~~~~~ 329 (375)
T cd05104 325 KFYKM 329 (375)
T ss_pred HHHHH
Confidence 33333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.60 Aligned_cols=216 Identities=30% Similarity=0.562 Sum_probs=180.4
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|.+...+|++++.||+|+||.||+|.. +++.|++|.+...... ...+.+|+.++++++|+|++++++.+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----------PEAFLAEANLMKQLQHPRLVRLYAVV 70 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----------HHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence 456778999999999999999999965 6789999988633221 12377899999999999999999876
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
... . ++++|||+++++|.+++.......+++..+..++.|++.+|++||+.|++|+||+|+||
T Consensus 71 ~~~-~----------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni 133 (260)
T cd05067 71 TQE-P----------------IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANI 133 (260)
T ss_pred ccC-C----------------cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhE
Confidence 332 2 28999999999999998766566789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++++++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|++++ |++||.+.+..++.
T Consensus 134 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 213 (260)
T cd05067 134 LVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213 (260)
T ss_pred EEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 99999999999999986544221 11222345678999999998889999999999999999999 99999988888877
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 214 ~~~~~~ 219 (260)
T cd05067 214 QNLERG 219 (260)
T ss_pred HHHHcC
Confidence 766543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.04 Aligned_cols=215 Identities=25% Similarity=0.316 Sum_probs=173.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||++.+ +|+.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-------QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQ 92 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-------hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 47899999999999999999965 5889999998643211 11223466899999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....+++|||+++ +|...+. ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 93 ~~~~----------~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~ 157 (359)
T cd07876 93 KSLE----------EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 157 (359)
T ss_pred CCcc----------ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 4321 12234899999954 6766653 2478889999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+.+
T Consensus 158 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 158 SDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred CCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999998643322 223345678899999999999999999999999999999999999998877665554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=272.22 Aligned_cols=198 Identities=30% Similarity=0.498 Sum_probs=164.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|.+++.||+|+||.||+|.+ +|+.||||++..... ......+.+|+.+++.++|+||+++++++..
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--------DTVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--------HHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 346788999999999999999976 589999999853221 1234457889999999999999999999877
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+.. ..++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 144 ~~~~----------------~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 201 (353)
T PLN00034 144 NGEI----------------QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201 (353)
T ss_pred CCeE----------------EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 6654 8999999999986532 35677888999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
++++.++|+|||.+..............++..|+|||.+.. ...+.++|||||||++|+|++|+.||...
T Consensus 202 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 202 NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999998765433333344578999999998753 23456899999999999999999999743
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=281.41 Aligned_cols=215 Identities=25% Similarity=0.454 Sum_probs=174.3
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKF 119 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 119 (292)
+.+.+...+++|.+.|.+|||+.||+|.+. |.+||+|.+-... +...+.+.+|+.++++| +|+|||.+
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d---------e~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND---------EEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC---------HHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 678888999999999999999999999764 3899999874221 12234578999999999 69999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRD 197 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~d 197 (292)
++........ .++. -.+.|+||||+||.|-+++.......+++.++++|+.++++|+.+||... |||||
T Consensus 101 idss~~~~~~----~~~~-----~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRD 171 (738)
T KOG1989|consen 101 IDSSAINRSS----NNGV-----WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRD 171 (738)
T ss_pred eccccccccC----CCce-----eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhh
Confidence 9943222111 1111 12389999999999999998666667999999999999999999999998 99999
Q ss_pred CCCCCeeEcCCCcEEEeecCcceeccCCCCCC---------CCCCCcccccCCccc---CCCCCCchhhHHHHHHHHHHH
Q 022794 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDM---------TGETGTLGYMAPEVL---NGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 198 i~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~---------~~~~~~~~y~aPE~~---~~~~~~~~~Diwslg~il~~l 265 (292)
||-+||||+.+|++||||||.++......... ....-|+-|++||++ ++...+.++|||+|||+||-|
T Consensus 172 LKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 172 LKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred hhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 99999999999999999999997533222111 112368899999997 567889999999999999999
Q ss_pred HhCCCCCCCC
Q 022794 266 YCCDMPYPDL 275 (292)
Q Consensus 266 ~~g~~pf~~~ 275 (292)
+....||...
T Consensus 252 Cy~t~PFe~s 261 (738)
T KOG1989|consen 252 CYFTTPFEES 261 (738)
T ss_pred HHhCCCcCcC
Confidence 9999999865
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=268.35 Aligned_cols=212 Identities=27% Similarity=0.497 Sum_probs=183.5
Q ss_pred CceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+-|.+.+.||+|-|.+|-+| +.+|++||||++...+-+.. ....+.+|++.++.+.|||||++|++.....
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-------st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-------STGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-------hhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 56889999999999999999 55999999999964432211 2344788999999999999999999988776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |+++|.-++|+|++||.+. ...+++..+.+++.||+.||.|+|+..++||||||+|+.+.+
T Consensus 91 Kl----------------yLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE 153 (864)
T KOG4717|consen 91 KL----------------YLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE 153 (864)
T ss_pred eE----------------EEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee
Confidence 66 8999999999999999875 356999999999999999999999999999999999988865
Q ss_pred C-CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 N-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
. |-+||.|||++.... +.......+|..+|-|||.+.|..|+ ++.||||||+|||-|++|++||...+..|.+-.|+
T Consensus 154 KlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm 232 (864)
T KOG4717|consen 154 KLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM 232 (864)
T ss_pred ecCceEeeeccccccCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence 5 889999999986543 34455668899999999999999987 68899999999999999999999988888887776
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
.
T Consensus 233 D 233 (864)
T KOG4717|consen 233 D 233 (864)
T ss_pred c
Confidence 4
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.12 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=171.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +|+.||+|+++.... ......+++.+|+.++++++||||+++++++.+.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~------~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~ 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS------ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc------cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence 6899999999999999999976 588999999863221 11233456889999999999999999999887765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
.. +++|||++|++|.+++.... ....+...++.++.|++.||++||+.|++||||
T Consensus 76 ~l----------------yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDL 139 (932)
T PRK13184 76 PV----------------YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDL 139 (932)
T ss_pred EE----------------EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 54 89999999999999985321 123566778899999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCC------------------CCCCCCCCcccccCCcccCCCCCCchhhHHHHHH
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNP------------------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~ 260 (292)
||+||+++.++.++|+|||.+....... .......|++.|+|||.+.+..++.++|+||+||
T Consensus 140 KPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV 219 (932)
T PRK13184 140 KPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219 (932)
T ss_pred chheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence 9999999999999999999987541110 0111245899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHH
Q 022794 261 CLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 261 il~~l~~g~~pf~~~~~~~ 279 (292)
++|+|++|..||...+..+
T Consensus 220 ILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 220 ILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred HHHHHHHCCCCCCCcchhh
Confidence 9999999999998755443
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=268.03 Aligned_cols=195 Identities=25% Similarity=0.410 Sum_probs=164.2
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.. +++.||+|+++.... ......+.+.+|..++.++ +||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~--- 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV------HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL--- 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh------hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE---
Confidence 3699999999999965 578999999863211 1122234577899999888 799999999998776655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~k 136 (327)
T cd05617 72 -------------FLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIK 136 (327)
T ss_pred -------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEE
Confidence 8999999999999988543 4699999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|+|||++..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 137 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred EeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 99999886433222333445689999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=269.21 Aligned_cols=194 Identities=26% Similarity=0.419 Sum_probs=162.9
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|+||.||+|.+ +++.||+|+++..... .......+.+|..++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~--- 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN------DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL--- 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc------chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE---
Confidence 3689999999999965 5789999998643211 111233466788888777 899999999998776655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~k 136 (329)
T cd05618 72 -------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 136 (329)
T ss_pred -------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEE
Confidence 8999999999999888543 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|+|||++..............|+..|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 137 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred EeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 9999998643332333334568999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=259.79 Aligned_cols=219 Identities=29% Similarity=0.517 Sum_probs=177.9
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
|++..++|++.+.||+|++|.||+|.+. +..||+|+++.... ......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~iv 72 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--------MRERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence 5667789999999999999999998653 45799998742211 11233477899999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHH
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
++++++...... +++|||+++++|.+++.... ...++...+..++.|++.||.+||
T Consensus 73 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 136 (277)
T cd05062 73 RLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN 136 (277)
T ss_pred eEEEEEcCCCCe----------------EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 999998766544 89999999999999986532 123577889999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
+.|++|+||||+||++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 137 ~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 216 (277)
T cd05062 137 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216 (277)
T ss_pred HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999988644322111 112344678999999998889999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHHh
Q 022794 268 -CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i~~~ 287 (292)
|..||.+.+..+..+.+.++
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 217 LAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC
Confidence 79999998888877766543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=268.30 Aligned_cols=216 Identities=24% Similarity=0.315 Sum_probs=177.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ .++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC-------chhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 47899999999999999999965 5889999998643211 11123466899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... ....++++|||++ ++|.+++.. .+++..+..++.|++.||.+||++|++||||||+||+++
T Consensus 96 ~~~~----------~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 160 (364)
T cd07875 96 KSLE----------EFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 160 (364)
T ss_pred cccc----------ccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC
Confidence 3221 1234589999995 578777742 478889999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||++...... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+...++.+
T Consensus 161 ~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 239 (364)
T cd07875 161 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239 (364)
T ss_pred CCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754332 222345688999999999999999999999999999999999999999888888777765
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 240 ~ 240 (364)
T cd07875 240 Q 240 (364)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=256.21 Aligned_cols=213 Identities=26% Similarity=0.455 Sum_probs=181.9
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||++.+ +++.+++|.++..... ...+.+.+|+.++++++|+|++++++.+.+.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 72 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--------SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH 72 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--------HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 588999999999999999965 5889999998643211 112346779999999999999999999876655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.......+++..++.++.|++.||.+||++|++|+||+|+||+++++
T Consensus 73 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 73 L----------------YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred E----------------EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 4 899999999999999876556678999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............++..|+|||++.+..++.++|+||+|+++|+|++|..||...+.......+.++
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 137 GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215 (255)
T ss_pred CcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC
Confidence 9999999999876554433334456788999999999888999999999999999999999999988887777766544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=269.41 Aligned_cols=203 Identities=32% Similarity=0.500 Sum_probs=179.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
...|...+.||+|.||.||+|.+ +++.||+|++........ ...+.+|+.+|.+++++||.++|+.+...
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--------Iediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--------IEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchh--------hHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 45688889999999999999965 689999999965443222 23377899999999999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
..+ +++||||.||++.+.+. ....+++..+..++++++.||.|||..+.+|||||+.|||+.
T Consensus 84 ~~L----------------wiiMey~~gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s 145 (467)
T KOG0201|consen 84 TKL----------------WIIMEYCGGGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS 145 (467)
T ss_pred ccH----------------HHHHHHhcCcchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe
Confidence 776 78999999999999884 334558889999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
..|.++|+|||++..............||+.|||||++.+..|+.++||||||++.+||++|.+||....+
T Consensus 146 ~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 146 ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 99999999999998776666666779999999999999988999999999999999999999999988766
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=255.64 Aligned_cols=216 Identities=32% Similarity=0.525 Sum_probs=178.1
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|.+..++|++.+.||+|++|.||+|.+. +..|++|.++.... . ...+.+|+.++++++|+||+++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~-------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---S-------PEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---C-------HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4456688999999999999999999764 45799998863221 1 12477899999999999999999876
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
... . .+++|||+++++|.+++.......+++..++.++.|++.||++||+.+++|+||+|.||
T Consensus 71 ~~~-~----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Ni 133 (262)
T cd05071 71 SEE-P----------------IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 133 (262)
T ss_pred CCC-C----------------cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccE
Confidence 432 2 28999999999999999765555688999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++++++.++|+|||.+......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+.+..++.
T Consensus 134 ll~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~ 213 (262)
T cd05071 134 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213 (262)
T ss_pred EEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence 9999999999999998754433221 122345678999999988889999999999999999999 89999988887777
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+..+
T Consensus 214 ~~~~~~ 219 (262)
T cd05071 214 DQVERG 219 (262)
T ss_pred HHHhcC
Confidence 666543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=255.35 Aligned_cols=217 Identities=33% Similarity=0.545 Sum_probs=181.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|++...+|++.+.||+|++|.||+|.+ +++.|++|.++..... .+.+.+|+.++++++|+|++++++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----------PKDFLAEAQIMKKLRHPKLIQLYAVC 70 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----------HHHHHHHHHHHHHCCCCCccceeEEE
Confidence 455667899999999999999999965 4678999988543211 22367899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++.......+++..+..++.|++.+|.+||+.|++|+||+|+||
T Consensus 71 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 134 (261)
T cd05068 71 TLEEPI----------------YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV 134 (261)
T ss_pred ecCCCe----------------eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence 765544 8999999999999999765555789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++++++.++|+|||.+......... ......+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+.+..++.
T Consensus 135 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 214 (261)
T cd05068 135 LVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214 (261)
T ss_pred EEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999998765432211 111223457999999998889999999999999999999 99999998888888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 215 ~~~~~~ 220 (261)
T cd05068 215 QQVDQG 220 (261)
T ss_pred HHHHcC
Confidence 777654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=255.35 Aligned_cols=210 Identities=35% Similarity=0.620 Sum_probs=175.8
Q ss_pred eeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
|++++.||+|+||+||++.+. ++.||+|++..... .........+|+.++++++||||+++++++.+....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-------EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-------HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-------cccccchhhhhhhccccccccccccccccccccccc
Confidence 789999999999999999774 56799999964321 111122234599999999999999999999875555
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+++||++++++|.+++. ....+++..++.++.|++++|.+||+.|++|+||||+||+++.++
T Consensus 74 ----------------~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~ 135 (260)
T PF00069_consen 74 ----------------YIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG 135 (260)
T ss_dssp ----------------EEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS
T ss_pred ----------------ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 89999999889999996 346689999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++|+|||.+..............++..|+|||.+. +..++.++|+||||+++++|++|..||......+....+.+
T Consensus 136 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~ 213 (260)
T PF00069_consen 136 EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK 213 (260)
T ss_dssp EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999875433334445567889999999998 78899999999999999999999999998854444444433
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=259.99 Aligned_cols=216 Identities=30% Similarity=0.409 Sum_probs=173.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceeceecC
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMG 125 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~ 125 (292)
+|++.+.||+|++|.||+|.+ +|+.||+|.++......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP-------LSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc-------hHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 589999999999999999965 58899999886543221111 1133455555544 79999999998765
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus 74 ~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili 141 (288)
T cd07863 74 SRTD-----------RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV 141 (288)
T ss_pred ccCC-----------CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 3221 1223489999996 589998876555568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+||++|+|++|.+||...+..+.+.++.
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred CCCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence 99999999999998754322 22233567889999999998889999999999999999999999999888887777765
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
.
T Consensus 221 ~ 221 (288)
T cd07863 221 D 221 (288)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=254.93 Aligned_cols=213 Identities=31% Similarity=0.585 Sum_probs=179.5
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
-+...+|++.+.||+|++|.||++...|..|++|..+... ..+.+.+|+.+++++.|+|++++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence 4456789999999999999999999999999999885321 12347789999999999999999987644
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+. ..++++||+++++|.+++.......+++..++.++.|++.+|++||++|++|+||+|+||++
T Consensus 71 ~~~---------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~ 135 (256)
T cd05082 71 EKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135 (256)
T ss_pred CCC---------------ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE
Confidence 322 23899999999999999976555568899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i 284 (292)
++++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..++...+
T Consensus 136 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05082 136 SEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212 (256)
T ss_pred cCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999886543222 22334568999999998889999999999999999997 99999988888877776
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.++
T Consensus 213 ~~~ 215 (256)
T cd05082 213 EKG 215 (256)
T ss_pred hcC
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=269.21 Aligned_cols=216 Identities=33% Similarity=0.550 Sum_probs=176.1
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-C
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-H 113 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h 113 (292)
...|.+..++|++++.||+|+||.||+|.+. +..||||+++.... ....+.+.+|+.+++++. |
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~~Ei~~l~~l~~H 100 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--------SSEKQALMSELKIMTHLGPH 100 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--------hHHHHHHHHHHHHHHhcCCC
Confidence 3578888899999999999999999999753 24699999853321 112345888999999995 9
Q ss_pred CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----------------------------
Q 022794 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------------------------- 165 (292)
Q Consensus 114 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------- 165 (292)
|||+++++++...... +++|||+++|+|.+++..+.
T Consensus 101 pnIv~l~~~~~~~~~~----------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (400)
T cd05105 101 LNIVNLLGACTKSGPI----------------YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTR 164 (400)
T ss_pred CCeeeEEEEEccCCce----------------EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccccc
Confidence 9999999998766554 89999999999999986432
Q ss_pred ------------------------------------------------------------------ccccCHHHHHHHHH
Q 022794 166 ------------------------------------------------------------------RRKLAFKVVVQLAL 179 (292)
Q Consensus 166 ------------------------------------------------------------------~~~~~~~~~~~i~~ 179 (292)
...+++..++.++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~ 244 (400)
T cd05105 165 SYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTY 244 (400)
T ss_pred chhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHH
Confidence 12467788899999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHH
Q 022794 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (292)
Q Consensus 180 qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws 257 (292)
|++.||.|||+.+++|+||||+||++++++.++|+|||++......... .....++..|+|||.+.+..++.++|+||
T Consensus 245 qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred HHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 9999999999999999999999999999999999999998754332221 12234567899999999888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 258 FGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 258 lg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
||+++|+|++ |..||......+..
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHHH
Confidence 9999999997 99999876554433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=260.78 Aligned_cols=215 Identities=31% Similarity=0.546 Sum_probs=178.4
Q ss_pred CCceeEeeeeccCcceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
.++|++.+.||+|++|.||+|...+ ..|++|.++.... ......+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~i~~~~~ 75 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--------PKVQQEFRQEAELMSDLQHPNIVCLLG 75 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--------HHHHHHHHHHHHHHHhcCCcccceEEE
Confidence 4679999999999999999996532 5699998753221 122445788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--------------cccCHHHHHHHHHHHHHHHHH
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------------RKLAFKVVVQLALDLARGLSY 187 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~ 187 (292)
++...... +++|||+++++|.+++..... ..+++..++.++.|++.||.+
T Consensus 76 ~~~~~~~~----------------~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~ 139 (283)
T cd05048 76 VCTKEQPT----------------CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEY 139 (283)
T ss_pred EEcCCCce----------------EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 98766544 899999999999999965321 457889999999999999999
Q ss_pred HHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHH
Q 022794 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 188 lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l 265 (292)
||..|++|+||||+||++++++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 140 lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el 219 (283)
T cd05048 140 LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219 (283)
T ss_pred HHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999999865432211 12234457789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHh
Q 022794 266 YC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 266 ~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
++ |..||.+.+..++...+.++
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 220 FSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcC
Confidence 98 99999999998888877654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=271.41 Aligned_cols=206 Identities=26% Similarity=0.370 Sum_probs=168.1
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceeceecCCcccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 132 (292)
||+|+||.||+|.+ +|+.||+|++..... ...........|..++.++ +||+|+++++.+...+..
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~--- 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL--- 71 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE---
Confidence 69999999999965 589999999853211 1111122234566666555 799999999988776655
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|.+++.+ ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++
T Consensus 72 -------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~k 136 (330)
T cd05586 72 -------------YLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIA 136 (330)
T ss_pred -------------EEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 899999999999998854 35689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||++..............|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..++...+..+
T Consensus 137 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred EecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 99999986543333333445689999999998765 4789999999999999999999999998888888777654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=255.03 Aligned_cols=217 Identities=34% Similarity=0.558 Sum_probs=182.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|++..++|.+.+.||+|++|.||+|.. ++..|++|.+...... ...+.+|+.++++++|+|++++++++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----------PEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----------HHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 456778999999999999999999965 4578999988633211 13377899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...... +++|||+++++|.+++.......+++..+..++.|++.||.+||++|++|+||+|+||
T Consensus 71 ~~~~~~----------------~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni 134 (261)
T cd05034 71 SEEEPI----------------YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134 (261)
T ss_pred ecCCce----------------EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence 765444 8999999999999999765556789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++++++.++|+|||.+........ .......+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+.+..+..
T Consensus 135 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred EEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999875442211 1112234568999999998889999999999999999998 99999998888888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 215 ~~~~~~ 220 (261)
T cd05034 215 EQVERG 220 (261)
T ss_pred HHHHcC
Confidence 877654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=255.59 Aligned_cols=217 Identities=30% Similarity=0.579 Sum_probs=181.6
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
|++...+|.+.+.||+|++|.||+|.+ +++.|++|++..... . ...+.+|+.+++++.|+|+++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~------~----~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------E----VEEFLKEAAVMKEIKHPNLVQLLGV 70 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch------H----HHHHHHHHHHHHhCCCCChhheEEE
Confidence 455667899999999999999999965 588999998853211 1 2346789999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...+.. +++|||+++++|.+++.......+++..++.++.|++.+|++||++|++|+||+|+|
T Consensus 71 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~n 134 (263)
T cd05052 71 CTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 134 (263)
T ss_pred EcCCCCc----------------EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcce
Confidence 8766554 899999999999999976555668999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCC-CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDM-TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
|++++++.++|+|||.+.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 135 il~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred EEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987544322211 11234567999999998889999999999999999998 9999999888888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 215 ~~~~~~~ 221 (263)
T cd05052 215 YELLEKG 221 (263)
T ss_pred HHHHHCC
Confidence 7776654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=258.13 Aligned_cols=196 Identities=29% Similarity=0.467 Sum_probs=163.4
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||+|+||.||++.. +|+.||+|.+...... .......+..|+.++++++||||+++++.+......
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~------~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~------ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK------KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL------ 68 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh------cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE------
Confidence 69999999999964 5899999998532111 011122345699999999999999999988765544
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
+++|||+++++|.+++.......+++..+..++.|++.||++||+.|++||||||+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~D 138 (277)
T cd05607 69 ----------CLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD 138 (277)
T ss_pred ----------EEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEee
Confidence 8999999999999988665556689999999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 216 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 139 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 139 LGLAVELKDGK-TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ceeeeecCCCc-eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99987544322 2233568889999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=257.95 Aligned_cols=211 Identities=28% Similarity=0.431 Sum_probs=180.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||++.+ +++.|++|++.... .........+.+|+.+++++.||||+++++++...+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK------IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence 4799999999999999999965 58999999985321 111223455788999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|.||+++.
T Consensus 75 ~~----------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~ 136 (290)
T cd05580 75 NL----------------YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136 (290)
T ss_pred eE----------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 54 8999999999999998654 56899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||.+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..+.+..+
T Consensus 137 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (290)
T cd05580 137 DGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213 (290)
T ss_pred CCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 999999999998755433 23346788999999998888899999999999999999999999988887777776654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=275.18 Aligned_cols=210 Identities=22% Similarity=0.366 Sum_probs=166.4
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC------CCccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD------HPNVT 117 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv 117 (292)
+...++|++++.||+|+||.||+|.+ +++.||||+++.... .......|+.+++.+. |.+++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----------YTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----------hHHHHHHHHHHHHHHhhcCcccCccee
Confidence 34457899999999999999999965 578899999853211 1122344666666554 44577
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHR 196 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~ 196 (292)
.+++++..... +.|++|+++ +++|.+++.+. ..+++..+..++.||+.||.|||+ .||+||
T Consensus 195 ~i~~~~~~~~~---------------~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHr 256 (467)
T PTZ00284 195 KIQRYFQNETG---------------HMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHT 256 (467)
T ss_pred eeEEEEEcCCc---------------eEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecC
Confidence 88777754322 238999998 77899988643 468999999999999999999998 599999
Q ss_pred CCCCCCeeEcCCC----------------cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHH
Q 022794 197 DVKTENMLLDKNR----------------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (292)
Q Consensus 197 di~p~Nili~~~~----------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~ 260 (292)
||||+|||++.++ .++|+|||.+.... .......+++.|+|||++.+..++.++|||||||
T Consensus 257 DlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 333 (467)
T PTZ00284 257 DLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333 (467)
T ss_pred CCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHH
Confidence 9999999997665 49999999875322 2233467899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 261 CLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 261 il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++|+|++|++||.+.+..+.+..+.+
T Consensus 334 il~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 334 IIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999999998888777666554
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.29 Aligned_cols=208 Identities=28% Similarity=0.488 Sum_probs=175.3
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+..++|++.+.||+|+||.||++.+ ++..+++|.+..... ......+.+|++++++++|+||+++++++.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--------HHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 4457999999999999999999976 578899998754311 112345788999999999999999999988
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCe
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENM 203 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~p~Ni 203 (292)
+.+.. +++|||+++++|.+++... ..+++..+..++.|++.+|.|||+. +++|+||||+||
T Consensus 74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Ni 135 (333)
T cd06650 74 SDGEI----------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 135 (333)
T ss_pred ECCEE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhE
Confidence 76554 8999999999999998643 4588999999999999999999975 799999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..++..
T Consensus 136 li~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 212 (333)
T cd06650 136 LVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212 (333)
T ss_pred EEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 9999999999999998644322 2233468889999999999889999999999999999999999998777655543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=267.04 Aligned_cols=216 Identities=24% Similarity=0.326 Sum_probs=175.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ .++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-------hHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 47899999999999999999965 5889999988543211 11233466899999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....+++|||+++ +|.+++.. .+++..++.++.|++.||.+||++|++||||||+||+++
T Consensus 89 ~~~~----------~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~ 153 (355)
T cd07874 89 KSLE----------EFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_pred cccc----------ccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence 3321 12335899999954 77776632 488889999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+.+
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 154 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred CCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999998754332 223345688999999999998999999999999999999999999998887776665554
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 233 ~ 233 (355)
T cd07874 233 Q 233 (355)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=271.24 Aligned_cols=226 Identities=35% Similarity=0.585 Sum_probs=190.2
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEE--C-C--ce-eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--D-G--HD-VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~-~--~~-valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 112 (292)
+-.++.|++.-++..+.+.||+|.||.||+|.. . + .. ||+|..+... .........+.+|++++++++
T Consensus 146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~------~~~~~~~~e~m~EArvMr~l~ 219 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS------ELTKEQIKEFMKEARVMRQLN 219 (474)
T ss_pred cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc------cccHHHHHHHHHHHHHHHhCC
Confidence 345677888888999999999999999999943 2 2 23 8999886321 112334566899999999999
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 192 (292)
||||++++|+......+ +++||+|.||+|.+|++++.. .++..+...++.+.+.+|+|||+++
T Consensus 220 H~NVVr~yGVa~~~~Pl----------------~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~ 282 (474)
T KOG0194|consen 220 HPNVVRFYGVAVLEEPL----------------MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN 282 (474)
T ss_pred CCCEEEEEEEEcCCCcc----------------EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC
Confidence 99999999999888777 899999999999999987654 6899999999999999999999999
Q ss_pred ccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 022794 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (292)
Q Consensus 193 i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~p 271 (292)
++||||...|+|++.++.+||+|||+++....-............|+|||.+....++.++||||+|+++||+.+ |..|
T Consensus 283 ~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~P 362 (474)
T KOG0194|consen 283 CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEP 362 (474)
T ss_pred CcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCC
Confidence 999999999999999999999999998644311111112245689999999999999999999999999999999 8889
Q ss_pred CCCCCHHHHHHHHHHh
Q 022794 272 YPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 272 f~~~~~~~~~~~i~~~ 287 (292)
|.+....++..+|+.+
T Consensus 363 y~g~~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 363 YPGMKNYEVKAKIVKN 378 (474)
T ss_pred CCCCCHHHHHHHHHhc
Confidence 9999999999999553
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=253.78 Aligned_cols=212 Identities=30% Similarity=0.591 Sum_probs=177.4
Q ss_pred CCceeEeeeeccCcceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.++|++.+.||+|++|.||++.+.+ ..+|+|.+..... . ...+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---S-------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---c-------HHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4679999999999999999997654 4699998753221 1 133778999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+.+++|.+++.... ..+++..++.++.|++.||++||+.|++|+||+|.||++++
T Consensus 73 ~~----------------~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 73 PI----------------YIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred Cc----------------EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 44 89999999999999986543 36899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++...+.
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05113 136 QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215 (256)
T ss_pred CCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh
Confidence 999999999988754332211 112335568999999988889999999999999999998 999999888888877776
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
++
T Consensus 216 ~~ 217 (256)
T cd05113 216 QG 217 (256)
T ss_pred cC
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=254.58 Aligned_cols=216 Identities=31% Similarity=0.525 Sum_probs=180.1
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|.+..++|++.+.||+|++|.||+|.+ .+..+++|.++..... .+.+.+|+.++++++|++++++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----------PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----------HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 456678999999999999999999965 4678999988643221 12377899999999999999999876
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
... . .+++|||+++++|.+++.......+++..++.++.|++.||++||++|++|+||+|+||
T Consensus 71 ~~~-~----------------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Ni 133 (260)
T cd05070 71 SEE-P----------------IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANI 133 (260)
T ss_pred CCC-C----------------cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 432 2 28999999999999999765555689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..+..
T Consensus 134 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 213 (260)
T cd05070 134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213 (260)
T ss_pred EEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999998765432221 122334568999999988889999999999999999999 99999998888888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 214 ~~~~~~ 219 (260)
T cd05070 214 EQVERG 219 (260)
T ss_pred HHHHcC
Confidence 777654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=268.40 Aligned_cols=215 Identities=28% Similarity=0.361 Sum_probs=174.2
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|+||.||+|.+ +|+.||+|.+...... ......+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-------LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-------hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCc
Confidence 477889999999999999975 6899999988532111 1112347789999999999999999999876542
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
.. ....++++||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.+
T Consensus 74 ~~-----------~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 74 DP-----------FEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred cc-----------cceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC
Confidence 10 113489999995 688887743 3568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||++....... .......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+..+.+..+.+
T Consensus 140 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 140 CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 999999999987543222 122334578899999999875 478999999999999999999999999888887777654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=258.57 Aligned_cols=203 Identities=28% Similarity=0.410 Sum_probs=170.8
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|++.+.||+|+||.||++.+ +++.||+|.+...... .......+.+|+.++++++|++++.+++.+.+.+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~ 74 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc------chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence 477889999999999999966 5889999988532211 11122345679999999999999999998876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||||+||+++.+
T Consensus 75 ~----------------~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 75 L----------------CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred E----------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 4 899999999999999866555679999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 139 ~~~~l~Dfg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 139 GHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCEEEeeccceeecCCCc-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999986543222 2233568899999999999899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=253.07 Aligned_cols=216 Identities=31% Similarity=0.522 Sum_probs=178.3
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|++..++|.+.+.||+|++|.||+|.+. +..+++|....... ..+.+.+|+.+++++.|+|++++++++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 70 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----------MPEAFLQEAQIMKKLRHDKLVPLYAVV 70 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----------cHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4556678999999999999999999764 45799998753221 123477899999999999999998876
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
... . .+++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus 71 ~~~-~----------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Ni 133 (260)
T cd05069 71 SEE-P----------------IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANI 133 (260)
T ss_pred cCC-C----------------cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 432 1 28999999999999999765555688999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++++++.++|+|||.+........ ......++..|+|||...+..++.++|+||||+++|+|++ |.+||.+.+..+..
T Consensus 134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 213 (260)
T cd05069 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213 (260)
T ss_pred EEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999876543222 1122345678999999988889999999999999999999 99999998888777
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 214 ~~~~~~ 219 (260)
T cd05069 214 EQVERG 219 (260)
T ss_pred HHHHcC
Confidence 766554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=249.55 Aligned_cols=219 Identities=27% Similarity=0.466 Sum_probs=185.6
Q ss_pred CceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 126 (292)
.+|.=.+.||.|..++|.++. .+|+.+++|++.........+. ...+++.-.+|+.+|+++ .||+|+++.+++...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-PYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-HHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456667889999999999884 4789999999876655444444 666777788999999999 899999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... ++|+|.++.|.|.+|+.. .-.+++...+.+++|+++++.|||.++|+||||||+|||++
T Consensus 96 sF~----------------FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 96 AFV----------------FLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD 157 (411)
T ss_pred chh----------------hhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec
Confidence 655 899999999999999964 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
++.+++|+|||.++.+... ......+||++|+|||.+... .|+...|+|++|+++|.++.|.+||--...--+
T Consensus 158 dn~~i~isDFGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM 236 (411)
T KOG0599|consen 158 DNMNIKISDFGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM 236 (411)
T ss_pred cccceEEeccceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH
Confidence 9999999999999976643 445557899999999998542 578899999999999999999999976555555
Q ss_pred HHHHHHhh
Q 022794 281 TSAVVRQV 288 (292)
Q Consensus 281 ~~~i~~~~ 288 (292)
+..|+.|+
T Consensus 237 LR~ImeGk 244 (411)
T KOG0599|consen 237 LRMIMEGK 244 (411)
T ss_pred HHHHHhcc
Confidence 66665553
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=252.83 Aligned_cols=212 Identities=31% Similarity=0.586 Sum_probs=177.1
Q ss_pred CCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..+|++.+.||+|+||.||++.+. +..+++|.+..... . ...+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---S-------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---c-------HHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 467899999999999999999664 56899998753221 1 123678999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++
T Consensus 73 ~~----------------~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 73 PL----------------YIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred CE----------------EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 54 89999999999999986533 35889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+.+..+.
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred CCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999988654322211 112234568999999998889999999999999999999 999999999888888887
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
++
T Consensus 216 ~~ 217 (256)
T cd05114 216 RG 217 (256)
T ss_pred CC
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=243.58 Aligned_cols=213 Identities=22% Similarity=0.342 Sum_probs=175.9
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
..+.-+..++|++.+.||+|||+-||++. .+++.||+|.+..... +..+...+|++..++++|||++++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---------~~~e~~~rEid~~rkf~s~~vl~l 83 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---------EDIEEALREIDNHRKFNSPNVLRL 83 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---------HHHHHHHHHHHHHHhhCCcchHHH
Confidence 55677889999999999999999999985 5899999998864431 113347789999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCC--ccc
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQK--IVH 195 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h 195 (292)
+++......- ...+.|++++|...|+|.+.+... ++..+++..++.|+.+++++|.+||... +.|
T Consensus 84 ~dh~l~~~~D-----------~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 84 VDHQLREEKD-----------GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HHHHHHhhcc-----------CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 9987654320 123449999999999999999654 3457999999999999999999999998 999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCC---------CCCCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHH
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASN---------PNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLW 263 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~ 263 (292)
|||||.|||+++.+.++|.|||+++...-. .+......++..|+|||.+.- ...+.++|||||||++|
T Consensus 153 ~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 153 RDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 999999999999999999999998643211 112233568999999999864 45789999999999999
Q ss_pred HHHhCCCCCCC
Q 022794 264 EIYCCDMPYPD 274 (292)
Q Consensus 264 ~l~~g~~pf~~ 274 (292)
.|+.|.-||..
T Consensus 233 a~mf~~sPfe~ 243 (302)
T KOG2345|consen 233 AMMFGESPFER 243 (302)
T ss_pred HHHHcCCcchH
Confidence 99999999964
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=268.81 Aligned_cols=196 Identities=29% Similarity=0.435 Sum_probs=165.5
Q ss_pred cCCceeEeeeeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
...+|.+++.||+|+||.||++.. .+..|++|.+.... ...+|+.++++++||||+++++.+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------------~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------------TPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------------cHHHHHHHHHhcCCCCccceeeeE
Confidence 345799999999999999999864 35679999874221 135799999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...... +++||++ +++|.+++. ....+++..++.++.||+.||.|||+.|++||||||+||
T Consensus 156 ~~~~~~----------------~lv~e~~-~~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Ni 216 (392)
T PHA03207 156 RWKSTV----------------CMVMPKY-KCDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENI 216 (392)
T ss_pred eeCCEE----------------EEEehhc-CCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 765544 8999999 468988883 345689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 204 LLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+++.++.++|+|||+++....... ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 217 ll~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred EEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999875443322 1223568999999999999999999999999999999999999997654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=275.82 Aligned_cols=215 Identities=31% Similarity=0.553 Sum_probs=185.0
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
.+.+...|++.-+...-++-||.|+.|-||+|+..++.||||.++.. -..++.-|++|+|+||+
T Consensus 112 k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------------kETdIKHLRkLkH~NII 175 (904)
T KOG4721|consen 112 KQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------------KETDIKHLRKLKHPNII 175 (904)
T ss_pred hhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh----------------hhhhHHHHHhccCccee
Confidence 34455567777667777788999999999999999999999987422 22478889999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
.|.++|....-+ ||+||||..|.|...++. ++++....+..|.++|+.++.|||.+.|||||
T Consensus 176 ~FkGVCtqsPcy----------------CIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRD 237 (904)
T KOG4721|consen 176 TFKGVCTQSPCY----------------CIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRD 237 (904)
T ss_pred eEeeeecCCcee----------------EEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhc
Confidence 999999876655 999999999999999954 46788889999999999999999999999999
Q ss_pred CCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 198 i~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
||.-||||+.+..|||+|||.++..... .....+.||..|||||+++..+.+.+.||||||+|||||+||..||.+.+.
T Consensus 238 LKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 238 LKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred cCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 9999999999999999999999766554 444558899999999999999999999999999999999999999998877
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
..++.-+-.+
T Consensus 317 sAIIwGVGsN 326 (904)
T KOG4721|consen 317 SAIIWGVGSN 326 (904)
T ss_pred heeEEeccCC
Confidence 6655444333
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=257.86 Aligned_cols=216 Identities=25% Similarity=0.491 Sum_probs=182.4
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
....+|++.+.||.|++|.||+|.+ .++.+++|++..... .....+.+|+.+++.++|+|++++++++..
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL---------LKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch---------hhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 3446799999999999999999965 478899999853221 112346789999999999999999998877
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 74 ~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv 137 (261)
T cd05148 74 GEPV----------------YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV 137 (261)
T ss_pred CCCe----------------EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE
Confidence 6554 899999999999999976656678999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i 284 (292)
++++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+++..+
T Consensus 138 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05148 138 GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217 (261)
T ss_pred cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 99999999999998765433322333445678999999988889999999999999999998 89999998888888877
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
..+
T Consensus 218 ~~~ 220 (261)
T cd05148 218 TAG 220 (261)
T ss_pred HhC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=251.56 Aligned_cols=212 Identities=33% Similarity=0.636 Sum_probs=181.3
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
.+...+|++.+.||.|++|.||+|...|+.|++|.++.... ..+.+.+|+.+++.++|+|++++++++.+
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh----------HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 45567899999999999999999999999999999853221 23457889999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+++++|.+++.......+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 72 ~~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili 135 (256)
T cd05039 72 GNPL----------------YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV 135 (256)
T ss_pred CCCe----------------EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE
Confidence 5444 899999999999999976554578999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i 284 (292)
+.++.++|+|||.+........ ....+..|+|||.+.+..++.++|+||||++++++++ |..||...+..++...+
T Consensus 136 ~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05039 136 SEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212 (256)
T ss_pred eCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999999875532221 2334568999999988889999999999999999997 99999988887776655
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
.+
T Consensus 213 ~~ 214 (256)
T cd05039 213 EK 214 (256)
T ss_pred hc
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=275.11 Aligned_cols=205 Identities=30% Similarity=0.469 Sum_probs=170.6
Q ss_pred CceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|..-+.||+|+||.||+++ .+|+.||||.++.... ..-+++..+|++++++++|+|||+.+++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--------~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--------LRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--------cchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 456667889999999999996 4799999999975432 122455778999999999999999998765544
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... ......++||||.+|+|...+++- ....+++..++.++..++.|+.|||.+||+||||||.||++.
T Consensus 85 ~~~----------~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~ 154 (732)
T KOG4250|consen 85 LGL----------VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQ 154 (732)
T ss_pred cCc----------ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEe
Confidence 211 123348999999999999999642 345699999999999999999999999999999999999994
Q ss_pred --CCCc--EEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 207 --KNRT--VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 207 --~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
++|+ .||+|||.|+...... ......||..|++||++.. +.|+...|+||+||++|++.||.+||-
T Consensus 155 ~Gedgq~IyKLtDfG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 155 IGEDGQSIYKLTDFGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ecCCCceEEeeecccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 4344 6999999998766554 6666899999999999985 778899999999999999999999995
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=256.26 Aligned_cols=218 Identities=29% Similarity=0.464 Sum_probs=188.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+..++|..+++||+|.||.|.+++ -+|+.+|+|+++..-... ..+. ..-..|-++|+.++||.+..+.-.|
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia--kdEV----AHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA--KDEV----AHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee--hHHh----hhhhhHHHHHHhccCcHHHHhhhhh
Confidence 3455789999999999999999995 479999999996443221 1222 2245689999999999999988888
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.+ |+||||..||.|.-.+.+ .+.+++...+.+...|+.||.|||+++|++||+|.+|+
T Consensus 238 Qt~drl----------------CFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENL 299 (516)
T KOG0690|consen 238 QTQDRL----------------CFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENL 299 (516)
T ss_pred ccCceE----------------EEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhh
Confidence 887776 999999999999988854 46799999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+++.+|++|+.|||++.............+||+.|+|||++....|..+.|-|.+|+++|+|++|++||.+.+.+.+.+-
T Consensus 300 lLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 300 LLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred eeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 99999999999999998665555566678999999999999999999999999999999999999999999999988877
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
|.-+
T Consensus 380 Il~e 383 (516)
T KOG0690|consen 380 ILME 383 (516)
T ss_pred HHhh
Confidence 6543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=258.08 Aligned_cols=213 Identities=27% Similarity=0.452 Sum_probs=177.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||.|++|.||+|.+ +++.||+|.++....... ...+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--------hhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 36799999999999999999965 578999999864432211 12356799999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||++ ++|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 77 ~~~----------------~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~ 138 (301)
T cd07873 77 KSL----------------TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN 138 (301)
T ss_pred CeE----------------EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC
Confidence 554 89999996 5899888653 34688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+..............+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+....+.
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 139 ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987544333333445678899999998664 57889999999999999999999999988887776665
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 219 ~~ 220 (301)
T cd07873 219 RI 220 (301)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=264.42 Aligned_cols=214 Identities=26% Similarity=0.401 Sum_probs=174.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +++.||+|.+..... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-------SLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 57899999999999999999965 578999998853211 111233466899999999999999999987644
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....+++++++ +++|.+++. ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 87 ~~~~----------~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~ 152 (343)
T cd07878 87 TSIE----------NFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN 152 (343)
T ss_pred cccc----------ccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC
Confidence 3211 123348999988 789988774 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.
T Consensus 153 ~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07878 153 EDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM 229 (343)
T ss_pred CCCCEEEcCCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999999998754432 233568899999999877 468899999999999999999999999887777666654
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
+
T Consensus 230 ~ 230 (343)
T cd07878 230 E 230 (343)
T ss_pred H
Confidence 4
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=250.61 Aligned_cols=215 Identities=27% Similarity=0.504 Sum_probs=179.9
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||++.+ +++.|++|.+...... ....+.+.+|+.++++++|+|++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 72 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGED- 72 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-
Confidence 489999999999999999965 5788999998533221 112344778999999999999999988764322
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
..++++|||+++++|.+++.......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 73 --------------~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~ 138 (257)
T cd08223 73 --------------GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138 (257)
T ss_pred --------------CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC
Confidence 223899999999999999976555678999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+...+...+.++
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (257)
T cd08223 139 NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217 (257)
T ss_pred CcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999876544333334456788999999999988999999999999999999999999988877776666544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=252.28 Aligned_cols=216 Identities=31% Similarity=0.533 Sum_probs=180.0
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
|++..++|++.+.||+|+||.||++.+ .+..+++|.+.... . ..+.+.+|+.++++++|+|++++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~------~----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS------M----SVEAFLAEANVMKTLQHDKLVKLHAVV 70 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh------h----HHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 567789999999999999999999965 56779999875321 1 123477899999999999999999887
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.. .. ++++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus 71 ~~-~~----------------~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 133 (260)
T cd05073 71 TK-EP----------------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 133 (260)
T ss_pred cC-CC----------------eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 65 22 28999999999999999765556688899999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
+++.++.++|+|||.+......... .....++..|+|||++.+..++.++|+||||+++|++++ |+.||...+..++.
T Consensus 134 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 213 (260)
T cd05073 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213 (260)
T ss_pred EEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999988754432221 122334567999999998889999999999999999998 99999998888777
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 214 ~~~~~~ 219 (260)
T cd05073 214 RALERG 219 (260)
T ss_pred HHHhCC
Confidence 766543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.61 Aligned_cols=214 Identities=25% Similarity=0.430 Sum_probs=182.6
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++++.||.|++|.||.+.. +++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-------KERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-------hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 589999999999999888754 68899999885433211 113346789999999999999999999987655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.......+++..+..++.|++.+|.+||+.|++|+||+|+||+++++
T Consensus 74 ~----------------~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 74 L----------------LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred E----------------EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 4 899999999999999976555678999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..+
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08221 138 GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG 216 (256)
T ss_pred CCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999876544443334456889999999998888899999999999999999999999998888887777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=264.30 Aligned_cols=214 Identities=34% Similarity=0.589 Sum_probs=172.8
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNV 116 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 116 (292)
|.+...+|++.+.||+|+||.||+|.. +++.||+|+++.... .. ....+.+|+.+++++ .|+||
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~----~~----~~~~~~~E~~~~~~l~~h~ni 73 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT----AS----EYKALMTELKILIHIGHHLNV 73 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC----HH----HHHHHHHHHHHHHhhccCcch
Confidence 667778999999999999999999853 246899999853221 11 123466799999999 89999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-------------------------------
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------- 165 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------- 165 (292)
+++++++...+. ..++++||+++++|.+++....
T Consensus 74 v~~~~~~~~~~~---------------~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (337)
T cd05054 74 VNLLGACTKPGG---------------PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSS 138 (337)
T ss_pred hheeeeEecCCC---------------CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCc
Confidence 999998765432 2378999999999999985432
Q ss_pred ----------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecC
Q 022794 166 ----------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217 (292)
Q Consensus 166 ----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg 217 (292)
...+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG 218 (337)
T cd05054 139 SQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 218 (337)
T ss_pred cccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccc
Confidence 1257889999999999999999999999999999999999999999999999
Q ss_pred cceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022794 218 VARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVT 281 (292)
Q Consensus 218 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~ 281 (292)
++......... .....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+....+..
T Consensus 219 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~ 285 (337)
T cd05054 219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285 (337)
T ss_pred cchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH
Confidence 98764332211 122345678999999999999999999999999999998 99999876654443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=231.06 Aligned_cols=213 Identities=27% Similarity=0.429 Sum_probs=186.8
Q ss_pred ceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.-.++||+|.||+||+|+ .+++.||+|..+.+..++..... ..+|+-+++.++|.||+++++.......
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpss-------alreicllkelkhknivrl~dvlhsdkk 75 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSS-------ALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHH-------HHHHHHHHHHhhhcceeehhhhhccCce
Confidence 45667899999999999994 46899999999876655444332 5679999999999999999999887776
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. -+|+||| ..+|..|... -+..++.+.++.++.|++.+|.++|++++.|||+||.|++|+.+
T Consensus 76 l----------------tlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 76 L----------------TLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN 137 (292)
T ss_pred e----------------EEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence 6 7899999 4599998865 34569999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~ 286 (292)
|.+||.|||+++..+.+....+....|.-|.+|+++.|.+ |+...|+||.||++.|+.. |++.|++.+..+.+++|.+
T Consensus 138 gelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 138 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred CcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 9999999999988777766677788899999999999875 8899999999999999987 8999999999999999987
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
..
T Consensus 218 ~l 219 (292)
T KOG0662|consen 218 LL 219 (292)
T ss_pred Hh
Confidence 54
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=258.56 Aligned_cols=221 Identities=34% Similarity=0.560 Sum_probs=179.0
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
+.|++..++|.+.+.||+|+||.||+|.+. +..+|+|.++.... . .....+.+|+.+++.+ +
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~----~----~~~~~~~~e~~~l~~l~~ 82 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT----E----KDLSDLISEMEMMKMIGK 82 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC----h----HHHHHHHHHHHHHHHhcC
Confidence 356667789999999999999999999652 24699998863311 1 1123467799999999 8
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
||||+++++++...+.. +++|||+++++|.+++.... ...+++..++.++
T Consensus 83 h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 146 (307)
T cd05098 83 HKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146 (307)
T ss_pred CCCEeeEEEEEecCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 99999999998766554 89999999999999996532 1347889999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.|++.||++||++|++|+||||+||++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+|
T Consensus 147 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred HHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 99999999999999999999999999999999999999998654322111 1112344689999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||+++|+|++ |..||...+..++...+..+
T Consensus 227 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 258 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC
Confidence 99999999998 89999988887777766544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.62 Aligned_cols=219 Identities=31% Similarity=0.508 Sum_probs=177.3
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
|++..++|++.+.||+|+||.||+|... +..||+|.++.... ......+.+|+.+++.++||||+
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~ 72 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--------LRERIEFLNEASVMKGFTCHHVV 72 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--------HHHHHHHHHHHHHHHhCCCCCee
Confidence 5677789999999999999999998532 45799998753211 11123467899999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHH
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
++++++...+.. +++|||+++++|.+++.... ...++...+..++.|++.||.+||
T Consensus 73 ~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 136 (288)
T cd05061 73 RLLGVVSKGQPT----------------LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN 136 (288)
T ss_pred eEEEEEcCCCCc----------------EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999988766544 89999999999999996532 123466788999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
++|++|+||||+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 137 ~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~ 216 (288)
T cd05061 137 AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216 (288)
T ss_pred hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHh
Confidence 999999999999999999999999999988654322211 112234668999999988889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHHh
Q 022794 268 -CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i~~~ 287 (292)
|..||.+.+.+++...+..+
T Consensus 217 ~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 217 LAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcC
Confidence 79999998888887766543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=251.36 Aligned_cols=210 Identities=34% Similarity=0.642 Sum_probs=178.3
Q ss_pred ecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+...+|++.+.||+|+||.||++..+++.|++|..+... ....+.+|+.++++++|||++++++.+...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----------TAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc-----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 345789999999999999999999999999999885321 123477899999999999999999887543
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
. .+++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++||||+|+||+++
T Consensus 72 ~-----------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~ 134 (254)
T cd05083 72 G-----------------LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134 (254)
T ss_pred C-----------------cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc
Confidence 2 27999999999999999765555689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+...... ......+..|+|||.+.+..++.++|+||||+++|+|++ |++||...+..+....+.
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 211 (254)
T cd05083 135 EDGVAKVSDFGLARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211 (254)
T ss_pred CCCcEEECCCccceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence 9999999999988653321 122334568999999988889999999999999999997 999999988888777765
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
++
T Consensus 212 ~~ 213 (254)
T cd05083 212 KG 213 (254)
T ss_pred CC
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=280.05 Aligned_cols=225 Identities=32% Similarity=0.520 Sum_probs=193.0
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 113 (292)
.....++...+.++.+.||+|.||.||+|.. ....||||.++.... .+.+..|.+|+.++..++|
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--------~~~~~dF~REaeLla~l~H 548 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--------NQARQDFRREAELLAELQH 548 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--------HHHHHHHHHHHHHHHhccC
Confidence 3344566677889999999999999999953 345699999975432 2345669999999999999
Q ss_pred CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------cc----ccCHHHHHHHHHHH
Q 022794 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RR----KLAFKVVVQLALDL 181 (292)
Q Consensus 114 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~----~~~~~~~~~i~~qi 181 (292)
||||++++++...+.+ ++|+||+..|+|.+|++... +. +++..+.+.|+.||
T Consensus 549 ~nIVrLlGVC~~~~P~----------------~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QI 612 (774)
T KOG1026|consen 549 PNIVRLLGVCREGDPL----------------CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQI 612 (774)
T ss_pred CCeEEEEEEEccCCee----------------EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999988887 99999999999999996432 22 38889999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCC--CCCCcccccCCcccCCCCCCchhhHHHHH
Q 022794 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT--GETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (292)
Q Consensus 182 ~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Diwslg 259 (292)
+.+..||-++.++||||...|.||++...|||+|||+++.......... ......+|||||.|..+++|.++||||+|
T Consensus 613 AaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~G 692 (774)
T KOG1026|consen 613 AAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFG 692 (774)
T ss_pred HHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhh
Confidence 9999999999999999999999999999999999999986544433222 24567899999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHHhhh
Q 022794 260 ICLWEIYC-CDMPYPDLSFSEVTSAVVRQVQ 289 (292)
Q Consensus 260 ~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 289 (292)
++|||+++ |..||.+.+++|+++-|.++..
T Consensus 693 VvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 693 VVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred hhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 99999999 9999999999999999988753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=251.34 Aligned_cols=217 Identities=28% Similarity=0.552 Sum_probs=180.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||+|.+ +++.+++|.+...................+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999965 578999999876554444334444555678899999999999999999999876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++++
T Consensus 81 ~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~ 142 (267)
T cd06628 81 L----------------NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK 142 (267)
T ss_pred c----------------EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC
Confidence 4 8999999999999999643 568899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCC------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPN------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.+.
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 222 (267)
T cd06628 143 GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222 (267)
T ss_pred CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH
Confidence 9999999998875542211 1112347789999999998889999999999999999999999998876655554
Q ss_pred HHH
Q 022794 283 AVV 285 (292)
Q Consensus 283 ~i~ 285 (292)
++.
T Consensus 223 ~~~ 225 (267)
T cd06628 223 KIG 225 (267)
T ss_pred HHh
Confidence 443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=250.99 Aligned_cols=214 Identities=28% Similarity=0.474 Sum_probs=176.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|++|.||.|.. +++.|++|.+....... ........+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP----ETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccch----hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 5789999999999999999964 68999999986433211 11222345788999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 78 ~~----------------~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 78 TL----------------SIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred eE----------------EEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 44 8999999999999988643 45889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCC---CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+...++
T Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 219 (263)
T cd06625 140 AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219 (263)
T ss_pred CCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH
Confidence 9999999999986543221111 2345678999999999988999999999999999999999999877666555444
Q ss_pred H
Q 022794 285 V 285 (292)
Q Consensus 285 ~ 285 (292)
.
T Consensus 220 ~ 220 (263)
T cd06625 220 A 220 (263)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=252.14 Aligned_cols=214 Identities=33% Similarity=0.577 Sum_probs=177.4
Q ss_pred CCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.++|++.+.||+|+||.||+|.+. ...|++|.++.... ......+.+|+.++++++||||+++++.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------DKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--------hHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 468999999999999999999653 35799998753221 11234477899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++.... ..+++..++.++.|++.+|.+||++|++|+||+|+||
T Consensus 75 ~~~~~~----------------~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 75 TKSRPV----------------MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred ecCCce----------------EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 765554 89999999999999986543 3689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCC--CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMT--GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
++++++.++|+|||.+........... ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~ 217 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV 217 (266)
T ss_pred EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH
Confidence 999999999999999876542211111 1234568999999998889999999999999999998 9999998888888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 218 ~~~~~~~ 224 (266)
T cd05033 218 IKAVEDG 224 (266)
T ss_pred HHHHHcC
Confidence 7777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=259.23 Aligned_cols=212 Identities=27% Similarity=0.562 Sum_probs=172.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+|++.+.||+|+||.||+|.+ +++ .||+|+++.... ....+.+.+|+.+++.++||||+++++
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456899999999999999999965 344 489998853211 112345778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.... . +++++|+++|+|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+
T Consensus 77 ~~~~~~-~----------------~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~ 138 (316)
T cd05108 77 ICLTST-V----------------QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAAR 138 (316)
T ss_pred EEcCCC-c----------------eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 886542 1 78999999999999987543 45888999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCC--CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
||+++.++.++|+|||.+.......... .....+..|++||.+.+..++.++|+||||+++|+|++ |..||.+.+..
T Consensus 139 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 139 NVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred heEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999997654332221 12234568999999999899999999999999999997 99999988877
Q ss_pred HHHHHHH
Q 022794 279 EVTSAVV 285 (292)
Q Consensus 279 ~~~~~i~ 285 (292)
++...+.
T Consensus 219 ~~~~~~~ 225 (316)
T cd05108 219 EISSILE 225 (316)
T ss_pred HHHHHHh
Confidence 7654443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=251.05 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=169.3
Q ss_pred CceeEe-eeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 50 SKLVIK-SVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 50 ~~~~~~-~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
++|.+- .+||-|-.|.|..+ +.+|+++|+|++... .+..+|+++.-.. .|||||.++++|..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 455543 48999999999988 457999999998532 2256788887777 89999999999865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.-.. ..-+.+|||+++||.|.+.+.......+.+.++..|+.||..|++|||+++|.||||||+|+|+
T Consensus 127 s~~~------------rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLy 194 (400)
T KOG0604|consen 127 SYQG------------RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLY 194 (400)
T ss_pred hccC------------ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheee
Confidence 3221 1122689999999999999998888899999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 206 ~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
.. +..+||+|||+|.... ..........|+.|+|||++...+|+..+|+||+|+++|-|++|.+||..+...
T Consensus 195 t~t~~na~lKLtDfGFAK~t~-~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 195 TTTSPNAPLKLTDFGFAKETQ-EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred ecCCCCcceEecccccccccC-CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 64 4469999999997543 345556678899999999999999999999999999999999999999865543
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.00 Aligned_cols=214 Identities=23% Similarity=0.375 Sum_probs=171.5
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+....+|.+++.||+|+||.||+|.+ ++..|++|++....... .....+..|+.+++++.||||++++
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-------~~~~~~~~EI~IL~~L~HPNIVrl~ 78 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-------REKSQLVIEVNVMRELKHKNIVRYI 78 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-------HHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 44555668999999999999999999966 57789999986432211 1234577899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhC-------
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQ------- 191 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~------- 191 (292)
++|.....- .+||||||+++++|.+++... ....+++..++.|+.||+.||.|||..
T Consensus 79 d~f~de~~~--------------~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 79 DRFLNKANQ--------------KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred EEEEecCCC--------------EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 988654322 238999999999999998643 235699999999999999999999985
Q ss_pred CccccCCCCCCeeEcCC-----------------CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC--CCCCch
Q 022794 192 KIVHRDVKTENMLLDKN-----------------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRK 252 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~-----------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~ 252 (292)
+|+|+||||+||||+.+ +.++|+|||++...... .......+++.|+|||++.+ ..++.+
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~K 223 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDK 223 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCch
Confidence 49999999999999642 34899999998754332 22234568999999999864 357899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 253 CDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 253 ~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
+|||||||++|+|++|..||...+..
T Consensus 224 SDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 224 SDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred hHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 99999999999999999999765443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=254.04 Aligned_cols=219 Identities=31% Similarity=0.534 Sum_probs=179.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
|.+..++|++.+.||+|+||.||+|.+. +..|++|.+.... . ......+.+|+.+++.++|+||+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~----~~~~~~~~~e~~~l~~~~~~~i~ 72 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----S----MRERIEFLNEASVMKEFNCHHVV 72 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----C----HHHHHHHHHHHHHHHhCCCCcee
Confidence 4566789999999999999999998653 3679999974321 1 11133477899999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHH
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
++++++...... +++|||+++++|.+++.... ...+++..++.++.|++.||.|||
T Consensus 73 ~~~~~~~~~~~~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH 136 (277)
T cd05032 73 RLLGVVSTGQPT----------------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA 136 (277)
T ss_pred EEEEEEcCCCCc----------------EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999998766544 89999999999999986432 123678899999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
+.|++|+||+|+||+++.++.++|+|||.++....... ......++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 137 ~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 216 (277)
T cd05032 137 AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216 (277)
T ss_pred hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhc
Confidence 99999999999999999999999999999865432221 1122345678999999988889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHHh
Q 022794 268 -CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i~~~ 287 (292)
|..||...+..+....+..+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 217 LAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred cCCCCCccCCHHHHHHHHhcC
Confidence 99999998888887776643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=255.61 Aligned_cols=216 Identities=31% Similarity=0.503 Sum_probs=179.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
..+|.+.+.||+|++|.||+|.. +++.|++|.++.... ......+.+|+.+++.+.|+||+++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--------NDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--------HHHHHHHHHHHHHHHhcCCCCchheee
Confidence 46789999999999999999954 246899999864322 112345788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc------------ccccCHHHHHHHHHHHHHHHHHHH
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------RRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
++...... +++|||+++++|.+++.... ...+++..+..++.|++.+|.+||
T Consensus 76 ~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 139 (280)
T cd05049 76 VCTEGDPP----------------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA 139 (280)
T ss_pred EEecCCCe----------------EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 98776544 89999999999999996532 235788899999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
++|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 140 ~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~ 219 (280)
T cd05049 140 SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219 (280)
T ss_pred hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999999865322211 1122345678999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHHhh
Q 022794 268 -CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|..||...+..+....+.++.
T Consensus 220 ~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 220 YGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC
Confidence 999999888888888777653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.65 Aligned_cols=216 Identities=31% Similarity=0.529 Sum_probs=187.7
Q ss_pred cCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
.-..|.+.+.||+|.|+.|.+|. .++..||||.+.....+ .. .++.+.+|+++++.++||||++++.+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln------~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN------PS-KRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC------hH-HHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 34689999999999999999995 47999999988643322 11 13337899999999999999999999887
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
...+ |+||||+.+|.+++|+.++ ..+.+..+..++.|++.|++|||+++|+|||||.+|+|+
T Consensus 127 ~~~l----------------ylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL 188 (596)
T KOG0586|consen 127 EATL----------------YLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL 188 (596)
T ss_pred ccee----------------EEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc
Confidence 7766 8999999999999999764 447779999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.+.+++|+|||++.+.. .......++|++.|.|||++.+..+. +..|+||+|+++|.|++|.+||.+.+--++-..+
T Consensus 189 ~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv 267 (596)
T KOG0586|consen 189 DENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV 267 (596)
T ss_pred ccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh
Confidence 999999999999998776 44556668999999999999998764 7899999999999999999999998888877777
Q ss_pred HHhhh
Q 022794 285 VRQVQ 289 (292)
Q Consensus 285 ~~~~~ 289 (292)
++++.
T Consensus 268 l~gk~ 272 (596)
T KOG0586|consen 268 LRGKY 272 (596)
T ss_pred eeeee
Confidence 76643
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=249.95 Aligned_cols=216 Identities=29% Similarity=0.475 Sum_probs=174.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+.+|.+.+.||+|++|.||++.+ +|+.|++|.+.......... .....+.+|+.+++++.||||+++++++.+.
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS----KEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccH----HHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 36799999999999999999965 58899999886433222111 2234578899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .++++|||+++++|.+++... ..+++..++.++.|++.+|++||+.|++|+||+|.||+++
T Consensus 77 ~~~--------------~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~ 140 (265)
T cd06652 77 MER--------------TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD 140 (265)
T ss_pred CCc--------------eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec
Confidence 322 237999999999999998643 4578899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......+
T Consensus 141 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 220 (265)
T cd06652 141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220 (265)
T ss_pred CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence 99999999999886433211 112224578899999999888899999999999999999999999987665554444
Q ss_pred H
Q 022794 284 V 284 (292)
Q Consensus 284 i 284 (292)
+
T Consensus 221 ~ 221 (265)
T cd06652 221 I 221 (265)
T ss_pred H
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=252.50 Aligned_cols=210 Identities=29% Similarity=0.430 Sum_probs=172.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||+|.. +++.|++|.++....... ....+.+|+.++++++|||++++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG-------VPSTAIREISLLKELQHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCC-------chHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe
Confidence 588999999999999999965 588999999864332211 12336679999999999999999999876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
. +++|||++ ++|.+++.... ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 74 ~----------------~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~ 136 (285)
T cd07861 74 L----------------YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN 136 (285)
T ss_pred E----------------EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC
Confidence 4 89999996 68988886433 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+..............+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 137 KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred CCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999999987554333333345668899999988764 4688999999999999999999999877665544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=254.17 Aligned_cols=213 Identities=28% Similarity=0.502 Sum_probs=174.0
Q ss_pred CceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+|++.+.||+|+||.||+|.. .+..+++|.+..... ......+.+|+.+++++.||||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--------PQQWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--------HHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 6789999999999999999963 457899998853211 11123477899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---------------ccccCHHHHHHHHHHHHHHHHHH
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------------RRKLAFKVVVQLALDLARGLSYL 188 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~i~~qi~~al~~l 188 (292)
...+.. +++|||+++++|.+++.... ...+++..+..++.|++.||.||
T Consensus 77 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 77 TQEQPV----------------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred ecCCce----------------EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 766554 89999999999999985321 23478889999999999999999
Q ss_pred HhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 022794 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 189 H~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~ 266 (292)
|++|++|+||||+||++++++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 141 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 220 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220 (283)
T ss_pred HhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999999987543221 1122234566899999998888999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHH
Q 022794 267 C-CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 267 ~-g~~pf~~~~~~~~~~~i~~ 286 (292)
+ |.+||.+.+..++.+.+..
T Consensus 221 ~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 221 SFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHc
Confidence 8 9999988877766665543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.93 Aligned_cols=212 Identities=32% Similarity=0.605 Sum_probs=175.1
Q ss_pred CCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..+|++.+.||+|++|.||++.+. +..+++|++..... . ...+.+|+.+++++.|+||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---S-------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---C-------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 356889999999999999999764 55899998753221 1 123677999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 73 ~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 73 PI----------------FIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred ce----------------EEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 44 89999999999999986543 36899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCC-CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDM-TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.
T Consensus 136 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05059 136 DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215 (256)
T ss_pred CCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Confidence 9999999999887543322111 11223457999999998889999999999999999999 899999888888777765
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
.+
T Consensus 216 ~~ 217 (256)
T cd05059 216 AG 217 (256)
T ss_pred cC
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=254.95 Aligned_cols=216 Identities=31% Similarity=0.491 Sum_probs=178.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+|.+.+.||+|+||.||++.. ++..+++|.+.... ......+.+|+.+++++.|||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------DNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 457899999999999999999963 24568888875321 11234477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-----------ccccCHHHHHHHHHHHHHHHHHHH
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----------RRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
+++...+.. +++|||+++++|.+++.... ...+++..++.++.|++.||++||
T Consensus 74 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH 137 (288)
T cd05093 74 GVCVEGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA 137 (288)
T ss_pred EEEecCCcc----------------EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 998765544 89999999999999986432 134899999999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
++|++||||||+||++++++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 138 ~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 138 SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999999875432221 1122334678999999998889999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHHhh
Q 022794 268 -CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|.+||...+..+....+.++.
T Consensus 218 ~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 218 YGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred CCCCCCCCCCHHHHHHHHHcCC
Confidence 999999988888888877653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=255.77 Aligned_cols=221 Identities=33% Similarity=0.561 Sum_probs=181.3
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
..|++...+|.+.+.||+|+||.||+|.+ ++..|++|....... ....+.+.+|+.+++.+ +
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--------EKDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--------hHHHHHHHHHHHHHHhhcc
Confidence 45778889999999999999999999964 234699998753211 11134477899999999 8
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
||||+++++.+...... +++|||+++++|.+++.... ...++...+..++
T Consensus 80 h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (304)
T cd05101 80 HKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143 (304)
T ss_pred CCCchheeEEEecCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHH
Confidence 99999999988766544 89999999999999996532 2357788899999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.|++.||.|||++|++|+||||+||++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+|
T Consensus 144 ~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred HHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 99999999999999999999999999999999999999998755432221 1223355789999999888899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||+++|+|++ |..||.+.+..++...+..+
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 255 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 99999999998 89999999988888877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=256.18 Aligned_cols=216 Identities=27% Similarity=0.425 Sum_probs=179.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|++|.||+|.. +++.|++|.+....... ......+.+|+.+++++.|+||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK------RNKVKRVLTEQEILATLDHPFLPTLYASFQTET 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch------HHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence 3789999999999999999966 57999999986432211 122345788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+.+++|.+++.......+++..++.++.|++.+|.+||+.|++|+||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 75 YL----------------CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred EE----------------EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 44 89999999999999987655567999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-----------------------------CCCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN-----------------------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
++.++|+|||.+........ ......++..|+|||.+.+..++.++|+|||
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 99999999998754321110 1112357788999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 259 GICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 259 g~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+++|+|++|..||.+.+..+...++..+
T Consensus 219 G~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 247 (316)
T cd05574 219 GILLYEMLYGTTPFKGSNRDETFSNILKK 247 (316)
T ss_pred HHHHHHHhhCCCCCCCCchHHHHHHHhcC
Confidence 99999999999999988888777766643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=254.53 Aligned_cols=206 Identities=27% Similarity=0.468 Sum_probs=173.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|++.+.||+|++|.||+|.+ +++.|++|.+...... ....+.+|+.+++.+.|+|++++++.+..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~ 88 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLV 88 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 346899999999999999999965 6889999988643321 12336789999999999999999998876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+++++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||++
T Consensus 89 ~~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill 149 (296)
T cd06654 89 GDEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149 (296)
T ss_pred CCEE----------------EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 5544 899999999999998843 357899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+..
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~ 225 (296)
T cd06654 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (296)
T ss_pred cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH
Confidence 9999999999998865433322333456788999999999888999999999999999999999999877664443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=259.26 Aligned_cols=209 Identities=28% Similarity=0.410 Sum_probs=180.8
Q ss_pred ceecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
+.+..+.|...++||+||||.||-+ ..+|+.+|+|.+..... ....-.....+|..+|.+++.+.||.+--.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi------Kkr~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI------KKRKGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH------HHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 5667789999999999999999977 56899999998843211 111112335689999999999999998888
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
|...+.+ |+|+..+.||+|.-.|....+..+++..++.++.+|+.+|.+||+.+|++||+||+|
T Consensus 254 feTkd~L----------------ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 254 FETKDAL----------------CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred ecCCCce----------------EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 8777766 999999999999988877677789999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||+++.|++.|+|+|+|..+...... ....||.+|||||++.+..|+...|.|+|||++|+|+.|+.||....
T Consensus 318 ILLDd~GhvRISDLGLAvei~~g~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 318 ILLDDHGHVRISDLGLAVEIPEGKPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred eeeccCCCeEeeccceEEecCCCCcc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 99999999999999999877655443 34699999999999999999999999999999999999999997533
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=254.17 Aligned_cols=211 Identities=35% Similarity=0.634 Sum_probs=174.5
Q ss_pred eEeeeeccCcceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 53 VIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.+.+.||.|.||.||+|.+. +..|+||+++... ... ..+.+.+|++.+++++||||+++++++...
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~----~~~----~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~ 73 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS----SEE----EEEEFLNEIQILRKLRHPNIVKLYGFCIEN 73 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS----SHH----HHHHHHHHHHHHHTHSBTTBE-EEEEEESS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc----ccc----cceeeeeccccccccccccccccccccccc
Confidence 46789999999999999776 6789999995321 111 134578899999999999999999999865
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... ++++||+++|+|.+++.......+++..++.|+.|++.||.|||+++++|++|+++||+++
T Consensus 74 ~~~----------------~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 74 EPL----------------FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp SSE----------------EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred ccc----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 554 8999999999999999876456799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~ 283 (292)
.++.+||+|||.+....... ...........|+|||.+.+..++.++||||||++++++++ |+.||.+.+..++..+
T Consensus 138 ~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~ 217 (259)
T PF07714_consen 138 SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK 217 (259)
T ss_dssp TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999987652211 12233456779999999988889999999999999999999 7899999999999988
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.++
T Consensus 218 ~~~~ 221 (259)
T PF07714_consen 218 LKQG 221 (259)
T ss_dssp HHTT
T ss_pred cccc
Confidence 8655
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=252.25 Aligned_cols=209 Identities=27% Similarity=0.479 Sum_probs=176.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++.+.||.|++|.||+|.+ +|+.|++|.+...... ....+.+|+.+++.++|||++++++.+...
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---------KKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---------hHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 35799999999999999999964 6899999988643221 123467899999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. ++++||+++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 89 DEL----------------FVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred ceE----------------EEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 554 899999999999998853 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999988654433333334567889999999998889999999999999999999999998877665544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=250.24 Aligned_cols=212 Identities=26% Similarity=0.401 Sum_probs=175.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +|+.|++|++........ ..+.+.+|+.+++++.|+|++++++++...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV-------IKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCcc-------ccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 4799999999999999999976 588999998864332111 1233678999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||++++.|..++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 74 ~~----------------~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 74 KL----------------HLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred EE----------------EEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 54 899999998888776643 345899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+..+....+.+
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (286)
T cd07847 136 QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK 215 (286)
T ss_pred CCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999998765544323334557788999999876 4578899999999999999999999998887766655544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=256.34 Aligned_cols=221 Identities=32% Similarity=0.562 Sum_probs=179.6
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
..|++...+|.+.+.||+|++|.||+|.. ....+++|.++.... .. ....+.+|+.+++++ .
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~----~~----~~~~~~~E~~~l~~l~~ 76 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT----DK----DLADLISEMELMKLIGK 76 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC----hH----HHHHHHHHHHHHHhccC
Confidence 45677778999999999999999999864 245699998753221 11 123477899999999 6
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
||||+++++++...+.. +++|||+++++|.+++.... ...+++..+..++
T Consensus 77 h~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 77 HKNIINLLGVCTQEGPL----------------YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred CCCeeeEEEEEccCCce----------------EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 99999999988765544 89999999999999996532 2358889999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCC--CCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.|++.||.+||++|++|+||||+||+++.++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+|
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhh
Confidence 999999999999999999999999999999999999999987543221111 112234579999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||+++|+|++ |..||...+..++...+..+
T Consensus 221 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999999 89999998888887776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=248.39 Aligned_cols=214 Identities=27% Similarity=0.470 Sum_probs=180.8
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|++|.||++.. +|+.|++|.+....... .....+.+|+.++++++||||+++++++...+.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-------KEREESRKEVAVLSNMKHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-------HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe
Confidence 589999999999999999965 68899999986432211 112347789999999999999999999876554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.......+++..++.++.|++.+|.+||++|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 74 L----------------YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred E----------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 4 899999999999999876555568899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+.+.++..+
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08218 138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG 216 (256)
T ss_pred CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC
Confidence 9999999999876544332223345788899999999888999999999999999999999999988888887777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=247.89 Aligned_cols=205 Identities=31% Similarity=0.563 Sum_probs=169.0
Q ss_pred eeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccc
Q 022794 57 VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
.||+|+||.||+|.+ +++.+++|+++..... ....+.+.+|+.+++.+.||||+++++++... .
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~---- 69 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-------PALKDELLREANVMQQLDNPYIVRMIGICEAE-S---- 69 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C----
Confidence 589999999999854 4788999998643221 12345578899999999999999999876432 1
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
.+++|||+++++|.+++... ..+++..+..++.|++.||++||++|++|+||||.||+++.++.++
T Consensus 70 ------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~k 135 (257)
T cd05116 70 ------------WMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAK 135 (257)
T ss_pred ------------cEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEE
Confidence 27999999999999998543 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++.+.+.++
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~ 214 (257)
T cd05116 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214 (257)
T ss_pred ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 9999998755433221 112233578999999988889999999999999999998 99999988888887777654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=247.35 Aligned_cols=211 Identities=28% Similarity=0.446 Sum_probs=177.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||.|++|.||+|.+ +++.+++|++...... ....+.+|+.++++++|||++++++.+...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------DFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---------hHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 36899999999999999999965 5788999998643221 234577899999999999999999988766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 73 ~~~----------------~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 73 DKL----------------WIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred CEE----------------EEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 554 8999999999999988653 25689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
.++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~ 215 (262)
T cd06613 136 EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL 215 (262)
T ss_pred CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999887554333333345678889999999776 788999999999999999999999988776665544
Q ss_pred HH
Q 022794 284 VV 285 (292)
Q Consensus 284 i~ 285 (292)
+.
T Consensus 216 ~~ 217 (262)
T cd06613 216 IS 217 (262)
T ss_pred HH
Confidence 43
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=251.35 Aligned_cols=211 Identities=28% Similarity=0.462 Sum_probs=171.9
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|++|.||+|.+ +|+.|++|.++....... ....+.+|+.++++++|||++++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~-------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc-------CccchhHHHHHHHhcCCCCeeeHHHHhccCCc
Confidence 588999999999999999976 688999999864332211 11235679999999999999999999877655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||++ ++|.+++... ...+++..++.++.||++||.+||++|++|+||+|+||+++.+
T Consensus 74 ~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 74 L----------------TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred e----------------EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 4 89999996 5888887543 3468999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~p-f~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+..............++..|+|||.+.+.. ++.++|+||||+++|+|++|..| |.+.+..+.++.+.+
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 215 (284)
T cd07839 136 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215 (284)
T ss_pred CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH
Confidence 9999999999875443333333456788999999987754 68999999999999999998877 566666666655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=251.98 Aligned_cols=204 Identities=29% Similarity=0.433 Sum_probs=170.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++.+.||+|+||.||+|.+ +++.|++|++...... ....+.+|+.++++++||||+++++.+...
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---------~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---------DFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---------hHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 45799999999999999999975 6889999998643211 012367899999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++.. ...+++..+..++.|++.+|.+||+.|++|+||+|.||+++
T Consensus 79 ~~~----------------~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 79 EKL----------------WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred CEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 544 899999999999998854 34689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
.++.++|+|||.+..............++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+..+
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~ 216 (267)
T cd06646 141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216 (267)
T ss_pred CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh
Confidence 999999999999876543333333456788999999884 3457889999999999999999999997655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=254.07 Aligned_cols=217 Identities=29% Similarity=0.524 Sum_probs=177.3
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
.|.+...+|.+.+.||+|+||.||++.+ .+..||+|.++.... . .....+.+|+.+++++ +|+|
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~~ 100 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----S----SEREALMSELKIMSHLGNHEN 100 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----h----HHHHHHHHHHHHHHhccCCCC
Confidence 4666778999999999999999999864 245799998753221 1 1134578899999999 8999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
|+++++.+...+.. +++|||+.+++|.+++.......+++..+..++.|++.+|.|||+.+++|
T Consensus 101 iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH 164 (302)
T cd05055 101 IVNLLGACTIGGPI----------------LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164 (302)
T ss_pred cceEEEEEecCCce----------------EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence 99999988766544 89999999999999997654455899999999999999999999999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPY 272 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf 272 (292)
+||+|+||++++++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||
T Consensus 165 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~ 244 (302)
T cd05055 165 RDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244 (302)
T ss_pred hhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999865433221 1112345678999999998889999999999999999998 99999
Q ss_pred CCCCHHHHHHHH
Q 022794 273 PDLSFSEVTSAV 284 (292)
Q Consensus 273 ~~~~~~~~~~~i 284 (292)
......+...+.
T Consensus 245 ~~~~~~~~~~~~ 256 (302)
T cd05055 245 PGMPVDSKFYKL 256 (302)
T ss_pred CCCCchHHHHHH
Confidence 877765544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=252.21 Aligned_cols=215 Identities=32% Similarity=0.506 Sum_probs=177.1
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+|.+.+.||+|++|.||+|.+ ++..+++|.+.... ......+.+|+.++++++|+||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---------LAARKDFQREAELLTNLQHEHIVKFY 73 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---------HHHHHHHHHHHHHHhcCCCCCcceEE
Confidence 346799999999999999999964 24568888874221 11123477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHHHHHHHHHH
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLS 186 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~ 186 (292)
+++...+.. +++|||+++++|.+++.... ...+++..++.++.|++.||+
T Consensus 74 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 137 (291)
T cd05094 74 GVCGDGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 137 (291)
T ss_pred EEEccCCce----------------EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 998765544 89999999999999996532 234789999999999999999
Q ss_pred HHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHH
Q 022794 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264 (292)
Q Consensus 187 ~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~ 264 (292)
+||++|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 138 ~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 138 YLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred HHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999999999999865433221 1223445778999999999899999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 265 IYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 265 l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|++ |..||...+..++...+..+
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCC
Confidence 998 99999988888887776654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=260.94 Aligned_cols=220 Identities=32% Similarity=0.557 Sum_probs=178.0
Q ss_pred hhcccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC
Q 022794 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (292)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 112 (292)
.....|.+...+|.+.+.||+|+||.||+|++. ++.||+|+++..... ...+.+.+|+.++.++.
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~~E~~~l~~l~ 98 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--------SEKQALMSELKIMSHLG 98 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--------hHHHHHHHHHHHHHhcC
Confidence 344558888889999999999999999999754 357999999643211 11234778999999996
Q ss_pred -CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-------------------------
Q 022794 113 -HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR------------------------- 166 (292)
Q Consensus 113 -h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------- 166 (292)
||||+++++.+...... +++|||+++|+|.+++.++..
T Consensus 99 ~H~niv~~~~~~~~~~~~----------------~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (401)
T cd05107 99 PHLNIVNLLGACTKGGPI----------------YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS 162 (401)
T ss_pred CCCCeEEEEEEEccCCCc----------------EEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence 99999999998776554 899999999999999965321
Q ss_pred -----------------------------------------------------------------------cccCHHHHH
Q 022794 167 -----------------------------------------------------------------------RKLAFKVVV 175 (292)
Q Consensus 167 -----------------------------------------------------------------------~~~~~~~~~ 175 (292)
..+++..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 242 (401)
T cd05107 163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLV 242 (401)
T ss_pred ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHH
Confidence 235677788
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchh
Q 022794 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKC 253 (292)
Q Consensus 176 ~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 253 (292)
.++.|++.||.|||+.+++|+||||+||++++++.++|+|||.+........ ......++..|+|||.+.+..++.++
T Consensus 243 ~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred HHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 9999999999999999999999999999999999999999999875432211 11223457789999999988899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022794 254 DVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (292)
Q Consensus 254 Diwslg~il~~l~~-g~~pf~~~~~~~~~~~ 283 (292)
|+||||+++|+|++ |..||......+....
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 99999999999998 8999987665554433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=249.92 Aligned_cols=214 Identities=31% Similarity=0.556 Sum_probs=175.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--C---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--D---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~---~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
..+|++.+.||+|+||.||+|.+ + +..+++|.++.... . .....+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT----E----KQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC----H----HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 46899999999999999999965 2 33689998753221 1 1234578899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++... ...+++..++.++.|++.+|++||+.|++|+||+|+||
T Consensus 75 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 75 TKSKPV----------------MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred ecCCcc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 765544 8999999999999999654 34689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCC---CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
+++.++.++|+|||.+.......... .....+..|++||.+.+..++.++|+||||+++|++++ |..||...+..+
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~ 217 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence 99999999999999987544322211 11223467999999998889999999999999999886 999999888888
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
....+.++
T Consensus 218 ~~~~~~~~ 225 (267)
T cd05066 218 VIKAIEEG 225 (267)
T ss_pred HHHHHhCC
Confidence 77776654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=248.24 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=171.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.. +++.|++|.++...... ......+.+|+.+++.++|||++++++.+...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD------AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC------HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence 5799999999999999999965 68999999875322111 122344778999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. ++++||+++++|.+++... ....+++..++.++.|++.||.+||++|++|+||+|+||++
T Consensus 76 ~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 76 EL----------------NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eE----------------EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 54 8999999999999988542 23458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 9999999999998876544333333356788999999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=252.15 Aligned_cols=213 Identities=34% Similarity=0.557 Sum_probs=172.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~--~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
++|++.+.||+|+||.||+|.. ++. .+++|.++.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 73 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS--------ENDHRDFAGELEVLCKLGHHPNIINLLGACE 73 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC--------HHHHHHHHHHHHHHHhhcCCCchhheEEEEc
Confidence 5799999999999999999965 333 468887752211 11134477899999999 7999999999887
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHHHHHHHHHHHHHh
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHS 190 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~ 190 (292)
..+.. ++++||+++++|.+++.... ...+++..++.++.|++.||++||+
T Consensus 74 ~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 74 NRGYL----------------YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred cCCcc----------------eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 65544 89999999999999996532 1347889999999999999999999
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CD 269 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~ 269 (292)
+|++|+||||+||++++++.++|+|||++....... .......+..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 138 ~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 138 KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred CCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999885322111 1111223457999999988889999999999999999997 99
Q ss_pred CCCCCCCHHHHHHHHHHh
Q 022794 270 MPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 270 ~pf~~~~~~~~~~~i~~~ 287 (292)
.||...+..++..++.++
T Consensus 217 ~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 217 TPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CCCCCCCHHHHHHHHhcC
Confidence 999999988888877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=258.23 Aligned_cols=212 Identities=33% Similarity=0.586 Sum_probs=170.2
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
.|.+..++|++.+.||+|+||.||+|.+ +++.||||+++.... . .....+.+|+.++.++ +|||
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~n 72 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIHIGHHLN 72 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC----h----HHHHHHHHHHHHHHhccCCcc
Confidence 3677788999999999999999999963 467899999863321 1 1123477899999999 7899
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc------------------------------
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------------------------ 165 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------ 165 (292)
|+++++++...+. ..+++|||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~~~---------------~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (343)
T cd05103 73 VVNLLGACTKPGG---------------PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRR 137 (343)
T ss_pred HhhhcceeecCCC---------------ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhh
Confidence 9999998754432 2279999999999999986431
Q ss_pred -----------------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 166 -----------------------------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 166 -----------------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
...+++..+..++.|++.||+|||++|++||||||.||+++.++.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~ 217 (343)
T cd05103 138 LDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV 217 (343)
T ss_pred ccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc
Confidence 123677888999999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 211 VKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 218 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 99999999875432211 1112234567999999988889999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.13 Aligned_cols=215 Identities=26% Similarity=0.452 Sum_probs=177.6
Q ss_pred CCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
..+|.+.+.||+|+||.||+|.+. ++.||+|+++.... ......+.+|+.+++++.||||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--------GPLREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--------HHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 356888999999999999999652 46899999864321 123455788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--------------cccccCHHHHHHHHHHHHHHHHH
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------RRRKLAFKVVVQLALDLARGLSY 187 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~ 187 (292)
.+...... ++++||+.+++|.+++... ....+++..++.++.|++.||.+
T Consensus 76 ~~~~~~~~----------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~ 139 (283)
T cd05091 76 VVTKEQPL----------------SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEF 139 (283)
T ss_pred EEcCCCce----------------EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 98776654 8899999999999998421 12357888899999999999999
Q ss_pred HHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHH
Q 022794 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 188 lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l 265 (292)
||++|++||||||+||++++++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 140 lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 219 (283)
T cd05091 140 LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219 (283)
T ss_pred HHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHH
Confidence 9999999999999999999999999999998765432211 11223456789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHh
Q 022794 266 YC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 266 ~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
++ |..||.+.+..++...+.++
T Consensus 220 ~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05091 220 FSYGLQPYCGYSNQDVIEMIRNR 242 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcC
Confidence 98 89999999998888887765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=249.39 Aligned_cols=213 Identities=27% Similarity=0.544 Sum_probs=173.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+|++.+.||+|+||+||+|.+ +|+ .||+|+++.... ......+.+|+.+++.+.|+||+++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--------PKANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--------HHHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 457899999999999999999965 444 489998853221 112344778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.... .+++++|+++|+|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 77 ~~~~~~-----------------~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 77 ICLTST-----------------VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred EEcCCC-----------------cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 876432 17899999999999998653 346899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
||++++++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus 139 Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred eEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999998765432221 112334568999999998889999999999999999998 99999987777
Q ss_pred HHHHHHHH
Q 022794 279 EVTSAVVR 286 (292)
Q Consensus 279 ~~~~~i~~ 286 (292)
++...+..
T Consensus 219 ~~~~~~~~ 226 (279)
T cd05109 219 EIPDLLEK 226 (279)
T ss_pred HHHHHHHC
Confidence 66655443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=284.54 Aligned_cols=222 Identities=29% Similarity=0.426 Sum_probs=189.8
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
....+..++|.++++||+|+||.|.+++. +++.||+|+++.- +.-...-...|+.|-.++...+.+=|++++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~------eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh 141 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKW------EMLKRAETACFREERDIMVFGNSEWIVQLH 141 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHH------HHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence 34456678999999999999999999955 6889999998521 001112234588899999988999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
-.|.+.+.+ |+||||++||+|-..+.+.. .+++..++.++..|+.||..||+.|+|||||||
T Consensus 142 yAFQD~~~L----------------YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKP 203 (1317)
T KOG0612|consen 142 YAFQDERYL----------------YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKP 203 (1317)
T ss_pred HHhcCccce----------------EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCc
Confidence 988887766 99999999999999986543 799999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceecc-CCCCCCCCCCCcccccCCcccC----C-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEA-SNPNDMTGETGTLGYMAPEVLN----G-NPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+|||++..|+++|.|||.+-.+. ++.-.....+|||.|.|||++. + +.|++.+|.||+|+++|||+.|.-||..
T Consensus 204 DNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 204 DNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred ceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99999999999999999876555 3334455678999999999984 3 5689999999999999999999999999
Q ss_pred CCHHHHHHHHHHhh
Q 022794 275 LSFSEVTSAVVRQV 288 (292)
Q Consensus 275 ~~~~~~~~~i~~~~ 288 (292)
-+--+.+.+|++..
T Consensus 284 dslveTY~KIm~hk 297 (1317)
T KOG0612|consen 284 DSLVETYGKIMNHK 297 (1317)
T ss_pred HHHHHHHHHHhchh
Confidence 99999999998864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=251.25 Aligned_cols=211 Identities=30% Similarity=0.472 Sum_probs=178.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||.|++|.||+|.+ +++.|++|.+...... .....+.+|+.+++.+.|+|++++++.+.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--------DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--------hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence 3688899999999999999965 6889999998643211 11234678999999999999999999887654
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+++++|.+++... .+++..++.++.|++.+|.+||+.+++|+||+|+||++++
T Consensus 73 ~~----------------~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 73 KL----------------WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred eE----------------EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 43 8999999999999998543 6899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+.
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 213 (274)
T cd06609 134 EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213 (274)
T ss_pred CCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc
Confidence 99999999999977654433444456788899999999888999999999999999999999999887776666555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=253.72 Aligned_cols=213 Identities=29% Similarity=0.474 Sum_probs=175.6
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..+.|++++.||+|++|.||+|.+ +++.+++|.+.... . .....+.+|+.+++.++|+|++++++.+..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----E----EELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-----H----HHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 346799999999999999999965 57899999985321 1 123447789999999999999999998876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+++++|..++.+. ...+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 81 ~~~~----------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 81 DGKL----------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred CCeE----------------EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 5543 8999999999998877543 3468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+.
T Consensus 144 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 223 (292)
T cd06644 144 TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223 (292)
T ss_pred cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH
Confidence 99999999999988654433333344567889999999853 3467899999999999999999999988777666
Q ss_pred HHHHHH
Q 022794 281 TSAVVR 286 (292)
Q Consensus 281 ~~~i~~ 286 (292)
+.++.+
T Consensus 224 ~~~~~~ 229 (292)
T cd06644 224 LLKIAK 229 (292)
T ss_pred HHHHhc
Confidence 655543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=252.09 Aligned_cols=205 Identities=28% Similarity=0.440 Sum_probs=171.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|++|.||+|.+ +++.|++|+++..... . ...+.+|+.+++.++||||+++++.+...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~----~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-----D----FAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-----H----HHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 5789999999999999999965 6889999998643211 1 123667999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 80 ~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~ 141 (267)
T cd06645 80 KL----------------WICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred EE----------------EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 54 8999999999999988543 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
++.++|+|||.+..............++..|+|||.+. ...++.++|+||||+++|+|++|..||.........
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~ 218 (267)
T cd06645 142 NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred CCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence 99999999999876544333334456889999999974 455788999999999999999999999765544433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=249.56 Aligned_cols=213 Identities=27% Similarity=0.496 Sum_probs=170.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+|++.+.||+|+||.||+|.+ +++ .+++|...... . ......+..|+..++++.||||+++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~----~----~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS----G----RQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc----c----hHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 346899999999999999999976 454 46777663211 1 112234677888899999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.... .++++||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|+||||+
T Consensus 77 ~~~~~~-----------------~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 77 ICPGAS-----------------LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred EECCCc-----------------cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 864322 27899999999999998653 346899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
||++++++.++|+|||.++....... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+....
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999976432221 1222345678999999988889999999999999999998 99999988777
Q ss_pred HHHHHHHH
Q 022794 279 EVTSAVVR 286 (292)
Q Consensus 279 ~~~~~i~~ 286 (292)
++.+.+.+
T Consensus 219 ~~~~~~~~ 226 (279)
T cd05111 219 EVPDLLEK 226 (279)
T ss_pred HHHHHHHC
Confidence 66555443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.47 Aligned_cols=216 Identities=29% Similarity=0.479 Sum_probs=175.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|.+.+.||+|++|.||+|.+ +++.|++|.+......... ......+.+|+.++++++|+||+++++.+.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET----SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh----hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 5799999999999999999965 6889999987543221111 122345788999999999999999999876543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. .+++++||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 78 ~~--------------~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~ 141 (264)
T cd06653 78 EK--------------KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS 141 (264)
T ss_pred CC--------------EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC
Confidence 22 237899999999999998543 35889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+....+...++
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 221 (264)
T cd06653 142 AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI 221 (264)
T ss_pred CCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence 9999999999987543211 1112345788999999999888999999999999999999999999887666655554
Q ss_pred H
Q 022794 285 V 285 (292)
Q Consensus 285 ~ 285 (292)
.
T Consensus 222 ~ 222 (264)
T cd06653 222 A 222 (264)
T ss_pred H
Confidence 4
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=253.78 Aligned_cols=212 Identities=30% Similarity=0.475 Sum_probs=177.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||.|++|.||++.+ ++..+++|+..... . .....+.+|+.++++++|||++++++.+....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-----E----EELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-----H----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 5799999999999999999966 58899999985321 1 11234778999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.+. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~ 138 (280)
T cd06611 76 KL----------------WILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138 (280)
T ss_pred eE----------------EEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence 44 8999999999999988653 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++.++|+|||.+..............++..|+|||.+. ...++.++|+||||+++|+|++|..||...+..+...
T Consensus 139 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~ 218 (280)
T cd06611 139 DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL 218 (280)
T ss_pred CCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH
Confidence 99999999998765443333334456788999999975 3346789999999999999999999999888777666
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
++.++
T Consensus 219 ~~~~~ 223 (280)
T cd06611 219 KILKS 223 (280)
T ss_pred HHhcC
Confidence 66543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=253.10 Aligned_cols=221 Identities=32% Similarity=0.540 Sum_probs=181.3
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCC
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 114 (292)
..+.+..++|++.+.||+|++|.||++... ...+++|.+..... . .....+.+|+.+++++ +|+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~ 76 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----E----KDLSDLVSEMEMMKMIGKHK 76 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC----H----HHHHHHHHHHHHHHhhcCCC
Confidence 457777889999999999999999999653 35799998853221 1 1123477899999999 899
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--------------cccccCHHHHHHHHHH
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------RRRKLAFKVVVQLALD 180 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~i~~q 180 (292)
||+++++++...+.. +++|||+++++|.+++... ....+++..++.++.|
T Consensus 77 ~i~~~~~~~~~~~~~----------------~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 140 (293)
T cd05053 77 NIINLLGVCTQEGPL----------------YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140 (293)
T ss_pred CeeeEEEEEcCCCCe----------------EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence 999999988766554 8999999999999998642 2356889999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
++.||.|||+.|++|+||+|+||++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+|||
T Consensus 141 i~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 141 VARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred HHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 999999999999999999999999999999999999998754332111 112234567999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 259 GICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 259 g~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+++|++++ |..||...+..++...+..+
T Consensus 221 G~il~el~~~g~~p~~~~~~~~~~~~~~~~ 250 (293)
T cd05053 221 GVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250 (293)
T ss_pred hhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999997 99999998888887776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=254.30 Aligned_cols=219 Identities=27% Similarity=0.408 Sum_probs=187.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 122 (292)
.+...+|.++.+||+|+||.|.+|... .+.+|||+++.+-....+..+ --+.|-++|... +-|.+++++.+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDve------ctm~EKrvLAL~~kppFL~qlHSc 418 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVE------CTMVEKRVLALPGKPPFLVQLHSC 418 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCccc------ceehhhhheecCCCCchHHHHHHH
Confidence 345578999999999999999999654 567999998754322222211 134577888777 56789999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
|...+.+ |+||||+.||+|--.++. -..+.++.+..++.+|+-+|-+||++||++||||.+|
T Consensus 419 FQTmDRL----------------yFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDN 480 (683)
T KOG0696|consen 419 FQTMDRL----------------YFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 480 (683)
T ss_pred hhhhhhe----------------eeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccc
Confidence 9988887 899999999999988854 3568899999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
|+++.+|++||.|||++..............||+.|+|||.+..++|+.+.|-||+|++||||+.|++||.+.+.+++.+
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~ 560 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 560 (683)
T ss_pred eEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999999999765555555566889999999999999999999999999999999999999999999999999
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.|...+
T Consensus 561 aI~ehn 566 (683)
T KOG0696|consen 561 AIMEHN 566 (683)
T ss_pred HHHHcc
Confidence 998764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=251.15 Aligned_cols=215 Identities=29% Similarity=0.483 Sum_probs=176.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+|++.+.||+|+||.||++.. ++..+++|.+.... ......+.+|+++++.+.|+||++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------ESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 346788999999999999999853 35678888874221 11233578899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-------------cccCHHHHHHHHHHHHHHHHH
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-------------RKLAFKVVVQLALDLARGLSY 187 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~ 187 (292)
+++...... +++|||+++++|.+++..... ..+++..++.++.|++.||+|
T Consensus 74 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 137 (280)
T cd05092 74 GVCTEGRPL----------------LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVY 137 (280)
T ss_pred EEEecCCce----------------EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHH
Confidence 988766544 899999999999999865321 347889999999999999999
Q ss_pred HHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHH
Q 022794 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 188 lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l 265 (292)
||+.|++|+||+|+||++++++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 138 LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 138 LASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred HHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999999999865432211 11223346789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHHHh
Q 022794 266 YC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 266 ~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
++ |.+||...+..+....+.++
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred HcCCCCCCccCCHHHHHHHHHcC
Confidence 98 99999988888877777665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=256.60 Aligned_cols=221 Identities=33% Similarity=0.559 Sum_probs=180.9
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
++|++...+|++++.||+|+||.||+|.+. +..|++|+++.... . .....+.+|+.+++++ +
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~----~~~~~~~~E~~~l~~l~~ 76 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT----D----KDLSDLVSEMEMMKMIGK 76 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC----H----HHHHHHHHHHHHHHhhcC
Confidence 568888889999999999999999999642 23689998753211 1 1134477899999999 8
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
||||+++++.+...+.. ++++||+++++|.+++.... ...++...+..++
T Consensus 77 h~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (334)
T cd05100 77 HKNIINLLGACTQDGPL----------------YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140 (334)
T ss_pred CCCeeeeeEEEccCCce----------------EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHH
Confidence 99999999998766544 89999999999999986532 2347788899999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.|++.||.+||.+|++|+||+|+||++++++.++|+|||.++........ .....++..|+|||.+.+..++.++|+|
T Consensus 141 ~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 220 (334)
T cd05100 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220 (334)
T ss_pred HHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhH
Confidence 99999999999999999999999999999999999999998754332211 1122334679999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||+++|+|++ |..||.+.+..++...+.++
T Consensus 221 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 252 (334)
T cd05100 221 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252 (334)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999998 89999999888888777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=245.84 Aligned_cols=208 Identities=38% Similarity=0.650 Sum_probs=176.3
Q ss_pred eeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 56 SVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
+.||+|+||.||+|.+. +..|++|.++...... ..+.+.+|+.+++.++|+|++++++++......
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~- 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--------ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPL- 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--------HHHHHHHHHHHHhhcCCCChheeeeeecCCCce-
Confidence 46899999999999664 7899999986433211 234578899999999999999999998775444
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhc-------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
+++|||+++++|.+++.... ...+++..++.++.|++.||.+||++|++|+||+|+||
T Consensus 72 ---------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni 136 (262)
T cd00192 72 ---------------YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136 (262)
T ss_pred ---------------EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence 89999999999999986532 36789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..++
T Consensus 137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999987654332 22233456789999999998889999999999999999999 6999999999888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 217 ~~~~~~~ 223 (262)
T cd00192 217 LEYLRKG 223 (262)
T ss_pred HHHHHcC
Confidence 8887754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=245.30 Aligned_cols=206 Identities=33% Similarity=0.567 Sum_probs=167.7
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|+||.||+|.+ +++.|++|...... . ......+.+|+++++++.||||+++++++......
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~----~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 68 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL----P----PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI---- 68 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC----C----HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe----
Confidence 3689999999999965 68899999874221 1 11234577899999999999999999998766544
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|.||+++.++.++|
T Consensus 69 ------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl 135 (252)
T cd05084 69 ------------YIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKI 135 (252)
T ss_pred ------------EEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEE
Confidence 8999999999999998643 345889999999999999999999999999999999999999999999
Q ss_pred eecCcceeccCCCCCC--CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022794 214 ADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 214 ~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~ 286 (292)
+|||.+.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.+
T Consensus 136 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~ 211 (252)
T cd05084 136 SDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211 (252)
T ss_pred CccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 9999986433221111 11123457999999998889999999999999999998 9999988887766665544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.74 Aligned_cols=191 Identities=28% Similarity=0.429 Sum_probs=161.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
...|.+.+.||+|+||.||+|.+ .++.||||.... ..+.+|++++++++|+||+++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 45799999999999999999976 478899996421 1245799999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|+++ .++|.+++... ...+++..++.++.|++.+|.|||++||+||||||+|||++
T Consensus 233 ~~~----------------~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~ 294 (461)
T PHA03211 233 GLT----------------CLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294 (461)
T ss_pred CEE----------------EEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC
Confidence 544 8999999 56898888643 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 207 KNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
.++.++|+|||+++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..|+
T Consensus 295 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 295 GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 999999999999876433211 122346899999999999999999999999999999999987654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=253.70 Aligned_cols=201 Identities=28% Similarity=0.486 Sum_probs=171.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++++.||+|++|.||++.+ +++.|++|.+...... ....+.+|+.+++.++|+|++++++.+...
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---------KKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---------hHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 36899999999999999999965 6899999988643221 123367899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~ 149 (297)
T cd06656 89 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149 (297)
T ss_pred CEE----------------EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 554 899999999999999853 4588899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+.
T Consensus 150 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999887544333333345678899999999988899999999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.64 Aligned_cols=212 Identities=28% Similarity=0.468 Sum_probs=175.2
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++++.||.|++|.||+|.+ +|+.|+||.++....... ....+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-------VPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc-------cchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 488999999999999999966 688999998864332211 12347789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+. ++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 74 L----------------YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred E----------------EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 4 89999995 689999876656678999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+..............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+...++.+
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 137 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred CCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999875543333333445678899999987654 58899999999999999999999988776665555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=256.37 Aligned_cols=209 Identities=22% Similarity=0.370 Sum_probs=168.1
Q ss_pred EeeeeccC--cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 54 IKSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 54 ~~~~lg~G--~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
++++||+| ++++||++.. +|+.||+|.++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-------NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEE
Confidence 56789999 6789999954 6899999998533211 12234577899999999999999999998876654
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 75 ----------------~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~ 138 (327)
T cd08227 75 ----------------WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138 (327)
T ss_pred ----------------EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC
Confidence 8999999999999999765555689999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 210 TVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.+++.||+.......... ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||......+.
T Consensus 139 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 999999986533221111 0111345678999999976 4588999999999999999999999988776665
Q ss_pred HHHHH
Q 022794 281 TSAVV 285 (292)
Q Consensus 281 ~~~i~ 285 (292)
.....
T Consensus 219 ~~~~~ 223 (327)
T cd08227 219 LLEKL 223 (327)
T ss_pred HHHHh
Confidence 54443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=249.38 Aligned_cols=215 Identities=33% Similarity=0.529 Sum_probs=173.2
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
..++|.+.+.||+|++|.||+|.+. +..|++|....... . .....+.+|+.+++.++|+||++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~---~-----~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS---E-----QDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC---H-----HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3467999999999999999999663 46788887743221 1 1123477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
+++.+.... +++|||+++++|.+++..... ..+++..+..++.||+.+|++||+++++|
T Consensus 76 ~~~~~~~~~----------------~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 139 (277)
T cd05036 76 GVSFERLPR----------------FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIH 139 (277)
T ss_pred EEEccCCCc----------------EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 988766544 899999999999999865432 25889999999999999999999999999
Q ss_pred cCCCCCCeeEcCCC---cEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CC
Q 022794 196 RDVKTENMLLDKNR---TVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CD 269 (292)
Q Consensus 196 ~di~p~Nili~~~~---~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~ 269 (292)
+||+|+||+++.++ .++|+|||.+........ .......+..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~ 219 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999997654 589999999875432211 1112233568999999988889999999999999999997 99
Q ss_pred CCCCCCCHHHHHHHHHH
Q 022794 270 MPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 270 ~pf~~~~~~~~~~~i~~ 286 (292)
.||.+.+..++...+..
T Consensus 220 ~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 220 MPYPGRTNQEVMEFVTG 236 (277)
T ss_pred CCCCCCCHHHHHHHHHc
Confidence 99999888887766543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=252.65 Aligned_cols=214 Identities=32% Similarity=0.535 Sum_probs=171.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCce--eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceece
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~--valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 122 (292)
.-.+|++.+.||+|+||.||+|.+ ++.. +++|.++... . ......+.+|+.++.++ +|+||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~----~----~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----S----KDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC----C----HHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 346899999999999999999965 4544 4666654211 1 11234577899999999 89999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHHHHHHHHHHHH
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYL 188 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~l 188 (292)
+...+.. +++|||+++++|.+++.+.. ...+++..++.++.|++.||++|
T Consensus 77 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 77 CEHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred ECCCCCc----------------eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 8766554 89999999999999996532 13578999999999999999999
Q ss_pred HhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-
Q 022794 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267 (292)
Q Consensus 189 H~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~- 267 (292)
|++|++||||||+||+++.++.++|+|||++....... .......+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 141 H~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 219 (303)
T cd05088 141 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219 (303)
T ss_pred HhCCccccccchheEEecCCCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhc
Confidence 99999999999999999999999999999885322111 1111233567999999988889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHH
Q 022794 268 CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 268 g~~pf~~~~~~~~~~~i~~ 286 (292)
|..||...+..+....+..
T Consensus 220 g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 220 GGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CCCCcccCChHHHHHHHhc
Confidence 9999998888887776644
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=250.21 Aligned_cols=214 Identities=24% Similarity=0.358 Sum_probs=177.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|++|.||++.+ +++.|++|.+.... .........+.+|+++++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN------LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh------hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence 3689999999999999999965 57889999885321 111223345778999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ..+++..+..++.|++.+|.+||++|++|+||+|.||+++.
T Consensus 75 ~~----------------~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~ 136 (305)
T cd05609 75 HL----------------CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS 136 (305)
T ss_pred EE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC
Confidence 44 8999999999999999543 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC---------------CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 208 NRTVKIADFGVARVEASNP---------------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf 216 (305)
T cd05609 137 MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 216 (305)
T ss_pred CCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999875311100 0111234677899999998888999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHh
Q 022794 273 PDLSFSEVTSAVVRQ 287 (292)
Q Consensus 273 ~~~~~~~~~~~i~~~ 287 (292)
.+.+..++...+..+
T Consensus 217 ~~~~~~~~~~~~~~~ 231 (305)
T cd05609 217 FGDTPEELFGQVISD 231 (305)
T ss_pred CCCCHHHHHHHHHhc
Confidence 998888888877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=255.27 Aligned_cols=196 Identities=27% Similarity=0.414 Sum_probs=157.0
Q ss_pred eeeeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 55 KSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
.++||+|+||.||+|.+ +++.||+|.+..... ...+.+|+.++++++||||+++++.+......
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 73 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------SMSACREIALLRELKHPNVISLQKVFLSHADR- 73 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCc-
Confidence 35799999999999974 457899998853221 11256799999999999999999988654332
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhc-------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
..++++||+ +++|.+++.... ...+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 74 -------------~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Ni 139 (317)
T cd07868 74 -------------KVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 139 (317)
T ss_pred -------------EEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence 238999999 568888875321 23588999999999999999999999999999999999
Q ss_pred eE----cCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 204 LL----DKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 204 li----~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|+ +..+.++|+|||.+........ ......+++.|+|||++.+. .++.++|+||+||++|+|++|++||...
T Consensus 140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 140 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99 4557899999999976543221 22335678999999999774 5889999999999999999999999754
Q ss_pred C
Q 022794 276 S 276 (292)
Q Consensus 276 ~ 276 (292)
.
T Consensus 220 ~ 220 (317)
T cd07868 220 Q 220 (317)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=245.11 Aligned_cols=204 Identities=29% Similarity=0.495 Sum_probs=172.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.. +|+.|++|.++...... ......+.+|+.++++++|++++++++.+...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~ 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD------AKARQDCLKEIDLLKQLDHPNVIKYLASFIENN 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc------hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 5799999999999999999966 58999999886422211 112345778999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. +++|||+++++|.+++... ....+++..++.++.+++.+|.+||+.|++|+||+|+||++
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~ 139 (267)
T cd08224 76 EL----------------NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI 139 (267)
T ss_pred eE----------------EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE
Confidence 44 8999999999999998643 23558999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 140 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 9999999999999876544333333456788999999999888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=245.25 Aligned_cols=216 Identities=30% Similarity=0.557 Sum_probs=175.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECC-----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDG-----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
++...+|.+.+.||+|++|.||+|.+.+ ..|++|....... ....+.+.+|+.+++++.|||+++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~ 73 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--------PSVREKFLQEAYIMRQFDHPHIVKLI 73 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCchhcee
Confidence 3456789999999999999999996532 3688898753321 12234578899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.. . +++|||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|
T Consensus 74 ~~~~~~~-~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p 135 (270)
T cd05056 74 GVITENP-V----------------WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAA 135 (270)
T ss_pred EEEcCCC-c----------------EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCh
Confidence 9876432 2 79999999999999996533 3589999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..
T Consensus 136 ~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~ 215 (270)
T cd05056 136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215 (270)
T ss_pred heEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 9999999999999999998754433211 112234468999999988889999999999999999986 99999988888
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
+....+.++
T Consensus 216 ~~~~~~~~~ 224 (270)
T cd05056 216 DVIGRIENG 224 (270)
T ss_pred HHHHHHHcC
Confidence 777766554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=250.84 Aligned_cols=213 Identities=31% Similarity=0.527 Sum_probs=172.8
Q ss_pred ceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 51 KLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
+|++.+.||+|+||.||+|... ...+++|.+..... ..+ ...+.+|+.+++.+.||||+++++.+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS----SSE----LRDLLSEFNLLKQVNHPHVIKLYGAC 72 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC----HHH----HHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 4788999999999999999653 25688888753221 111 24477899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----------------------ccccCHHHHHHHHHHH
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------------RRKLAFKVVVQLALDL 181 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi 181 (292)
...+.. ++++||+.+++|.+++.... ...+++..++.++.|+
T Consensus 73 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 73 SQDGPL----------------LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred ecCCCc----------------EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 765544 89999999999999986421 1357889999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHH
Q 022794 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (292)
Q Consensus 182 ~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg 259 (292)
+.+|.+||+.|++|+||+|+||++++++.++|+|||.++....... ......++..|+|||.+.+..++.++|+||||
T Consensus 137 ~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 216 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216 (290)
T ss_pred HHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence 9999999999999999999999999999999999999865432211 11223456789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 260 ICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 260 ~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
+++++|++ |..||.+....++.+.+.++
T Consensus 217 ~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 245 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIAPERLFNLLKTG 245 (290)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 99999998 99999998888877666543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=248.73 Aligned_cols=215 Identities=27% Similarity=0.421 Sum_probs=174.5
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
.+.|.+.+.||+|+||.||+|.+ +++.||+|.+...... ...+.+|+.+++++ +|+|++++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIATYYGAFIK 74 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----------HHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence 46788999999999999999965 6789999998643211 12366789999998 79999999998865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
..... .....+++|||+++++|.+++.......+++..+..++.|++.+|+|||+++++|+||+|+||++
T Consensus 75 ~~~~~----------~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili 144 (272)
T cd06637 75 KNPPG----------MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL 144 (272)
T ss_pred cCCCC----------CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE
Confidence 43210 12345899999999999999876555678999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
++++.++|+|||.+..............++..|+|||++.+ ..++.++|+||+|+++|+|++|..||........
T Consensus 145 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~ 224 (272)
T cd06637 145 TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224 (272)
T ss_pred CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 99999999999998755433333344568889999999863 3578899999999999999999999987665544
Q ss_pred HHH
Q 022794 281 TSA 283 (292)
Q Consensus 281 ~~~ 283 (292)
...
T Consensus 225 ~~~ 227 (272)
T cd06637 225 LFL 227 (272)
T ss_pred HHH
Confidence 443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=249.01 Aligned_cols=205 Identities=30% Similarity=0.477 Sum_probs=172.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|++|.||+|.+ +++.++||.+..... ........+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL------MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh------hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence 4688999999999999999964 789999998753221 11122345788999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. +++|||+++++|.+++... ....+++..++.++.|++.+|.+||++|++|+||+|+||++
T Consensus 76 ~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 76 EL----------------NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred eE----------------EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 54 8999999999999988642 23468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 99999999999988765443333334567889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=246.17 Aligned_cols=216 Identities=27% Similarity=0.487 Sum_probs=180.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||+|.+ +++.|++|++...... ....+.+.+|+.++++++|+|++++++.+.....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 588999999999999999965 6789999988643221 1113457789999999999999999987765432
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLH-----SQKIVHRDVKTE 201 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH-----~~~i~h~di~p~ 201 (292)
. ..++++||+++++|.+++... ....+++..++.++.|++.+|.+|| ..+++|+||+|+
T Consensus 74 ~--------------~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 74 Q--------------TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred C--------------EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 2 238999999999999998653 2456899999999999999999999 889999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
||++++++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++++|++|..||...+..++.
T Consensus 140 nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 219 (265)
T cd08217 140 NIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA 219 (265)
T ss_pred HEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH
Confidence 99999999999999999876654443234456888999999999888999999999999999999999999988877777
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
+.+.++
T Consensus 220 ~~~~~~ 225 (265)
T cd08217 220 SKIKEG 225 (265)
T ss_pred HHHhcC
Confidence 776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=246.00 Aligned_cols=205 Identities=30% Similarity=0.582 Sum_probs=167.1
Q ss_pred eeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccc
Q 022794 57 VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
.||+|+||.||+|.+ .+..||+|++..... ....+.+.+|+.+++++.||||+++++.+... .
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-~---- 68 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-A---- 68 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-C----
Confidence 389999999999865 345699998853321 12234588899999999999999999976432 2
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
.+++|||+++++|.+++... ...+++..++.++.|++.+|.+||++|++|+||||+||+++.++.++
T Consensus 69 ------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k 135 (257)
T cd05115 69 ------------LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK 135 (257)
T ss_pred ------------eEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEE
Confidence 28999999999999998643 34689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..++...+.++
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred eccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 9999998754332221 111223568999999988889999999999999999996 99999998888877766654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=243.10 Aligned_cols=213 Identities=32% Similarity=0.616 Sum_probs=177.2
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
...+|++.+.||+|++|.||++.+. +..+++|.+..... . ...+.+|+++++++.||+++++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---S-------EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---C-------HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 3468999999999999999999664 78899998753221 1 12367899999999999999999988765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... ++++||+++++|.+++.... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++
T Consensus 72 ~~~----------------~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~ 134 (256)
T cd05112 72 SPI----------------CLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG 134 (256)
T ss_pred Cce----------------EEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc
Confidence 544 89999999999999986532 4578999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i 284 (292)
.++.++|+|||.+........ .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......++.+.+
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05112 135 ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214 (256)
T ss_pred CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 999999999998865432211 1122334568999999998889999999999999999998 99999988888888877
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.++
T Consensus 215 ~~~ 217 (256)
T cd05112 215 NAG 217 (256)
T ss_pred hCC
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=269.51 Aligned_cols=209 Identities=20% Similarity=0.333 Sum_probs=158.1
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC---CceeEEEEeecCCCCC--------ccHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGH--------RTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~valK~~~~~~~~~--------~~~~~~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
...+|++++.||+|+||.||++... +..++.|......... ............+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998542 2223333111100000 0000111234557899999999999999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHhCCc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKI 193 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i 193 (292)
+++++++...+.. +++++++ +++|.+++.... ........++.++.||+.||.|||++||
T Consensus 226 v~l~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gI 288 (501)
T PHA03210 226 LKIEEILRSEANT----------------YMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKL 288 (501)
T ss_pred CcEeEEEEECCee----------------EEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 9999998776654 8899999 568888774321 1223456788899999999999999999
Q ss_pred cccCCCCCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCC-C
Q 022794 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-P 271 (292)
Q Consensus 194 ~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~-p 271 (292)
+||||||+|||++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++|.. |
T Consensus 289 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred ecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999976543322 2233568999999999999999999999999999999999875 5
Q ss_pred CC
Q 022794 272 YP 273 (292)
Q Consensus 272 f~ 273 (292)
|.
T Consensus 369 ~~ 370 (501)
T PHA03210 369 IG 370 (501)
T ss_pred cc
Confidence 54
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=262.23 Aligned_cols=193 Identities=33% Similarity=0.524 Sum_probs=167.4
Q ss_pred eeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+.||+|.||+||-|+ .+|+.||||++....-..+.+ ..+.+|+.||+.+.||+||.+.-.|...+.+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-------sqlR~EVaILq~l~HPGiV~le~M~ET~erv---- 638 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-------SQLRNEVAILQNLHHPGIVNLECMFETPERV---- 638 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH-------HHHHHHHHHHHhcCCCCeeEEEEeecCCceE----
Confidence 589999999999884 579999999986544333322 3477899999999999999999999888877
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC---CCc
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---NRT 210 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~---~~~ 210 (292)
|+|||.+ .|+..+.|.......+++.....+..||+.||+|||..||+|+||||+|||+.. -.+
T Consensus 639 ------------FVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQ 705 (888)
T KOG4236|consen 639 ------------FVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQ 705 (888)
T ss_pred ------------EEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCc
Confidence 8899999 567777776666678999999999999999999999999999999999999954 357
Q ss_pred EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
+||||||.|++++... ......||++|+|||+++.+.|...-|+||.|+|+|.-+.|..||+
T Consensus 706 vKlCDFGfARiIgEks-FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 706 VKLCDFGFARIIGEKS-FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred eeeccccceeecchhh-hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 9999999999876543 3344789999999999999999999999999999999999999996
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=247.41 Aligned_cols=215 Identities=27% Similarity=0.566 Sum_probs=177.0
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
+...+|++.+.||+|+||.||+|.+ +|+ .+++|....... ......+.+|+.++++++|||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--------PKANKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3457899999999999999999964 333 588888753322 22334577899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.. ... ++++||+++++|.+++... ...+++..++.++.|++.||++||+.|++|+||+|
T Consensus 76 ~~~~~-~~~----------------~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p 137 (279)
T cd05057 76 GICLS-SQV----------------QLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAA 137 (279)
T ss_pred EEEec-Cce----------------EEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCc
Confidence 98865 222 8999999999999998654 33589999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCC--CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
+||++++++.++|+|||.+.......... ....++..|+|||.+....++.++|+||||+++|++++ |..||...+.
T Consensus 138 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 138 RNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred ceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 99999999999999999987654322211 11223567999999988889999999999999999998 9999999998
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 218 ~~~~~~~~~~ 227 (279)
T cd05057 218 VEIPDLLEKG 227 (279)
T ss_pred HHHHHHHhCC
Confidence 8888777654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.20 Aligned_cols=205 Identities=29% Similarity=0.504 Sum_probs=172.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|+||.||++.+ ++..+++|.+..... ......+.+|++++++++||||+++++.+...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--------PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3689999999999999999965 578899998753211 122345778999999999999999999987766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nili~ 206 (292)
.. +++|||+++++|.+++... ..+++..+..++.|++.+|.|||+ .+++|+||+|.||+++
T Consensus 73 ~~----------------~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 73 EI----------------SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred EE----------------EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 54 8999999999999998653 568999999999999999999997 6999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......
T Consensus 135 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 208 (308)
T cd06615 135 SRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208 (308)
T ss_pred cCCcEEEccCCCccccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence 9999999999988644322 1233567889999999988889999999999999999999999998766554443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=245.76 Aligned_cols=215 Identities=28% Similarity=0.465 Sum_probs=174.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|++|.||+|.+ ++..|++|.+........ .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE----TSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch----hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 5789999999999999999965 688999998864432211 1223445788999999999999999999876532
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ..++++||+++++|.+++... ..+++..++.++.|++.+|.+||+.+++|+||+|+||+++.
T Consensus 78 ~~--------------~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~ 141 (266)
T cd06651 78 EK--------------TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS 141 (266)
T ss_pred CC--------------EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 22 238999999999999998543 45889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+...++
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 142 AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221 (266)
T ss_pred CCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 99999999998865432111 112244778999999999888999999999999999999999999877665555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.34 Aligned_cols=213 Identities=28% Similarity=0.493 Sum_probs=175.0
Q ss_pred ceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
+|++.+.||+|+||.||+|.. +|+.+|+|.+....... .........+.+|+.++++++|+||+++++++.+.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV---LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch---hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 478899999999999999965 68889999886443221 12223345588999999999999999999998776544
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
++++||+++++|.+++.+. ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++
T Consensus 78 ----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~ 139 (265)
T cd06631 78 ----------------SIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139 (265)
T ss_pred ----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC
Confidence 8999999999999999543 4588999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCC------CCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 210 TVKIADFGVARVEASN------PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
.++|+|||.+...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 219 (265)
T cd06631 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219 (265)
T ss_pred eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence 9999999988643211 1112234578899999999988899999999999999999999999987665554443
Q ss_pred H
Q 022794 284 V 284 (292)
Q Consensus 284 i 284 (292)
+
T Consensus 220 ~ 220 (265)
T cd06631 220 I 220 (265)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=246.51 Aligned_cols=219 Identities=28% Similarity=0.491 Sum_probs=172.5
Q ss_pred eeEeeeeccCcceEEEEEEEC--Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 52 LVIKSVIARGTFGTVHRGLYD--GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~--~~--~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+.+.+.||+|+||.||+|.+. +. .+|+|.++.... . ......+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~---~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---T----RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC---C----HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 356789999999999999764 22 589998754321 1 111345778999999999999999998775432
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh----cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN----RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
... .....+++|||+++++|.+++... ....+++..+..++.|++.||+|||++|++||||||+||
T Consensus 74 ~~~----------~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 143 (272)
T cd05075 74 ESE----------GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNC 143 (272)
T ss_pred ccc----------CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhe
Confidence 210 012348999999999999988532 224588999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
++++++.++|+|||.+......... ......+..|++||.+.+..++.++|+||||+++|+|++ |..||...+..++
T Consensus 144 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 144 MLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred EEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999998765432211 112235668999999998889999999999999999999 8999998888887
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 224 ~~~~~~~ 230 (272)
T cd05075 224 YDYLRQG 230 (272)
T ss_pred HHHHHcC
Confidence 7776654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.98 Aligned_cols=214 Identities=27% Similarity=0.373 Sum_probs=176.5
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||+|.+ +|+.|++|.++....... .......+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA----KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc----cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE
Confidence 588899999999999999975 588999999865432211 11223446679999999999999999999877554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++||||+ +++|.+++.... ..+++..++.++.|+++||.+||++|++|+||+|+||+++.+
T Consensus 77 ~----------------~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~ 138 (298)
T cd07841 77 I----------------NLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD 138 (298)
T ss_pred E----------------EEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC
Confidence 4 8999999 889999986532 368999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+.++.+
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~ 217 (298)
T cd07841 139 GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE 217 (298)
T ss_pred CCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH
Confidence 99999999998765544333344456788999998865 4578999999999999999999999988887776666654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=248.56 Aligned_cols=209 Identities=26% Similarity=0.448 Sum_probs=170.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +++.|++|.+......... ..+.+|+.++++++|+||+++++++.+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP--------FTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc--------hhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 6899999999999999999965 5889999998644322111 12457999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+. ++|.+++.... ..+++..++.++.|+++||.+||++|++|+||+|+||+++.
T Consensus 77 ~~----------------~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~ 138 (291)
T cd07844 77 TL----------------TLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138 (291)
T ss_pred eE----------------EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC
Confidence 44 89999996 49999886543 36889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~-~~~~~~~i 284 (292)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.. ..+....+
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 217 (291)
T cd07844 139 RGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217 (291)
T ss_pred CCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH
Confidence 9999999999886543322222334467889999998764 57889999999999999999999997665 44444433
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=250.63 Aligned_cols=215 Identities=31% Similarity=0.421 Sum_probs=177.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++.+.||.|++|.||+|.+ +|+.||+|.++........ ...+.+|+.++++++|+|++++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGI-------PISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCC-------cchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 46899999999999999999966 5899999998654322111 11245699999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. ...+++|||+. ++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 79 ~~--------------~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 142 (309)
T cd07845 79 HL--------------DSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT 142 (309)
T ss_pred CC--------------CeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 32 12389999995 5898888653 35689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+..............++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+..+.+..+.
T Consensus 143 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 143 DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998765543333333445778999999876 457899999999999999999999999999888888776
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
+
T Consensus 223 ~ 223 (309)
T cd07845 223 Q 223 (309)
T ss_pred H
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=246.57 Aligned_cols=211 Identities=27% Similarity=0.402 Sum_probs=176.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||+|.+ +|+.|++|++....... .....+.+|+.++++++|||++++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-------GIPNQALREIKALQACQHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-------hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 589999999999999999975 68899999986543211 112347789999999999999999999877554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+ +++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 74 F----------------VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred e----------------EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 4 8999999 999999986533 568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+........ ......++..|+|||.+.+.. ++.++|+||+|+++++|++|.+||...+..+....+.+
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 136 GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred CcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 9999999999875543321 233456788999999987654 68899999999999999999999988877776666554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=249.68 Aligned_cols=211 Identities=29% Similarity=0.466 Sum_probs=174.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
-|++.+.||+|++|.||++.+ ++..+++|.+.... . .....+.+|+.+++.+.|||++++++.+...+.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-----E----EELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-----H----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 368889999999999999976 46788888874321 1 113346789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|..++.. ....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 77 ~----------------~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~ 139 (282)
T cd06643 77 L----------------WILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD 139 (282)
T ss_pred E----------------EEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC
Confidence 3 899999999999988754 23568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+.++|+|||.+..............++..|+|||++. +..++.++|+||+|+++|+|++|.+||...+..+...+
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 219 (282)
T cd06643 140 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219 (282)
T ss_pred CCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence 9999999999865443333334456888999999984 34577899999999999999999999998887777766
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.+.
T Consensus 220 ~~~~ 223 (282)
T cd06643 220 IAKS 223 (282)
T ss_pred Hhhc
Confidence 6544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.93 Aligned_cols=220 Identities=22% Similarity=0.307 Sum_probs=192.6
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECCce--eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHD--VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~--valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
++.-.+++++..||-||||.|=++..+++. +|+|+++..+. ......+.+..|-+++..+..|.||++|..|
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI------VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI------VDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc------cchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 445578889999999999999999776655 89998864332 1122344577899999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+...+ |++||-|-||.|+..+++ +..+++.+.+.++..+++|+.|||++||++|||||+|+
T Consensus 490 rd~kyv----------------YmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 490 RDSKYV----------------YMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred ccchhh----------------hhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 887766 899999999999999864 35699999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+++.+|-+||.|||.|..+..... .....||+.|.|||.+.....+.+.|.|+||+++|||++|.+||++.++-..+..
T Consensus 552 lLd~~Gy~KLVDFGFAKki~~g~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 552 LLDNRGYLKLVDFGFAKKIGSGRK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred eeccCCceEEeehhhHHHhccCCc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 999999999999999987765544 3448899999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhc
Q 022794 284 VVRQVQY 290 (292)
Q Consensus 284 i~~~~~~ 290 (292)
|.+|+..
T Consensus 631 ILkGid~ 637 (732)
T KOG0614|consen 631 ILKGIDK 637 (732)
T ss_pred HHhhhhh
Confidence 9999764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=243.75 Aligned_cols=206 Identities=31% Similarity=0.567 Sum_probs=171.7
Q ss_pred eeeccCcceEEEEEEEC---C--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 56 SVIARGTFGTVHRGLYD---G--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~---~--~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
+.||+|++|.||+|.+. + ..|++|.+...... ...+.+.+|+.++++++||||+++++.+.. ...
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~- 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPL- 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeE-
Confidence 36899999999999652 2 26899988543221 345568899999999999999999998876 332
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
++++||+++++|.+++.......+++..++.++.|++.||++||+.|++|+||+|+||+++.++.
T Consensus 71 ---------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~ 135 (257)
T cd05040 71 ---------------MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK 135 (257)
T ss_pred ---------------EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE
Confidence 89999999999999997654356899999999999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCCCCC---CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022794 211 VKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~ 286 (292)
++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++...+..
T Consensus 136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999987654322211 12345678999999998889999999999999999998 9999998888888777664
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=242.61 Aligned_cols=213 Identities=30% Similarity=0.517 Sum_probs=178.2
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|++|.||+|.+ +++.+++|.+...... ......+.+|+.++++++|||++++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-------KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-------cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE
Confidence 589999999999999999855 6889999998643211 1113457889999999999999999998866554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.......+++..+..++.|++.+|.+||++|++|+||+|+||+++++
T Consensus 74 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 74 L----------------MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred E----------------EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 4 899999999999999976555668999999999999999999999999999999999999755
Q ss_pred -CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 -RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+..+
T Consensus 138 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 138 KMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred CCEEEEccCCCceecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 457999999987654332 222356788999999999888899999999999999999999999988877777666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=245.85 Aligned_cols=219 Identities=28% Similarity=0.497 Sum_probs=175.1
Q ss_pred eeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 52 LVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
|++.+.||+|+||.||+|... +..||+|.++..... . .....+.+|+..++.++|||++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT---Y----SEIEEFLSEAACMKDFDHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC---H----HHHHHHHHHHHHHHhCCCCCeeeEEeeeccC
Confidence 567899999999999999642 367999998643221 1 1123477899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhh----cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN----RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
.... .....++++||+++++|..++... ....+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 74 ~~~~----------~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~N 143 (273)
T cd05035 74 SSLQ----------KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143 (273)
T ss_pred Cccc----------cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhe
Confidence 4310 123348999999999999998543 22468899999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCC--CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
|++++++.++|+|||.+.......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+
T Consensus 144 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 144 CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred EEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999987654332211 11234568999999988889999999999999999999 999999988888
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
+.+.+.++
T Consensus 224 ~~~~~~~~ 231 (273)
T cd05035 224 IYDYLRHG 231 (273)
T ss_pred HHHHHHcC
Confidence 88777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=249.44 Aligned_cols=215 Identities=33% Similarity=0.538 Sum_probs=175.6
Q ss_pred cCCceeEeeeeccCcceEEEEEEECC------------------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHH
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYDG------------------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~~------------------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 109 (292)
...+|++++.||+|+||.||+|.+.+ ..|++|.+...... .....+.+|+++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--------~~~~~~~~e~~~l~ 74 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--------NAREDFLKEVKILS 74 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--------HHHHHHHHHHHHHH
Confidence 45789999999999999999986532 45899988533211 22345788999999
Q ss_pred hCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---------ccccCHHHHHHHHHH
Q 022794 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------RRKLAFKVVVQLALD 180 (292)
Q Consensus 110 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~q 180 (292)
++.|||++++++++...+.. ++++|++++++|.+++.... ...+++..++.++.|
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPL----------------CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138 (296)
T ss_pred hcCCCCEeEEEEEEecCCCc----------------EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHH
Confidence 99999999999988765444 89999999999999986543 126899999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
++.||++||++|++|+||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+|||
T Consensus 139 i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred HHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 99999999999999999999999999999999999999865432211 1122345678999999988889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCHHHHHHHHHH
Q 022794 259 GICLWEIYC--CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 259 g~il~~l~~--g~~pf~~~~~~~~~~~i~~ 286 (292)
|+++|+|++ +..||...+..+++..+..
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 248 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTDQQVIENAGH 248 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcChHHHHHHHHh
Confidence 999999998 7889988887777666553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.71 Aligned_cols=216 Identities=31% Similarity=0.567 Sum_probs=176.3
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCc---eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGH---DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~---~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+...+|+..+.||+|++|.||+|.. ++. .+++|..+.... ....+.+.+|+.+++++.|+|++++.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--------EKQRQDFLSEASIMGQFSHHNIIRLEG 73 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--------HHHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence 3456889999999999999999965 333 689988753211 112345778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...+.. +++|||+++++|.+++... ...+++..+..++.|++.||.+||+.|++|+||+|+
T Consensus 74 ~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~ 136 (268)
T cd05063 74 VVTKFKPA----------------MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAAR 136 (268)
T ss_pred EEccCCCc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchh
Confidence 98766554 8999999999999998653 356899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCC---CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMT---GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
||+++.++.++|+|||.+........... ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 137 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 137 NILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred hEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 99999999999999999875443222111 1123457999999988889999999999999999997 9999998888
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 217 ~~~~~~i~~~ 226 (268)
T cd05063 217 HEVMKAINDG 226 (268)
T ss_pred HHHHHHHhcC
Confidence 8888777643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=247.78 Aligned_cols=208 Identities=32% Similarity=0.502 Sum_probs=175.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|+..+.||.|++|.||+|.+ ++..||+|++..... ......+.+|+.+++++.|+|++++++.+.+..
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 4678889999999999999975 578999998853211 112345788999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. .++++..+..++.|++.+|.+||+.+++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 76 KL----------------WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred EE----------------EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 54 899999999999998853 45889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred CCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 99999999999876544333333345778899999999888999999999999999999999999877766655544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=246.85 Aligned_cols=211 Identities=26% Similarity=0.398 Sum_probs=174.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +++.||+|.+....... .....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCC
Confidence 4789999999999999999976 58899999875432211 12334678999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+++++|.++... ...+++..++.++.|++.+|.|||+.|++|+||+|+||++++
T Consensus 74 ~~----------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 74 RL----------------YLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred eE----------------EEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 54 899999999888887643 235899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++++|++|.+||...+..+....+.
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 136 SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred CCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 9999999999987654443333445678899999998754 46789999999999999999999998877666555554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=245.01 Aligned_cols=202 Identities=29% Similarity=0.421 Sum_probs=172.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||+|.+ +++.|++|++...... .....+.+.+|+.++++++||||+++++.+.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV------EKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN 74 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc------chhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence 589999999999999999966 4899999998633211 11223457889999999999999999998876655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++... ..+++..+..++.|++++|.+||..|++|+||+|+||+++++
T Consensus 75 ~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 136 (258)
T cd05578 75 M----------------YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ 136 (258)
T ss_pred E----------------EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC
Confidence 4 8999999999999998653 468999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
+.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.
T Consensus 137 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 137 GHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 999999999987544332 23345678899999999888899999999999999999999999998773
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=245.83 Aligned_cols=212 Identities=28% Similarity=0.462 Sum_probs=176.3
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||+|.+ +|+.|++|.++....... ...+.+|+.++++++|+|++++++.+.+.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--------PSTAIREISLMKELKHENIVRLHDVIHTENK 72 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc--------hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence 588999999999999999976 588999999865432211 1235679999999999999999999887655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
. +++|||+++ +|.+++.... ...+++..+..++.|++.||.+||+.|++|+||+|+||++++
T Consensus 73 ~----------------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~ 135 (284)
T cd07836 73 L----------------MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK 135 (284)
T ss_pred E----------------EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC
Confidence 4 899999974 8988886432 246899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............++..|++||.+.+. .++.++|+||||+++|+|++|..||.+.+..+...++.+
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 136 RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 9999999999987544333333445567889999988654 578899999999999999999999999888887777654
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 216 ~ 216 (284)
T cd07836 216 I 216 (284)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=247.64 Aligned_cols=217 Identities=26% Similarity=0.420 Sum_probs=175.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
..+.|++.+.||+|+||.||+|.+ +++.+++|+..... . ....+..|+.+++++ +|+|++++++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~------~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE------D----EEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh------H----HHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 447899999999999999999966 67899999885321 1 123367789999988 7999999999886
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..... .....++++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus 84 ~~~~~----------~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nil 153 (282)
T cd06636 84 KKSPP----------GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVL 153 (282)
T ss_pred ccccc----------CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 43211 01334589999999999999997666667889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
+++++.++|+|||.+..............++..|+|||.+. ...++.++|+||||+++|+|++|..||......+
T Consensus 154 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 154 LTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred ECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 99999999999998865433333334456888999999986 3457889999999999999999999998766555
Q ss_pred HHHHH
Q 022794 280 VTSAV 284 (292)
Q Consensus 280 ~~~~i 284 (292)
....+
T Consensus 234 ~~~~~ 238 (282)
T cd06636 234 ALFLI 238 (282)
T ss_pred hhhhH
Confidence 44433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=245.58 Aligned_cols=213 Identities=31% Similarity=0.563 Sum_probs=173.8
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--C---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--G---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~---~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
..+|++.+.||+|+||.||+|... + ..|++|.+.... . ......+..|+.+++++.||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----T----EKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----C----HHHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 357899999999999999999653 3 359999885321 1 11234578899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...... +++|||+++++|.+++... ...+++..++.++.|++.||++||+.|++|+||+|+||
T Consensus 75 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 75 TKSRPV----------------MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred CCCCce----------------EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 766554 8999999999999998653 34688999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCC--CCCCC---CcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPND--MTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~---~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
+++.++.++|+|||.+......... ..... .+..|+|||.+.+..++.++|+||+|+++|++++ |..||...+.
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 9999999999999988654332211 11111 2357999999998889999999999999999886 9999998888
Q ss_pred HHHHHHHHH
Q 022794 278 SEVTSAVVR 286 (292)
Q Consensus 278 ~~~~~~i~~ 286 (292)
.++...+..
T Consensus 218 ~~~~~~i~~ 226 (269)
T cd05065 218 QDVINAIEQ 226 (269)
T ss_pred HHHHHHHHc
Confidence 877776643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=248.54 Aligned_cols=216 Identities=31% Similarity=0.515 Sum_probs=176.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+|++.+.||+|+||.||+|.+ ++..|++|++..... ......+.+|+.+++++.|||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--------HHHHHHHHHHHHHHHhcCCCchheEE
Confidence 346899999999999999999965 457899998853211 12234577899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------------ccccCHHHHHHHHHH
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------------RRKLAFKVVVQLALD 180 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~i~~q 180 (292)
+++.+.+.. ++++||+++++|.+++.... ...+++..++.++.|
T Consensus 75 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 138 (288)
T cd05050 75 GVCAVGKPM----------------CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQ 138 (288)
T ss_pred EEEcCCCcc----------------EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHH
Confidence 988766544 89999999999999996432 124778889999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
++.||.+||+.|++|+||+|+||++++++.++|+|||.+........ .......+..|+|||.+.+..++.++|+|||
T Consensus 139 i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 139 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 99999999999999999999999999999999999998864432211 1122334567999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 259 GICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 259 g~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+++|+|++ |..||.+.+..+....+.++
T Consensus 219 G~il~el~~~~~~p~~~~~~~~~~~~~~~~ 248 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 999999997 88999888888877766544
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=249.05 Aligned_cols=214 Identities=30% Similarity=0.526 Sum_probs=172.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC------------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHH
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD------------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH 109 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~------------------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 109 (292)
..++|++.+.||+|+||.||++.+. +..+|+|+++.... ......+.+|+.+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~E~~~l~ 74 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--------KNARNDFLKEIKIMS 74 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--------HHHHHHHHHHHHHHH
Confidence 4568999999999999999988432 34689998853311 122345788999999
Q ss_pred hCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc---------cccCHHHHHHHHHH
Q 022794 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---------RKLAFKVVVQLALD 180 (292)
Q Consensus 110 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~q 180 (292)
.++|+||+++++++...+.. +++|||+++++|.+++..... ..+++..++.++.|
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPL----------------CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ 138 (296)
T ss_pred hCCCCCcceEEEEEecCCcc----------------EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHH
Confidence 99999999999998776554 899999999999999865321 24677889999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
++.||++||+.|++|+||||+||+++.++.++|+|||.+......... ......+..|++||...+..++.++|+|||
T Consensus 139 i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl 218 (296)
T cd05095 139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218 (296)
T ss_pred HHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH
Confidence 999999999999999999999999999999999999998654322111 111233568999999888889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCHHHHHHHHH
Q 022794 259 GICLWEIYC--CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 259 g~il~~l~~--g~~pf~~~~~~~~~~~i~ 285 (292)
|+++|+|++ |..||...+..+....+.
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~ 247 (296)
T cd05095 219 GVTLWEILTLCKEQPYSQLSDEQVIENTG 247 (296)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 999999998 789999888877766543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=243.25 Aligned_cols=196 Identities=27% Similarity=0.489 Sum_probs=164.3
Q ss_pred eeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCccccc
Q 022794 55 KSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 131 (292)
.+.||+|+|+.|-.+ +.+|..||||++.... ...+.++.+|++++.++ .|+||++++++|.+...+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F-- 151 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF-- 151 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE--
Confidence 358999999999987 5689999999985432 12356688999999999 899999999999988776
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc-
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT- 210 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~- 210 (292)
|+|||.+.||+|...|.+ ...+++.++.++.++|+.||.+||.+||.|||+||+|||.....+
T Consensus 152 --------------YLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 152 --------------YLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKV 215 (463)
T ss_pred --------------EEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCc
Confidence 899999999999999965 457999999999999999999999999999999999999976654
Q ss_pred --EEEeecCcceeccC-------CCCCCCCCCCcccccCCcccC---C--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 211 --VKIADFGVARVEAS-------NPNDMTGETGTLGYMAPEVLN---G--NPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 211 --~~l~Dfg~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~---~--~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+|||||+++.-... ..+......|+..|||||+.. + ..|+.++|+||||+|+|-|++|.+||.+..
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 89999988753211 122233456888999999863 2 258999999999999999999999998764
Q ss_pred H
Q 022794 277 F 277 (292)
Q Consensus 277 ~ 277 (292)
.
T Consensus 296 g 296 (463)
T KOG0607|consen 296 G 296 (463)
T ss_pred C
Confidence 3
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=247.75 Aligned_cols=193 Identities=32% Similarity=0.556 Sum_probs=165.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +++.||+|+...... ......+.+|+.++++++|||++++++.+...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--------VELQKQIMSELEILYKCDSPYIIGFYGAFFVEN 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC
Confidence 3688899999999999999965 688999998854321 112345788999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|..+. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 73 ~~----------------~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 73 RI----------------SICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred EE----------------EEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 54 8999999999997642 4778889999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 131 ~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 131 RGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 999999999998654322 23335688899999999988899999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=246.53 Aligned_cols=212 Identities=26% Similarity=0.413 Sum_probs=173.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +|+.|++|.+....... .....+.+|+.++++++|||++++++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-------cchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 5799999999999999999965 58899999885432211 11234678999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||++ ++|.+++.......+++..++.++.||+.||++||++|++|+||+|+||+++.
T Consensus 75 ~~----------------~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~ 137 (294)
T PLN00009 75 RL----------------YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR 137 (294)
T ss_pred eE----------------EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC
Confidence 44 89999995 58888886555555788899999999999999999999999999999999985
Q ss_pred -CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 -NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.+.++.
T Consensus 138 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 138 RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5679999999987544333333345667899999998764 57889999999999999999999999887766666554
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=246.87 Aligned_cols=219 Identities=26% Similarity=0.432 Sum_probs=177.1
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.+...+|++.+.||+|+||.||+|.+. +..|++|.+.... . ......+.+|+.+++++.|+|++++
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~----~----~~~~~~~~~e~~~l~~l~h~ni~~~ 73 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA----S----EIQVTLLLQESCLLYGLSHQNILPI 73 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC----C----HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 456689999999999999999999653 4789999875221 1 1123446789999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc------cccCHHHHHHHHHHHHHHHHHHHhCCc
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR------RKLAFKVVVQLALDLARGLSYLHSQKI 193 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~i 193 (292)
++++...+. ..+++++|+++++|.+++..... ..+++..++.++.|++.||+|||+.++
T Consensus 74 ~~~~~~~~~---------------~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i 138 (280)
T cd05043 74 LHVCIEDGE---------------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGV 138 (280)
T ss_pred EEEEecCCC---------------CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 998765322 22899999999999999865322 458899999999999999999999999
Q ss_pred cccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCC
Q 022794 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDM 270 (292)
Q Consensus 194 ~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~ 270 (292)
+|+||+|+||++++++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|++++ |++
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 9999999999999999999999999875432211 1122345678999999998889999999999999999999 999
Q ss_pred CCCCCCHHHHHHHHHHh
Q 022794 271 PYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 271 pf~~~~~~~~~~~i~~~ 287 (292)
||...+..++...+.++
T Consensus 219 p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 219 PYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CcCcCCHHHHHHHHHcC
Confidence 99988877776655543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=227.82 Aligned_cols=231 Identities=25% Similarity=0.416 Sum_probs=185.5
Q ss_pred cCccchhhhhhcccceecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH
Q 022794 31 IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108 (292)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 108 (292)
.........-..+++++......-+..||+|++|.|-+. ..+|...|+|.++..-. .+...++.+|+.+.
T Consensus 27 ~Ld~~a~i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--------~q~q~r~L~dldi~ 98 (282)
T KOG0984|consen 27 NLDSRALIYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--------SQEQKRLLMDLDII 98 (282)
T ss_pred ccCCCceEEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--------hHHHHHHHHhhhhh
Confidence 333333333444457777888888999999999987544 67899999998853321 22344577788888
Q ss_pred HhC-CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHHHHHHHH
Q 022794 109 HKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGL 185 (292)
Q Consensus 109 ~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al 185 (292)
.+. ..|.+|.+++...+...+ |+.||.+ ..+|+.+-++ ..+..++|..+-+|+..++.||
T Consensus 99 ~r~~~CPf~V~FyGa~~regdv----------------wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al 161 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDV----------------WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHAL 161 (282)
T ss_pred ccCCCCCeEEEeehhhhccccE----------------EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHH
Confidence 777 899999999988777666 8899999 5699888653 3567899999999999999999
Q ss_pred HHHHhC-CccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC----CCCchhhHHHHHH
Q 022794 186 SYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGI 260 (292)
Q Consensus 186 ~~lH~~-~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~Diwslg~ 260 (292)
.|||++ .++|||+||+||||+.+|++|+||||.+..+.++ -..+...|...|+|||.+..+ .|+.++||||||+
T Consensus 162 ~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGI 240 (282)
T KOG0984|consen 162 EFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGI 240 (282)
T ss_pred HHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhh
Confidence 999976 8999999999999999999999999998765433 233335678899999998653 6899999999999
Q ss_pred HHHHHHhCCCCCC-CCCHHHHHHHHHHh
Q 022794 261 CLWEIYCCDMPYP-DLSFSEVTSAVVRQ 287 (292)
Q Consensus 261 il~~l~~g~~pf~-~~~~~~~~~~i~~~ 287 (292)
.++||.+++.||. ..++=+++++++.+
T Consensus 241 tmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 241 TMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhhhhhccccccccCCHHHHHHHHhcC
Confidence 9999999999997 56777888887764
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=244.87 Aligned_cols=219 Identities=30% Similarity=0.459 Sum_probs=178.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
.++|++.+.||+|++|.||+|.+ +++.+++|++..... ..+.+.+|+.+++++ .|+||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----------EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----------hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 47899999999999999999976 578899999864321 123477899999999 79999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.... .....++++|||+++++|.+++.... +..+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus 75 ~~~~----------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni 144 (275)
T cd06608 75 KNPP----------GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144 (275)
T ss_pred cCCC----------CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 5431 01234489999999999999986543 46789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
++++++.++|+|||.+..............++..|+|||.+.. ..++.++|+||||+++|+|++|..||......
T Consensus 145 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 224 (275)
T cd06608 145 LLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224 (275)
T ss_pred EEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH
Confidence 9999999999999998765443333344567889999998754 24678899999999999999999999877665
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
....++.++
T Consensus 225 ~~~~~~~~~ 233 (275)
T cd06608 225 RALFKIPRN 233 (275)
T ss_pred HHHHHhhcc
Confidence 555555443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=249.65 Aligned_cols=208 Identities=31% Similarity=0.502 Sum_probs=173.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|+..+.||+|++|.||+|.+ +++.||+|.+..... ......+.+|+.++++++||||+++++.+...+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--------hHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 4577788999999999999965 578999998753221 112345788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+++++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||++++
T Consensus 76 ~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~ 136 (277)
T cd06642 76 KL----------------WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 136 (277)
T ss_pred ce----------------EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC
Confidence 44 899999999999998843 46889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred CCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 99999999999875543332233345788999999999888999999999999999999999999876665554443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=241.84 Aligned_cols=212 Identities=37% Similarity=0.659 Sum_probs=176.5
Q ss_pred eeEeeeeccCcceEEEEEEECC------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 52 LVIKSVIARGTFGTVHRGLYDG------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~~------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
+++.+.||.|+||.||++.+.+ ..|++|+++...... ....+.+|+.+++.++|+|++++++.+.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--------QIEEFLREARIMRKLDHPNIVKLLGVCTE 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--------HHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 3567899999999999997653 789999985432210 23457789999999999999999999887
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+++.......+++..+..++.|++.+|++||+.|++|+||+|+||++
T Consensus 73 ~~~~----------------~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 73 EEPL----------------MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred CCee----------------EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 6544 899999999999999865443338999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCC-CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~ 283 (292)
+.++.++|+|||.+........... ...++..|+|||.+.+..++.++|+||||+++++|++ |.+||...+..++.+.
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 216 (258)
T smart00219 137 GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY 216 (258)
T ss_pred ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999875543311111 2336678999999988889999999999999999998 8999998888888877
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.++
T Consensus 217 ~~~~ 220 (258)
T smart00219 217 LKKG 220 (258)
T ss_pred HhcC
Confidence 7654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=242.67 Aligned_cols=205 Identities=33% Similarity=0.573 Sum_probs=167.5
Q ss_pred eeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 56 SVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
+.||+|+||.||+|.+. +..+++|.+...... ...+.+.+|+.+++++.|+|++++++++... .
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~-- 69 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--------AGKKEFLREASVMAQLDHPCIVRLIGVCKGE-P-- 69 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-c--
Confidence 46899999999999652 367999988533221 2234577899999999999999999876432 2
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
.+++|||+++++|.+++... ..+++..++.++.|++.+|.+||..+++|+||+|+||+++.++.
T Consensus 70 --------------~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~ 133 (257)
T cd05060 70 --------------LMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ 133 (257)
T ss_pred --------------eEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc
Confidence 28999999999999999654 36899999999999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCCCCCC---CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022794 211 VKIADFGVARVEASNPNDMT---GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~ 286 (292)
++|+|||.+........... ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..++...+..
T Consensus 134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 99999999875543322211 1223457999999998889999999999999999998 9999998888777766654
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 214 ~ 214 (257)
T cd05060 214 G 214 (257)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=245.66 Aligned_cols=218 Identities=31% Similarity=0.442 Sum_probs=175.6
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
..++|.+.+.||+|++|.||+|.. +++.+++|+...... ....+.+|+.+++++ +|||++++++++.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----------~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----------VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----------HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 357899999999999999999965 688999999853211 122356788899988 8999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
..+.. ....+++++||+++++|.+++... ....+++..++.++.|++.+|++||+.|++|+||+|+|
T Consensus 90 ~~~~~-----------~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~n 158 (291)
T cd06639 90 KADKL-----------VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNN 158 (291)
T ss_pred ecccc-----------CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 54321 122348999999999999988532 34568999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
|+++.++.++|+|||.+..............++..|+|||.+... .++.++|+||||+++|+|++|+.||...+.
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999999999999999887544333233345678899999998643 367899999999999999999999998777
Q ss_pred HHHHHHHHH
Q 022794 278 SEVTSAVVR 286 (292)
Q Consensus 278 ~~~~~~i~~ 286 (292)
.+.+..+.+
T Consensus 239 ~~~~~~~~~ 247 (291)
T cd06639 239 VKTLFKIPR 247 (291)
T ss_pred HHHHHHHhc
Confidence 665555543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=239.92 Aligned_cols=207 Identities=33% Similarity=0.606 Sum_probs=169.7
Q ss_pred eeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccc
Q 022794 56 SVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 134 (292)
+.||+|++|.||+|.. ++..+++|.++.... ......+.+|+.+++++.||||+++++++...+..
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----- 67 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI----- 67 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc-----
Confidence 3689999999999954 577899998753321 11233477899999999999999999988766544
Q ss_pred cccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEe
Q 022794 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214 (292)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~ 214 (292)
+++|||+++++|.+++... ...+++..+..++.|++.+|.++|++|++|+||+|+||+++.++.++|+
T Consensus 68 -----------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~ 135 (250)
T cd05085 68 -----------YIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKIS 135 (250)
T ss_pred -----------EEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEEC
Confidence 8999999999999988653 3457899999999999999999999999999999999999999999999
Q ss_pred ecCcceeccCCCCCCC-CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 215 DFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 215 Dfg~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||.+........... ....+..|+|||++.+..++.++|+||||+++|++++ |..||...+..+....+.++
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 136 DFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred CCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 9998865332221111 1233567999999998889999999999999999998 99999988887777666544
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=249.27 Aligned_cols=199 Identities=30% Similarity=0.506 Sum_probs=175.0
Q ss_pred CceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+-|.++++||+|+||.||+|+ .+|..+|+|...... ..+.+..|+.+++++..|++|++|+.+....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----------hHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 347889999999999999995 579999999874322 1344778999999999999999999988776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |+|||||..|++.+.++. +++++++.++..+++..+.+|+|||...-+|||||..|||++.
T Consensus 102 DL----------------WIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT 164 (502)
T KOG0574|consen 102 DL----------------WIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT 164 (502)
T ss_pred ce----------------EeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc
Confidence 66 899999999999998764 5678999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+|..||.|||.+..+.+---..+...||+.|||||++..-.|+..+||||||+...+|..|++||.+.-
T Consensus 165 ~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 165 DGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred cchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 999999999999765544444556789999999999998889999999999999999999999997643
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=255.36 Aligned_cols=193 Identities=30% Similarity=0.491 Sum_probs=161.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|.+++.||+|+||.||+|.+ +++.||+|+..... ...|+.++++++|+||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------------~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------------TLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------------cHHHHHHHHhCCCCCCcChhheEEe
Confidence 345799999999999999999976 46789999753211 3458999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... ++++|++ .++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 129 ~~~~----------------~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill 190 (357)
T PHA03209 129 GAIT----------------CMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI 190 (357)
T ss_pred CCee----------------EEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 6544 8999999 5689888864 34568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPD 274 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~-~pf~~ 274 (292)
+.++.++|+|||.+...... .......++..|+|||++.+..++.++|+|||||++|+|+++. .+|..
T Consensus 191 ~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 191 NDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred CCCCCEEEecCccccccccC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 99999999999998643322 2223356889999999999999999999999999999999854 44443
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=247.46 Aligned_cols=201 Identities=31% Similarity=0.491 Sum_probs=164.2
Q ss_pred Cce-eEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 50 SKL-VIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 50 ~~~-~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
++| ++.+.||+|+||+||++.. ++..||+|+++.... ......+.+|+.+++.+.||||++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--------QQNTSGWKKEINILKTLYHENIVKYKGC 74 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345 8999999999999988642 577899999864321 1123447789999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+..... ...+++|||+++++|.+++.. ..+++..++.++.|++.+|.+||++|++|+||||+|
T Consensus 75 ~~~~~~--------------~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N 137 (283)
T cd05080 75 CSEQGG--------------KGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137 (283)
T ss_pred EecCCC--------------ceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence 765332 123899999999999999854 358999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred EEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999998754432221 11233556799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.31 Aligned_cols=216 Identities=29% Similarity=0.545 Sum_probs=179.6
Q ss_pred Cce-eEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 50 SKL-VIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~-~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
++| ++...||+|.|-+||+|.++ |..||=--++. +.........++|..|+.+|+.|+||||+++++++.+.
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~-----~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKI-----RDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhH-----HHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 444 55678999999999999764 55554322221 11122233356799999999999999999999999988
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p~Nil 204 (292)
....+ .++.|.+..|+|..|+++. +.++.+.+..|++||+.+|.|||.+. |+|||||-+|||
T Consensus 114 ~n~~i--------------n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 114 DNKTI--------------NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF 177 (632)
T ss_pred CCcee--------------eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence 76544 8999999999999999765 45889999999999999999999995 999999999999
Q ss_pred EcCC-CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHH
Q 022794 205 LDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP-DLSFSEVTS 282 (292)
Q Consensus 205 i~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~-~~~~~~~~~ 282 (292)
|+.. |.|||+|+|+|.....+ ......|||.|||||++. ..|+...||||||.++.||.|+..||. -.++.++++
T Consensus 178 inG~~G~VKIGDLGLAtl~r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK 254 (632)
T KOG0584|consen 178 VNGNLGEVKIGDLGLATLLRKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK 254 (632)
T ss_pred EcCCcCceeecchhHHHHhhcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH
Confidence 9755 99999999999865533 333378999999999998 679999999999999999999999997 789999999
Q ss_pred HHHHhhh
Q 022794 283 AVVRQVQ 289 (292)
Q Consensus 283 ~i~~~~~ 289 (292)
++..|++
T Consensus 255 KV~SGiK 261 (632)
T KOG0584|consen 255 KVTSGIK 261 (632)
T ss_pred HHHcCCC
Confidence 9998864
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=250.82 Aligned_cols=208 Identities=29% Similarity=0.465 Sum_probs=173.8
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|.....||+|+||.||++.. +++.|+||.+.... ......+.+|+.+++.++|+|++++++.+...+.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---------QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---------HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 455567799999999999965 68899999874321 1123447789999999999999999998876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.. ..+++..++.++.|++.+|.+||++|++|+||+|+||+++++
T Consensus 94 ~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 154 (292)
T cd06658 94 L----------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154 (292)
T ss_pred E----------------EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC
Confidence 4 899999999999998743 358899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.+..+.+
T Consensus 155 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 232 (292)
T cd06658 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232 (292)
T ss_pred CCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999999999886544333333345678899999999888899999999999999999999999998877776665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=246.09 Aligned_cols=197 Identities=29% Similarity=0.430 Sum_probs=164.8
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||+|+||.||+|.+ +|+.|++|++..... ........+.+|+.++++++|||++++++.+...+..
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------ 68 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL------KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL------ 68 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh------hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE------
Confidence 68999999999954 588999999853221 1112233456799999999999999999988766544
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
|++|||+++++|.+++.......+++..++.++.|++.+|.+||+.|++|+||+|+||++++++.++|+|
T Consensus 69 ----------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~d 138 (277)
T cd05577 69 ----------CLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISD 138 (277)
T ss_pred ----------EEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcc
Confidence 8999999999999999765555799999999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 216 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
||.+..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....
T Consensus 139 fg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 139 LGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred Ccchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 998865432 2222335677899999999888899999999999999999999999976544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=247.92 Aligned_cols=214 Identities=30% Similarity=0.525 Sum_probs=172.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEECC----------------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYDG----------------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 111 (292)
...+|++.+.||+|+||.||++...+ ..||+|.++.... . .....+.+|+++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~ei~~l~~l 74 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT----K----TARNDFLKEIKIMSRL 74 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC----H----HHHHHHHHHHHHHHhC
Confidence 34689999999999999999986532 2489998853211 1 1234578899999999
Q ss_pred CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----------ccccCHHHHHHHHHHH
Q 022794 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------RRKLAFKVVVQLALDL 181 (292)
Q Consensus 112 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~qi 181 (292)
+|+|++++++++...+.. +++|||+++++|.+++.... ...+++..++.++.|+
T Consensus 75 ~h~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 138 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPL----------------CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQI 138 (295)
T ss_pred CCCCcCeEEEEEcCCCcc----------------EEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHH
Confidence 999999999998766554 89999999999999985421 1236788999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHH
Q 022794 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (292)
Q Consensus 182 ~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg 259 (292)
+.||.+||+.|++|+||||+||++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||
T Consensus 139 ~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 218 (295)
T cd05097 139 ASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218 (295)
T ss_pred HHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHH
Confidence 99999999999999999999999999999999999988654322111 1122346789999999888899999999999
Q ss_pred HHHHHHHh--CCCCCCCCCHHHHHHHHH
Q 022794 260 ICLWEIYC--CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 260 ~il~~l~~--g~~pf~~~~~~~~~~~i~ 285 (292)
+++|+|++ +..||...+..+.+..+.
T Consensus 219 ~~l~el~~~~~~~p~~~~~~~~~~~~~~ 246 (295)
T cd05097 219 VTLWEMFTLCKEQPYSLLSDEQVIENTG 246 (295)
T ss_pred HHHHHHHHcCCCCCCcccChHHHHHHHH
Confidence 99999988 678999888877776654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.95 Aligned_cols=207 Identities=29% Similarity=0.461 Sum_probs=172.8
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|.....||+|+||.||+|.+ +++.|++|.+...... ....+.+|+.+++.+.|||++++++.+...+.
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---------RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---------hHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 455566899999999999965 6899999998543211 12336789999999999999999998876655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 93 ~----------------~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~ 153 (297)
T cd06659 93 L----------------WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD 153 (297)
T ss_pred E----------------EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC
Confidence 4 899999999999987743 458899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.+..+.
T Consensus 154 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 154 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred CcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 99999999988644333333334567889999999998889999999999999999999999998877766665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=244.59 Aligned_cols=215 Identities=28% Similarity=0.465 Sum_probs=175.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
..++|++...||+|+||.||+|.. ..+.+++|.+.... .......+.+|+++++++.|+|+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--------DENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--------chHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 346899999999999999999964 24579999874321 112344578899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-------cccCHHHHHHHHHHHHHHHHHHHhCCc
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-------RKLAFKVVVQLALDLARGLSYLHSQKI 193 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~i 193 (292)
+++.+.+.. +++|||+++++|.+++..... ..+++..+..++.|++.+|+|||+.|+
T Consensus 75 ~~~~~~~~~----------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i 138 (275)
T cd05046 75 GLCREAEPH----------------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARF 138 (275)
T ss_pred EEECCCCcc----------------eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCc
Confidence 988765544 899999999999999965441 258999999999999999999999999
Q ss_pred cccCCCCCCeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 022794 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (292)
Q Consensus 194 ~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~p 271 (292)
+|+||||+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus 139 ~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p 218 (275)
T cd05046 139 VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218 (275)
T ss_pred ccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999875432211 12223345677999999988888999999999999999998 8899
Q ss_pred CCCCCHHHHHHHHHH
Q 022794 272 YPDLSFSEVTSAVVR 286 (292)
Q Consensus 272 f~~~~~~~~~~~i~~ 286 (292)
|...+..+++..+..
T Consensus 219 ~~~~~~~~~~~~~~~ 233 (275)
T cd05046 219 FYGLSDEEVLNRLQA 233 (275)
T ss_pred ccccchHHHHHHHHc
Confidence 988887777776653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=241.73 Aligned_cols=214 Identities=27% Similarity=0.487 Sum_probs=178.1
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||++.+ +|..+++|.+........ ..+.+.+|+.++++++|+|++++++.+...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-------EKEASKKEVILLAKMKHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch-------hhHHHHHHHHHHHhCCCCChhhhhheeccCCe
Confidence 588999999999999999965 578999999854321111 12346789999999999999999998876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.+.....+++..+..++.|++.+|.+||+.+++|+||+|+||+++++
T Consensus 74 ~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 74 L----------------FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred E----------------EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 4 899999999999999976555568999999999999999999999999999999999999887
Q ss_pred C-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 R-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+ .++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+..+....+.++
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 217 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG 217 (257)
T ss_pred CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 5 469999998876544333333345788999999998888999999999999999999999999988777776665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=240.01 Aligned_cols=213 Identities=31% Similarity=0.510 Sum_probs=175.9
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|+..+.||+|++|.||+|.. +++.|++|.+......... ....+.+.+|+.+++.++|+|++++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG----QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccc----hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 477889999999999999966 5899999998654322111 1223457889999999999999999998876654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.+. ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.+
T Consensus 77 ~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~ 138 (258)
T cd06632 77 L----------------YIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138 (258)
T ss_pred E----------------EEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 4 8999999999999998653 458899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||......+...++.+
T Consensus 139 ~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 139 GVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred CCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 999999999887544332 233456788999999987776 88999999999999999999999987776555555443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=244.80 Aligned_cols=209 Identities=32% Similarity=0.504 Sum_probs=175.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+-|++.+.||.|+||.||+|.+ +++.||+|+...... ......+.+|+.++++++|||++++++.+....
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 3577889999999999999965 578999998743211 112345788999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~ 136 (277)
T cd06641 76 KL----------------WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred eE----------------EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC
Confidence 44 899999999999998843 45889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+.
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 137 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred CCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 999999999988655433323333467888999999988888999999999999999999999998877766665543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=242.34 Aligned_cols=207 Identities=33% Similarity=0.538 Sum_probs=162.1
Q ss_pred eeccCcceEEEEEEE-C---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccc
Q 022794 57 VIARGTFGTVHRGLY-D---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~-~---~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
.||+|+||.||+|.. + ...+++|.+.... . ......+.+|+.+++.++|+||+++++.+......
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~----~----~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~--- 70 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA----T----PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY--- 70 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC----C----hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce---
Confidence 589999999999953 3 3457777654221 1 11123477899999999999999999988766554
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcc---cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+++|||+++++|.+++..... ...++..++.++.|++.||+|||++|++||||||+||+++.++
T Consensus 71 -------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~ 137 (269)
T cd05042 71 -------------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL 137 (269)
T ss_pred -------------EEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC
Confidence 899999999999999965432 2356788899999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 210 TVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-------NPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
.++|+|||.+........ ......++..|+|||++.. ..++.++|+||||+++|+|++ |..||......+
T Consensus 138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (269)
T cd05042 138 SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217 (269)
T ss_pred cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 999999998864322111 1122345677999998743 356789999999999999999 899999888877
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
...++..+
T Consensus 218 ~~~~~~~~ 225 (269)
T cd05042 218 VLKQVVRE 225 (269)
T ss_pred HHHHHhhc
Confidence 77666544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=244.99 Aligned_cols=201 Identities=28% Similarity=0.464 Sum_probs=165.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|++|.||+|.+ +|+.|++|++........ ...+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--------PFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--------cHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 6799999999999999999965 588999999864432211 112567999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+. ++|.+++... ...+++..+..++.|++.||.+||+.|++|+||||+||+++.
T Consensus 77 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 138 (291)
T cd07870 77 TL----------------TFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY 138 (291)
T ss_pred eE----------------EEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC
Confidence 44 89999995 6887777543 245778889999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
++.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+
T Consensus 139 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 139 LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 9999999999887543333333445578899999998764 47889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=241.48 Aligned_cols=207 Identities=28% Similarity=0.487 Sum_probs=176.0
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|++|.||+|... ++.+++|.+.... . ...+.+|+.++++++|+|++++++.+...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------D----LQEIIKEISILKQCDSPYIVKYYGSYFKN 70 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------H----HHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence 367999999999999999999663 7899999985221 1 34588899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... ++++||+++++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|.||+++
T Consensus 71 ~~~----------------~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 71 TDL----------------WIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred CcE----------------EEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 544 8999999999999998643 35689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+..+....
T Consensus 134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~ 210 (256)
T cd06612 134 EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210 (256)
T ss_pred CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence 99999999999987654433333334578899999999988899999999999999999999999987766554433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=244.28 Aligned_cols=218 Identities=26% Similarity=0.356 Sum_probs=173.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 126 (292)
++|++.+.||+|++|.||+|.+ +|+.||+|..+....... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-------IPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-------CchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 4689999999999999999965 588999998764332111 123367799999999 569999999988665
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
+.. .....+++|||+++ +|.+++.... ...+++..++.++.||+.||.+||+.|++|+||+|+||
T Consensus 74 ~~~-----------~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ni 141 (295)
T cd07837 74 EKN-----------GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141 (295)
T ss_pred CCC-----------CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 431 11224899999975 8988886432 24689999999999999999999999999999999999
Q ss_pred eEcC-CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 204 LLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+++. ++.++|+|||.+..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+
T Consensus 142 l~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 221 (295)
T cd07837 142 LVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221 (295)
T ss_pred EEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 9998 889999999998755433333333456788999998865 45789999999999999999999999987776666
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
.++.+
T Consensus 222 ~~~~~ 226 (295)
T cd07837 222 LHIFK 226 (295)
T ss_pred HHHHH
Confidence 55543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=241.81 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=171.3
Q ss_pred eccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||.|++|.||+|.+. ++.|++|++...... .......+.+|+.+++.++||||+++++.+.+.+..
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 68 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV------ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI------ 68 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch------hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc------
Confidence 699999999999775 899999998633211 112234588899999999999999999988766554
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
++++||+++++|.+++.+. ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~d 136 (262)
T cd05572 69 ----------YMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVD 136 (262)
T ss_pred ----------EEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEee
Confidence 8999999999999999643 4588999999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Q 022794 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS--FSEVTSAVVR 286 (292)
Q Consensus 216 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~--~~~~~~~i~~ 286 (292)
||.+....... ......++..|++||.+.+..++.++|+||+|+++|+|++|..||.... ..++..++.+
T Consensus 137 f~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 208 (262)
T cd05572 137 FGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208 (262)
T ss_pred CCcccccCccc-ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc
Confidence 99987654332 2223457889999999988889999999999999999999999998777 6666666653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=242.30 Aligned_cols=213 Identities=30% Similarity=0.464 Sum_probs=176.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||.|++|+||+|.. ++..+++|++....... ....+.+|+.+++.+.|+|++++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--------SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--------HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC
Confidence 4789999999999999999965 67899999985332211 2344788999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. ++++|++++++|.+++..... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus 73 ~~----------------~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~ 136 (267)
T cd06610 73 EL----------------WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG 136 (267)
T ss_pred EE----------------EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc
Confidence 44 899999999999999965432 5689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCC----CCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+++.++|+|||.+......... .....++..|+|||.+... .++.++|+||||+++++|++|..||...+..+.+
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~ 216 (267)
T cd06610 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL 216 (267)
T ss_pred CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence 9999999999988654433222 1224578899999998776 7889999999999999999999999887776655
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
.++.+
T Consensus 217 ~~~~~ 221 (267)
T cd06610 217 MLTLQ 221 (267)
T ss_pred HHHhc
Confidence 55444
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=245.11 Aligned_cols=216 Identities=31% Similarity=0.449 Sum_probs=172.9
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 123 (292)
...++|++.+.||+|++|.||+|.+ +++.+++|++..... ....+.+|+.+++.+ +|||++++++++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----------IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----------hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 3457899999999999999999965 688999998753211 112366789999999 799999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
...... .....+++|||+++++|.+++... ....+++..++.++.|++.+|.+||+.+++|+||+|+
T Consensus 85 ~~~~~~-----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 153 (286)
T cd06638 85 YKKDVK-----------NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGN 153 (286)
T ss_pred eecccC-----------CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHH
Confidence 532210 123458999999999999987532 2356889999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||++++++.++|+|||.+..............++..|+|||.+.. ..++.++|+||+|+++|+|++|..||...+
T Consensus 154 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred hEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 999999999999999998765443333334568889999999853 347889999999999999999999998776
Q ss_pred HHHHHHH
Q 022794 277 FSEVTSA 283 (292)
Q Consensus 277 ~~~~~~~ 283 (292)
..+.+.+
T Consensus 234 ~~~~~~~ 240 (286)
T cd06638 234 PMRALFK 240 (286)
T ss_pred hhHHHhh
Confidence 5444433
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=251.49 Aligned_cols=215 Identities=24% Similarity=0.328 Sum_probs=175.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++.+.||+|++|.||+|.+ +|+.||+|.+...... ......+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-------VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-------hhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 47899999999999999999965 6899999988532211 11123356799999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....+++|||+. ++|.+.+.. .+++..+..++.|++.||++||+.|++|+||||+||+++
T Consensus 88 ~~~~----------~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 88 KSLE----------EFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred CCcc----------ccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 3220 1234589999995 588887743 288999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+...++.+
T Consensus 153 ~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 231 (353)
T cd07850 153 SDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231 (353)
T ss_pred CCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99999999999997654322 22334578899999999999999999999999999999999999998877666666544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=248.31 Aligned_cols=204 Identities=28% Similarity=0.487 Sum_probs=172.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||+|+||.||++.+ +++.|++|.+..... ...+.+.+|+.+++.++|||++++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---------PKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---------hHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 36899999999999999999964 678999998853211 1124477899999999999999999988766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. ++++||+++++|.+++.+ ..+++..+..++.|++.+|++||++|++|+||+|+||+++
T Consensus 89 ~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 89 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred CcE----------------EEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 544 899999999999999853 3578889999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.++.++|+|||.+..............++..|++||.+.+..++.++|+||||+++|++++|..||...+..+.
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 99999999999876544433333445678889999999888899999999999999999999999987665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=242.79 Aligned_cols=206 Identities=32% Similarity=0.554 Sum_probs=170.4
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|+..+.||+|++|.||++.+ +++.|++|++...... ..........+.+|+.++++++|+|++++++++.+.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT---SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC---chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 477889999999999999965 6899999998643321 11223345668899999999999999999999877665
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|.||+++.+
T Consensus 78 ~----------------~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~ 139 (268)
T cd06630 78 F----------------NLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139 (268)
T ss_pred E----------------EEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 4 8999999999999998643 468899999999999999999999999999999999999876
Q ss_pred C-cEEEeecCcceeccCCCCC----CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 209 R-TVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 209 ~-~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
+ .++|+|||.+......... .....++..|+|||.+.+..++.++|+||+|+++++|++|..||.....
T Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 140 GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred CCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 5 5999999998655432111 1223577899999999888899999999999999999999999975443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=242.82 Aligned_cols=211 Identities=29% Similarity=0.462 Sum_probs=173.1
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
|++.+.||.|++|.||+|.+ +|+.|++|++........ ....+.+|+.++++++|||++++++++.+.+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-------VPSTAIREISLLKELNHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc-------chhHHHHHHHHHHhcCCCCccCHhheeccCCeE
Confidence 57789999999999999965 689999999865432211 122366799999999999999999998766544
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
++++||+ +++|.+++.......+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++
T Consensus 74 ----------------~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~ 136 (283)
T cd07835 74 ----------------YLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG 136 (283)
T ss_pred ----------------EEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 8999999 46999998765545689999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+.+.++.+
T Consensus 137 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 137 ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999986544333333334567889999988664 468899999999999999999999988777665555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=244.39 Aligned_cols=218 Identities=22% Similarity=0.280 Sum_probs=160.6
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHH--HHHHHHHHHHHHHHHhCCCCcc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEI--AALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i 116 (292)
..++...+|++.+.||+|+||.||+|.+. +..+++|+..........+... .........+...+..+.|+++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 34566789999999999999999999754 3467777654333221111100 0011122334455666799999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++++........ ..+.+++++++ ..++.+.+... ...++..++.++.|++.+|.+||+.+++||
T Consensus 86 ~~~~~~~~~~~~~------------~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 86 PKYYGCGSFKRCR------------MYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred CcEEEeeeEecCC------------ceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999865443321 11236788887 44777766432 336788899999999999999999999999
Q ss_pred CCCCCCeeEcCCCcEEEeecCcceeccCCC-------CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 022794 197 DVKTENMLLDKNRTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 197 di~p~Nili~~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~ 269 (292)
||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~ 230 (294)
T PHA02882 151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230 (294)
T ss_pred CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999987543221 1112246899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 022794 270 MPYPDLS 276 (292)
Q Consensus 270 ~pf~~~~ 276 (292)
+||.+.+
T Consensus 231 ~P~~~~~ 237 (294)
T PHA02882 231 LPWKGFG 237 (294)
T ss_pred CCCCccc
Confidence 9998773
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=249.75 Aligned_cols=195 Identities=27% Similarity=0.414 Sum_probs=155.6
Q ss_pred eeeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccc
Q 022794 56 SVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
..||+|+||.||+|.. ++..||+|.+..... ...+.+|+.++++++||||+++++++......
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 73 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------SMSACREIALLRELKHPNVIALQKVFLSHSDR-- 73 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--
Confidence 5799999999999975 347899998753221 11256799999999999999999988654322
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhh-------cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..++++||+. ++|.+++... ....+++..++.++.|++.||.+||+.|++||||||+||+
T Consensus 74 ------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil 140 (317)
T cd07867 74 ------------KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 140 (317)
T ss_pred ------------eEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEE
Confidence 2389999995 5888877432 1235888999999999999999999999999999999999
Q ss_pred E----cCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 205 L----DKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 205 i----~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+ +.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||....
T Consensus 141 ~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 141 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred EccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 9 4567899999999976543221 12234678899999998764 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=242.08 Aligned_cols=206 Identities=28% Similarity=0.426 Sum_probs=162.5
Q ss_pred eeeccCcceEEEEEEEC----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccc
Q 022794 56 SVIARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
+.||+|+||.||+|.+. +..+++|.++.... . .....+.+|+.++++++||||+++++.+.+....
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 70 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----V----QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY-- 70 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----h----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc--
Confidence 35899999999999653 35689998753321 1 1122477899999999999999999988765544
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
+++|||+++++|.+++.... ....++..+..++.|++.||+|||+.|++|+||||+||+++.+
T Consensus 71 --------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~ 136 (269)
T cd05087 71 --------------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD 136 (269)
T ss_pred --------------EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC
Confidence 89999999999999986532 2245677888999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 209 RTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGN-------PYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-------~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+.++|+|||.+........ ......++..|+|||++.+. .++.++|+||||+++|+|++ |..||...+..
T Consensus 137 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 216 (269)
T cd05087 137 LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE 216 (269)
T ss_pred CcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence 9999999998864332211 11224467789999998642 35789999999999999996 99999988877
Q ss_pred HHHHHHH
Q 022794 279 EVTSAVV 285 (292)
Q Consensus 279 ~~~~~i~ 285 (292)
+......
T Consensus 217 ~~~~~~~ 223 (269)
T cd05087 217 QVLTYTV 223 (269)
T ss_pred HHHHHHh
Confidence 7655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=238.98 Aligned_cols=213 Identities=31% Similarity=0.542 Sum_probs=180.8
Q ss_pred ceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||.|++|.||++.+. ++.|++|++...... ......+.+|++++++++|+|++++.+.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-------EKEREDALNEVKILKKLNHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-------hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE
Confidence 5889999999999999999765 899999998643321 1223447789999999999999999998877644
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
. ++++|++++++|.+++.... ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++
T Consensus 74 ~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~ 137 (258)
T cd08215 74 L----------------CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137 (258)
T ss_pred E----------------EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc
Confidence 4 89999999999999987543 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+++.++|+|||.+..............+++.|+|||...+..++.++|+||+|+++++|++|..||...+..++...+.+
T Consensus 138 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 138 SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217 (258)
T ss_pred CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 99999999999987654443233345678899999999888899999999999999999999999998887777766554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=245.65 Aligned_cols=215 Identities=30% Similarity=0.409 Sum_probs=177.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +++.+++|.++...... .....+.+|+.++++++||||+++++++...+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-------GFPITSLREINILLKLQHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-------cchhhHHHHHHHHHhcCCCCEEEEEEEEEecC
Confidence 5789999999999999999976 47899999986443221 11223567999999999999999999886552
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
. ...++++||++ ++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 78 ~--------------~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~ 141 (293)
T cd07843 78 L--------------DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN 141 (293)
T ss_pred C--------------CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence 1 23389999996 59998886533 36899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++++|++|.+||...+..+...++.+
T Consensus 142 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (293)
T cd07843 142 RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221 (293)
T ss_pred CCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999999876554433344456788899999987654 68899999999999999999999998888777777654
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 222 ~ 222 (293)
T cd07843 222 L 222 (293)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=239.65 Aligned_cols=211 Identities=31% Similarity=0.530 Sum_probs=178.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++.+.||+|++|.||+|.+ +++.|++|.+...... .....+.+|+..+++++|+|++++++.+....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--------EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 3688999999999999999965 4899999998643221 22445788999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nili~ 206 (292)
.. ++++||+++++|.+++... ..+++..++.++.|+++++.+||. .|++|+||+|+||+++
T Consensus 73 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 73 EI----------------SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred eE----------------EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 44 8999999999999999653 568999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL---SFSEVTSA 283 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~---~~~~~~~~ 283 (292)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+....
T Consensus 135 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (264)
T cd06623 135 SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214 (264)
T ss_pred CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH
Confidence 999999999999876554433333456788999999999888999999999999999999999999877 44555554
Q ss_pred HHH
Q 022794 284 VVR 286 (292)
Q Consensus 284 i~~ 286 (292)
+.+
T Consensus 215 ~~~ 217 (264)
T cd06623 215 ICD 217 (264)
T ss_pred Hhc
Confidence 443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=244.93 Aligned_cols=208 Identities=25% Similarity=0.483 Sum_probs=169.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|++|.||++.+ +|+.||+|.++.... . .....+.+|+.++++++|+||+++++.+...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~----~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----E----SKFNQIIMELDILHKAVSPYIVDFYGAFFIEG 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC----H----HHHHHHHHHHHHHHhcCCCcHHhhhhheecCC
Confidence 3688999999999999999976 589999998853211 1 11245778999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nili 205 (292)
.. +++|||+++++|..++.... ...+++..+..++.|++.+|.+||. .|++|+||+|+||++
T Consensus 73 ~~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 136 (286)
T cd06622 73 AV----------------YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV 136 (286)
T ss_pred eE----------------EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence 44 89999999999999885421 2368999999999999999999996 599999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
+.++.++|+|||.+...... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+...
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 137 NGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred CCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 99999999999988654322 222245778899999986543 4789999999999999999999998766555
Q ss_pred HHHH
Q 022794 280 VTSA 283 (292)
Q Consensus 280 ~~~~ 283 (292)
....
T Consensus 215 ~~~~ 218 (286)
T cd06622 215 IFAQ 218 (286)
T ss_pred HHHH
Confidence 4443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=242.15 Aligned_cols=202 Identities=31% Similarity=0.543 Sum_probs=164.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
..+|++.+.||+|+||.||++.. +++.|++|.+.... ....+.+.+|+.+++++.|||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 73 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---------AEHLRDFEREIEILKSLQHDNIVKYKGV 73 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---------HHHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence 46899999999999999999863 47889999985322 1123457789999999999999999987
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...+.. ..++++||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||||+|
T Consensus 74 ~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~n 138 (284)
T cd05081 74 CYSAGRR--------------NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN 138 (284)
T ss_pred EccCCCC--------------ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhh
Confidence 7544322 238999999999999998653 2458899999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCC---CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|++++++.++|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++++|++|..|+..
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 999999999999999987654322211 112234569999999988899999999999999999998777653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=240.55 Aligned_cols=215 Identities=28% Similarity=0.508 Sum_probs=174.5
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCC-CccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEG-HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+|.+.+.||+|++|.||+|.. +|+.+++|.++..... ...........+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688899999999999999954 6889999988643221 1122223334556888999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+++++|.+++.+. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 82 ~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 82 YL----------------SIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA 143 (272)
T ss_pred ce----------------EEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC
Confidence 54 8999999999999998654 46899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++.++|+|||.+........ ......++..|+|||.+.... ++.++|+||||++++++++|..||......+....
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 99999999999865432211 122345778999999987654 78999999999999999999999986665544433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.37 Aligned_cols=211 Identities=28% Similarity=0.467 Sum_probs=178.4
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
....|.+.+.||+|++|.||+|.+. +..|++|++..... ....+.+|+.++++++|+|++++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----------NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 3457899999999999999999764 88999999864322 23347789999999999999999999877
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... ++++||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 87 ~~~~----------------~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 87 GDEL----------------WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred CCEE----------------EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 6554 89999999999999997543 368999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 150 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 150 SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987654433323333457788999999988889999999999999999999999999877766555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.27 Aligned_cols=211 Identities=27% Similarity=0.418 Sum_probs=173.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|++|.||+|.+ +++.|++|.++..... ......+.+|+.+++++.|+||+++++.+...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-------EDVKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-------ccchhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 4799999999999999999966 5789999988543221 112345788999999999999999999987755
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||++++.+..+... ...+++..++.++.|++.+|.+||..|++|+||+|+||++++
T Consensus 74 ~~----------------~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 74 RL----------------YLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred EE----------------EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 44 899999987666655432 345899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+.+..+.
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred CCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999876544332 33345677889999999888 78999999999999999999999998776665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=245.84 Aligned_cols=212 Identities=26% Similarity=0.593 Sum_probs=170.4
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+|++.+.||+|++|.||+|.+ +|. .|++|.+..... ......+.+|+.+++++.||||+++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~h~niv~~~~ 76 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--------PKANVEFMDEALIMASMDHPHLVRLLG 76 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 346789999999999999999965 454 468887753221 111234778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
.+.... . +++++|+++|+|.+++... ...+++..++.++.|++.+|.|||++|++|+||||+
T Consensus 77 ~~~~~~-~----------------~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 77 VCLSPT-I----------------QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred EEcCCC-c----------------eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 876432 1 6899999999999998653 335889999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
||++++++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+....
T Consensus 139 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~ 218 (303)
T cd05110 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218 (303)
T ss_pred eeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998754432221 122334678999999998889999999999999999997 99999887766
Q ss_pred HHHHHHH
Q 022794 279 EVTSAVV 285 (292)
Q Consensus 279 ~~~~~i~ 285 (292)
+....+.
T Consensus 219 ~~~~~~~ 225 (303)
T cd05110 219 EIPDLLE 225 (303)
T ss_pred HHHHHHH
Confidence 6554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.31 Aligned_cols=209 Identities=29% Similarity=0.471 Sum_probs=175.1
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|...+.||+|++|.||++.+ +++.+++|.+..... ...+.+.+|+.++++++|||++++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---------hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 456678999999999999965 578899998753221 112347789999999999999999998876555
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.. ..+++..+..++.|++.+|++||++|++||||+|+||+++.+
T Consensus 91 ~----------------~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 91 L----------------WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred E----------------EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 4 899999999999999854 458899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.+..+...
T Consensus 152 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~ 230 (285)
T cd06648 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230 (285)
T ss_pred CcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence 9999999998764433333333356788999999998888999999999999999999999999888777776666544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=237.31 Aligned_cols=201 Identities=34% Similarity=0.561 Sum_probs=170.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|++|.||++.. +++.|++|+++..... ....+.+.+|+.++++++|+||+++++.+...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-------hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE
Confidence 588999999999999999965 6889999998644321 2334568899999999999999999998766554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|.||+++++
T Consensus 74 ~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 74 V----------------YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred E----------------EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 4 8999999999999998543 457889999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCC----CCCCcccccCCcccCCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 209 RTVKIADFGVARVEASNPNDMT----GETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~---~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+.++|+|||.+........... ...++..|+|||.+.+.. ++.++|+||+|++++++++|..||....
T Consensus 136 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 9999999999876543322221 245678999999998766 7899999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=253.60 Aligned_cols=208 Identities=23% Similarity=0.325 Sum_probs=166.8
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 119 (292)
..-+.+.+..|++++.||+||.+.||++... ...||+|.......+ .+..+-+.+|+.+|.+| .|.+|+++
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-------~qtl~gy~nEI~lL~KLkg~~~IIqL 425 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-------NQTLDGYRNEIALLNKLKGHDKIIQL 425 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-------HHHHHHHHHHHHHHHHhcCCceEEEE
Confidence 4557888899999999999999999999765 456777755432221 23345688999999999 79999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
+++-...+.+ |+||||= ..+|..++++... ..+.-.++.++.||+.|+.++|++||||.|||
T Consensus 426 ~DYEv~d~~l----------------YmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLK 487 (677)
T KOG0596|consen 426 YDYEVTDGYL----------------YMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLK 487 (677)
T ss_pred eeeeccCceE----------------EEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCC
Confidence 9998765544 9999988 6699999976433 34434788999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCC-----------CCCchhhHHHHHHHHHHHH
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGN-----------PYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-----------~~~~~~Diwslg~il~~l~ 266 (292)
|.|+|+ -.|.+||+|||.|..+...... .....||+.||+||.+... +.++++||||||||||+|+
T Consensus 488 PANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 488 PANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred cccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 999998 6788999999999765544332 2346799999999998422 2568899999999999999
Q ss_pred hCCCCCCCC
Q 022794 267 CCDMPYPDL 275 (292)
Q Consensus 267 ~g~~pf~~~ 275 (292)
.|+.||...
T Consensus 567 YgktPf~~~ 575 (677)
T KOG0596|consen 567 YGKTPFGQI 575 (677)
T ss_pred hcCCchHHH
Confidence 999999753
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.15 Aligned_cols=207 Identities=33% Similarity=0.548 Sum_probs=165.2
Q ss_pred eeeccCcceEEEEEEEC--Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccc
Q 022794 56 SVIARGTFGTVHRGLYD--GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~--~~--~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 130 (292)
+.||+|+||.||+|.+. +. .+++|.++.... . .....+.+|+.+++++ .||||+++++++...+..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~----~----~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~- 71 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS----K----DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL- 71 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC----H----HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCc-
Confidence 36899999999999653 33 467887752211 1 1123477899999999 899999999998765543
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++|||+++++|.+++.... ...+++..++.++.|++.||++||+.|++|+
T Consensus 72 ---------------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~ 136 (270)
T cd05047 72 ---------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 136 (270)
T ss_pred ---------------eEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 89999999999999986532 1247889999999999999999999999999
Q ss_pred CCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 197 di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
||||+||++++++.++|+|||++....... .......+..|+|||++.+..++.++|+||||+++|+|++ |..||.+.
T Consensus 137 dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 215 (270)
T cd05047 137 DLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 215 (270)
T ss_pred ccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 999999999999999999999875222111 1111223567999999988889999999999999999997 99999988
Q ss_pred CHHHHHHHHHHh
Q 022794 276 SFSEVTSAVVRQ 287 (292)
Q Consensus 276 ~~~~~~~~i~~~ 287 (292)
+..+....+..+
T Consensus 216 ~~~~~~~~~~~~ 227 (270)
T cd05047 216 TCAELYEKLPQG 227 (270)
T ss_pred CHHHHHHHHhCC
Confidence 888877776553
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=270.59 Aligned_cols=217 Identities=37% Similarity=0.632 Sum_probs=183.2
Q ss_pred ecCCceeEeeeeccCcceEEEEEEEC---Cc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYD---GH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
+...+.++...||+|.||.||.|... |. .||+|.++.... .+....|.+|+.+++.++||||+++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--------~~~~~~Fl~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--------EQEVSDFLKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--------HHHHHHHHHHHHHHhcCCCcceeeE
Confidence 44678899999999999999999652 32 489998864432 1223458899999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 194 (292)
++++.+.... +|++|||++|+|..||++.+ ...++...++.++.+++++..||+++++|
T Consensus 761 iGv~l~~~~~----------------~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fv 824 (1025)
T KOG1095|consen 761 IGVCLDSGPP----------------LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFV 824 (1025)
T ss_pred EEeecCCCCc----------------EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCc
Confidence 9999986655 89999999999999998652 45688999999999999999999999999
Q ss_pred ccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC-CCC-CCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 022794 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPND-MTG-ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMP 271 (292)
Q Consensus 195 h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~-~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~p 271 (292)
||||...|+|+++...+|++|||+|+........ ... ......|||||.+..+.++.++||||||+++||+++ |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999843322221 111 245579999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHh
Q 022794 272 YPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 272 f~~~~~~~~~~~i~~~ 287 (292)
|.+.++.+++.-+.++
T Consensus 905 Y~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 905 YPSRSNFEVLLDVLEG 920 (1025)
T ss_pred CCCcchHHHHHHHHhC
Confidence 9999999999877665
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=245.89 Aligned_cols=202 Identities=27% Similarity=0.505 Sum_probs=170.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|++.+.||+|++|.||++.+ +|+.|++|+...... ......+.+|+.+++.++||||+++++.+..
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--------SSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--------chHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 346899999999999999999976 488999998864321 1123457889999999999999999999877
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCee
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENML 204 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nil 204 (292)
.+.. ++++||+++++|.+++.+. ..+++..+..++.+++.+|.|||+ .+++|+||+|+||+
T Consensus 75 ~~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 75 ENNI----------------CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred CCEE----------------EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 6544 8999999999999988543 468999999999999999999997 68999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
+++++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+||++|++++|..||.....
T Consensus 137 ~~~~~~~~l~d~gl~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 137 VNSRGQIKLCDFGVSGELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ECCCCcEEEccCCcccchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 999999999999987643222 12234678899999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=238.74 Aligned_cols=206 Identities=28% Similarity=0.454 Sum_probs=172.5
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||.|++|.||++.+ +|+.+++|++.... .........+.+|++++++++|+|++++++.+...+..
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD------MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL------ 68 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh------hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE------
Confidence 68999999999976 48999999985322 11123345678899999999999999999887665544
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
++++||+++++|.+++.+. ..+++..++.++.|++++|++||+.|++|+||+|+||++++++.++|+|
T Consensus 69 ----------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~d 136 (265)
T cd05579 69 ----------YLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTD 136 (265)
T ss_pred ----------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEe
Confidence 8999999999999998653 3689999999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCC--------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 216 FGVARVEASNPN--------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 216 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
||.+........ ......++..|++||...+..++.++|+||||+++|++++|..||...+..+....+..+
T Consensus 137 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (265)
T cd05579 137 FGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG 216 (265)
T ss_pred cccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 998865433211 223345678899999998888899999999999999999999999988888888777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=241.08 Aligned_cols=213 Identities=29% Similarity=0.464 Sum_probs=177.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 126 (292)
++|.+.+.||+|++|.||+|.. +|+.|++|++...... .....+.+.+|..+++++. |+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc------chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence 4799999999999999999966 6899999998542211 1112345778999999998 99999999988766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++||++++++|.+++.+. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 75 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~ 136 (280)
T cd05581 75 ENL----------------YFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136 (280)
T ss_pred ceE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 554 8999999999999999653 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC--------------------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN--------------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~ 266 (292)
.++.++|+|||.+........ ......++..|+|||...+..++.++|+||||+++++++
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~ 216 (280)
T cd05581 137 KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216 (280)
T ss_pred CCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH
Confidence 999999999998875433221 122345678999999998888999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHH
Q 022794 267 CCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 267 ~g~~pf~~~~~~~~~~~i~~ 286 (292)
+|..||...+.......+.+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 217 TGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred hCCCCCCCccHHHHHHHHHh
Confidence 99999998877666666553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=247.22 Aligned_cols=213 Identities=25% Similarity=0.382 Sum_probs=169.5
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|++|.||+|.+ +|+.||+|.+..... ......+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--------QTFCQRTLREIKILRRFKHENIIGILDIIRPP 75 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--------chhHHHHHHHHHHHHhCCCCCcCchhheeecc
Confidence 36899999999999999999965 688999998853211 11234467799999999999999999876554
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .....++++||+. ++|.+.+. ...+++..++.++.|++.||++||+.|++|+||||+||+++
T Consensus 76 ~~~-----------~~~~~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~ 140 (336)
T cd07849 76 SFE-----------SFNDVYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 140 (336)
T ss_pred ccc-----------ccceEEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC
Confidence 321 1223489999995 58887773 34689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+......
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~ 220 (336)
T cd07849 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220 (336)
T ss_pred CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999875433221 1122457888999998754 468899999999999999999999998776555444
Q ss_pred HH
Q 022794 283 AV 284 (292)
Q Consensus 283 ~i 284 (292)
.+
T Consensus 221 ~~ 222 (336)
T cd07849 221 LI 222 (336)
T ss_pred HH
Confidence 33
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=241.26 Aligned_cols=201 Identities=25% Similarity=0.398 Sum_probs=165.1
Q ss_pred ceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
+|++.+.||+|+||.||+|.+ +|+.||+|+++.... .......+.+.+|+.+++++ +|++|+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-----hhcchHHHHHHHHHHHHHhcccCCChhceeeEee
Confidence 488999999999999999865 688999999863221 11122334577899999999 6999999998887
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..... ++++||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+
T Consensus 76 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil 137 (290)
T cd05613 76 TDTKL----------------HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL 137 (290)
T ss_pred cCCeE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 65544 8999999999999998653 46889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 205 LDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.++.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus 138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 9999999999999886543221 111234578899999998753 467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=244.27 Aligned_cols=201 Identities=28% Similarity=0.472 Sum_probs=164.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
...|++++.||+|+||.||++.. ++..|++|.++.... ......+.+|+.+++++.|||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------GNHIADLKKEIEILRNLYHENIVKYKGI 74 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--------HHHHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 45679999999999999999863 477899999753221 1123457889999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...+.. ..+++|||+++++|.+++.+. ...+++..++.++.|++.||++||++|++|+||+|+|
T Consensus 75 ~~~~~~~--------------~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~N 139 (284)
T cd05079 75 CTEDGGN--------------GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 139 (284)
T ss_pred EecCCCC--------------ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchhe
Confidence 7664222 238999999999999998653 2358999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
|+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|+++..|+
T Consensus 140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 99999999999999998754432211 12234566899999998888999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=236.52 Aligned_cols=204 Identities=26% Similarity=0.384 Sum_probs=165.8
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH-HHhCCCCcccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV-WHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
+.||+|++|.||+|.+ +|+.||+|++...... .... ...+..|..+ .....|+|++++++.+...+..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-----~~~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~--- 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-----AKNQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL--- 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-----HHHH-HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE---
Confidence 5689999999999966 6889999998532110 1111 1223344444 4455999999999998766544
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
++++||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 73 -------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~ 137 (260)
T cd05611 73 -------------YLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137 (260)
T ss_pred -------------EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence 8999999999999998543 4689999999999999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+|||.+..... .....++..|++||.+.+..++.++|+||+|+++|+|++|..||...+..++...+..+
T Consensus 138 l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (260)
T cd05611 138 LTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208 (260)
T ss_pred Eeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 999998864332 22345778899999998888899999999999999999999999998888877776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=240.92 Aligned_cols=205 Identities=31% Similarity=0.536 Sum_probs=170.2
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---CCcccceeceecC
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATMG 125 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 125 (292)
.|++.+.||+|++|.||+|.+ +++.|++|.++...... ....+.+|+.+++++. |||++++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~ 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--------DVSDIQREVALLSQLRQSQPPNITKYYGSYLK 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--------hHHHHHHHHHHHHHhccCCCCCeeeEeeeeee
Confidence 477889999999999999975 68899999986432111 1223667888998886 9999999998876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 74 ~~~~----------------~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 74 GPRL----------------WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred CCEE----------------EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 5544 899999999999998843 368899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++++.++|+|||.+..............++..|+|||.+.++ .++.++|+||||+++|+|++|..||.+.+......
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (277)
T cd06917 135 TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM 212 (277)
T ss_pred cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh
Confidence 999999999999987665444334445688899999998654 46889999999999999999999998776655443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=236.03 Aligned_cols=212 Identities=33% Similarity=0.559 Sum_probs=178.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||++.+ +++.+++|.+...... ......+.+|+.++++++|+||+++++++.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-------QKEREDAVNEIRILASVNHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE
Confidence 588999999999999999965 6789999998533211 1123446779999999999999999998877654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
. ++++||+++++|.+++.+. ....+++..++.++.|++.||++||+.|++|+||+|.||+++
T Consensus 74 ~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~ 137 (256)
T cd08530 74 L----------------CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV 137 (256)
T ss_pred E----------------EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe
Confidence 4 8999999999999998652 235688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||...+..++...+..
T Consensus 138 ~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 138 ANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred cCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 9999999999998765443 22234578899999999988899999999999999999999999999888777666554
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 216 ~ 216 (256)
T cd08530 216 G 216 (256)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=251.70 Aligned_cols=217 Identities=31% Similarity=0.527 Sum_probs=185.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
-++......++++||+|-||.|.++...+ ..||+|.++.... ...+..|.+|+++|.+|+||||+.++++|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--------~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--------KNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--------hhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 34556788999999999999999997665 9999999974432 12256699999999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.+ ++++||++.|+|..|+.++.-..........++.||+.+++||.+.+++|||+.+.|+
T Consensus 605 ~~DePi----------------cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc 668 (807)
T KOG1094|consen 605 VQDDPL----------------CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC 668 (807)
T ss_pred ecCCch----------------HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence 988877 8999999999999999876544456667788999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCC--CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMT--GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC--CDMPYPDLSFSE 279 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~--g~~pf~~~~~~~ 279 (292)
|++.++++|++|||.++-+........ ......+|+|||.+.-++++.++|+|++|+.+||+++ ...||...+.++
T Consensus 669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 999999999999999975544333222 2446789999999999999999999999999999765 789999999999
Q ss_pred HHHHHH
Q 022794 280 VTSAVV 285 (292)
Q Consensus 280 ~~~~i~ 285 (292)
+++...
T Consensus 749 vven~~ 754 (807)
T KOG1094|consen 749 VVENAG 754 (807)
T ss_pred HHHhhh
Confidence 887653
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=238.93 Aligned_cols=202 Identities=33% Similarity=0.517 Sum_probs=168.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|...+.||.|++|.||++.+ +++.+++|.+...... .....+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--------DLQKQILRELEINKSCKSPYIVKYYGAFLDES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--------HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC
Confidence 4688999999999999999976 6889999988633211 22345788999999999999999999886543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. .++++|||+++++|.+++... ....+++..+..++.|++.+|.|||..|++|+||+|.||++
T Consensus 73 ~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~ 138 (287)
T cd06621 73 SS--------------SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL 138 (287)
T ss_pred CC--------------eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 22 238999999999999987532 34568899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
++++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 139 TRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999986443221 12345678899999999888999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=240.27 Aligned_cols=199 Identities=31% Similarity=0.572 Sum_probs=168.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||.|++|.||++.+ +++.+++|.+...... .....+.+|+.+++++.||||+++++.+...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--------AIQKQILRELDILHKCNSPYIVGFYGAFYNNG 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--------HHHHHHHHHHHHHHHCCCCchhhhheeeecCC
Confidence 3678889999999999999976 4889999988643211 22345778999999999999999999887665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nili~ 206 (292)
.. ++++||+++++|.+++.... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||+++
T Consensus 73 ~~----------------~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 73 DI----------------SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred EE----------------EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 44 89999999999999986533 578999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+++.++|+|||.+......... ...++..|+|||.+.+..++.++|+||+|+++++|++|..||...
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 136 SRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred CCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999987644322111 156778999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=259.60 Aligned_cols=211 Identities=28% Similarity=0.489 Sum_probs=179.5
Q ss_pred CceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.-|.|++.||.|+||.||+|... +--.|-|++.. ...++.. .+.-|+.||..+.||+|+.+++.|+..+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELE----DylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELE----DYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHh----hhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 34788999999999999999554 44456666642 2223322 3567999999999999999999988777
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ ||++|||.||-.+..+.. -++.+.+..+..+++|++.||.|||+.+|+|||||..|||++-
T Consensus 103 kL----------------wiliEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl 165 (1187)
T KOG0579|consen 103 KL----------------WILIEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL 165 (1187)
T ss_pred ce----------------EEEEeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe
Confidence 66 899999999999988765 4567999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+|.++|.|||.+............+.||+.|||||+.. ..+|+.++||||||+.|++|..+.+|....++-.++-
T Consensus 166 dGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll 245 (1187)
T KOG0579|consen 166 DGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 245 (1187)
T ss_pred cCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH
Confidence 99999999999876655555666789999999999964 3578999999999999999999999999999988887
Q ss_pred HHHH
Q 022794 283 AVVR 286 (292)
Q Consensus 283 ~i~~ 286 (292)
+|-+
T Consensus 246 KiaK 249 (1187)
T KOG0579|consen 246 KIAK 249 (1187)
T ss_pred HHhh
Confidence 7755
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=240.01 Aligned_cols=206 Identities=32% Similarity=0.558 Sum_probs=166.4
Q ss_pred eeccCcceEEEEEEECC--------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 57 VIARGTFGTVHRGLYDG--------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~~~--------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.||+|++|.||+|.... ..+++|.+..... ......+.+|+.+++.+.||||+++++++...+.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc--------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 68999999999996532 5789998743211 1113347789999999999999999998876554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
. +++|||+++++|.+++.... ...+++..+..++.|++.+|+|||+.+++|+||+|+||
T Consensus 74 ~----------------~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 137 (269)
T cd05044 74 Q----------------YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNC 137 (269)
T ss_pred e----------------EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheE
Confidence 4 89999999999999996432 23478899999999999999999999999999999999
Q ss_pred eEcCCC-----cEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 204 LLDKNR-----TVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 204 li~~~~-----~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
+++.++ .++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 138 l~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred EEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 998877 899999998864432211 1112345678999999998889999999999999999998 99999988
Q ss_pred CHHHHHHHHHH
Q 022794 276 SFSEVTSAVVR 286 (292)
Q Consensus 276 ~~~~~~~~i~~ 286 (292)
+..+....+..
T Consensus 218 ~~~~~~~~~~~ 228 (269)
T cd05044 218 NNQEVLQHVTA 228 (269)
T ss_pred CHHHHHHHHhc
Confidence 88777766554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.57 Aligned_cols=210 Identities=32% Similarity=0.519 Sum_probs=177.7
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||++.+ +++.|++|.+...... ......+.+|+++++++.|+|++++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 588999999999999999965 5789999998644321 1224458889999999999999999998876544
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 ~----------------~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 74 L----------------YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred E----------------EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 4 8999999999999998654 568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++|+|||.+..............++..|+|||...+..++.++|+|++|+++++|++|..||...+......++.
T Consensus 136 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 136 GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred CCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 99999999998766544443344567889999999988888999999999999999999999998777655555443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=237.01 Aligned_cols=208 Identities=33% Similarity=0.536 Sum_probs=163.2
Q ss_pred eeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 56 SVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
+.||+|+||.||+|.+. +..||+|...... .. .....+.+|+.+++.++|||++++++.+...+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 70 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DL----EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG-- 70 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CH----HHHHHHHHHHHHHccCCCCCcceEEEEeecCCC--
Confidence 36899999999999642 3579999874221 11 113447789999999999999999997654322
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
..++++||+.+++|.+++.... ...++..+..++.|++.||.+||+.+++|+||+|+||++++++.
T Consensus 71 -------------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~ 136 (262)
T cd05058 71 -------------SPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT 136 (262)
T ss_pred -------------CcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc
Confidence 2289999999999999986532 34677788899999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCC----CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022794 211 VKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~ 285 (292)
++|+|||.++...... .......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+..++...+.
T Consensus 137 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05058 137 VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216 (262)
T ss_pred EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 9999999986443211 11112334668999999988889999999999999999999 578888877777666655
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
++
T Consensus 217 ~~ 218 (262)
T cd05058 217 QG 218 (262)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=236.07 Aligned_cols=207 Identities=27% Similarity=0.485 Sum_probs=162.0
Q ss_pred eeccCcceEEEEEEE-CCc---eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccc
Q 022794 57 VIARGTFGTVHRGLY-DGH---DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~-~~~---~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
.||+|+||.||++.. ++. .+++|.+..... ......+.+|+.+++.++|||++++++.+......
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~--- 70 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--------SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY--- 70 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--------hHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc---
Confidence 589999999999953 333 355555532211 11134578899999999999999999998766544
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
+++|||+++++|.+++.+.. ....++..++.++.|++.||.|||+.+++|+||||+||+++.++.
T Consensus 71 -------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~ 137 (268)
T cd05086 71 -------------LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT 137 (268)
T ss_pred -------------EEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc
Confidence 89999999999999996542 234667788899999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCC--CCCCCCCCcccccCCcccCC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 211 VKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNG-------NPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
++|+|||.+....... .......++..|+|||++.. ..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 138 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 217 (268)
T cd05086 138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV 217 (268)
T ss_pred EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999875322111 11223456789999999753 235788999999999999997 6789998888888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+..+.++
T Consensus 218 ~~~~~~~ 224 (268)
T cd05086 218 LNHVIKD 224 (268)
T ss_pred HHHHHhh
Confidence 8776655
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=235.42 Aligned_cols=206 Identities=35% Similarity=0.640 Sum_probs=168.9
Q ss_pred eeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccc
Q 022794 56 SVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 134 (292)
+.||+|++|.||++.+. ++.|++|........ .....+.+|+.+++++.|+||+++++++.+....
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----- 67 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI----- 67 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe-----
Confidence 46899999999999654 899999988543221 2234578899999999999999999988766554
Q ss_pred cccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEe
Q 022794 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214 (292)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~ 214 (292)
+++|||+++++|.+++... ...+++..+..++.+++.+|.+||++|++|+||+|+||+++.++.++|+
T Consensus 68 -----------~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~ 135 (251)
T cd05041 68 -----------YIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKIS 135 (251)
T ss_pred -----------EEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEe
Confidence 8999999999999998653 3357899999999999999999999999999999999999999999999
Q ss_pred ecCcceeccCCCCCCC--CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022794 215 DFGVARVEASNPNDMT--GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 215 Dfg~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~ 286 (292)
|||.+........... ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~ 210 (251)
T cd05041 136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES 210 (251)
T ss_pred eccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc
Confidence 9999865432211111 1223557999999988889999999999999999999 8999988877766665543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=241.00 Aligned_cols=220 Identities=26% Similarity=0.331 Sum_probs=173.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|++|.||+|.+ +++.||+|.+......... ...+.+|+.+++++.||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc-------hhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 46899999999999999999965 5889999988644322111 12245799999999999999999988665
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .......+++|||+. ++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 84 ~~~~--------~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~ 153 (310)
T cd07865 84 ATPY--------NRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT 153 (310)
T ss_pred cccc--------cCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 4320 011234589999995 5888877542 34689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~ 233 (310)
T cd07865 154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233 (310)
T ss_pred CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999875433221 11234567889999988765 3688999999999999999999999988776555
Q ss_pred HHHH
Q 022794 282 SAVV 285 (292)
Q Consensus 282 ~~i~ 285 (292)
..+.
T Consensus 234 ~~~~ 237 (310)
T cd07865 234 TLIS 237 (310)
T ss_pred HHHH
Confidence 4443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=233.00 Aligned_cols=207 Identities=32% Similarity=0.573 Sum_probs=175.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||++.+ +++.+++|++..... .....+.+|+.+++++.|++++++++.+.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 478899999999999999976 488999999864332 223457789999999999999999998877654
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. ++++||+++++|.+++.... ..+++..++.++.|++.+|.+||..|++|+||+|+||+++++
T Consensus 72 ~----------------~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (253)
T cd05122 72 L----------------WIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134 (253)
T ss_pred E----------------EEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC
Confidence 4 89999999999999986532 568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 135 ~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 135 GEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred CeEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 9999999998875543322 33456788999999999888999999999999999999999999887554444433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=237.03 Aligned_cols=194 Identities=26% Similarity=0.438 Sum_probs=158.7
Q ss_pred eeeccCcceEEEEEEECCc------------eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 56 SVIARGTFGTVHRGLYDGH------------DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~------------~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
+.||+|+||.||+|.+.+. .+++|++..... . ...+.+|+.++++++||||+++++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------~--~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--------D--SLAFFETASLMSQLSHKHLVKLYGVC 70 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--------h--HHHHHHHHHHHHcCCCcchhheeeEE
Confidence 4689999999999976432 377777642211 0 34577899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.. ... +++|||+++++|.+++..... .+++..+..++.|++.+|.|||+.|++|+||||+||
T Consensus 71 ~~-~~~----------------~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Ni 132 (259)
T cd05037 71 VR-DEN----------------IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNI 132 (259)
T ss_pred ec-CCc----------------EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceE
Confidence 66 333 899999999999999865432 688999999999999999999999999999999999
Q ss_pred eEcCCC-------cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHh-CCCCCC
Q 022794 204 LLDKNR-------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYC-CDMPYP 273 (292)
Q Consensus 204 li~~~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~-g~~pf~ 273 (292)
+++.++ .++|+|||.+..... .....+...|+|||.+.+. .++.++|+||||+++++|++ |..||.
T Consensus 133 ll~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~ 208 (259)
T cd05037 133 LVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208 (259)
T ss_pred EEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence 998887 799999999875443 2224466789999999876 78899999999999999999 688998
Q ss_pred CCCHHHHH
Q 022794 274 DLSFSEVT 281 (292)
Q Consensus 274 ~~~~~~~~ 281 (292)
..+..+..
T Consensus 209 ~~~~~~~~ 216 (259)
T cd05037 209 TLSSSEKE 216 (259)
T ss_pred cCCchhHH
Confidence 77654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.88 Aligned_cols=220 Identities=30% Similarity=0.573 Sum_probs=187.0
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC----Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD----GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~--~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 115 (292)
-.+..+..+.....++||.|.||.||.|+++ |+ .||||+.+....... .+.|..|+.+++.+.|||
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--------tekflqEa~iMrnfdHph 452 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--------TEKFLQEASIMRNFDHPH 452 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--------HHHHHHHHHHHHhCCCcc
Confidence 3456666677788889999999999999764 22 589998875543222 456899999999999999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
|+++++++.+..- |||||.++.|.|..|++.++. .++...+..++.||+.||.|||+.+++|
T Consensus 453 IikLIGv~~e~P~-----------------WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVH 514 (974)
T KOG4257|consen 453 IIKLIGVCVEQPM-----------------WIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVH 514 (974)
T ss_pred hhheeeeeeccce-----------------eEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhh
Confidence 9999999976532 899999999999999987554 5889999999999999999999999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCC-CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~ 273 (292)
|||...|||+.....+||+|||+++.+.+...... .......|||||.+.-.+++.++|+|.||+++||++. |..||.
T Consensus 515 RDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 515 RDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred hhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 99999999999999999999999998766544333 3345679999999999999999999999999999988 999999
Q ss_pred CCCHHHHHHHHHHh
Q 022794 274 DLSFSEVTSAVVRQ 287 (292)
Q Consensus 274 ~~~~~~~~~~i~~~ 287 (292)
+..+.+++-.|.+|
T Consensus 595 gvkNsDVI~~iEnG 608 (974)
T KOG4257|consen 595 GVKNSDVIGHIENG 608 (974)
T ss_pred cccccceEEEecCC
Confidence 99998887776665
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=245.09 Aligned_cols=216 Identities=27% Similarity=0.358 Sum_probs=172.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||+|++|+||+|.+ +++.|++|.++....... ....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-------DAKRTLREIKLLRHLDHENVIAIKDIMPPP 76 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc-------hhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence 35899999999999999999965 588999998863321111 122356799999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .....++++||+. ++|.+++.. ...+++..++.++.|++.||.+||+++++|+||+|+||+++
T Consensus 77 ~~~-----------~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~ 142 (337)
T cd07858 77 HRE-----------AFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 142 (337)
T ss_pred ccc-----------ccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 321 1123489999994 689988854 35689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||++..............++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+.
T Consensus 143 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 222 (337)
T cd07858 143 ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLIT 222 (337)
T ss_pred CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Confidence 9999999999998765433233334567889999998865 458899999999999999999999998877655554443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=237.44 Aligned_cols=220 Identities=23% Similarity=0.472 Sum_probs=177.2
Q ss_pred ceeEeeeeccCcceEEEEEEEC---CceeEEEEeecCCCCCcc-HHHHHHHHHHHHHHHHHHHh-CCCCcccceeceecC
Q 022794 51 KLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRT-EAEIAALRSAFTQEVAVWHK-LDHPNVTKFIGATMG 125 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~---~~~valK~~~~~~~~~~~-~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 125 (292)
.|++.+.||+|++|.||+|.+. ++.+++|.+......... ..........+.+|+.++.+ ++|||++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999764 578999988644322111 11112233446678888865 699999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTEN 202 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~N 202 (292)
.+.. +++|||+++++|.+++... ....+++..++.++.|++.+|.+||. .|++|+||+|.|
T Consensus 81 ~~~~----------------~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~n 144 (269)
T cd08528 81 NDRL----------------YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNN 144 (269)
T ss_pred CCeE----------------EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHH
Confidence 6554 8999999999999988542 34568999999999999999999996 689999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
|+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 145 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~ 223 (269)
T cd08528 145 IMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223 (269)
T ss_pred EEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence 999999999999999987654332 3344567889999999998889999999999999999999999998887777666
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.++
T Consensus 224 ~~~~~ 228 (269)
T cd08528 224 KIVEA 228 (269)
T ss_pred HHhhc
Confidence 66544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=237.34 Aligned_cols=219 Identities=30% Similarity=0.520 Sum_probs=171.9
Q ss_pred eeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 52 LVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
|.+.+.||+|++|.||+|.+ ++..||||++...... . ...+.+.+|+.++++++|||++++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~---~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS---S----SDIEEFLREAACMKEFDHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC---h----HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 56788999999999999964 3678999998533211 1 1133467899999999999999999987654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
..... ....+++++|+.+++|.+++.... ...++...++.++.|++.+|+|||++|++|+||||+|
T Consensus 74 ~~~~~----------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~n 143 (273)
T cd05074 74 RAKGR----------LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143 (273)
T ss_pred CCCCc----------ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhh
Confidence 32110 112378999999999998874321 2247888999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
|+++.++.++|+|||.+......... .....++..|++||.+.+..++.++|+||||+++|+|++ |.+||...+..+
T Consensus 144 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 144 CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred EEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 99999999999999998754322211 112334568999999988889999999999999999999 899999888877
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
+...+.++
T Consensus 224 ~~~~~~~~ 231 (273)
T cd05074 224 IYNYLIKG 231 (273)
T ss_pred HHHHHHcC
Confidence 77666543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=241.90 Aligned_cols=207 Identities=28% Similarity=0.441 Sum_probs=172.3
Q ss_pred eEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
.....||+|++|.||++.. +|+.|++|.+..... .....+.+|+.+++.++|+|++++++.+...+..
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 92 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL- 92 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE-
Confidence 3346799999999999965 688999998743211 1234478899999999999999999998776554
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
+++|||+++++|.+++.. ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.++.
T Consensus 93 ---------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~ 154 (292)
T cd06657 93 ---------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR 154 (292)
T ss_pred ---------------EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC
Confidence 899999999999997742 35889999999999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+..+
T Consensus 155 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~ 231 (292)
T cd06657 155 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231 (292)
T ss_pred EEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Confidence 99999998865544333333456788999999998888899999999999999999999999987777666555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=245.03 Aligned_cols=217 Identities=27% Similarity=0.404 Sum_probs=173.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
....++|.+.+.||+|+||.||+|.+ +|+.||+|.+...... ......+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-------IIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-------hHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 33458899999999999999999964 6889999988532111 11123467899999999999999999987
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
....... ..+..+++++++ +++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus 86 ~~~~~~~----------~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 151 (345)
T cd07877 86 TPARSLE----------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 151 (345)
T ss_pred eeccccc----------ccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence 6443211 122347888887 7899887743 3589999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..+.+.
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred EEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999865332 2233467888999999866 467889999999999999999999999888777666
Q ss_pred HHHH
Q 022794 283 AVVR 286 (292)
Q Consensus 283 ~i~~ 286 (292)
++.+
T Consensus 229 ~~~~ 232 (345)
T cd07877 229 LILR 232 (345)
T ss_pred HHHH
Confidence 6554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.22 Aligned_cols=216 Identities=29% Similarity=0.410 Sum_probs=174.2
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceeceecCC
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGS 126 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~ 126 (292)
|++.+.||+|++|.||+|.+ +++.|++|.++....... ....+.+|+.+++++ .|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-------IPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch-------hhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 67899999999999999976 489999999864432111 112244577666655 699999999998775
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. .....+++|||+. ++|.+++.......+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 74 ~~~-----------~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~ 141 (287)
T cd07838 74 RTD-----------RELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141 (287)
T ss_pred cCC-----------CCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc
Confidence 541 0112389999996 5899988765545689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|.+||...+..+.+.++.+
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred cCCCEEEeccCcceeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 99999999999987653322 22223467889999999988899999999999999999999999999998888877765
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 221 ~ 221 (287)
T cd07838 221 V 221 (287)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=241.68 Aligned_cols=210 Identities=26% Similarity=0.435 Sum_probs=177.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC--C----ccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--P----NVT 117 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv 117 (292)
+....+|.+++.+|+|.||.|-.+.+ ++..||||+++ .+..+++...-|+++|+++++ | -++
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik----------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK----------NVDKYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHH----------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 44578999999999999999999966 47789999985 345566667789999999933 2 366
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
++.++|...+.. |||+|.+ |.++.+++..+...+++...++.++.|+++++++||+.+++|.|
T Consensus 155 ~m~~wFdyrghi----------------Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTD 217 (415)
T KOG0671|consen 155 QMRDWFDYRGHI----------------CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTD 217 (415)
T ss_pred eeehhhhccCce----------------EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecC
Confidence 777777766665 9999999 77999999988888999999999999999999999999999999
Q ss_pred CCCCCeeEc--------------------CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHH
Q 022794 198 VKTENMLLD--------------------KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257 (292)
Q Consensus 198 i~p~Nili~--------------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 257 (292)
|||+|||+- ....++++|||.|...... .+..+.|..|.|||++.+-.++.++||||
T Consensus 218 LKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 218 LKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred CChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCcee
Confidence 999999993 1234899999999765433 24467899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 258 FGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 258 lg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+||||+|+++|...|+..+..|.++-|.
T Consensus 295 iGCIL~ElytG~~LFqtHen~EHLaMMe 322 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHENLEHLAMME 322 (415)
T ss_pred eeeEEEEeeccceecccCCcHHHHHHHH
Confidence 9999999999999999999888664443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=235.20 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=156.9
Q ss_pred eeeccCcceEEEEEEEC--------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 56 SVIARGTFGTVHRGLYD--------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~--------------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+.||+|++|.||+|... ...|++|++.... ......+.+|+.+++.++||||+++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------~~~~~~~~~~~~~l~~l~hp~iv~~~~ 71 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---------RDISLAFFETASMMRQVSHKHIVLLYG 71 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---------hhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 36899999999999642 2358888864221 122345778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...... +++|||+++++|..++... ...+++..++.++.|++.||+|||+.|++||||||.
T Consensus 72 ~~~~~~~~----------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 134 (262)
T cd05077 72 VCVRDVEN----------------IMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTK 134 (262)
T ss_pred EEecCCCC----------------EEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcc
Confidence 98766544 8999999999999887542 346899999999999999999999999999999999
Q ss_pred CeeEcCCCc-------EEEeecCcceeccCCCCCCCCCCCcccccCCcccC-CCCCCchhhHHHHHHHHHHHH-hCCCCC
Q 022794 202 NMLLDKNRT-------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLWEIY-CCDMPY 272 (292)
Q Consensus 202 Nili~~~~~-------~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Diwslg~il~~l~-~g~~pf 272 (292)
||+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||+++|+|+ .|..||
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999976654 899999988644322 2245678899999986 456889999999999999998 589999
Q ss_pred CCCCHHHH
Q 022794 273 PDLSFSEV 280 (292)
Q Consensus 273 ~~~~~~~~ 280 (292)
......+.
T Consensus 211 ~~~~~~~~ 218 (262)
T cd05077 211 KDKTLAEK 218 (262)
T ss_pred CCcchhHH
Confidence 87665443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=242.95 Aligned_cols=215 Identities=25% Similarity=0.381 Sum_probs=173.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|++|.||+|.+ +|+.||+|.+..... .......+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-------SELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-------chHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 457899999999999999999965 588999998853211 11223457789999999999999999998865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
...... ....+++|+|+ +++|.+++. ...+++..++.++.|++.||++||+.|++|+||+|+||++
T Consensus 86 ~~~~~~----------~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill 151 (343)
T cd07880 86 DLSLDR----------FHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV 151 (343)
T ss_pred Cccccc----------cceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 543210 11238999999 779988874 2468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++.++|+|||.+...... .....++..|++||.+.+ ..++.++|+||||+++|++++|+.||...+....+.++
T Consensus 152 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07880 152 NEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI 228 (343)
T ss_pred cCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998654322 223456788999999876 35789999999999999999999999987776666655
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
.+
T Consensus 229 ~~ 230 (343)
T cd07880 229 MK 230 (343)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=244.72 Aligned_cols=215 Identities=25% Similarity=0.366 Sum_probs=177.7
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||.|++|.||+|.+ +++.|++|.+..... .....+.+.+|+.+++.++|+|++++++++.....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCc
Confidence 589999999999999999975 478999998853321 11223457789999999999999999998877642
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. .....+++|+|+. ++|.+++.. ...+++..++.++.|++.||++||+.|++|+||||.||+++.+
T Consensus 74 ~-----------~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 74 E-----------DFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred c-----------cccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 1 1123489999996 589888854 3379999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i 219 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 999999999998655443 123334578889999999887 7899999999999999999999999999888877776
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
..
T Consensus 220 ~~ 221 (330)
T cd07834 220 VE 221 (330)
T ss_pred HH
Confidence 65
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=237.88 Aligned_cols=211 Identities=28% Similarity=0.425 Sum_probs=175.9
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
|.+.+.||+|++|.||+|.. +|+.+++|.+....... .....+.+|+.++++++|+|++++++.+...+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-------GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-------hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCE
Confidence 56788999999999999965 68899999886433221 1234577899999999999999999988776544
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
++++||+++ +|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++
T Consensus 74 ----------------~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~ 135 (283)
T cd05118 74 ----------------YLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG 135 (283)
T ss_pred ----------------EEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC
Confidence 899999965 8888876532 5789999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
.++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+.+.++.+.
T Consensus 136 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 136 VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999987655443233345577889999998876 7889999999999999999999999988887777666543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=244.54 Aligned_cols=213 Identities=24% Similarity=0.375 Sum_probs=171.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|.+.+.||+|++|.||+|.+ +|+.|++|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-------TLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc-------cchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 6899999999999999999964 68999999986432211 11334667999999999999999998876543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ....++++||+. ++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 78 ~~------------~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 78 AD------------FKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred CC------------CceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 21 234489999995 689888853 345899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+.
T Consensus 143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 99999999999875433221 1123467889999999865 457899999999999999999999998877655544
Q ss_pred HH
Q 022794 283 AV 284 (292)
Q Consensus 283 ~i 284 (292)
.+
T Consensus 223 ~~ 224 (334)
T cd07855 223 LI 224 (334)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=243.65 Aligned_cols=207 Identities=27% Similarity=0.426 Sum_probs=165.7
Q ss_pred ceeEeeeeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 51 KLVIKSVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+|.+.+.||+|++|.||+|.+ .++.||+|.+........ .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT------GISQSACREIALLRELKHENVVSLVEVFLEH 74 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc------CccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence 588999999999999999976 578999999875331111 1123356799999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
... ..++||||++ ++|.+++.... ...+++..++.++.|++.+|.|||+.+++|+||+|+||
T Consensus 75 ~~~--------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Ni 139 (316)
T cd07842 75 ADK--------------SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANI 139 (316)
T ss_pred CCc--------------eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHE
Confidence 222 2389999996 47777775332 23689999999999999999999999999999999999
Q ss_pred eEcC----CCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 204 LLDK----NRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 204 li~~----~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+++. ++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++++|++|++||.+.
T Consensus 140 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred EEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9998 89999999999875443322 12234567889999988764 5789999999999999999999999866
Q ss_pred CHH
Q 022794 276 SFS 278 (292)
Q Consensus 276 ~~~ 278 (292)
...
T Consensus 220 ~~~ 222 (316)
T cd07842 220 EAK 222 (316)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=238.83 Aligned_cols=224 Identities=25% Similarity=0.359 Sum_probs=176.1
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|++|.||+|.. +|+.|++|.++........ ...+.+|+.++++++|||++++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-------~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF-------PITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc-------hHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 346899999999999999999976 5889999998754322111 1235679999999999999999998876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
..... ....+....++++||+++ ++...+... ...+++..++.++.|++.||++||+.|++|+||+|+||++
T Consensus 78 ~~~~~------~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 149 (302)
T cd07864 78 KQDAL------DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149 (302)
T ss_pred cchhh------hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 55211 011112345899999965 777777543 3468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++++|++|++||...+..+.+..
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999875543321 12223457789999988654 468899999999999999999999998877777666
Q ss_pred HHH
Q 022794 284 VVR 286 (292)
Q Consensus 284 i~~ 286 (292)
+.+
T Consensus 230 ~~~ 232 (302)
T cd07864 230 ISR 232 (302)
T ss_pred HHH
Confidence 655
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.22 Aligned_cols=195 Identities=30% Similarity=0.503 Sum_probs=164.2
Q ss_pred eeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccc
Q 022794 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 134 (292)
+||+|.||+||.|++ +....|||-+..... ...+-+..|+.+.++++|.|||++++.+..++.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---------r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~----- 647 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---------REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFF----- 647 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---------hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeE-----
Confidence 799999999999976 456778887632211 1123477899999999999999999997665544
Q ss_pred cccccCCCCceEEEEeecCCCCHHHHHHhhccccc--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC-CcE
Q 022794 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL--AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTV 211 (292)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~-~~~ 211 (292)
-|.||.++||+|.+.++.. =+++ ++.++..+.+||+++|.|||.+.|+|||||-+|+||+.. |.+
T Consensus 648 -----------kIFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvl 715 (1226)
T KOG4279|consen 648 -----------KIFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVL 715 (1226)
T ss_pred -----------EEEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceE
Confidence 6899999999999988642 3345 789999999999999999999999999999999999765 889
Q ss_pred EEeecCcceeccCCCCCCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 212 ~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
||.|||.+.++..-.+......||..|||||++..+ .|.+++|||||||.+.||.||++||...-.
T Consensus 716 KISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 716 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred EecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 999999998877666666678899999999999765 588999999999999999999999975543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=235.80 Aligned_cols=195 Identities=27% Similarity=0.395 Sum_probs=156.3
Q ss_pred eeccCcceEEEEEEEC--------------------------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh
Q 022794 57 VIARGTFGTVHRGLYD--------------------------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~~--------------------------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 110 (292)
.||+|+||.||+|... ...|++|++... .......+.+|+.++++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---------~~~~~~~~~~~~~~~~~ 72 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---------HRDIALAFFETASLMSQ 72 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---------HHHHHHHHHHHHHHHhc
Confidence 6899999999998521 134788887421 12234457889999999
Q ss_pred CCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh
Q 022794 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190 (292)
Q Consensus 111 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 190 (292)
++||||+++++++...... ++||||+++++|..++... ...+++..+..++.|++.||+|||+
T Consensus 73 l~h~niv~~~~~~~~~~~~----------------~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 73 VSHIHLAFVHGVCVRGSEN----------------IMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred CCCCCeeeEEEEEEeCCce----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 9999999999998766544 8999999999999988653 3468899999999999999999999
Q ss_pred CCccccCCCCCCeeEcCCC-------cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHH
Q 022794 191 QKIVHRDVKTENMLLDKNR-------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICL 262 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il 262 (292)
.|++||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l 211 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence 9999999999999997543 3799999987543221 22356778999998865 5688999999999999
Q ss_pred HHHH-hCCCCCCCCCHHHHH
Q 022794 263 WEIY-CCDMPYPDLSFSEVT 281 (292)
Q Consensus 263 ~~l~-~g~~pf~~~~~~~~~ 281 (292)
|+++ +|..||...+..+..
T Consensus 212 ~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 212 LEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred HHHHhCCCCCccccChHHHH
Confidence 9985 699999887766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=235.72 Aligned_cols=196 Identities=27% Similarity=0.381 Sum_probs=155.9
Q ss_pred eeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccc
Q 022794 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 134 (292)
.||+|+||.||+|.+ +++.||+|.+........... ...........+++...||+++.+++.+...+..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~----- 72 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL----- 72 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE-----
Confidence 479999999999965 588999998864322111111 1111112233445556899999999988876655
Q ss_pred cccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEe
Q 022794 135 NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214 (292)
Q Consensus 135 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~ 214 (292)
+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+
T Consensus 73 -----------~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~ 139 (278)
T cd05606 73 -----------SFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 139 (278)
T ss_pred -----------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEc
Confidence 899999999999998854 3469999999999999999999999999999999999999999999999
Q ss_pred ecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|||.+...... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...
T Consensus 140 dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 140 DLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 99988644322 22235688999999998754 6889999999999999999999999866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=242.94 Aligned_cols=219 Identities=23% Similarity=0.375 Sum_probs=172.4
Q ss_pred CCcee-EeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccH-----HHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 49 PSKLV-IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTE-----AEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 49 ~~~~~-~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.++|. +.+.||.|++|.||+|.+ +++.||+|.++......... .........+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35675 457799999999999965 58899999986443221100 00001112467899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++...+.. +++|||+. ++|.+++.. ...+++..+..++.|++.||++||+.|++|+||+|
T Consensus 87 ~~~~~~~~~----------------~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~ 147 (335)
T PTZ00024 87 DVYVEGDFI----------------NLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSP 147 (335)
T ss_pred EEEecCCcE----------------EEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 998765544 89999995 699998854 34589999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCC--------------CCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASN--------------PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l 265 (292)
+||+++.++.++|+|||.+.....+ ........++..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999988754411 1112223457789999998765 468899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHH
Q 022794 266 YCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 266 ~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++|.+||.+.+..+.+..+..
T Consensus 228 ~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 228 LTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred HhCCCCCCCCCHHHHHHHHHH
Confidence 999999998888877766654
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=231.42 Aligned_cols=203 Identities=33% Similarity=0.563 Sum_probs=172.7
Q ss_pred ceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|++.+.||+|++|.||+|.+. ++.|++|++...... ....+.+.+|+.++++++|+|++++++.+.....
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-------EEELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 4788999999999999999764 889999998644322 2234557889999999999999999998876621
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
...++++||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 74 --------------~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 74 --------------NTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred --------------CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 12289999999999999986543 78999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 209 RTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred CCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999876554432 1334567889999999988889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=231.06 Aligned_cols=205 Identities=30% Similarity=0.443 Sum_probs=173.0
Q ss_pred eccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||.|++|.||++.+ +++.+++|+++..... .......+.+|+.+++++.|+|++++++.+...+..
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII------KRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL------ 68 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhc------chHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee------
Confidence 68999999999976 4889999998643211 112344578899999999999999999888765544
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
+++|||+++++|.+++... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|
T Consensus 69 ----------~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d 136 (250)
T cd05123 69 ----------YLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTD 136 (250)
T ss_pred ----------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEee
Confidence 8999999999999999643 3589999999999999999999999999999999999999999999999
Q ss_pred cCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 216 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
||.+..............++..|+|||.+.+..++.++|+||||+++|++++|..||...+..++...+.+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 137 FGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred cCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99987654432233445678899999999888889999999999999999999999998887777777654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=235.83 Aligned_cols=201 Identities=29% Similarity=0.495 Sum_probs=163.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
........||+|+||.||+|.+ ++..|++|.+..... .....+.+|+.++++++|+||+++++++...+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---------RYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---------HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 3444556899999999999965 467899998753211 11235778999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhccccc--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL--AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. ++++||+++++|.+++.... ..+ ++..+..++.|++.||++||+.|++|+||+|+||++
T Consensus 79 ~~----------------~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~ 141 (268)
T cd06624 79 FF----------------KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141 (268)
T ss_pred EE----------------EEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 44 89999999999999986532 234 788889999999999999999999999999999999
Q ss_pred cC-CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 206 DK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 206 ~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+. ++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||....
T Consensus 142 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 142 NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 76 67899999998875543333333355788999999986643 7889999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=240.68 Aligned_cols=208 Identities=23% Similarity=0.330 Sum_probs=167.7
Q ss_pred eeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccc
Q 022794 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
+.+.+.+|.|+++.|+++..+++.||+|+++...... ...+.+.+|+.++++++|+||+++++++...+..
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~-- 74 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL-- 74 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccch-------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE--
Confidence 3455566677777777777789999999986432111 1234588899999999999999999998776554
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcE
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~ 211 (292)
+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus 75 --------------~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~ 140 (314)
T cd08216 75 --------------YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140 (314)
T ss_pred --------------EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCce
Confidence 899999999999999976555668999999999999999999999999999999999999999999
Q ss_pred EEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 212 KIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 212 ~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+|.||+.+........ ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||..........
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~ 220 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999998764432211 11223466789999998763 57889999999999999999999998776555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=235.18 Aligned_cols=194 Identities=24% Similarity=0.402 Sum_probs=159.0
Q ss_pred CceeEeeee--ccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 50 SKLVIKSVI--ARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 50 ~~~~~~~~l--g~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
.+|.+.+.+ |+|+||.||++.. ++..+++|+........ .|......+ +|||++++++.+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 456666666 9999999999964 68899999985332110 022222222 7999999999998
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+.. +++|||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+
T Consensus 80 ~~~~~----------------~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 141 (267)
T PHA03390 80 TLKGH----------------VLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141 (267)
T ss_pred cCCee----------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 76654 8999999999999999654 37999999999999999999999999999999999999
Q ss_pred EcCCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 205 LDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 205 i~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
++.++ .++|+|||.+...... ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+
T Consensus 142 ~~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 142 YDRAKDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred EeCCCCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 99888 9999999988755432 22457889999999998889999999999999999999999998655443
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=243.14 Aligned_cols=207 Identities=24% Similarity=0.354 Sum_probs=165.5
Q ss_pred eeeccC--cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccc
Q 022794 56 SVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 56 ~~lg~G--~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
..||+| ++|+||+|.+ +|+.||+|+....... . ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~-- 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---E----EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL-- 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---H----HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce--
Confidence 456666 9999999976 7899999998643221 1 1234578899999999999999999999876554
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcE
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~ 211 (292)
++++||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 75 --------------~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~ 140 (328)
T cd08226 75 --------------WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140 (328)
T ss_pred --------------EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcE
Confidence 899999999999999876555568999999999999999999999999999999999999999999
Q ss_pred EEeecCcceeccCCCCC-------CCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 212 KIADFGVARVEASNPND-------MTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 212 ~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++.||+.+......... .....++..|+|||++.+. .++.++|+||+||++|+|++|..||......+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred EEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 99999754322111110 0112245679999999764 47899999999999999999999999877766655
Q ss_pred HHH
Q 022794 283 AVV 285 (292)
Q Consensus 283 ~i~ 285 (292)
.+.
T Consensus 221 ~~~ 223 (328)
T cd08226 221 QKL 223 (328)
T ss_pred HHh
Confidence 444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=243.65 Aligned_cols=213 Identities=27% Similarity=0.386 Sum_probs=170.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
.++|++.+.||+|++|.||+|.+ +|+.+++|.+....... .....+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-------~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~ 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-------TDAQRTFREIMFLQELGDHPNIVKLLNVIKA 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-------hhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence 36899999999999999999976 58899999874321110 1123356799999999 99999999998765
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. .++++|||++ ++|.+++... .+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 79 ~~~~--------------~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill 140 (337)
T cd07852 79 ENDK--------------DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140 (337)
T ss_pred CCCc--------------eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 4322 2389999996 5999888542 68888999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC-----CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPN-----DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
+.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+
T Consensus 141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~ 220 (337)
T cd07852 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220 (337)
T ss_pred cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999998875433221 1222457888999998765 457889999999999999999999999887776
Q ss_pred HHHHHHH
Q 022794 280 VTSAVVR 286 (292)
Q Consensus 280 ~~~~i~~ 286 (292)
....+..
T Consensus 221 ~~~~~~~ 227 (337)
T cd07852 221 QLEKIIE 227 (337)
T ss_pred HHHHHHH
Confidence 6665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=237.99 Aligned_cols=204 Identities=31% Similarity=0.582 Sum_probs=167.9
Q ss_pred CCceeEeeeeccCcceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
...|++.+.||+|+||.||+|.++ ++.+|+|++...... .....+.+|+.+++.+.|+||++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~ei~~l~~l~~~~i~~~~~~ 74 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------QHRSDFEREIEILRTLDHENIVKYKGV 74 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------HHHHHHHHHHHHHHhCCCCChheEEee
Confidence 467888999999999999999653 678999998643321 223458889999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...... ..+++|||+++++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+|
T Consensus 75 ~~~~~~~--------------~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n 139 (284)
T cd05038 75 CEKPGGR--------------SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN 139 (284)
T ss_pred eecCCCC--------------ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 7663322 2389999999999999996543 358999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|+++.++.++|+|||.+......... .....++..|++||.+.+..++.++|+||||+++++|++|..||...
T Consensus 140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred EEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 99999999999999998765422111 11223455799999998888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=235.52 Aligned_cols=193 Identities=29% Similarity=0.428 Sum_probs=154.3
Q ss_pred eeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH---HHHHhCCCCcccceeceecCCccccc
Q 022794 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV---AVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
.||+|+||.||++.+ +++.+|+|.+.......... + ..+.+|. .++....||+++.+++.+...+..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-- 72 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-E-----TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL-- 72 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH-H-----HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE--
Confidence 489999999999965 58899999886433221111 1 1122333 334445899999999988776654
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcE
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~ 211 (292)
+++|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||||+||++++++.+
T Consensus 73 --------------~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~ 136 (279)
T cd05633 73 --------------CFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136 (279)
T ss_pred --------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCE
Confidence 8999999999999988643 468999999999999999999999999999999999999999999
Q ss_pred EEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 212 ~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+|+|||.+...... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus 137 ~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 137 RISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred EEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 99999998644322 2223468899999999864 56889999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=237.77 Aligned_cols=221 Identities=27% Similarity=0.388 Sum_probs=173.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|++|.||+|.+ +++.+++|.+......... ...+.+|+.+++.++|+||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-------PITALREIKILKKLKHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-------chhHHHHHHHHHhcCCCCccchhhheecc
Confidence 37899999999999999999976 5889999988644321111 11256799999999999999999887654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .......+++++|+. ++|...+.. ....+++..+..++.|+++||.+||+.|++|+||+|+||+++
T Consensus 80 ~~~~--------~~~~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~ 149 (311)
T cd07866 80 PDKS--------KRKRGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID 149 (311)
T ss_pred cccc--------cccCceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 4320 112334589999995 577777654 234699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCC-----------CCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 207 KNRTVKIADFGVARVEASNPND-----------MTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+++.++|+|||++......... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||.+
T Consensus 150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999988654322111 1122456789999988654 578899999999999999999999998
Q ss_pred CCHHHHHHHHHH
Q 022794 275 LSFSEVTSAVVR 286 (292)
Q Consensus 275 ~~~~~~~~~i~~ 286 (292)
.+..+..+.+.+
T Consensus 230 ~~~~~~~~~~~~ 241 (311)
T cd07866 230 KSDIDQLHLIFK 241 (311)
T ss_pred CCHHHHHHHHHH
Confidence 888777666554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=233.40 Aligned_cols=209 Identities=26% Similarity=0.360 Sum_probs=166.9
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcc
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSE 128 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 128 (292)
|++.+.||+|++|.||+|.+ +++.|++|.++....... . ....+|+.++.++ +|+|++++++++.+...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~---~-----~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 72 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE---Q-----VNNLREIQALRRLSPHPNILRLIEVLFDRKT 72 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch---h-----hhHHHHHHHHhhcCCCCCccceEEEEecCCC
Confidence 67899999999999999965 688999998864321111 1 1134688888888 59999999999876521
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
...++++||++ ++|.+++... ...+++..++.++.|++.||++||+.|++|+||+|+||+++.
T Consensus 73 --------------~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 73 --------------GRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred --------------CcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 12389999996 5888887543 346899999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+.+..+.+
T Consensus 136 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~ 213 (282)
T cd07831 136 DILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD 213 (282)
T ss_pred CCeEEEecccccccccCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH
Confidence 999999999987554332 2233457889999997654 4578899999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=235.38 Aligned_cols=199 Identities=27% Similarity=0.499 Sum_probs=159.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH-HHhCCCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV-WHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~ 126 (292)
.+|++.+.||+|+||.||+|.+ +|+.||+|.++..... .. ...+..|..+ ++.++|||++++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~-----~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QE-----QKRLLMDLDISMRSVDCPYTVTFYGALFRE 72 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HH-----HHHHHHHHHHHHHHcCCCCeeeeeEEEecC
Confidence 3689999999999999999976 5899999988643211 11 1123345554 5667999999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCe
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENM 203 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~p~Ni 203 (292)
+.. +++|||++ ++|.+++... ....+++..++.++.|++.+|.+||++ +++|+||+|+||
T Consensus 73 ~~~----------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~ni 135 (283)
T cd06617 73 GDV----------------WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNV 135 (283)
T ss_pred CcE----------------EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHE
Confidence 554 89999995 6898887543 234689999999999999999999997 999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG----NPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+++.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..
T Consensus 136 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 136 LINRNGQVKLCDFGISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred EECCCCCEEEeecccccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 9999999999999998654322 12223457888999999865 3468899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=232.34 Aligned_cols=215 Identities=30% Similarity=0.503 Sum_probs=172.3
Q ss_pred ceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|.+.+.||+|++|.||++.+. +..+++|+.+..........+ ...+..|+.++++++|||++++++.+.+...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE----TVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcch----HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 5899999999999999999664 455777776543221111111 1225568899999999999999998876655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
. ++++||+++++|.+++... ....+++..++.++.|++.+|.+||++|++|+||+|+||+++
T Consensus 77 ~----------------~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~ 140 (260)
T cd08222 77 F----------------CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK 140 (260)
T ss_pred e----------------EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee
Confidence 4 8999999999999988642 345689999999999999999999999999999999999996
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+ +.++|+|||.+..............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+..+...++..
T Consensus 141 ~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~ 219 (260)
T cd08222 141 N-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219 (260)
T ss_pred c-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 5 569999999887654433333345678899999999888889999999999999999999999987777666665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=228.16 Aligned_cols=212 Identities=25% Similarity=0.443 Sum_probs=169.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 125 (292)
.++.+.++.||.|..|+|+++.. +|...|||.+..... .+ + ..++...+++....+ .|.||+.+++|..
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N---ke-e----~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN---KE-E----NKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC---HH-H----HHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 34567788999999999999965 579999998853321 11 1 334667788887774 8999999999998
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCee
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTENML 204 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~Nil 204 (292)
...+ +++||.+ ..-++..+++ ...+++|..+-++...++.||.||.. +|++|||+||+|||
T Consensus 163 n~dV----------------~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL 224 (391)
T KOG0983|consen 163 NTDV----------------FICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 224 (391)
T ss_pred CchH----------------HHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE
Confidence 8777 6688888 4455555543 45679999999999999999999975 58999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEV 280 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwslg~il~~l~~g~~pf~~-~~~~~~ 280 (292)
+++.|++||||||.+.++.++ ...+...|.+.|||||.+... .|+.++|+||||+.++||.||+.||.+ .+.=++
T Consensus 225 lDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ 303 (391)
T KOG0983|consen 225 LDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV 303 (391)
T ss_pred EccCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH
Confidence 999999999999998765433 333445688999999999754 688999999999999999999999996 344566
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+.+|.++
T Consensus 304 ltkvln~ 310 (391)
T KOG0983|consen 304 LTKVLNE 310 (391)
T ss_pred HHHHHhc
Confidence 6666654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=252.19 Aligned_cols=203 Identities=29% Similarity=0.421 Sum_probs=171.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|.-++.||.|+||-||.|.+ +.+.||||.+........ +.+ ..+..|++.|++++|||++.+-++|....
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~-----EKW-qDIlKEVrFL~~l~HPntieYkgCyLre~ 99 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-----EKW-QDILKEVRFLRQLRHPNTIEYKGCYLREH 99 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH-----HHH-HHHHHHHHHHHhccCCCcccccceeeccc
Confidence 3577788999999999999965 688999999876544322 222 23677999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. |+||||| -|+-.+.+.- ..+++.+..+..|+.+.+.+|+|||+++.||||||..|||+++
T Consensus 100 Ta----------------WLVMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse 161 (948)
T KOG0577|consen 100 TA----------------WLVMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE 161 (948)
T ss_pred hH----------------HHHHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC
Confidence 44 8999999 6688887753 3467999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.|.|||.|||.+.... ..+.++|||.|||||++. .+.|+-+.||||||++.++|...++|+-+++.-.-
T Consensus 162 ~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 162 PGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred CCeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH
Confidence 9999999999997543 345589999999999984 56799999999999999999999999877665443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=250.19 Aligned_cols=216 Identities=24% Similarity=0.381 Sum_probs=179.9
Q ss_pred ecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+...-|..++.||-|+||.|.++ +++...||+|.++... .-..........|-.||.....+=||++|-.|.
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD------Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD------VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH------HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 34556899999999999999999 4677789999885221 112223445677999999999999999999999
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.+.+ |+||+|++||++-..|.+. ..++|..++.++.++.+|+++.|+.|+|||||||+|||
T Consensus 700 DkdnL----------------YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNIL 761 (1034)
T KOG0608|consen 700 DKDNL----------------YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL 761 (1034)
T ss_pred cCCce----------------EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceE
Confidence 88877 8999999999999998765 46999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceec---------cCC---------------------------------CCCCCCCCCcccccCCc
Q 022794 205 LDKNRTVKIADFGVARVE---------ASN---------------------------------PNDMTGETGTLGYMAPE 242 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~---------~~~---------------------------------~~~~~~~~~~~~y~aPE 242 (292)
|+.+|++||+|||++.-. ... .......+||+.|+|||
T Consensus 762 IDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiape 841 (1034)
T KOG0608|consen 762 IDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPE 841 (1034)
T ss_pred EccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence 999999999999987410 000 00112235899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 243 VLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 243 ~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++....++..+|.||.|+|||+|+.|+.||...++.+...+|++
T Consensus 842 vl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 842 VLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN 885 (1034)
T ss_pred HhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee
Confidence 99999999999999999999999999999998888776666654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.44 Aligned_cols=204 Identities=32% Similarity=0.504 Sum_probs=172.0
Q ss_pred CceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
-+|+-...||.|.||.||.|. ++|+-.|+|.++........ ...+.+|..++..++|||+|+++++-...+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~-------~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKT-------FKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcccccc-------CcchHHHHHHHHhccCccccccCceeecHH
Confidence 367888899999999999995 57999999987654332221 233778999999999999999999988887
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +|-||||++|+|.+.+.. ++..++.....+..|+++++.|||++|||||||||+||+++.
T Consensus 1308 kv----------------~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~ 1369 (1509)
T KOG4645|consen 1308 KV----------------YIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF 1369 (1509)
T ss_pred HH----------------HHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec
Confidence 77 679999999999998843 455778888888999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC----CCCCCCCCcccccCCcccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 208 NRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
+|.+|++|||.|..+.... ...+...||+.|||||++.+. ....++||||||||+.||+||+.||...+.+
T Consensus 1370 ~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1370 NGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred CCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 9999999999997655442 233456799999999999764 3567899999999999999999999876654
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=233.84 Aligned_cols=212 Identities=28% Similarity=0.410 Sum_probs=172.6
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
|.+.+.||.|++|.||+|.+ +|+.+++|.+....... .....+.+|+.++++++|+|++++++.+....
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE-------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKG-- 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc-------cchHHHHHHHHHHHhccCCCeeeheeeEecCC--
Confidence 67899999999999999966 47899999997543111 11234678999999999999999999887651
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
....++++||++ ++|.+++... ...+++..++.++.|++.||++||+.|++|+||+|+||++++++
T Consensus 72 ------------~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~ 137 (287)
T cd07840 72 ------------KGSIYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG 137 (287)
T ss_pred ------------CCcEEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC
Confidence 112389999996 4898887543 24689999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 210 TVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++++|++|..||...+..+.+..+.+
T Consensus 138 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999876543321 12334567789999987654 578999999999999999999999998888777776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=236.94 Aligned_cols=206 Identities=28% Similarity=0.411 Sum_probs=168.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|.+.+.||+|++|.||+|.. +|+.|++|.+....... ......+.+|+.+++.++|||++++++++.+.+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 5799999999999999999965 68999999885432211 112344778999999999999999999988765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+. ++|.+++... ...+++..+..++.|++.+|.|||..|++|+||+|+||++++
T Consensus 89 ~~----------------~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~ 150 (307)
T cd06607 89 TA----------------WLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150 (307)
T ss_pred eE----------------EEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC
Confidence 54 89999996 5787777543 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++.++|+|||.+...... ....++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+.......
T Consensus 151 ~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~ 225 (307)
T cd06607 151 PGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (307)
T ss_pred CCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH
Confidence 999999999988654322 2345778899999874 34578899999999999999999999987665554433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=234.22 Aligned_cols=210 Identities=30% Similarity=0.470 Sum_probs=174.7
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
|++.+.||+|++|.||+|.. +++.|++|++........ ....+.+|+.++++++|+|++++++++...+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-------IPSTALREISLLKELKHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccccc-------ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCce
Confidence 56788999999999999965 489999999875431111 123356799999999999999999998776544
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
++++||++ ++|.+++.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||++++++
T Consensus 74 ----------------~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~ 135 (282)
T cd07829 74 ----------------YLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG 135 (282)
T ss_pred ----------------EEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC
Confidence 89999996 59999986532 4689999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++|+|||.+...............+..|+|||.+.+. .++.++|+||||++++++++|.+||...+..+.+.++.+
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 136 VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 99999999987654433333344567789999998776 788999999999999999999999999888777766654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=233.50 Aligned_cols=209 Identities=29% Similarity=0.419 Sum_probs=171.7
Q ss_pred eeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCCcc
Q 022794 52 LVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSE 128 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 128 (292)
|++.+.||+|++|.||+|.. +++.|++|.+...... .. .....+|+..++++. |+|++++++.+.+.+.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 72 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WE-----ECMNLREVKSLRKLNEHPNIVKLKEVFRENDE 72 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hh-----HHHHHHHHHHHHhccCCCCchhHHHHhhcCCc
Confidence 67889999999999999976 5788999987533211 01 112346889999998 9999999999877554
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+ +++|.+++.......+++..+..++.|++.+|.+||++|++|+||+|.||+++++
T Consensus 73 ~----------------~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 73 L----------------YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred E----------------EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 4 8999999 7899998876544578999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|.+||...+..+.+.++.+
T Consensus 136 ~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 136 EVVKIADFGLAREIRSRP-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred CCEEEeecccceeccCCC-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 999999999987554322 2233567889999998754 4578999999999999999999999998887776665553
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=240.11 Aligned_cols=224 Identities=23% Similarity=0.306 Sum_probs=173.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||.|++|.||+|.+ +|+.|++|.+...... ..+.+.+|+.++++++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---------~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---------SVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---------hHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 47899999999999999999965 5889999988644321 123467799999999999999999887654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
..... ...........+++++||++ ++|.+++.. ..+++..++.++.|+++||.+||+.|++|+||||+||+++
T Consensus 75 ~~~~~--~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLT--EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccc--cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 32110 00011222345689999996 589888742 4588999999999999999999999999999999999997
Q ss_pred -CCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 207 -KNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 207 -~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..+..
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 456789999999875432211 1122356788999998654 45788999999999999999999999988877777
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.+.
T Consensus 229 ~~~~~~ 234 (342)
T cd07854 229 QLILES 234 (342)
T ss_pred HHHHHh
Confidence 666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=234.30 Aligned_cols=201 Identities=25% Similarity=0.381 Sum_probs=165.2
Q ss_pred ceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
+|++.+.||+|++|.||++.. +++.|++|+++.... .........+.+|+.+++++ +||+++++++.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeee
Confidence 488999999999999999864 467899999863211 12223345577899999999 6999999998887
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..... +++|||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|.||+
T Consensus 76 ~~~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil 137 (288)
T cd05583 76 TDTKL----------------HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL 137 (288)
T ss_pred cCCEE----------------EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 65544 8999999999999998543 46889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 205 LDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.++.++|+|||.+........ ......++..|++||.+.+.. .+.++|+||||+++|+|++|..||..
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999999999998865433221 122245788999999987665 77899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=240.31 Aligned_cols=215 Identities=27% Similarity=0.416 Sum_probs=174.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|.+.+.||+|++|.||+|.+ +++.|++|++...... ......+.+|+.+++++.|+|++++.+++..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-------AIHAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-------hhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 457899999999999999999976 5789999987532111 1122346679999999999999999987765
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... ......++++||+ +++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 86 ~~~~----------~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill 151 (343)
T cd07851 86 ASSL----------EDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 151 (343)
T ss_pred cccc----------cccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 4431 0112348999999 6799998853 468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++++.++|+|||.+...... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 152 NEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred CCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999998754322 2334567889999998653 6788999999999999999999999988877776665
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
.+
T Consensus 229 ~~ 230 (343)
T cd07851 229 MN 230 (343)
T ss_pred HH
Confidence 54
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=236.93 Aligned_cols=214 Identities=23% Similarity=0.336 Sum_probs=168.5
Q ss_pred ceeEeeeeccCcceEEEEEEEC----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 51 KLVIKSVIARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
+|.+.+.||+|+||.||++.+. +..||+|.+...... ......+.+|+.+++++ +||||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-------KILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-------chhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 5889999999999999999764 668999987532111 11233467799999999 69999999986533
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... .....+++++++. ++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||++
T Consensus 74 ~~~------------~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili 138 (332)
T cd07857 74 FPG------------NFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138 (332)
T ss_pred ccc------------cCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence 211 1123378999984 689998853 4568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...+..+.
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~ 218 (332)
T cd07857 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218 (332)
T ss_pred cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence 9999999999999875432211 1223467889999998765 4688999999999999999999999998777666
Q ss_pred HHHHHH
Q 022794 281 TSAVVR 286 (292)
Q Consensus 281 ~~~i~~ 286 (292)
...+++
T Consensus 219 ~~~~~~ 224 (332)
T cd07857 219 LNQILQ 224 (332)
T ss_pred HHHHHH
Confidence 665544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=233.26 Aligned_cols=196 Identities=25% Similarity=0.428 Sum_probs=157.0
Q ss_pred eeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 56 SVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+.||+|+||.||+|.+. ...+++|.+... .....+.+.+|+.+++.+.|||++++++++...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 71 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG 71 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC
Confidence 36899999999999653 234777776311 122334577899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++.... ..+++..+..++.|++.+|+|||+.|++||||||+||+++
T Consensus 72 ~~~----------------~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 72 DES----------------IMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred CCc----------------EEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 554 89999999999999986543 3688999999999999999999999999999999999997
Q ss_pred CCCc--------EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCC
Q 022794 207 KNRT--------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCC-DMPYPDLS 276 (292)
Q Consensus 207 ~~~~--------~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g-~~pf~~~~ 276 (292)
.++. ++++|||.+..... .....++..|+|||++.+. .++.++|+||||+++|+|++| .+||...+
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~ 210 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210 (258)
T ss_pred cccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence 7654 69999998754332 1224567889999999864 578999999999999999998 57877766
Q ss_pred HHHHH
Q 022794 277 FSEVT 281 (292)
Q Consensus 277 ~~~~~ 281 (292)
.....
T Consensus 211 ~~~~~ 215 (258)
T cd05078 211 SQKKL 215 (258)
T ss_pred HHHHH
Confidence 65443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=235.95 Aligned_cols=205 Identities=28% Similarity=0.416 Sum_probs=166.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|++.+.||.|+||.||+|.+ +++.|++|.+....... .....+.+|+.+++++.|||++++.+++..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-------VLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-------chhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 457899999999999999999964 68899999875322111 112336679999999999999999998865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... .+++++||+ +++|.+++.. ..+++..+..++.|++++|.+||+.|++|+||+|.||++
T Consensus 81 ~~~---------------~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili 141 (328)
T cd07856 81 PLE---------------DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI 141 (328)
T ss_pred CCC---------------cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE
Confidence 322 238999999 6689888742 457888899999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
++++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.....
T Consensus 142 ~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 142 NENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred CCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999998864322 2223456788999998766 56889999999999999999999999877664433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=230.15 Aligned_cols=211 Identities=28% Similarity=0.465 Sum_probs=168.7
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
......+++...+.+-++.||.|.||+|++..+ .|+..|||.++.... +. ...++..|.....+. +.||
T Consensus 53 p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~k----eq~rll~e~d~~mks~~cp~ 124 (361)
T KOG1006|consen 53 PDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EK----EQKRLLMEHDTVMKSSNCPN 124 (361)
T ss_pred CCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hH----HHHHHHHHHHHHHhhcCCcH
Confidence 344455777788888899999999999999854 699999999864432 11 233456666666555 8999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHH---hhcccccCHHHHHHHHHHHHHHHHHHHhC-
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI---KNRRRKLAFKVVVQLALDLARGLSYLHSQ- 191 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~i~~qi~~al~~lH~~- 191 (292)
||++++....++ .+|++||.+ ..+|+.+.. .-....++|..+..|....+.||.||-..
T Consensus 125 IVkfyGa~F~EG----------------dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l 187 (361)
T KOG1006|consen 125 IVKFYGALFSEG----------------DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL 187 (361)
T ss_pred HHHHhhhhhcCC----------------ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh
Confidence 999999876544 459999999 568776653 22456799999999999999999999764
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCC
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~ 269 (292)
.|+|||+||+|||++..|.+||||||.+..+.. .-..+...|..+|+|||.+... .|+.++|+||||+.|||+.||+
T Consensus 188 kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 188 KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred hhhhccCChhheEEecCCCEeeecccchHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence 899999999999999999999999998864432 2344556788999999999653 5899999999999999999999
Q ss_pred CCCCCC
Q 022794 270 MPYPDL 275 (292)
Q Consensus 270 ~pf~~~ 275 (292)
.||..-
T Consensus 267 fPyr~w 272 (361)
T KOG1006|consen 267 FPYRKW 272 (361)
T ss_pred CCcchH
Confidence 999753
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=234.17 Aligned_cols=209 Identities=27% Similarity=0.422 Sum_probs=170.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|...+.||+|+||.||++.+ ++..|++|.+....... ......+.+|+.++++++|||++++++++....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS------NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc------hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 3478889999999999999965 68899999886432211 112334778999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+. ++|.+.+... ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.
T Consensus 99 ~~----------------~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~ 160 (317)
T cd06635 99 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE 160 (317)
T ss_pred eE----------------EEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC
Confidence 44 89999996 5787776543 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+..... .....++..|+|||.+. ...++.++|+||+|+++|+|++|..||...+..+....+
T Consensus 161 ~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 236 (317)
T cd06635 161 PGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236 (317)
T ss_pred CCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 99999999998754322 22345778899999974 456888999999999999999999999887776666655
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
.+
T Consensus 237 ~~ 238 (317)
T cd06635 237 AQ 238 (317)
T ss_pred Hh
Confidence 44
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=230.34 Aligned_cols=203 Identities=25% Similarity=0.407 Sum_probs=167.4
Q ss_pred CceeEeeeeccCcceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
..|.+.+.||+|.||.||+|... .+.+|||.++-.+....... ..-+|+.+++.++|||++.+..+|
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~-------SAcREiaL~REl~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISM-------SACREIALLRELKHPNVISLVKVF 96 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCH-------HHHHHHHHHHHhcCCcchhHHHHH
Confidence 57999999999999999999431 34799999976654333322 245799999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
...+. .+++++||.+ .+|...|... ..+.++...+..++.||+.++.|||++-++||||||
T Consensus 97 l~~d~---------------~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKP 160 (438)
T KOG0666|consen 97 LSHDK---------------KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKP 160 (438)
T ss_pred hccCc---------------eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCc
Confidence 87422 1289999995 4999988643 234688899999999999999999999999999999
Q ss_pred CCeeEcCC----CcEEEeecCcceeccCCCCCC---CCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 201 ENMLLDKN----RTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 201 ~Nili~~~----~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
.||++..+ |.+||.|||+++....+.... ...+.|.-|.|||++.|. .|+++.|+|+.|||+.||++-.+.|
T Consensus 161 aNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 161 ANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 99999877 899999999998766554432 224568899999999987 5999999999999999999999999
Q ss_pred CCC
Q 022794 273 PDL 275 (292)
Q Consensus 273 ~~~ 275 (292)
.+.
T Consensus 241 ~g~ 243 (438)
T KOG0666|consen 241 KGR 243 (438)
T ss_pred cch
Confidence 863
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=232.68 Aligned_cols=208 Identities=28% Similarity=0.425 Sum_probs=169.2
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|...+.||+|++|.||+|.+ +|+.|++|.+........ .....+.+|+.+++.++|||++++++++.+.+.
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN------EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch------HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 367778899999999999965 688999999864432111 112346789999999999999999999877655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+. ++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus 96 ~----------------~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~ 157 (313)
T cd06633 96 A----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157 (313)
T ss_pred E----------------EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC
Confidence 4 89999995 5888877543 3568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++|+|||.+.... ......++..|+|||++. +..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 158 ~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 158 GQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred CCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999875322 223356788999999984 4568889999999999999999999998777666555544
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
.
T Consensus 234 ~ 234 (313)
T cd06633 234 Q 234 (313)
T ss_pred h
Confidence 3
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=237.46 Aligned_cols=216 Identities=25% Similarity=0.433 Sum_probs=171.6
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
|.+ ..+|.+.+.||+|++|.||+|.+ +|+.||+|.+...... ......+.+|+.+++.+.||||++++++
T Consensus 11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~ 82 (342)
T cd07879 11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-------EIFAKRAYRELTLLKHMQHENVIGLLDV 82 (342)
T ss_pred hcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-------ccchhHHHHHHHHHHhcCCCCccchhhe
Confidence 444 46899999999999999999965 6899999988543211 1112336789999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+....... .....++++||+. .+|..+. ...+++..+..++.|++.||++||++|++||||+|+|
T Consensus 83 ~~~~~~~~----------~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~N 147 (342)
T cd07879 83 FTSAVSGD----------EFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN 147 (342)
T ss_pred ecccccCC----------CCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 86543221 1122389999995 4777654 2358899999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+
T Consensus 148 Ill~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~ 224 (342)
T cd07879 148 LAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224 (342)
T ss_pred EEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999864322 2223456788999999876 45888999999999999999999999988776666
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
..+..
T Consensus 225 ~~~~~ 229 (342)
T cd07879 225 TQILK 229 (342)
T ss_pred HHHHH
Confidence 65554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=229.62 Aligned_cols=209 Identities=23% Similarity=0.388 Sum_probs=179.6
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCccc
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVT 117 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 117 (292)
....|.+.-.+|.++.+||+|+|..|.++. .+.+.+|+|+++..--+.... .+-...|..+..+. +||.+|
T Consensus 241 ~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded------idwvqtek~vfe~asn~pflv 314 (593)
T KOG0695|consen 241 IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED------IDWVQTEKHVFEQASNNPFLV 314 (593)
T ss_pred cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc------chhHHhhHHHHHhccCCCeEE
Confidence 345567777899999999999999999884 578899999987543222111 22345566677666 899999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
.++.+|..+..+ ++|.||+.||+|--.+++ .+.++++.++.+..+|+-||.+||.+||++||
T Consensus 315 glhscfqtesrl----------------ffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrd 376 (593)
T KOG0695|consen 315 GLHSCFQTESRL----------------FFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRD 376 (593)
T ss_pred ehhhhhcccceE----------------EEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeee
Confidence 999999988877 889999999999766643 46799999999999999999999999999999
Q ss_pred CCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 198 i~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
+|..|+|++..|++||.|+|.......+....+...||+.|.|||.++|..|....|-|+||+++++|+.|+.||.
T Consensus 377 lkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 377 LKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 9999999999999999999999876666666777899999999999999999999999999999999999999996
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=235.50 Aligned_cols=201 Identities=29% Similarity=0.507 Sum_probs=161.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 126 (292)
.+|...+.||+|+||.||++.+ +++.||+|.+...... .....+.+|+.++.++. |+||+++++++...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 4667788999999999999966 5789999988532211 22344778999999995 99999999988765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHH---HhhcccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL---IKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTEN 202 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~p~N 202 (292)
... +++|||+. +++.++. .......+++..+..++.|++.||+|||+. +++||||+|+|
T Consensus 76 ~~~----------------~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N 138 (288)
T cd06616 76 GDC----------------WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSN 138 (288)
T ss_pred CcE----------------EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHH
Confidence 444 78999985 4665543 223346799999999999999999999975 99999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
|+++.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||....
T Consensus 139 il~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 139 ILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred EEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 999999999999999986543322 22234578899999999776 68899999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.60 Aligned_cols=217 Identities=32% Similarity=0.588 Sum_probs=188.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
++......|.++||.|.||.|++|.. +...||||.++.... +..+..|..|+.|+.++.||||+++.
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--------ekqrrdFL~EAsIMGQFdHPNIIrLE 696 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--------EKQRRDFLSEASIMGQFDHPNIIRLE 696 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--------HHHHhhhhhhhhhcccCCCCcEEEEE
Confidence 45567889999999999999999943 245799999975432 33466699999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
++......+ .|+.|||++|+|+.|++.+.+ .+..-++..+++.|+.+++||-++|++||||..
T Consensus 697 GVVTks~Pv----------------MIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAA 759 (996)
T KOG0196|consen 697 GVVTKSKPV----------------MIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAA 759 (996)
T ss_pred EEEecCcee----------------EEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhh
Confidence 998877776 789999999999999987654 488889999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCC-CCCCCC--cccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPND-MTGETG--TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~--~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~ 276 (292)
.|||++.+-..|+.|||+++.+.+.+.. .....| ..+|.|||.+...+++.++|+||+|+++||.++ |..||=+++
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 9999999999999999999987655533 332323 469999999999999999999999999999877 999999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
+.++++.|.++
T Consensus 840 NQdVIkaIe~g 850 (996)
T KOG0196|consen 840 NQDVIKAIEQG 850 (996)
T ss_pred hHHHHHHHHhc
Confidence 99999999876
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=249.73 Aligned_cols=217 Identities=28% Similarity=0.508 Sum_probs=186.6
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC---C--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD---G--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.+..++..+.++||+|+||+|++|.|+ | ..||||.++...... ..+.|.+|+.++-+|.|+|++++|
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--------~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--------IMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--------hHHHHHHHHHHHHhccCcceeEEe
Confidence 344567888999999999999999875 3 369999997655432 244589999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
++..+. .+ -+|+|.+++|+|.+.+++-....+-...+..++.||+.|+.||..+++|||||..
T Consensus 178 GvVl~q-p~----------------mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAA 240 (1039)
T KOG0199|consen 178 GVVLDQ-PA----------------MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAA 240 (1039)
T ss_pred eeeccc-hh----------------hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 998873 22 5899999999999999875666788899999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCCC---CCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDMT---GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~ 276 (292)
.|+++.....+||+|||+.+-+......+. .......|||||.++..+++.++|+|++|+.+|||++ |..||.+.+
T Consensus 241 RNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 241 RNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred hhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 999999999999999999987665544332 2334669999999999999999999999999999999 799999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
..++++.|.++
T Consensus 321 g~qIL~~iD~~ 331 (1039)
T KOG0199|consen 321 GIQILKNIDAG 331 (1039)
T ss_pred HHHHHHhcccc
Confidence 99999998744
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=230.74 Aligned_cols=215 Identities=27% Similarity=0.444 Sum_probs=167.9
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFI 120 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 120 (292)
.+.+..++|.+.+.||+|++|.||+|.+. ++.||||.++..... .....+..|+.++.+. .|+||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~~i~~~~ 80 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--------EENKRILMDLDVVLKSHDCPYIVKCY 80 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--------HHHHHHHHHHHHHHhccCCCchHhhh
Confidence 44556688999999999999999999775 899999998643211 1112344566666666 599999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVK 199 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~ 199 (292)
+++.+.... +++|||+ +++|.+.+... ...+++..+..++.|++.+++|||+ .|++|+||+
T Consensus 81 ~~~~~~~~~----------------~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~ 142 (296)
T cd06618 81 GYFITDSDV----------------FICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK 142 (296)
T ss_pred eeeecCCeE----------------EEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc
Confidence 998776554 8999998 45787776543 3478999999999999999999997 599999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus 143 p~nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 143 PSNILLDASGNVKLCDFGISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999886543222 222345678999999987654 788999999999999999999999763
Q ss_pred CH-HHHHHHHH
Q 022794 276 SF-SEVTSAVV 285 (292)
Q Consensus 276 ~~-~~~~~~i~ 285 (292)
.. .+.+..+.
T Consensus 222 ~~~~~~~~~~~ 232 (296)
T cd06618 222 KTEFEVLTKIL 232 (296)
T ss_pred hhHHHHHHHHh
Confidence 32 34444443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=252.89 Aligned_cols=148 Identities=27% Similarity=0.418 Sum_probs=126.9
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+++.||+|+||.||+|.+. ++.||||+++..... .......+.+|+.+++.++|+||+++++.+...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI------NKNMVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc------CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 368999999999999999999775 899999998643211 112234577899999999999999999887665
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. |+||||+.+++|.+++... ..+++..++.++.||+.||.|||..||+||||||+|||++
T Consensus 77 ~~~----------------~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~ 138 (669)
T cd05610 77 NNV----------------YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138 (669)
T ss_pred CEE----------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc
Confidence 544 8999999999999998543 4588999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcce
Q 022794 207 KNRTVKIADFGVAR 220 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~ 220 (292)
.++.++|+|||+++
T Consensus 139 ~~g~vkL~DFGls~ 152 (669)
T cd05610 139 NEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCEEEEeCCCCc
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=240.29 Aligned_cols=225 Identities=29% Similarity=0.564 Sum_probs=196.3
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 115 (292)
....-+.|+++..+.....+||.|.||.||.|.|. .-.||||.++.+. .+ ...|..|+.+++.++|||
T Consensus 255 vSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt------Me----veEFLkEAAvMKeikHpN 324 (1157)
T KOG4278|consen 255 VSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------ME----VEEFLKEAAVMKEIKHPN 324 (1157)
T ss_pred ecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc------hh----HHHHHHHHHHHHhhcCcc
Confidence 34445789999999999999999999999999886 4579999985321 12 345889999999999999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
+|+++++|..+..+ ||+.||+..|+|.+|+++..+..++.-.++.++.||..|+.||..+++||
T Consensus 325 LVqLLGVCT~EpPF----------------YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIH 388 (1157)
T KOG4278|consen 325 LVQLLGVCTHEPPF----------------YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIH 388 (1157)
T ss_pred HHHHhhhhccCCCe----------------EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhh
Confidence 99999999877665 89999999999999999888888888899999999999999999999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCCC-CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDM-TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~ 273 (292)
|||...|.|+.++..+|+.|||+++++....... ......+.|.|||-+....++.++|+|+||++|||+.| |-.||+
T Consensus 389 RDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 389 RDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred hhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999999876544332 22345678999999999999999999999999999999 788999
Q ss_pred CCCHHHHHHHHHHhh
Q 022794 274 DLSFSEVTSAVVRQV 288 (292)
Q Consensus 274 ~~~~~~~~~~i~~~~ 288 (292)
+.+-.+++.-+.++-
T Consensus 469 GidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 469 GIDLSQVYGLLEKGY 483 (1157)
T ss_pred CccHHHHHHHHhccc
Confidence 999999998887763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=230.48 Aligned_cols=201 Identities=35% Similarity=0.620 Sum_probs=162.5
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC--CCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~ 127 (292)
.+.++.+.||+|.||.||+|.|.|+.||||+|.... + +.+.+|.++++.. +|+||+.|++.=...+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E-------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----E-------RSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----h-------hhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 578899999999999999999999999999995322 1 2367788888776 9999999997643332
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVK 199 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~i~h~di~ 199 (292)
. .| ..+|||.+|.+.|||.||+.+ ..++....++++..++.+|+|||.. .|.|||||
T Consensus 279 g--------s~----TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK 343 (513)
T KOG2052|consen 279 G--------SW----TQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK 343 (513)
T ss_pred C--------ce----EEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence 2 22 235999999999999999954 5799999999999999999999975 49999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCC----CCCCCCCCCcccccCCcccCCCC----C--CchhhHHHHHHHHHHHHhC-
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGNP----Y--NRKCDVYSFGICLWEIYCC- 268 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~Diwslg~il~~l~~g- 268 (292)
..|||+..++..-|.|+|+|-.-... .-..+..+||.+|||||++...- + -..+||||||.++||+...
T Consensus 344 SKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc 423 (513)
T KOG2052|consen 344 SKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRC 423 (513)
T ss_pred cccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999998643322 12234578999999999997542 1 2578999999999998762
Q ss_pred ---------CCCCCCCCH
Q 022794 269 ---------DMPYPDLSF 277 (292)
Q Consensus 269 ---------~~pf~~~~~ 277 (292)
++||.+..+
T Consensus 424 ~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 424 ESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred hcCCEehhhcCCcccCCC
Confidence 678875443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=230.17 Aligned_cols=209 Identities=28% Similarity=0.419 Sum_probs=168.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|...+.||+|++|.||+|.+ +++.+++|.+........ .....+.+|+.+++.++|+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN------EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh------HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 4588889999999999999965 678899998864321111 11234678999999999999999999887655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++++||+. ++|.+++... ...+++..+..++.|++.++.+||+.+++|+||+|+||+++.
T Consensus 89 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~ 150 (308)
T cd06634 89 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (308)
T ss_pred ee----------------EEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC
Confidence 44 89999995 6888776543 345899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||.+...... ....++..|+|||.+. ...++.++|+||||+++|+|++|..||...+..+....+
T Consensus 151 ~~~~kl~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 226 (308)
T cd06634 151 PGLVKLGDFGSASIMAPA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (308)
T ss_pred CCcEEECCcccceeecCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH
Confidence 999999999988654322 2245778999999974 345788999999999999999999999877666555544
Q ss_pred HH
Q 022794 285 VR 286 (292)
Q Consensus 285 ~~ 286 (292)
.+
T Consensus 227 ~~ 228 (308)
T cd06634 227 AQ 228 (308)
T ss_pred hh
Confidence 43
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=224.19 Aligned_cols=221 Identities=26% Similarity=0.369 Sum_probs=179.2
Q ss_pred ecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCC-CCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEE-GHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~-~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+.+.|.-+.+||+|.||.||+| ..+|++|++|..-...+ .+.. ....+|+.+|..++|+|++.+++.+
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp--------italreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP--------ITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc--------HHHHHHHHHHHHhcchhHHHHHHHH
Confidence 34567888889999999999998 45788899986543222 1121 2246799999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
........ .....+++||++|+ .+|.-.+. +....++..++..++.+++.+|.|+|++.|+|||+|++|+
T Consensus 86 ~tk~Tp~~--------r~r~t~ylVf~~ce-hDLaGlLs-n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNv 155 (376)
T KOG0669|consen 86 RTKATPTN--------RDRATFYLVFDFCE-HDLAGLLS-NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANV 155 (376)
T ss_pred hhccCCcc--------cccceeeeeHHHhh-hhHHHHhc-CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhE
Confidence 76544322 12345699999995 48888764 3445799999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCC----CCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 204 LLDKNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
||+.+|.++|.|||+++....+ .+.+..++.|..|++||.+.|. .|+++.|+|..||++.+|+++.+.|+++++.
T Consensus 156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 9999999999999999654322 3345556779999999999886 5899999999999999999999999999988
Q ss_pred HHHHHHH
Q 022794 279 EVTSAVV 285 (292)
Q Consensus 279 ~~~~~i~ 285 (292)
+.+.-|.
T Consensus 236 qql~~Is 242 (376)
T KOG0669|consen 236 QQLHLIS 242 (376)
T ss_pred HHHHHHH
Confidence 8877664
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=235.35 Aligned_cols=216 Identities=24% Similarity=0.420 Sum_probs=174.8
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
+..+......+|.++.+||+|||+.||+| ...++.||+|+-...+.... +..+.+.....+|.+|.+.|.||.||+
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wrd--EKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRD--EKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhh--HhhhhHHHHHHHHHhhhhccCcceeee
Confidence 34455666789999999999999999999 45788999998754443322 222344556778999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC--Ccccc
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--KIVHR 196 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~i~h~ 196 (292)
+|++|.-.... +|-|+|||+|.+|+-|++. .+.+++.+++.|+.||+.||.||... .|+|-
T Consensus 532 lYDyfslDtds---------------FCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHY 594 (775)
T KOG1151|consen 532 LYDYFSLDTDS---------------FCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHY 594 (775)
T ss_pred eeeeeeecccc---------------ceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeee
Confidence 99998644332 2889999999999999964 46799999999999999999999977 59999
Q ss_pred CCCCCCeeEc---CCCcEEEeecCcceeccCCCCCC-------CCCCCcccccCCcccCCC----CCCchhhHHHHHHHH
Q 022794 197 DVKTENMLLD---KNRTVKIADFGVARVEASNPNDM-------TGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICL 262 (292)
Q Consensus 197 di~p~Nili~---~~~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~----~~~~~~Diwslg~il 262 (292)
||||.|||+- ..|.+||.|||++.++....... +...||..|+|||.+.-+ ..+.+.||||+|+|+
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 9999999994 44789999999998876554432 224588999999998533 467899999999999
Q ss_pred HHHHhCCCCCCCC
Q 022794 263 WEIYCCDMPYPDL 275 (292)
Q Consensus 263 ~~l~~g~~pf~~~ 275 (292)
|.++.|+.||...
T Consensus 675 yQClYGrKPFGhn 687 (775)
T KOG1151|consen 675 YQCLYGRKPFGHN 687 (775)
T ss_pred hhhhccCCCCCCc
Confidence 9999999999753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=229.57 Aligned_cols=213 Identities=35% Similarity=0.588 Sum_probs=170.5
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC--CCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~ 127 (292)
...++.+.||+|+||.||+|+.+++.||||++... .++.+.+|-+|++.. +|+||++|++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ------------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH------------HHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 34677889999999999999999999999999522 245578888888776 8999999998765444
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC---------CccccCC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------KIVHRDV 198 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---------~i~h~di 198 (292)
.. ...++||++|.+.|+|.+|+.. ..+++....+++..++.+|+|||.. .|+||||
T Consensus 278 ~~------------~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl 342 (534)
T KOG3653|consen 278 AD------------RMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL 342 (534)
T ss_pred cc------------ccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence 11 2233899999999999999954 4699999999999999999999975 5999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCC--CCCCCCCCCcccccCCcccCCCC-CC-----chhhHHHHHHHHHHHHhC--
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNP-YN-----RKCDVYSFGICLWEIYCC-- 268 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Diwslg~il~~l~~g-- 268 (292)
|..|||+..|+...|+|||+|...... ........||.+|||||++.|.- +. .+.||||+|.++|||++.
T Consensus 343 kSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 343 KSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred cccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999765422 22334478999999999998752 21 578999999999999884
Q ss_pred ----------CCCCC-----CCCHHHHHHHHHHhhh
Q 022794 269 ----------DMPYP-----DLSFSEVTSAVVRQVQ 289 (292)
Q Consensus 269 ----------~~pf~-----~~~~~~~~~~i~~~~~ 289 (292)
++||. ..+.+++-.-+++.+.
T Consensus 423 ~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~ 458 (534)
T KOG3653|consen 423 DADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQ 458 (534)
T ss_pred cccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhcc
Confidence 23554 4566666666666543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=244.05 Aligned_cols=211 Identities=30% Similarity=0.476 Sum_probs=183.0
Q ss_pred cCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
....|.+.+.||.|.+|.||++ .++|+.+|+|+......... .+..|.++|+.. .|||++.++++|.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de----------EiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE----------EIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH----------HHHHHHHHHHhccCCCCcceEEEEEE
Confidence 3467999999999999999988 56899999999875543211 245688999888 8999999999986
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
-.+. ..+..+|||||||.+|+..|.++...+..+.|..+..|++.++.++.|||++.++|||||-.|||
T Consensus 87 k~~~-----------~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL 155 (953)
T KOG0587|consen 87 KKDP-----------GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL 155 (953)
T ss_pred EecC-----------CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence 5543 13566799999999999999998777888999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
++.++.+||+|||.+..+...........||+.|||||++... .|+.++|+||||++..||..|.+|+-++-+--
T Consensus 156 LT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred EeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 9999999999999998887777777889999999999998643 57789999999999999999999997765543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=239.80 Aligned_cols=203 Identities=26% Similarity=0.411 Sum_probs=168.0
Q ss_pred CCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
.+.|.+...+|.|+|+.|-.+. .+++..++|++.....+ ..+|..++.+. +||||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------------~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------------NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------------cccccchhhhhcCCCcceeecceecC
Confidence 4678888999999999999884 46889999998655221 23466565555 89999999999988
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... |+|||.+.|+-|.+.+...+. +. ..+..|+.+|+.|+.+||.+|++|||+||+|||+
T Consensus 388 ~~~~----------------~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 388 GKEI----------------YLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred Ccee----------------eeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 8776 899999999988887754322 32 6778899999999999999999999999999999
Q ss_pred -cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Q 022794 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS-EVTSA 283 (292)
Q Consensus 206 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~-~~~~~ 283 (292)
+..++++|+|||.++..... ......|..|+|||+.....|+.++|+||||++||+|++|+.||...... ++...
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~ 525 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR 525 (612)
T ss_pred cCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh
Confidence 68999999999999765543 33346688999999999999999999999999999999999999977766 55555
Q ss_pred HHH
Q 022794 284 VVR 286 (292)
Q Consensus 284 i~~ 286 (292)
|..
T Consensus 526 i~~ 528 (612)
T KOG0603|consen 526 IQM 528 (612)
T ss_pred hcC
Confidence 443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=237.76 Aligned_cols=212 Identities=26% Similarity=0.429 Sum_probs=178.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC------Cccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH------PNVT 117 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv 117 (292)
+++..+|.+....|+|-|++|..|.+ .|..||||+++... .+...=..|+.+|++|+. -|.+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----------~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----------VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----------HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 46678999999999999999999966 58899999996322 223345679999999942 3788
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++..|...+++ |||+|-+ ..+|.+.+++.. +-.+....++.++.|+.-||.+|-..|++|.
T Consensus 498 rl~r~F~hknHL----------------ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHa 560 (752)
T KOG0670|consen 498 RLFRHFKHKNHL----------------CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHA 560 (752)
T ss_pred HHHHHhhhccee----------------EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeec
Confidence 888888766555 9999999 569999997653 3468888999999999999999999999999
Q ss_pred CCCCCCeeEcCCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 197 DVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 197 di~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
||||.|||+++.. .+||||||.|.... .+..+....+..|.|||.+.|.+|+...|+||+||+||||+||+..|++.
T Consensus 561 DIKPDNiLVNE~k~iLKLCDfGSA~~~~--eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 561 DIKPDNILVNESKNILKLCDFGSASFAS--ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccCccceEeccCcceeeeccCccccccc--cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 9999999999875 57999999996543 34455566788999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHH
Q 022794 276 SFSEVTSAVVR 286 (292)
Q Consensus 276 ~~~~~~~~i~~ 286 (292)
++.+++.-++.
T Consensus 639 TNN~MLrl~me 649 (752)
T KOG0670|consen 639 TNNQMLRLFME 649 (752)
T ss_pred CcHHHHHHHHH
Confidence 99999876653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=254.58 Aligned_cols=209 Identities=33% Similarity=0.523 Sum_probs=160.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|..++.||+||||.||++++ +|..||||.+.... ......++.+|+..|++|+|||||+++..+....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--------SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 4677889999999999999965 79999999885332 3344567889999999999999999995554321
Q ss_pred ccccc-------------c-------------------------------------------------------ccc---
Q 022794 128 ELHIQ-------------T-------------------------------------------------------ENG--- 136 (292)
Q Consensus 128 ~~~~~-------------~-------------------------------------------------------~~~--- 136 (292)
..... . ++|
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 10000 0 000
Q ss_pred --------c-----------------ccC-------CCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHH
Q 022794 137 --------Q-----------------VAM-------PSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARG 184 (292)
Q Consensus 137 --------~-----------------~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~a 184 (292)
+ .+. ....+||-||||+..+|.+++.++.... .....|+++++|+++
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHH
Confidence 0 000 0146899999999878887775542211 467889999999999
Q ss_pred HHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceecc------------------CCCCCCCCCCCcccccCCcccCC
Q 022794 185 LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA------------------SNPNDMTGETGTLGYMAPEVLNG 246 (292)
Q Consensus 185 l~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~------------------~~~~~~~~~~~~~~y~aPE~~~~ 246 (292)
|.|+|+.|++||||||.|||++++++|||+|||+++... .+....+...||.-|+|||++.+
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999999999999999999999999999999999987511 11123455679999999999977
Q ss_pred CC---CCchhhHHHHHHHHHHHHh
Q 022794 247 NP---YNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 247 ~~---~~~~~Diwslg~il~~l~~ 267 (292)
.. |+.++|+||||+|+|||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 54 9999999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-31 Score=211.32 Aligned_cols=212 Identities=34% Similarity=0.498 Sum_probs=175.0
Q ss_pred eeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
|.+.+.||.|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++.+......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPL 72 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCce
Confidence 567889999999999999764 689999998644322 2345678899999999999999999988765444
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
++++|++++++|.+++..... .+++..++.++.+++.++.+||+.+++|+|++|.||+++.++
T Consensus 73 ----------------~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 73 ----------------YLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG 135 (225)
T ss_pred ----------------EEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 899999999999999865422 178999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCC-CCCCCCCCcccccCCccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHH
Q 022794 210 TVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPD--LSFSEVTSAVV 285 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~-~~~~~~~~~Diwslg~il~~l~~g~~pf~~--~~~~~~~~~i~ 285 (292)
.++|+|||.+....... .......+...|++||.+ ....++.++|+|+||+++++|++|+.||.. .+..++.+.|.
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 99999999887654432 122234567789999998 666778899999999999999999999987 55557777777
Q ss_pred Hhh
Q 022794 286 RQV 288 (292)
Q Consensus 286 ~~~ 288 (292)
++.
T Consensus 216 ~~~ 218 (225)
T smart00221 216 FGV 218 (225)
T ss_pred cCC
Confidence 665
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-34 Score=222.75 Aligned_cols=210 Identities=27% Similarity=0.372 Sum_probs=170.9
Q ss_pred eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+-||.|.||+||.+.+ +|+.|++|.+.. -.......+++.+|+.+|+.++|.|++..+++......-++
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pn-------vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF-- 129 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPN-------VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF-- 129 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcch-------HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH--
Confidence 5799999999999976 699999998732 22333446678899999999999999999887655432211
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEE
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKI 213 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l 213 (292)
...|++.|.+ ..+|.+.|- ..+.++...+..+.+||+.+|.|||+.||.||||||.|+|++.+..+||
T Consensus 130 ---------qEiYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKI 197 (449)
T KOG0664|consen 130 ---------QELYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKI 197 (449)
T ss_pred ---------HHHHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEe
Confidence 1126677877 458887763 4467888899999999999999999999999999999999999999999
Q ss_pred eecCcceeccCC-CCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 214 ADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 214 ~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
||||+++..... .........|..|.|||.+.|. .|+.+.||||.||++.|++-.+..|...++-+.++-|.+
T Consensus 198 CDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 198 CDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred cccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 999999864322 2233445678899999999886 589999999999999999999999999998888877764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=217.75 Aligned_cols=179 Identities=22% Similarity=0.262 Sum_probs=148.4
Q ss_pred CcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccccccc
Q 022794 61 GTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQV 138 (292)
Q Consensus 61 G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 138 (292)
|.+|.||++.+ +++.||+|.++.... ..+|...+....|||++++++++...+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~--------- 60 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------------YSRERLTIIPHCVPNMVCLHKYIVSEDSV--------- 60 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------------hhhHHHHHHhcCCCceeehhhheecCCeE---------
Confidence 88999999966 688999999854321 22344445556799999999988776554
Q ss_pred cCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCc
Q 022794 139 AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218 (292)
Q Consensus 139 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~ 218 (292)
+++|||+++++|.+++.+. ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++++|||.
T Consensus 61 -------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~ 131 (237)
T cd05576 61 -------FLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR 131 (237)
T ss_pred -------EEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccc
Confidence 8999999999999998653 3589999999999999999999999999999999999999999999999997
Q ss_pred ceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 219 ARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+...... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..
T Consensus 132 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 132 WSEVEDS---CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred hhccccc---cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 7544322 1223456679999999888899999999999999999999987654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=223.05 Aligned_cols=136 Identities=24% Similarity=0.377 Sum_probs=117.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC--------CCccc
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--------HPNVT 117 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv 117 (292)
...+|.+.++||.|-|++||+|.++ .+.||+|+.+ ....+.+....|+.+|+++. ..+||
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK----------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK----------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe----------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 3489999999999999999999774 6789999986 33445566778999999982 24799
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHR 196 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~ 196 (292)
++++.|..... .+.++|+|+|++ |..|..+|.+...+.++...+..|++|++.+|.|||.. ||+|.
T Consensus 146 ~LlD~FkhsGp------------NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHT 212 (590)
T KOG1290|consen 146 QLLDHFKHSGP------------NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHT 212 (590)
T ss_pred eeeccceecCC------------CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 99998865543 356779999999 88999999998889999999999999999999999976 99999
Q ss_pred CCCCCCeeEc
Q 022794 197 DVKTENMLLD 206 (292)
Q Consensus 197 di~p~Nili~ 206 (292)
||||+|||+.
T Consensus 213 DlKPENvLl~ 222 (590)
T KOG1290|consen 213 DLKPENVLLC 222 (590)
T ss_pred CCCcceeeee
Confidence 9999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=208.88 Aligned_cols=207 Identities=20% Similarity=0.374 Sum_probs=173.5
Q ss_pred cCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
..++|++++++|+|-++.||.|+ .++++++||+++..+ +..+.+|+.+|+.| .+|||+.++++..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------------kkKIkREikIL~nL~gg~NIi~L~DiV~ 103 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------------KKKIKREIKILQNLRGGPNIIKLLDIVK 103 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------------HHHHHHHHHHHHhccCCCCeeehhhhhc
Confidence 35689999999999999999995 688999999996432 34588999999999 6999999999988
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+..... +.+++||+.+.+..... ..++...++.++.+++.||.|+|++||.|||+||.|++
T Consensus 104 Dp~Skt--------------paLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 104 DPESKT--------------PSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred CccccC--------------chhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 876543 38999999887766543 45888899999999999999999999999999999999
Q ss_pred EcCC-CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHH
Q 022794 205 LDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPY-PDLSFSEVT 281 (292)
Q Consensus 205 i~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf-~~~~~~~~~ 281 (292)
|+.. -.++|+|+|+|-+.. +....+....+..|--||.+..- .|+.+-|+|||||++..|+..+.|| .+.++.+.+
T Consensus 165 Idh~~rkLrlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL 243 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 243 (338)
T ss_pred echhhceeeeeecchHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence 9765 569999999997543 44566667788889999998664 5888999999999999999987765 577887777
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
.+|-+
T Consensus 244 VkIak 248 (338)
T KOG0668|consen 244 VKIAK 248 (338)
T ss_pred HHHHH
Confidence 77654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=232.20 Aligned_cols=204 Identities=25% Similarity=0.373 Sum_probs=166.2
Q ss_pred CceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---CCcccceeceec
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATM 124 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~ 124 (292)
.+|..++.+|.|+||.|++|+++ ...|+||.+...+--. +........-.+-.|+.||..++ |+||++++++|.
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~-DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILV-DTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhh-hhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 46899999999999999999764 6689999874322100 00000111112445999999996 999999999999
Q ss_pred CCcccccccccccccCCCCceEEEEeecC-CCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLP-GGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
+.+.+ ||++|-.. +-+|+++|... ..++|.++..|+.|++.++++||+.||+|||||-+|+
T Consensus 640 ddd~y----------------yl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenv 701 (772)
T KOG1152|consen 640 DDDYY----------------YLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENV 701 (772)
T ss_pred cCCee----------------EEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccE
Confidence 88876 78888653 45999999654 4599999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
.++..|.++|+|||.+....+ .......||..|.|||++.|.+| ...-|||+||+++|.+.....||.+
T Consensus 702 ivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999999865433 34455889999999999999887 4678999999999999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=235.61 Aligned_cols=214 Identities=29% Similarity=0.546 Sum_probs=181.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CC----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DG----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~----~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
...+..++||+|+||+||+|.| .| -+||+|++........ ...+..|+.++.++.|||++++++++
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--------s~e~LdeAl~masldHpnl~RLLgvc 767 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--------SIELLDEALRMASLDHPNLLRLLGVC 767 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--------hHHHHHHHHHHhcCCCchHHHHhhhc
Confidence 3456678999999999999966 33 3789998864432211 23478899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.... . -||.+|++.|.|.+|++.++ ..+-....+.|+.||++++.|||..+++||||...||
T Consensus 768 ~~s~-~----------------qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNV 829 (1177)
T KOG1025|consen 768 MLST-L----------------QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNV 829 (1177)
T ss_pred ccch-H----------------HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhe
Confidence 7665 2 57999999999999998754 4577888999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCC--CcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
|+....++|+.|||+++.+........... ..+.|+|-|.++...++.++||||+|+.+||++| |..|+.+.+.+|+
T Consensus 830 LVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 830 LVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred eecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 999999999999999988766655544433 4568999999999999999999999999999999 9999999999999
Q ss_pred HHHHHHhhh
Q 022794 281 TSAVVRQVQ 289 (292)
Q Consensus 281 ~~~i~~~~~ 289 (292)
-..+.++..
T Consensus 910 ~dlle~geR 918 (1177)
T KOG1025|consen 910 PDLLEKGER 918 (1177)
T ss_pred hHHHhcccc
Confidence 888877643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=250.12 Aligned_cols=185 Identities=26% Similarity=0.407 Sum_probs=152.3
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.+...+.||+|+||.||+|.. +|..||+|.++..... ...|+..+++++||||+++++++.+.+.
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------------PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------------cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 355667899999999999974 6899999988532211 1235788899999999999999977655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCCeeE
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH---SQKIVHRDVKTENMLL 205 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~h~di~p~Nili 205 (292)
. ++||||+++++|.+++. .+++..+..++.|++.|++||| +.+++||||||+||++
T Consensus 758 ~----------------~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 758 A----------------YLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred C----------------EEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 4 89999999999999984 3788999999999999999999 6699999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+.++..++. ++...... ......++..|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 817 ~~~~~~~~~-~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 817 DGKDEPHLR-LSLPGLLC----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCCceEEE-eccccccc----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 988877665 54432211 11223578899999999998999999999999999999999999853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=205.67 Aligned_cols=197 Identities=35% Similarity=0.549 Sum_probs=164.0
Q ss_pred cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccccccc
Q 022794 62 TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVA 139 (292)
Q Consensus 62 ~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 139 (292)
+||.||+|.+ +|+.+++|++........ .+.+.+|++.+++++|+|++++++.+......
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~---------- 62 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--------RERILREISILKKLKHPNIVRLYDVFEDEDKL---------- 62 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEE----------
Confidence 5899999976 469999999864432211 34578899999999999999999988765444
Q ss_pred CCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcc
Q 022794 140 MPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219 (292)
Q Consensus 140 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~ 219 (292)
++++|++++++|.+++.... .++...++.++.+++.++.+||+.+++|+||+|.||++++++.++|+|||.+
T Consensus 63 ------~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~ 134 (244)
T smart00220 63 ------YLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLA 134 (244)
T ss_pred ------EEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccce
Confidence 89999999989999986533 3889999999999999999999999999999999999999999999999998
Q ss_pred eeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Q 022794 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD-LSFSEVTSAVV 285 (292)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~-~~~~~~~~~i~ 285 (292)
....... ......++..|++||.+.+..++.++|+|++|++++++++|..||.. .....+.+.+.
T Consensus 135 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~ 200 (244)
T smart00220 135 RQLDPGG-LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG 200 (244)
T ss_pred eeecccc-ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 7654332 33345678899999999888889999999999999999999999987 55555554443
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=231.70 Aligned_cols=222 Identities=34% Similarity=0.570 Sum_probs=184.4
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CC
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 113 (292)
.|++..++..+.+.||.|.||.|++|.-. ...||||.++..... ...+.+..|+.+++.+ .|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--------~~~~~~~~El~~m~~~g~H 361 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--------SEKKDLMSELNVLKELGKH 361 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--------HHHHHHHHHHHHHHHhcCC
Confidence 78888888899999999999999998421 457999998654432 1244588899999999 79
Q ss_pred CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc------------c--cccCHHHHHHHHH
Q 022794 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------R--RKLAFKVVVQLAL 179 (292)
Q Consensus 114 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~--~~~~~~~~~~i~~ 179 (292)
+|++.+++.+...... ++++||++.|+|.+|++.++ . ..++...++.++.
T Consensus 362 ~niv~llG~~t~~~~~----------------~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~ 425 (609)
T KOG0200|consen 362 PNIVNLLGACTQDGPL----------------YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAY 425 (609)
T ss_pred cchhhheeeeccCCce----------------EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHH
Confidence 9999999999885444 89999999999999997765 0 1388899999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCC-CCCC--CcccccCCcccCCCCCCchhhHH
Q 022794 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDM-TGET--GTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 180 qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~--~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
||+.+++||++.+++||||...|||++.+..++++|||+++......... .... ....|||||.+....|+.++|+|
T Consensus 426 QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVW 505 (609)
T KOG0200|consen 426 QIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVW 505 (609)
T ss_pred HHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhh
Confidence 99999999999999999999999999999999999999998543332221 1112 35569999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCC-HHHHHHHHHHhhh
Q 022794 257 SFGICLWEIYC-CDMPYPDLS-FSEVTSAVVRQVQ 289 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~-~~~~~~~i~~~~~ 289 (292)
|+|+++||+.+ |..||.+.. ..++++.+.+|..
T Consensus 506 SfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r 540 (609)
T KOG0200|consen 506 SFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNR 540 (609)
T ss_pred HHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC
Confidence 99999999999 899999877 7788777776643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=222.09 Aligned_cols=219 Identities=22% Similarity=0.292 Sum_probs=151.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEE------------------CCceeEEEEeecCCCCCccHHH-----HHHHHHHHHHH
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY------------------DGHDVAVKLLDWGEEGHRTEAE-----IAALRSAFTQE 104 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~------------------~~~~valK~~~~~~~~~~~~~~-----~~~~~~~~~~e 104 (292)
..++|.+.++||+|+||+||+|.. .++.||||.++........... ..........|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 457899999999999999999853 3467999998643321110000 00112234457
Q ss_pred HHHHHhCCCCcc-----cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------
Q 022794 105 VAVWHKLDHPNV-----TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------------- 165 (292)
Q Consensus 105 ~~~l~~l~h~~i-----v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------- 165 (292)
+.++.+++|.++ +.+++++..... ...+.....++|+||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~--------~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g 294 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTA--------DGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAG 294 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccc--------cccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcC
Confidence 777777766544 555665543211 00112334589999999999999885321
Q ss_pred --------ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC-CCCCCCcc
Q 022794 166 --------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND-MTGETGTL 236 (292)
Q Consensus 166 --------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~ 236 (292)
...+++..++.++.|++.+|.+||+.+++||||||+||+++.++.++|+|||++......... .....+++
T Consensus 295 ~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp 374 (507)
T PLN03224 295 KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDP 374 (507)
T ss_pred CchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCc
Confidence 112456778899999999999999999999999999999999999999999998654322111 11123478
Q ss_pred cccCCcccCCCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCC
Q 022794 237 GYMAPEVLNGNPY----------------------NRKCDVYSFGICLWEIYCCDM-PYPD 274 (292)
Q Consensus 237 ~y~aPE~~~~~~~----------------------~~~~Diwslg~il~~l~~g~~-pf~~ 274 (292)
.|+|||.+..... ....|+||+||++|+|++|.+ ||.+
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9999999754321 124699999999999999986 7753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=206.25 Aligned_cols=217 Identities=24% Similarity=0.350 Sum_probs=179.5
Q ss_pred cCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
...+|.-++.+|.|.- .|-.| ...+.+|++|....+-.+ ....++..+|..++..++|+||+.++.+|..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-------~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-------QTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-------CccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 3578999999999998 56566 346899999987544222 1123446789999999999999999999977
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
...... ....|+|||++ ..+|...+. -.++-..+..++.|++++++|||+.||+||||||+||++
T Consensus 87 ~~~l~~----------~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv 151 (369)
T KOG0665|consen 87 QKTLEE----------FQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV 151 (369)
T ss_pred cccHHH----------HHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee
Confidence 665432 34458999999 669999885 237778899999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
..++.+|++|||+++..... -..+....+..|.|||++.+-.+....||||+||++.||++|..-|++.+.-+..-+|+
T Consensus 152 ~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 152 NSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII 230 (369)
T ss_pred cchhheeeccchhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH
Confidence 99999999999999754332 23455678899999999999889999999999999999999999999999888888887
Q ss_pred Hhh
Q 022794 286 RQV 288 (292)
Q Consensus 286 ~~~ 288 (292)
+..
T Consensus 231 ~~l 233 (369)
T KOG0665|consen 231 EQL 233 (369)
T ss_pred HHh
Confidence 653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=201.48 Aligned_cols=213 Identities=21% Similarity=0.345 Sum_probs=172.6
Q ss_pred ceecCCceeEeeeeccCcceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 121 (292)
..+.+-.|.+.++||+|.||+++.| ..++++||||.-....+.+. +..|.+..+.| ..++|.+.+-
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ-----------LrdEYr~YKlL~g~~GIP~vYY 91 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ-----------LRDEYRTYKLLGGTEGIPQVYY 91 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcch-----------HHHHHHHHHHHcCCCCCCceee
Confidence 4456788999999999999999999 46899999998754443322 45678888888 6788988775
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
+-..+..- .||+|.+ |.+|+|.+.- .++.++..++..++.|++.-++++|.+.+|+|||||+
T Consensus 92 FGqeG~~N----------------iLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPd 153 (449)
T KOG1165|consen 92 FGQEGKYN----------------ILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPD 153 (449)
T ss_pred eccccchh----------------hhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 54444332 6899999 8999997653 5678999999999999999999999999999999999
Q ss_pred CeeEcCCC-----cEEEeecCcceeccCCCCC-------CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 022794 202 NMLLDKNR-----TVKIADFGVARVEASNPND-------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 202 Nili~~~~-----~~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~ 269 (292)
|+||...+ .+.++|||+|....++... .....||-+||+..-+.|...+.+.|+.+||-++++.|.|.
T Consensus 154 NFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 154 NFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred ceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence 99997554 4899999999865444322 23356999999999999999999999999999999999999
Q ss_pred CCCCCCCHH---HHHHHHHH
Q 022794 270 MPYPDLSFS---EVTSAVVR 286 (292)
Q Consensus 270 ~pf~~~~~~---~~~~~i~~ 286 (292)
+||.+..+. +.+++|-.
T Consensus 234 LPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 234 LPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred CccccccCcchHHHHHHhcc
Confidence 999976544 44555533
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-31 Score=232.55 Aligned_cols=206 Identities=27% Similarity=0.452 Sum_probs=162.7
Q ss_pred eeEeeeeccCcceE-EEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCccc
Q 022794 52 LVIKSVIARGTFGT-VHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 52 ~~~~~~lg~G~~g~-V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 129 (292)
|.-.+.+|.|+.|+ ||+|...|+.||||.+-. ...+...+|+..|+.. .||||+++++.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~------------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q-- 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE------------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ-- 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh------------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCc--
Confidence 44456789999985 899999999999998732 2234467899999999 8999999998765544
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
|.||+.|.| ..+|.+++... .......-..+.+..|++.+|+|||+.+|+||||||.||||..
T Consensus 577 --------------F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~ 641 (903)
T KOG1027|consen 577 --------------FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISV 641 (903)
T ss_pred --------------eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEc
Confidence 449999999 56999999652 1111221445788999999999999999999999999999965
Q ss_pred ---C--CcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHH
Q 022794 208 ---N--RTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278 (292)
Q Consensus 208 ---~--~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g-~~pf~~~~~~ 278 (292)
+ ..++|.|||++.......+. .....|+-+|.|||++.....+.+.|||||||++|+.++| .+||...-.+
T Consensus 642 ~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 642 PSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 3 46899999999877655443 3446789999999999998888899999999999999996 8999765544
Q ss_pred HHHHHHHHhh
Q 022794 279 EVTSAVVRQV 288 (292)
Q Consensus 279 ~~~~~i~~~~ 288 (292)
+ ..|++++
T Consensus 722 ~--~NIl~~~ 729 (903)
T KOG1027|consen 722 Q--ANILTGN 729 (903)
T ss_pred h--hhhhcCc
Confidence 3 3444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=225.35 Aligned_cols=205 Identities=19% Similarity=0.223 Sum_probs=138.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--C----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--D----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.+..++|.+.+.||+|+||.||+|.+ + +..||+|.+..... .+. ...+ .++...+.++..+
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~------~~~e--~l~~~~~~~~~~~ 194 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEI------WMNE--RVRRACPNSCADF 194 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHH------HHHH--HHHhhchhhHHHH
Confidence 34557999999999999999999965 3 67999998753211 010 0001 1111222222222
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc------------------cccCHHHHHHHHHHH
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR------------------RKLAFKVVVQLALDL 181 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~i~~qi 181 (292)
+..+..... .......++++||+.+++|.+++..... .......+..++.|+
T Consensus 195 ~~~~~~~~~----------~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~ql 264 (566)
T PLN03225 195 VYGFLEPVS----------SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQI 264 (566)
T ss_pred HHhhhcccc----------cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHH
Confidence 222211100 1123345899999999999998854311 011234567899999
Q ss_pred HHHHHHHHhCCccccCCCCCCeeEcC-CCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCC-----------
Q 022794 182 ARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNP----------- 248 (292)
Q Consensus 182 ~~al~~lH~~~i~h~di~p~Nili~~-~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~----------- 248 (292)
+.+|.|||+.||+||||||+|||+++ ++.++|+|||++....... .......+++.|+|||.+....
T Consensus 265 l~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~ 344 (566)
T PLN03225 265 LFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVA 344 (566)
T ss_pred HHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCcccccc
Confidence 99999999999999999999999985 5789999999997543221 2223456889999999764322
Q ss_pred -----------CCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 249 -----------YNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 249 -----------~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
++.++||||+||++|+|+++..|+.
T Consensus 345 ~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 345 TALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 2345699999999999999877754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=192.24 Aligned_cols=209 Identities=23% Similarity=0.338 Sum_probs=167.2
Q ss_pred ecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC-Ccccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~ 123 (292)
+..++|.+++.||.|+||.+|+|. .+|+.||||+-+.....+. +.-|.++.+.+.+ ..|..+.-+.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpq-----------L~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQ-----------LLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcc-----------hhHHHHHHHHhccCCCCchhhhhc
Confidence 456899999999999999999994 5899999999865544333 5568888888844 4555544433
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+... -.+||+.+ |.+|++.+.- ..+.++..+++-++-|++.-++|+|.++++||||||+|+
T Consensus 81 ~e~~y----------------nvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNF 142 (341)
T KOG1163|consen 81 TEKDY----------------NVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNF 142 (341)
T ss_pred ccccc----------------ceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccce
Confidence 33222 27999999 8999998764 345699999999999999999999999999999999999
Q ss_pred eEcCC---CcEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 204 LLDKN---RTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 204 li~~~---~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|..-+ ..+.|+|||++....+... ......||..|.+-..+.+...+.+.|+-|+|+++.++..|.+||+
T Consensus 143 LMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 143 LMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred eeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 99643 5699999999975433222 2233568999999999999899999999999999999999999999
Q ss_pred CCCHHHHHHHH
Q 022794 274 DLSFSEVTSAV 284 (292)
Q Consensus 274 ~~~~~~~~~~i 284 (292)
+..+....++-
T Consensus 223 glka~tk~QKy 233 (341)
T KOG1163|consen 223 GLKAATKKQKY 233 (341)
T ss_pred ccchhhHHHHH
Confidence 88776655443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=208.18 Aligned_cols=209 Identities=25% Similarity=0.350 Sum_probs=166.0
Q ss_pred ceeEeeeeccCcceEEEEEEECC---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC----CCcccceecee
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDG---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD----HPNVTKFIGAT 123 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~ 123 (292)
+|.+.+.||+|+||.||+|.+.. +.+|+|+.......... .+..|..++..+. -+++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---------~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---------VLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---------cchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 89999999999999999997754 36999987654322211 1455777777775 35888888776
Q ss_pred c-CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 124 M-GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 124 ~-~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
. .. .+.++||+.+ |.+|.+.......+.++..++..++.|++.+|.+||+.|++||||||.|
T Consensus 90 ~~~~----------------~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 90 RSTE----------------DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred cCCC----------------ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 4 22 2338999999 8899998766666789999999999999999999999999999999999
Q ss_pred eeEcCC-----CcEEEeecCcce--eccCCC--------CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 203 MLLDKN-----RTVKIADFGVAR--VEASNP--------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 203 ili~~~-----~~~~l~Dfg~~~--~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
+++... ..+.|+|||+++ ...... .......||..|+++..+.+...+++.|+||+++++.++..
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~ 232 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK 232 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc
Confidence 999765 359999999998 321111 11234569999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHH
Q 022794 268 CDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 268 g~~pf~~~~~~~~~~~i~ 285 (292)
|.+||..........++.
T Consensus 233 g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 233 GSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCCCccccccchHHHHH
Confidence 999998777544444443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=203.26 Aligned_cols=204 Identities=21% Similarity=0.347 Sum_probs=156.5
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
.......++ .+.|.|.+.||+|.||.+.++.+ +++.+++|.+..+... .+.|.+|..---.| .|.|
T Consensus 14 ~~el~kv~l-~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----------~~dF~rEfhY~~~Ls~H~h 82 (378)
T KOG1345|consen 14 MEELKKVDL-EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----------QADFVREFHYSFFLSPHQH 82 (378)
T ss_pred cccccccch-hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----------HHHHHHHhccceeeccchh
Confidence 333344443 36799999999999999999966 4678999988533221 22366676655555 6899
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
|+.-|+...+... ++++++||++-|+|.+-+.. ..+-+.....++.|+++||.+||+.+++|
T Consensus 83 Ii~tY~vaFqt~d---------------~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVH 144 (378)
T KOG1345|consen 83 IIDTYEVAFQTSD---------------AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVH 144 (378)
T ss_pred hhHHHHHHhhcCc---------------eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhh
Confidence 9988877655433 23799999999999988743 46888899999999999999999999999
Q ss_pred cCCCCCCeeEc--CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-----CCCchhhHHHHHHHHHHHHhC
Q 022794 196 RDVKTENMLLD--KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 196 ~di~p~Nili~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diwslg~il~~l~~g 268 (292)
||||.+||||. +..++||||||..+..+.-- ........|.+||+.... ...+.+|+|.||+++|++++|
T Consensus 145 RdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG 221 (378)
T KOG1345|consen 145 RDLKAENILIFDADFYRVKLCDFGLTRKVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTG 221 (378)
T ss_pred cccccceEEEecCCccEEEeeecccccccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecC
Confidence 99999999994 34579999999886443221 112345678999986432 246889999999999999999
Q ss_pred CCCCCC
Q 022794 269 DMPYPD 274 (292)
Q Consensus 269 ~~pf~~ 274 (292)
.+||+.
T Consensus 222 ~~PWQk 227 (378)
T KOG1345|consen 222 KFPWQK 227 (378)
T ss_pred CCcchh
Confidence 999983
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=202.00 Aligned_cols=228 Identities=22% Similarity=0.395 Sum_probs=185.4
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 110 (292)
.....+.+.+...+++...++.+|.||.||.|++. .+.|-+|.++.... +.....+.+|.-++..
T Consensus 272 ~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--------~iQv~~~L~es~lly~ 343 (563)
T KOG1024|consen 272 FNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--------QIQVNLLLQESMLLYG 343 (563)
T ss_pred HhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--------HHHHHHHHHHHHHHhc
Confidence 34455667777889999999999999999999663 34566666543221 2234557889999999
Q ss_pred CCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh------cccccCHHHHHHHHHHHHHH
Q 022794 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN------RRRKLAFKVVVQLALDLARG 184 (292)
Q Consensus 111 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~a 184 (292)
+.|||+.++.++..... .++++++.+..-|+|..|+... ..+.++..++..++.|++.|
T Consensus 344 ~sH~nll~V~~V~ie~~---------------~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~a 408 (563)
T KOG1024|consen 344 ASHPNLLSVLGVSIEDY---------------ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMA 408 (563)
T ss_pred CcCCCccceeEEEeecc---------------CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHH
Confidence 99999999998876532 3458899999889999999733 23457778889999999999
Q ss_pred HHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHH
Q 022794 185 LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262 (292)
Q Consensus 185 l~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il 262 (292)
+.|||++|++|.||...|.+|++.-++||+|-.+++.+-..... .........||+||.+....|+.++|+||||+++
T Consensus 409 m~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 409 MEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 99999999999999999999999999999999988754333222 2233456799999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022794 263 WEIYC-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 263 ~~l~~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|||+| |+.||-+.++.|+..-+++|.
T Consensus 489 WELmtlg~~PyaeIDPfEm~~ylkdGy 515 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEMEHYLKDGY 515 (563)
T ss_pred HHHHhcCCCCccccCHHHHHHHHhccc
Confidence 99999 999999999999999888873
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-27 Score=185.81 Aligned_cols=183 Identities=39% Similarity=0.683 Sum_probs=154.7
Q ss_pred eccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 58 IARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 58 lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
||+|.+|.||++... ++.+++|++....... ....+.+|+..++.+.|++++++++++......
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~------ 66 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL------ 66 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE------
Confidence 689999999999876 8999999986443221 234588899999999999999999998775443
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC-CCcEEEe
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-NRTVKIA 214 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~-~~~~~l~ 214 (292)
++++|++.+++|.+++.... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+
T Consensus 67 ----------~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~ 135 (215)
T cd00180 67 ----------YLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLA 135 (215)
T ss_pred ----------EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEe
Confidence 89999999899999986432 46889999999999999999999999999999999999999 8999999
Q ss_pred ecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHH
Q 022794 215 DFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l 265 (292)
||+.+..............+...|++||.+... .++.++|+|++|++++++
T Consensus 136 d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 136 DFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 999987654432223345678899999999877 788999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=202.47 Aligned_cols=203 Identities=24% Similarity=0.392 Sum_probs=166.1
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEE--E---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGL--Y---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~--~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
..-.+.+......|.++.+||.|.|++||++. . .++.||+|.+...... .++.+|+++|..+ .
T Consensus 25 ~~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----------~ri~~El~~L~~~gG 93 (418)
T KOG1167|consen 25 EQLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----------SRILNELEMLYRLGG 93 (418)
T ss_pred HHHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----------hHHHHHHHHHHHhcc
Confidence 33344456667889999999999999999983 2 5678999988544332 3478899999999 7
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 192 (292)
+.||+++.+++..++.. .+|+||++.....++.. .++...+..++..++.||.++|.+|
T Consensus 94 ~~ni~~~~~~~rnnd~v----------------~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G 152 (418)
T KOG1167|consen 94 SDNIIKLNGCFRNNDQV----------------AIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG 152 (418)
T ss_pred chhhhcchhhhccCCee----------------EEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC
Confidence 99999999999888877 88999999988888773 3778889999999999999999999
Q ss_pred ccccCCCCCCeeEcCC-CcEEEeecCcceecc-----------------C---------------------------CCC
Q 022794 193 IVHRDVKTENMLLDKN-RTVKIADFGVARVEA-----------------S---------------------------NPN 227 (292)
Q Consensus 193 i~h~di~p~Nili~~~-~~~~l~Dfg~~~~~~-----------------~---------------------------~~~ 227 (292)
|+||||||+|++.+.. +.-.|+|||++.... . .+.
T Consensus 153 IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~ 232 (418)
T KOG1167|consen 153 IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPS 232 (418)
T ss_pred ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccc
Confidence 9999999999999754 778999999985100 0 000
Q ss_pred CCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 228 DMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 228 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
......||++|.|||++.+. ..+++.|+||.|+|+.-+++++.||-
T Consensus 233 ~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 233 ERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 11123489999999998765 58899999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=208.38 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=175.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.++..+|.|.||.||+|++ +++..|+|+++....... ..+.+|+-+++.++||||+.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---------~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---------SGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---------cccccceeeeecCCCcChHHHHhhhhhh
Confidence 35799999999999999999955 799999999986543322 2266799999999999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. |++||||.+|+|.+.- +...++++.++..+++..+.+|+|||..|-+|||||-.||+++
T Consensus 85 dkl----------------wicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt 146 (829)
T KOG0576|consen 85 DKL----------------WICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT 146 (829)
T ss_pred cCc----------------EEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec
Confidence 776 8999999999999865 4567899999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL---NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+.|.+++.|||.+..+..-........|++.|+|||+- +.+.|...+|+|++|+...++-.-++|....-+-..
T Consensus 147 d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~ 223 (829)
T KOG0576|consen 147 DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA 223 (829)
T ss_pred ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH
Confidence 99999999999886655444455568899999999985 445688999999999999999888888765544433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=188.72 Aligned_cols=171 Identities=21% Similarity=0.183 Sum_probs=125.5
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
......+|.+.+.||+|+||+||+|.+ +++.||||.......... .......+.+|++++++++|+|+++.+.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~----~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS----KPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc----cHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 344568899999999999999999965 467789998642211000 1123445889999999999999985332
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC-CC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV-KT 200 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di-~p 200 (292)
.+ .. .+++|||++|++|.. +. . .. ...++.|++++|.+||++|++|||| ||
T Consensus 89 ~~---~~----------------~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP 140 (365)
T PRK09188 89 AT---GK----------------DGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKP 140 (365)
T ss_pred Ec---CC----------------cEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCc
Confidence 11 11 289999999999963 21 1 11 1467889999999999999999999 99
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCC--------CCCCCcccccCCcccCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDM--------TGETGTLGYMAPEVLNGN 247 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~ 247 (292)
+||+++.++.++|+|||+++......... ....++..|++||.+...
T Consensus 141 ~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 141 QNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999988999999999998654432211 223467778999988543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=180.73 Aligned_cols=188 Identities=12% Similarity=0.107 Sum_probs=135.4
Q ss_pred ecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+..++|++.+.+|.|+||.||++..++..+|+|+++................+.+.+|++.+.++.|++|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45789999999999999999998778889999999754432221111111233468899999999999999998886643
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
....+ .-....+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|||++|+||+++
T Consensus 108 ~~~~~--------~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 108 ERKTL--------RYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS 169 (232)
T ss_pred ccccc--------cccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe
Confidence 21100 00123489999999999988741 223 2456999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l 265 (292)
++| ++|+|||........ ... ........+..++|+|+||+.+..+
T Consensus 170 ~~g-i~liDfg~~~~~~e~--~a~----------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQR--KAK----------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCC-EEEEECCCcccccch--hhH----------HHHHHHhHhcccccccceeEeehHH
Confidence 888 999999977533211 100 0022233456789999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=168.14 Aligned_cols=146 Identities=16% Similarity=0.182 Sum_probs=108.1
Q ss_pred eeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHH-----------------HHHHHHHHHHHHHHHHhCCCCcc
Q 022794 55 KSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAE-----------------IAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
.+.||+|++|.||+|.. +|+.||||+++..........+ .........+|+.+++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999965 6999999999765322111100 00112234569999999987776
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH-HhCCccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYL-HSQKIVH 195 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l-H~~~i~h 195 (292)
......... . .+++|||++++++...... ...++...+..++.|++.+|.++ |+.|++|
T Consensus 82 ~~p~~~~~~--~----------------~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiH 141 (190)
T cd05147 82 PCPEPILLK--S----------------HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVH 141 (190)
T ss_pred CCCcEEEec--C----------------CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 433322111 1 1799999988777654322 34688999999999999999999 7999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCccee
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
|||||+||+++ ++.++|+|||++..
T Consensus 142 rDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 142 ADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CCCCHHHEEEE-CCcEEEEEcccccc
Confidence 99999999998 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-22 Score=171.81 Aligned_cols=203 Identities=33% Similarity=0.497 Sum_probs=168.3
Q ss_pred eeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC-cccceeceecCCcccc
Q 022794 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP-NVTKFIGATMGSSELH 130 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 130 (292)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|..+++.+.|+ +++++.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~- 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS------KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL- 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch------hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE-
Confidence 788899999999999999877 8889998865443222 2345588899999999888 799999988554432
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+++++++.++++.+++..... ..++......++.|++.++.++|..+++|||+||+|++++..+
T Consensus 74 ---------------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~ 138 (384)
T COG0515 74 ---------------YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDG 138 (384)
T ss_pred ---------------EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCC
Confidence 899999999999976644321 2688999999999999999999999999999999999999888
Q ss_pred -cEEEeecCcceeccCCCC------CCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 210 -TVKIADFGVARVEASNPN------DMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 210 -~~~l~Dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
.++++|||.+........ ......++..|++||.+.+ ...+...|+|++|++++++++|..||.....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 139 RVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 799999999875443332 2355779999999999987 5788899999999999999999999987764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=205.12 Aligned_cols=153 Identities=20% Similarity=0.263 Sum_probs=111.4
Q ss_pred CCC-CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Q 022794 111 LDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 111 l~h-~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
+.| +||..++++|.....-.. ....++.++|++ +++|.+++.. ....+++..++.++.||+.||.|||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGL---------DDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred hhHHHHHHHhhcccCCcccccc---------ccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHH
Confidence 345 577777777632221100 011236678887 6799999964 2456999999999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCc-------------------EEEeecCcceeccCCC----------------CCCCCCCC
Q 022794 190 SQKIVHRDVKTENMLLDKNRT-------------------VKIADFGVARVEASNP----------------NDMTGETG 234 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~-------------------~~l~Dfg~~~~~~~~~----------------~~~~~~~~ 234 (292)
++||+||||||+||||+..+. ++++|||.++...... .......+
T Consensus 98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 999999999999999965444 5555555554211100 00011346
Q ss_pred cccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 235 ~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.|+|||++.+..++.++|||||||++|||++|.+||..
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 7889999999999999999999999999999999998864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=159.60 Aligned_cols=148 Identities=17% Similarity=0.146 Sum_probs=110.3
Q ss_pred eeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHH-----------------HHHHHHHHHHHHHHHHhCCCCcc
Q 022794 55 KSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAE-----------------IAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~-----------------~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
.+.||+|++|.||+|.+ +|+.||||+++..........+ .......+..|...+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999976 5999999999865322111000 01112335679999999988887
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVH 195 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h 195 (292)
.....+.... .+++|||++++++...... ...++...+..++.|++.++.++|+ .|++|
T Consensus 82 ~~p~~~~~~~------------------~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givH 141 (190)
T cd05145 82 PVPEPILLKK------------------NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVH 141 (190)
T ss_pred CCceEEEecC------------------CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 5443332211 1799999988755443222 2457888999999999999999999 99999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceecc
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEA 223 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~ 223 (292)
|||||+||+++ ++.++|+|||++....
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999998 7899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=168.62 Aligned_cols=216 Identities=22% Similarity=0.313 Sum_probs=131.5
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC----------CCcccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD----------HPNVTK 118 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~iv~ 118 (292)
.+...+.||.|+++.||.+++ +|++++||++........ .+... +.+|.-....+. |-.++-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~--~~~~~----~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA--NEYEQ----LKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT--THHHH----HHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch--HHHHH----HHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 567788999999999999987 469999999987763322 22222 334443333331 112222
Q ss_pred eeceecCC-cccccccccccccCCCCceEEEEeecCCCCHHHHHHh---hc--ccccCHHHHHHHHHHHHHHHHHHHhCC
Q 022794 119 FIGATMGS-SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK---NR--RRKLAFKVVVQLALDLARGLSYLHSQK 192 (292)
Q Consensus 119 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ 192 (292)
.++..... .........+.........+++|+-. .++|.+.+.. .. ...+.......+..|++..+++||..|
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 23322221 11111111111111111236788888 5699888642 11 122334455666789999999999999
Q ss_pred ccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC--------CCCCchhhHHHHHHHHHH
Q 022794 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--------NPYNRKCDVYSFGICLWE 264 (292)
Q Consensus 193 i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diwslg~il~~ 264 (292)
++|+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||.... ..++.+.|.|+||+++|.
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999999987654432221 334578899997633 246889999999999999
Q ss_pred HHhCCCCCCCCC
Q 022794 265 IYCCDMPYPDLS 276 (292)
Q Consensus 265 l~~g~~pf~~~~ 276 (292)
|||+.+||...+
T Consensus 243 lWC~~lPf~~~~ 254 (288)
T PF14531_consen 243 LWCGRLPFGLSS 254 (288)
T ss_dssp HHHSS-STCCCG
T ss_pred HHHccCCCCCCC
Confidence 999999998543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-22 Score=157.07 Aligned_cols=187 Identities=13% Similarity=0.058 Sum_probs=137.3
Q ss_pred eEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCccccc
Q 022794 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 131 (292)
.+...|++|+||+||++...+.+++.+.+...... ........+.+|+++|+++ +++++++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~-----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~----~~-- 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW-----LRGVAWWLARREALALRQLDGLPRTPRLLHWD----GR-- 73 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhh-----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc----CE--
Confidence 35678999999999999889999998877533211 1111123578999999999 558899888751 12
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCCeeEcCCCc
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV-KTENMLLDKNRT 210 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di-~p~Nili~~~~~ 210 (292)
+++|+|+.|.+|...+.. . ...++.|++.+|.++|+.|++|||| ||.||+++.++.
T Consensus 74 --------------~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~ 130 (218)
T PRK12274 74 --------------HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS 130 (218)
T ss_pred --------------EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC
Confidence 799999999998754311 1 1347789999999999999999999 799999999999
Q ss_pred EEEeecCcceeccCCCCC----C---------CCCCCcccccCCcccCCC-CCC-chhhHHHHHHHHHHHHhCCCCCC
Q 022794 211 VKIADFGVARVEASNPND----M---------TGETGTLGYMAPEVLNGN-PYN-RKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~----~---------~~~~~~~~y~aPE~~~~~-~~~-~~~Diwslg~il~~l~~g~~pf~ 273 (292)
++|+|||.+......... . .-...++.+++|+...-- ..+ .+.+.++.|+-+|.++|+..|+-
T Consensus 131 i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 131 PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 999999999744322210 0 001146677777765443 344 56677889999999999988764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=156.32 Aligned_cols=118 Identities=29% Similarity=0.432 Sum_probs=98.8
Q ss_pred CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCC
Q 022794 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234 (292)
Q Consensus 155 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 234 (292)
|+|.+++... ...+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g 66 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRV 66 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCC
Confidence 6899988643 456999999999999999999999999 999999999999999 99887644321 257
Q ss_pred cccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Q 022794 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF-SEVTSAVVR 286 (292)
Q Consensus 235 ~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~-~~~~~~i~~ 286 (292)
++.|+|||++.+..++.++||||+|+++|+|++|..||..... .+.+..+..
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 8999999999999999999999999999999999999975433 344444443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=185.05 Aligned_cols=201 Identities=20% Similarity=0.292 Sum_probs=157.6
Q ss_pred hhcccceecCCceeEeeeeccCcceEEEEEE-ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---CCc
Q 022794 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGL-YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPN 115 (292)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~ 115 (292)
.....+++...+|.|.+.||+|+||.||.|. .+|+.||||+-+....-+.-. + .+++.+|+ -+.
T Consensus 688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI------~------~q~~~RLk~~~~~~ 755 (974)
T KOG1166|consen 688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI------C------LQVMERLKPQMLPS 755 (974)
T ss_pred CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee------h------HHHHHhhchhhhcc
Confidence 3455678888999999999999999999994 459999999987665443322 1 12222232 244
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
|..+...+...+.. +++++|.+.|+|.+++. ..+.+++..+..+..|++..+.+||..+|||
T Consensus 756 ~~~~~~a~~~~~~S----------------~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIH 817 (974)
T KOG1166|consen 756 IMHISSAHVFQNAS----------------VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIH 817 (974)
T ss_pred hHHHHHHHccCCcc----------------eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceec
Confidence 55555554444433 78999999999999995 5677999999999999999999999999999
Q ss_pred cCCCCCCeeEcC-------CCcEEEeecCcceecc--CCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 022794 196 RDVKTENMLLDK-------NRTVKIADFGVARVEA--SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 196 ~di~p~Nili~~-------~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~ 266 (292)
|||||+|++|.. ..-++|+|||.+.-+. .........+.+-.+--+|+..|..++..+|.|.++.+++.|+
T Consensus 818 gDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL 897 (974)
T KOG1166|consen 818 GDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML 897 (974)
T ss_pred ccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH
Confidence 999999999942 2348999999885322 1223455567888899999999999999999999999999999
Q ss_pred hCCC
Q 022794 267 CCDM 270 (292)
Q Consensus 267 ~g~~ 270 (292)
.|+.
T Consensus 898 FG~y 901 (974)
T KOG1166|consen 898 FGKY 901 (974)
T ss_pred HHHH
Confidence 9963
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-21 Score=152.04 Aligned_cols=142 Identities=24% Similarity=0.338 Sum_probs=113.2
Q ss_pred eeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
+.||+|++|.||+|.+.|..+++|+........ ...........+.+|+.++..+.|+++.....++.+....
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~------ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRH-PELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF------ 74 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcC-hHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC------
Confidence 578999999999999999999999875332211 1122223345678899999999999887766665444333
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
+++|||++|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|
T Consensus 75 ----------~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liD 137 (211)
T PRK14879 75 ----------IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLID 137 (211)
T ss_pred ----------EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEE
Confidence 89999999999999885321 1 7788999999999999999999999999999998 78899999
Q ss_pred cCccee
Q 022794 216 FGVARV 221 (292)
Q Consensus 216 fg~~~~ 221 (292)
||.+..
T Consensus 138 f~~a~~ 143 (211)
T PRK14879 138 FGLAEF 143 (211)
T ss_pred CCcccC
Confidence 998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-20 Score=146.56 Aligned_cols=138 Identities=21% Similarity=0.304 Sum_probs=106.6
Q ss_pred eeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccccc
Q 022794 57 VIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENG 136 (292)
Q Consensus 57 ~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 136 (292)
.||+|++|.||++.++|..+++|+....... ....+......++.+|+++++.+.++++.....++...+..
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~------- 72 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYR-HPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK------- 72 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCc-CchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC-------
Confidence 4799999999999999999999996533211 11122233345678899999999887655444443333322
Q ss_pred cccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeec
Q 022794 137 QVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216 (292)
Q Consensus 137 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Df 216 (292)
+++|||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++||
T Consensus 73 ---------~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDf 133 (199)
T TIGR03724 73 ---------TIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDF 133 (199)
T ss_pred ---------EEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEEC
Confidence 79999999999999874321 1 6889999999999999999999999999998 889999999
Q ss_pred Cccee
Q 022794 217 GVARV 221 (292)
Q Consensus 217 g~~~~ 221 (292)
|.+..
T Consensus 134 g~a~~ 138 (199)
T TIGR03724 134 GLGKY 138 (199)
T ss_pred CCCcC
Confidence 98864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=152.58 Aligned_cols=148 Identities=22% Similarity=0.222 Sum_probs=110.5
Q ss_pred ceeEeeeeccCcceEEEEEE---ECCceeEEEEeecCCCCCccH---------------HHHHHHHHHHHHHHHHHHhCC
Q 022794 51 KLVIKSVIARGTFGTVHRGL---YDGHDVAVKLLDWGEEGHRTE---------------AEIAALRSAFTQEVAVWHKLD 112 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~---~~~~~valK~~~~~~~~~~~~---------------~~~~~~~~~~~~e~~~l~~l~ 112 (292)
-|.+.+.||+|++|.||+|. .+|+.||+|+++......... .........+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999997 368999999997543221110 011122344678999999996
Q ss_pred CCc--ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh
Q 022794 113 HPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS 190 (292)
Q Consensus 113 h~~--iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 190 (292)
+.+ +.++++. . . .+++|||+++.+|..+... ........+..++.|++.++.+||+
T Consensus 109 ~~~i~~p~~~~~---~-~----------------~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~ 166 (237)
T smart00090 109 EAGVPVPKPIAW---R-R----------------NVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYK 166 (237)
T ss_pred hcCCCCCeeeEe---c-C----------------ceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHh
Confidence 532 3333321 1 1 1799999998888765422 2345666778999999999999999
Q ss_pred CC-ccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 QK-IVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 ~~-i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.| ++|+||||+||+++ ++.++|+|||.+..
T Consensus 167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred cCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 99 99999999999998 88899999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=177.68 Aligned_cols=204 Identities=30% Similarity=0.400 Sum_probs=157.1
Q ss_pred eEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
.....+|.|.+|.|+.+.. ..+.++.|.++.. .. ....+ ......+..|+-+-..+.|+|++..+..+.+....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~-~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESE-RKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccH-HHHhhhhhhheeecccccCCchhhhHHHHhhcccc-
Confidence 4567889999998887743 3555666655421 10 11111 11122277788888889999998888877766655
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
.-.||||+. +|...+... ..+....+.-++.|++.+++|+|..|+.|||+|++|+++...|.
T Consensus 397 ---------------~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~ 458 (601)
T KOG0590|consen 397 ---------------LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI 458 (601)
T ss_pred ---------------hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc
Confidence 234999998 999988543 45888889999999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCC----CCCCCCCCcccccCCcccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 211 VKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNR-KCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~-~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
++++|||.+.....+. .......|+-+|+|||++.+..|.+ ..||||.|++++.|.+|+.||.-....
T Consensus 459 lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 459 LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 9999999886543222 2345577899999999999999875 679999999999999999999865544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=177.44 Aligned_cols=198 Identities=21% Similarity=0.276 Sum_probs=148.0
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
++...+.||.+.|-.|.+|+++...|+||++-...+.... ....+++. |++ ....++||.+++.-+....+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL----~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAA- 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL----RPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAA- 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc----hHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHH-
Confidence 6888999999999999999887777999999655432221 12222222 333 5556999999988775555444
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
|++-+|+ ..+|.|.+.. +.-+...+...|+.|++.||..+|..||+|||||.+||||+.-..
T Consensus 97 ---------------ylvRqyv-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW 158 (1431)
T KOG1240|consen 97 ---------------YLVRQYV-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW 158 (1431)
T ss_pred ---------------HHHHHHH-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech
Confidence 6788888 5599998832 234667777888999999999999999999999999999999999
Q ss_pred EEEeecCccee--cc-CCCCCC----CCCCCcccccCCcccCCC----------C-CCchhhHHHHHHHHHHHHh-CCCC
Q 022794 211 VKIADFGVARV--EA-SNPNDM----TGETGTLGYMAPEVLNGN----------P-YNRKCDVYSFGICLWEIYC-CDMP 271 (292)
Q Consensus 211 ~~l~Dfg~~~~--~~-~~~~~~----~~~~~~~~y~aPE~~~~~----------~-~~~~~Diwslg~il~~l~~-g~~p 271 (292)
+.|.||...+. ++ +.+..+ ........|.|||.+... . .+++.||||+||+++|+++ |++|
T Consensus 159 ~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl 238 (1431)
T KOG1240|consen 159 LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL 238 (1431)
T ss_pred hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCc
Confidence 99999987542 11 111111 122344589999998542 1 5688999999999999999 7999
Q ss_pred CC
Q 022794 272 YP 273 (292)
Q Consensus 272 f~ 273 (292)
|.
T Consensus 239 F~ 240 (1431)
T KOG1240|consen 239 FT 240 (1431)
T ss_pred cc
Confidence 85
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=146.52 Aligned_cols=138 Identities=17% Similarity=0.308 Sum_probs=101.5
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-----CCCcccceeceecCCccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-----DHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 129 (292)
...||+|++|.||....++.. +||+....... ..+.+.+|+.+++.+ .||||+++++++.+....
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~---------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDG---------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred cceecCCCceEEEECCCCcCe-EEEEEeccccc---------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 467999999999964334444 68887543211 123478899999999 579999999999876321
Q ss_pred ccccccccccCCCCceEEEEee--cCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCeeEc
Q 022794 130 HIQTENGQVAMPSNICCVVVEY--LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGL-SYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al-~~lH~~~i~h~di~p~Nili~ 206 (292)
+..+.+++|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+||+++
T Consensus 77 ------------g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~ 139 (210)
T PRK10345 77 ------------GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQ 139 (210)
T ss_pred ------------eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEe
Confidence 0112478999 5578999999542 35555 35577877777 999999999999999999996
Q ss_pred C----CCcEEEee-cCcc
Q 022794 207 K----NRTVKIAD-FGVA 219 (292)
Q Consensus 207 ~----~~~~~l~D-fg~~ 219 (292)
. +..++|+| ||..
T Consensus 140 ~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 140 RISESEVIPVVCDNIGES 157 (210)
T ss_pred ccCCCCCcEEEEECCCCc
Confidence 4 23799999 4544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=170.26 Aligned_cols=195 Identities=28% Similarity=0.390 Sum_probs=158.5
Q ss_pred eeccCcceEEEEE-----EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCCcccc
Q 022794 57 VIARGTFGTVHRG-----LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELH 130 (292)
Q Consensus 57 ~lg~G~~g~V~~~-----~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 130 (292)
.+|+|.||.|+++ .+.|.-+++|+.+......+... ....|..++..++ ||.++.+...|......
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-------~t~~er~il~~~~~~~f~v~lhyafqt~~kl- 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-------HTKQERIILAFVHNTPFLVKLHYAFQTDGKL- 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-------ccccHHHHHhhccCCCceeeeeeeeccccch-
Confidence 3699999999976 34678899999876554333221 2445777888885 99999999988887776
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
++++++..++.|...+.. ...+.+.....+...++-++.++|+.+++|+|+|++||+++.+|+
T Consensus 73 ---------------~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh 135 (612)
T KOG0603|consen 73 ---------------YLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH 135 (612)
T ss_pred ---------------hHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc
Confidence 789999999999887743 345777888888999999999999999999999999999999999
Q ss_pred EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 211 VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 211 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
+++.|||.++..-.... .+|+..|+|||.++ ....+.|-||+|+++|+|++|..||.. ++...|.+
T Consensus 136 i~~tdfglske~v~~~~----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 136 IKLTDFGLSKEAVKEKI----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred cccCCchhhhHhHhhhh----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 99999999875332211 27899999999998 457789999999999999999999988 55555555
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-19 Score=162.18 Aligned_cols=144 Identities=21% Similarity=0.298 Sum_probs=113.2
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
.|...+.||+|+||+||++.+.+..+++|+...... .....+......++.+|+++++.+.|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~-~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~- 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGY-RHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK- 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccc-cchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC-
Confidence 345688999999999999998888888776532211 111122223345688999999999999988776655543332
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~ 210 (292)
+++|||+++++|.+++. ....++.+++.+|.+||+.|++|||+||+||++ +++.
T Consensus 412 ---------------~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 412 ---------------TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred ---------------EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCc
Confidence 79999999999999884 246689999999999999999999999999999 6788
Q ss_pred EEEeecCcceec
Q 022794 211 VKIADFGVARVE 222 (292)
Q Consensus 211 ~~l~Dfg~~~~~ 222 (292)
++|+|||.++..
T Consensus 466 ~~liDFGla~~~ 477 (535)
T PRK09605 466 LYLIDFGLGKYS 477 (535)
T ss_pred EEEEeCcccccC
Confidence 999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5e-19 Score=140.30 Aligned_cols=143 Identities=23% Similarity=0.232 Sum_probs=106.7
Q ss_pred ceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccH-------------HHHHHHHHHHHHHHHHHHhCCCCc-
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTE-------------AEIAALRSAFTQEVAVWHKLDHPN- 115 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~- 115 (292)
.|.+.+.||+|++|.||++.. +|+.|+||+++......... ............|..++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 488889999999999999966 69999999986543111110 011122334677889998887764
Q ss_pred -ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 022794 116 -VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (292)
Q Consensus 116 -iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 194 (292)
++..++. . ..+++|||+++++|.+.... .....++.+++.++.++|+.|++
T Consensus 96 ~v~~~~~~----~----------------~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~ 147 (198)
T cd05144 96 PVPKPIDW----N----------------RHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGII 147 (198)
T ss_pred CCCceeec----C----------------CceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCC
Confidence 3333321 1 12799999999998765421 23567889999999999999999
Q ss_pred ccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 195 HRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 195 h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
|+||+|+||++++++.++|+|||.+..
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCcccc
Confidence 999999999999999999999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.5e-20 Score=144.30 Aligned_cols=203 Identities=29% Similarity=0.513 Sum_probs=161.6
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
...+..+|.....|..|+|+|.|..++.|+++......+. .+.|..|...|+-+.||||+.+++.+......
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ri-------srdfneefp~lrifshpnilpvlgacnsppnl- 262 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARI-------SRDFNEEFPALRIFSHPNILPVLGACNSPPNL- 262 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhh-------cchhhhhCcceeeecCCchhhhhhhccCCCCc-
Confidence 3455667888999999999999999999998755443333 34588899999999999999999998876554
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCeeEcCC
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKN 208 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p~Nili~~~ 208 (292)
.++..|++.|+|...+....+-..+..++.+++.+++.+.+|||+.. |.---++...++|+++
T Consensus 263 ---------------v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided 327 (448)
T KOG0195|consen 263 ---------------VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED 327 (448)
T ss_pred ---------------eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch
Confidence 78999999999999997766667888899999999999999999985 4455788899999998
Q ss_pred CcEEE--eecCcceeccCCCCCCCCCCCcccccCCcccCCCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 209 RTVKI--ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY---NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 209 ~~~~l--~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
...+| .|--.+.. .......+.|++||.+...+- -.++|+|||+++++|+-|...||.+.++-|.=.+
T Consensus 328 ltarismad~kfsfq-------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk 400 (448)
T KOG0195|consen 328 LTARISMADTKFSFQ-------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK 400 (448)
T ss_pred hhhheecccceeeee-------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence 76544 44333321 122456789999999977643 3678999999999999999999998887665433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=143.92 Aligned_cols=159 Identities=25% Similarity=0.399 Sum_probs=118.1
Q ss_pred CCCcccceeceecCCccccc-----------ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHH
Q 022794 112 DHPNVTKFIGATMGSSELHI-----------QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (292)
Q Consensus 112 ~h~~iv~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 180 (292)
+||||+++...|.+.-.... .--+.+...+....|+||...+ .+|..|+.. +..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence 79999999999977643211 0001123344568899999884 599999943 45778888889999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeE--cCC--CcEEEeecCcceeccC------CCCCCCCCCCcccccCCcccCCC--C
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLL--DKN--RTVKIADFGVARVEAS------NPNDMTGETGTLGYMAPEVLNGN--P 248 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili--~~~--~~~~l~Dfg~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~--~ 248 (292)
+++|+.|||++|+.|||+|.+|||+ ++| ..+++.|||++--... -........|.-..+|||....- +
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999999999999999999 344 3588999998632111 11223345577788999987432 1
Q ss_pred C----CchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 249 Y----NRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 249 ~----~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
. -.++|.|+.|.+.||++....||..
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 1 1478999999999999999999976
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-17 Score=134.86 Aligned_cols=147 Identities=17% Similarity=0.182 Sum_probs=105.6
Q ss_pred eeec-cCcceEEEEEEECCceeEEEEeecCCCCCccH-HH---HHHHHHHHHHHHHHHHhCCCCcc--cceeceecCCcc
Q 022794 56 SVIA-RGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTE-AE---IAALRSAFTQEVAVWHKLDHPNV--TKFIGATMGSSE 128 (292)
Q Consensus 56 ~~lg-~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~-~~---~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~ 128 (292)
..|| .||.|+||.+...+..++||.+....--.+.. .+ ......++.+|+.++.++.|+++ +.+++.......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 3576 78999999998889999999886432100000 00 01234567889999999988775 556655332211
Q ss_pred cccccccccccCCCCceEEEEeecCC-CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
. ....++++|+++| .+|.+++.. ..+++. .+.+++.+|.+||+.|++|+||||.|||++.
T Consensus 117 ~------------~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~ 177 (239)
T PRK01723 117 L------------FYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP 177 (239)
T ss_pred c------------ceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC
Confidence 1 0112599999997 699988743 235544 3568999999999999999999999999998
Q ss_pred CCcEEEeecCccee
Q 022794 208 NRTVKIADFGVARV 221 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~ 221 (292)
++.++|+|||.+..
T Consensus 178 ~~~v~LIDfg~~~~ 191 (239)
T PRK01723 178 DGKFWLIDFDRGEL 191 (239)
T ss_pred CCCEEEEECCCccc
Confidence 88999999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-17 Score=128.73 Aligned_cols=143 Identities=24% Similarity=0.229 Sum_probs=94.8
Q ss_pred eeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHH---------------HHHHHHHHHHHHHHHhCCCCc--c
Q 022794 55 KSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEI---------------AALRSAFTQEVAVWHKLDHPN--V 116 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~---------------~~~~~~~~~e~~~l~~l~h~~--i 116 (292)
.+.||+|++|.||+|.+. |+.||||+++............ .........|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999765 9999999987543221111110 000111234555555553332 3
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHH-HHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCcc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY-LIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIV 194 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~ 194 (292)
.++++.. ..+++|||++++.+... +.... . ...+..++.+++.++.++|. .|++
T Consensus 82 ~~~~~~~--------------------~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~iv 137 (187)
T cd05119 82 PKPIDLN--------------------RHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLV 137 (187)
T ss_pred CceEecC--------------------CCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcC
Confidence 3333211 12899999988443211 11110 1 15678899999999999999 9999
Q ss_pred ccCCCCCCeeEcCCCcEEEeecCcceec
Q 022794 195 HRDVKTENMLLDKNRTVKIADFGVARVE 222 (292)
Q Consensus 195 h~di~p~Nili~~~~~~~l~Dfg~~~~~ 222 (292)
|+||+|+||+++ ++.++|+|||.+...
T Consensus 138 H~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 138 HGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cCCCChhhEEEE-CCcEEEEECcccccc
Confidence 999999999999 889999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=118.64 Aligned_cols=131 Identities=21% Similarity=0.238 Sum_probs=105.4
Q ss_pred EeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC--CcccceeceecCCccccc
Q 022794 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PNVTKFIGATMGSSELHI 131 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~ 131 (292)
+++.||+|.++.||++...+..+++|....... ...+.+|..+++.+.+ ..+++++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~-- 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----------GADREREVAILQLLARKGLPVPKVLASGESDGWS-- 68 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc-----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc--
Confidence 457899999999999998889999998753321 2236778899988865 5788887766544332
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCCeeEcCC
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---KIVHRDVKTENMLLDKN 208 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~h~di~p~Nili~~~ 208 (292)
++++||+++.++..+ +......++.+++++++.+|.. +++|+|++|.||+++..
T Consensus 69 --------------~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 69 --------------YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred --------------EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 899999988777653 4455667889999999999985 69999999999999998
Q ss_pred CcEEEeecCcce
Q 022794 209 RTVKIADFGVAR 220 (292)
Q Consensus 209 ~~~~l~Dfg~~~ 220 (292)
+.++++||+.+.
T Consensus 126 ~~~~l~Df~~~~ 137 (155)
T cd05120 126 KILGIIDWEYAG 137 (155)
T ss_pred cEEEEEeccccc
Confidence 999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.9e-17 Score=148.48 Aligned_cols=107 Identities=30% Similarity=0.532 Sum_probs=92.6
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCC-------------CCC--CCCCCCcccccCCcccC
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN-------------PND--MTGETGTLGYMAPEVLN 245 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~-------------~~~--~~~~~~~~~y~aPE~~~ 245 (292)
++.+++|+|+.||+|||+||+|.+|+.-|++|+.|||+....... ... .....+|+.|.|||++.
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 378999999999999999999999999999999999987642111 000 12246899999999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 246 GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 246 ~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
.+.|.+..|.|++|+|+|+.+-|..||.+-++++++.+++.-
T Consensus 232 rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 232 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 999999999999999999999999999999999999988764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-15 Score=113.95 Aligned_cols=151 Identities=19% Similarity=0.289 Sum_probs=117.4
Q ss_pred EeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccc
Q 022794 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 133 (292)
..+.+.+|+-+.|+++.+.|+..+||-- ..+...-...+....+.+..+|+++|.++.--.|.-..-+|.+...-
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~R-f~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~---- 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKER-FSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG---- 85 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeec-ccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC----
Confidence 5678999999999999999999999853 33333334455566678899999999999655665555555444333
Q ss_pred ccccccCCCCceEEEEeecCC-CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCc--
Q 022794 134 ENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-- 210 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~-- 210 (292)
+|+|||++| .++.+++...............++++|-+.+.-||.++++||||..+||++..++.
T Consensus 86 ------------~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 86 ------------QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred ------------eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC
Confidence 789999976 38899987665555555555789999999999999999999999999999976653
Q ss_pred -EEEeecCccee
Q 022794 211 -VKIADFGVARV 221 (292)
Q Consensus 211 -~~l~Dfg~~~~ 221 (292)
+.++|||++..
T Consensus 154 ~~~lIdfgls~~ 165 (229)
T KOG3087|consen 154 TPILIDFGLSSV 165 (229)
T ss_pred ceEEEeecchhc
Confidence 58999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.5e-17 Score=141.07 Aligned_cols=122 Identities=25% Similarity=0.525 Sum_probs=106.0
Q ss_pred CceEEEEeecCCCCHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 143 NICCVVVEYLPGGALKTYLIK-NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 143 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.+++|.|++|...+|.+|+.+ ......+....+.++.|++.++.| ++.+|+|+||.||+...+.+++|+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 346899999999999999963 334457788899999999999999 9999999999999999999999999999875
Q ss_pred ccCCC------CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 222 EASNP------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 222 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
..... .......++..||+||.+.+..|+.+.|||+||++++|++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 54333 13345679999999999999999999999999999999998
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-14 Score=107.70 Aligned_cols=139 Identities=24% Similarity=0.283 Sum_probs=107.7
Q ss_pred eeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccccccc
Q 022794 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTEN 135 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 135 (292)
..+++|+-+.++.+.+-|.++++|.- .++.......+....+.+..+|++++.++..-.+.-.+=++.+.+..
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~R-i~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~------ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKER-IPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG------ 74 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEee-cCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC------
Confidence 35789999999999888888777753 33333444455555677788999999999666666555555555554
Q ss_pred ccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEee
Q 022794 136 GQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215 (292)
Q Consensus 136 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~D 215 (292)
.|+|||++|..|.+++... ...++..+-..+.-||..||+|+||+++||.+..++ +.++|
T Consensus 75 ----------~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~ID 134 (204)
T COG3642 75 ----------LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFID 134 (204)
T ss_pred ----------EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEE
Confidence 6899999999999888543 144677888888999999999999999999996655 99999
Q ss_pred cCccee
Q 022794 216 FGVARV 221 (292)
Q Consensus 216 fg~~~~ 221 (292)
||++..
T Consensus 135 fGLg~~ 140 (204)
T COG3642 135 FGLGEF 140 (204)
T ss_pred CCcccc
Confidence 999864
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.5e-14 Score=109.91 Aligned_cols=144 Identities=13% Similarity=0.146 Sum_probs=99.1
Q ss_pred eeeeccCcceEEEEEEEC--------CceeEEEEeecCCCCCccH-----------------HHHHHHHHHHHHHHHHHH
Q 022794 55 KSVIARGTFGTVHRGLYD--------GHDVAVKLLDWGEEGHRTE-----------------AEIAALRSAFTQEVAVWH 109 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~--------~~~valK~~~~~~~~~~~~-----------------~~~~~~~~~~~~e~~~l~ 109 (292)
.+.||.|--+.||.|... +..+|||+++......+.. ...........+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 467999999999999653 4799999986432111111 112222333448999999
Q ss_pred hCCC--CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHH
Q 022794 110 KLDH--PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSY 187 (292)
Q Consensus 110 ~l~h--~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 187 (292)
++.. -++..++++. .. +++|||+.+..+..... ....++......+..+++.++..
T Consensus 82 rl~~~Gv~vP~pi~~~----~~----------------~lvME~Ig~~~~~~~~L--kd~~~~~~~~~~i~~~i~~~l~~ 139 (197)
T cd05146 82 RMQKAGIPCPEVVVLK----KH----------------VLVMSFIGDDQVPAPKL--KDAKLNDEEMKNAYYQVLSMMKQ 139 (197)
T ss_pred HHHHcCCCCCeEEEec----CC----------------EEEEEEcCCCCccchhh--hccccCHHHHHHHHHHHHHHHHH
Confidence 9943 3455555431 11 79999996643322111 11235556677788999999999
Q ss_pred H-HhCCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 188 L-HSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 188 l-H~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
| |+.|++|+||++.||++. ++.+.++|||.+..
T Consensus 140 l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 140 LYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHhCCeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 8 899999999999999996 46799999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.4e-14 Score=123.38 Aligned_cols=148 Identities=23% Similarity=0.277 Sum_probs=94.0
Q ss_pred eeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHH--------------------------HHHHHHHH------HH
Q 022794 56 SVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEA--------------------------EIAALRSA------FT 102 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~--------------------------~~~~~~~~------~~ 102 (292)
+.||.|++|.||+|+. +|+.||||+.+..-.. .... -....... +.
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~-~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEK-TIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHH-HHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999965 7999999998643211 0000 01111111 33
Q ss_pred HHHHHHHhC----CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHH
Q 022794 103 QEVAVWHKL----DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLA 178 (292)
Q Consensus 103 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 178 (292)
+|++.+.++ .+.+-+.+-..+.+.. ...+++|||++|.+|.++...... ..+ ...++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---------------~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia 262 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT---------------SERVLTMEWIDGIPLSDIAALDEA-GLD---RKALA 262 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc---------------CCceEEEEeECCcccccHHHHHhc-CCC---HHHHH
Confidence 444444444 1222222222221110 112799999999999987643211 122 23456
Q ss_pred HHHHH-HHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceecc
Q 022794 179 LDLAR-GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223 (292)
Q Consensus 179 ~qi~~-al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~ 223 (292)
.+++. .+..+|..|++|+|++|.||++.+++.++++|||++....
T Consensus 263 ~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 263 ENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 66665 4788999999999999999999999999999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.6e-16 Score=142.72 Aligned_cols=206 Identities=26% Similarity=0.392 Sum_probs=156.8
Q ss_pred CceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 125 (292)
..|.+.+.||+|.++.|-++.. ....+++|.+........ .......|..+-+.+. |+|++.+++....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~-------~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSED-------SSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccc-------hhhhcCccccccccccccccccccCCccCC
Confidence 4566777799999999987743 344566665543321111 1222445677777775 9999999998887
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCee
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENML 204 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~h~di~p~Nil 204 (292)
.+.. ++.+++..++++.+.+........+....-.++.|+..++.|+| ..++.|+|++|+|.+
T Consensus 93 ~~~~----------------~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 93 PRSY----------------LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred Cccc----------------ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 7665 78999999999998773222224666777889999999999999 999999999999999
Q ss_pred EcCCC-cEEEeecCcceeccC-C--CCCCCCCCC-cccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 205 LDKNR-TVKIADFGVARVEAS-N--PNDMTGETG-TLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 205 i~~~~-~~~l~Dfg~~~~~~~-~--~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
++..+ .+++.|||.+..... . ........| ++.|.+||...+. ...+..|+||.|+++.-+++|..||......
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999975443 1 222334557 9999999999884 4567899999999999999999999865443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.3e-14 Score=109.77 Aligned_cols=127 Identities=20% Similarity=0.164 Sum_probs=92.3
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc-ceeceecCCccccccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT-KFIGATMGSSELHIQT 133 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~ 133 (292)
++.|+.|.++.||++...++.|++|+....... ...+..|+.+++.+.+.+++ +++..... .
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~----------~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~----- 65 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL----------LINRENEAENSKLAAEAGIGPKLYYFDPE--T----- 65 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc----------ccCHHHHHHHHHHHHHhCCCCceEEEeCC--C-----
Confidence 356889999999999999999999997533211 01145688888887544433 44433211 1
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCCeeEcCC
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKI-----VHRDVKTENMLLDKN 208 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i-----~h~di~p~Nili~~~ 208 (292)
.+++|||++|.++.... .. ...++.+++.+|+.||..++ +|+|++|.||+++ +
T Consensus 66 -----------~~lv~e~i~G~~l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 66 -----------GVLITEFIEGSELLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred -----------CeEEEEecCCCcccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 17899999998876430 11 12356789999999999985 9999999999998 6
Q ss_pred CcEEEeecCcce
Q 022794 209 RTVKIADFGVAR 220 (292)
Q Consensus 209 ~~~~l~Dfg~~~ 220 (292)
+.++++||+.+.
T Consensus 124 ~~~~liDf~~a~ 135 (170)
T cd05151 124 GRLWLIDWEYAG 135 (170)
T ss_pred CeEEEEeccccc
Confidence 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.8e-14 Score=125.50 Aligned_cols=161 Identities=33% Similarity=0.567 Sum_probs=129.4
Q ss_pred HhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH
Q 022794 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYL 188 (292)
Q Consensus 109 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l 188 (292)
+.+.|.|+.++++.+.+.... +++-+||.-|+|.+.+.. ....++..-...+.++++.+++||
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~----------------~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~yl 64 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEM----------------IVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYL 64 (484)
T ss_pred cccchhhhhhheeeEecCCce----------------EEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHH
Confidence 457899999999999888655 789999999999998865 455688888888999999999999
Q ss_pred HhCCc-cccCCCCCCeeEcCCCcEEEeecCcceeccC--CCCCCCCCCCcccccCCcccCCC---C----CCchhhHHHH
Q 022794 189 HSQKI-VHRDVKTENMLLDKNRTVKIADFGVARVEAS--NPNDMTGETGTLGYMAPEVLNGN---P----YNRKCDVYSF 258 (292)
Q Consensus 189 H~~~i-~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~---~----~~~~~Diwsl 258 (292)
|...+ .|+.++..|.+++..-.+||.|||+...... ............-|.|||.+++. . .+.+.|+||+
T Consensus 65 h~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 65 HNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred hcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 99876 9999999999999999999999998865532 11111222245578999999874 1 4677999999
Q ss_pred HHHHHHHHhCCCCCCC----CCHHHHHHHHHH
Q 022794 259 GICLWEIYCCDMPYPD----LSFSEVTSAVVR 286 (292)
Q Consensus 259 g~il~~l~~g~~pf~~----~~~~~~~~~i~~ 286 (292)
|++++++++...||.. .++++++..+.+
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence 9999999999999985 333456666555
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=126.23 Aligned_cols=160 Identities=17% Similarity=0.190 Sum_probs=98.8
Q ss_pred ceeEeeeeccCcceEEEEEEE-C-CceeEEEEeecCCCC-------------------------CccHHHHHHHHHHHHH
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-D-GHDVAVKLLDWGEEG-------------------------HRTEAEIAALRSAFTQ 103 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-~-~~~valK~~~~~~~~-------------------------~~~~~~~~~~~~~~~~ 103 (292)
.|.. +.||.|++|.||+|+. + |+.||||+.+..-.. .+...-.....+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 6899999999999965 3 899999999743210 0111222334455556
Q ss_pred HHHHHHhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc----cccCHHHHHHHHH
Q 022794 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----RKLAFKVVVQLAL 179 (292)
Q Consensus 104 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~ 179 (292)
|+.+.+.. .|+.++...|.+...+.+..-.... -...+++|||++|+++.+...-... ..+.+..+..++.
T Consensus 200 ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 200 ELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred hhCHHHHH--HHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 66665555 3555555554443332211100000 1122799999999999875321111 1233333444444
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeeEcCCC----cEEEeecCcceecc
Q 022794 180 DLARGLSYLHSQKIVHRDVKTENMLLDKNR----TVKIADFGVARVEA 223 (292)
Q Consensus 180 qi~~al~~lH~~~i~h~di~p~Nili~~~~----~~~l~Dfg~~~~~~ 223 (292)
| +...|++|+|++|.||+++.++ .++++|||++....
T Consensus 275 Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 Q-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 4469999999999999999888 99999999987543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-12 Score=113.61 Aligned_cols=165 Identities=18% Similarity=0.249 Sum_probs=125.1
Q ss_pred EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccccccccCCCCceEEEE
Q 022794 70 LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149 (292)
Q Consensus 70 ~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 149 (292)
..++.+|.|++.+.... .......+-+..|+.++||||+++++.+...... |+|.
T Consensus 34 k~~~~~vsVF~~~~~~~---------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~----------------ylvT 88 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTL----------------YLVT 88 (690)
T ss_pred eccCCceEEEEEeCCCc---------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCce----------------EEEe
Confidence 45788899988865443 1122355677889999999999999998877755 8999
Q ss_pred eecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC
Q 022794 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228 (292)
Q Consensus 150 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 228 (292)
|-+ .+|..++.+. ....+..-+.||+.||.+|| +.+++|++|+...|+++..|..+|++|..++....-...
T Consensus 89 ErV--~Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 89 ERV--RPLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred ecc--ccHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 998 4899888653 25566677889999999997 668999999999999999999999999987643322211
Q ss_pred CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC
Q 022794 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 229 ~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g 268 (292)
.........|..|+.+.... -..|.|.|||++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 22223334566777665443 347999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.3e-13 Score=115.13 Aligned_cols=202 Identities=25% Similarity=0.262 Sum_probs=152.1
Q ss_pred eecCCceeEeeeecc--CcceEEEEEE----ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccc
Q 022794 46 EIEPSKLVIKSVIAR--GTFGTVHRGL----YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~--G~~g~V~~~~----~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 118 (292)
.+....+.+.+.+|. |.+|.||.+. .++..+++|.-+..-..+... .+-.+|..-...+ .|++.++
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-------~~k~~~~~s~~~i~~~~~~v~ 182 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-------KRKLREFLSHHKIDSHENPVR 182 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-------ccccchhhcccccCccccccc
Confidence 344567788899999 9999999773 468889999754333221111 1123455555566 6888888
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHH----HHHHHHhCCcc
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR----GLSYLHSQKIV 194 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~----al~~lH~~~i~ 194 (292)
.+..+...+.. ++-.|.+ +.+|..+... ...-+++..++..+.+... ||.++|..+++
T Consensus 183 ~~~~~e~~~~l----------------fiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~ 244 (524)
T KOG0601|consen 183 DSPAWEGSGIL----------------FIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIV 244 (524)
T ss_pred cCcccccCCcc----------------eeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCccc
Confidence 77777766665 7788888 6788887743 3445888889999999999 99999999999
Q ss_pred ccCCCCCCeeEcCC-CcEEEeecCcceeccCCCCCC-----CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC
Q 022794 195 HRDVKTENMLLDKN-RTVKIADFGVARVEASNPNDM-----TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 195 h~di~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g 268 (292)
|.|++|.|++...+ ...+++||+....+....-.. ....+...|++||...+ .++...|++++|.++.+..++
T Consensus 245 ~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~ 323 (524)
T KOG0601|consen 245 HDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILG 323 (524)
T ss_pred ccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhh
Confidence 99999999999998 889999999987654433211 12267789999999875 477899999999999998887
Q ss_pred CCCCC
Q 022794 269 DMPYP 273 (292)
Q Consensus 269 ~~pf~ 273 (292)
..++.
T Consensus 324 ~~~~~ 328 (524)
T KOG0601|consen 324 SHLPS 328 (524)
T ss_pred ccccc
Confidence 65543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-11 Score=95.68 Aligned_cols=132 Identities=27% Similarity=0.301 Sum_probs=83.7
Q ss_pred EEEEEEE-CCceeEEEEeecCCCCC-----------c------cHHHHHHHHHHHHHHHHHHHhCCCC--cccceeceec
Q 022794 65 TVHRGLY-DGHDVAVKLLDWGEEGH-----------R------TEAEIAALRSAFTQEVAVWHKLDHP--NVTKFIGATM 124 (292)
Q Consensus 65 ~V~~~~~-~~~~valK~~~~~~~~~-----------~------~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 124 (292)
.||.|.. +|..+|||+.+...... + .............+|.+.|.++..- ++.+++++..
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 4899965 78899999986532111 1 1222334456788899999999665 4556654321
Q ss_pred CCcccccccccccccCCCCceEEEEeecC--CCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCC
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLP--GGALKTYLIKNRRRKLAFKVVVQLALDLARGLSY-LHSQKIVHRDVKTE 201 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~-lH~~~i~h~di~p~ 201 (292)
. +|+|||++ |..+...... .++......++.+++..+.. +|..|++|||+++.
T Consensus 81 ----~----------------~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~ 136 (188)
T PF01163_consen 81 ----N----------------VIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEY 136 (188)
T ss_dssp ----T----------------EEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STT
T ss_pred ----C----------------EEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChh
Confidence 1 79999998 6566553321 12233456677888885444 68999999999999
Q ss_pred CeeEcCCCcEEEeecCccee
Q 022794 202 NMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~ 221 (292)
||+++++ .+.++|||.+..
T Consensus 137 NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 137 NILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp SEEEETT-CEEE--GTTEEE
T ss_pred hEEeecc-eEEEEecCccee
Confidence 9999887 899999998853
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.3e-11 Score=97.06 Aligned_cols=144 Identities=17% Similarity=0.110 Sum_probs=95.0
Q ss_pred EEEEEEECCceeEEEEeecCCCCCccHHHHH---HHHHHHHHHHHHHHhCCCCccc--ceeceecCCccccccccccccc
Q 022794 65 TVHRGLYDGHDVAVKLLDWGEEGHRTEAEIA---ALRSAFTQEVAVWHKLDHPNVT--KFIGATMGSSELHIQTENGQVA 139 (292)
Q Consensus 65 ~V~~~~~~~~~valK~~~~~~~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~~~~~ 139 (292)
.|++....|+.|.||......... ...... .-...+.+|.+.+.+|...+|. .++.+.......
T Consensus 37 rvvr~~~~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~---------- 105 (268)
T PRK15123 37 RTLRFELAGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP---------- 105 (268)
T ss_pred eEEEEEECCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC----------
Confidence 366778889999999763221100 000000 0001366788888877443333 333333221100
Q ss_pred CCCCceEEEEeecCCC-CHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC-------CCcE
Q 022794 140 MPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-------NRTV 211 (292)
Q Consensus 140 ~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~-------~~~~ 211 (292)
.....++|+|++++. +|.+++........+......++.+++..++.||..|++|+|++++|||++. +..+
T Consensus 106 -~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 106 -ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred -ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceE
Confidence 011237999999876 8999885433445667778899999999999999999999999999999975 4679
Q ss_pred EEeecCcce
Q 022794 212 KIADFGVAR 220 (292)
Q Consensus 212 ~l~Dfg~~~ 220 (292)
.|+||+.+.
T Consensus 185 ~LIDl~r~~ 193 (268)
T PRK15123 185 SVIDLHRAQ 193 (268)
T ss_pred EEEECCccc
Confidence 999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.9e-11 Score=96.00 Aligned_cols=142 Identities=23% Similarity=0.238 Sum_probs=104.4
Q ss_pred eeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHH-------------HHHHHHHHHHHHHHHHHhCCCC--c
Q 022794 52 LVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEA-------------EIAALRSAFTQEVAVWHKLDHP--N 115 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~--~ 115 (292)
..+...||-|--+.||.|.+ +|.++|||.-+......+... .....+....+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 35667899999999999976 599999998765533222111 1122245577899999999544 6
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
+...+++- -..++||+++|..|...- ++......++..|++.+..+-..|++|
T Consensus 173 VP~P~~~n--------------------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVH 225 (304)
T COG0478 173 VPKPIAWN--------------------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVH 225 (304)
T ss_pred CCCccccc--------------------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccc
Confidence 66666542 127999999987776532 234445566777777777777999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcce
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
+|+++-||+++++|.+.++||.-+.
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccc
Confidence 9999999999999999999997653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.2e-12 Score=118.05 Aligned_cols=216 Identities=21% Similarity=0.286 Sum_probs=150.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
...+.+.+-+..|.++.++.+.. .|...+.|+.......... ..+....+-.++-.-.+|-++.....+...
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~------~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN------DYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccc------cccccCCccCccccCCCCceecccCCCCCC
Confidence 35677777888999999998854 3444455544211100000 000111122222222345555444443333
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. .+++++|..+++|..-+... .+.+..-.+.....+..++++||...+.|+|++|.|.++.
T Consensus 877 sP----------------~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 877 SP----------------LPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CC----------------cchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhc
Confidence 33 37899999889998887432 3566667777888999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCC------------------------C-------CCCCCCCCcccccCCcccCCCCCCchhhH
Q 022794 207 KNRTVKIADFGVARVEASN------------------------P-------NDMTGETGTLGYMAPEVLNGNPYNRKCDV 255 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~------------------------~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 255 (292)
.+++..+.||+......-. . .......+++.|.+||...+.....++|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 9999999999833211000 0 01122458899999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022794 256 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 256 wslg~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|+.|+++++.++|.+||...++.++.+.|.++.
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~ 1051 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIFENILNRD 1051 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhhhccccCC
Confidence 999999999999999999999999998887753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=91.81 Aligned_cols=141 Identities=23% Similarity=0.224 Sum_probs=96.3
Q ss_pred eeeccCcceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc--ccceeceecCCcccccc
Q 022794 56 SVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQ 132 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~ 132 (292)
+.|+.|..+.||++...+ +.+++|........ . ....+.+|+.+++.+.+.+ +.+++.+......
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~-------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~---- 71 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-P-------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV---- 71 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-c-------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc----
Confidence 568999999999996654 89999987543221 0 1123677899999986533 4556655443210
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh----------------------
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS---------------------- 190 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~---------------------- 190 (292)
....+++|||++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 72 ---------~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 139 (223)
T cd05154 72 ---------LGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQV 139 (223)
T ss_pred ---------cCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHH
Confidence 1123799999998887764421 235555555666666666666663
Q ss_pred ----------------------------------CCccccCCCCCCeeEcC--CCcEEEeecCcce
Q 022794 191 ----------------------------------QKIVHRDVKTENMLLDK--NRTVKIADFGVAR 220 (292)
Q Consensus 191 ----------------------------------~~i~h~di~p~Nili~~--~~~~~l~Dfg~~~ 220 (292)
..++|+|+.|.||+++. ++.+.++||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 140 ARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 24699999999999988 5678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-10 Score=97.21 Aligned_cols=129 Identities=16% Similarity=0.311 Sum_probs=104.3
Q ss_pred EEEEeecCCC-CHHHHHH----hhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 146 CVVVEYLPGG-ALKTYLI----KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 146 ~lv~e~~~~~-~L~~~l~----~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.++|+.+.+. ....+.. ++.....++.-+++.++.++.+.+.||..|.+-+|++++|+|+++++.+.|.|-+.-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 6788888765 4444332 1223357788999999999999999999999999999999999999999999977654
Q ss_pred eccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 022794 221 VEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275 (292)
Q Consensus 221 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g-~~pf~~~ 275 (292)
. ........+..+...|.+||... +...+...|.|.||+++|+++.| ++||.+.
T Consensus 166 i-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 I-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred e-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 3 34455666788999999999875 34567789999999999999997 9999874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=94.64 Aligned_cols=153 Identities=23% Similarity=0.392 Sum_probs=113.5
Q ss_pred HHhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHH
Q 022794 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGL 185 (292)
Q Consensus 108 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al 185 (292)
|-++-|.|+++++.++.+.... +..-..++.||++.|++..++++. ....+......+|+.||+.||
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~-----------e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal 189 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYE-----------EKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSAL 189 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccc-----------cccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhh
Confidence 3445799999999998776542 123336899999999999999754 345688889999999999999
Q ss_pred HHHHhCC--ccccCCCCCCeeEcCCCcEEEeecCccee----ccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHH
Q 022794 186 SYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARV----EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFG 259 (292)
Q Consensus 186 ~~lH~~~--i~h~di~p~Nili~~~~~~~l~Dfg~~~~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg 259 (292)
.|||+.. ++|+++....|++..+|-+++.-..-... .....-......+.++|.+||.=....-+.++|||++|
T Consensus 190 ~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg 269 (458)
T KOG1266|consen 190 SYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG 269 (458)
T ss_pred hhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh
Confidence 9999984 99999999999999888888764321110 00001112224467789999974444556789999999
Q ss_pred HHHHHHHhCCCC
Q 022794 260 ICLWEIYCCDMP 271 (292)
Q Consensus 260 ~il~~l~~g~~p 271 (292)
.+..+|.-+..-
T Consensus 270 mcAlemailEiq 281 (458)
T KOG1266|consen 270 MCALEMAILEIQ 281 (458)
T ss_pred HHHHHHHHheec
Confidence 999999887653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.5e-10 Score=87.24 Aligned_cols=153 Identities=18% Similarity=0.201 Sum_probs=94.4
Q ss_pred ecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHH--HHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAAL--RSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+...+|.+.+.+-......|.+-..+|+.+++|..+.... +........ -....+.+..+.++...++..+.+.+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457899999999988899999899999999999864221 111000000 011233334343442222222222111
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..... .+. -....+++|||++|..|.+... +++ .+...+.+++..||+.|+.|+|.+|.|++
T Consensus 106 ~~ekk-------~~~-~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 106 AAEKK-------IFR-YTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred eeeee-------ecc-ceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 00000 000 0122368999999998877542 222 24456778899999999999999999999
Q ss_pred EcCCCcEEEeecCcce
Q 022794 205 LDKNRTVKIADFGVAR 220 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~ 220 (292)
+++++ +.++||+...
T Consensus 168 v~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKR 182 (229)
T ss_pred EECCc-EEEEECcccc
Confidence 98655 9999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=2e-09 Score=85.70 Aligned_cols=109 Identities=22% Similarity=0.254 Sum_probs=79.8
Q ss_pred HHHHHHHHHHHhCCCCc--ccceeceecCCcccccccccccccCCCCceEEEEeecCCC-CHHHHHHhhcccccCHHHHH
Q 022794 99 SAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVV 175 (292)
Q Consensus 99 ~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~ 175 (292)
.+..+|.+.+.++..-+ .+.++.+....... ....++++|++++. +|.+++..... .+.....
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~------------~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~ 121 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGG------------GYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRR 121 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC------------ceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHH
Confidence 34667777777773332 33444443332111 01237999999875 89998864322 6667778
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC---cEEEeecCccee
Q 022794 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR---TVKIADFGVARV 221 (292)
Q Consensus 176 ~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~---~~~l~Dfg~~~~ 221 (292)
.++.+++..++.||..|++|+|+++.|||++.++ .+.|+||+-+..
T Consensus 122 ~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 122 ELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 8999999999999999999999999999998887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.8e-09 Score=83.36 Aligned_cols=160 Identities=18% Similarity=0.165 Sum_probs=108.8
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEee-cCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc-
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLD-WGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN- 115 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~-~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~- 115 (292)
.+...-+|..+++. |.||-+.|+.....|+.+=+|.-. +....-.- ..-...|.+|...++++..-+
T Consensus 13 ~w~~~~~wve~pN~-------~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~----P~g~ptf~rE~~~L~~L~~~Gv 81 (216)
T PRK09902 13 WWATEGDWVEEPNY-------RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRY----PFGRPTIVREVAVIKELERAGV 81 (216)
T ss_pred HHhCCCceecCCCc-------CCCCcceEEEEEeCCcEEEEEeccCcccccccC----CCCchHHHHHHHHHHHHHHcCC
Confidence 45555556555553 779999999988888877777653 11111000 001344888999998884333
Q ss_pred -ccceeceec-CCcccccccccccccCCCCceEEEEeecCC-CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC
Q 022794 116 -VTKFIGATM-GSSELHIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192 (292)
Q Consensus 116 -iv~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 192 (292)
+.+++ ++. ..... .-..+||+|-+.+ .+|.+++....-.+.+......++.+++.+|+.||+.|
T Consensus 82 PVP~pv-f~~~~k~~~------------~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G 148 (216)
T PRK09902 82 IVPKIV-FGEAVKIEG------------EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN 148 (216)
T ss_pred CCCccc-eeeeeccCC------------ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC
Confidence 33433 221 11110 1112789998854 49999886544445678888899999999999999999
Q ss_pred ccccCCCCCCeeEcCCCc--EEEeecCccee
Q 022794 193 IVHRDVKTENMLLDKNRT--VKIADFGVARV 221 (292)
Q Consensus 193 i~h~di~p~Nili~~~~~--~~l~Dfg~~~~ 221 (292)
+.|+|+.+.||+++.++. +.++||..++.
T Consensus 149 v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 149 RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999999999999986667 99999987754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-09 Score=92.54 Aligned_cols=170 Identities=21% Similarity=0.283 Sum_probs=123.4
Q ss_pred ceEEEEE--EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccccccccccC
Q 022794 63 FGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAM 140 (292)
Q Consensus 63 ~g~V~~~--~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 140 (292)
-.+.|++ ..+|..|++|.++-........ ...-++.++++.|+|+|++.++|.....
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---------~t~lve~wkkl~h~NvV~frevf~t~tF------------ 347 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---------DTSLVEAWKKLCHTNVVPFREVFLTYTF------------ 347 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---------chHHHHHHHHhccCceeehhhhhhhhcc------------
Confidence 3567888 4589999999984222111100 2245788899999999999999873322
Q ss_pred CCCceEEEEeecCCC-CHHHHHHhh-------------cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 141 PSNICCVVVEYLPGG-ALKTYLIKN-------------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 141 ~~~~~~lv~e~~~~~-~L~~~l~~~-------------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.+..+++|++|.++. +|.+....+ .+...++..+|.++.|+..||.++|+.|+..+-+.|.+|++.
T Consensus 348 ~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 348 GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT 427 (655)
T ss_pred CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee
Confidence 244568999999864 777765321 134578899999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM 270 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~ 270 (292)
.+.+++|...|........+. +-+.+ -.+-|.=.||.+++.|.||..
T Consensus 428 G~~RIriS~C~i~Dvl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CcceEEEecccceeeecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 888899887776654433220 11111 135688899999999999954
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.3e-11 Score=102.77 Aligned_cols=197 Identities=21% Similarity=0.179 Sum_probs=141.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
..+|..+..||.|.|+.|+.+.. .+..|++|-.......... ...-..|+-+...+ -|.++++.+..+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-------di~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-------DIFSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-------hhcchhhhhHhhHhhcccccCCCCCCcc
Confidence 45789999999999999998743 4678888876543322111 11123455555556 6888888887777
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+.. ++-.|||+++++...+. -...+++...+++..|++.++.++|...++|+|++|+||+
T Consensus 337 ~~r~~----------------~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~ 398 (524)
T KOG0601|consen 337 QLRQG----------------YIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNIL 398 (524)
T ss_pred ccccc----------------cCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccchhhhccccccccee
Confidence 76665 56789999988877662 2345888889999999999999999999999999999999
Q ss_pred EcCC-CcEEEeecCcceeccCCCCCCCCCCCccccc--CCcccCCCCCCchhhHHHHHHHHHHHHhCC-CCCC
Q 022794 205 LDKN-RTVKIADFGVARVEASNPNDMTGETGTLGYM--APEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYP 273 (292)
Q Consensus 205 i~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~Diwslg~il~~l~~g~-~pf~ 273 (292)
+..+ +.-++.||++...+...... ....-.+. ++.......+-.+.|+++||.-+.+..++. +++.
T Consensus 399 i~~~~~~~~~~~~~~~t~~~~~~~~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~ 468 (524)
T KOG0601|consen 399 ISNDGFFSKLGDFGCWTRLAFSSGV---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES 468 (524)
T ss_pred eccchhhhhccccccccccceeccc---ccccccccccchhhccccccccccccccccccccccccCcccCcc
Confidence 9775 77889999988643222111 11222333 444455556778899999999999988875 3444
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-08 Score=77.01 Aligned_cols=131 Identities=24% Similarity=0.277 Sum_probs=94.6
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc-ceeceecCCccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT-KFIGATMGSSEL 129 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~ 129 (292)
...+.+.|++|++|.||++.+.|..+|+|+-+.+.. +..+..|+++|..+.-.++. +++.+-.+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~-----------r~~l~kEakiLeil~g~~~~p~vy~yg~~---- 87 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP-----------RRNLEKEAKILEILAGEGVTPEVYFYGED---- 87 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc-----------hhhHHHHHHHHHHhhhcCCCceEEEechh----
Confidence 446678999999999999999999999999875543 33477899999888655444 33322111
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC-CCeeEcCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT-ENMLLDKN 208 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p-~Nili~~~ 208 (292)
++.|||+.|.+|.+.-... + .+....++++---|-..||-|+.|+- ...++..+
T Consensus 88 ----------------~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~ 142 (201)
T COG2112 88 ----------------FIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND 142 (201)
T ss_pred ----------------hhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC
Confidence 5679999888998865321 1 22345677777778889999999974 44444455
Q ss_pred CcEEEeecCccee
Q 022794 209 RTVKIADFGVARV 221 (292)
Q Consensus 209 ~~~~l~Dfg~~~~ 221 (292)
+.+.|+||..|+.
T Consensus 143 ~~~~iIDFd~At~ 155 (201)
T COG2112 143 RDVYIIDFDSATF 155 (201)
T ss_pred CcEEEEEccchhh
Confidence 5899999999874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.4e-08 Score=79.44 Aligned_cols=145 Identities=19% Similarity=0.156 Sum_probs=94.2
Q ss_pred EeeeeccCcceEEEEEE-ECCceeEEEEeecCCCCCccHH---------------HHHHHHHHHHHHHHHHHhCC--CCc
Q 022794 54 IKSVIARGTFGTVHRGL-YDGHDVAVKLLDWGEEGHRTEA---------------EIAALRSAFTQEVAVWHKLD--HPN 115 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~-~~~~~valK~~~~~~~~~~~~~---------------~~~~~~~~~~~e~~~l~~l~--h~~ 115 (292)
+.+.|++|--+.||+|. .++..+|+|+++......+... .......-...|..-|+++. +=.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 45578889999999995 5799999999975433222111 11111233445777777773 233
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCcc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIV 194 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~ 194 (292)
+.+.+.+... .|+|||+....+-.- ....-.+.......+..++++.+.-|-. .+++
T Consensus 132 vP~Pi~~~~n--------------------VLvMEfIg~~g~pAP--~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LV 189 (268)
T COG1718 132 VPEPIAFRNN--------------------VLVMEFIGDDGLPAP--RLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLV 189 (268)
T ss_pred CCCceeecCC--------------------eEEEEeccCCCCCCC--CcccCCcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence 4444443321 799999954311000 0011123333677788888888888766 8999
Q ss_pred ccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 195 HRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 195 h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
|+||+.=|||+. ++.+.++||+-+..
T Consensus 190 HgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 190 HGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cccchhhheEEE-CCeEEEEECccccc
Confidence 999999999998 88899999998753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-08 Score=89.49 Aligned_cols=148 Identities=20% Similarity=0.271 Sum_probs=90.6
Q ss_pred eeeccCcceEEEEEEE-CCceeEEEEeecCC----------------------C---CCccHHHHHHHHHHHHHHHHHH-
Q 022794 56 SVIARGTFGTVHRGLY-DGHDVAVKLLDWGE----------------------E---GHRTEAEIAALRSAFTQEVAVW- 108 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~-~~~~valK~~~~~~----------------------~---~~~~~~~~~~~~~~~~~e~~~l- 108 (292)
.-|+.++-|.||+|+. +|+.||||+.+..- . ............+.+..|+...
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4688999999999965 59999999985431 1 1222333344444444444433
Q ss_pred -----HhC-----CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHH
Q 022794 109 -----HKL-----DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLA 178 (292)
Q Consensus 109 -----~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 178 (292)
.++ +.+++. +=.++.+- . ..-.++|||++|..+.+...... ...+...+ +
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~-----t----------~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a 270 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEY-----T----------TRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---A 270 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhc-----c----------CCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---H
Confidence 222 122211 11111110 0 11179999999999998753222 34553333 3
Q ss_pred HHHHHH-HHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceecc
Q 022794 179 LDLARG-LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223 (292)
Q Consensus 179 ~qi~~a-l~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~ 223 (292)
..++.+ +..+=..|+.|.|..|.||++..+|.+.+.|||......
T Consensus 271 ~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 271 ELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 333322 344455899999999999999999999999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.5e-07 Score=71.20 Aligned_cols=150 Identities=23% Similarity=0.351 Sum_probs=100.7
Q ss_pred CceeEeeeeccCcc-eEEEEEEECCceeEEEEeec---CCCCCc---------cHHHHHHHHHHHHHHHHHHHhC---CC
Q 022794 50 SKLVIKSVIARGTF-GTVHRGLYDGHDVAVKLLDW---GEEGHR---------TEAEIAALRSAFTQEVAVWHKL---DH 113 (292)
Q Consensus 50 ~~~~~~~~lg~G~~-g~V~~~~~~~~~valK~~~~---~~~~~~---------~~~~~~~~~~~~~~e~~~l~~l---~h 113 (292)
.+++.++.||.|.- |.||++...|+.+|||+++. ...... .........+-|..|.+...+| ++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 99999999999999999432 111100 1111224456788899988877 44
Q ss_pred Ccc--cceeceecCCccccccc--ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Q 022794 114 PNV--TKFIGATMGSSELHIQT--ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 114 ~~i--v~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
.++ ++++++..-...-.... ..+..........||.||.+... .+... -+.+|.+-+..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHHH
Confidence 455 89998885442111100 01222233445578999886644 12222 2457777888899
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcc
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVA 219 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~ 219 (292)
+.||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999985 3 378999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=6e-07 Score=72.38 Aligned_cols=135 Identities=12% Similarity=0.139 Sum_probs=76.9
Q ss_pred eeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc--ccceeceecCCccccccc
Q 022794 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQT 133 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~ 133 (292)
..||+|..+.||+. .|..+++|...... . ...+.+|.++++.+..-+ +.+++.+..+.+..
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~----~-------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~---- 69 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF----D-------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRL---- 69 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC----C-------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCee----
Confidence 46899999999974 36678899875322 1 112467888888875333 34555554443333
Q ss_pred ccccccCCCCceEEEEeecCCCC-HHHHH--------------Hh----hcc---cccCHHHHH-HHHHH----------
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGA-LKTYL--------------IK----NRR---RKLAFKVVV-QLALD---------- 180 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~-L~~~l--------------~~----~~~---~~~~~~~~~-~i~~q---------- 180 (292)
.++|++++|.+ +...+ .+ -.. ......... .+..+
T Consensus 70 ------------glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~ 137 (226)
T TIGR02172 70 ------------GLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKD 137 (226)
T ss_pred ------------eeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHH
Confidence 67999998863 21111 00 000 011111100 01000
Q ss_pred HHHH-HHHHH----hCCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 181 LARG-LSYLH----SQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 181 i~~a-l~~lH----~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
+... ..+|. ...++|+|+.|.||++++++ +.++||+.+.
T Consensus 138 ~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 138 YKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 1111 11121 12478999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1e-06 Score=78.59 Aligned_cols=146 Identities=21% Similarity=0.245 Sum_probs=87.3
Q ss_pred eeeeccCcceEEEEE-EECCceeEEEEeecCCCCC----------------------ccHHHHHHHHHHHHHHHHHHHhC
Q 022794 55 KSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGH----------------------RTEAEIAALRSAFTQEVAVWHKL 111 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~-~~~~~~valK~~~~~~~~~----------------------~~~~~~~~~~~~~~~e~~~l~~l 111 (292)
.+.||.-+.|.||+| ..+|+.||||+-+..-... .-..-..+....+..|+..++..
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 357899999999999 4579999999985432111 11111122223333343333222
Q ss_pred ----------CCCc------ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHH
Q 022794 112 ----------DHPN------VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175 (292)
Q Consensus 112 ----------~h~~------iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 175 (292)
.|-+ |.+++-.+.. ...|+|||++|..+.+.-. -....++...
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st------------------~RVLtME~~~G~~i~Dl~~-i~~~gi~~~~-- 304 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST------------------KRVLTMEYVDGIKINDLDA-IDKRGISPHD-- 304 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc------------------ceEEEEEecCCccCCCHHH-HHHcCCCHHH--
Confidence 2333 3333322211 1279999999987766421 1233455543
Q ss_pred HHHHHHHHHH-HHHHhCCccccCCCCCCeeEcC----CCcEEEeecCcceec
Q 022794 176 QLALDLARGL-SYLHSQKIVHRDVKTENMLLDK----NRTVKIADFGVARVE 222 (292)
Q Consensus 176 ~i~~qi~~al-~~lH~~~i~h~di~p~Nili~~----~~~~~l~Dfg~~~~~ 222 (292)
++..+.++. ..|=..|++|+|-.|.||++.. ++.+.+.|||+....
T Consensus 305 -i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 305 -ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred -HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 344444442 3345678999999999999983 578999999987543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.6e-06 Score=68.15 Aligned_cols=81 Identities=19% Similarity=0.232 Sum_probs=53.0
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC--cccceeceecCCcccccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP--NVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~ 132 (292)
++.|+.|..+.||++..++..+++|..... .....+.+|..+++.+... .+.+++........
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~-----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~---- 66 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP-----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF---- 66 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH-----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE----
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC-----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc----
Confidence 467899999999999888889999997421 1223466788888777433 34455543222111
Q ss_pred cccccccCCCCceEEEEeecCCCCHHH
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKT 159 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~ 159 (292)
....+++|++++|.++..
T Consensus 67 ---------~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 67 ---------NGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp ---------TSEEEEEEEEESSEEHHH
T ss_pred ---------cccceEEEEEeccccccc
Confidence 112489999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.8e-06 Score=67.66 Aligned_cols=29 Identities=21% Similarity=0.343 Sum_probs=26.0
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999988778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-07 Score=85.43 Aligned_cols=95 Identities=26% Similarity=0.434 Sum_probs=73.4
Q ss_pred HHHHHHHHHhC-CccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC---------CCCCCCCcccccCCcccCCCCCC
Q 022794 181 LARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN---------DMTGETGTLGYMAPEVLNGNPYN 250 (292)
Q Consensus 181 i~~al~~lH~~-~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~ 250 (292)
.+.++.++|+. +++|++|.|++|.++..+..||+.|+.+.-...+.. -.........|.+||.+.+...+
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~~ 187 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTNT 187 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccccc
Confidence 33899999977 799999999999999999999999987643222111 11112346689999999998889
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 251 RKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 251 ~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
.++|++|+|+++|.+.. |..-+...
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhcc
Confidence 99999999999999984 55544443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=9.9e-07 Score=72.98 Aligned_cols=140 Identities=23% Similarity=0.237 Sum_probs=97.8
Q ss_pred eeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHH-------------HHHHHHHHHHHHHHHHhCCCC--c
Q 022794 52 LVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAE-------------IAALRSAFTQEVAVWHKLDHP--N 115 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~--~ 115 (292)
+.++..||-|--+.||.+-+ .|++.++|.-+......+.... .-..+-...+|...++.|... -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56778999999999999866 5999999976544332222111 112234456788888887332 2
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
+...+++ +-.++|||++.+.+|...-. .. ....+...++..|-.|-.+|+||
T Consensus 174 VPkpiD~--------------------~RH~Vvmelv~g~Pl~~v~~-----v~---d~~~ly~~lm~~Iv~la~~GlIH 225 (465)
T KOG2268|consen 174 VPKPIDH--------------------NRHCVVMELVDGYPLRQVRH-----VE---DPPTLYDDLMGLIVRLANHGLIH 225 (465)
T ss_pred CCCcccc--------------------cceeeHHHhhcccceeeeee-----cC---ChHHHHHHHHHHHHHHHHcCcee
Confidence 2333332 12289999999988876431 11 22346677888888999999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcc
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVA 219 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~ 219 (292)
+|.+-=||++.+++.++++||.-.
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred cccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.22 E-value=6.2e-05 Score=58.79 Aligned_cols=100 Identities=21% Similarity=0.239 Sum_probs=78.0
Q ss_pred HHHHHHHHhCCC-CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHh-hcccccCHHHHHHHHH
Q 022794 102 TQEVAVWHKLDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK-NRRRKLAFKVVVQLAL 179 (292)
Q Consensus 102 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~ 179 (292)
.+|..+++.+.+ +++++++|++-. +++.||...+++...... ..-...++..+.+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------------------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~ 66 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------------------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIAL 66 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------------------EEEEEeecCccccccccccccccccCHHHHHHHHH
Confidence 468888888855 699999998843 578999976655421000 0112477999999999
Q ss_pred HHHHHHHHHHh---CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 180 DLARGLSYLHS---QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 180 qi~~al~~lH~---~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
++++.+.+++. ..+.-.|++++|+.++++++++++|++.+..
T Consensus 67 ~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 67 QLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred HHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999988 3588889999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.3e-05 Score=64.66 Aligned_cols=134 Identities=17% Similarity=0.151 Sum_probs=75.6
Q ss_pred eccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc-cceeceecCCcccccccccc
Q 022794 58 IARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TKFIGATMGSSELHIQTENG 136 (292)
Q Consensus 58 lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~~ 136 (292)
+..|-.+.+|+...+++.+++|+.......... ...+|..+++.+...++ .+++... .+
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~---------~r~~E~~~l~~l~~~g~~P~~i~~~--~~--------- 63 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGV---------DRQREYQILQALSALGLAPKPILVN--EH--------- 63 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccC---------cHHHHHHHHHHHHhcCCCCceEEEe--CC---------
Confidence 456777889998888889999976432211100 13467888888854333 2333221 11
Q ss_pred cccCCCCceEEEEeecCCCCHHHH--------------HHhhc-----ccccCH-HHHHHHHHHH---------HHHHHH
Q 022794 137 QVAMPSNICCVVVEYLPGGALKTY--------------LIKNR-----RRKLAF-KVVVQLALDL---------ARGLSY 187 (292)
Q Consensus 137 ~~~~~~~~~~lv~e~~~~~~L~~~--------------l~~~~-----~~~~~~-~~~~~i~~qi---------~~al~~ 187 (292)
++++||++|.++..- +.+-. ..+++. ..+..+..++ ...+..
T Consensus 64 ---------~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 134 (256)
T TIGR02721 64 ---------WLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQ 134 (256)
T ss_pred ---------EEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHH
Confidence 689999988665321 11100 111121 1112221111 112222
Q ss_pred HHh--------CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 188 LHS--------QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 188 lH~--------~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
+-. ..++|+|+.|.||++++++ +.++||..+..
T Consensus 135 ~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 135 FRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred HHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 221 2489999999999998877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.5e-05 Score=61.45 Aligned_cols=29 Identities=24% Similarity=0.483 Sum_probs=26.1
Q ss_pred CccccCCCCCCeeEcC-CCcEEEeecCcce
Q 022794 192 KIVHRDVKTENMLLDK-NRTVKIADFGVAR 220 (292)
Q Consensus 192 ~i~h~di~p~Nili~~-~~~~~l~Dfg~~~ 220 (292)
+++|+|+.+.||+++. ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5999999999999987 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.7e-05 Score=63.36 Aligned_cols=29 Identities=28% Similarity=0.479 Sum_probs=25.0
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
+++|+|+.+.||++++++..-++||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999876656799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=9.7e-05 Score=70.97 Aligned_cols=82 Identities=18% Similarity=0.146 Sum_probs=52.0
Q ss_pred EeeeeccCcceEEEEEEECC----ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcc--cceeceecCC
Q 022794 54 IKSVIARGTFGTVHRGLYDG----HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNV--TKFIGATMGS 126 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~ 126 (292)
-+..++.|.+..+|+....+ ..+++|......... . ...+.+|.++++.+. |+++ .+++.++.+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~ 113 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-S-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDA 113 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-c-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC
Confidence 35778999999999886554 467888753222111 1 123668999999984 6655 5666555443
Q ss_pred cccccccccccccCCCCceEEEEeecCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGA 156 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 156 (292)
.. ....|+||||++|..
T Consensus 114 ~v-------------~G~~flVME~v~G~~ 130 (822)
T PLN02876 114 SV-------------IGTAFYIMEYLEGRI 130 (822)
T ss_pred Cc-------------CCCceEEEEecCCcc
Confidence 21 122389999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=8.1e-05 Score=62.99 Aligned_cols=144 Identities=18% Similarity=0.187 Sum_probs=94.3
Q ss_pred eEeeeeccCcceEEEEEE-ECCceeEEEEeecC--------------------CCCCccHHHHHHHHHHHHHHHHHHHhC
Q 022794 53 VIKSVIARGTFGTVHRGL-YDGHDVAVKLLDWG--------------------EEGHRTEAEIAALRSAFTQEVAVWHKL 111 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~-~~~~~valK~~~~~--------------------~~~~~~~~~~~~~~~~~~~e~~~l~~l 111 (292)
.+-+.|..|--..||.|. .+|..+|||+++.. -........+..+ ...|++-|+++
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~W---AEKE~RNLkRl 223 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTW---AEKEMRNLKRL 223 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHH---HHHHHHHHHHH
Confidence 455688889999999995 57899999998432 1111122222222 34588888888
Q ss_pred CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH-Hh
Q 022794 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYL-HS 190 (292)
Q Consensus 112 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l-H~ 190 (292)
+...|.-.--+... ...|||+|+. .+=+-.= +-++-.++...+..+-.+++..++-| |.
T Consensus 224 ~~aGIP~PePIlLk------------------~hVLVM~FlG-rdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~ 283 (520)
T KOG2270|consen 224 NNAGIPCPEPILLK------------------NHVLVMEFLG-RDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQK 283 (520)
T ss_pred HhcCCCCCCceeee------------------cceEeeeecc-CCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHH
Confidence 66654432222111 1179999994 2211110 11334577777888888888888776 56
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.++||.||+--|+|+. +|.+.++|.+-+.
T Consensus 284 c~LVHADLSEfN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 284 CRLVHADLSEFNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred hceeccchhhhhheEE-CCEEEEEEccccc
Confidence 7999999999999994 5679999988663
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00042 Score=54.49 Aligned_cols=139 Identities=21% Similarity=0.295 Sum_probs=86.9
Q ss_pred eeeccCcceEEEEEEECCceeEEEEeecCCCCCccHH-------HHHHHHHHHHHHHHHHHhCC------CCcccceece
Q 022794 56 SVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEA-------EIAALRSAFTQEVAVWHKLD------HPNVTKFIGA 122 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 122 (292)
..||+|+.=.||..- .+....||+.+.......... ......+...+|+.-..++. +.+|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 468999999999532 344567888865540000000 00001223444555555444 7899999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCC------CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPG------GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
..+.-.. .+|+|.+.+ .+|.+++.. ..++. . +...+-+-..+|-+++|+.+
T Consensus 86 veT~~G~----------------Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~ 142 (199)
T PF10707_consen 86 VETNLGL----------------GLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIR 142 (199)
T ss_pred EecCCce----------------EEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeec
Confidence 8887666 566665542 378888843 33554 3 33444556668889999999
Q ss_pred CCCCCCeeEcCC--C--cEEEee-cCc
Q 022794 197 DVKTENMLLDKN--R--TVKIAD-FGV 218 (292)
Q Consensus 197 di~p~Nili~~~--~--~~~l~D-fg~ 218 (292)
|++|.||++... + .++|+| ||.
T Consensus 143 dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 143 DLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCcccEEEEecCCCceEEEEEeCCCC
Confidence 999999999533 2 578888 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=61.32 Aligned_cols=145 Identities=20% Similarity=0.208 Sum_probs=80.4
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc--ccceeceecCCcccccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQ 132 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~ 132 (292)
.+.|..|....+|+...++..+++|+.... .. ..+..|+.++..+.+.+ +.+++... .+.. +.
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-----~~-------~~~~~e~~~l~~L~~~g~~vp~~i~~~--~g~~-~~ 83 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-----SA-------EELPFFLALLDHLAERGLPVPRPIADR--DGEY-LS 83 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC-----Ch-------HhccHHHHHHHHHHHCCCCCCccccCC--CCcE-ee
Confidence 556777888899998777778999987531 11 12445777777764332 33443321 1111 10
Q ss_pred cccccccCCCCceEEEEeecCCCCHHH-----------HHHh---h-cc--cc------cCHHHH----------HHHHH
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKT-----------YLIK---N-RR--RK------LAFKVV----------VQLAL 179 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~-----------~l~~---~-~~--~~------~~~~~~----------~~i~~ 179 (292)
. ..+..++++++++|..+.. .+.+ . .. .. ..+... .....
T Consensus 84 ~-------~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 156 (296)
T cd05153 84 E-------LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRA 156 (296)
T ss_pred e-------eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHH
Confidence 0 1223478999998866421 1100 0 00 00 000000 00111
Q ss_pred HHHHHHHHHHh-------CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 180 DLARGLSYLHS-------QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 180 qi~~al~~lH~-------~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.+..++..+.+ .+++|+|+.|.|+++++++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 157 LLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 12233444443 3799999999999999887778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00023 Score=60.73 Aligned_cols=31 Identities=26% Similarity=0.433 Sum_probs=26.3
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++||+|+.|.||+++++...-++||+.++.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998665568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00027 Score=59.95 Aligned_cols=149 Identities=19% Similarity=0.227 Sum_probs=80.3
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc--ccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~ 128 (292)
.......++.|....+|++..++..+++|+.+.... .. .+..|..++..|...+ +.+++... +.
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~----~~-------~i~~e~~~l~~L~~~g~pvp~~i~t~---~g 88 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK----AE-------ELPFFLALTTHLAARGLPVPKPVKSR---DG 88 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCCC----HH-------HHHHHHHHHHHHHHCCCCCCccccCC---CC
Confidence 344567778888889999876677899998753211 11 1334556666663222 33333221 11
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHH-----------HHHHhh--ccccc--------CHH---HHH---------
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALK-----------TYLIKN--RRRKL--------AFK---VVV--------- 175 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~-----------~~l~~~--~~~~~--------~~~---~~~--------- 175 (292)
..+.. .....+++++|++|.++. ..+.+. ....+ ... ...
T Consensus 89 ~~~~~-------~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 89 RQLST-------LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ 161 (307)
T ss_pred Ceehh-------cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence 11111 123348899999875431 111100 00000 000 000
Q ss_pred ---HHHHHHHHHHHHHH-------hCCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 176 ---QLALDLARGLSYLH-------SQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 176 ---~i~~qi~~al~~lH-------~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.....+...+.++. ..+++|+|+.+.|+++++++...++||+.+.
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 00111223444443 2579999999999999888777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00019 Score=60.75 Aligned_cols=30 Identities=27% Similarity=0.431 Sum_probs=26.6
Q ss_pred CccccCCCCCCeeEcCC----CcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKN----RTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~----~~~~l~Dfg~~~~ 221 (292)
.++|+|+.+.||+++++ +.+.++||..+..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999874 8899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=8.4e-06 Score=73.03 Aligned_cols=184 Identities=18% Similarity=0.180 Sum_probs=120.7
Q ss_pred eEeeeeccCcceEEEEEEECCceeE-EEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc-ccceeceecCCcccc
Q 022794 53 VIKSVIARGTFGTVHRGLYDGHDVA-VKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN-VTKFIGATMGSSELH 130 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~va-lK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~ 130 (292)
......++++++.+++.+.+.++.. .+++... . ...-++++|.+++||| .+..++-+..
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l-------~~rl~~eLLdK~n~P~~~v~~~~d~~~----- 305 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------L-------SRRLAIELLDKVNNPNPVVRYLEDYDG----- 305 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------h-------hhHHHHHHHHHccCCCCcccccccCCc-----
Confidence 3445568999999998877654433 3333211 1 1334788999999999 4444433322
Q ss_pred cccccccccCCCCceEEEEeecCCC-CHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+...++.++++.++ +...-.. -..-.+.+-....+++.-.+.++++|+.--+|+| ||+..+ +
T Consensus 306 -----------E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~ 368 (829)
T KOG0576|consen 306 -----------EDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E 368 (829)
T ss_pred -----------ccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c
Confidence 33447899999776 2211110 0111233344555666667788999988768887 666544 6
Q ss_pred cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
..+.+||+....+.... ......+++.++|||+.....+....|.|++|.-..++.-|.+|-.
T Consensus 369 ~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 369 EVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 68999999876544332 2344678999999999999999999999999987777777766643
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0056 Score=53.49 Aligned_cols=29 Identities=21% Similarity=0.390 Sum_probs=24.7
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
..++|||+.+.||++.++ .++++|+..+.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 358999999999999776 58999998664
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0009 Score=64.37 Aligned_cols=155 Identities=21% Similarity=0.238 Sum_probs=103.9
Q ss_pred HHHHHHHHHhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHH
Q 022794 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (292)
Q Consensus 101 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 180 (292)
...|...+..+.|+|+..++.+-.......+ ...+..+++...++...+.. -...+..+.+.+..+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~------------~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~ 294 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGI------------VLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQK 294 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchH------------HHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHH
Confidence 3456777788899999999887655433211 11346677877788777643 356888899999999
Q ss_pred HHHHHHHHHhCCccccCCCCC---CeeEcCCCcEEEe--ecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC--chh
Q 022794 181 LARGLSYLHSQKIVHRDVKTE---NMLLDKNRTVKIA--DFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN--RKC 253 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~---Nili~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~ 253 (292)
+.+++.++|+....|.-+..+ +...+..+.+... ||+............. ......+.++|.......+ ...
T Consensus 295 ~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 295 LLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred HhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhh
Confidence 999999999996555544443 3333444555555 8887765444333222 3445566777776655444 457
Q ss_pred hHHHHHHHHHHHHhCCC
Q 022794 254 DVYSFGICLWEIYCCDM 270 (292)
Q Consensus 254 Diwslg~il~~l~~g~~ 270 (292)
|+|++|..+..+..|..
T Consensus 374 dL~~lgll~~~~~~~~~ 390 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGED 390 (1351)
T ss_pred HHHHHHHHHhhhhhcCc
Confidence 99999999999888754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.48 E-value=2.9e-05 Score=76.16 Aligned_cols=164 Identities=14% Similarity=0.034 Sum_probs=115.4
Q ss_pred HHHHHHHHHHHHHhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHH
Q 022794 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVV 174 (292)
Q Consensus 97 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 174 (292)
+++-...|...++...|+++.....-......... +..++++.+|.+.+.+.+.- .......-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee--------------~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v 1337 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEE--------------YIRSLYVEFGKLFSIIIKGLEESPDLDRSPV 1337 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHH--------------HHHHHHHHHhHHHHHHHhccccCCcchhchH
Confidence 34445556666777789988877665554433322 78999999999999986532 222333222
Q ss_pred HHHHHHHHHHHHHHHhCC-----ccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC
Q 022794 175 VQLALDLARGLSYLHSQK-----IVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY 249 (292)
Q Consensus 175 ~~i~~qi~~al~~lH~~~-----i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 249 (292)
....++.+....-+|... .+|+++++.|.+|..+..+++.++|+.+.............+++.|+.|+....-.+
T Consensus 1338 ~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~ 1417 (2724)
T KOG1826|consen 1338 HLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF 1417 (2724)
T ss_pred HHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh
Confidence 222333355555656541 689999999999999999999999998744433334444567778888888777778
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 250 NRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 250 ~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+.++|+|..++-+|....|..+|-.
T Consensus 1418 t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1418 TKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred hhHHHHHHHHHHHHHHhcccHHHHH
Confidence 8889999999999998888888743
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0034 Score=53.24 Aligned_cols=29 Identities=28% Similarity=0.469 Sum_probs=25.4
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0042 Score=52.43 Aligned_cols=30 Identities=27% Similarity=0.564 Sum_probs=27.2
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++|||+.+.|+++++++-+-++||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 489999999999999988899999998864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0053 Score=52.62 Aligned_cols=29 Identities=21% Similarity=0.440 Sum_probs=25.5
Q ss_pred ccccCCCCCCeeEcC-CCcEEEeecCccee
Q 022794 193 IVHRDVKTENMLLDK-NRTVKIADFGVARV 221 (292)
Q Consensus 193 i~h~di~p~Nili~~-~~~~~l~Dfg~~~~ 221 (292)
++|+|+.+.||++++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 47899999998853
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0031 Score=53.20 Aligned_cols=84 Identities=12% Similarity=0.044 Sum_probs=55.7
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC---CcccceeceecCCc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH---PNVTKFIGATMGSS 127 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~ 127 (292)
...-.+.||.|..+.||.....+..+.+|..+.... ...+..|+..|+.+.. -.+.++++.+....
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~-----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~ 83 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFST-----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ 83 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEeccccc-----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence 344567899999999999876666788888642111 1236778888888843 35667776654321
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHH
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALK 158 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 158 (292)
. ....++|||++++.++.
T Consensus 84 ~-------------~g~~~LVmE~i~G~~~~ 101 (297)
T PRK10593 84 S-------------PGPDVLLLERLRGVSVE 101 (297)
T ss_pred c-------------CCCeEEEEeccCCEecC
Confidence 1 11238999999987664
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0032 Score=52.47 Aligned_cols=30 Identities=27% Similarity=0.539 Sum_probs=25.2
Q ss_pred CccccCCCCCCeeEcCCCc-EEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRT-VKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~-~~l~Dfg~~~~ 221 (292)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0027 Score=53.94 Aligned_cols=30 Identities=23% Similarity=0.350 Sum_probs=27.6
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
++||+|+.+.|+++++++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.017 Score=49.88 Aligned_cols=30 Identities=27% Similarity=0.562 Sum_probs=26.2
Q ss_pred CccccCCCCCCeeEcC-CCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDK-NRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~-~~~~~l~Dfg~~~~ 221 (292)
.++|+|+++.||++++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999976 47899999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.022 Score=48.68 Aligned_cols=134 Identities=14% Similarity=0.152 Sum_probs=82.2
Q ss_pred eEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeeEcCCCcEEEeecCcceecc
Q 022794 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223 (292)
Q Consensus 145 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~ 223 (292)
.|++|++- |+++... ..-..+++..++.+-+..+.-+... ..-|||+...||+|+ .|++.|+||.+++...
T Consensus 301 ~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 301 LYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred EEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 37777777 6676532 1244667778888877777777655 689999999999998 9999999999998433
Q ss_pred CCCCCCCCCCCcccccCCcccCC--------------------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 224 SNPNDMTGETGTLGYMAPEVLNG--------------------NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 224 ~~~~~~~~~~~~~~y~aPE~~~~--------------------~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
......... +--|..+.| ..+-+.+.++-|-++.-.++...--=...+..+-...
T Consensus 373 ~q~~isy~r-----ldhp~lF~G~dd~QFeIYrlMr~l~~g~wa~F~P~TNvlWL~yLs~~llkk~~~~~~kt~~nr~~~ 447 (488)
T COG5072 373 SQGIISYNR-----LDHPDLFNGVDDYQFEIYRLMRRLLKGRWAQFEPITNVLWLYYLSHQLLKKKNLSSPKTETNRLMR 447 (488)
T ss_pred CCceeeccc-----cCchhhhcCccceeeeHHHHHHHHhcCcHHhcccchhhHHHHHHHHHHHhhcccccccchHHHHHH
Confidence 222211111 111222211 1345677777777776666664433333444444444
Q ss_pred HHHhhhcc
Q 022794 284 VVRQVQYL 291 (292)
Q Consensus 284 i~~~~~~~ 291 (292)
+.++.-+|
T Consensus 448 ~l~~ithl 455 (488)
T COG5072 448 RLKQITHL 455 (488)
T ss_pred HHHHHHhh
Confidence 55554443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.025 Score=49.39 Aligned_cols=29 Identities=24% Similarity=0.256 Sum_probs=24.4
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
...+|.|+.+.||+..+ +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 46899999999998754 559999999875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.015 Score=49.49 Aligned_cols=28 Identities=32% Similarity=0.584 Sum_probs=25.5
Q ss_pred ccccCCCCCCeeEcCCCc-EEEeecCcce
Q 022794 193 IVHRDVKTENMLLDKNRT-VKIADFGVAR 220 (292)
Q Consensus 193 i~h~di~p~Nili~~~~~-~~l~Dfg~~~ 220 (292)
+||+|+.|.||+++++.. ..++||+-++
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999988875 8999999775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.008 Score=50.25 Aligned_cols=76 Identities=20% Similarity=0.180 Sum_probs=44.1
Q ss_pred eeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceeceecCCcc
Q 022794 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGSSE 128 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~ 128 (292)
.+-.+.++.|....+|+...+++.+-||+...... ..+..|+.-|+.| .--.+++++.+....+.
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~------------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR------------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC------------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhhH------------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 44566788899999999998899999999862211 1256677777777 33356677766544333
Q ss_pred cccccccccccCCCCceEEEEeecCCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGG 155 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~ 155 (292)
. +++|||++.+
T Consensus 87 ~----------------fLlle~l~~~ 97 (288)
T PF03881_consen 87 A----------------FLLLEFLEMG 97 (288)
T ss_dssp C----------------EEEEE-----
T ss_pred c----------------eEEEEeecCC
Confidence 2 8999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.1 Score=45.73 Aligned_cols=81 Identities=9% Similarity=-0.056 Sum_probs=47.4
Q ss_pred EeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---CCcccceeceecCCcccc
Q 022794 54 IKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATMGSSELH 130 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 130 (292)
..+.||.|....||+....+..++||.-......... +......+...|+..|+.+. ...+.+++.+..+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga--~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~--- 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGE--SWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMA--- 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCc--cccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCC---
Confidence 3667899999999999877778999975421110000 00001122334556665552 236667776654322
Q ss_pred cccccccccCCCCceEEEEeecCC
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPG 154 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~ 154 (292)
+++||++++
T Consensus 111 ---------------vlvME~L~~ 119 (418)
T PLN02756 111 ---------------LIGMRYLEP 119 (418)
T ss_pred ---------------EEEEeecCC
Confidence 688999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.025 Score=48.58 Aligned_cols=29 Identities=17% Similarity=0.399 Sum_probs=24.4
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
..++|||+.+.||++++++ ++++|+..+.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 3589999999999997765 7799998765
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.056 Score=48.20 Aligned_cols=28 Identities=18% Similarity=0.433 Sum_probs=24.0
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.++|+|+.+.||+..+++ +.|+||..+.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 489999999999876544 9999999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.061 Score=43.07 Aligned_cols=76 Identities=25% Similarity=0.268 Sum_probs=50.7
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceeceecCCccccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~ 131 (292)
.+.+..|..-..|...+...++-||+-... ....|..|+.-|..+ +.-.+.+++.+-...+..
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~~------------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~s-- 86 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQRE------------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHS-- 86 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecchh------------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCee--
Confidence 445666777788888888889999986311 123355666666666 334566666655544443
Q ss_pred ccccccccCCCCceEEEEeecCCCCHH
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALK 158 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~ 158 (292)
|+||||++.+++.
T Consensus 87 --------------ylVle~L~~~~~d 99 (286)
T COG3001 87 --------------YLVLEYLPTGPLD 99 (286)
T ss_pred --------------EEEEeeccCCCCC
Confidence 8999999987664
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.12 Score=44.13 Aligned_cols=28 Identities=25% Similarity=0.318 Sum_probs=23.9
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
.++||+|+.+.||+++ + .+.++||+.++
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999875
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.072 Score=52.67 Aligned_cols=30 Identities=30% Similarity=0.620 Sum_probs=25.4
Q ss_pred CCccccCCCCCCeeEcCCC--cEE-EeecCcce
Q 022794 191 QKIVHRDVKTENMLLDKNR--TVK-IADFGVAR 220 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~--~~~-l~Dfg~~~ 220 (292)
.++||+|+++.||+++.++ ++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4699999999999998775 554 99999775
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.017 Score=47.91 Aligned_cols=49 Identities=20% Similarity=0.306 Sum_probs=37.5
Q ss_pred HHHHHHHHHHHHHHHHHhC--CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 173 VVVQLALDLARGLSYLHSQ--KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 173 ~~~~i~~qi~~al~~lH~~--~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.+...+..+-.++.-.+.. -+||+|+.|.|++.++.+.++|+||..|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3334455555555555555 599999999999999989999999998863
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.09 Score=45.87 Aligned_cols=28 Identities=21% Similarity=0.404 Sum_probs=24.3
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
-++|||+.|.||++++++ ++++|...+.
T Consensus 228 aLlHGDlHtGSI~v~~~~-~kvIDpEFAf 255 (409)
T PRK12396 228 ALIHGDLHTGSVFVKNDS-TKVIDPEFAF 255 (409)
T ss_pred hhccCcCCCCCEEecCCc-eEEEcccccc
Confidence 489999999999998764 8999988775
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.047 Score=48.81 Aligned_cols=117 Identities=23% Similarity=0.318 Sum_probs=72.9
Q ss_pred HHHHHHHHHhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHH
Q 022794 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (292)
Q Consensus 101 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 180 (292)
+.....+++.+.|+|..+.+++....-.- ..+|+|++ +.+|.+++.... +... +
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r---------------~IVV~e~~-~~Sled~~~~~~---l~~~-------s 82 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHER---------------VIVVMEHY-TMSLEDILKTGN---LKDE-------S 82 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccce---------------EEEEehhh-ccchHHHHHhcc---cchh-------h
Confidence 55678889999999999988776443221 27899999 789999885432 1111 1
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHH
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~ 260 (292)
+. .+|+.| .|++. .+| ...... |-. ..+++|||++|.
T Consensus 83 ~~-------~~~~~~-----~~~~~-------~td-----~~~t~~--------------~~~-----~~pKsdVwsl~~ 119 (725)
T KOG1093|consen 83 LL-------AHGVLH-----LNIIY-------ITD-----HFLTKY--------------PSP-----IGPKSDVWSLGF 119 (725)
T ss_pred hc-------ccccce-----ehhhh-------ccc-----cccccC--------------CCC-----CCcchhhhhHHH
Confidence 11 222222 12221 222 011000 000 114899999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 261 CLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 261 il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++.-|..-|...+..+.++.+.+
T Consensus 120 i~~el~L~~~l~~~~~~s~~l~~i~k 145 (725)
T KOG1093|consen 120 IILELYLGISLEAELTESEYLEILLK 145 (725)
T ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHH
Confidence 99999999999988888887776653
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.022 Score=44.18 Aligned_cols=28 Identities=21% Similarity=0.387 Sum_probs=25.1
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCcce
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVAR 220 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~ 220 (292)
-.+|+|+.|.|+++++++ ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 369999999999998877 8999999885
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 292 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-39 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-31 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-30 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-30 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-30 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-29 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-29 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-29 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-29 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-29 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-28 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-28 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-26 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-26 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-25 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-25 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-25 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-25 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-25 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-25 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-25 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-25 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-25 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-25 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-25 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-25 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-25 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-25 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-25 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-25 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-25 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-25 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-25 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-25 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-24 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-24 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-24 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-24 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-23 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-23 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-23 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-23 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-23 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-23 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-23 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-23 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-23 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-22 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-22 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-22 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-22 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-22 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-22 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-22 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-22 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-22 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-22 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-22 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-21 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-21 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-21 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-21 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-21 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-21 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-21 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-21 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-21 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-21 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-21 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-21 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-20 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-20 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-20 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-20 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-20 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-20 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-20 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-20 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-19 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-19 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-19 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-19 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-19 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-19 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-19 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-19 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-19 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-19 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-18 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-18 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-18 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-18 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-18 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-18 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-18 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-18 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-18 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-18 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-18 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-18 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-18 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-18 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-18 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-18 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-17 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-16 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-16 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-16 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-15 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-15 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-14 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-14 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-13 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-09 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-109
Identities = 93/248 (37%), Positives = 137/248 (55%), Gaps = 26/248 (10%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
D +I L IK I G+FGTVHR + G DVAVK+L + A + F
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKIL-------MEQDFHAERVNEFL 82
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+EVA+ +L HPN+ F+GA L +V EYL G+L L
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPNL----------------SIVTEYLSRGSLYRLLH 126
Query: 163 KN-RRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVA 219
K+ R +L + + +A D+A+G++YLH++ IVHR++K+ N+L+DK TVK+ DFG++
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
R++AS GT +MAPEVL P N K DVYSFG+ LWE+ P+ +L+ ++
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 280 VTSAVVRQ 287
V +AV +
Sbjct: 247 VVAAVGFK 254
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = e-102
Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 31/249 (12%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
I+ +L + + G + +G + G+D+ VK+L + R + F +
Sbjct: 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRD-------FNE 56
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E HPNV +GA P+ ++ ++P G+L L +
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSP--------------PAPHPTLITHWMPYGSLYNVLHE 102
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ V+ ALD+ARG+++LH+ + I + + ++++D++ T +I+ V
Sbjct: 103 GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYN---RKCDVYSFGICLWEIYCCDMPYPDLSFS 278
G ++APE L P + R D++SF + LWE+ ++P+ DLS
Sbjct: 163 F-----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217
Query: 279 EVTSAVVRQ 287
E+ V +
Sbjct: 218 EIGMKVALE 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-101
Identities = 60/274 (21%), Positives = 121/274 (44%), Gaps = 40/274 (14%)
Query: 28 ATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEG 87
A + ++ Q+W+I +L I +I +G FG V+ G + G +VA++L+D +
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDN 69
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
F +EV + + H NV F+GA M L +
Sbjct: 70 EDQLKA-------FKREVMAYRQTRHENVVLFMGACMSPPHL----------------AI 106
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
+ G L + + ++ + L Q+A ++ +G+ YLH++ I+H+D+K++N+ D
Sbjct: 107 ITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD- 164
Query: 208 NRTVKIADFGVARVEA-----SNPNDMTGETGTLGYMAPEVL---------NGNPYNRKC 253
N V I DFG+ + + + + G L ++APE++ + P+++
Sbjct: 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224
Query: 254 DVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
DV++ G +E++ + P+ + +
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = e-100
Identities = 76/256 (29%), Positives = 128/256 (50%), Gaps = 34/256 (13%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
+ DWEI ++ + I G+FGTV++G + G DVAVK+L+ +
Sbjct: 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA----- 66
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F EV V K H N+ F+G + +V ++ G +L
Sbjct: 67 --FKNEVGVLRKTRHVNILLFMGYSTAPQ-----------------LAIVTQWCEGSSLY 107
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
+L K K ++ +A ARG+ YLH++ I+HRD+K+ N+ L ++ TVKI DFG+
Sbjct: 108 HHL-HASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 219 ARVEA--SNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYP 273
A ++ S + +G++ +MAPEV+ NPY+ + DVY+FGI L+E+ +PY
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
Query: 274 DLSFSEVTSAVVRQVQ 289
+++ + ++ V
Sbjct: 227 NINNRD---QIIEMVG 239
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 5e-98
Identities = 69/254 (27%), Positives = 121/254 (47%), Gaps = 37/254 (14%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
EI+ ++L ++ +I G FG V+R + G +VAVK + +I+ QE
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHD-----PDEDISQTIENVRQE 56
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
++ L HPN+ G + L C+V+E+ GG L L
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNL----------------CLVMEFARGGPLNRVL--- 97
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTENMLLDK--------NRTVKI 213
+++ ++V A+ +ARG++YLH + I+HRD+K+ N+L+ + N+ +KI
Sbjct: 98 SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
Query: 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFG+AR G +MAPEV+ + +++ DV+S+G+ LWE+ ++P+
Sbjct: 158 TDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215
Query: 274 DLSFSEVTSAVVRQ 287
+ V V
Sbjct: 216 GIDGLAVAYGVAMN 229
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 2e-97
Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 37/260 (14%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALR 98
+ + + +++ + I +G FG VH+G D VA+K L G+ E E+
Sbjct: 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS--EGETEMIEKF 67
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +EV + L+HPN+ K G N +V+E++P G L
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMH------------------NPPRMVMEFVPCGDLY 109
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLLDK-----NRTV 211
L ++ + + V ++L LD+A G+ Y+ +Q IVHRD+++ N+ L
Sbjct: 110 HRL-LDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168
Query: 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCD 269
K+ADFG+++ + ++G G +MAPE + Y K D YSF + L+ I +
Sbjct: 169 KVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 270 MPYPDLSFSEVT--SAVVRQ 287
P+ + S+ ++ + + +
Sbjct: 226 GPFDEYSYGKIKFINMIREE 245
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 2e-94
Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 37/246 (15%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
I+ ++ ++ V+ RG FG V + + DVA+K ++ E R AF E
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-----------RKAFIVE 51
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ +++HPN+ K GA + N C+V+EY GG+L L
Sbjct: 52 LRQLSRVNHPNIVKLYGACL------------------NPVCLVMEYAEGGSLYNVLHGA 93
Query: 165 RRR-KLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTENMLLDKNRTV-KIADFGVA 219
+ L ++G++YLHS + ++HRD+K N+LL TV KI DFG A
Sbjct: 94 EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 220 RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
++ MT G+ +MAPEV G+ Y+ KCDV+S+GI LWE+ P+ ++
Sbjct: 154 CDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA 210
Query: 280 VTSAVV 285
Sbjct: 211 FRIMWA 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-89
Identities = 70/258 (27%), Positives = 107/258 (41%), Gaps = 38/258 (14%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
PS L+ V+ +G FG + + + + + F
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMK-------ELIRFDEETQRTF 54
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+EV V L+HPNV KFIG L+ + EY+ GG L+ +
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNF----------------ITEYIKGGTLRGII 98
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
K+ + + V A D+A G++YLHS I+HRD+ + N L+ +N+ V +ADFG+AR+
Sbjct: 99 -KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARL 157
Query: 222 EASNPND--------------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
G +MAPE++NG Y+ K DV+SFGI L EI
Sbjct: 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217
Query: 268 CDMPYPDLSFSEVTSAVV 285
PD + +
Sbjct: 218 RVNADPDYLPRTMDFGLN 235
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-85
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 62/279 (22%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
++ + I +G +G V G + G VAVK+ EE +++ +
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE------------ASWFR 78
Query: 104 EVAVWH--KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ + H N+ FI A + + Q ++ +Y G+L YL
Sbjct: 79 ETEIYQTVLMRHENILGFIAADIKGTGSWTQ------------LYLITDYHENGSLYDYL 126
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKI 213
+ L K +++LA GL +LH++ I HRD+K++N+L+ KN T I
Sbjct: 127 ---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183
Query: 214 ADFGVARVEASNPND----MTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLW 263
AD G+A S+ N+ GT YM PEVL+ D+YSFG+ LW
Sbjct: 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243
Query: 264 EIYCC----------DMPYPDL-----SFSEVTSAVVRQ 287
E+ +PY DL S+ ++ V +
Sbjct: 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK 282
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 2e-84
Identities = 75/279 (26%), Positives = 116/279 (41%), Gaps = 62/279 (22%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+V++ I +G FG V RG + G +VAVK+ EE ++ +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE------------RSWFR 83
Query: 104 EVAVWH--KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E ++ L H N+ FI A + Q +V +Y G+L YL
Sbjct: 84 EAEIYQTVMLRHENILGFIAADNKDNGTWTQ------------LWLVSDYHEHGSLFDYL 131
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKI 213
R + + +++LAL A GL++LH + I HRD+K++N+L+ KN T I
Sbjct: 132 ---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188
Query: 214 ADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLW 263
AD G+A S + GT YMAPEVL+ + ++ D+Y+ G+ W
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 264 EIYCC---------------DMPYPDLSFSEVTSAVVRQ 287
EI D+ D S E+ V Q
Sbjct: 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 4e-84
Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 62/271 (22%)
Query: 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWH-- 109
+ + + +G +G V RG + G +VAVK+ +E ++ +E +++
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE------------KSWFRETELYNTV 57
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
L H N+ FI + M S Q ++ Y G+L YL + L
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQ------------LWLITHYHEMGSLYDYL---QLTTL 102
Query: 170 AFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+++ L +A GL++LH + I HRD+K++N+L+ KN IAD G+A +
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
Query: 222 EASNPND----MTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCC--- 268
+ + N GT YMAPEVL+ ++ D+++FG+ LWE+
Sbjct: 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
Query: 269 ------------DMPYPDLSFSEVTSAVVRQ 287
D+ D SF ++ V
Sbjct: 223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVD 253
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-80
Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 60/279 (21%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEE-GHRTEAEIAALRSAF 101
++ + L + V ARG FG V + VAVK+ ++ + E E+ +L
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLP--- 73
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+ H N+ +FIGA + + + ++ + G+L +L
Sbjct: 74 --------GMKHENILQFIGAEKRGTSVDVD------------LWLITAFHEKGSLSDFL 113
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ----------KIVHRDVKTENMLLDKNRTV 211
+ +++ + +A +ARGL+YLH I HRD+K++N+LL N T
Sbjct: 114 ---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 212 KIADFGVARV--EASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWE 264
IADFG+A + D G+ GT YMAPEVL G + D+Y+ G+ LWE
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 265 IYCCDMPY----------------PDLSFSEVTSAVVRQ 287
+ S ++ VV +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHK 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 242 bits (618), Expect = 6e-79
Identities = 70/290 (24%), Positives = 120/290 (41%), Gaps = 72/290 (24%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
+ ++ L + +I RG +G V++G D VAVK+ + F
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR------------QNFI 53
Query: 103 QEVAVWH--KLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
E ++ ++H N+ +FI +++ ++ +V+EY P G+L
Sbjct: 54 NEKNIYRVPLMEHDNIARFIVGDERVTADGRME------------YLLVMEYYPNGSLXK 101
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------KIVHRDVKTENMLLDKNRT 210
YL + +LA + RGL+YLH++ I HRD+ + N+L+ + T
Sbjct: 102 YL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158
Query: 211 VKIADFGVARVEASNP--------NDMTGETGTLGYMAPEVLNG-------NPYNRKCDV 255
I+DFG++ N N E GT+ YMAPEVL G ++ D+
Sbjct: 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218
Query: 256 YSFGICLWEIY--CCD-----------MPYPDL-----SFSEVTSAVVRQ 287
Y+ G+ WEI+ C D M + +F ++ V R+
Sbjct: 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE 268
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-60
Identities = 75/250 (30%), Positives = 112/250 (44%), Gaps = 30/250 (12%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH--DVAVKLLDWGEEGHRTEAEIAALRS 99
+ W + LV+ I RG FG V G VAVK E L++
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC--------RETLPPDLKA 157
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F QE + + HPN+ + IG V +V+E + GG T
Sbjct: 158 KFLQEARILKQYSHPNIVRLIG----------------VCTQKQPIYIVMELVQGGDFLT 201
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + +L K ++Q+ D A G+ YL S+ +HRD+ N L+ + +KI+DFG++
Sbjct: 202 FL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
Query: 220 RVEASNPNDMTGETGTLGY--MAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLS 276
R EA +G + APE LN Y+ + DV+SFGI LWE + PYP+LS
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320
Query: 277 FSEVTSAVVR 286
+ V +
Sbjct: 321 NQQTREFVEK 330
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-57
Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 38/251 (15%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
R W + +L + I +G FG V G Y G+ VAVK + A A
Sbjct: 12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----------ATAQA 60
Query: 101 FTQEVAVWHKLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F E +V +L H N+ + +G L+I V EY+ G+L
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI----------------VTEYMAKGSLVD 104
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
YL R L +++ +LD+ + YL VHRD+ N+L+ ++ K++DFG+
Sbjct: 105 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
Query: 220 RVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
+ + + + + + APE L ++ K DV+SFGI LWEIY +PYP +
Sbjct: 165 KEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
Query: 276 SFSEVTSAVVR 286
+V V +
Sbjct: 219 PLKDVVPRVEK 229
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-57
Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 34/262 (12%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGH 88
P + ++ WEI L ++ + G FG V Y+ H VAVK + G
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS- 226
Query: 89 RTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVV 148
AF E V L H + K ++
Sbjct: 227 ---------VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-----------------IYII 260
Query: 149 VEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
E++ G+L +L + K ++ + +A G++++ + +HRD++ N+L+ +
Sbjct: 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS 320
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLG---YMAPEVLNGNPYNRKCDVYSFGICLWEI 265
KIADFG+ARV N+ T G + APE +N + K DV+SFGI L EI
Sbjct: 321 LVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEI 378
Query: 266 Y-CCDMPYPDLSFSEVTSAVVR 286
+PYP +S EV A+ R
Sbjct: 379 VTYGRIPYPGMSNPEVIRALER 400
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-57
Identities = 67/262 (25%), Positives = 120/262 (45%), Gaps = 29/262 (11%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHR 89
S+ LK++ +D I + + ++ +G FG+V D VAVK+L +
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADII 64
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
++ F +E A + DHP+V K +G + + V++
Sbjct: 65 ASSD----IEEFLREAACMKEFDHPHVAKLVGVS---------LRSRAKGRLPIPM-VIL 110
Query: 150 EYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
++ G L +L+ +R L + +V+ +D+A G+ YL S+ +HRD+ N +L
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML 170
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLW 263
++ TV +ADFG++R S G L ++A E L N Y DV++FG+ +W
Sbjct: 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMW 230
Query: 264 EIY-CCDMPYPDLSFSEVTSAV 284
EI PY + +E+ + +
Sbjct: 231 EIMTRGQTPYAGIENAEIYNYL 252
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-56
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 16/222 (7%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+I G FG V + DG +K + + E + E E+ AL KLDH
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALA-----------KLDHV 64
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ + G G + + + +E+ G L+ ++ K R KL +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
++L + +G+ Y+HS+K+++RD+K N+ L + VKI DFG+ N T G
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS-LKNDGKRTRSKG 183
Query: 235 TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
TL YM+PE ++ Y ++ D+Y+ G+ L E+ + S
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS 225
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-56
Identities = 67/264 (25%), Positives = 122/264 (46%), Gaps = 30/264 (11%)
Query: 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEG 87
+ S L+ + +D I+ + L++ ++ G FG+V G D VAVK + +
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM---KLD 73
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
+ ++ E F E A HPNV + +G E +P + V
Sbjct: 74 NSSQRE----IEEFLSEAACMKDFSHPNVIRLLGVC---------IEMSSQGIPKPM--V 118
Query: 148 VVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
++ ++ G L TYL+ +R + + + +++ +D+A G+ YL ++ +HRD+ N
Sbjct: 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGIC 261
+L + TV +ADFG+++ S G + ++A E L Y K DV++FG+
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 262 LWEIY-CCDMPYPDLSFSEVTSAV 284
+WEI PYP + E+ +
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYL 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-56
Identities = 68/256 (26%), Positives = 110/256 (42%), Gaps = 44/256 (17%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRS 99
+WE+ L + + G FG V G Y+GH VAVK L G +
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG----------SMSPD 53
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC-----CVVVEYLPG 154
AF E + +L H + + + ++ EY+
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYA----------------------VVTQEPIYIITEYMEN 91
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
G+L +L KL ++ +A +A G++++ + +HRD++ N+L+ + KIA
Sbjct: 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151
Query: 215 DFGVARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DM 270
DFG+AR+ N+ T G + APE +N + K DV+SFGI L EI +
Sbjct: 152 DFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
Query: 271 PYPDLSFSEVTSAVVR 286
PYP ++ EV + R
Sbjct: 210 PYPGMTNPEVIQNLER 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 2e-56
Identities = 65/250 (26%), Positives = 120/250 (48%), Gaps = 30/250 (12%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH--DVAVKLLDWGEEGHRTEAEIAALR 98
WE+E + + +K + G +G V+ G++ + VAVK L +E E
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEE----- 262
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E AV ++ HPN+ + +G + T ++ E++ G L
Sbjct: 263 --FLKEAAVMKEIKHPNLVQLLG---------VCTREPPF-------YIITEFMTYGNLL 304
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + R++++ V++ +A ++ + YL + +HR++ N L+ +N VK+ADFG+
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
Query: 219 ARVEASNPNDMTGETG-TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLS 276
+R+ + + + APE L N ++ K DV++FG+ LWEI PYP +
Sbjct: 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424
Query: 277 FSEVTSAVVR 286
S+V + +
Sbjct: 425 LSQVYELLEK 434
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-56
Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 38/250 (15%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
R W + +L + I +G FG V G Y G+ VAVK + A AF
Sbjct: 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----------ATAQAF 233
Query: 102 TQEVAVWHKLDHPNVTKFIGA-TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E +V +L H N+ + +G L+I V EY+ G+L Y
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYI----------------VTEYMAKGSLVDY 277
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L R L +++ +LD+ + YL VHRD+ N+L+ ++ K++DFG+ +
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 221 VEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLS 276
+ + + + + APE L ++ K DV+SFGI LWEIY +PYP +
Sbjct: 338 EAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391
Query: 277 FSEVTSAVVR 286
+V V +
Sbjct: 392 LKDVVPRVEK 401
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 9e-56
Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 34/248 (13%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFT 102
WEI+P L + G FG V G + G DVA+K++ G + F
Sbjct: 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG----------SMSEDEFI 67
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E V L H + + G V ++ EY+ G L YL
Sbjct: 68 EEAKVMMNLSHEKLVQLYG----------------VCTKQRPIFIITEYMANGCLLNYL- 110
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ R + + ++++ D+ + YL S++ +HRD+ N L++ VK++DFG++R
Sbjct: 111 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
Query: 223 ASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278
++ T G+ + PEVL + ++ K D+++FG+ +WEIY MPY + S
Sbjct: 171 LD--DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228
Query: 279 EVTSAVVR 286
E + +
Sbjct: 229 ETAEHIAQ 236
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-55
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 34/247 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
E++ ++ + + G FG V G + G +DVAVK++ G + F Q
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG----------SMSEDEFFQ 52
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E KL HP + KF G ++I V EY+ G L YL +
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYI----------------VTEYISNGCLLNYL-R 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+ + L ++++ D+ G+++L S + +HRD+ N L+D++ VK++DFG+ R
Sbjct: 96 SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 224 SNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
+ GT + APEV + Y+ K DV++FGI +WE++ MPY + SE
Sbjct: 156 D--DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
Query: 280 VTSAVVR 286
V V +
Sbjct: 214 VVLKVSQ 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 4e-55
Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 34/249 (13%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGH--DVAVKLLDWGEEGHRTEAEIAALRSAF 101
WE+E + + +K + G +G V+ G++ + VAVK L F
Sbjct: 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----------TMEVEEF 56
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+E AV ++ HPN+ + +G + T ++ E++ G L YL
Sbjct: 57 LKEAAVMKEIKHPNLVQLLG---------VCTREPPF-------YIITEFMTYGNLLDYL 100
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ R++++ V++ +A ++ + YL + +HRD+ N L+ +N VK+ADFG++R+
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
Query: 222 EASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
+ T G + APE L N ++ K DV++FG+ LWEI PYP +
Sbjct: 161 MTG--DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218
Query: 278 SEVTSAVVR 286
S+V + +
Sbjct: 219 SQVYELLEK 227
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-55
Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 34/247 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
W I+PS+L I G FG VH G + VA+K + EG +E + F +
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEED-------FIE 52
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E V KL HP + + G + + + + V E++ G L YL +
Sbjct: 53 EAEVMMKLSHPKLVQLYGVCLEQAPICL----------------VTEFMEHGCLSDYL-R 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
+R A + ++ + LD+ G++YL ++HRD+ N L+ +N+ +K++DFG+ R
Sbjct: 96 TQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155
Query: 224 SNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSE 279
+ T TGT + +PEV + + Y+ K DV+SFG+ +WE++ +PY + S SE
Sbjct: 156 D--DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
Query: 280 VTSAVVR 286
V +
Sbjct: 214 VVEDIST 220
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-55
Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 49/276 (17%)
Query: 34 ASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEG 87
A + R + E L + +G FG+V YD VAVK L E
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 84
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
H + F +E+ + L H N+ K+ G + ++ +
Sbjct: 85 HLRD---------FEREIEILKSLQHDNIVKYKGVCYSAGRRNL--------------KL 121
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
++EYLP G+L+ YL + + ++ ++Q + +G+ YL +++ +HRD+ T N+L++
Sbjct: 122 IMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 180
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
VKI DFG+ +V + + + + APE L + ++ DV+SFG+ L+E
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 265 I--YCCD--------------MPYPDLSFSEVTSAV 284
+ Y + + +
Sbjct: 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 64/256 (25%), Positives = 106/256 (41%), Gaps = 33/256 (12%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIA 95
Q I L + + G+FG V RG +D VAVK L + ++ E
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL---KPDVLSQPEA- 64
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
F +EV H LDH N+ + G + +V E P G
Sbjct: 65 --MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-----------------MKMVTELAPLG 105
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
+L L + + + + A+ +A G+ YL S++ +HRD+ N+LL VKI D
Sbjct: 106 SLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMP 271
FG+ R N + + + APE L ++ D + FG+ LWE++ P
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 272 YPDLSFSEVTSAVVRQ 287
+ L+ S++ + ++
Sbjct: 225 WIGLNGSQILHKIDKE 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-54
Identities = 59/265 (22%), Positives = 110/265 (41%), Gaps = 49/265 (18%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALR 98
+ E L + +G FG+V YD VAVK L E H +
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD------- 57
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E+ + L H N+ K+ G + ++ +++EYLP G+L+
Sbjct: 58 --FEREIEILKSLQHDNIVKYKGVCYSAGRRNL--------------KLIMEYLPYGSLR 101
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + + ++ ++Q + +G+ YL +++ +HRD+ T N+L++ VKI DFG+
Sbjct: 102 DYL-QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160
Query: 219 ARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YCCD---- 269
+V + + + + APE L + ++ DV+SFG+ L+E+ Y
Sbjct: 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220
Query: 270 ----------MPYPDLSFSEVTSAV 284
+ + +
Sbjct: 221 PAEFMRMIGNDKQGQMIVFHLIELL 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 73/251 (29%), Positives = 109/251 (43%), Gaps = 34/251 (13%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRS 99
+ WEI L ++ + +G FG V G ++G VA+K L G
Sbjct: 175 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------- 224
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
AF QE V KL H + + P I V EY+ G+L
Sbjct: 225 AFLQEAQVMKKLRHEKLVQLYAVVSEE--------------PIYI---VTEYMSKGSLLD 267
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+A
Sbjct: 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
Query: 220 RVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDL 275
R+ N+ T G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 328 RLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 276 SFSEVTSAVVR 286
EV V R
Sbjct: 386 VNREVLDQVER 396
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-54
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 47/261 (18%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEA 92
+ +D+EI+ ++ + I G FG VH+G+Y + VA+K +
Sbjct: 3 MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSV 59
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC-----CV 147
R F QE + DHP++ K IG + +
Sbjct: 60 -----REKFLQEALTMRQFDHPHIVKLIG----------------------VITENPVWI 92
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207
++E G L+++L + R+ L ++ A L+ L+YL S++ VHRD+ N+L+
Sbjct: 93 IMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 151
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWE 264
N VK+ DFG++R + + +MAPE +N + DV+ FG+C+WE
Sbjct: 152 NDCVKLGDFGLSRYMED--STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209
Query: 265 IYCC-DMPYPDLSFSEVTSAV 284
I P+ + ++V +
Sbjct: 210 ILMHGVKPFQGVKNNDVIGRI 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-54
Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 47/257 (18%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAA 96
+ I +V+ ++ G FG V+ G+Y H VAVK ++ +
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDN---- 56
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC-----CVVVEY 151
+ F E + LDHP++ K IG I +++E
Sbjct: 57 -KEKFMSEAVIMKNLDHPHIVKLIG----------------------IIEEEPTWIIMEL 93
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
P G L YL + + L +V +L + + ++YL S VHRD+ N+L+ V
Sbjct: 94 YPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152
Query: 212 KIADFGVARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-C 267
K+ DFG++R D + T +M+PE +N + DV+ F +C+WEI
Sbjct: 153 KLGDFGLSRYIED--EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF 210
Query: 268 CDMPYPDLSFSEVTSAV 284
P+ L +V +
Sbjct: 211 GKQPFFWLENKDVIGVL 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-54
Identities = 73/251 (29%), Positives = 108/251 (43%), Gaps = 34/251 (13%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-DVAVKLLDWGEEGHRTEAEIAALRS 99
+ WEI L ++ + +G FG V G ++G VA+K L G
Sbjct: 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------- 307
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
AF QE V KL H + + P I V EY+ G+L
Sbjct: 308 AFLQEAQVMKKLRHEKLVQLYAVVSEE--------------PIYI---VTEYMSKGSLLD 350
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+A
Sbjct: 351 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
Query: 220 RVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDL 275
R+ N+ T G + APE + K DV+SFGI L E+ +PYP +
Sbjct: 411 RLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 276 SFSEVTSAVVR 286
EV V R
Sbjct: 469 VNREVLDQVER 479
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-54
Identities = 69/253 (27%), Positives = 118/253 (46%), Gaps = 35/253 (13%)
Query: 41 QRQDWEIEPSKLVIKS-VIARGTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIA 95
+ ++ ++ L ++ + G FGTV +G Y VAVK+L + EA
Sbjct: 7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEANDP 59
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
AL+ E V +LD+P + + IG + + +V+E G
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIG----------------ICEAESWM-LVMEMAELG 102
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
L YL +NR + K +++L ++ G+ YL VHRD+ N+LL KI+D
Sbjct: 103 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISD 160
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMP 271
FG+++ ++ N +T + + APE +N ++ K DV+SFG+ +WE + P
Sbjct: 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 272 YPDLSFSEVTSAV 284
Y + SEVT+ +
Sbjct: 221 YRGMKGSEVTAML 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-54
Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 49/277 (17%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGE 85
G + L + G FG V YD + VAVK L +
Sbjct: 13 GALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---K 69
Query: 86 EGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC 145
+ RS + QE+ + L H ++ K+ G + G ++
Sbjct: 70 ADAGPQH-----RSGWKQEIDILRTLYHEHIIKYKG---------CCEDAGAASL----- 110
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+V+EY+P G+L+ YL R + ++ A + G++YLH+Q +HRD+ N+LL
Sbjct: 111 QLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL 167
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICL 262
D +R VKI DFG+A+ + + APE L + DV+SFG+ L
Sbjct: 168 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 263 WEI--YC-------------CDMPYPDLSFSEVTSAV 284
+E+ +C + ++ +T +
Sbjct: 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 9e-54
Identities = 78/259 (30%), Positives = 116/259 (44%), Gaps = 36/259 (13%)
Query: 38 LKKQRQDWEIEPSKLVIK--SVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + Q I PS L++ VI RG FG V+ G +D AVK L+
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----D 66
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
E S F E + HPNV +G VV+
Sbjct: 67 IGE----VSQFLTEGIIMKDFSHPNVLSLLGI---------------CLRSEGSPLVVLP 107
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L+ ++ +N K ++ L +A+G+ YL S+K VHRD+ N +LD+ T
Sbjct: 108 YMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT 166
Query: 211 VKIADFGVAR-VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR + + +TG +MA E L + K DV+SFG+ LWE+
Sbjct: 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
Query: 267 C-CDMPYPDLSFSEVTSAV 284
PYPD++ ++T +
Sbjct: 227 TRGAPPYPDVNTFDITVYL 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-53
Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 42/259 (16%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAA 96
+WE+ K+ + + +G+FG V+ G+ G VA+K + E + E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAA-SMRE--- 71
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R F E +V + + +V + +G ++ V++E + G
Sbjct: 72 -RIEFLNEASVMKEFNCHHVVRLLGVV---------SQGQPT-------LVIMELMTRGD 114
Query: 157 LKTYLIKNR--------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
LK+YL R + ++Q+A ++A G++YL++ K VHRD+ N ++ ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TVKI DFG+ R G G L +M+PE L + DV+SFG+ LWEI
Sbjct: 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 267 -CCDMPYPDLSFSEVTSAV 284
+ PY LS +V V
Sbjct: 235 TLAEQPYQGLSNEQVLRFV 253
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-53
Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 34/246 (13%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTE 91
L + E L S + +G FG+V YD VAVK L + +
Sbjct: 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSG-PD 66
Query: 92 AEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
+ F +E+ + L + K+ G + G + +V+EY
Sbjct: 67 QQ-----RDFQREIQILKALHSDFIVKYRGVSYGPGRQSL--------------RLVMEY 107
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
LP G L+ +L ++R R L ++ + + +G+ YL S++ VHRD+ N+L++ V
Sbjct: 108 LPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166
Query: 212 KIADFGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-C 267
KIADFG+A++ + + + + APE L+ N ++R+ DV+SFG+ L+E++
Sbjct: 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY 226
Query: 268 CDMPYP 273
CD
Sbjct: 227 CDKSCS 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-53
Identities = 64/264 (24%), Positives = 112/264 (42%), Gaps = 47/264 (17%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALR 98
E L + G FG V YD VAVK L +
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNH-----I 67
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
+ +E+ + L H N+ K+ G I TE+G + +++E+LP G+LK
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKG---------ICTEDGGNGI-----KLIMEFLPSGSLK 113
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + K+ K ++ A+ + +G+ YL S++ VHRD+ N+L++ VKI DFG+
Sbjct: 114 EYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172
Query: 219 ARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEI--YC------ 267
+ ++ T + + + APE L + + DV+SFG+ L E+ YC
Sbjct: 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 268 -------CDMPYPDLSFSEVTSAV 284
+ ++ + + + +
Sbjct: 233 MALFLKMIGPTHGQMTVTRLVNTL 256
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-53
Identities = 72/259 (27%), Positives = 114/259 (44%), Gaps = 36/259 (13%)
Query: 38 LKKQRQDWEIEPSKLVIKS--VIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + +D I ++V S VI +G FG V+ G Y A+K L
Sbjct: 7 LLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEM 63
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ AF +E + L+HPNV IG + P + V++
Sbjct: 64 QQ-----VEAFLREGLLMRGLNHPNVLALIGI---------------MLPPEGLPHVLLP 103
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L ++ ++ +R K ++ L +ARG+ YL QK VHRD+ N +LD++ T
Sbjct: 104 YMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162
Query: 211 VKIADFGVAR-VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR + + + A E L + K DV+SFG+ LWE+
Sbjct: 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 267 -CCDMPYPDLSFSEVTSAV 284
PY + ++T +
Sbjct: 223 TRGAPPYRHIDPFDLTHFL 241
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 69/250 (27%), Positives = 115/250 (46%), Gaps = 34/250 (13%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGH-----DVAVKLLDWGEEGHRTEAEIAALR 98
EIE S++ I+ +I G G V G VA+K L G TE + R
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQ----R 94
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E ++ + DHPN+ + G V + +V EY+ G+L
Sbjct: 95 RDFLSEASIMGQFDHPNIIRLEG----------------VVTRGRLAMIVTEYMENGSLD 138
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
T+L + + +V + + G+ YL VHRD+ N+L+D N K++DFG+
Sbjct: 139 TFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 219 ARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
+RV +P+ TG + + APE + ++ DV+SFG+ +WE+ + PY +
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 275 LSFSEVTSAV 284
++ +V S+V
Sbjct: 258 MTNRDVISSV 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 8e-53
Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 35/253 (13%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGH------DVAVKLLDWGEEGHRTEAEIA 95
+ EI PS + + VI G FG V++G+ VA+K L
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTE 87
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
R F E + + H N+ + G V ++ EY+ G
Sbjct: 88 KQRVDFLGEAGIMGQFSHHNIIRLEG----------------VISKYKPMMIITEYMENG 131
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
AL +L + + + + +V + +A G+ YL + VHRD+ N+L++ N K++D
Sbjct: 132 ALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD 190
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMP 271
FG++RV +P +G + + APE ++ + DV+SFGI +WE+ + P
Sbjct: 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
Query: 272 YPDLSFSEVTSAV 284
Y +LS EV A+
Sbjct: 251 YWELSNHEVMKAI 263
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-52
Identities = 61/253 (24%), Positives = 114/253 (45%), Gaps = 35/253 (13%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEI 94
+ + ++L V+ G FGTVH+G++ V +K++ E+ ++
Sbjct: 4 KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI---EDKSGRQS-- 58
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
A T + LDH ++ + +G GSS +V +YLP
Sbjct: 59 ---FQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-----------------LQLVTQYLPL 98
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
G+L ++ + R L ++++ + +A+G+ YL +VHR++ N+LL V++A
Sbjct: 99 GSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA 157
Query: 215 DFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMP 271
DFGVA + + + +MA E ++ Y + DV+S+G+ +WE+ P
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
Query: 272 YPDLSFSEVTSAV 284
Y L +EV +
Sbjct: 218 YAGLRLAEVPDLL 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-52
Identities = 67/249 (26%), Positives = 110/249 (44%), Gaps = 34/249 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRS 99
E++ + + I V+ G FG V G VA+K L G TE + R
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQ----RR 91
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F E ++ + DHPN+ + G V S +V EY+ G+L +
Sbjct: 92 DFLGEASIMGQFDHPNIIRLEG----------------VVTKSKPVMIVTEYMENGSLDS 135
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+L + + +V + +A G+ YL VHRD+ N+L++ N K++DFG+
Sbjct: 136 FL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 220 RVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDL 275
RV +P G + + +PE + + DV+S+GI LWE+ + PY ++
Sbjct: 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
Query: 276 SFSEVTSAV 284
S +V AV
Sbjct: 255 SNQDVIKAV 263
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-52
Identities = 67/266 (25%), Positives = 102/266 (38%), Gaps = 54/266 (20%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
I+ +V+K + G FG V VAVK L E R +
Sbjct: 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD------ 89
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F +E + L H ++ +F G TE + +V EY+ G L
Sbjct: 90 ---FQREAELLTMLQHQHIVRFFGVC---------TEGRPL-------LMVFEYMRHGDL 130
Query: 158 KTYLIKNR-------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+L + L ++ +A +A G+ YL VHRD+ T N L
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLG-----YMAPEVLNGNPYNRKCDVYSFG 259
+ + VKI DFG++R S D G +M PE + + + DV+SFG
Sbjct: 191 VGQGLVVKIGDFGMSRDIYS--TDYY-RVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247
Query: 260 ICLWEIY-CCDMPYPDLSFSEVTSAV 284
+ LWEI+ P+ LS +E +
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAIDCI 273
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-52
Identities = 71/271 (26%), Positives = 109/271 (40%), Gaps = 49/271 (18%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRT 90
+ I+ +V+K + G FG V VAVK L ++ T
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDP--T 57
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
A R F +E + L H ++ KF G + + +V E
Sbjct: 58 LAA----RKDFQREAELLTNLQHEHIVKFYGVC---------GDGDPL-------IMVFE 97
Query: 151 YLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196
Y+ G L +L + + +L ++ +A +A G+ YL SQ VHR
Sbjct: 98 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHR 157
Query: 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCD 254
D+ T N L+ N VKI DFG++R S G L +M PE + + + D
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 217
Query: 255 VYSFGICLWEIY-CCDMPYPDLSFSEVTSAV 284
V+SFG+ LWEI+ P+ LS +EV +
Sbjct: 218 VWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-52
Identities = 60/247 (24%), Positives = 119/247 (48%), Gaps = 35/247 (14%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALRSA 100
++ ++ V+ G FGTV++GL+ VA+K L E +A
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKA-----NKE 63
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E V +D+P+V + +G + S+ +Q ++ + +P G L Y
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTST---VQ--------------LITQLMPFGCLLDY 106
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ + + + + ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A+
Sbjct: 107 V-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 221 VEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 277
+ + + E G + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 278 SEVTSAV 284
SE++S +
Sbjct: 226 SEISSIL 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-51
Identities = 70/263 (26%), Positives = 101/263 (38%), Gaps = 48/263 (18%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
E+ + + + G FG V+ G G VAVK L E +
Sbjct: 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD----- 76
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
F E + K +H N+ + IG + ++ +++E + GG L
Sbjct: 77 ELDFLMEALIISKFNHQNIVRCIGVS---------LQSLPR-------FILMELMAGGDL 120
Query: 158 KTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---NR 209
K++L + R LA ++ +A D+A G YL +HRD+ N LL R
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180
Query: 210 TVKIADFGVARVEASNPNDMTGETGTLGY-----MAPEVLNGNPYNRKCDVYSFGICLWE 264
KI DFG+AR G M PE + K D +SFG+ LWE
Sbjct: 181 VAKIGDFGMARDIYRA--SYY-RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237
Query: 265 IY-CCDMPYPDLSFSEVTSAVVR 286
I+ MPYP S EV V
Sbjct: 238 IFSLGYMPYPSKSNQEVLEFVTS 260
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-51
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 25/236 (10%)
Query: 53 VIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V I G+FG DG +K ++ + E R +EVAV
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS---RMSSKEREESR----REVAVLAN 79
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ HPN+ ++ + + L+I V++Y GG L + +
Sbjct: 80 MKHPNIVQYRESFEENGSLYI----------------VMDYCEGGDLFKRINAQKGVLFQ 123
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++ + + L ++H +KI+HRD+K++N+ L K+ TV++ DFG+ARV S
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
GT Y++PE+ PYN K D+++ G L+E+ + S + ++
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 36/259 (13%)
Query: 38 LKKQRQDWEIEPSKLVIK--SVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + Q I PS L++ VI RG FG V+ G +D AVK L
Sbjct: 75 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRIT-D 130
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
E S F E + HPNV +G VV+
Sbjct: 131 IGE----VSQFLTEGIIMKDFSHPNVLSLLGI---------------CLRSEGSPLVVLP 171
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L+ ++ +N K ++ L +A+G+ +L S+K VHRD+ N +LD+ T
Sbjct: 172 YMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 230
Query: 211 VKIADFGVAR-VEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR + + + +TG +MA E L + K DV+SFG+ LWE+
Sbjct: 231 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 267 C-CDMPYPDLSFSEVTSAV 284
PYPD++ ++T +
Sbjct: 291 TRGAPPYPDVNTFDITVYL 309
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-51
Identities = 62/251 (24%), Positives = 114/251 (45%), Gaps = 35/251 (13%)
Query: 43 QDWEIEPSKLVI-KSVIARGTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIAAL 97
+ ++ L+I + G FG+V +G+Y DVA+K+L ++G
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKAD----- 53
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
+E + H+LD+P + + IG V + +V+E GG L
Sbjct: 54 TEEMMREAQIMHQLDNPYIVRLIG----------------VCQAEALM-LVMEMAGGGPL 96
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
+L +R ++ V +L ++ G+ YL + VHRD+ N+LL KI+DFG
Sbjct: 97 HKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 218 VARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYP 273
+++ ++ + T + L + APE +N ++ + DV+S+G+ +WE PY
Sbjct: 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215
Query: 274 DLSFSEVTSAV 284
+ EV + +
Sbjct: 216 KMKGPEVMAFI 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-51
Identities = 54/266 (20%), Positives = 99/266 (37%), Gaps = 63/266 (23%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDG---------HDVAVKLLDWGEEGHRTEAEIA 95
+I L+ + +GTF + +G+ +V +K+LD + HR +E
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNYSE-- 57
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
+F + ++ KL H ++ G V + + +V E++ G
Sbjct: 58 ----SFFEAASMMSKLSHKHLVLNYG----------------VCVCGDENILVQEFVKFG 97
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-------- 207
+L TYL K + + +++A LA + +L ++H +V +N+LL +
Sbjct: 98 SLDTYL-KKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGN 156
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGY-------MAPEVL-NGNPYNRKCDVYSFG 259
+K++D G++ + PE + N N D +SFG
Sbjct: 157 PPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 260 ICLWEIYCC-DMPYPDLSFSEVTSAV 284
LWEI D P L
Sbjct: 206 TTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-51
Identities = 73/261 (27%), Positives = 106/261 (40%), Gaps = 42/261 (16%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
E+ + + + G FG V+ G G VAVK L E +E +
Sbjct: 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVC-SEQD--- 117
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
F E + K +H N+ + IG + ++ P +++E + GG
Sbjct: 118 -ELDFLMEALIISKFNHQNIVRCIGVS---------LQSL----P---RFILLELMAGGD 160
Query: 157 LKTYLIKNR-----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---N 208
LK++L + R LA ++ +A D+A G YL +HRD+ N LL
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLG--YMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
R KI DFG+AR G L +M PE + K D +SFG+ LWEI+
Sbjct: 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 267 -CCDMPYPDLSFSEVTSAVVR 286
MPYP S EV V
Sbjct: 281 SLGYMPYPSKSNQEVLEFVTS 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-51
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 37/234 (15%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+V+ +G FG V R D A+K + TE +++ + EV + L
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTIL----SEVMLLASL 59
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---RK 168
+H V ++ A + + + + +EY G L + R
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVK---KKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV------- 221
+++ Q+ LSY+HSQ I+HRD+K N+ +D++R VKI DFG+A+
Sbjct: 117 EYWRLFRQILE----ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 222 -------EASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYC 267
+ +++T GT Y+A EVL+G YN K D+YS GI +E+
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 9e-51
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 37/250 (14%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALR 98
D+EI+ ++ + I G FG VH+G+Y + VA+K + R
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSV-----R 435
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F QE + DHP++ K IG + +++E G L+
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENP-----------------VWIIMELCTLGELR 478
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++L + L ++ A L+ L+YL S++ VHRD+ N+L+ N VK+ DFG+
Sbjct: 479 SFLQVRKFS-LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537
Query: 219 ARVEASNPNDMTGETGTL---GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPD 274
+R + + +MAPE +N + DV+ FG+C+WEI P+
Sbjct: 538 SRYMED--STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595
Query: 275 LSFSEVTSAV 284
+ ++V +
Sbjct: 596 VKNNDVIGRI 605
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-50
Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 56/284 (19%)
Query: 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGE 85
+ L + E + + I G FG V + G VAVK+L +
Sbjct: 30 RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---K 86
Query: 86 EGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC 145
E + ++ F +E A+ + D+PN+ K +G +
Sbjct: 87 EEA-SADM----QADFQREAALMAEFDNPNIVKLLGVC---------AVGKPM------- 125
Query: 146 CVVVEYLPGGALKTYLIKNR----------------------RRKLAFKVVVQLALDLAR 183
C++ EY+ G L +L L+ + +A +A
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185
Query: 184 GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAP 241
G++YL +K VHRD+ T N L+ +N VKIADFG++R S + +M P
Sbjct: 186 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP 245
Query: 242 EVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSFSEVTSAV 284
E + N Y + DV+++G+ LWEI+ PY ++ EV V
Sbjct: 246 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 2e-50
Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 48/264 (18%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAAL 97
EI S + + FG V++G G VA+K L ++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKA-EGPL---- 55
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
R F E + +L HPNV +G T++ + ++ Y G L
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVV---------TKDQPL-------SMIFSYCSHGDL 99
Query: 158 KTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
+L+ + L V L +A G+ YL S +VH+D+ T N+
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 159
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGIC 261
L+ VKI+D G+ R + L +MAPE + ++ D++S+G+
Sbjct: 160 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVV 219
Query: 262 LWEIY-CCDMPYPDLSFSEVTSAV 284
LWE++ PY S +V +
Sbjct: 220 LWEVFSYGLQPYCGYSNQDVVEMI 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 6e-50
Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 57 VIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I RG F V+R DG VA+K + A +E+ + +L+HP
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQI--FDLMDAKARADCI----KEIDLLKQLNHP 92
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK-- 172
NV K+ + + +EL+I V+E G L + +++K
Sbjct: 93 NVIKYYASFIEDNELNI----------------VLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
V + + L L ++HS++++HRD+K N+ + VK+ D G+ R +S
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
GT YM+PE ++ N YN K D++S G L+E+ P+
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 7e-50
Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 55/265 (20%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD----VAVKLLDWGEEGHRTEAEIAALRSA 100
++ + + + VI G FG V + A+K + +E ++ +
Sbjct: 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYA-SKDD----HRD 71
Query: 101 FTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
F E+ V KL HPN+ +GA G + + +EY P G L
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGAC---------EHRGYL-------YLAIEYAPHGNLLD 115
Query: 160 YLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+L K+R L+ + ++ A D+ARG+ YL ++ +HRD+ N+L+
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLG-----YMAPEVLNGNPYNRKCDVYSFGI 260
+N KIADFG++R T+G +MA E LN + Y DV+S+G+
Sbjct: 176 GENYVAKIADFGLSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229
Query: 261 CLWEIYCC-DMPYPDLSFSEVTSAV 284
LWEI PY ++ +E+ +
Sbjct: 230 LLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-49
Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 56/275 (20%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE LV+ + G FG V + VAVK+L +E + +E
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENA-SPSE--- 69
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
E V +++HP+V K GA +++G + ++VEY G+
Sbjct: 70 -LRDLLSEFNVLKQVNHPHVIKLYGAC---------SQDGPL-------LLIVEYAKYGS 112
Query: 157 LKTYLIKNR----------------------RRKLAFKVVVQLALDLARGLSYLHSQKIV 194
L+ +L ++R R L ++ A +++G+ YL K+V
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172
Query: 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRK 252
HRD+ N+L+ + R +KI+DFG++R + + G + +MA E L + Y +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 253 CDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVR 286
DV+SFG+ LWEI PYP + + + +
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT 267
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 59/247 (23%), Positives = 117/247 (47%), Gaps = 35/247 (14%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALRSA 100
++ ++ V+ G FGTV++GL+ VA+K L E +A
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKA-----NKE 63
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E V +D+P+V + +G + S+ ++ + +P G L Y
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQ-----------------LITQLMPFGCLLDY 106
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ + + + + ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A+
Sbjct: 107 V-REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 221 VEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMPYPDLSF 277
+ + + E G + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 278 SEVTSAV 284
SE++S +
Sbjct: 226 SEISSIL 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-49
Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 29/225 (12%)
Query: 57 VIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I RG+F TV++GL +VA L + T++E + +E + L HP
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQ---DRKLTKSERQRFK----EEAEMLKGLQHP 85
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ +F S + +V E + G LKTYL + + + KV+
Sbjct: 86 NIVRFYD-----SWESTVKGKKCI-------VLVTELMTSGTLKTYLKRFK--VMKIKVL 131
Query: 175 VQLALDLARGLSYLHSQK--IVHRDVKTENMLLD-KNRTVKIADFGVARVEASNPNDMTG 231
+ +GL +LH++ I+HRD+K +N+ + +VKI D G+A + +
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFAKA 189
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
GT +MAPE+ Y+ DVY+FG+C+ E+ + PY +
Sbjct: 190 VIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-49
Identities = 81/290 (27%), Positives = 125/290 (43%), Gaps = 51/290 (17%)
Query: 25 NATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VA 77
+ P+ + L WE +L + + RG FG V G D VA
Sbjct: 2 DPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 61
Query: 78 VKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTENG 136
VK+L +EG T +E A E+ + + H NV +GA T+ G
Sbjct: 62 VKML---KEGA-THSE----HRALMSELKILIHIGHHLNVVNLLGAC---------TKPG 104
Query: 137 QVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLA 182
P V+VE+ G L TYL R + L + ++ + +A
Sbjct: 105 G---P---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 158
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMA 240
+G+ +L S+K +HRD+ N+LL + VKI DFG+AR +P+ + L +MA
Sbjct: 159 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 218
Query: 241 PEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVRQVQ 289
PE + Y + DV+SFG+ LWEI+ PYP + E R+++
Sbjct: 219 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLK 265
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 8e-49
Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 49 PSKL---VIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
PS+ + I G++G R DG + K LD+G TEAE L
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG---SMTEAEKQMLV----S 54
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV + +L HPN+ ++ + I N + +V+EY GG L + + K
Sbjct: 55 EVNLLRELKHPNIVRYY-------DRIIDRTNTTL-------YIVMEYCEGGDLASVITK 100
Query: 164 NRRRKLAF--KVVVQLALDLARGLSYLHSQK-----IVHRDVKTENMLLDKNRTVKIADF 216
+ + + V+++ L L H + ++HRD+K N+ LD + VK+ DF
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 217 GVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
G+AR+ + + GT YM+PE +N YN K D++S G L+E+ P+ S
Sbjct: 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220
Query: 277 FSEVTSAVVR 286
E+ +
Sbjct: 221 QKELAGKIRE 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-48
Identities = 82/291 (28%), Positives = 124/291 (42%), Gaps = 52/291 (17%)
Query: 24 ANATATP-IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------- 75
+ + P + S + + WE KL + + G FG V G D
Sbjct: 8 HHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEA 67
Query: 76 --VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132
VAVK+L ++ TE + S E+ + + H N+ +GA
Sbjct: 68 VTVAVKML---KDDA-TEKD----LSDLVSEMEMMKMIGKHKNIINLLGAC--------- 110
Query: 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178
T++G + V+VEY G L+ YL R ++ FK +V
Sbjct: 111 TQDGPL-------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL-- 236
LARG+ YL SQK +HRD+ N+L+ +N +KIADFG+AR + G L
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 237 GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAVVR 286
+MAPE L Y + DV+SFG+ +WEI+ PYP + E+ +
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 81/278 (29%), Positives = 120/278 (43%), Gaps = 51/278 (18%)
Query: 34 ASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWG 84
S + + WE KL + + G FG V G D VAVK+L
Sbjct: 65 VSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--- 121
Query: 85 EEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSN 143
++ TE + S E+ + + H N+ +GA T++G +
Sbjct: 122 KDDA-TEKD----LSDLVSEMEMMKMIGKHKNIINLLGAC---------TQDGPL----- 162
Query: 144 ICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLH 189
V+VEY G L+ YL R ++ FK +V LARG+ YL
Sbjct: 163 --YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220
Query: 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGN 247
SQK +HRD+ N+L+ +N +KIADFG+AR + G L +MAPE L
Sbjct: 221 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 248 PYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSAV 284
Y + DV+SFG+ +WEI+ PYP + E+ +
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-48
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 29/227 (12%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ RG FG V + D + A+K + R +EV KL+HP
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--------REKVMREVKALAKLEHP 63
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF--K 172
+ ++ A + + + + ++ LK + R
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSP----KVYLYIQMQLCRKENLKD-WMNGRCTIEERERS 118
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV----------- 221
V + + L +A + +LHS+ ++HRD+K N+ + VK+ DFG+
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 222 -EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TG+ GT YM+PE ++GN Y+ K D++S G+ L+E+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-48
Identities = 71/273 (26%), Positives = 111/273 (40%), Gaps = 54/273 (19%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE ++L + G FG V G VAVK+L + E
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSA-HLTE--- 69
Query: 97 LRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
R A E+ V L +H N+ +GA T G V+ EY G
Sbjct: 70 -REALMSELKVLSYLGNHMNIVNLLGAC---------TIGGPT-------LVITEYCCYG 112
Query: 156 ALKTYLIKNR----------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
L +L + R L + ++ + +A+G+++L S+ +HRD+
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYS 257
N+LL R KI DFG+AR ++ N + L +MAPE + Y + DV+S
Sbjct: 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 258 FGICLWEIYCC-DMPYPDLSFSEVTSAVVRQVQ 289
+GI LWE++ PYP + V S + ++
Sbjct: 233 YGIFLWELFSLGSSPYPGMP---VDSKFYKMIK 262
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-48
Identities = 64/256 (25%), Positives = 94/256 (36%), Gaps = 38/256 (14%)
Query: 21 AASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAV 78
++ +P S +Q ++ S + G++G V + DG AV
Sbjct: 35 GEASETLQSPGYDPSRPESFFQQSFQRL-------SRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 79 KLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQ 137
K G + A EV K+ HP + A L++QTE
Sbjct: 88 KRSMSPFRGPKDRARK-------LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE--- 137
Query: 138 VAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197
L G +L + L V D L++LHSQ +VH D
Sbjct: 138 --------------LCGPSL-QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYS 257
VK N+ L K+ DFG+ E + G YMAPE+L G Y DV+S
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFS 240
Query: 258 FGICLWEIYCCDMPYP 273
G+ + E+ C+M P
Sbjct: 241 LGLTILEV-ACNMELP 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-48
Identities = 71/265 (26%), Positives = 107/265 (40%), Gaps = 48/265 (18%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE + L + G FG V G VAVK+L + E
Sbjct: 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTA-HADE--- 92
Query: 97 LRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
+ A E+ + L H N+ +GA T G V V+ EY G
Sbjct: 93 -KEALMSELKIMSHLGQHENIVNLLGAC---------THGGPV-------LVITEYCCYG 135
Query: 156 ALKTYLIKNRR------------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
L +L + R + + ++ + +A+G+++L S+ +HRDV N+
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGIC 261
LL KI DFG+AR ++ N + L +MAPE + Y + DV+S+GI
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 262 LWEIYCC-DMPYP-DLSFSEVTSAV 284
LWEI+ PYP L S+ V
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLV 280
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 79/270 (29%), Positives = 118/270 (43%), Gaps = 51/270 (18%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEI 94
WE+ +LV+ + G FG V G D VAVK+L + TE +
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDA-TEKD- 117
Query: 95 AALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
S E+ + + H N+ +GA T++G + V+VEY
Sbjct: 118 ---LSDLISEMEMMKMIGKHKNIINLLGAC---------TQDGPL-------YVIVEYAS 158
Query: 154 GGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
G L+ YL R +L+ K +V A +ARG+ YL S+K +HRD+
Sbjct: 159 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYS 257
N+L+ ++ +KIADFG+AR G L +MAPE L Y + DV+S
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 258 FGICLWEIYCC-DMPYPDLSFSEVTSAVVR 286
FG+ LWEI+ PYP + E+ +
Sbjct: 279 FGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 62/253 (24%), Positives = 114/253 (45%), Gaps = 35/253 (13%)
Query: 41 QRQDWEIEPSKLVI-KSVIARGTFGTVHRGLYDGH----DVAVKLLDWGEEGHRTEAEIA 95
+ + ++ L+I + G FG+V +G+Y DVA+K+L G E
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------K 377
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
A +E + H+LD+P + + IG + +V+E GG
Sbjct: 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----------------LMLVMEMAGGG 420
Query: 156 ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
L +L +R ++ V +L ++ G+ YL + VHR++ N+LL KI+D
Sbjct: 421 PLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD 479
Query: 216 FGVARVEASNPNDMTGETGT---LGYMAPEVLNGNPYNRKCDVYSFGICLWEIY-CCDMP 271
FG+++ ++ + T + L + APE +N ++ + DV+S+G+ +WE P
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 272 YPDLSFSEVTSAV 284
Y + EV + +
Sbjct: 540 YKKMKGPEVMAFI 552
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 58/270 (21%), Positives = 91/270 (33%), Gaps = 64/270 (23%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEG 87
+G S + ++ I G FG+V + + DG A+K G
Sbjct: 2 AMGMKSRYT----TEFHEL-------EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG 50
Query: 88 HRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICC 146
E +EV L H +V ++ A + IQ E
Sbjct: 51 SVDEQNA-------LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE------------ 91
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
Y GG+L + +N R FK + L L + RGL Y+HS +VH D+K N+
Sbjct: 92 ----YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147
Query: 205 LDKN-------------------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN 245
+ + KI D G + E G ++A EVL
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQV-EEGDSRFLANEVLQ 203
Query: 246 GN-PYNRKCDVYSFGICLWEIYCCDMPYPD 274
N + K D+++ + + P P
Sbjct: 204 ENYTHLPKADIFALALTVVCA-AGAEPLPR 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-47
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 21 AASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAV 78
+S + G+ + + Q I+ + + G F V GL+DGH A+
Sbjct: 2 GSSHHHHHHSSGRENLYF--QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYAL 59
Query: 79 KLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQV 138
K + E+ R EA+ +E + +HPN+ + + + E G
Sbjct: 60 KRILCHEQQDREEAQ---------READMHRLFNHPNILRLVA--------YCLRERGA- 101
Query: 139 AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQKIVHR 196
+ +++ + G L + + + + ++ L L + RGL +H++ HR
Sbjct: 102 ---KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR 158
Query: 197 DVKTENMLLDKNRTVKIADFGVARVEASNPN---------DMTGETGTLGYMAPEVLNGN 247
D+K N+LL + D G + D + T+ Y APE+ +
Sbjct: 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218
Query: 248 PY---NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQVQY 290
+ + + DV+S G L+ + + PY + + A+ Q Q
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-46
Identities = 75/265 (28%), Positives = 108/265 (40%), Gaps = 56/265 (21%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLDWGEEGHRTEAEIAA 96
WE L V+ G FG V G VAVK+L +E +E
Sbjct: 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKA-DSSE--- 91
Query: 97 LRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG 155
R A E+ + +L H N+ +GA T +G + ++ EY G
Sbjct: 92 -REALMSELKMMTQLGSHENIVNLLGAC---------TLSGPI-------YLIFEYCCYG 134
Query: 156 ALKTYLIKNR---------------------RRKLAFKVVVQLALDLARGLSYLHSQKIV 194
L YL R L F+ ++ A +A+G+ +L + V
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194
Query: 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRK 252
HRD+ N+L+ + VKI DFG+AR S+ N + L +MAPE L Y K
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 254
Query: 253 CDVYSFGICLWEIYCC-DMPYPDLS 276
DV+S+GI LWEI+ PYP +
Sbjct: 255 SDVWSYGILLWEIFSLGVNPYPGIP 279
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-46
Identities = 55/226 (24%), Positives = 86/226 (38%), Gaps = 40/226 (17%)
Query: 58 IARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ RG+FG VHR G AVK + L +E+ L P
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR--------------LEVFRVEELVACAGLSSPR 111
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ GA ++I +E L GG+L + + L +
Sbjct: 112 IVPLYGAVREGPWVNI----------------FMELLEGGSLGQLI--KQMGCLPEDRAL 153
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTVKIADFGVARVEASNPNDMTGET- 233
GL YLH+++I+H DVK +N+LL + + DFG A + + T
Sbjct: 154 YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 234 ----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ G P + K D++S + + P+
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-45
Identities = 61/245 (24%), Positives = 115/245 (46%), Gaps = 33/245 (13%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAA 96
+ +++ E + + V+ +GT+G V+ G + +A+K + R
Sbjct: 11 ESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-----ERDSRYSQP 65
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
L +E+A+ L H N+ +++G+ + + I +E +PGG+
Sbjct: 66 LH----EEIALHKHLKHKNIVQYLGSFSENGFIKI----------------FMEQVPGGS 105
Query: 157 LKTYLIKNRRRKLAFK--VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKI 213
L L++++ L + + GL YLH +IVHRD+K +N+L++ + +KI
Sbjct: 106 LSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKI 164
Query: 214 ADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMP 271
+DFG ++ A TGTL YMAPE+++ P Y + D++S G + E+ P
Sbjct: 165 SDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
Query: 272 YPDLS 276
+ +L
Sbjct: 225 FYELG 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 63/256 (24%), Positives = 112/256 (43%), Gaps = 36/256 (14%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
Q W+ L I RG +G+V++ ++ G +AVK + + E E L
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLL-- 68
Query: 101 FTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
++ V + D P + +F GA + I +E + K
Sbjct: 69 --MDLDVVMRSSDCPYIVQFYGALFREGDCWI----------------CMELMSTSFDKF 110
Query: 160 YLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADF 216
Y +++ ++ L + L++L KI+HRD+K N+LLD++ +K+ DF
Sbjct: 111 YKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
Query: 217 GVARVEASNPNDMTGETGTLGYMAPEVLNGN----PYNRKCDVYSFGICLWEIYCCDMPY 272
G++ + + T + G YMAPE ++ + Y+ + DV+S GI L+E+ PY
Sbjct: 171 GISG-QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
Query: 273 PDL-SFSEVTSAVVRQ 287
P S + + VV+
Sbjct: 230 PKWNSVFDQLTQVVKG 245
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 67/264 (25%), Positives = 120/264 (45%), Gaps = 33/264 (12%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEG 87
+ FL ++++ E++ S + G G V + + G +A KL+
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----L 68
Query: 88 HRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
A + +E+ V H+ + P + F GA E+ I
Sbjct: 69 EIKPAIRNQII----RELQVLHECNSPYIVGFYGAFYSDGEISI---------------- 108
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLD 206
+E++ GG+L L K R + +++ ++++ + +GL+YL + KI+HRDVK N+L++
Sbjct: 109 CMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 166
Query: 207 KNRTVKIADFGVA-RVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+K+ DFGV+ ++ S N G T YM+PE L G Y+ + D++S G+ L E+
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMANSFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 266 YCCDMPYPDLSFSEVTSAVVRQVQ 289
P P E+ QV+
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVE 247
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-42
Identities = 70/235 (29%), Positives = 101/235 (42%), Gaps = 53/235 (22%)
Query: 48 EPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDW-----GEEGHRTEAEIAALRSAFT 102
E V + + G FG V++G + VAVK L EE + + F
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQ---Q-------FD 78
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV-------VVEYLPGG 155
QE+ V K H N+ + +G V Y+P G
Sbjct: 79 QEIKVMAKCQHENLVELLG-----------------------FSSDGDDLCLVYVYMPNG 115
Query: 156 ALKTYL-IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
+L L + L++ + ++A A G+++LH +HRD+K+ N+LLD+ T KI+
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKIS 175
Query: 215 DFGVARVEASNPNDMTGET----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
DFG+AR T T GT YMAPE L G K D+YSFG+ L EI
Sbjct: 176 DFGLARASEK--FAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEI 227
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-41
Identities = 57/253 (22%), Positives = 105/253 (41%), Gaps = 36/253 (14%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHR 89
GK + +L Q ++ E + L + GT G V + + GH +AVK +
Sbjct: 7 GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--- 63
Query: 90 TEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVV 148
+ E + ++ V K D P + + G + ++++ I
Sbjct: 64 -KEENKRIL----MDLDVVLKSHDCPYIVQCFGTFITNTDVFI----------------A 102
Query: 149 VEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDK 207
+E + A K + +++ ++ + + + L YL + ++HRDVK N+LLD+
Sbjct: 103 MELMGTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICL 262
+K+ DFG++ + G YMAPE + Y+ + DV+S GI L
Sbjct: 161 RGQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219
Query: 263 WEIYCCDMPYPDL 275
E+ PY +
Sbjct: 220 VELATGQFPYKNC 232
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 67/264 (25%), Positives = 102/264 (38%), Gaps = 36/264 (13%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHR 89
G++ + + WE+ K + G FG V R G VA+K
Sbjct: 3 GRSPSLPTQTCGPWEM-------KERLGTGGFGYVLRWIHQDTGEQVAIKQCR------- 48
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
+ R + E+ + KL+HPNV + Q P+++ + +
Sbjct: 49 -QELSPKNRERWCLEIQIMKKLNHPNVVS----------AREVPDGLQKLAPNDLPLLAM 97
Query: 150 EYLPGGALKTYLIKNRRR-KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
EY GG L+ YL + L + L D++ L YLH +I+HRD+K EN++L
Sbjct: 98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG 157
Query: 209 R---TVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
KI D G A+ GTL Y+APE+L Y D +SFG +
Sbjct: 158 PQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQ 287
E P+ VR+
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVRE 238
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 51/228 (22%)
Query: 55 KSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
K+++ RG FG V++G L DG VAVK L E E + F EV + H
Sbjct: 35 KNILGRGGFGKVYKGRLADGTLVAVKRLK-EERTQGGELQ-------FQTEVEMISMAVH 86
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCV-------VVEYLPGGALKTYL--IKN 164
N+ + G C+ V Y+ G++ + L
Sbjct: 87 RNLLRLRG-----------------------FCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQ---KIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ L + ++AL ARGL+YLH KI+HRDVK N+LLD+ + DFG+A++
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 222 EASNPNDMTGET----GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
T T GT+G++APE L+ + K DV+ +G+ L E+
Sbjct: 184 ---MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 68/230 (29%), Positives = 102/230 (44%), Gaps = 54/230 (23%)
Query: 55 KSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
K +I G FG V++G L DG VA+K E + E F E+ H
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEE-------FETEIETLSFCRH 94
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCV-------VVEYLPGGALKTYL--IKN 164
P++ IG C + +Y+ G LK +L
Sbjct: 95 PHLVSLIG-----------------------FCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
++++ +++ + ARGL YLH++ I+HRDVK+ N+LLD+N KI DFG+++
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK---K 188
Query: 225 NPNDMTGET-------GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+T GTLGY+ PE K DVYSFG+ L+E+ C
Sbjct: 189 GTEL--DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 57/252 (22%), Positives = 105/252 (41%), Gaps = 35/252 (13%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
E++ L + RG +G V + + G +AVK + E L
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN----SQEQKRLL----M 54
Query: 104 EVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY-L 161
++ + + D P F GA ++ I +E + K Y
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWI----------------CMELMDTSLDKFYKQ 98
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ ++ + + ++ ++A+ + + L +LHS+ ++HRDVK N+L++ VK+ DFG++
Sbjct: 99 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158
Query: 221 VEASNPNDMTGETGTLGYMAPEV----LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL- 275
+ + G YMAPE LN Y+ K D++S GI + E+ PY
Sbjct: 159 -YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217
Query: 276 SFSEVTSAVVRQ 287
+ + VV +
Sbjct: 218 TPFQQLKQVVEE 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 47/254 (18%), Positives = 91/254 (35%), Gaps = 44/254 (17%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAV 107
++ ++ +G V RG G A+K+ + + E L+
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK--------- 62
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RR 166
KL+H N+ K + + +++E+ P G+L T L +
Sbjct: 63 --KLNHKNIVKLFAI--------EEETT------TRHKVLIMEFCPCGSLYTVLEEPSNA 106
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVE 222
L + + D+ G+++L IVHR++K N++ D K+ DFG AR
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGN--------PYNRKCDVYSFGICLWEIYCCDMPYPD 274
+ GT Y+ P++ Y D++S G+ + +P+
Sbjct: 167 EDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
Query: 275 LSFSEVTSAVVRQV 288
V+ ++
Sbjct: 226 FEGPRRNKEVMYKI 239
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 40/246 (16%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
W I ++ VI G V VA+K ++ + + + L
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTSMDELL---- 61
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E+ + HPN+ + + + EL + V++ L GG++ +I
Sbjct: 62 KEIQAMSQCHHPNIVSYYTSFVVKDELWL----------------VMKLLSGGSV-LDII 104
Query: 163 KNRRRKLAFKVVV----QLAL---DLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
K+ K K V +A ++ GL YLH +HRDVK N+LL ++ +V+IAD
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164
Query: 216 FGVARVEASNPNDMTGET-----GTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCD 269
FGV+ A+ + + GT +MAPEV+ Y+ K D++SFGI E+
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 270 MPYPDL 275
PY
Sbjct: 225 APYHKY 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 59/238 (24%), Positives = 91/238 (38%), Gaps = 28/238 (11%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHR 89
G L D E + VI +G F V R G AVK++D +
Sbjct: 7 GGGGGILDMADDDVLFE-DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65
Query: 90 TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
L+ +E ++ H L HP++ + + L++ V
Sbjct: 66 PGLSTEDLK----REASICHMLKHPHIVELLETYSSDGMLYM----------------VF 105
Query: 150 EYLPGGALKTYLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-- 205
E++ G L ++K + V + L Y H I+HRDVK +LL
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLAS 165
Query: 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+ + VK+ FGVA + G GT +MAPEV+ PY + DV+ G+ L
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 53/268 (19%), Positives = 96/268 (35%), Gaps = 66/268 (24%)
Query: 57 VIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ RG FG V + D + A+K + E +EV KL+HP
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK--------VMREVKALAKLEHP 64
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNIC----------------------------- 145
+ ++ A + + Q E ++ +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 146 ------------CVVVEYLPGGALKTYLIKNRRRKLAF--KVVVQLALDLARGLSYLHSQ 191
+ ++ LK + R V + + + +A + +LHS+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV------------EASNPNDMTGETGTLGYM 239
++HRD+K N+ + VK+ DFG+ TG+ GT YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 240 APEVLNGNPYNRKCDVYSFGICLWEIYC 267
+PE ++GN Y+ K D++S G+ L+E+
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLY 271
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-40
Identities = 72/239 (30%), Positives = 119/239 (49%), Gaps = 36/239 (15%)
Query: 43 QDWEIEPSKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRS 99
Q+ + +P +L I +G+FG V +G+ VA+K++D EE +I
Sbjct: 14 QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-EEAEDEIEDI----- 67
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
QE+ V + D P VTK+ G+ + ++L I ++EYL GG+
Sbjct: 68 --QQEITVLSQCDSPYVTKYYGSYLKDTKLWI----------------IMEYLGGGSALD 109
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
L++ L + + ++ +GL YLHS+K +HRD+K N+LL ++ VK+ADFGVA
Sbjct: 110 -LLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 220 RVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ GT +MAPEV+ + Y+ K D++S GI E+ + P+ +L
Sbjct: 167 ---GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 48/254 (18%), Positives = 96/254 (37%), Gaps = 36/254 (14%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRT 90
N + + E + +VI +G TV+ Y G V V+ ++ +
Sbjct: 10 ENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---S 66
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ L+ E+ V +HPN+ + + +EL + V
Sbjct: 67 NEMVTFLQ----GELHVSKLFNHPNIVPYRATFIADNELWV----------------VTS 106
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
++ G+ K + + + + + + + L Y+H VHR VK ++L+ +
Sbjct: 107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 166
Query: 211 VKIADFGVA-------RVEASNPNDMTGETGTLGYMAPEVL--NGNPYNRKCDVYSFGIC 261
V ++ + + + L +++PEVL N Y+ K D+YS GI
Sbjct: 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226
Query: 262 LWEIYCCDMPYPDL 275
E+ +P+ D+
Sbjct: 227 ACELANGHVPFKDM 240
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 47/253 (18%), Positives = 90/253 (35%), Gaps = 44/253 (17%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVW 108
+ ++ +G V RG G A+K+ + + E L+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK---------- 62
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RRR 167
KL+H N+ K + + +++E+ P G+L T L +
Sbjct: 63 -KLNHKNIVKLFAI--------EEETT------TRHKVLIMEFCPCGSLYTVLEEPSNAY 107
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEA 223
L + + D+ G+++L IVHR++K N++ D K+ DFG AR
Sbjct: 108 GLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 224 SNPNDMTGETGTLGYMAPEVLNGN--------PYNRKCDVYSFGICLWEIYCCDMPYPDL 275
+ GT Y+ P++ Y D++S G+ + +P+
Sbjct: 168 DD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 276 SFSEVTSAVVRQV 288
V+ ++
Sbjct: 227 EGPRRNKEVMYKI 239
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 39/272 (14%)
Query: 24 ANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLL 81
A + + Q E+ +L ++ V+A G F V+ + + G + A+K L
Sbjct: 2 AGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL 61
Query: 82 DWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAM 140
EE QEV KL HPN+ +F A E T +
Sbjct: 62 LSNEEEKNRAII---------QEVCFMKKLSGHPNIVQFCSAASIGKE-ESDTGQAEF-- 109
Query: 141 PSNICCVVVEYLPGGALKTYLIKNRRR-KLAFKVVVQLALDLARGLSYLHSQK--IVHRD 197
+++ L G L +L K R L+ V+++ R + ++H QK I+HRD
Sbjct: 110 ------LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASNPN------------DMTGETGTLGYMAPEVLN 245
+K EN+LL T+K+ DFG A + P+ + T Y PE+++
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 246 ---GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
P K D+++ G L+ + P+ D
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-39
Identities = 47/248 (18%), Positives = 94/248 (37%), Gaps = 41/248 (16%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLD--------WGEEGHRT 90
+ +D I +++ + +G F + D A+K + + +
Sbjct: 22 YVKEKDKYINDYRII--RTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ I + F E+ + + + G I + ++ E
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEG--------IITN-------YDEVY-IIYE 123
Query: 151 YLPGGALKTYLIKNRR------RKLAFKVVVQLALDLARGLSYLHSQK-IVHRDVKTENM 203
Y+ ++ + + +V+ + + SY+H++K I HRDVK N+
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183
Query: 204 LLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP--YNRKCDVYSFG 259
L+DKN VK++DFG + + + GT +M PE + K D++S G
Sbjct: 184 LMDKNGRVKLSDFGES---EYMVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 260 ICLWEIYC 267
ICL+ ++
Sbjct: 240 ICLYVMFY 247
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 7e-39
Identities = 48/239 (20%), Positives = 90/239 (37%), Gaps = 43/239 (17%)
Query: 54 IKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
I I G V + L + A+K ++ EA+ L S + E+A +KL
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDS-YRNEIAYLNKLQ 84
Query: 113 HPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ + + + T+ I +V+E L ++L K ++ +
Sbjct: 85 QHSDKIIRLYD--------YEITDQ-------YIY-MVMEC-GNIDLNSWLKK--KKSID 125
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++ + +H IVH D+K N L+ +K+ DFG+A + +
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVV 184
Query: 231 GET--GTLGYMAPEVLNGNP-----------YNRKCDVYSFGICLWEIYCCDMPYPDLS 276
++ GT+ YM PE + + K DV+S G L+ + P+ +
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 7e-39
Identities = 37/278 (13%), Positives = 81/278 (29%), Gaps = 31/278 (11%)
Query: 17 TTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGH 74
A + AT P + Q KL + + G V +
Sbjct: 33 PAAMVEAVTATVWPQNAETTVDSLLSQ----GERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 75 DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTE 134
D A+K+ G E R+E E + +L + +
Sbjct: 89 DFALKVFTMGAENSRSELE------RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 135 NGQVAM---------PSNICCVVVEYLPGGALKTYL-----IKNRRRKLAFKVVVQLALD 180
Q + +++ L+ + R + L
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 181 LARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMA 240
L R + L S+ +VH +N+ + + + + D + + + Y
Sbjct: 203 LIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS---SVPVTYAP 259
Query: 241 PEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
E LN + + + + G+ ++ ++C +P+ ++
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-39
Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 36/223 (16%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G++G+V++ ++ G VA+K + + EI +E+++ + D P+
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEI-------IKEISIMQQCDSPH 85
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
V K+ G+ +++L I V+EY G++ + +I+ R + L +
Sbjct: 86 VVKYYGSYFKNTDLWI----------------VMEYCGAGSV-SDIIRLRNKTLTEDEIA 128
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-- 233
+ +GL YLH + +HRD+K N+LL+ K+ADFGVA + M
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTMAKRNTV 185
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ YN D++S GI E+ PY D+
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 47 IEPSKLVIKSVIARGTFGT-VHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
+ K V+ G GT V+RG++D DVAVK + S +EV
Sbjct: 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL------------PECFSFADREV 68
Query: 106 AVWHKLD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ + D HPNV ++ +I +E L+ Y ++
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYI----------------AIELC-AATLQEY-VEQ 110
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVA 219
+ + L GL++LHS IVHRD+K N+L+ I+DFG+
Sbjct: 111 KDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 220 RV---EASNPNDMTGETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWEIYC 267
+ + + +G GT G++APE+L+ + D++S G + +
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 39/251 (15%), Positives = 85/251 (33%), Gaps = 48/251 (19%)
Query: 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEA 92
K + ++++ + + ++ G F V+ + +K+ + E
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEF 111
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYL 152
I TQ + KF A +NG +V E
Sbjct: 112 YI------GTQLMERLKPSMQHMFMKFYSA--------HLFQNG--------SVLVGELY 149
Query: 153 PGGALKTYLIKNRR---RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---- 205
G L + + + + +V+ A+ + + +H +I+H D+K +N +L
Sbjct: 150 SYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209
Query: 206 -------DKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVY 256
D + + + D G + P T + T G+ E+L+ P+N + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 257 SFGICLWEIYC 267
++ +
Sbjct: 270 GVAATVYCMLF 280
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 48/258 (18%), Positives = 95/258 (36%), Gaps = 50/258 (19%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAE 93
+ + + + + I I G V + L + A+K ++ EA+
Sbjct: 1 NECISVKGRIYSI-------LKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEAD 47
Query: 94 IAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEY 151
L S + E+A +KL + + + + T+ I +V+E
Sbjct: 48 NQTLDS-YRNEIAYLNKLQQHSDKIIRLYD--------YEITDQ-------YIY-MVMEC 90
Query: 152 LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211
L ++L K ++ + ++ + +H IVH D+K N L+ +
Sbjct: 91 -GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-L 146
Query: 212 KIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP-----------YNRKCDVYSF 258
K+ DFG+A + + ++ GT+ YM PE + + K DV+S
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 259 GICLWEIYCCDMPYPDLS 276
G L+ + P+ +
Sbjct: 207 GCILYYMTYGKTPFQQII 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 60/266 (22%), Positives = 103/266 (38%), Gaps = 36/266 (13%)
Query: 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLD----WGE 85
+++K+ + G +G V + A+K++
Sbjct: 21 INPGMYVRKKEGKIG---ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 86 EGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNIC 145
I E+++ LDHPN+ K ++
Sbjct: 78 RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL-------------- 123
Query: 146 CVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203
V E+ GG L +I + A ++ Q+ G+ YLH IVHRD+K EN+
Sbjct: 124 --VTEFYEGGELFEQIINRHKFDECDAANIMKQIL----SGICYLHKHNIVHRDIKPENI 177
Query: 204 LL---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
LL + +KI DFG++ + + + GT Y+APEVL YN KCDV+S G+
Sbjct: 178 LLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGV 235
Query: 261 CLWEIYCCDMPYPDLSFSEVTSAVVR 286
++ + C P+ + ++ V +
Sbjct: 236 IMYILLCGYPPFGGQNDQDIIKKVEK 261
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-38
Identities = 71/284 (25%), Positives = 112/284 (39%), Gaps = 37/284 (13%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEI---EPSKL-VIKS 56
M + D +I T P G + LK +P KL
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G+FG V+ + VA+K + + + + + +EV KL HP
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD------IIKEVRFLQKLRHP 114
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N ++ G + + V+EY G A L++ ++ L +
Sbjct: 115 NTIQYRGCYLREHTAWL----------------VMEYCLGSASD--LLEVHKKPLQEVEI 156
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
+ +GL+YLHS ++HRDVK N+LL + VK+ DFG A + N G
Sbjct: 157 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANSF---VG 212
Query: 235 TLGYMAPEV---LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
T +MAPEV ++ Y+ K DV+S GI E+ P ++
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-38
Identities = 43/265 (16%), Positives = 87/265 (32%), Gaps = 31/265 (11%)
Query: 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAE--------IAAL 97
P LV +V+ + G V + + E + + L
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 98 RSAFTQEVAVWHK--------LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVV 149
R Q+ A H + P K I + ++ + + P +
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR--FFLYPRMQSNL-- 191
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
G L ++ ++ L +QL L + R L+ LH +VH ++ +++LD+
Sbjct: 192 -QTFGEVLLSHSSTHKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248
Query: 210 TVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNP-----YNRKCDVYSFGICLW 263
V + F + ++ G A +L D ++ G+ ++
Sbjct: 249 GVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308
Query: 264 EIYCCDMPYPDLSFSEVTSAVVRQV 288
I+C D+P D + + + R
Sbjct: 309 WIWCADLPNTDDAALGGSEWIFRSC 333
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-38
Identities = 64/254 (25%), Positives = 116/254 (45%), Gaps = 44/254 (17%)
Query: 38 LKKQRQDWEIE----PSKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRT 90
++K R+ + P+++ I + G FG V++ G A K+++ E
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE 61
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ + E+ + DHP + K +GA +L I ++E
Sbjct: 62 D---------YIVEIEILATCDHPYIVKLLGAYYHDGKLWI----------------MIE 96
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
+ PGGA+ ++ R L + + + L++LHS++I+HRD+K N+L+
Sbjct: 97 FCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD 155
Query: 211 VKIADFGVARVEASNPNDMTGET---GTLGYMAPEV-----LNGNPYNRKCDVYSFGICL 262
+++ADFGV+ A N + GT +MAPEV + PY+ K D++S GI L
Sbjct: 156 IRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 212
Query: 263 WEIYCCDMPYPDLS 276
E+ + P+ +L+
Sbjct: 213 IEMAQIEPPHHELN 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-38
Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 39/261 (14%)
Query: 33 KASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRT 90
F+ ++ + G +G V + A+K++ + +
Sbjct: 23 TPGMFITSKKGHLS---EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR---KTSVS 76
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+ + L +EVAV LDHPN+ K ++ V+E
Sbjct: 77 TSSNSKLL----EEVAVLKLLDHPNIMKLYDFFEDKRNYYL----------------VME 116
Query: 151 YLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--- 205
GG L +I + A ++ Q+ G++YLH IVHRD+K EN+LL
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVL----SGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
+K+ +KI DFG++ V + M GT Y+APEVL Y+ KCDV+S G+ L+ +
Sbjct: 173 EKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFIL 230
Query: 266 YCCDMPYPDLSFSEVTSAVVR 286
P+ + E+ V +
Sbjct: 231 LAGYPPFGGQTDQEILRKVEK 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-38
Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
+++ W +E I + +G FG V+ R +A+K+L + + E A +
Sbjct: 2 KKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF------KAQLEKAGVE 53
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
+EV + L HPN+ + G + + +++EY P G +
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYG--------YFHDAT-------RVY-LILEYAPLGTVY 97
Query: 159 TYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADF 216
L K + + + +LA LSY HS++++HRD+K EN+LL +KIADF
Sbjct: 98 RELQKLSKFDEQRTATYITELAN----ALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 217 GVARVEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
G + P+ + GTL Y+ PE++ G ++ K D++S G+ +E P+
Sbjct: 154 GWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
Query: 276 SFSE 279
++ E
Sbjct: 211 TYQE 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 47/288 (16%), Positives = 99/288 (34%), Gaps = 50/288 (17%)
Query: 5 KKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFG 64
K+ + + + A+ + + + + I I G
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI-------LKQIGSGGSS 70
Query: 65 TVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIG 121
V + L + A+K ++ EA+ L S + E+A +KL + + +
Sbjct: 71 KVFQVLNEKKQIYAIKYVN------LEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLYD 123
Query: 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDL 181
+ +++ V+E L ++L K ++ + ++
Sbjct: 124 YEITDQYIYM----------------VMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNM 164
Query: 182 ARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYM 239
+ +H IVH D+K N L+ +K+ DFG+A + + ++ G + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 240 APEVLNGNP-----------YNRKCDVYSFGICLWEIYCCDMPYPDLS 276
PE + + K DV+S G L+ + P+ +
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 38/259 (14%)
Query: 35 SNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEA 92
F++ + + + V+ +G+FG V G + AVK++ + + +
Sbjct: 14 GMFVQHSTAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKT 68
Query: 93 EIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYL 152
+ +L +EV + +LDHPN+ K ++ V E
Sbjct: 69 DKESLL----REVQLLKQLDHPNIMKLYEFFEDKGYFYL----------------VGEVY 108
Query: 153 PGGALKTYLIKNRRR--KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DK 207
GG L +I +R A +++ Q+ G++Y+H KIVHRD+K EN+LL K
Sbjct: 109 TGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNKIVHRDLKPENLLLESKSK 164
Query: 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+ ++I DFG++ ++ M + GT Y+APEVL+G Y+ KCDV+S G+ L+ +
Sbjct: 165 DANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLS 222
Query: 268 CDMPYPDLSFSEVTSAVVR 286
P+ + ++ V +
Sbjct: 223 GCPPFNGANEYDILKKVEK 241
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 63/258 (24%), Positives = 100/258 (38%), Gaps = 47/258 (18%)
Query: 26 ATATPIGKASNFLKKQRQDWEIEPSKL----VIKSVIARGTFGTVHRGLY--DGHDVAVK 79
A + K F D + P L ++ + G G V VA++
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR 166
Query: 80 LLD---WGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENG 136
++ + R + E+ + KL+HP + K E+
Sbjct: 167 IISKRKFAIGSAREADPALNVE----TEIEILKKLNHPCIIKIKNF--------FDAED- 213
Query: 137 QVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIV 194
+V+E + GG L ++ N+R Q+ L + YLH I+
Sbjct: 214 --------YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLHENGII 261
Query: 195 HRDVKTENMLL---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN---P 248
HRD+K EN+LL +++ +KI DFG +++ + M GT Y+APEVL
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAG 320
Query: 249 YNRKCDVYSFG----ICL 262
YNR D +S G ICL
Sbjct: 321 YNRAVDCWSLGVILFICL 338
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
K ++ RG V R ++ + AVK++D G + E+ LR A +EV + K+
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 112 D-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RK 168
HPN+ + ++ + V + + G L YL + K
Sbjct: 81 SGHPNIIQLKDTYETNTFFFL----------------VFDLMKKGELFDYLTEKVTLSEK 124
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
K++ L + LH IVHRD+K EN+LLD + +K+ DFG +
Sbjct: 125 ETRKIMRALL----EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EK 179
Query: 229 MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFG----ICL 262
+ GT Y+APE++ + Y ++ D++S G L
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 34/246 (13%)
Query: 22 ASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVK 79
++ +G+ S F+ + +K + +G F V R ++ G + A K
Sbjct: 4 MASMTGGQQMGRGSEFMMNASTKFS---DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 80 LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVA 139
+++ + + L +E + KL HPN+ + + S ++
Sbjct: 61 IIN---TKKLSARDFQKLE----REARICRKLQHPNIVRLHDSIQEESFHYL-------- 105
Query: 140 MPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
V + + GG L ++ R + + ++Y HS IVHR++K
Sbjct: 106 --------VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 200 TENMLL---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVY 256
EN+LL K VK+ADFG+A +E ++ G GT GY++PEVL +PY++ D++
Sbjct: 156 PENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIW 214
Query: 257 SFGICL 262
+ G+ L
Sbjct: 215 ACGVIL 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G GTV+ + G +VA++ ++ ++ + E I E+ V + +PN
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII--------NEILVMRENKNPN 78
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
+ ++ + + EL + V+EYL GG+L + + + V
Sbjct: 79 IVNYLDSYLVGDELWV----------------VMEYLAGGSLTDVVTETCMDEGQIAAVC 122
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-- 233
+ L + L +LHS +++HRD+K++N+LL + +VK+ DFG A + + +
Sbjct: 123 RECL---QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITPEQSKRSTM 176
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
GT +MAPEV+ Y K D++S GI E+ + PY + +
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-37
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
V+ G F V G A+K + + E E+AV K+
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---------NEIAVLKKI 63
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
H N+ ++ ++ V++ + GG L +++ K
Sbjct: 64 KHENIVTLEDIYESTTHYYL----------------VMQLVSGGELFDRILERGVYTEKD 107
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A V+ Q+ + YLH IVHRD+K EN+L ++N + I DFG++++E
Sbjct: 108 ASLVIQQVL----SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QN 161
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
M+ GT GY+APEVL PY++ D +S G+
Sbjct: 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-37
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+K + +G F V R + G + A K+++ + + L +E + KL
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIIN---TKKLSARDFQKLE----REARICRKL 62
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ + + S ++ V + + GG L ++ R +
Sbjct: 63 QHPNIVRLHDSIQEESFHYL----------------VFDLVTGGELFEDIVA--REFYSE 104
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPND 228
+ ++Y HS IVHR++K EN+LL K VK+ADFG+A +
Sbjct: 105 ADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA 163
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFG----ICL 262
G GT GY++PEVL +PY++ D+++ G I L
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-37
Identities = 58/246 (23%), Positives = 109/246 (44%), Gaps = 36/246 (14%)
Query: 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAA 96
+ ++ + I+ I + +G FG V+ R + +A+K+L +++ E
Sbjct: 5 EMPKRKFTID--DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF------KSQLEKEG 56
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
+ +E+ + L HPN+ + + I +++E+ P G
Sbjct: 57 VEHQLRREIEIQSHLRHPNILRMYN--------YFHDR-------KRIY-LMLEFAPRGE 100
Query: 157 LKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
L L K+ R + + + +LA L Y H +K++HRD+K EN+L+ +KIA
Sbjct: 101 LYKELQKHGRFDEQRSATFMEELAD----ALHYCHERKVIHRDIKPENLLMGYKGELKIA 156
Query: 215 DFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273
DFG + P+ GTL Y+ PE++ G ++ K D++ G+ +E P+
Sbjct: 157 DFGWS---VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213
Query: 274 DLSFSE 279
S +E
Sbjct: 214 SPSHTE 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-37
Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 60 RGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
+G+F V+ ++ G +VA+K++D + A + EV + +L HP++
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMID------KKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR---KLAFKVV 174
+ + + N + +V+E G + YL + A +
Sbjct: 75 ELYN--------YFEDSN-------YVY-LVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET- 233
Q+ G+ YLHS I+HRD+ N+LL +N +KIADFG+A + P++ T
Sbjct: 119 HQII----TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKH-YTL 172
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
GT Y++PE+ + + + DV+S G + +
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-37
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 58 IARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I G+ G V G VAVK++D ++ R EV + H N
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---------LFNEVVIMRDYQHFN 103
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVV 175
V + + + EL + ++E+L GGAL + + R + V
Sbjct: 104 VVEMYKSYLVGEELWV----------------LMEFLQGGALTDIVSQVRLNEEQIATVC 147
Query: 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-- 233
+ L + L+YLH+Q ++HRD+K++++LL + VK++DFG A D+
Sbjct: 148 EAVL---QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSL 201
Query: 234 -GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
GT +MAPEV++ + Y + D++S GI + E+ + PY S
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 62/240 (25%), Positives = 94/240 (39%), Gaps = 48/240 (20%)
Query: 53 VIKSVIARGTFGTVH--RGLYDGHDVAVKLLD--------------WGEEGHRTEAEIAA 96
+K I +G++G V D A+K+L
Sbjct: 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 97 LRSAFTQ---EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
R Q E+A+ KLDHPNV K + +E H+ +V E +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL--------------YMVFELVN 121
Query: 154 GGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
G + A L G+ YLH QKI+HRD+K N+L+ ++ +K
Sbjct: 122 QGPVMEVPTLKPLSEDQARFYFQDLIK----GIEYLHYQKIIHRDIKPSNLLVGEDGHIK 177
Query: 213 IADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGN--PYN-RKCDVYSFGICLWEIYC 267
IADFGV+ +D GT +MAPE L+ ++ + DV++ G+ L YC
Sbjct: 178 IADFGVSNE--FKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL---YC 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 37/262 (14%), Positives = 79/262 (30%), Gaps = 28/262 (10%)
Query: 48 EPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEG-----HRTEAEIAALRSA 100
P LV +V+ + G V + + E + + E+ LR
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL- 129
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
H + + + + L+T+
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 161 L-----IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIAD 215
+ + L +QL L + R L+ LH +VH ++ +++LD+ V +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVL-----------NGNPYNRKCDVYSFGICLWE 264
F + + + G+ PE+ D ++ G+ ++
Sbjct: 250 FEHLVRD----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 265 IYCCDMPYPDLSFSEVTSAVVR 286
I+C D+P + + + R
Sbjct: 306 IWCADLPITKDAALGGSEWIFR 327
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-36
Identities = 70/240 (29%), Positives = 113/240 (47%), Gaps = 36/240 (15%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I ++ +G+FG V + + AVK+++ + + + + +EV + KL
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTIL----REVELLKKL 78
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
DHPN+ K SS +I V E GG L +IK +R
Sbjct: 79 DHPNIMKLFEILEDSSSFYI----------------VGELYTGGELFDEIIKRKRFSEHD 122
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A +++ Q+ G++Y+H IVHRD+K EN+LL +K+ +KI DFG++ N
Sbjct: 123 AARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
M GT Y+APEVL G Y+ KCDV+S G+ L+ + P+ + ++ V
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 61/236 (25%), Positives = 110/236 (46%), Gaps = 29/236 (12%)
Query: 49 PSKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
P+ + + ++ GT+G V++G + G A+K++D + E EI QE+
Sbjct: 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIK-------QEI 71
Query: 106 AVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+ K H N+ + GA + + + + +V+E+ G++ +
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQ----------LWLVMEFCGAGSVTDLIKNT 121
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ L + + + ++ RGLS+LH K++HRD+K +N+LL +N VK+ DFGV+
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 225 NPNDMTGETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275
GT +MAPEV+ Y+ K D++S GI E+ P D+
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-36
Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 30/214 (14%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + +G F V R + G + A +++ + + L +E + L
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIIN---TKKLSARDHQKLE----REARICRLL 67
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ + + ++ + + + GG L ++ R +
Sbjct: 68 KHPNIVRLHDSISEEGHHYL----------------IFDLVTGGELFEDIVA--REYYSE 109
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPND 228
+ + + H +VHR++K EN+LL K VK+ADFG+A
Sbjct: 110 ADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
G GT GY++PEVL +PY + D+++ G+ L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 54/241 (22%), Positives = 92/241 (38%), Gaps = 36/241 (14%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+K I +G++G V A+K+++ + ++ ++ EV + KL
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK----TEVRLMKKL 85
Query: 112 DHPNVTKFIGATMGSSELHIQTE----------------------NGQVAMPSNICCVVV 149
HPN+ + + + E V C
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DK 207
++ K++ + + L YLH+Q I HRD+K EN L +K
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 208 NRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGIC 261
+ +K+ DFG+++ N MT + GT ++APEVLN Y KCD +S G+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 262 L 262
L
Sbjct: 266 L 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-35
Identities = 55/246 (22%), Positives = 100/246 (40%), Gaps = 60/246 (24%)
Query: 53 VIKSVIARGTFGTV-HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
V + ++ G+ GTV +G + G VAVK + +IA E+ + +
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIA------LMEIKLLTES 65
Query: 112 D-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-----R 165
D HPNV ++ + L+I +E L+ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYI----------------ALELC-NLNLQDLVESKNVSDEN 108
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-------------KNRTVK 212
+ + L +A G+++LHS KI+HRD+K +N+L+ +N +
Sbjct: 109 LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 213 IADFGVARV----EASNPNDMTGETGTLGYMAPEVLNGN-------PYNRKCDVYSFGIC 261
I+DFG+ + ++S ++ +GT G+ APE+L + R D++S G
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 262 LWEIYC 267
+ I
Sbjct: 229 FYYILS 234
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 55/225 (24%), Positives = 84/225 (37%), Gaps = 49/225 (21%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLL--DWGEEGH-----RTEAEIAALRSAFTQ 103
++ ++ RG G V+ D VA+KL+ + + EA A
Sbjct: 38 LRRLVGRGGMGDVYEA-EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG------- 89
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQ-TENGQ--VAMPSNICCVVVEYLPGGALKTY 160
+L P+V +H +GQ V M + G L
Sbjct: 90 ------RLQEPHVV----------PIHDFGEIDGQLYVDM---------RLINGVDLAAM 124
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L R+ LA V + + L H+ HRDVK EN+L+ + + DFG+A
Sbjct: 125 L--RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS 182
Query: 221 VEASNPNDMTGET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
G T GTL YMAPE + + + D+Y+ L+E
Sbjct: 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYE 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ K + G FG VH G + +K ++ R++ + + E+ V
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTIN----KDRSQVPMEQIE----AEIEVLKS 76
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
LDHPN+ K ++I V+E GG L ++ + R A
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYI----------------VMETCEGGELLERIVSAQARGKA 120
Query: 171 F--KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASN 225
V +L + L+Y HSQ +VH+D+K EN+L + +KI DFG+A + S+
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
T GT YMAPEV + KCD++S G+ +
Sbjct: 181 -EHSTNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVM 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-35
Identities = 62/235 (26%), Positives = 95/235 (40%), Gaps = 53/235 (22%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G +G V VAVK++D + + EI + L+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----------LN 63
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H NV KF G H + + + +EY GG L + +
Sbjct: 64 HENVVKFYG--------HRRE-------GNIQY-LFLEYCSGGELFDRIEPDIG------ 101
Query: 173 VVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ A+ G+ YLH I HRD+K EN+LLD+ +KI+DFG+A V
Sbjct: 102 ----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 225 NPNDMTGET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLS 276
N + GTL Y+APE+L ++ DV+S GI L + ++P+ S
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 29/215 (13%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
I + G TV+ D VA+K + E F +EV +
Sbjct: 15 IVDKLGGGGMSTVYLA-EDTILNIKVAIKAI------FIPPREKEETLKRFEREVHNSSQ 67
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
L H N+ + E +V+EY+ G L Y+ L+
Sbjct: 68 LSHQNIVS----------MIDVDEEDDCYY------LVMEYIEGPTLSEYI--ESHGPLS 109
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + G+ + H +IVHRD+K +N+L+D N+T+KI DFG+A+ + T
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 231 GET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
GT+ Y +PE G + D+YS GI L+E
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 40/267 (14%)
Query: 3 KSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGT 62
S +N+ + ++ +A+A ++ + ++S + RG
Sbjct: 7 HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALS-DFFEVESELGRGA 65
Query: 63 FGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120
V+R A+K+L + +R E+ V +L HPN+ K
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVR----TEIGVLLRLSHPNIIKLK 114
Query: 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLA 178
+E+ + V+E + GG L +++ + A V Q+
Sbjct: 115 EIFETPTEISL----------------VLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 179 LDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPNDMTGETGT 235
++YLH IVHRD+K EN+L + +KIADFG++++ + M GT
Sbjct: 159 ----EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGT 213
Query: 236 LGYMAPEVLNGNPYNRKCDVYSFGICL 262
GY APE+L G Y + D++S GI
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + G F V + G + A K + + + + R +EV + ++
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIK---KRRLSSSRRGVSREEIEREVNILREI 65
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +++ + ++E + GG L +L + + L
Sbjct: 66 RHPNIITLHDIFENKTDVVL----------------ILELVSGGELFDFLAE--KESLTE 107
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
Q + G+ YLHS++I H D+K EN++L N +K+ DFG+A + N
Sbjct: 108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-N 166
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 46/213 (21%), Positives = 86/213 (40%), Gaps = 36/213 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+K I G++ R + AVK++D + E EI +
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------------LLRYG 73
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +++ V E + GG L +++ ++ +
Sbjct: 74 QHPNIITLKDVYDDGKYVYV----------------VTELMKGGELLDKILR--QKFFSE 115
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + + + + YLH+Q +VHRD+K N+L +++I DFG A+ +
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ T ++APEVL Y+ CD++S G+
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGV 208
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-35
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 40/219 (18%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ +G F A K++ ++ R + E+++ L H +
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVP------KSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK--LAFKV 173
V F G + + VV+E +L + + A
Sbjct: 77 VVGFHG--------FFED-------NDFVF-VVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE- 232
+ Q+ G YLH +++HRD+K N+ L+++ VKI DFG+ + + GE
Sbjct: 121 LRQIV----LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL-----ATKVEYDGER 171
Query: 233 --T--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
GT Y+APEVL+ ++ + DV+S G ++ +
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-35
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 43/226 (19%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVW 108
+ + G G V VA+K++ + R + E+ +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE----TEIEIL 69
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-- 166
KL+HP + K E+ +V+E + GG L ++ N+R
Sbjct: 70 KKLNHPCIIKIKNF--------FDAED---------YYIVLELMEGGELFDKVVGNKRLK 112
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEA 223
Q+ L + YLH I+HRD+K EN+LL +++ +KI DFG +++
Sbjct: 113 EATCKLYFYQMLL----AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL- 167
Query: 224 SNPNDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFG----ICL 262
+ M GT Y+APEVL YNR D +S G ICL
Sbjct: 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-35
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTE-AEIAALRSAFTQE---VA 106
+ ++ G VH D DVAVK+L R + A + F +E A
Sbjct: 16 LGEILGFGGMSEVHLA-RDLRDHRDVAVKVL-------RADLARDPSFYLRFRREAQNAA 67
Query: 107 VWHKLDHPNVTKF--IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
L+HP + G + E +P +V+EY+ G L+ + +
Sbjct: 68 ---ALNHPAIVAVYDTG----------EAETPAGPLPY----IVMEYVDGVTLRDIV--H 108
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ K +++ D + L++ H I+HRDVK N+++ VK+ DFG+AR A
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 225 NPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
+ N +T GT Y++PE G+ + + DVYS G L+E
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-35
Identities = 69/216 (31%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I ++ +G+FG V + + AVK+++ + S +EV + KL
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-------KASAKNKDTSTILREVELLKKL 78
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
DHPN+ K SS +I V E GG L +IK +R
Sbjct: 79 DHPNIMKLFEILEDSSSFYI----------------VGELYTGGELFDEIIKRKRFSEHD 122
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A +++ Q+ G++Y+H IVHRD+K EN+LL +K+ +KI DFG++ N
Sbjct: 123 AARIIKQVF----SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
M GT Y+APEVL G Y+ KCDV+S G+ L
Sbjct: 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 39/273 (14%)
Query: 17 TTAAAASANATATPIGKASNFLKKQRQDWEIEPSKL---VIKSVIARGTFGTVHRG--LY 71
A A P A+ K+ + ++P V + +G F
Sbjct: 5 ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDAD 64
Query: 72 DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131
A K++ ++ R + E+++ L H +V F G
Sbjct: 65 TKEVFAGKIVP------KSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG--------FF 110
Query: 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ 191
+ + + VV+E +L RR+ L + G YLH
Sbjct: 111 EDND-------FVF-VVLELCRRRSLLELHK--RRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 192 KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE---T--GTLGYMAPEVLNG 246
+++HRD+K N+ L+++ VKI DFG+ + + GE GT Y+APEVL+
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGL-----ATKVEYDGERKKVLCGTPNYIAPEVLSK 215
Query: 247 NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
++ + DV+S G ++ + P+ E
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 39/225 (17%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
K VI RG V R ++ GH+ AVK+++ + ++ +R A +E + ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIME-VTAERLSPEQLEEVREATRRETHILRQV 156
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---R 167
HP++ I + SS + + V + + G L YL + +
Sbjct: 157 AGHPHIITLIDSYESSSFMFL----------------VFDLMRKGELFDYLTEKVALSEK 200
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+ ++ L +S+LH+ IVHRD+K EN+LLD N ++++DFG +
Sbjct: 201 E-TRSIMRSLL----EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-E 254
Query: 228 DMTGETGTLGYMAPEVLNGN------PYNRKCDVYSFG----ICL 262
+ GT GY+APE+L + Y ++ D+++ G L
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 53/233 (22%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLD---WGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
+ G +G V VAVK++D + + EI + L+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM-----------LN 63
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H NV KF G H + + + +EY GG L + +
Sbjct: 64 HENVVKFYG--------HRRE-------GNIQY-LFLEYCSGGELFDRIEPDIG------ 101
Query: 173 VVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ A+ G+ YLH I HRD+K EN+LLD+ +KI+DFG+A V
Sbjct: 102 ----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 225 NPNDMTGET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
N + GTL Y+APE+L ++ DV+S GI L + ++P+
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G F V + G + A K + + + R +EV++ ++
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVCREEIEREVSILRQV 72
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +++ + ++E + GG L +L + + L+
Sbjct: 73 LHPNIITLHDVYENRTDVVL----------------ILELVSGGELFDFLAQ--KESLSE 114
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + G++YLH++KI H D+K EN++L +K+ DFG+A
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-V 173
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G F V + G + A K + + + R +EV++ ++
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIK---KRQSRASRRGVSREEIEREVSILRQV 72
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H NV +++ + ++E + GG L +L + + L+
Sbjct: 73 LHHNVITLHDVYENRTDVVL----------------ILELVSGGELFDFLAQ--KESLSE 114
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + G++YLH++KI H D+K EN++L +K+ DFG+A
Sbjct: 115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-V 173
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-34
Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+++ I RG++G V A K + ++ + QE+ + L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-----KYFVEDVDRFK----QEIEIMKSL 63
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKL 169
DHPN+ + ++++++ V+E GG L ++ R
Sbjct: 64 DHPNIIRLYETFEDNTDIYL----------------VMELCTGGELFERVVHKRVFRESD 107
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
A +++ + ++Y H + HRD+K EN L + +K+ DFG+A
Sbjct: 108 AARIMKDVL----SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
M + GT Y++P+VL G Y +CD +S G+ +
Sbjct: 163 KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMM 197
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 30/214 (14%)
Query: 53 VIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ + RG F V + + G + A K L + R + A + E+AV
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEIL----HEIAVLEL 84
Query: 111 LDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
P V +SE+ + ++EY GG + + + +
Sbjct: 85 AKSCPRVINLHEVYENTSEIIL----------------ILEYAAGGEIFSLCLPELAEMV 128
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
+ V++L + G+ YLH IVH D+K +N+LL +KI DFG++R
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA- 187
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
++ GT Y+APE+LN +P D+++ GI
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGI 221
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 61/271 (22%), Positives = 102/271 (37%), Gaps = 46/271 (16%)
Query: 20 AAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVA 77
+ + P + +D E ++ + ++ +G FGTV G L D VA
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA 60
Query: 78 VKLLD------WG--EEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129
+K++ W + E+A L V HP V + L
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWK-------VGAGGGHPGVIR----------L 103
Query: 130 HIQTENGQV-AMPSNICCVVVEY-LPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGL 185
+V+E LP L Y+ + + Q+ +
Sbjct: 104 L------DWFETQEGFM-LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV----AAI 152
Query: 186 SYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL 244
+ HS+ +VHRD+K EN+L+D R K+ DFG + P GT Y PE +
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--DGTRVYSPPEWI 210
Query: 245 NGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
+ + Y+ V+S GI L+++ C D+P+
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ + G+F + AVK++ + + +E+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS------------KRMEANTQKEITALKL 61
Query: 111 LD-HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+ HPN+ K + V+E L GG L + K ++
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFL----------------VMELLNGGELFERIKK--KKHF 103
Query: 170 AFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNP 226
+ + L +S++H +VHRD+K EN+L + N +KI DFG AR++ +
Sbjct: 104 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ TL Y APE+LN N Y+ CD++S G+
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGV 197
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 49/235 (20%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
I +G F V + G +VA+K++D + + ++ +EV + L+HPN
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL-------FREVRIMKILNHPN 75
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L I+T + +++EY GG + YL+ + R
Sbjct: 76 IVK----------LFEVIET-------EKTLY-LIMEYASGGEVFDYLVAHGR------- 110
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ AR + Y H ++IVHRD+K EN+LLD + +KIADFG + +
Sbjct: 111 ---MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TV 166
Query: 226 PNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
+ G Y APE+ G Y+ + DV+S G+ L+ + +P+ + E
Sbjct: 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G F V + G A K + + + R +EV++ ++
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEI 71
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPNV +++ + ++E + GG L +L + + L
Sbjct: 72 QHPNVITLHEVYENKTDVIL----------------ILELVAGGELFDFLAE--KESLTE 113
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL----DKNRTVKIADFGVARVEASNPN 227
+ + + G+ YLHS +I H D+K EN++L +KI DFG+A N
Sbjct: 114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-N 172
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+ GT ++APE++N P + D++S G+
Sbjct: 173 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 205
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 40/217 (18%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ K V+ G G V G A+KLL + + E+ W
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVDHH----------WQA 78
Query: 111 LDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
P++ + G L I ++E + GG L + + +
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLI----------------IMECMEGGELFSRIQERGD 122
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEA 223
+ + ++ D+ + +LHS I HRDVK EN+L +K+ +K+ DFG A+
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET- 181
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
N + T Y+APEVL Y++ CD++S G+
Sbjct: 182 -TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-33
Identities = 61/235 (25%), Positives = 91/235 (38%), Gaps = 48/235 (20%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVKLLD------WGEEGHRTEAEIAALRSAFTQEVAVW 108
++ G++G V AVK+L + EI LR
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR---------- 61
Query: 109 HKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGA--LKTYLIKN 164
+L H NV + L + E + +V+EY G + + +
Sbjct: 62 -RLRHKNVIQ----------LVDVLYNEE-----KQKMY-MVMEYCVCGMQEMLDSVPEK 104
Query: 165 R-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEA 223
R A QL GL YLHSQ IVH+D+K N+LL T+KI+ GVA
Sbjct: 105 RFPVCQAHGYFCQLID----GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 224 SNPNDMTGET--GTLGYMAPEVLNGN-PYN-RKCDVYSFGICLWEIYCCDMPYPD 274
D T T G+ + PE+ NG ++ K D++S G+ L+ I P+
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 37/263 (14%)
Query: 2 EKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARG 61
K R D + + + + + D I + G
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYD------YYDILEELGSG 62
Query: 62 TFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119
FG VHR + G K ++ + ++ E+++ ++L HP +
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVK----NEISIMNQLHHPKLINL 113
Query: 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLAL 179
A E+ + ++E+L GG L + K++ V+
Sbjct: 114 HDAFEDKYEMVL----------------ILEFLSGGELFDRIAA-EDYKMSEAEVINYMR 156
Query: 180 DLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
GL ++H IVH D+K EN++ K +VKI DFG+A + + + T T
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATAE 215
Query: 238 YMAPEVLNGNPYNRKCDVYSFGI 260
+ APE+++ P D+++ G+
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGV 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 58/241 (24%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
S + G FG V + +V VK + + E L T E+A+ +
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLEIAILSR 85
Query: 111 LDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-- 166
++H N+ K + + V+ ++ G L ++ ++ R
Sbjct: 86 VEHANIIK----------VLDIFEN-------QGFFQLVMEKHGSGLDLFAFIDRHPRLD 128
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP 226
LA + QL + YL + I+HRD+K EN+++ ++ T+K+ DFG A
Sbjct: 129 EPLASYIFRQLV----SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
Query: 227 NDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285
T GT+ Y APEVL GNPY + +++S G+ L+ + + P+ + E A +
Sbjct: 185 LFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEETVEAAI 241
Query: 286 R 286
Sbjct: 242 H 242
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-33
Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 34/215 (15%)
Query: 54 IKSVIARGTFGTVHRGL---YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+K IA G G ++ L +G V +K L + A E +
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGL------VHSGDAEAQAM--AMAERQFLAE 135
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ HP++ + G + M EY+ G +LK +KL
Sbjct: 136 VVHPSIVQIF--NFVEHTDRHGDPVGYIVM---------EYVGGQSLKRSK----GQKLP 180
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ L++ LSYLHS +V+ D+K EN++L + + +K+ D G +
Sbjct: 181 VAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS-----RINSF 234
Query: 231 GET-GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
G GT G+ APE++ P D+Y+ G L
Sbjct: 235 GYLYGTPGFQAPEIVRTGPTVA-TDIYTVGRTLAA 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-33
Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 60/236 (25%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ GTFG V G GH VAVK+L+ R + + +E+ HP+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN------RQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L+ I T P++ +V+EY+ GG L Y+ K+ R
Sbjct: 73 IIK----------LYQVIST-------PTDFF-MVMEYVSGGELFDYICKHGR------- 107
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+ AR + Y H +VHRD+K EN+LLD + KIADFG++
Sbjct: 108 ---VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------ 158
Query: 226 PNDMTG----ET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
N M+ T G+ Y APEV++G Y + D++S G+ L+ + C +P+ D
Sbjct: 159 -NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 55 KSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
++ G FG VH+ G +A K++ R + ++ E++V ++LD
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGMKDKEEVK----NEISVMNQLD 144
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H N+ + A +++ + V+EY+ GG L +I L
Sbjct: 145 HANLIQLYDAFESKNDIVL----------------VMEYVDGGELFDRIID-ESYNLTEL 187
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPNDMT 230
+ + G+ ++H I+H D+K EN+L + +KI DFG+AR +
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLK 246
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
GT ++APEV+N + + D++S G+
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 34/212 (16%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + RG FG VHR + K + + ++ +E+++ +
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVK----KEISILNIA 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H N+ + EL + + E++ G + + +L
Sbjct: 59 RHRNILHLHESFESMEELVM----------------IFEFISGLDIFERINT-SAFELNE 101
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPND- 228
+ +V + L +LHS I H D++ EN++ ++ T+KI +FG AR P D
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDN 159
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
Y APEV + + D++S G
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 43/219 (19%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V V+ G G V + A+K+L R E E+ W
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL------------HWRA 111
Query: 111 LDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
P++ + + G L I V+E L GG L + + R
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLI----------------VMECLDGGELFSRIQD--R 153
Query: 167 RKLAF--KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARV 221
AF + ++ + + YLHS I HRDVK EN+L N +K+ DFG A+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 222 EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
S+ N +T T Y+APEVL Y++ CD++S G+
Sbjct: 214 TTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-32
Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 31/211 (14%)
Query: 54 IKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G FG VHR G++ A K + E++ +R +E+ L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVR----KEIQTMSVL 211
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP + A +E+ + + E++ GG L + K++
Sbjct: 212 RHPTLVNLHDAFEDDNEMVM----------------IYEFMSGGELFEKVAD-EHNKMSE 254
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVARVEASNPNDM 229
V+ + +GL ++H VH D+K EN++ ++ +K+ DFG+ +
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV 313
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260
TGT + APEV G P D++S G+
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 67/234 (28%), Positives = 98/234 (41%), Gaps = 58/234 (24%)
Query: 58 IARGTFGTVH--RGLYDGHDVAVKLLDWGE-EGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
I G FG R VAVK ++ G + EI RS L HP
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRS-----------LRHP 76
Query: 115 NVTKFIGATMGSSELHIQTENGQV-AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ +F +V P+++ +++EY GG L + R
Sbjct: 77 NIVRFK----------------EVILTPTHLA-IIMEYASGGELYERICNAGR------- 112
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRT--VKIADFGVARVEA 223
+ D AR G+SY HS +I HRD+K EN LLD + +KI DFG +
Sbjct: 113 ---FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS---K 166
Query: 224 SNPNDMTGET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
S+ ++ GT Y+APEVL Y+ + DV+S G+ L+ + P+ D
Sbjct: 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 60/297 (20%), Positives = 110/297 (37%), Gaps = 69/297 (23%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
M S + ++ + A N + +++ P ++
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGP-------LLGS 53
Query: 61 GTFGTVHRG--LYDGHDVAVKLLD------WGEEGH--RTEAEIAALRSAFTQEVAVWHK 110
G FG+V+ G + D VA+K ++ WGE + R E+ L+ K
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK-----------K 102
Query: 111 LDH--PNVTKFIGATMGSSELHIQTENGQV-AMPSNICCVVVEY-LPGGALKTYLIKNRR 166
+ V + L P + +++E P L ++ +
Sbjct: 103 VSSGFSGVIR----------LL------DWFERPDSFV-LILERPEPVQDLFDFITERGA 145
Query: 167 --RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEA 223
+LA Q+ + + H+ ++HRD+K EN+L+D NR +K+ DFG
Sbjct: 146 LQEELARSFFWQVL----EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG---- 197
Query: 224 SNPNDMTGET-----GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
+ GT Y PE + + Y+ R V+S GI L+++ C D+P+
Sbjct: 198 ---ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-31
Identities = 73/236 (30%), Positives = 108/236 (45%), Gaps = 60/236 (25%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ GTFG V G GH VAVK+L+ R + + +E+ HP+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN------RQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L+ I T PS+I +V+EY+ GG L Y+ KN R
Sbjct: 78 IIK----------LYQVIST-------PSDIF-MVMEYVSGGELFDYICKNGR------- 112
Query: 174 VVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
L +R G+ Y H +VHRD+K EN+LLD + KIADFG++
Sbjct: 113 ---LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------ 163
Query: 226 PNDMTG----ET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
N M+ T G+ Y APEV++G Y + D++S G+ L+ + C +P+ D
Sbjct: 164 -NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-31
Identities = 71/310 (22%), Positives = 109/310 (35%), Gaps = 68/310 (21%)
Query: 30 PIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD-------VAVKLLD 82
P+ + L WE +L + + RG FG V G D VAVK+L
Sbjct: 2 PLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML- 60
Query: 83 WGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPN-------VTKFIGATM---------- 124
+EG T +E A E+ + + H N TK G M
Sbjct: 61 --KEGA-THSE----HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 113
Query: 125 -------------GSSELHIQTENGQ---------------VAMPSNICCVVVEYLPGGA 156
+ G+ S
Sbjct: 114 LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
Query: 157 LKT----YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
+ L + ++ + +A+G+ +L S+K +HRD+ N+LL + VK
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 213 IADFGVARVEASNPNDMTGETGTL--GYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-D 269
I DFG+AR +P+ + L +MAPE + Y + DV+SFG+ LWEI+
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293
Query: 270 MPYPDLSFSE 279
PYP + E
Sbjct: 294 SPYPGVKIDE 303
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-31
Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 45/228 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115
+ G+FG V VA+K + R + + + +E++ L HP+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS------RQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 116 VTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
+ K L+ I T P++I +V+EY GG L Y+++ +R +
Sbjct: 71 IIK----------LYDVITT-------PTDIV-MVIEYA-GGELFDYIVEKKR--MTEDE 109
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG-- 231
+ + + Y H KIVHRD+K EN+LLD N VKIADFG++ N MT
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------NIMTDGN 162
Query: 232 --ET--GTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274
+T G+ Y APEV+NG Y + DV+S GI L+ + +P+ D
Sbjct: 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 37/214 (17%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I G++G V + G VA+K L + + ALR E+ + +L H
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALR-----EIRMLKQLKH 61
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
PN+ + LH+ V EY + + +R + +
Sbjct: 62 PNLVNLLEVFRRKRRLHL----------------VFEYCDHT-VLHE-LDRYQRGVPEHL 103
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V + + +++ H +HRDVK EN+L+ K+ +K+ DFG AR+ + E
Sbjct: 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T Y +PE+L G Y + +W I C
Sbjct: 164 ATRWYRSPELLVG------DTQYGPPVDVWAIGC 191
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 55/256 (21%), Positives = 93/256 (36%), Gaps = 48/256 (18%)
Query: 23 SANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKL 80
A P + + Q + P ++ G+F TV R L + A+K+
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62
Query: 81 LDWGEEGHRTEAEIAALRS-AFTQ-EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQV 138
L+ + I + E V +LDHP K Q +
Sbjct: 63 LE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT--------FQDDEK-- 104
Query: 139 AMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHS 190
+ Y G L Y+ K R L YLH
Sbjct: 105 ------LYFGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAEIVSALEYLHG 148
Query: 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP 248
+ I+HRD+K EN+LL+++ ++I DFG A+V + + GT Y++PE+L
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 249 YNRKCDVYSFGICLWE 264
+ D+++ G +++
Sbjct: 209 ACKSSDLWALGCIIYQ 224
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 55 KSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111
+ V+ G V L + AVK+++ + I RS +EV + ++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIE------KQPGHI---RSRVFREVEMLYQCQ 68
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H NV + I ++ V E + GG++ +++ K RR
Sbjct: 69 GHRNVLELIEFFEEEDRFYL----------------VFEKMRGGSILSHIHK--RRHFNE 110
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARV------- 221
+ D+A L +LH++ I HRD+K EN+L ++ VKI DF +
Sbjct: 111 LEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 222 EASNPNDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGI 260
+ ++ G+ YMAPEV+ + Y+++CD++S G+
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 61 GTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+GTV + VA+K LD +EG +ALR E+ + +L H N+
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEG----VPSSALR-----EICLLKELKHKNI 63
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ +L + V E+ LK Y + L ++V
Sbjct: 64 VRLHDVLHSDKKLTL----------------VFEFCDQD-LKKYF-DSCNGDLDPEIVKS 105
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTL 236
L +GL + HS+ ++HRD+K +N+L+++N +K+A+FG+AR + E TL
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 237 GYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y P+VL G +YS I +W C
Sbjct: 166 WYRPPDVLFG------AKLYSTSIDMWSAGC 190
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 36/210 (17%)
Query: 61 GTFGTVHRGLY-DGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
GT+G V++ G VA+K LD +EG A+R E+++ +L HPN+
Sbjct: 32 GTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIR-----EISLLKELHHPNIV 82
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQL 177
I L + V E++ LK + + L +
Sbjct: 83 SLIDVIHSERCLTL----------------VFEFMEKD-LKKV-LDENKTGLQDSQIKIY 124
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
L RG+++ H +I+HRD+K +N+L++ + +K+ADFG+AR T E TL
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 238 YMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y AP+VL G YS + +W I C
Sbjct: 185 YRAPDVLMG------SKKYSTSVDIWSIGC 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 37/214 (17%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ G++G V + G VA+K L ++ + A+R E+ + +L H
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM----VKKIAMR-----EIKLLKQLRH 83
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ + ++ V E++ + L + L ++V
Sbjct: 84 ENLVNLLEVCKKKKRWYL----------------VFEFVDHT-ILDDL-ELFPNGLDYQV 125
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V + + G+ + HS I+HRD+K EN+L+ ++ VK+ DFG AR A+ E
Sbjct: 126 VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV 185
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T Y APE+L G Y + +W I C
Sbjct: 186 ATRWYRAPELLVG------DVKYGKAVDVWAIGC 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-- 111
I G +GTV++ + GH VA+K + G G I+ +R EVA+ +L
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGG-GGGLPISTVR-----EVALLRRLEA 70
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+HPNV + + S +V + V E++ L+TYL K L
Sbjct: 71 FEHPNVVRLMDVCATSR----TDREIKVTL-------VFEHVDQD-LRTYLDKAPPPGLP 118
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + L RGL +LH+ IVHRD+K EN+L+ TVK+ADFG+AR S +T
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALT 177
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
TL Y APEVL + Y D++S G
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVG 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 61 GTFGTVHRGLYD-GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117
GT+G V++ + G A+K L+ +EG +R E+++ +L H N+
Sbjct: 13 GTYGVVYKAQNNYGETFALKKIRLEKEDEG----IPSTTIR-----EISILKELKHSNIV 63
Query: 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQL 177
K L + V E+L LK + L
Sbjct: 64 KLYDVIHTKKRLVL----------------VFEHLDQD-LKKL-LDVCEGGLESVTAKSF 105
Query: 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLG 237
L L G++Y H ++++HRD+K +N+L+++ +KIADFG+AR T E TL
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 238 YMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
Y AP+VL G YS I +W + C
Sbjct: 166 YRAPDVLMG------SKKYSTTIDIWSVGC 189
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-29
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 58 IARGTFGTVHRGL---YDGHDVAVK--LLDWGEEGHRTEA--EIAALRSAFTQEVAVWHK 110
I G +G V + G VA+K + GEEG E+A LR
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL--------ET 70
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+HPNV + S ++ + V E++ L TYL K +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDR----ETKLTL-------VFEHVDQD-LTTYLDKVPEPGVP 118
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ + + L RGL +LHS ++VHRD+K +N+L+ + +K+ADFG+AR+ S +T
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALT 177
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFG 259
TL Y APEVL + Y D++S G
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVG 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 61 GTFGTVHRG--LYDGHDVAVK-----LLDWGEEG-HRTEAEIAALRSAFTQEVAVWHKLD 112
G F TV++ VA+K ++G +RT ALR E+ + +L
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRT-----ALR-----EIKLLQELS 70
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
HPN+ + A S + + V +++ L+ IK+ L
Sbjct: 71 HPNIIGLLDAFGHKSNISL----------------VFDFMETD-LEVI-IKDNSLVLTPS 112
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+ L +GL YLH I+HRD+K N+LLD+N +K+ADFG+A+ S T +
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T Y APE+L G +Y G+ +W + C
Sbjct: 173 VVTRWYRAPELLFG------ARMYGVGVDMWAVGC 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 58 IARGTFGTVHRGLYD--GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
+ GT+ TV++G + VA+K L+ EEG A A+R EV++ L H
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLE-HEEG----APCTAIR-----EVSLLKDLKH 59
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
N+ L + V EYL LK YL + +
Sbjct: 60 ANIVTLHDIIHTEKSLTL----------------VFEYLDKD-LKQYL-DDCGNIINMHN 101
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233
V L RGL+Y H QK++HRD+K +N+L+++ +K+ADFG+AR ++ E
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TL Y P++L G YS I +W + C
Sbjct: 162 VTLWYRPPDILLG------STDYSTQIDMWGVGC 189
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 61 GTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+ TV++G G VA+K LD EEG A+R E+++ +L H N+
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVKLD-SEEG----TPSTAIR-----EISLMKELKHENI 65
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL----IKNRRRKLAFK 172
+ ++L + V E++ LK Y+ + N R L
Sbjct: 66 VRLYDVIHTENKLTL----------------VFEFMDND-LKKYMDSRTVGNTPRGLELN 108
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
+V L +GL++ H KI+HRD+K +N+L++K +K+ DFG+AR N + E
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE 168
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
TL Y AP+VL G YS I +W C
Sbjct: 169 VVTLWYRAPDVLMG------SRTYSTSIDIWSCGC 197
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 64/260 (24%), Positives = 105/260 (40%), Gaps = 52/260 (20%)
Query: 31 IGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGH 88
+ A F K +Q + I VI RG FG V + A+K+L+
Sbjct: 56 LEWAKPFTSKVKQM-RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN------ 108
Query: 89 RTEAEIAALR-SAFTQ-EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICC 146
+ E+ +A + E V D +T A Q +N+
Sbjct: 109 --KWEMLKRAETACFREERDVLVNGDSKWITTLHYA--------FQD-------DNNL-Y 150
Query: 147 VVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDV 198
+V++Y GG L T L K R L ++AR + +H VHRD+
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDR---------LPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNP-----YNRK 252
K +N+L+D N +++ADFG + + GT Y++PE+L Y +
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261
Query: 253 CDVYSFGICLWEIYCCDMPY 272
CD +S G+C++E+ + P+
Sbjct: 262 CDWWSLGVCMYEMLYGETPF 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 68/294 (23%), Positives = 112/294 (38%), Gaps = 75/294 (25%)
Query: 3 KSKKQRNSDDNILVTTAAAASANATATPIGK--ASNFLKKQRQDWEIEPSKLVIK----- 55
++ + + D + A A+ P + S + + Q +E +
Sbjct: 131 VARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDF 190
Query: 56 SVIARGTFGTV----HRG---LYDGHDVAVKLL-------DWGEEGHRTEAEIAALRSAF 101
V+ RG FG V + LY A K L G +G E +I A
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLY-----ACKKLNKKRLKKRKGYQGAMVEKKILA----- 240
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKT 159
K+ + L +T+ C+V+ + GG ++
Sbjct: 241 --------KVHSRFIVS----------LAYAFETKTD--------LCLVMTIMNGGDIRY 274
Query: 160 YLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTV 211
++ F+ A GL +LH + I++RD+K EN+LLD + V
Sbjct: 275 HIYNVDEDNPGFQ------EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV 328
Query: 212 KIADFGVARVEASNPNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
+I+D G+A VE T G GT G+MAPE+L G Y+ D ++ G+ L+E
Sbjct: 329 RISDLGLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH 113
I +GTFG V + G VA+K L++ +EG I ALR E+ + L H
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP----ITALR-----EIKILQLLKH 75
Query: 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKV 173
NV I + G + + V ++ L L N K
Sbjct: 76 ENVVNLIEI-CRTKASPYNRCKGSIYL-------VFDFCEHD-LAGLL-SNVLVKFTLSE 125
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV----EASNPNDM 229
+ ++ L GL Y+H KI+HRD+K N+L+ ++ +K+ADFG+AR + S PN
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
T TL Y PE+L G Y I LW C
Sbjct: 186 TNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGC 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-27
Identities = 59/256 (23%), Positives = 102/256 (39%), Gaps = 59/256 (23%)
Query: 35 SNFLKKQR------QDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEE 86
++FL+ ++ ++ I VI RG F V + G A+K+++ +
Sbjct: 40 ADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99
Query: 87 GHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNI 144
R E F +E V D +T+ LH Q + +
Sbjct: 100 LKRGEVS------CFREERDVLVNGDRRWITQ----------LHFAFQD-------ENYL 136
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHR 196
+V+EY GG L T L K R + ++AR + +H VHR
Sbjct: 137 -YLVMEYYVGGDLLTLLSKFGER---------IPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 197 DVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNG-------NP 248
D+K +N+LLD+ +++ADFG ++ + GT Y++PE+L
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 249 YNRKCDVYSFGICLWE 264
Y +CD ++ G+ +E
Sbjct: 247 YGPECDWWALGVFAYE 262
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 47/131 (35%), Positives = 73/131 (55%), Gaps = 6/131 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C V+EY GG L +L +R R + ++ L YLHS+ +V+RD+K EN++L
Sbjct: 81 CFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
DK+ +KI DFG+ + E + T GT Y+APEVL N Y R D + G+ ++
Sbjct: 139 DKDGHIKITDFGLCK-EGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 196
Query: 264 EIYCCDMPYPD 274
E+ C +P+ +
Sbjct: 197 EMMCGRLPFYN 207
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 53/224 (23%)
Query: 57 VIARGTFGTV----HRG---LYDGHDVAVKLL-------DWGEEGHRTEAEIAALRSAFT 102
V+ +G FG V R +Y A K L GE E +I
Sbjct: 191 VLGKGGFGEVCACQVRATGKMY-----ACKKLEKKRIKKRKGEAMALNEKQILE------ 239
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTY 160
K++ F+ L +T++ C+V+ + GG LK +
Sbjct: 240 -------KVNSR----FV------VSLAYAYETKD--------ALCLVLTLMNGGDLKFH 274
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ + V A ++ GL LH ++IV+RD+K EN+LLD + ++I+D G+A
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA- 333
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
V + G GT+GYMAPEV+ Y D ++ G L+E
Sbjct: 334 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 42/245 (17%)
Query: 35 SNFLKKQR------QDWEIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEE 86
NFL + + +D ++ + VI RG FG V R A+KLL E
Sbjct: 48 DNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107
Query: 87 GHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNI 144
R+++ F +E + + P ++ +L Q +
Sbjct: 108 IKRSDSA------FFWEERDIMAFANSP----WV------VQLFYAFQD-------DRYL 144
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204
+V+EY+PGG L + + K ++ L +HS +HRDVK +NML
Sbjct: 145 -YMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML 200
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGET-GTLGYMAPEVLNGNP----YNRKCDVYSFG 259
LDK+ +K+ADFG GT Y++PEVL Y R+CD +S G
Sbjct: 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 260 ICLWE 264
+ L+E
Sbjct: 261 VFLYE 265
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 43/216 (19%)
Query: 61 GTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116
GT+G V++ VA+K L+ EEG A+R EV++ +L H N+
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----VPGTAIR-----EVSLLKELQHRNI 95
Query: 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQ 176
+ + LH+ + EY LK Y+ ++ ++ +V+
Sbjct: 96 IELKSVIHHNHRLHL----------------IFEYAEND-LKKYM--DKNPDVSMRVIKS 136
Query: 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT-----VKIADFGVARVEASNPNDMTG 231
L G+++ HS++ +HRD+K +N+LL + +KI DFG+AR T
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
E TL Y PE+L G YS + +W I C
Sbjct: 197 EIITLWYRPPEILLG------SRHYSTSVDIWSIAC 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 45/125 (36%), Positives = 68/125 (54%), Gaps = 10/125 (8%)
Query: 145 CCVVVEYLPGGALKTYLIKNRRRKLAFK-VVVQL-ALDLARGLSYLHSQKIVHRDVKTEN 202
+VV+ L GG L+ +L +N FK V+L +L L YL +Q+I+HRD+K +N
Sbjct: 90 MFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFG 259
+LLD++ V I DF +A +T GT YMAPE+ + G Y+ D +S G
Sbjct: 146 ILLDEHGHVHITDFNIAA-MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG 204
Query: 260 ICLWE 264
+ +E
Sbjct: 205 VTAYE 209
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 47/236 (19%)
Query: 57 VIARGTFGTV----HRGLYDGHDVAVKLLDWG-----EEGHRTEAEIAALRSAFTQEVAV 107
VI RG++ V + A+K++ E+ + E + F Q
Sbjct: 16 VIGRGSYAKVLLVRLKK--TDRIYAMKVVKKELVNDDEDIDWVQTE----KHVFEQAS-- 67
Query: 108 WHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+HP F+ LH QT S + V+EY+ GG L ++ R
Sbjct: 68 ----NHP----FL------VGLHSCFQT-------ESRLF-FVIEYVNGGDLMFHM--QR 103
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+RKL + + +++ L+YLH + I++RD+K +N+LLD +K+ D+G+ + E
Sbjct: 104 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLR 162
Query: 226 PNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
P D T T GT Y+APE+L G Y D ++ G+ ++E+ P+ + S+
Sbjct: 163 PGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 47/236 (19%)
Query: 57 VIARGTFGTV----HRGLYDGHDVAVKLLDWG-----EEGHRTEAEIAALRSAFTQEVAV 107
VI RG++ V + A++++ E+ + E + F Q
Sbjct: 59 VIGRGSYAKVLLVRLKK--TDRIYAMRVVKKELVNDDEDIDWVQTE----KHVFEQAS-- 110
Query: 108 WHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+HP F+ LH QT S + V+EY+ GG L ++ R
Sbjct: 111 ----NHP----FL------VGLHSCFQT-------ESRLF-FVIEYVNGGDLMFHM--QR 146
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
+RKL + + +++ L+YLH + I++RD+K +N+LLD +K+ D+G+ + E
Sbjct: 147 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLR 205
Query: 226 PNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
P D T T GT Y+APE+L G Y D ++ G+ ++E+ P+ + S+
Sbjct: 206 PGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 50/131 (38%), Positives = 73/131 (55%), Gaps = 6/131 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EYL GG L ++ K A ++ GL +LHS+ IV+RD+K +N+LL
Sbjct: 94 FFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
DK+ +KIADFG+ + E + T T GT Y+APE+L G YN D +SFG+ L+
Sbjct: 152 DKDGHIKIADFGMCK-ENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 264 EIYCCDMPYPD 274
E+ P+
Sbjct: 210 EMLIGQSPFHG 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 54/235 (22%)
Query: 57 VIARGTFGTV----HRGLYDGHDV-AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
V+ +G+FG V D + A+K+L R R + ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD-------ILVEV 83
Query: 112 DHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
+HP FI +LH QTE +++++L GG L T L K
Sbjct: 84 NHP----FI------VKLHYAFQTEGK--------LYLILDFLRGGDLFTRLSKEVM--- 122
Query: 170 AFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
F + + L +LHS I++RD+K EN+LLD+ +K+ DFG+++
Sbjct: 123 -FT------EEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK- 174
Query: 222 EASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
E+ + + GT+ YMAPEV+N + + D +SFG+ ++E+ +P+
Sbjct: 175 ESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 48/132 (36%), Positives = 73/132 (55%), Gaps = 7/132 (5%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK-IVHRDVKTENML 204
C V+EY GG L +L +R R + ++ L YLHS+K +V+RD+K EN++
Sbjct: 224 CFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 205 LDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
LDK+ +KI DFG+ + E T GT Y+APEVL N Y R D + G+ +
Sbjct: 282 LDKDGHIKITDFGLCK-EGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 263 WEIYCCDMPYPD 274
+E+ C +P+ +
Sbjct: 340 YEMMCGRLPFYN 351
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 43/131 (32%), Positives = 72/131 (54%), Gaps = 6/131 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L ++ + + V A ++A GL +L S+ I++RD+K +N++L
Sbjct: 418 YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
D +KIADFG+ + E T T GT Y+APE++ PY + D ++FG+ L+
Sbjct: 476 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533
Query: 264 EIYCCDMPYPD 274
E+ P+
Sbjct: 534 EMLAGQAPFEG 544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 70/227 (30%), Positives = 108/227 (47%), Gaps = 57/227 (25%)
Query: 54 IKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ------EV 105
I + G+FG VH R ++G A+K+L + + L+ Q E
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLK----QVEHTNDER 57
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
+ + HP + + G Q I ++++Y+ GG L + L K++
Sbjct: 58 LMLSIVTHPFIIRMWGTF--------QD-------AQQIF-MIMDYIEGGELFSLLRKSQ 101
Query: 166 RRKLAFKVVV------QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
R F V ++ L L YLHS+ I++RD+K EN+LLDKN +KI DFG A
Sbjct: 102 R----FPNPVAKFYAAEVCL----ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
Query: 220 RVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264
+ D+T T GT Y+APEV++ PYN+ D +SFGI ++E
Sbjct: 154 KYV----PDVTY-TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 195
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 66/242 (27%)
Query: 57 VIARGTFGTV----HRGLYDGHDV-AVKLL-------DWGEEGHRTEAEIAALRSAFTQE 104
V+ +G +G V + + A+K+L + + H T+AE R+
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH-TKAE----RN----- 73
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+ ++ HP FI +L QT +++EYL GG L L
Sbjct: 74 --ILEEVKHP----FI------VDLIYAFQTGGK--------LYLILEYLSGGELFMQLE 113
Query: 163 KNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
+ F D A L +LH + I++RD+K EN++L+ VK+
Sbjct: 114 REGI----FM------EDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163
Query: 215 DFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY 272
DFG+ + E+ + +T T GT+ YMAPE+L + +NR D +S G ++++ P+
Sbjct: 164 DFGLCK-ESIHDGTVTH-TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 273 PD 274
Sbjct: 222 TG 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 43/131 (32%), Positives = 72/131 (54%), Gaps = 6/131 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+EY+ GG L ++ + + V A ++A GL +L S+ I++RD+K +N++L
Sbjct: 97 YFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
D +KIADFG+ + E T T GT Y+APE++ PY + D ++FG+ L+
Sbjct: 155 DSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 212
Query: 264 EIYCCDMPYPD 274
E+ P+
Sbjct: 213 EMLAGQAPFEG 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 70/239 (29%), Positives = 100/239 (41%), Gaps = 63/239 (26%)
Query: 57 VIARGTFGTV----HRGLYDGHDVAVKLLDWG-----EEGHRTEAEIAALRSAFTQEVAV 107
VI +G+FG V H+ + AVK+L +E +E R+ + V
Sbjct: 45 VIGKGSFGKVLLARHKA--EEVFYAVKVLQKKAILKKKEEKHIMSE----RNVLLKNV-- 96
Query: 108 WHKLDHPNVTKFIGATMGSSELH--IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
HP F+ LH QT + V++Y+ GG L +L + R
Sbjct: 97 ----KHP----FL------VGLHFSFQT-------ADKL-YFVLDYINGGELFYHLQRER 134
Query: 166 RRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
F AR L YLHS IV+RD+K EN+LLD + + DFG
Sbjct: 135 C----FL------EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184
Query: 218 VARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274
+ + E N T T GT Y+APEVL+ PY+R D + G L+E+ P+
Sbjct: 185 LCK-ENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 6/131 (4%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
V+E++ GG L ++ + R+ A ++ L +LH + I++RD+K +N+LL
Sbjct: 100 FFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 206 DKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLW 263
D K+ADFG+ + E T T GT Y+APE+L Y D ++ G+ L+
Sbjct: 158 DHEGHCKLADFGMCK-EGICNGVTTA-TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 264 EIYCCDMPYPD 274
E+ C P+
Sbjct: 216 EMLCGHAPFEA 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 52/240 (21%), Positives = 100/240 (41%), Gaps = 61/240 (25%)
Query: 46 EIEPSKLVIKSVIARGTFGTVH--RGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
+ + + G+FG V + G+ A+K+LD + ++ L+ Q
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLK----Q 84
Query: 104 ------EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
E + ++ P + K + + SN+ +V+EY+ GG +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSF--------KD-------NSNLY-MVMEYVAGGEM 128
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRDVKTENMLLDKNR 209
++L + R + AR YLHS +++RD+K EN+L+D+
Sbjct: 129 FSHLRRIGR----------FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
Query: 210 TVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
+++ DFG A+ T T GT +APE++ YN+ D ++ G+ ++E+
Sbjct: 179 YIQVTDFGFAKRV----KGRTW-TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 37/121 (30%), Positives = 65/121 (53%), Gaps = 7/121 (5%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
+++ + GG L +L ++ + + A ++ GL ++H++ +V+RD+K N+LL
Sbjct: 268 SFILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 206 DKNRTVKIADFGVARVEASNPNDMT-GETGTLGYMAPEVLN-GNPYNRKCDVYSFGICLW 263
D++ V+I+D G+A GT GYMAPEVL G Y+ D +S G L+
Sbjct: 326 DEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 382
Query: 264 E 264
+
Sbjct: 383 K 383
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 47/219 (21%), Positives = 74/219 (33%), Gaps = 60/219 (27%)
Query: 53 VIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V V+ G G V + A+K+L R E E+ W
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVEL------------HWRA 67
Query: 111 LDHPNVTKFIGA----TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
P++ + + G L I V+E L GG L + +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLI----------------VMECLDGGELFSRIQDRGD 111
Query: 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEA 223
+ + ++ + + YLHS I HRDVK EN+L N +K+ DFG
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------ 165
Query: 224 SNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
A E Y++ CD++S G+ +
Sbjct: 166 ---------------FAKETTGEK-YDKSCDMWSLGVIM 188
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 37/253 (14%)
Query: 17 TTAAAASANATATPIGKASNFLKKQRQDWEI---EPSKLVIKSVIARGTFGTVHRG-LYD 72
T + A P+ + +K D + VI G+FG V + L +
Sbjct: 4 TMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVE 63
Query: 73 GHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130
+VA+K L D + R E+ +R + HPNV
Sbjct: 64 SDEVAIKKVLQDKRFKN-R---ELQIMR-----------IVKHPNVVDL---------KA 99
Query: 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF-KVVVQLAL-DLARGLSYL 188
NG + +V+EY+P + + K ++++L + L R L+Y+
Sbjct: 100 FFYSNGDKKDEVFLN-LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 189 HSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN 247
HS I HRD+K +N+LLD +K+ DFG A++ + + Y APE++ G
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGA 216
Query: 248 P-YNRKCDVYSFG 259
Y D++S G
Sbjct: 217 TNYTTNIDIWSTG 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-23
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 30/229 (13%)
Query: 53 VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRT-EAEIAALRSAFTQEVAVWH 109
++ + G F TV + + VA+K++ + E EI L+ +
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 110 KLDHPNVTKFIGATM--GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ ++ K + G + +H+ +V E L G L + K R
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHV--------------VMVFEVL-GENLLALIKKYEHR 126
Query: 168 KLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLD------KNRTVKIADFGVAR 220
+ V Q++ L GL Y+H + I+H D+K EN+L++ +KIAD G A
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269
T T Y +PEVL G P+ D++S ++E+ D
Sbjct: 187 WY---DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 37/139 (26%), Positives = 70/139 (50%), Gaps = 23/139 (16%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLAR--------GLSYLHSQKIVHRD 197
++++Y+ GG L T+L + R F + L +LH I++RD
Sbjct: 135 HLILDYINGGELFTHLSQRER----FT------EHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 198 VKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNP--YNRKC 253
+K EN+LLD N V + DFG+++ ++ + GT+ YMAP+++ G +++
Sbjct: 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAPDIVRGGDSGHDKAV 243
Query: 254 DVYSFGICLWEIYCCDMPY 272
D +S G+ ++E+ P+
Sbjct: 244 DWWSLGVLMYELLTGASPF 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
VI G+FG V++ G VA+K L D E+ +R KLD
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMR-----------KLD 105
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF- 171
H N+ + + +G+ + +V++Y+P + R K
Sbjct: 106 HCNIVRL---------RYFFYSSGEKKDEVYLN-LVLDYVPE-TVYRVARHYSRAKQTLP 154
Query: 172 KVVVQLAL-DLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEASNPNDM 229
+ V+L + L R L+Y+HS I HRD+K +N+LLD + +K+ DFG A+
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PN 213
Query: 230 TGETGTLGYMAPEVLNGNP-YNRKCDVYSFG 259
+ Y APE++ G Y DV+S G
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-22
Identities = 42/222 (18%), Positives = 82/222 (36%), Gaps = 36/222 (16%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRS 99
+W + + RG + V + + V VK+L + + + EI L
Sbjct: 29 VVEWGN-QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILE- 85
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
+ PN+ I + S +V E++ K
Sbjct: 86 ---------NLRGGPNIITL---------ADIVKDP-----VSRTPALVFEHVNNTDFKQ 122
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKIADFGV 218
+ L + ++ + L Y HS I+HRDVK N+++D ++R +++ D+G+
Sbjct: 123 LY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
Query: 219 ARVEASNPNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFG 259
A + + + PE+L + Y+ D++S G
Sbjct: 178 AEFYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 8e-22
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 56/236 (23%)
Query: 53 VIKSVIARGTFGTVHRG----LYDGHDVAVKLLDWGEEGHRTEA--EIAALRSAFTQEVA 106
+ RGT+G V++ D D A+K + G A EIA LR
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISMSACREIALLRE------- 74
Query: 107 VWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166
L HPNV ++ + + +V + + +Y L IK R
Sbjct: 75 ----LKHPNVISLQ-------KVFLSHADRKVWL-------LFDYAEHD-LWHI-IKFHR 114
Query: 167 RKLAFKVVVQLALD--------LARGLSYLHSQKIVHRDVKTENMLLDKNR----TVKIA 214
A K VQL + G+ YLH+ ++HRD+K N+L+ VKIA
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 215 DFGVARVEASNPNDMTGETG---TLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267
D G AR+ S + T Y APE+L G Y+ I +W I C
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGC 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 51/235 (21%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVK----LLDWGEEGHRTEAEIAAL 97
+ + S ++ I+ G++G V G+ +G VA+K + G +
Sbjct: 16 ELHAM-QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 98 RSAFTQEVAVWHKLDHPNVTK----FIGATMGS-SELHIQTENGQVAMPSNICCVVVEYL 152
R +E+ + + HPN+ F+ + +L++ TE M +++ V
Sbjct: 75 RV--LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE----LMRTDLAQV----- 123
Query: 153 PGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212
I ++R ++ + + + GL LH +VHRD+ N+LL N +
Sbjct: 124 ---------IHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174
Query: 213 IADFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
I DF +AR + ++ N T Y APE+ + + + D++S G + E++
Sbjct: 175 ICDFNLAREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-21
Identities = 29/239 (12%), Positives = 60/239 (25%), Gaps = 57/239 (23%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ + D VA+ +D +G + + S T ++ +
Sbjct: 35 LLIFHGGVPPLQFWQA-LDTALDRQVALTFVD--PQGVLPDDVLQETLSR-TLRLS---R 87
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+D P V + + VV E++ GG+L+ +
Sbjct: 88 IDKPGVAR----------VLDVVHTR------AGGLVVAEWIRGGSLQEVA----DTSPS 127
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
++ LA H + + + + V +A
Sbjct: 128 PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQVQ 289
M N + D+ G L+ + P P+ + R
Sbjct: 175 -------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-20
Identities = 52/246 (21%), Positives = 90/246 (36%), Gaps = 51/246 (20%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVK--LLDWGEEGHRTEAEIAALRSAF 101
E K + + G+FG V + G A+K L D E+ ++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMK--- 55
Query: 102 TQEVAVWHKLDHPNVTK----FIGATMGSSELHIQTENGQVAMPSNICC----------- 146
LDH N+ K F + ++ N
Sbjct: 56 --------VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNP 107
Query: 147 -------VVVEYLPG---GALKTYLIKNRRRKLAFKVVVQLAL-DLARGLSYLHSQKIVH 195
V++EY+P LK+++ R + + + + L R + ++HS I H
Sbjct: 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNL---ISIYIYQLFRAVGFIHSLGICH 164
Query: 196 RDVKTENMLLDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKC 253
RD+K +N+L++ T+K+ DFG A+ + + Y APE+ L Y
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSI 223
Query: 254 DVYSFG 259
D++S G
Sbjct: 224 DLWSIG 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 52/236 (22%), Positives = 93/236 (39%), Gaps = 46/236 (19%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLL----DWGEEGHRTEAEIA 95
+ + + I G G V +VA+K L R E+
Sbjct: 55 DSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFI------GATMGSSELHIQTENGQVAMPSNICCVVV 149
++ ++H N+ + ++++ E M +N+C V
Sbjct: 114 LMK-----------CVNHKNIISLLNVFTPQKTLEEFQDVYLVME----LMDANLCQV-- 156
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
++ L R L ++++ G+ +LHS I+HRD+K N+++ +
Sbjct: 157 -------IQMELDHERMSYLLYQML--------CGIKHLHSAGIIHRDLKPSNIVVKSDC 201
Query: 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
T+KI DFG+AR ++ MT T Y APEV+ G Y D++S G + E+
Sbjct: 202 TLKILDFGLARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 46/236 (19%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLL----DWGEEGHRTEAEIA 95
+ + + I G G V +VA+K L R E+
Sbjct: 18 DSTFTV-LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76
Query: 96 ALRSAFTQEVAVWHKLDHPNVTKFI------GATMGSSELHIQTENGQVAMPSNICCVVV 149
++ ++H N+ + + +++I E M +N+C V
Sbjct: 77 LMKC-----------VNHKNIIGLLNVFTPQKSLEEFQDVYIVME----LMDANLCQV-- 119
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
++ L R L ++++ G+ +LHS I+HRD+K N+++ +
Sbjct: 120 -------IQMELDHERMSYLLYQML--------CGIKHLHSAGIIHRDLKPSNIVVKSDC 164
Query: 210 TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265
T+KI DFG+AR ++ MT T Y APEV+ G Y D++S G + E+
Sbjct: 165 TLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 32/228 (14%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVK-LLDWGEEGHRTEAEIAAL 97
+ + V + + +GTFGTV G G VA+K ++ +R + L
Sbjct: 15 DERSRKEMDRFQVER-MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL 73
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
L HPN+ + G+ VV+EY+P L
Sbjct: 74 A-----------VLHHPNIVQL---------QSYFYTLGERDRRDIYLNVVMEYVPD-TL 112
Query: 158 KTYLIKNRRRKLAFKVV-VQLAL-DLARGLSYLH--SQKIVHRDVKTENMLLDK-NRTVK 212
RR++A + +++ L L R + LH S + HRD+K N+L+++ + T+K
Sbjct: 113 HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK 172
Query: 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFG 259
+ DFG A+ + + + Y APE++ GN Y D++S G
Sbjct: 173 LCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLL----DWGEEGHRTEAEI 94
+ WE+ P V + + G +G+V + G VA+K L R E+
Sbjct: 16 NKTAWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL 74
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
L+ + H NV L + T + + +V+ ++
Sbjct: 75 LLLKH-----------MQHENVIGL---------LDVFTPASSLRNFYDFY-LVMPFMQ- 112
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIA 214
T L K K + + + L + +GL Y+HS +VHRD+K N+ ++++ +KI
Sbjct: 113 ----TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 215 DFGVARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIY 266
DFG+AR +MTG T Y APEV L+ YN+ D++S G + E+
Sbjct: 169 DFGLARHAD---AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 35/84 (41%), Positives = 53/84 (63%), Gaps = 4/84 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242
RGL Y+HS I+HRD+K N+ ++++ +KI DFG+AR ++MTG T Y APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPE 199
Query: 243 V-LNGNPYNRKCDVYSFGICLWEI 265
+ LN YN+ D++S G + E+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 33/85 (38%), Positives = 52/85 (61%), Gaps = 4/85 (4%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPE 242
+GL Y+H+ I+HRD+K N+ ++++ +KI DFG+AR ++MTG T Y APE
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPE 195
Query: 243 V-LNGNPYNRKCDVYSFGICLWEIY 266
V LN Y + D++S G + E+
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 33/236 (13%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGH--RTEAEIAAL 97
+++ S+ + + G G V + VA+K + + EI +
Sbjct: 4 IHGFDL-GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKII 62
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP---G 154
R +LDH N+ K + T++ N +V EY+
Sbjct: 63 R-----------RLDHDNIVKVF--EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA 109
Query: 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKI 213
L+ + +L + QL RGL Y+HS ++HRD+K N+ ++ ++ +KI
Sbjct: 110 NVLEQGPLLEEHARL---FMYQLL----RGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 214 ADFGVARV---EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
DFG+AR+ S+ ++ T Y +P + L+ N Y + D+++ G E+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-18
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 50/241 (20%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEA-----EI 94
Q +++ + S I G +G V + VA+K + E H+T EI
Sbjct: 20 GQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREI 76
Query: 95 AALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS-----ELHIQTENGQVAMPSNICCVVV 149
L + H N+ + +++I + M +++ +
Sbjct: 77 KILL-----------RFRHENIIGINDIIRAPTIEQMKDVYIVQD----LMETDLYKL-- 119
Query: 150 EYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209
LKT + N + Q+ RGL Y+HS ++HRD+K N+LL+
Sbjct: 120 -------LKTQHLSNDHICY---FLYQIL----RGLKYIHSANVLHRDLKPSNLLLNTTC 165
Query: 210 TVKIADFGVARV---EASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEI 265
+KI DFG+ARV + + +T T Y APE+ LN Y + D++S G L E+
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
Query: 266 Y 266
Sbjct: 226 L 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 54 IKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ VI +G+FG V + YD VA+K++ +E+ +
Sbjct: 101 VLKVIGKGSFGQVVKA-YDHKVHQHVALKMV----------RNEKRFHRQAAEEIRILEH 149
Query: 111 L---DHPNVTKFIGATMGSS---ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
L D N I M + HI C+ E L L + KN
Sbjct: 150 LRKQDKDNTMNVI--HMLENFTFRNHI--------------CMTFELL-SMNLYELIKKN 192
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-DKNRT-VKIADFGVARVE 222
+ + + +V + A + + L LH +I+H D+K EN+LL + R+ +K+ DFG + E
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ + Y APEV+ G Y D++S G L E+
Sbjct: 253 ---HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 5e-17
Identities = 67/307 (21%), Positives = 109/307 (35%), Gaps = 88/307 (28%)
Query: 1 MEKSKKQRNSDDNILVTTAAAASANATATPIGKASNFLKKQRQDWEIEPSKLVIKSVIAR 60
+ +Q NS V+ + K + + + DW+I P + I+ +I
Sbjct: 5 EAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGT 63
Query: 61 GTFGTVHRGL--YDGHDVAVK--LLDWGEEGH--RTEAEIAALRSAFTQEVAVWHKLDHP 114
G++G V + VA+K L + + R EIA L +L+H
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN-----------RLNHD 112
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICC-----VVVEYLP---------GGALKTY 160
+V K + + +P ++ VV+E L
Sbjct: 113 HVVKVL----------------DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
IK ++ L G+ Y+HS I+HRD+K N L++++ +VK+ DFG+AR
Sbjct: 157 HIKT--------LLYNLL----VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204
Query: 221 VEASNPND---------------------------MTGETGTLGYMAPEV-LNGNPYNRK 252
N +TG T Y APE+ L Y
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264
Query: 253 CDVYSFG 259
DV+S G
Sbjct: 265 IDVWSIG 271
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYM--- 239
R + LH ++HRD+K N+L++ N +K+ DFG+AR+ + D + TG M
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 240 -------APEV-LNGNPYNRKCDVYSFG 259
APEV L Y+R DV+S G
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCG 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 8/125 (6%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENM 203
C+V E L L L R ++ + + A + L +L + + I+H D+K EN+
Sbjct: 132 CLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 204 LL--DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGIC 261
LL K +KI DFG + + + Y +PEVL G PY+ D++S G
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI 247
Query: 262 LWEIY 266
L E++
Sbjct: 248 LVEMH 252
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 22/99 (22%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND-------------- 228
+ + YLHS ++HRD+K N+LL+ VK+ADFG++R +
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 229 -------MTGETGTLGYMAPEV-LNGNPYNRKCDVYSFG 259
+T T Y APE+ L Y + D++S G
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND-------------- 228
G +++H I+HRD+K N LL+++ +VK+ DFG+AR S +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 229 --------MTGETGTLGYMAPEV-LNGNPYNRKCDVYSFG 259
+T T Y APE+ L Y + D++S G
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 7e-14
Identities = 42/171 (24%), Positives = 65/171 (38%), Gaps = 54/171 (31%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENML 204
C+V E L G L ++IK+ + L V ++ + +GL YLH++ +I+H D+K EN+L
Sbjct: 121 CMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 205 L-------------------------------------------------DKNRTVKIAD 215
L + VKIAD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 216 FGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
G A T + T Y + EVL G+ YN D++S +E+
Sbjct: 240 LGNACWV---HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 9e-14
Identities = 42/229 (18%), Positives = 83/229 (36%), Gaps = 44/229 (19%)
Query: 58 IARGTFGTVHRG----------LYDGHDVAVKLLDWGEEGH-RTEAEIAAL-RSAFTQEV 105
R G ++ ++KL + R E R+A +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL----DAKDGRLFNEQNFFQRAAKPLQV 105
Query: 106 AVW---HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
W + + +G G + +V+ L G +L++ L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGF--GVHQ-------------DKYRFLVLPSL-GRSLQSALD 149
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKNRTVKIADFGVAR 220
+ + L+ + V+Q+A L L +LH + VH +V EN+ + + V +A +G A
Sbjct: 150 VSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
Query: 221 VEASN-------PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262
+ + G L +++ ++ G +R+ D+ S G C+
Sbjct: 210 RYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 46/225 (20%), Positives = 82/225 (36%), Gaps = 33/225 (14%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGH---RTEAEI--AALRSAFTQEVAVWHK 110
I G FG ++ A ++ + + +E + + ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
LD+ + F G S L M V+E L G L+ +
Sbjct: 105 LDYLGIPLFYG-----SGLTEFKGRSYRFM-------VMERL-GIDLQKIS--GQNGTFK 149
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD--KNRTVKIADFGVARVEASN--- 225
V+QL + + L Y+H + VH D+K N+LL V +AD+G++ N
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 226 ----PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
N G GT+ + + + G +R+ DV G C+ +
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCM--LR 252
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-13
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 66/247 (26%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + GTFG V + + AVK++ + + A+I E + K+
Sbjct: 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKI---------EADILKKI 88
Query: 112 --DHPNVTKFIGATMGSSEL--------HIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
D N + + H+ C++ E L G +L +
Sbjct: 89 QNDDINNNNIV-------KYHGKFMYYDHM--------------CLIFEPL-GPSLYEII 126
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+N + + +++ + L+YL + H D+K EN+LLD K
Sbjct: 127 TRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186
Query: 222 EASNPNDMTGETGTL-----G-----------------YMAPEVLNGNPYNRKCDVYSFG 259
+ ++ + G Y APEV+ ++ D++SFG
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 260 ICLWEIY 266
L E+Y
Sbjct: 247 CVLAELY 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 38/147 (25%), Positives = 58/147 (39%), Gaps = 37/147 (25%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+ E L G +L +N + V +A L L +LH ++ H D+K EN+L
Sbjct: 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156
Query: 206 -------------------DKNRTVKIADFGVARVEASNPNDMTGETGTLG-------YM 239
KN ++++ADFG A T + Y
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----------TFDHEHHTTIVATRHYR 206
Query: 240 APEVLNGNPYNRKCDVYSFGICLWEIY 266
PEV+ + + CDV+S G L+E Y
Sbjct: 207 PPEVILELGWAQPCDVWSIGCILFEYY 233
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 1e-12
Identities = 38/207 (18%), Positives = 67/207 (32%), Gaps = 28/207 (13%)
Query: 39 KKQRQDWE--IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLL-----DWGEEGHRTE 91
+K + + KL I G FG V + + D VA+K++ D H+
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 92 AEIAALRSAFTQEVAVWHKL---DHPNVTKFIGA---------TMGSSELHIQTENGQ-- 137
E ++E+++ + + H + G
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 138 ---VAMPSNICCVVVEYLPGGA-LKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKI 193
+ +V+E+ GG L+ K A ++ QL LA + L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR---F 183
Query: 194 VHRDVKTENMLLDKNRTVKIADFGVAR 220
HRD+ N+LL K K+ +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 37/147 (25%)
Query: 146 CVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205
C+V E L G + ++ +N + ++A + + +++LHS K+ H D+K EN+L
Sbjct: 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 206 D-------------------KNRTVKIADFGVARVEASNPNDMTGETGTLG-------YM 239
N +K+ DFG A T + Y
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----------TYDDEHHSTLVSTRHYR 201
Query: 240 APEVLNGNPYNRKCDVYSFGICLWEIY 266
APEV+ +++ CDV+S G L E Y
Sbjct: 202 APEVILALGWSQPCDVWSIGCILIEYY 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 37/171 (21%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-P 114
I G FG + G LY VA+KL E ++ E + +L
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL-----EPMKSR------APQLHLEYRFYKQLGSGD 65
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
+ + G + N +V+E L G +L L R + K V
Sbjct: 66 GIPQVYYF--GPCGKY------------NA--MVLELL-GPSL-EDLFDLCDRTFSLKTV 107
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVAR 220
+ +A+ L + Y+HS+ +++RDVK EN L+ + + I DF +A+
Sbjct: 108 LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 34/227 (14%)
Query: 58 IARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEI--AALRSAFTQEVAVW 108
I +G FG ++ + VK+ TE + A + Q+
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
KL + V K+ G S LH + M +++ G L+ N + +
Sbjct: 103 RKLKYLGVPKYWG-----SGLHDKNGKSYRFM-------IMDRF-GSDLQKIYEANAK-R 148
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD--KNRTVKIADFGVARV----- 221
+ K V+QL+L + L Y+H + VH D+K N+LL+ V + D+G+A
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 222 --EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+A + GT+ + + + NG +R+ D+ G C+ I
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM--IQ 253
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 46/223 (20%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-P 114
I G+FG ++ G + G +VA+KL E +T+ E ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTK------HPQLHIESKIYKMMQGGV 65
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
+ G+ + N+ V+E L G +L+ L RK + K V
Sbjct: 66 GIPTIRWC--GAEGDY------------NVM--VMELL-GPSLE-DLFNFCSRKFSLKTV 107
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPNDMT- 230
+ LA + + Y+HS+ +HRDVK +N L+ K V I DFG+A+ + +
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-KYRDARTHQH 166
Query: 231 -------GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TGT Y + G +R+ D+ S G L +Y
Sbjct: 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL--MY 207
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 48/229 (20%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G+FG + G L + VA+K E R++ E + L
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSD------APQLRDEYRTYKLL 62
Query: 112 DH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ G LH N+ +V++ L G +L+ L+ RK +
Sbjct: 63 AGCTGIPNVYYF--GQEGLH------------NV--LVIDLL-GPSLE-DLLDLCGRKFS 104
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-----DKNRTVKIADFGVARVEASN 225
K V A + + +H + +V+RD+K +N L+ + + DFG+ + +
Sbjct: 105 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK-FYRD 163
Query: 226 PNDMT--------GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
P +GT YM+ G +R+ D+ + G +Y
Sbjct: 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF--MY 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 44/222 (19%)
Query: 58 IARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114
I G+FG ++ G + +VA+KL E +T+ E ++ L
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTK------HPQLLYESKIYRILQGGT 63
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
+ G + N+ +V++ L G +L+ L RKL+ K V
Sbjct: 64 GIPNVRWF--GVEGDY------------NV--LVMDLL-GPSLE-DLFNFCSRKLSLKTV 105
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT---VKIADFGVA---RVEASN--- 225
+ LA + + ++HS+ +HRD+K +N L+ R V I DFG+A R +++
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 226 -PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
+ TGT Y + G +R+ D+ S G L +Y
Sbjct: 166 PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL--MY 205
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 292 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.72 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.0 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.78 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.45 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.42 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.12 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.81 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.39 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.75 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=370.90 Aligned_cols=216 Identities=23% Similarity=0.390 Sum_probs=189.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||+||+|.+ +|+.||||++.... .......+.+.+|+.++++++||||++++++|.+.
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH------CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 36799999999999999999976 68999999995321 11112245688999999999999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 105 ~~~----------------yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~ 166 (311)
T 4aw0_A 105 EKL----------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 166 (311)
T ss_dssp SEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CEE----------------EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc
Confidence 765 8999999999999999653 5699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|+|||||++|+|++|++||.+.+..+++.+|
T Consensus 167 ~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 246 (311)
T 4aw0_A 167 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246 (311)
T ss_dssp TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998764322 2334568999999999999999999999999999999999999999999999999999
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 247 ~~~~ 250 (311)
T 4aw0_A 247 IKLE 250 (311)
T ss_dssp HHTC
T ss_pred HcCC
Confidence 8763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=373.13 Aligned_cols=216 Identities=26% Similarity=0.453 Sum_probs=184.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||||+++..... . ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---S----KEREESRREVAVLANMKHPNIVQYRESFEENG 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---H----HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 6899999999999999999976 5899999999754322 1 12456889999999999999999999998776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |||||||+||+|.+++...+...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 97 ~~----------------yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 160 (350)
T 4b9d_A 97 SL----------------YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 160 (350)
T ss_dssp EE----------------EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT
T ss_pred EE----------------EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence 65 89999999999999998766677899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|.+||+|||+++.............||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+|.++
T Consensus 161 ~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 240 (350)
T 4b9d_A 161 DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG 240 (350)
T ss_dssp TCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred CCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 99999999999976543222223356999999999999999999999999999999999999999999999999999876
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 241 ~ 241 (350)
T 4b9d_A 241 S 241 (350)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=366.82 Aligned_cols=210 Identities=29% Similarity=0.442 Sum_probs=188.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|++++.||+|+||.||+|.+ +|+.||||+++....... +.+.+|+.++++++||||++++++|.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---------ELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG---------GGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH---------HHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5699999999999999999976 589999999975443222 23678999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |||||||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 145 ~~----------------~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 145 EL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp EE----------------EEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EE----------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 65 899999999999998854 45999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|.+||+|||+++.............||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++..|.++
T Consensus 206 ~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 206 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp TCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 99999999999987665555556678999999999999999999999999999999999999999999999999888765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=366.35 Aligned_cols=210 Identities=29% Similarity=0.442 Sum_probs=189.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+.|++++.||+|+||.||+|.+ +|+.||||++........ +.+.+|+.++++++||||++++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---------~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---------ELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG---------GGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH---------HHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 5699999999999999999976 589999999975543222 23778999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |||||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 222 ~~----------------~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~ 282 (423)
T 4fie_A 222 EL----------------WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282 (423)
T ss_dssp EE----------------EEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT
T ss_pred EE----------------EEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC
Confidence 65 899999999999999853 45999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|.+||+|||++..............||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++..|.++
T Consensus 283 ~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 283 DGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp TCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 99999999999987665555556678999999999999999999999999999999999999999999999999888765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=360.43 Aligned_cols=216 Identities=28% Similarity=0.433 Sum_probs=182.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
.+++|++++.||+|+||+||+|.+ +++.||||+++........ ..++.+|+.++++++||||++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-------RVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-------CC------CCCCCCCCTTEECEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-------HHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 346899999999999999999965 4678999998643221111 1136679999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.+.+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 95 ~~~~~~~----------------~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 95 FQTEGKL----------------YLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp EEETTEE----------------EEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred EEECCEE----------------EEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 9887665 8999999999999999653 569999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
||++.+|.+||+|||+++.............||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++.
T Consensus 157 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 236 (304)
T 3ubd_A 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236 (304)
T ss_dssp EEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence 99999999999999999865544445556789999999999999999999999999999999999999999999999999
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
+|.++.
T Consensus 237 ~i~~~~ 242 (304)
T 3ubd_A 237 MILKAK 242 (304)
T ss_dssp HHHHCC
T ss_pred HHHcCC
Confidence 988763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=345.08 Aligned_cols=213 Identities=29% Similarity=0.546 Sum_probs=172.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++..... .......+.+|+.++++++||||+++++++.+.+
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA------KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 6899999999999999999975 6899999999643221 1122445889999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |+||||+ +|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 ~~----------------~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~ 147 (275)
T 3hyh_A 87 EI----------------IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE 147 (275)
T ss_dssp EE----------------EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT
T ss_pred EE----------------EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC
Confidence 65 8999999 68999998653 56999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.+||+|||+++..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+..++++.|.+
T Consensus 148 ~~~vkl~DFGla~~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~ 226 (275)
T 3hyh_A 148 HLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 226 (275)
T ss_dssp TCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEEeecCCCeecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 999999999999764432 23344689999999999998876 5799999999999999999999999999999998887
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
+.
T Consensus 227 ~~ 228 (275)
T 3hyh_A 227 GV 228 (275)
T ss_dssp TC
T ss_pred CC
Confidence 64
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=353.99 Aligned_cols=209 Identities=25% Similarity=0.345 Sum_probs=180.4
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..+.|.+.++||+|+||.||+|.+ +|+.||||+++.... ..+|+.++++++|||||++++++.+
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------------~~~E~~il~~l~HpnIV~l~~~~~~ 121 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------------RVEELVACAGLSSPRIVPLYGAVRE 121 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CTHHHHTTTTCCCTTBCCEEEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------------HHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 446799999999999999999976 589999999974321 2369999999999999999999987
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.+ ||||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 122 ~~~~----------------~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 183 (336)
T 4g3f_A 122 GPWV----------------NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL 183 (336)
T ss_dssp TTEE----------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE
T ss_pred CCEE----------------EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE
Confidence 6655 8999999999999999653 569999999999999999999999999999999999999
Q ss_pred cCCC-cEEEeecCcceeccCCCC-----CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 206 DKNR-TVKIADFGVARVEASNPN-----DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 206 ~~~~-~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
+.+| ++||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+
T Consensus 184 ~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 9887 699999999986543221 1123469999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHhh
Q 022794 280 VTSAVVRQV 288 (292)
Q Consensus 280 ~~~~i~~~~ 288 (292)
++.+|.++.
T Consensus 264 ~~~~i~~~~ 272 (336)
T 4g3f_A 264 LCLKIASEP 272 (336)
T ss_dssp CHHHHHHSC
T ss_pred HHHHHHcCC
Confidence 888887653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=346.41 Aligned_cols=220 Identities=35% Similarity=0.615 Sum_probs=180.0
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
....|++..+++++.+.||+|+||+||+|.+.+ .||||+++..... . ...+.|.+|+.++++++||||++++
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~---~----~~~~~f~~E~~il~~l~HpNIV~l~ 98 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPT---P----EQFQAFRNEVAVLRKTRHVNILLFM 98 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCC---H----HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCC---H----HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 345689999999999999999999999998766 5999998644322 1 1245688999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++... .. +|||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus 99 g~~~~~-~~----------------~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp 160 (307)
T 3omv_A 99 GYMTKD-NL----------------AIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKS 160 (307)
T ss_dssp EEECSS-SC----------------EEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCS
T ss_pred EEEECC-eE----------------EEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCH
Confidence 987543 22 8999999999999999653 35699999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCC--CCCCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+|||+++++.+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.
T Consensus 161 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~ 240 (307)
T 3omv_A 161 NNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI 240 (307)
T ss_dssp SSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999764322 122344679999999999864 35899999999999999999999999987
Q ss_pred CHHHHHHHHHH
Q 022794 276 SFSEVTSAVVR 286 (292)
Q Consensus 276 ~~~~~~~~i~~ 286 (292)
+..+.+..++.
T Consensus 241 ~~~~~~~~~~~ 251 (307)
T 3omv_A 241 NNRDQIIFMVG 251 (307)
T ss_dssp CCHHHHHHHHH
T ss_pred ChHHHHHHHHh
Confidence 76655555443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=347.23 Aligned_cols=219 Identities=30% Similarity=0.476 Sum_probs=182.1
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
..+..+++.+.+.||+|+||.||+|.+ +++.||||+++... . ...+.|.+|+.++++++|||||
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~----~~~~~f~~E~~il~~l~HpnIV 106 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----E----SARQDFQREAELLTMLQHQHIV 106 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-----H----HHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-----H----HHHHHHHHHHHHHHhCCCCCCC
Confidence 345567899999999999999999975 36789999986321 1 2245688999999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-------------ccccCHHHHHHHHHHHHHH
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------------RRKLAFKVVVQLALDLARG 184 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~i~~qi~~a 184 (292)
++++++.+.+.. +|||||+++|+|.+++.... ..++++..++.++.|++.|
T Consensus 107 ~l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 170 (329)
T 4aoj_A 107 RFFGVCTEGRPL----------------LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170 (329)
T ss_dssp CEEEEECSSSSE----------------EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHH
T ss_pred cEEEEEEECCEE----------------EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 999999877665 89999999999999996532 2458999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHH
Q 022794 185 LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262 (292)
Q Consensus 185 l~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il 262 (292)
|.|||+++|+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||++
T Consensus 171 l~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl 250 (329)
T 4aoj_A 171 MVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250 (329)
T ss_dssp HHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHH
Confidence 9999999999999999999999999999999999976533222 22335689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022794 263 WEIYC-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 263 ~~l~~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|||+| |+.||.+.+..+++..|.++.
T Consensus 251 ~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 251 WEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp HHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999 899999999999999988764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=346.05 Aligned_cols=217 Identities=31% Similarity=0.501 Sum_probs=185.1
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
+..++|.+.+.||+|+||.||+|.+ ++..||||+++... . ...+.|.+|+.++++++|||||++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-----~----~~~~~f~~E~~il~~l~HpnIV~l 80 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-----D----NARKDFHREAELLTNLQHEHIVKF 80 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-----H----HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-----h----HHHHHHHHHHHHHHhCCCCCCccE
Confidence 4457899999999999999999965 36789999986321 1 123558899999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-----------ccccCHHHHHHHHHHHHHHHHHH
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-----------RRKLAFKVVVQLALDLARGLSYL 188 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~l 188 (292)
++++.+.+.. ++||||+++|+|.+++.... ...+++..++.++.|++.||.||
T Consensus 81 ~g~~~~~~~~----------------~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T 4asz_A 81 YGVCVEGDPL----------------IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL 144 (299)
T ss_dssp EEEECSSSSE----------------EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeeCCEE----------------EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999877665 89999999999999997532 34699999999999999999999
Q ss_pred HhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 022794 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 189 H~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~ 266 (292)
|+++|+||||||+|||++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||+
T Consensus 145 H~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 145 ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999754332221 22245889999999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHHhh
Q 022794 267 C-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 267 ~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
| |+.||.+.+..+++..+.++.
T Consensus 225 t~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 225 TYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp TTTCCTTTTSCHHHHHHHHHHTC
T ss_pred cCCCCCCCCCCHHHHHHHHHcCC
Confidence 8 899999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=343.84 Aligned_cols=218 Identities=28% Similarity=0.495 Sum_probs=186.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
++...++++.+.||+|+||.||+|.+ +++.||||+++...... ..+.|.+|+.++++++||||++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~--------~~~~f~~E~~il~~l~HpNIV~ 93 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--------LREEFRHEAMLRARLQHPNVVC 93 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH--------HHHHHHHHHHHHHhCCCCCCCC
Confidence 45557899999999999999999975 46789999996443221 1345889999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHHHHHHHH
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARG 184 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~a 184 (292)
+++++.+.+.. ++||||+++|+|.+++.... ...+++..++.++.||+.|
T Consensus 94 l~g~~~~~~~~----------------~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 157 (308)
T 4gt4_A 94 LLGVVTKDQPL----------------SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 157 (308)
T ss_dssp EEEEECSSSSC----------------EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHH
T ss_pred cceEEEECCEE----------------EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHH
Confidence 99999877665 89999999999999996432 2458999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHH
Q 022794 185 LSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICL 262 (292)
Q Consensus 185 l~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il 262 (292)
|.|||+++++||||||+|||+++++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 158 l~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl 237 (308)
T 4gt4_A 158 MEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 237 (308)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHH
Confidence 999999999999999999999999999999999997543322 223345789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 263 WEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 263 ~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||+| |..||.+.+..+++..|.++
T Consensus 238 ~El~t~g~~Pf~~~~~~~~~~~i~~~ 263 (308)
T 4gt4_A 238 WEVFSYGLQPYCGYSNQDVVEMIRNR 263 (308)
T ss_dssp HHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99998 89999999999999988775
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=334.35 Aligned_cols=214 Identities=29% Similarity=0.525 Sum_probs=175.4
Q ss_pred Cce-eEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 50 SKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~-~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
++| ++.+.||+|+||.||+|.+ ++..||+|++...... . ...+.+.+|+.++++++|||||+++++|.+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---K----SERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---H----HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---H----HHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 455 7888999999999999976 4789999998644321 1 1245688999999999999999999998653
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p~Nil 204 (292)
... ...+||||||+++|+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 98 ~~~------------~~~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NIL 163 (290)
T 3fpq_A 98 VKG------------KKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 163 (290)
T ss_dssp ETT------------EEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEE
T ss_pred cCC------------CcEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhee
Confidence 110 1223899999999999999965 356999999999999999999999998 999999999999
Q ss_pred Ec-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q 022794 205 LD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS-FSEVTS 282 (292)
Q Consensus 205 i~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~-~~~~~~ 282 (292)
++ .++.+||+|||+|+.... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+ ..++..
T Consensus 164 l~~~~g~vKl~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~ 240 (290)
T 3fpq_A 164 ITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred EECCCCCEEEEeCcCCEeCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH
Confidence 97 478999999999975332 23345679999999999875 59999999999999999999999997654 455555
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.++
T Consensus 241 ~i~~~ 245 (290)
T 3fpq_A 241 RVTSG 245 (290)
T ss_dssp HHTTT
T ss_pred HHHcC
Confidence 55544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=348.10 Aligned_cols=219 Identities=23% Similarity=0.350 Sum_probs=183.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||+||+|.+ +|+.||||+++..... . ...+.+.+|+.+|++++||||+++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~---~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV---V----TNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc---h----HHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 46899999999999999999976 5899999998643221 1 1234577899999999999999999988654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .....+||||||++ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 126 ~~~----------~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 126 VPY----------GEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN 192 (398)
T ss_dssp SCT----------TTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred ccc----------ccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC
Confidence 322 12345599999995 689999854 46799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCC----CCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 207 KNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
.++.+||+|||+++..... ........||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l 272 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999765332 2233456899999999998876 4689999999999999999999999999999999
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..|.+.
T Consensus 273 ~~I~~~ 278 (398)
T 4b99_A 273 QLIMMV 278 (398)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=341.48 Aligned_cols=229 Identities=31% Similarity=0.531 Sum_probs=186.2
Q ss_pred hhhhhhcccceecCCceeEeeeeccCcceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH
Q 022794 36 NFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108 (292)
Q Consensus 36 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 108 (292)
..++.....|++..++|++.+.||+|+||.||+|.+.+ +.||||.++.... . ...+.+.+|+.++
T Consensus 50 ~~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~----~----~~~~~~~~E~~il 121 (353)
T 4ase_A 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKIL 121 (353)
T ss_dssp GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHH
T ss_pred hcCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----h----HHHHHHHHHHHHH
Confidence 33444455689999999999999999999999997643 5799999864321 1 1134588999999
Q ss_pred HhCCC-CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--------------cccCHHH
Q 022794 109 HKLDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------------RKLAFKV 173 (292)
Q Consensus 109 ~~l~h-~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~ 173 (292)
+++.| ||||++++++...+. .+++|||||++|+|.+++..... ..+++..
T Consensus 122 ~~l~hhpnIV~l~g~~~~~~~---------------~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~ 186 (353)
T 4ase_A 122 IHIGHHLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186 (353)
T ss_dssp HHHCCCTTBCCEEEEECCTTS---------------CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHH
T ss_pred HHcCCCCcEEEEEEEEEecCC---------------EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHH
Confidence 99955 899999999865432 12899999999999999975432 3488999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCc
Q 022794 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNR 251 (292)
Q Consensus 174 ~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ 251 (292)
+..++.||+.||.|||+++++||||||+|||+++++.+||+|||+++........ .....+|+.|+|||++.+..++.
T Consensus 187 ~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ 266 (353)
T 4ase_A 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 266 (353)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCC
Confidence 9999999999999999999999999999999999999999999999865433221 22345789999999999999999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHHh
Q 022794 252 KCDVYSFGICLWEIYC-CDMPYPDLSFSEVT-SAVVRQ 287 (292)
Q Consensus 252 ~~Diwslg~il~~l~~-g~~pf~~~~~~~~~-~~i~~~ 287 (292)
++|||||||++|||+| |..||.+.+..+.+ ..+.++
T Consensus 267 ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 267 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred cccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC
Confidence 9999999999999998 99999987755544 444443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=325.89 Aligned_cols=210 Identities=26% Similarity=0.488 Sum_probs=160.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||||+++.... . ...+.+.+|+.++++++||||++++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~----~----~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 76 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----E----LAREKVMREVKALAKLEHPGIVRYFNAWLEKN 76 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS----H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC----H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence 4699999999999999999976 589999999865431 1 12345889999999999999999999987655
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
...... ...+..++|++||||++|+|.+++..... ...++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~~----~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 77 TTEKLQ----PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp --------------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred cccccc----ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence 321100 01123345899999999999999965422 2355677899999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC------------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 207 KNRTVKIADFGVARVEASNPN------------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++ ||..
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999999999999976543221 1123469999999999999999999999999999999996 8865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=324.24 Aligned_cols=207 Identities=23% Similarity=0.321 Sum_probs=172.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 121 (292)
..++|++.+.||+|+||+||+|.+ +++.||+|.+..... ..++.+|+.+++.+ +||||+++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~E~~~l~~~~~h~nIv~l~~ 87 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----------PIRIAAELQCLTVAGGQDNVMGVKY 87 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----------HHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----------HHHHHHHHHHHHHhcCCCCCceEEE
Confidence 346899999999999999999965 367899998853321 12367899999998 7999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
+|.+.+.+ |+||||+++++|.+++. .+++..++.++.||+.||+|||++||+||||||+
T Consensus 88 ~~~~~~~~----------------~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPe 146 (361)
T 4f9c_A 88 CFRKNDHV----------------VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPS 146 (361)
T ss_dssp EEEETTEE----------------EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEECCEE----------------EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHH
Confidence 99877665 89999999999999882 4899999999999999999999999999999999
Q ss_pred CeeEcCC-CcEEEeecCcceeccCCC----------------------------CCCCCCCCcccccCCcccCCC-CCCc
Q 022794 202 NMLLDKN-RTVKIADFGVARVEASNP----------------------------NDMTGETGTLGYMAPEVLNGN-PYNR 251 (292)
Q Consensus 202 Nili~~~-~~~~l~Dfg~~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~ 251 (292)
|||++.+ +.+||+|||+|+...... .......||+.|+|||++.+. .++.
T Consensus 147 NiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~ 226 (361)
T 4f9c_A 147 NFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTT 226 (361)
T ss_dssp GEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCT
T ss_pred HeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCC
Confidence 9999876 899999999997543221 112335699999999999876 5899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHH
Q 022794 252 KCDVYSFGICLWEIYCCDMPYP-DLSFSEVTSAVVR 286 (292)
Q Consensus 252 ~~Diwslg~il~~l~~g~~pf~-~~~~~~~~~~i~~ 286 (292)
++||||+||++|+|++|+.||. +.+..+.+..|.+
T Consensus 227 ~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 227 AIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMT 262 (361)
T ss_dssp HHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred ccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999999999995 5566666666654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=340.55 Aligned_cols=218 Identities=25% Similarity=0.349 Sum_probs=177.6
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+..++|.+++.||+|+||.||+|.+ +|+.||||+++........ ..........++.+++.++||||++++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~---~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ---GETLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT---CHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh---hHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 45567999999999999999999976 6899999999532110000 011112233456777788999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.+.+ |+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 262 ~~~~~l----------------ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 262 HTPDKL----------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred EECCEE----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 887766 8999999999999999653 5699999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDL---SFSE 279 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~---~~~~ 279 (292)
|++.+|++||+|||+++..... ......||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||.+. +..+
T Consensus 324 Lld~~G~vKL~DFGlA~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 324 LLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp EECTTSCEEECCCTTCEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred EEeCCCCEEecccceeeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999865433 2344689999999999964 57999999999999999999999999753 3344
Q ss_pred HHHHHHH
Q 022794 280 VTSAVVR 286 (292)
Q Consensus 280 ~~~~i~~ 286 (292)
+...+..
T Consensus 402 i~~~i~~ 408 (689)
T 3v5w_A 402 IDRMTLT 408 (689)
T ss_dssp HHHHHHH
T ss_pred HHHhhcC
Confidence 4444443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=319.77 Aligned_cols=198 Identities=34% Similarity=0.495 Sum_probs=160.8
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
.+|.+.+.||+|+||.||+|.++|+.||||+++... .. ......|+..+.+++||||+++++++.+.+..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~-------~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER---SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG-------HH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 578999999999999999999999999999985321 11 11123466677788999999999998765421
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTE 201 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~i~h~di~p~ 201 (292)
...++|||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 73 ------------~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~ 137 (303)
T 3hmm_A 73 ------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp ------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG
T ss_pred ------------ceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc
Confidence 1123899999999999999954 4589999999999999999999987 9999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCC----CCCCCCcccccCCcccCCC------CCCchhhHHHHHHHHHHHHhCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIYCCDMP 271 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Diwslg~il~~l~~g~~p 271 (292)
|||++.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||+||.+|
T Consensus 138 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~ 217 (303)
T 3hmm_A 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred cEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCC
Confidence 999999999999999999865443221 2235699999999999764 357799999999999999999765
Q ss_pred C
Q 022794 272 Y 272 (292)
Q Consensus 272 f 272 (292)
|
T Consensus 218 ~ 218 (303)
T 3hmm_A 218 G 218 (303)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=338.44 Aligned_cols=211 Identities=24% Similarity=0.406 Sum_probs=185.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+++.||+|+||.||+|.+ +|+.||+|++.... .. ..+.+.+|+.+|+.++||||++++++|.+.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ES----DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HH----HHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hh----hHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 5899999999999999999976 68999999986432 11 1345778999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |++|||++||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 228 ~~----------------~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 228 EM----------------VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp EE----------------EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 65 8999999999999998543 346999999999999999999999999999999999999975
Q ss_pred C--CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 N--RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+ +.+||+|||+++..... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..|.
T Consensus 291 ~~~~~vKl~DFG~a~~~~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 291 KRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp SSCCCEEECCCSSCEECCTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeeccceeEccCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 4 89999999999876433 23334679999999999999999999999999999999999999999999999999987
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 370 ~~ 371 (573)
T 3uto_A 370 SC 371 (573)
T ss_dssp TT
T ss_pred hC
Confidence 75
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=309.39 Aligned_cols=218 Identities=25% Similarity=0.395 Sum_probs=182.6
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 123 (292)
+..++|++++.||+|+||.||+|.+ +|+.||||+++.. ..........+.+|..+++.+ +||||+++++++
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~------~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD------VILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH------HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH------HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 3457999999999999999999976 5889999998532 111122344577899999988 799999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.+.. |+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 94 ~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 155 (353)
T 3txo_A 94 QTPDRL----------------FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155 (353)
T ss_dssp ECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred EeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHE
Confidence 877655 8999999999999999653 5699999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
|++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+++.+
T Consensus 156 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 235 (353)
T 3txo_A 156 LLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 235 (353)
T ss_dssp EECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999997544444444556799999999999988899999999999999999999999999999999999
Q ss_pred HHHhh
Q 022794 284 VVRQV 288 (292)
Q Consensus 284 i~~~~ 288 (292)
|.++.
T Consensus 236 i~~~~ 240 (353)
T 3txo_A 236 ILNDE 240 (353)
T ss_dssp HHHCC
T ss_pred HHcCC
Confidence 88753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=304.64 Aligned_cols=216 Identities=29% Similarity=0.451 Sum_probs=186.6
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|.+++.||+|+||.||+|.+ +|+.||+|+++... .........+.+|..+++.++||||+++++++.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH------hhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 347899999999999999999976 58999999986321 0011123457789999999999999999999987
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 77 ~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 138 (337)
T 1o6l_A 77 HDRL----------------CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138 (337)
T ss_dssp SSEE----------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred CCEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE
Confidence 7655 8999999999999998643 568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..++...+.
T Consensus 139 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 218 (337)
T 1o6l_A 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999754444444455678999999999999999999999999999999999999999999999888887
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
.+
T Consensus 219 ~~ 220 (337)
T 1o6l_A 219 ME 220 (337)
T ss_dssp HC
T ss_pred cC
Confidence 64
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=301.70 Aligned_cols=222 Identities=41% Similarity=0.662 Sum_probs=180.3
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+++...+|++.+.||+|+||.||+|.++|+.||+|++...... . ...+.+.+|+.++++++||||+++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH---A----ERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCS---H----HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCC---H----HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3456677789999999999999999999999999999998644321 1 12345788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDV 198 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di 198 (292)
++.+.... +++|||+++++|.+++.... ...+++..++.++.|++.||++||+.| ++||||
T Consensus 102 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Di 165 (309)
T 3p86_A 102 AVTQPPNL----------------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL 165 (309)
T ss_dssp EECSTTCC----------------EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTC
T ss_pred EEEECCce----------------EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCC
Confidence 99876655 89999999999999996532 234999999999999999999999999 999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
||+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 166 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~ 245 (309)
T 3p86_A 166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245 (309)
T ss_dssp CGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred ChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999976544433444567899999999999999999999999999999999999999999988
Q ss_pred HHHHHHHH
Q 022794 279 EVTSAVVR 286 (292)
Q Consensus 279 ~~~~~i~~ 286 (292)
+....+..
T Consensus 246 ~~~~~~~~ 253 (309)
T 3p86_A 246 QVVAAVGF 253 (309)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 88777653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=311.06 Aligned_cols=217 Identities=28% Similarity=0.422 Sum_probs=180.2
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHH-HHhCCCCcccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV-WHKLDHPNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~ 123 (292)
+..++|++++.||+|+||.||+|.+ +++.||+|+++........ ....+.+|..+ ++.++||||+++++++
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~------~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK------EEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------CCBCCCCCTTBCCEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH------HHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 3457899999999999999999976 4788999999754321111 12234556665 5678999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.+.. |+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 109 ~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 109 QTADKL----------------YFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp ECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred EeCCEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 877655 8999999999999999653 4689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+++.+++++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+++..
T Consensus 171 ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~ 250 (373)
T 2r5t_A 171 LLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 250 (373)
T ss_dssp EECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH
T ss_pred EECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 99999999999999997644444445557899999999999999999999999999999999999999999999999998
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
|.++
T Consensus 251 i~~~ 254 (373)
T 2r5t_A 251 ILNK 254 (373)
T ss_dssp HHHS
T ss_pred HHhc
Confidence 8775
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=301.72 Aligned_cols=214 Identities=28% Similarity=0.510 Sum_probs=186.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-------PTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 36899999999999999999976 6899999999654321 11234577899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. ++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 87 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~ 148 (328)
T 3fe3_A 87 KTL----------------YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148 (328)
T ss_dssp SEE----------------EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CEE----------------EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc
Confidence 655 8999999999999999654 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||++...... .......+++.|+|||.+.+..++ .++||||||+++|+|++|..||.+.+..++...+.
T Consensus 149 ~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 227 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227 (328)
T ss_dssp TTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998754432 234456799999999999888765 78999999999999999999999999999998887
Q ss_pred Hhh
Q 022794 286 RQV 288 (292)
Q Consensus 286 ~~~ 288 (292)
++.
T Consensus 228 ~~~ 230 (328)
T 3fe3_A 228 RGK 230 (328)
T ss_dssp HCC
T ss_pred hCC
Confidence 764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=302.85 Aligned_cols=219 Identities=28% Similarity=0.442 Sum_probs=186.1
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 122 (292)
.+..++|.+.+.||+|+||.||+|.+ +|+.||+|+++.... ........+..|..+++.+ +||||++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~ 86 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 86 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH------HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh------hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 34568999999999999999999976 588999999963210 0111233466788888877 99999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.+.. ++||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 87 ~~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 148 (345)
T 1xjd_A 87 FQTKENL----------------FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 148 (345)
T ss_dssp EECSSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EEeCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhh
Confidence 9876655 8999999999999999653 469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
|+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..++..
T Consensus 149 Ill~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~ 228 (345)
T 1xjd_A 149 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228 (345)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999999754433344455779999999999999999999999999999999999999999999999998
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
+|..+.
T Consensus 229 ~i~~~~ 234 (345)
T 1xjd_A 229 SIRMDN 234 (345)
T ss_dssp HHHHCC
T ss_pred HHHhCC
Confidence 887653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=300.37 Aligned_cols=219 Identities=24% Similarity=0.379 Sum_probs=177.9
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+..++|++.+.||+|+||.||+|.+ +|+.||+|+++...... .......+.+|+.++++++||||+++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 4457999999999999999999975 68899999986432111 1112334678999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...+.. +++|||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+
T Consensus 89 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~ 150 (327)
T 3a62_A 89 AFQTGGKL----------------YLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPE 150 (327)
T ss_dssp EEECSSCE----------------EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT
T ss_pred EEEcCCEE----------------EEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHH
Confidence 99876655 8999999999999999643 46899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
||+++.++.++|+|||++..............|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+
T Consensus 151 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 230 (327)
T 3a62_A 151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230 (327)
T ss_dssp TEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999875443333344567899999999999999999999999999999999999999999999988
Q ss_pred HHHHHhh
Q 022794 282 SAVVRQV 288 (292)
Q Consensus 282 ~~i~~~~ 288 (292)
..+.+..
T Consensus 231 ~~i~~~~ 237 (327)
T 3a62_A 231 DKILKCK 237 (327)
T ss_dssp HHHHHTC
T ss_pred HHHHhCC
Confidence 8887653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=296.92 Aligned_cols=211 Identities=26% Similarity=0.463 Sum_probs=185.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +|+.||+|++....... .+.+.+|+.++++++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---------HHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 46899999999999999999965 68899999987543321 23477899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 90 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 90 DEL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (297)
T ss_dssp TEE----------------EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CEE----------------EEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC
Confidence 655 899999999999999854 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 230 (297)
T 3fxz_A 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (297)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 99999999999988766555555567899999999999999999999999999999999999999998888777666654
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 231 ~ 231 (297)
T 3fxz_A 231 N 231 (297)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=303.13 Aligned_cols=219 Identities=25% Similarity=0.374 Sum_probs=186.6
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 122 (292)
.+..++|.+++.||+|+||.||+|.+. |+.||+|+++... .........+..|..++..+ +||+|++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~------~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV------VIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 345689999999999999999999774 6789999986321 01111234567899999888 89999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.+.. |++|||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|
T Consensus 90 ~~~~~~~----------------~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 151 (353)
T 2i0e_A 90 FQTMDRL----------------YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151 (353)
T ss_dssp EECSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EEcCCEE----------------EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 9876655 8999999999999999653 469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
|+++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..++++
T Consensus 152 Ill~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~ 231 (353)
T 2i0e_A 152 VMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231 (353)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999999999754433344455679999999999999999999999999999999999999999999999998
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
+|.++.
T Consensus 232 ~i~~~~ 237 (353)
T 2i0e_A 232 SIMEHN 237 (353)
T ss_dssp HHHHCC
T ss_pred HHHhCC
Confidence 887753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=305.00 Aligned_cols=206 Identities=24% Similarity=0.392 Sum_probs=175.4
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 121 (292)
..+..++|.+++.||+|+||.||+|.+ +++.||+|+++....... .....+.+|..++.++ +||||+++++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~------~~~~~~~~E~~il~~~~~hp~Iv~l~~ 120 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD------EDIDWVQTEKHVFEQASNHPFLVGLHS 120 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----------CCHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH------HHHHHHHHHHHHHHhcCCCCCcCeeEE
Confidence 344567999999999999999999976 578999999975432111 1123366788888877 8999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+.+.. ++||||+++|+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 121 ~~~~~~~~----------------~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~ 182 (396)
T 4dc2_A 121 CFQTESRL----------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182 (396)
T ss_dssp EEECSSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EEEECCEE----------------EEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH
Confidence 99877665 8999999999999998653 56999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|||++.++.++|+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 183 NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 183 NVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred HEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9999999999999999997644444455567899999999999999999999999999999999999999963
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=303.50 Aligned_cols=221 Identities=34% Similarity=0.578 Sum_probs=186.6
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
..+.+..++|.+.+.||+|+||.||+|.+ ++..||||+++... .. ...+.+.+|+.+++++ +
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~~ 145 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TE----KDLSDLVSEMEMMKMIGK 145 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BH----HHHHHHHHHHHHHHHSCC
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CH----HHHHHHHHHHHHHHHhcC
Confidence 34667778999999999999999999975 24569999986432 11 2234578999999999 8
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
||||+++++++.+.+.. ++||||+++++|.+++.... ...+++..++.++
T Consensus 146 hpnIv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 209 (370)
T 2psq_A 146 HKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209 (370)
T ss_dssp CTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHH
T ss_pred CCCEeeEEEEEccCCCE----------------EEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHH
Confidence 99999999998876655 89999999999999997643 2357899999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.||+.||.|||++|++||||||+||+++.++.++|+|||++........ ......+++.|+|||++.+..++.++|||
T Consensus 210 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvw 289 (370)
T 2psq_A 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 289 (370)
T ss_dssp HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHH
Confidence 9999999999999999999999999999999999999999976543322 22334567899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||+++|+|++ |..||.+.+..++...+.++
T Consensus 290 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 321 (370)
T 2psq_A 290 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321 (370)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 99999999999 99999999988888877665
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=296.52 Aligned_cols=212 Identities=29% Similarity=0.469 Sum_probs=184.5
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +|+.||+|+++... .......+.+.+|..+++.++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI------VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence 47899999999999999999976 58999999985321 11111234577899999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 79 ~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 140 (318)
T 1fot_A 79 QQI----------------FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140 (318)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred CEE----------------EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc
Confidence 655 8999999999999999653 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||++...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+.+.++.+
T Consensus 141 ~~g~~kL~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 141 KNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp TTSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecCcceecCCc---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 9999999999999765432 2345789999999999999999999999999999999999999999999998888876
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 218 ~ 218 (318)
T 1fot_A 218 A 218 (318)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=310.85 Aligned_cols=221 Identities=29% Similarity=0.422 Sum_probs=187.3
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
..+.+..++|.+++.||+|+||.||+|.+ +++.||+|+++... .........+.+|..+++.++||||++++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE------MIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhh------hhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34556678999999999999999999976 57899999985311 00000112367899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.+.. ++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||
T Consensus 136 ~~~~~~~~~----------------~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp 196 (410)
T 3v8s_A 136 YAFQDDRYL----------------YMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196 (410)
T ss_dssp EEEECSSEE----------------EEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEEECCEE----------------EEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCH
Confidence 999876655 899999999999998854 3589999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNP----YNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+|||++.++.++|+|||++........ ......||+.|+|||++.+.. ++.++|+||||+++|+|++|..||.+.
T Consensus 197 ~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 276 (410)
T 3v8s_A 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276 (410)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence 999999999999999999976543321 233567999999999997765 788999999999999999999999999
Q ss_pred CHHHHHHHHHHhh
Q 022794 276 SFSEVTSAVVRQV 288 (292)
Q Consensus 276 ~~~~~~~~i~~~~ 288 (292)
+..+++.+|.++.
T Consensus 277 ~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 277 SLVGTYSKIMNHK 289 (410)
T ss_dssp SHHHHHHHHHTHH
T ss_pred ChhhHHHHHHhcc
Confidence 9999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=307.38 Aligned_cols=215 Identities=22% Similarity=0.392 Sum_probs=186.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-------ARDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-------HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-------HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 36899999999999999999976 6899999998654321 11234578999999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus 83 ~~~----------------~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~ 144 (444)
T 3soa_A 83 GHH----------------YLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144 (444)
T ss_dssp SEE----------------EEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred CEE----------------EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 655 8999999999999998653 5699999999999999999999999999999999999997
Q ss_pred ---CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 207 ---KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
.++.++|+|||++..............|++.|+|||++.+..++.++||||||+++|+|++|.+||.+.+..++...
T Consensus 145 ~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~ 224 (444)
T 3soa_A 145 SKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224 (444)
T ss_dssp BSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 46789999999997665554445557899999999999999999999999999999999999999999999999998
Q ss_pred HHHhh
Q 022794 284 VVRQV 288 (292)
Q Consensus 284 i~~~~ 288 (292)
+.++.
T Consensus 225 i~~~~ 229 (444)
T 3soa_A 225 IKAGA 229 (444)
T ss_dssp HHHTC
T ss_pred HHhCC
Confidence 88764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=297.00 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=175.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
..++|++++.||+|+||.||+|.+ +|+.||+|+++...... ....+.+.+|..+++++ +||||+++++++.
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc------hHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 447899999999999999999976 48899999997543211 11234577899999988 8999999999998
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.+.. +++|||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 81 ~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 142 (345)
T 3a8x_A 81 TESRL----------------FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142 (345)
T ss_dssp CSSEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred eCCEE----------------EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 76655 8999999999999999653 46999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
++.++.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 9999999999999997544444444556899999999999999999999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=310.18 Aligned_cols=223 Identities=26% Similarity=0.423 Sum_probs=188.1
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
..+.+..++|.+++.||+|+||.||+|.+ +++.||+|+++... .........+.+|..++..++||||++++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 140 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE------MLKRAETACFREERDVLVNGDSKWITTLH 140 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH------HHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH------hhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 34556678999999999999999999976 47899999985311 00011122367899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.+.. ++||||+++|+|.+++.+. ...+++..++.++.|++.||.|||++||+||||||
T Consensus 141 ~~~~~~~~~----------------~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp 203 (437)
T 4aw2_A 141 YAFQDDNNL----------------YLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203 (437)
T ss_dssp EEEECSSEE----------------EEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEeeCCEE----------------EEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCH
Confidence 999877665 8999999999999999653 35699999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+|||++.++.++|+|||++........ ......||+.|+|||++. ...++.++|+|||||++|+|++|..||.+
T Consensus 204 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred HHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999976543322 223457999999999986 45689999999999999999999999999
Q ss_pred CCHHHHHHHHHHhh
Q 022794 275 LSFSEVTSAVVRQV 288 (292)
Q Consensus 275 ~~~~~~~~~i~~~~ 288 (292)
.+..+.+.+|.+..
T Consensus 284 ~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 284 ESLVETYGKIMNHK 297 (437)
T ss_dssp SSHHHHHHHHHTHH
T ss_pred CChhHHHHhhhhcc
Confidence 99999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=299.32 Aligned_cols=215 Identities=22% Similarity=0.330 Sum_probs=186.9
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
...++|.+++.||+|+||.||+|.+ +|+.||+|+++... .........+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH------hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4457999999999999999999976 58999999985321 111122345788999999999999999999998
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.... +++|||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 112 ~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 173 (350)
T 1rdq_E 112 DNSNL----------------YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173 (350)
T ss_dssp CSSEE----------------EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCCEE----------------EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEE
Confidence 76655 8999999999999999653 46999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++.++|+|||.+...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+++.+|
T Consensus 174 l~~~g~~kL~DFg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 250 (350)
T 1rdq_E 174 IDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEcccccceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH
Confidence 999999999999999865432 23457899999999999999999999999999999999999999999999999988
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 251 ~~~~ 254 (350)
T 1rdq_E 251 VSGK 254 (350)
T ss_dssp HHCC
T ss_pred HcCC
Confidence 8763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=292.53 Aligned_cols=216 Identities=25% Similarity=0.421 Sum_probs=178.8
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+..++|++++.||+|+||.||+|.+ +++.||+|++....... ....+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK------EETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC------HHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc------HHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 3457999999999999999999976 58899999986543221 122455889999999999999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||++|++||||||+||+
T Consensus 82 ~~~~~----------------~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil 143 (294)
T 4eqm_A 82 EDDCY----------------YLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143 (294)
T ss_dssp CSSEE----------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred eCCeE----------------EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 76655 8999999999999999653 46999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+..+...+
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~ 223 (294)
T 4eqm_A 144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223 (294)
T ss_dssp ECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH
T ss_pred ECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999999987543322 122335689999999999999999999999999999999999999999888776555
Q ss_pred HHH
Q 022794 284 VVR 286 (292)
Q Consensus 284 i~~ 286 (292)
...
T Consensus 224 ~~~ 226 (294)
T 4eqm_A 224 HIQ 226 (294)
T ss_dssp HHS
T ss_pred Hhh
Confidence 443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=296.18 Aligned_cols=217 Identities=22% Similarity=0.407 Sum_probs=185.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||+|+++......... ....+.+.+|+.+++++.||||+++++++.+.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc---hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 46899999999999999999976 58899999997554322110 00123477899999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus 88 ~~~----------------~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 149 (361)
T 2yab_A 88 TDV----------------VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (361)
T ss_dssp SEE----------------EEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred CEE----------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 655 899999999999999954 35699999999999999999999999999999999999998
Q ss_pred CCC----cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++ .++|+|||++...... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+++.
T Consensus 150 ~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~ 228 (361)
T 2yab_A 150 DKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228 (361)
T ss_dssp CTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred CCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 776 7999999999865443 23344679999999999999999999999999999999999999999999999988
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.|.++
T Consensus 229 ~i~~~ 233 (361)
T 2yab_A 229 NITAV 233 (361)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 88765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=306.25 Aligned_cols=223 Identities=25% Similarity=0.383 Sum_probs=188.5
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
....+..++|.+++.||+|+||.||+|.+ +|+.||+|+++.. ..........+.+|..++..++||||++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~------~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW------DMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHH------HHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH------HhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 34556678999999999999999999976 5899999998521 111111223477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.+.. |+||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||
T Consensus 128 ~~~~~~~~~----------------~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp 190 (412)
T 2vd5_A 128 FAFQDENYL----------------YLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190 (412)
T ss_dssp EEEECSSEE----------------EEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEeeCCEE----------------EEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCH
Confidence 999876655 8999999999999999653 34699999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccC-------CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLN-------GNPYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
+|||++.+++++|+|||++........ ......||+.|+|||++. +..++.++|+|||||++|+|++|+.||
T Consensus 191 ~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 270 (412)
T 2vd5_A 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270 (412)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred HHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence 999999999999999999976543322 223457999999999987 356899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHhh
Q 022794 273 PDLSFSEVTSAVVRQV 288 (292)
Q Consensus 273 ~~~~~~~~~~~i~~~~ 288 (292)
.+.+..+++.+|.+..
T Consensus 271 ~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 271 YADSTAETYGKIVHYK 286 (412)
T ss_dssp CCSSHHHHHHHHHTHH
T ss_pred CCCCHHHHHHHHHhcc
Confidence 9999999999988653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=291.78 Aligned_cols=215 Identities=27% Similarity=0.428 Sum_probs=181.6
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..++|++++.||+|+||+||+|.+ +|+.||+|+++..... ......+.+|+.++++++||||+++++++.+.
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-------EGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-------chhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 458999999999999999999977 6889999998643321 12234577899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||++ ++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 92 ~~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~ 153 (311)
T 3niz_A 92 RCL----------------TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN 153 (311)
T ss_dssp SCE----------------EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CEE----------------EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC
Confidence 654 89999996 5888888653 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus 154 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 154 SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999999876555455555678999999999876 468999999999999999999999999988888888876
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 234 ~~ 235 (311)
T 3niz_A 234 SI 235 (311)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=296.06 Aligned_cols=230 Identities=22% Similarity=0.338 Sum_probs=191.7
Q ss_pred cCccCccchhhhhhcccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH
Q 022794 28 ATPIGKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105 (292)
Q Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~ 105 (292)
.+.............+...+..++|.+++.||+|+||.||+|.+ +++.||||+++.. . .....+..|+
T Consensus 13 ~~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~e~ 82 (360)
T 3llt_A 13 NLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI------K----KYTRSAKIEA 82 (360)
T ss_dssp -------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------H----HHHHHHHHHH
T ss_pred ceeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc------h----hhhhhhHHHH
Confidence 33344444455556677778889999999999999999999987 6889999998521 1 1233466799
Q ss_pred HHHHhCC-----CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHH
Q 022794 106 AVWHKLD-----HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALD 180 (292)
Q Consensus 106 ~~l~~l~-----h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 180 (292)
.+++.+. ||||+++++++...+.. +++|||+ +++|.+++.......+++..++.++.|
T Consensus 83 ~~l~~l~~~~~~h~~iv~~~~~~~~~~~~----------------~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~q 145 (360)
T 3llt_A 83 DILKKIQNDDINNNNIVKYHGKFMYYDHM----------------CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145 (360)
T ss_dssp HHHHHTCCCSTTGGGBCCEEEEEEETTEE----------------EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCCeecccceeeECCee----------------EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHH
Confidence 9999986 99999999998876654 8999999 899999998766667999999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeeEcC-------------------------CCcEEEeecCcceeccCCCCCCCCCCCc
Q 022794 181 LARGLSYLHSQKIVHRDVKTENMLLDK-------------------------NRTVKIADFGVARVEASNPNDMTGETGT 235 (292)
Q Consensus 181 i~~al~~lH~~~i~h~di~p~Nili~~-------------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 235 (292)
|+.||.|||+.|++||||||+|||++. ++.++|+|||.+...... .....++
T Consensus 146 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt 222 (360)
T 3llt_A 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINT 222 (360)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSC
T ss_pred HHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCc
Confidence 999999999999999999999999975 788999999999764432 2346789
Q ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 236 LGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 236 ~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.+.
T Consensus 223 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 274 (360)
T 3llt_A 223 RQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274 (360)
T ss_dssp GGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999999998888877654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=295.79 Aligned_cols=213 Identities=26% Similarity=0.443 Sum_probs=184.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +|+.||+|++...... . ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---A----RDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---H----HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 5799999999999999999976 5889999999754322 1 12345788999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus 102 ~~----------------~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 102 FH----------------YLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp EE----------------EEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred EE----------------EEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 55 899999999999999854 356899999999999999999999999999999999999975
Q ss_pred C---CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 N---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+ +.++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|.+||.+.+..++...+
T Consensus 164 ~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 242 (362)
T 2bdw_A 164 KAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242 (362)
T ss_dssp SSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 4 45999999999765432 2334467899999999999989999999999999999999999999999999998888
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 243 ~~~~ 246 (362)
T 2bdw_A 243 KAGA 246 (362)
T ss_dssp HHTC
T ss_pred HhCC
Confidence 7763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=298.52 Aligned_cols=217 Identities=26% Similarity=0.400 Sum_probs=180.2
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+..++|++++.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.+++.++||||+++++
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 82 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK------CVERNEVRNVFKELQIMQGLEHPFLVNLWY 82 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh------cccHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3455568999999999999999999976 57889999985321 111112345788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+.... +++|||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 83 ~~~~~~~~----------------~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 144 (384)
T 4fr4_A 83 SFQDEEDM----------------FMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPD 144 (384)
T ss_dssp EEECSSEE----------------EEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EEEeCCEE----------------EEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence 99877665 899999999999999864 356999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCC---C
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPD---L 275 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~~l~~g~~pf~~---~ 275 (292)
||+++.++.++|+|||++...... .......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.. .
T Consensus 145 NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~ 223 (384)
T 4fr4_A 145 NILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223 (384)
T ss_dssp GEEECTTSCEEECCCTTCEECCTT-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS
T ss_pred HeEECCCCCEEEeccceeeeccCC-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc
Confidence 999999999999999999865433 33445779999999999974 4588999999999999999999999974 3
Q ss_pred CHHHHHHHHH
Q 022794 276 SFSEVTSAVV 285 (292)
Q Consensus 276 ~~~~~~~~i~ 285 (292)
...++...+.
T Consensus 224 ~~~~~~~~~~ 233 (384)
T 4fr4_A 224 SSKEIVHTFE 233 (384)
T ss_dssp CHHHHHHHHH
T ss_pred cHHHHHHHHh
Confidence 3444444443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=310.49 Aligned_cols=219 Identities=27% Similarity=0.441 Sum_probs=178.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
..+..++|++++.||+|+||.||+|.+ +|+.||||+++.... ........+.+|+.+++.++||||++++++
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI------VAKDEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH------C-------------CCCCCSCTTSCCEEEE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh------hhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 334557899999999999999999976 588999999863211 011122346789999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTE 201 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~ 201 (292)
+...+.. ++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+
T Consensus 217 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~ 278 (446)
T 4ejn_A 217 FQTHDRL----------------CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278 (446)
T ss_dssp EEETTEE----------------EEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGG
T ss_pred EeeCCEE----------------EEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHH
Confidence 9876655 8999999999999998643 569999999999999999999998 99999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|||++.++.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..++.
T Consensus 279 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 358 (446)
T 4ejn_A 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358 (446)
T ss_dssp GEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred HEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH
Confidence 99999999999999999975444444455578999999999999999999999999999999999999999999999888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+..+
T Consensus 359 ~~i~~~ 364 (446)
T 4ejn_A 359 ELILME 364 (446)
T ss_dssp HHHHHC
T ss_pred HHHHhC
Confidence 887654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=294.95 Aligned_cols=218 Identities=31% Similarity=0.548 Sum_probs=182.8
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.++..++|.+.+.||+|+||.||+|.+ .+..||||+++... . ....+.+.+|+.++++++||||+++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~~iv~~ 115 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----T----ERQRRDFLSEASIMGQFDHPNIIRL 115 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----C----HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----C----HHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 456678999999999999999999976 34469999996332 1 1223457889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+.+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|||||
T Consensus 116 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 178 (325)
T 3kul_A 116 EGVVTRGRLA----------------MIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178 (325)
T ss_dssp EEEECGGGCC----------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEEeCCcc----------------EEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 9998766554 8999999999999998643 3469999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 179 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 258 (325)
T 3kul_A 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258 (325)
T ss_dssp GGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999865433222 222345678999999998889999999999999999999 99999999
Q ss_pred CHHHHHHHHHHh
Q 022794 276 SFSEVTSAVVRQ 287 (292)
Q Consensus 276 ~~~~~~~~i~~~ 287 (292)
+..++...+.++
T Consensus 259 ~~~~~~~~~~~~ 270 (325)
T 3kul_A 259 TNRDVISSVEEG 270 (325)
T ss_dssp CHHHHHHHHHTT
T ss_pred CHHHHHHHHHcC
Confidence 999998888765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=285.11 Aligned_cols=218 Identities=32% Similarity=0.644 Sum_probs=186.9
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
..|.+..++|++.+.||+|+||.||+|.+ +++.||+|++...... .+.+.+|+.++++++||||+++++
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~ 72 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYG 72 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 35777889999999999999999999977 6888999999644321 123778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+.... +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||||+
T Consensus 73 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~ 135 (269)
T 4hcu_A 73 VCLEQAPI----------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 135 (269)
T ss_dssp EECSSSSE----------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEecCCce----------------EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchh
Confidence 98876654 8999999999999998653 346899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 136 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~ 215 (269)
T 4hcu_A 136 NCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215 (269)
T ss_dssp GEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred eEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999987543221 12233456778999999998899999999999999999999 999999999999
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
+...+..+
T Consensus 216 ~~~~~~~~ 223 (269)
T 4hcu_A 216 VVEDISTG 223 (269)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhcC
Confidence 98888765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=292.85 Aligned_cols=212 Identities=21% Similarity=0.337 Sum_probs=183.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +++.||+|++.... . ....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------T----DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------H----HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc------c----cHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 47899999999999999999976 58899999985321 1 123477899999999999999999999776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 74 ~~~----------------~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~ 136 (321)
T 1tki_A 74 EEL----------------VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp TEE----------------EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CEE----------------EEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc
Confidence 655 8999999999999998542 34699999999999999999999999999999999999998
Q ss_pred C--CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 K--NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
. ++.++|+|||.+...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+++..+
T Consensus 137 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 215 (321)
T 1tki_A 137 TRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCCCEEEEECCCCeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence 7 789999999999765432 2233356899999999999888899999999999999999999999999999999888
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 216 ~~~~ 219 (321)
T 1tki_A 216 MNAE 219 (321)
T ss_dssp HHTC
T ss_pred HcCC
Confidence 7653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=317.22 Aligned_cols=219 Identities=25% Similarity=0.373 Sum_probs=187.4
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 122 (292)
.+...+|.+++.||+|+||.||+|.+ +++.||||+++... .........+..|..++..+ +||+|++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~ 410 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV------VIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 410 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH------HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc------cccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 44567899999999999999999976 57789999986321 01111234467789999888 89999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.+.+ |+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 411 ~~~~~~~----------------~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~N 472 (674)
T 3pfq_A 411 FQTMDRL----------------YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472 (674)
T ss_dssp CBCSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTT
T ss_pred EEeCCEE----------------EEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhh
Confidence 9876655 8999999999999999654 469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
||++.++.++|+|||++..............||+.|+|||++.+..++.++|+||||+++|+|++|.+||.+.+..++++
T Consensus 473 ILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~ 552 (674)
T 3pfq_A 473 VMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552 (674)
T ss_dssp EEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999999999865444444555789999999999999999999999999999999999999999999999999
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.|.++.
T Consensus 553 ~i~~~~ 558 (674)
T 3pfq_A 553 SIMEHN 558 (674)
T ss_dssp HHHSSC
T ss_pred HHHhCC
Confidence 988753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=289.18 Aligned_cols=214 Identities=29% Similarity=0.472 Sum_probs=170.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||+|+++....... ...+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--------PSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS--------CHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc--------HHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 46899999999999999999965 589999999975543222 12366899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.. +++|||++ ++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 76 ~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 76 NKL----------------TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138 (317)
T ss_dssp TEE----------------EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CeE----------------EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence 654 89999996 69999986532 2358999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|+++.++.++|+|||.+..............+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+.+
T Consensus 139 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 218 (317)
T 2pmi_A 139 LLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218 (317)
T ss_dssp EEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999998765444445556789999999999764 5899999999999999999999999999999988
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.+.
T Consensus 219 ~~i~~~ 224 (317)
T 2pmi_A 219 KLIFDI 224 (317)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=286.99 Aligned_cols=213 Identities=29% Similarity=0.426 Sum_probs=177.6
Q ss_pred CceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
++|++++.||+|+||.||+|.+. |+.||+|+++........ ...+.+|+.++++++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-------PSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC-------CHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc-------chhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 68999999999999999999774 889999998654322211 2336789999999999999999999887655
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++ +|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 75 ~----------------~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 136 (288)
T 1ob3_A 75 L----------------VLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (288)
T ss_dssp E----------------EEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred E----------------EEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC
Confidence 4 899999965 999988643 3568999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+.+..+.+.
T Consensus 137 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 216 (288)
T 1ob3_A 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (288)
T ss_dssp SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999987655443444456789999999999764 5899999999999999999999999999998888887763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=284.54 Aligned_cols=213 Identities=27% Similarity=0.445 Sum_probs=181.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||+|+++....... ....+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT-------HHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCC-------cchHHHHHHHHHhcCCCCCEeeEEeEEEeCC
Confidence 5899999999999999999977 588999999975543222 1234678999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++ +|.+++... ...+++..++.++.|++.||.+||++|++||||||+||+++.
T Consensus 75 ~~----------------~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~ 136 (292)
T 3o0g_A 75 KL----------------TLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136 (292)
T ss_dssp EE----------------EEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EE----------------EEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 54 899999965 676666542 456999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~p-f~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+..............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..| |.+.+..+.+..+.
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp TSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 99999999999987665555556678899999999998765 79999999999999999987666 77888888888877
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 217 ~~ 218 (292)
T 3o0g_A 217 RL 218 (292)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=306.91 Aligned_cols=220 Identities=25% Similarity=0.390 Sum_probs=185.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+..++|.+.+.||+|+||.||+|.+ +|+.||+|++.... .........+.+|..++++++||||+++++++
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~------~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR------LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH------hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 35567999999999999999999976 58999999985321 11111234577899999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
.+.... |+||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 255 ~~~~~l----------------~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~ 318 (543)
T 3c4z_A 255 ETKTDL----------------CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318 (543)
T ss_dssp ECSSEE----------------EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred eeCCEE----------------EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH
Confidence 876655 89999999999999986543 446999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL----SF 277 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~----~~ 277 (292)
||+++.+|.++|+|||++..............||+.|+|||++.+..++.++|+|||||++|+|++|..||... +.
T Consensus 319 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~ 398 (543)
T 3c4z_A 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398 (543)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred HEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence 99999999999999999987654444444468999999999999999999999999999999999999999875 34
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.+.
T Consensus 399 ~~~~~~i~~~ 408 (543)
T 3c4z_A 399 KELKQRVLEQ 408 (543)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHhhc
Confidence 5666666543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=291.57 Aligned_cols=218 Identities=25% Similarity=0.435 Sum_probs=180.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +|+.||||++......... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP----GLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS----SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc----cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 46899999999999999999976 5899999998532100000 00123478899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.. +++|||+++++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 99 ~~~----------------~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl 162 (351)
T 3c0i_A 99 GML----------------YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162 (351)
T ss_dssp TEE----------------EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CEE----------------EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence 554 89999999999998886532 335899999999999999999999999999999999999
Q ss_pred EcCCCc---EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 205 LDKNRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 205 i~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
++.++. ++|+|||.+..............+++.|+|||++.+..++.++||||||+++|+|++|..||.+. ..++.
T Consensus 163 ~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~ 241 (351)
T 3c0i_A 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLF 241 (351)
T ss_dssp ECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHH
T ss_pred EecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHH
Confidence 976654 99999999987655444445567999999999999999999999999999999999999999874 55666
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.++
T Consensus 242 ~~i~~~ 247 (351)
T 3c0i_A 242 EGIIKG 247 (351)
T ss_dssp HHHHHT
T ss_pred HHHHcC
Confidence 666554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.51 Aligned_cols=215 Identities=22% Similarity=0.314 Sum_probs=186.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||+|+||.||++.+ +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 46899999999999999999976 47899999986433211 12245578899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ..+++..++.++.|++.+|.+||++|++|+||||+||+++
T Consensus 114 ~~~----------------~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 175 (335)
T 2owb_A 114 DFV----------------FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175 (335)
T ss_dssp SEE----------------EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred CeE----------------EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc
Confidence 554 8999999999999988643 5689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+..............++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence 99999999999998765444444556789999999999988899999999999999999999999999888887777665
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 256 ~ 256 (335)
T 2owb_A 256 N 256 (335)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=303.99 Aligned_cols=217 Identities=31% Similarity=0.603 Sum_probs=188.1
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...|.+..++|++.+.||+|+||.||+|.++|+.||||+++.... .+.+.+|+.++++++||||+++++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~ 253 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLG 253 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTT-----------SHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchH-----------HHHHHHHHHHHHhccCCCEEEEEE
Confidence 567888889999999999999999999999999999999964321 234788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++..... ..+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+
T Consensus 254 ~~~~~~~---------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 254 VIVEEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp EEECTTS---------------CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEcCCC---------------ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 8765432 1289999999999999998765556899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
|||++.++.++|+|||+++..... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..++
T Consensus 319 Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 319 NVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp GEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred hEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999999754322 122356789999999999999999999999999999998 9999999998888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 396 ~~~i~~~ 402 (450)
T 1k9a_A 396 VPRVEKG 402 (450)
T ss_dssp HHHHHTT
T ss_pred HHHHHcC
Confidence 8887765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.78 Aligned_cols=210 Identities=22% Similarity=0.330 Sum_probs=177.6
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 123 (292)
+..++|++.+.||+|+||.||+|.+ +|+.||||++....... .+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-----------QLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC-----------CHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH-----------HHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 4568999999999999999999974 68999999987543321 267899999999 999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+ +++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 75 ~~~~~~----------------~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 136 (330)
T 2izr_A 75 PCGKYN----------------AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENF 136 (330)
T ss_dssp EETTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred ecCCcc----------------EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 776554 8999999 99999999754 45799999999999999999999999999999999999
Q ss_pred eEcCCCc-----EEEeecCcceeccCCCCC-------CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 022794 204 LLDKNRT-----VKIADFGVARVEASNPND-------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (292)
Q Consensus 204 li~~~~~-----~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~p 271 (292)
+++.++. ++|+|||++......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 137 ll~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~P 216 (330)
T 2izr_A 137 LIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216 (330)
T ss_dssp EECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 9998887 999999999865433221 2346789999999999999999999999999999999999999
Q ss_pred CCCCCH---HHHHHHHH
Q 022794 272 YPDLSF---SEVTSAVV 285 (292)
Q Consensus 272 f~~~~~---~~~~~~i~ 285 (292)
|.+.+. .+.+..+.
T Consensus 217 f~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 217 WQGLKADTLKERYQKIG 233 (330)
T ss_dssp TTTCCCSSHHHHHHHHH
T ss_pred ccccccccHHHHHHHHH
Confidence 997544 34444443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.91 Aligned_cols=222 Identities=33% Similarity=0.552 Sum_probs=188.6
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL- 111 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 111 (292)
...|.+..++|.+.+.||+|+||.||+|.+. +..||+|+++.... . .....+.+|+.+++++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT----E----KDLSDLISEMEMMKMIG 132 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHHHC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC----H----HHHHHHHHHHHHHHHhc
Confidence 3456777889999999999999999999753 35799999864321 1 1234578899999999
Q ss_pred CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHH
Q 022794 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQL 177 (292)
Q Consensus 112 ~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i 177 (292)
+||||+++++++...+.. +++|||+++++|.+++.... ...+++..++.+
T Consensus 133 ~hpnIv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 196 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196 (382)
T ss_dssp CCTTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHH
T ss_pred CCchhhhheeeeccCCce----------------EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHH
Confidence 999999999999876655 89999999999999997643 245899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhH
Q 022794 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDV 255 (292)
Q Consensus 178 ~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 255 (292)
+.|++.||.+||+.|++||||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++||
T Consensus 197 ~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 276 (382)
T 3tt0_A 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276 (382)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHH
T ss_pred HHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHH
Confidence 9999999999999999999999999999999999999999997554322 22233456789999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 256 wslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
||||+++|+|++ |..||.+.+..++...+.++
T Consensus 277 wslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 309 (382)
T 3tt0_A 277 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309 (382)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999 99999999999988887765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=286.85 Aligned_cols=222 Identities=28% Similarity=0.410 Sum_probs=177.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccH-----------------HHHHHHHHHHHHHHHHHH
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTE-----------------AEIAALRSAFTQEVAVWH 109 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~-----------------~~~~~~~~~~~~e~~~l~ 109 (292)
.++|++.+.||+|+||.||+|.+ +|+.||||++.......... .......+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999976 58899999986543211100 001112345789999999
Q ss_pred hCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH
Q 022794 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 110 ~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
+++||||+++++++.+.... ..+++|||+++++|.+++ ....+++..++.++.|++.||.|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~--------------~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNED--------------HLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSS--------------EEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCC--------------EEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998764322 238999999999998765 3357999999999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC---CCchhhHHHHHHHHHHHH
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Diwslg~il~~l~ 266 (292)
++|++||||||+||+++.++.++|+|||++..............+++.|+|||.+.+.. ++.++|+||||+++|+|+
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 99999999999999999999999999999986654433344567899999999998765 378899999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHh
Q 022794 267 CCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 267 ~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|..||...+..++...+..+
T Consensus 235 ~g~~pf~~~~~~~~~~~~~~~ 255 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIKSQ 255 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHHHC
T ss_pred HCCCCCCCccHHHHHHHHhcc
Confidence 999999998888777776654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=285.35 Aligned_cols=216 Identities=24% Similarity=0.401 Sum_probs=183.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +|+.||+|+++......... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 5799999999999999999976 58899999987544321110 001234778999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 88 ~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 149 (326)
T 2y0a_A 88 DV----------------ILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 149 (326)
T ss_dssp EE----------------EEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred EE----------------EEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec
Confidence 54 899999999999999954 356999999999999999999999999999999999999988
Q ss_pred CC----cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 208 NR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 208 ~~----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++ .++|+|||.+...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....
T Consensus 150 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 228 (326)
T 2y0a_A 150 RNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228 (326)
T ss_dssp SSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred CCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 77 7999999999765433 233446789999999999999999999999999999999999999999888888877
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.+.
T Consensus 229 ~~~~ 232 (326)
T 2y0a_A 229 VSAV 232 (326)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=292.17 Aligned_cols=222 Identities=26% Similarity=0.429 Sum_probs=179.5
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
....++|++.+.||+|+||.||+|.+ +++.||||+++...... ......+.+|+.++++++||||+++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD------PSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS------HHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC------HHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 34568999999999999999999975 68899999996543211 22344578899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...... ...++++|||+++++|.+++... ..+++..++.++.|++.+|.|||++|++||||||+||
T Consensus 82 ~~~~~~------------~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 147 (311)
T 3ork_A 82 EAETPA------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI 147 (311)
T ss_dssp EEEETT------------EEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eccCCC------------CcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence 665432 12338999999999999999643 4699999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 148 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 227 (311)
T 3ork_A 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 227 (311)
T ss_dssp EEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999875443221 22234589999999999999999999999999999999999999999988887
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 228 ~~~~~~~ 234 (311)
T 3ork_A 228 AYQHVRE 234 (311)
T ss_dssp HHHHHHC
T ss_pred HHHHhcC
Confidence 7666554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=297.37 Aligned_cols=221 Identities=21% Similarity=0.345 Sum_probs=184.9
Q ss_pred cceecCCceeEeeeeccC--cceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 44 DWEIEPSKLVIKSVIARG--TFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G--~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.+....++|++++.||+| +||.||+|.+ +|+.||||+++..... ....+.+.+|+.++++++||||+++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~ 91 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-------NEMVTFLQGELHVSKLFNHPNIVPY 91 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-------hHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 344566899999999999 9999999977 4899999999754321 1234557889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+.+.. ++||||+++++|.+++.......+++..++.++.||+.||.|||++|++|||||
T Consensus 92 ~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 155 (389)
T 3gni_B 92 RATFIADNEL----------------WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155 (389)
T ss_dssp EEEEEETTEE----------------EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred eEEEEECCEE----------------EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999876655 899999999999999977655679999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCC-------CCCCCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDM 270 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g~~ 270 (292)
|+|||++.++.++|+|||.+....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 156 p~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 235 (389)
T 3gni_B 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235 (389)
T ss_dssp GGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 999999999999999999875432111 11222468889999999987 578999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHh
Q 022794 271 PYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 271 pf~~~~~~~~~~~i~~~ 287 (292)
||.+.+..+.+..+.++
T Consensus 236 pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 236 PFKDMPATQMLLEKLNG 252 (389)
T ss_dssp TTTTCCSTTHHHHC---
T ss_pred CCCCCCHHHHHHHHhcC
Confidence 99988777776665543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=286.85 Aligned_cols=209 Identities=28% Similarity=0.437 Sum_probs=182.8
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
.|...+.||+|+||.||+|.+ +|+.||||++....... .+.+.+|+.++++++||||+++++++...+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---------RELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---------HHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---------HHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 478889999999999999976 58999999997543221 2347789999999999999999999887665
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++|||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.+
T Consensus 117 ~----------------~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 117 L----------------WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp E----------------EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred E----------------EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 4 899999999999998843 469999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.+.
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 256 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 256 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 9999999999876655444445567999999999999999999999999999999999999999998888887776654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=294.95 Aligned_cols=222 Identities=31% Similarity=0.503 Sum_probs=187.2
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 115 (292)
..+.+..++|.+.+.||+|+||.||+|.+.+ +.||+|+++.... ....+.+.+|+.++++++|||
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~ 111 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDNPN 111 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCC
Confidence 4467777899999999999999999997653 7899999864321 123455889999999999999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----------------------ccccCHHH
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------------RRKLAFKV 173 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~ 173 (292)
|+++++++.+.+.. +++|||+++++|.+++.... ...+++..
T Consensus 112 iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 175 (343)
T 1luf_A 112 IVKLLGVCAVGKPM----------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175 (343)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred EEEEEEEEccCCce----------------EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHH
Confidence 99999998776554 89999999999999997642 15689999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCc
Q 022794 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNR 251 (292)
Q Consensus 174 ~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 251 (292)
++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.
T Consensus 176 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 255 (343)
T 1luf_A 176 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 255 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc
Confidence 99999999999999999999999999999999999999999999987543221 1223355788999999999888999
Q ss_pred hhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022794 252 KCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 252 ~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
++|+||||+++|+|++ |..||.+.+..++...+.++.
T Consensus 256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 293 (343)
T 1luf_A 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN 293 (343)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC
Confidence 9999999999999999 999999999999888877653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=280.41 Aligned_cols=218 Identities=31% Similarity=0.566 Sum_probs=186.3
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
++++..++|++.+.||+|+||.||+|.+. +..||+|+++..... .+.+.+|+.++++++||||++++++
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----------EDEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 45677889999999999999999999775 558999999644321 1237789999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.... +++|||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|+||||+|
T Consensus 72 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 134 (268)
T 3sxs_A 72 CSKEYPI----------------YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN 134 (268)
T ss_dssp ECSSSSE----------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGG
T ss_pred EccCCce----------------EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcce
Confidence 8766554 8999999999999999654 3469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
|+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+.
T Consensus 135 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (268)
T 3sxs_A 135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214 (268)
T ss_dssp EEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence 9999999999999999976543322 2233456678999999988889999999999999999999 9999999999988
Q ss_pred HHHHHHhh
Q 022794 281 TSAVVRQV 288 (292)
Q Consensus 281 ~~~i~~~~ 288 (292)
...+.++.
T Consensus 215 ~~~~~~~~ 222 (268)
T 3sxs_A 215 VLKVSQGH 222 (268)
T ss_dssp HHHHHTTC
T ss_pred HHHHHcCC
Confidence 88877653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=283.62 Aligned_cols=219 Identities=28% Similarity=0.591 Sum_probs=184.6
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
..|.+..++|++++.||+|+||.||++.+. +..||+|+++..... .+.+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~~ 86 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYG 86 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----------HHHHHHHHHHHhcCCCCCEeeEEE
Confidence 567778899999999999999999999775 558999999644321 123778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+.+.. +++|||+++++|.+++... ...+++..++.++.|++.+|.+||++|++|+||||+
T Consensus 87 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~ 149 (283)
T 3gen_A 87 VCTKQRPI----------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149 (283)
T ss_dssp EECSSSSE----------------EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred EEecCCCe----------------EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccc
Confidence 98776554 8999999999999999653 356999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 150 NCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp GEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 9999999999999999987543221 12233456778999999998889999999999999999998 999999999999
Q ss_pred HHHHHHHhh
Q 022794 280 VTSAVVRQV 288 (292)
Q Consensus 280 ~~~~i~~~~ 288 (292)
....+.++.
T Consensus 230 ~~~~~~~~~ 238 (283)
T 3gen_A 230 TAEHIAQGL 238 (283)
T ss_dssp HHHHHHTTC
T ss_pred HHHHHhccc
Confidence 888887663
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.65 Aligned_cols=212 Identities=27% Similarity=0.444 Sum_probs=165.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
+...++|.+.+.||+|+||.||+|.+ +++.||||+++.... .+.+.+|+.++++++||||+++++++
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~ 117 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----------KKIVRTEIGVLLRLSHPNIIKLKEIF 117 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------------CHHHHHCCCTTBCCEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----------HHHHHHHHHHHHhCCCCCCcceeeeE
Confidence 34457899999999999999999987 477899999964321 23467899999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 118 ~~~~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 179 (349)
T 2w4o_A 118 ETPTEI----------------SLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179 (349)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ecCCeE----------------EEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccE
Confidence 876654 899999999999999854 35689999999999999999999999999999999999
Q ss_pred eEcC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Q 022794 204 LLDK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE- 279 (292)
Q Consensus 204 li~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~- 279 (292)
+++. ++.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+
T Consensus 180 ll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 258 (349)
T 2w4o_A 180 LYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258 (349)
T ss_dssp EESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred EEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence 9975 789999999998754432 22334568999999999999999999999999999999999999998766554
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
+...+.+.
T Consensus 259 ~~~~i~~~ 266 (349)
T 2w4o_A 259 MFRRILNC 266 (349)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHhC
Confidence 55555443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.39 Aligned_cols=219 Identities=30% Similarity=0.545 Sum_probs=188.4
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...|.+..++|.+.+.||+|+||.||+|.+. +..||||+++.... . .+.+.+|+.++++++||||++++
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~-------~~~~~~E~~~l~~l~h~~iv~l~ 249 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---S-------VEAFLAEANVMKTLQHDKLVKLH 249 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---C-------HHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---c-------HHHHHHHHHHHhhCCCCCEeeEE
Confidence 4568888899999999999999999999875 77899999974331 1 23478999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.. ... +++|||+++|+|.+++.......+++..++.++.|++.||.|||++|++||||||
T Consensus 250 ~~~~~-~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 312 (454)
T 1qcf_A 250 AVVTK-EPI----------------YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312 (454)
T ss_dssp EEECS-SSC----------------EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred EEEeC-Ccc----------------EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence 98753 222 8999999999999999765556789999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+|||++.++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 313 ~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp GGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred HHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997543221 11223446778999999998889999999999999999999 99999999999
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
++...+.++
T Consensus 393 ~~~~~i~~~ 401 (454)
T 1qcf_A 393 EVIRALERG 401 (454)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHcC
Confidence 999888765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=293.58 Aligned_cols=203 Identities=16% Similarity=0.262 Sum_probs=172.8
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEE-------ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGL-------YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--- 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-------~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--- 112 (292)
..+.+..++|.+.+.||+|+||.||+|. .+++.||+|+++... ...+..|..+++++.
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------PWEFYIGTQLMERLKPSM 125 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------HHHHHHHHHHHHHSCGGG
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------hhHHHHHHHHHHHhhhhh
Confidence 4556677899999999999999999993 368899999986321 123567788888885
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN---RRRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
|+||+.+++++...+.. ++||||+++|+|.+++... ....+++..++.++.|++.||+|||
T Consensus 126 ~~~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH 189 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGS----------------VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189 (365)
T ss_dssp GGGBCCEEEEEECSSCE----------------EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhheeeecCCCc----------------EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 89999999998876665 8999999999999999653 2456999999999999999999999
Q ss_pred hCCccccCCCCCCeeEcC-----------CCcEEEeecCcceeccC--CCCCCCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 190 SQKIVHRDVKTENMLLDK-----------NRTVKIADFGVARVEAS--NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~-----------~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
+.||+||||||+|||++. ++.++|+|||++..... .........||+.|+|||++.+..++.++|||
T Consensus 190 ~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (365)
T 3e7e_A 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269 (365)
T ss_dssp TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHH
T ss_pred hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHH
Confidence 999999999999999988 89999999999975432 22233456799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCC
Q 022794 257 SFGICLWEIYCCDMPYP 273 (292)
Q Consensus 257 slg~il~~l~~g~~pf~ 273 (292)
|||+++|+|++|+.||.
T Consensus 270 slG~il~elltg~~pf~ 286 (365)
T 3e7e_A 270 GVAATVYCMLFGTYMKV 286 (365)
T ss_dssp HHHHHHHHHHHSSCCCE
T ss_pred HHHHHHHHHHhCCCccc
Confidence 99999999999998875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=288.08 Aligned_cols=219 Identities=22% Similarity=0.368 Sum_probs=178.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
....++|++.+.||+|+||.||+|.+. |+.||||+++....... .+.+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--------VDVQMREFEVLKKLNHKNIVKLFAIE 76 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--------HHHHHHHHHHHHhcCCCCcceEEEEe
Confidence 345689999999999999999999775 88999999864322111 23467899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
...... ..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 77 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (319)
T 4euu_A 77 EETTTR--------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142 (319)
T ss_dssp ECTTTC--------------CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ecCCCc--------------eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHH
Confidence 765432 23899999999999999975432 238999999999999999999999999999999999
Q ss_pred eeE----cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC--------CCCCCchhhHHHHHHHHHHHHhCCC
Q 022794 203 MLL----DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN--------GNPYNRKCDVYSFGICLWEIYCCDM 270 (292)
Q Consensus 203 ili----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Diwslg~il~~l~~g~~ 270 (292)
|++ +.++.++|+|||.+....... ......+++.|+|||++. +..++.++||||||+++|+|++|..
T Consensus 143 Ill~~~~~~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 221 (319)
T 4euu_A 143 IMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (319)
T ss_dssp EEEEECTTSCEEEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred EEEeccCCCCceEEEccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999 677789999999998654432 333467899999999985 5678999999999999999999999
Q ss_pred CCCCCC----HHHHHHHHHHh
Q 022794 271 PYPDLS----FSEVTSAVVRQ 287 (292)
Q Consensus 271 pf~~~~----~~~~~~~i~~~ 287 (292)
||.... ..+++.++..+
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 222 PFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp SEECTTCGGGCHHHHHHHHHH
T ss_pred CCCCCCccchhHHHHHHHhcC
Confidence 997433 34555555544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.35 Aligned_cols=218 Identities=29% Similarity=0.543 Sum_probs=186.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+..++|.+.+.||+|+||.||+|.+ +|+.||||+++... .........+.+|+.+++.++||||+++++++
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK------IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH------HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh------ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34457999999999999999999976 58999999985321 11112244688999999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||
T Consensus 86 ~~~~~~----------------~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 86 STPSDI----------------FMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp ECSSEE----------------EEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred EECCEE----------------EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 876655 899999999999999853 45699999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+++.++.++|+|||++...... .......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+..++..
T Consensus 148 ll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 226 (476)
T 2y94_A 148 LLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK 226 (476)
T ss_dssp EECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH
T ss_pred EEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9999999999999999865432 23344678999999999998765 689999999999999999999999999988888
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
++.++.
T Consensus 227 ~i~~~~ 232 (476)
T 2y94_A 227 KICDGI 232 (476)
T ss_dssp HHHTTC
T ss_pred HHhcCC
Confidence 887764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=290.59 Aligned_cols=213 Identities=26% Similarity=0.417 Sum_probs=172.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.++++++||||+++++++.+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-------GVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-------ccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 36899999999999999999965 68899999986443211 1233467899999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||++ ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 106 ~~~----------------~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~ 166 (329)
T 3gbz_A 106 HRL----------------HLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166 (329)
T ss_dssp TEE----------------EEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred CEE----------------EEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEe
Confidence 655 89999996 5999998653 4599999999999999999999999999999999999994
Q ss_pred -----CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 -----KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 -----~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
..+.++|+|||.+..............+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 246 (329)
T 3gbz_A 167 VSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246 (329)
T ss_dssp C-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH
Confidence 44569999999997665444445556789999999999875 489999999999999999999999999999998
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+.++.+.
T Consensus 247 ~~~~~~~ 253 (329)
T 3gbz_A 247 LFKIFEV 253 (329)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=281.28 Aligned_cols=219 Identities=30% Similarity=0.551 Sum_probs=187.1
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.++|.+..++|++++.||+|+||.||+|.+. +..||+|+++..... .+.+.+|+.++++++||||++++
T Consensus 5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~~i~~~~ 74 (279)
T 1qpc_A 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRLY 74 (279)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----------HHHHHHHHHHHHhCCCcCcceEE
Confidence 3568888999999999999999999999775 568999998643321 23477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.... .+++|||+++++|.+++.......+++..++.++.|++.||.+||++|++|+||||
T Consensus 75 ~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 137 (279)
T 1qpc_A 75 AVVTQEP-----------------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRA 137 (279)
T ss_dssp EEECSSS-----------------CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEcCCC-----------------cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 9875432 28999999999999999655445799999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..
T Consensus 138 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 217 (279)
T 1qpc_A 138 ANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (279)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence 999999999999999999976543321 2233456778999999988889999999999999999999 99999999998
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
++...+.++
T Consensus 218 ~~~~~~~~~ 226 (279)
T 1qpc_A 218 EVIQNLERG 226 (279)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHhcc
Confidence 888887665
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=280.54 Aligned_cols=216 Identities=32% Similarity=0.628 Sum_probs=173.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
++..++|++.+.||+|+||.||+|.++|+.||+|+++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDE-----DISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcc-----cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 456689999999999999999999999999999998643221 112223457889999999999999999999887
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCC
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK---IVHRDVKTEN 202 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~h~di~p~N 202 (292)
.+.. +++|||+++++|.+++. ...+++..++.++.|++.||.+||+.| ++|+||||+|
T Consensus 78 ~~~~----------------~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N 138 (271)
T 3dtc_A 78 EPNL----------------CLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138 (271)
T ss_dssp C--C----------------EEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred CCce----------------EEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence 6654 89999999999999883 457999999999999999999999999 8999999999
Q ss_pred eeEcC--------CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 203 MLLDK--------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 203 ili~~--------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|+++. ++.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+
T Consensus 139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 139 ILILQKVENGDLSNKILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp EEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred EEEecccccccccCcceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99986 6789999999997544322 2245689999999999988899999999999999999999999999
Q ss_pred CCHHHHHHHHHHh
Q 022794 275 LSFSEVTSAVVRQ 287 (292)
Q Consensus 275 ~~~~~~~~~i~~~ 287 (292)
.+..+....+..+
T Consensus 217 ~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 217 IDGLAVAYGVAMN 229 (271)
T ss_dssp SCHHHHHHHHHTS
T ss_pred CCHHHHHHhhhcC
Confidence 8887777666544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=283.75 Aligned_cols=220 Identities=31% Similarity=0.587 Sum_probs=179.5
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
......|.+..++|++.+.||+|++|.||+|.++|+.||+|+++... ..+.+.+|+.++++++||||++
T Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~ 78 (278)
T 1byg_A 10 EFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----------TAQAFLAEASVMTQLRHSNLVQ 78 (278)
T ss_dssp -----CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCC
T ss_pred hhhhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----------HHHHHHHHHHHHHhCCCCCEee
Confidence 34455677788999999999999999999999999999999986432 1234788999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++..... ..+++|||+++++|.+++.......+++..++.++.|++.||.+||++|++|+||
T Consensus 79 ~~~~~~~~~~---------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 143 (278)
T 1byg_A 79 LLGVIVEEKG---------------GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143 (278)
T ss_dssp EEEEECCC-----------------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEEcCCC---------------ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 9998755432 2289999999999999997665556899999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
||+||+++.++.++|+|||.+...... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 144 kp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 144 AARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp SGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred CcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998754322 222456788999999988889999999999999999998 9999999888
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 221 ~~~~~~~~~~ 230 (278)
T 1byg_A 221 KDVVPRVEKG 230 (278)
T ss_dssp GGHHHHHTTT
T ss_pred HHHHHHHhcC
Confidence 8877776554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=305.22 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=179.1
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+..++|.+.+.||+|+||.||+|.+ +|+.||+|++.... .........+.+|+.++++++||||+++++++
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~------~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR------IKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh------hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 46678899999999999999999976 68999999985321 11111234477899999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.+.. ++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+||
T Consensus 254 ~~~~~l----------------~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 254 ETKDAL----------------CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred eeCCEE----------------EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 876655 8999999999999999765555699999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
|++.++.++|+|||++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 318 Lld~~g~vKL~DFGla~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 318 LLDDHGHIRISDLGLAVHVPEGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp EECTTSCEEECCCTTCEECCTTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred EEeCCCCeEEEecccceecccCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999997654332 2334579999999999999899999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=301.11 Aligned_cols=221 Identities=26% Similarity=0.473 Sum_probs=182.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCc----cHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHR----TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
..++|.+++.||+|+||.||+|.+ +++.||+|++........ .........+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 357899999999999999999976 578999999875432110 01111223456889999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+.... ++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+
T Consensus 114 ~~~~~~~~----------------~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 175 (504)
T 3q5i_A 114 VFEDKKYF----------------YLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPE 175 (504)
T ss_dssp EEECSSEE----------------EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEcCCEE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHH
Confidence 99876655 8999999999999998653 56999999999999999999999999999999999
Q ss_pred CeeEcCCC---cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 202 NMLLDKNR---TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 202 Nili~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
||+++.++ .++|+|||++...... .......+++.|+|||++.+ .++.++||||+|+++|+|++|.+||.+.+..
T Consensus 176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 176 NILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp GEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99998775 6999999999765433 33344679999999999874 5899999999999999999999999999999
Q ss_pred HHHHHHHHhh
Q 022794 279 EVTSAVVRQV 288 (292)
Q Consensus 279 ~~~~~i~~~~ 288 (292)
+++..+.++.
T Consensus 254 ~~~~~i~~~~ 263 (504)
T 3q5i_A 254 DIIKKVEKGK 263 (504)
T ss_dssp HHHHHHHHCC
T ss_pred HHHHHHHcCC
Confidence 9999888764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=284.91 Aligned_cols=213 Identities=24% Similarity=0.384 Sum_probs=177.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||+|++...... ....+.+.+|+.++++++||||+++++++...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-------PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-------hHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 6899999999999999999977 4889999988543321 223445778999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||||+||+++.
T Consensus 76 ~~----------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~ 137 (311)
T 4agu_A 76 RL----------------HLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137 (311)
T ss_dssp EE----------------EEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred eE----------------EEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC
Confidence 54 899999999999988753 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.+
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 138 HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp TSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999876544444455678999999999876 5689999999999999999999999999999988887766
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 218 ~ 218 (311)
T 4agu_A 218 T 218 (311)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=281.93 Aligned_cols=205 Identities=35% Similarity=0.565 Sum_probs=174.7
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
..+..++|++.+.||+|+||.||+|.+ +++.||+|++... . ....+.+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-----~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-----D----EETQRTFLKEVKVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-----C----HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-----C----HHHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence 456678999999999999999999976 4889999987421 1 1224458899999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.+.. +++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 76 ~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N 138 (310)
T 3s95_A 76 LYKDKRL----------------NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138 (310)
T ss_dssp EEETTEE----------------EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred EecCCee----------------EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCe
Confidence 8876554 8999999999999999653 4569999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCC--------------CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDM--------------TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g 268 (292)
|+++.++.++|+|||.+.......... ....|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 139 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 218 (310)
T 3s95_A 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218 (310)
T ss_dssp EEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcC
Confidence 999999999999999997654322211 135689999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 022794 269 DMPYPDL 275 (292)
Q Consensus 269 ~~pf~~~ 275 (292)
..||...
T Consensus 219 ~~~~~~~ 225 (310)
T 3s95_A 219 VNADPDY 225 (310)
T ss_dssp CCSSTTT
T ss_pred CCCCcch
Confidence 9998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=289.91 Aligned_cols=204 Identities=29% Similarity=0.546 Sum_probs=173.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||+|++.... .........+.+|+.+++.++||||+++++++...
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL------LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP 81 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH------ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 37899999999999999999986 68899999985211 11111234578899999999999999999999877
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+ +|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 82 ~~~----------------~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 142 (336)
T 3h4j_B 82 TDI----------------VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142 (336)
T ss_dssp SEE----------------EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC
T ss_pred CEE----------------EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc
Confidence 655 8999999 78999988653 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
.++.++|+|||++...... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+....
T Consensus 143 ~~~~~kl~DFG~s~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 143 DNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp TTCCEEECCSSCTBTTTTS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred CCCCEEEEEeccceeccCC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 9999999999998754432 33345678999999999988776 68999999999999999999999875443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=286.32 Aligned_cols=224 Identities=31% Similarity=0.409 Sum_probs=179.5
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIG 121 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~ 121 (292)
+..++|++++.||+|+||.||+|.+ +|+.||||+++.......... ....+.+|+.+++++ .||||+++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG----LPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC----CCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc----cchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 4467999999999999999999974 688999999874432111000 011244566666555 5999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...... .....+++|||+. ++|.+++.......+++..++.++.|++.||+|||++|++||||||+
T Consensus 82 ~~~~~~~~-----------~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 82 VCATSRTD-----------REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp EEEECCSS-----------SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred eeeccCCC-----------CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 98764421 0112389999995 69999997766566999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
||+++.++.++|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|++||.+.+..+.+
T Consensus 150 Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 150 NILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228 (308)
T ss_dssp TEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred HEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999999754332 2334467899999999999999999999999999999999999999999999999
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
.++.+.
T Consensus 229 ~~i~~~ 234 (308)
T 3g33_A 229 GKIFDL 234 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=298.57 Aligned_cols=216 Identities=24% Similarity=0.320 Sum_probs=177.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||||++..... ......++.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 133 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-------ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence 47899999999999999999966 588999999864311 112244577899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....++||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 134 ~~~~----------~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 134 KTLE----------EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp CSTT----------TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred Cccc----------cCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 4321 12345899999965 6776663 2489999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..|.+
T Consensus 199 ~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp TTSCEEECCCCCC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEEEEEeeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999765432 234446789999999999999999999999999999999999999999999999988876
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 278 ~ 278 (464)
T 3ttj_A 278 Q 278 (464)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=294.59 Aligned_cols=226 Identities=31% Similarity=0.545 Sum_probs=184.3
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 110 (292)
+......|++..++|++.+.||+|+||.||+|.+ +++.||||+++.... . ...+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~ 81 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIH 81 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHH
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC----H----HHHHHHHHHHHHHHh
Confidence 4445567788889999999999999999999974 357899999964321 1 113457889999999
Q ss_pred C-CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-----------------------
Q 022794 111 L-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----------------------- 166 (292)
Q Consensus 111 l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------- 166 (292)
+ +||||+++++++.+.+.. .+++|||+++++|.+++.....
T Consensus 82 l~~hpniv~~~~~~~~~~~~---------------~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (359)
T 3vhe_A 82 IGHHLNVVNLLGACTKPGGP---------------LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146 (359)
T ss_dssp HCCCTTBCCEEEEECSTTSC---------------CEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred hcCCcceeeeeeeeecCCCc---------------eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence 9 899999999998765431 2899999999999999975432
Q ss_pred -----------------------------------------cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 167 -----------------------------------------RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 167 -----------------------------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
..+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll 226 (359)
T 3vhe_A 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226 (359)
T ss_dssp -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 128899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~ 282 (292)
+.++.++|+|||.+........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+.
T Consensus 227 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 306 (359)
T 3vhe_A 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306 (359)
T ss_dssp CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH
Confidence 9999999999999975433222 2233457788999999998899999999999999999998 999999877655544
Q ss_pred HHHH
Q 022794 283 AVVR 286 (292)
Q Consensus 283 ~i~~ 286 (292)
....
T Consensus 307 ~~~~ 310 (359)
T 3vhe_A 307 RRLK 310 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=285.22 Aligned_cols=220 Identities=29% Similarity=0.570 Sum_probs=189.5
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.+.|++...+|++.+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~ 74 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----------EVEEFLKEAAVMKEIKHPNLVQL 74 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 3578888999999999999999999999775 88999999863321 12347789999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+.+.. +++|||+++++|.+++.......+++..++.++.|++.+|.+||++|++|+|||
T Consensus 75 ~~~~~~~~~~----------------~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik 138 (288)
T 3kfa_A 75 LGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138 (288)
T ss_dssp EEEECSSSSE----------------EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCS
T ss_pred EEEEccCCCE----------------EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence 9998776654 899999999999999987666779999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 139 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 139 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp GGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999875443221 1222345678999999998899999999999999999999 9999999888
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.+.
T Consensus 219 ~~~~~~~~~~ 228 (288)
T 3kfa_A 219 SQVYELLEKD 228 (288)
T ss_dssp GGHHHHHHTT
T ss_pred HHHHHHHhcc
Confidence 8887777654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=292.95 Aligned_cols=214 Identities=25% Similarity=0.374 Sum_probs=170.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 125 (292)
..+|++++.||+|+||.||+|.+ +|+.||||++..... . .....++.+|+.+++++. ||||+++++++..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ---N----STDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C---C----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc---C----hHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 36899999999999999999976 589999999853221 1 122345678999999996 9999999999875
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. .+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||+
T Consensus 81 ~~~~--------------~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll 142 (388)
T 3oz6_A 81 DNDR--------------DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142 (388)
T ss_dssp TTSS--------------CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCC--------------EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence 4422 2389999996 699998854 468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCC---------------------CCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASN---------------------PNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLW 263 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~ 263 (292)
+.++.++|+|||+++..... ........+|+.|+|||++.+ ..++.++|||||||++|
T Consensus 143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 222 (388)
T 3oz6_A 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222 (388)
T ss_dssp CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence 99999999999999754321 112233578999999999987 57899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 264 EIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 264 ~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|++|++||.+.+..+.+..|.+.
T Consensus 223 ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 223 EILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999999999999998888753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=280.23 Aligned_cols=218 Identities=24% Similarity=0.424 Sum_probs=183.9
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+.+..++|++.+.||+|+||.||+|.++++.||+|+++...... ...+.+.+|+.++++++||||+++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWST-------RKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCH-------HHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCH-------HHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 345666899999999999999999999999999999997543221 1234588999999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTE 201 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p~ 201 (292)
.+.... ..+++|||+++++|.+++.......+++..++.++.|++.||.|||+.| ++|+||||+
T Consensus 77 ~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~ 142 (271)
T 3kmu_A 77 QSPPAP--------------HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSR 142 (271)
T ss_dssp CTTTSS--------------SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGG
T ss_pred ccCCCC--------------CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccc
Confidence 776321 2389999999999999997655556999999999999999999999999 999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNR---KCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
||+++.++.+++.|||.+.... .....+++.|+|||.+.+..++. ++||||||+++|+|++|..||...+..
T Consensus 143 Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 217 (271)
T 3kmu_A 143 SVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM 217 (271)
T ss_dssp GEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH
T ss_pred eEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH
Confidence 9999999999999988764322 22356789999999998765443 799999999999999999999999988
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
+....+...
T Consensus 218 ~~~~~~~~~ 226 (271)
T 3kmu_A 218 EIGMKVALE 226 (271)
T ss_dssp HHHHHHHHS
T ss_pred HHHHHHHhc
Confidence 887776654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=286.28 Aligned_cols=222 Identities=30% Similarity=0.528 Sum_probs=187.4
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 114 (292)
...+++...+|.+.+.||+|+||.||+|.+ +++.||+|+++... .. ...+.+.+|+.++++++||
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~hp 86 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SP----SELRDLLSEFNVLKQVNHP 86 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CH----HHHHHHHHHHHHHTTCCCT
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CH----HHHHHHHHHHHHHhhCCCC
Confidence 356778889999999999999999999965 34789999986332 11 1234578899999999999
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc----------------------cccCHH
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----------------------RKLAFK 172 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~ 172 (292)
||+++++++.+.+.. +++|||+++++|.+++..... ..+++.
T Consensus 87 ~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (314)
T 2ivs_A 87 HVIKLYGACSQDGPL----------------LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150 (314)
T ss_dssp TBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHH
T ss_pred ceeeEEEEEecCCce----------------EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHH
Confidence 999999998776554 899999999999999975432 348999
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCC
Q 022794 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYN 250 (292)
Q Consensus 173 ~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 250 (292)
.++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++
T Consensus 151 ~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 230 (314)
T 2ivs_A 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC
Confidence 9999999999999999999999999999999999999999999999976543322 22334567889999999888899
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 251 RKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 251 ~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
.++|+||||+++|+|++ |..||.+.+..++...+..+
T Consensus 231 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 268 (314)
T 2ivs_A 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268 (314)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC
Confidence 99999999999999999 99999998888887776654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=303.32 Aligned_cols=220 Identities=29% Similarity=0.569 Sum_probs=190.4
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
...|.+...+|.+.+.||+|+||.||+|.+. +..||||+++..... .+.+.+|+.++++++||||+++
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~l 281 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQL 281 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----------hHHHHHHHHHHHhcCCCCEeeE
Confidence 4568888899999999999999999999775 789999998643321 2347889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++...... ++||||+++++|.+++.......+++..++.++.|++.||.|||++|++|||||
T Consensus 282 ~~~~~~~~~~----------------~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 345 (495)
T 1opk_A 282 LGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345 (495)
T ss_dssp EEEECSSSSC----------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEecCCcE----------------EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999876655 899999999999999987666679999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
|+|||++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 346 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp GGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999976543221 2223445678999999998889999999999999999999 9999999998
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 426 ~~~~~~~~~~ 435 (495)
T 1opk_A 426 SQVYELLEKD 435 (495)
T ss_dssp GGHHHHHHTT
T ss_pred HHHHHHHHcC
Confidence 8888777654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=289.12 Aligned_cols=222 Identities=32% Similarity=0.527 Sum_probs=182.5
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CC
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 113 (292)
...|++..++|.+.+.||+|+||.||+|.+ ++..||+|+++.... ......+.+|+.+++++ .|
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h 108 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------SSEREALMSELKMMTQLGSH 108 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCC
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--------HHHHHHHHHHHHHHHhhcCC
Confidence 346788889999999999999999999975 456899999963321 11234578899999999 99
Q ss_pred CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc---------------------cccCHH
Q 022794 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR---------------------RKLAFK 172 (292)
Q Consensus 114 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~ 172 (292)
|||+++++++...+.. +++|||+++++|.+++..... ..+++.
T Consensus 109 p~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 172 (344)
T 1rjb_A 109 ENIVNLLGACTLSGPI----------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172 (344)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred CCeeeEEEEEeeCCcc----------------EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHH
Confidence 9999999998876654 899999999999999975432 247899
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCC
Q 022794 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYN 250 (292)
Q Consensus 173 ~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~ 250 (292)
.++.++.|++.||.+||++|++||||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++
T Consensus 173 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 252 (344)
T 1rjb_A 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence 99999999999999999999999999999999999999999999999755433221 1223467789999999888899
Q ss_pred chhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 251 RKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 251 ~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
.++||||||+++|+|++ |..||.+.+..+....+++.
T Consensus 253 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 290 (344)
T 1rjb_A 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 290 (344)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHT
T ss_pred hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhc
Confidence 99999999999999998 99999987766655555443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.92 Aligned_cols=210 Identities=24% Similarity=0.404 Sum_probs=175.1
Q ss_pred ceeE--eeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 51 KLVI--KSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 51 ~~~~--~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.|.+ .+.||+|+||.||+|.+ +|+.||+|+++... . ...+.+.+|+.++++++||||+++++++.+.
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 158 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----M----KDKEEVKNEISVMNQLDHANLIQLYDAFESK 158 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----c----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3444 67899999999999976 58899999986432 1 1234578999999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE-
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL- 205 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili- 205 (292)
+.. ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+|||+
T Consensus 159 ~~~----------------~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 221 (373)
T 2x4f_A 159 NDI----------------VLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCV 221 (373)
T ss_dssp SEE----------------EEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred CEE----------------EEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEe
Confidence 654 8999999999999988653 3468999999999999999999999999999999999999
Q ss_pred -cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++.++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+
T Consensus 222 ~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 300 (373)
T 2x4f_A 222 NRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300 (373)
T ss_dssp ETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 56678999999999865433 2333456899999999999988999999999999999999999999999999888888
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.+.
T Consensus 301 ~~~ 303 (373)
T 2x4f_A 301 LAC 303 (373)
T ss_dssp HHT
T ss_pred Hhc
Confidence 765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=277.38 Aligned_cols=215 Identities=25% Similarity=0.426 Sum_probs=185.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+ +|+.||+|++...... . ...+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---A----RDFQKLEREARICRKLQHPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC---H----HHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence 357999999999999999999976 4889999999754322 1 123457789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||++
T Consensus 77 ~~~~----------------~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~ 138 (284)
T 3kk8_A 77 ESFH----------------YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL 138 (284)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCEE----------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEE
Confidence 6554 8999999999999988643 569999999999999999999999999999999999999
Q ss_pred cCCCc---EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 DKNRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.++. ++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+...
T Consensus 139 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 217 (284)
T 3kk8_A 139 ASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA 217 (284)
T ss_dssp SSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH
Confidence 76655 999999999765433 23344678999999999999999999999999999999999999999999999888
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.+..+.
T Consensus 218 ~~~~~~ 223 (284)
T 3kk8_A 218 QIKAGA 223 (284)
T ss_dssp HHHHTC
T ss_pred HHHhcc
Confidence 887663
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=290.78 Aligned_cols=211 Identities=31% Similarity=0.466 Sum_probs=176.4
Q ss_pred hhcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 40 KQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
....++.+...+|++.+.||+|+||.||+|.+.++.||||++.... . .......|+.++++++||||+++
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~----~~~~~~~E~~~l~~l~hpniv~~ 83 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD------K----QSWQNEYEVYSLPGMKHENILQF 83 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG------H----HHHHHHHHHHTSTTCCCTTBCCE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc------h----HHHHHHHHHHHHhcCCCCCchhh
Confidence 3456778888999999999999999999999999999999985321 1 12234558899999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC--------
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-------- 191 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-------- 191 (292)
++++...... ...++++|||+++++|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 84 ~~~~~~~~~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~ 148 (322)
T 3soc_A 84 IGAEKRGTSV------------DVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148 (322)
T ss_dssp EEEEEEECSS------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEE
T ss_pred cceeccCCCC------------CceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhcccccccc
Confidence 9998765431 1234899999999999999954 3599999999999999999999999
Q ss_pred --CccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCC-----CCCchhhHHHHHHHH
Q 022794 192 --KIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGN-----PYNRKCDVYSFGICL 262 (292)
Q Consensus 192 --~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diwslg~il 262 (292)
|++||||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+. .++.++||||||+++
T Consensus 149 ~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il 228 (322)
T 3soc_A 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228 (322)
T ss_dssp ECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHH
Confidence 999999999999999999999999999976543322 22335689999999999874 455688999999999
Q ss_pred HHHHhCCCCCCCC
Q 022794 263 WEIYCCDMPYPDL 275 (292)
Q Consensus 263 ~~l~~g~~pf~~~ 275 (292)
|+|++|..||.+.
T Consensus 229 ~el~tg~~pf~~~ 241 (322)
T 3soc_A 229 WELASRCTAADGP 241 (322)
T ss_dssp HHHHTTBTTSSSC
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=285.68 Aligned_cols=214 Identities=24% Similarity=0.408 Sum_probs=177.5
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+. |+.||+|++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-------hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 378999999999999999999774 889999998644321 12234477899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 97 ~~~----------------~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~ 158 (331)
T 4aaa_A 97 KRW----------------YLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158 (331)
T ss_dssp TEE----------------EEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CEE----------------EEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc
Confidence 554 899999999888887643 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+..............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 99999999999997655444444556789999999999876 68999999999999999999999999999888887776
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
..
T Consensus 239 ~~ 240 (331)
T 4aaa_A 239 MC 240 (331)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.12 Aligned_cols=204 Identities=29% Similarity=0.468 Sum_probs=163.2
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
...++|++++.||+|+||.||+|.+ +++.||||++....... ..+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----------ENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----------HHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----------HHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3457999999999999999999976 68899999996543221 23678999999999999999999998
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.... +++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 87 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 87 TPTHL----------------AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp CSSEE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred eCCEE----------------EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 76655 8999999999999998643 46999999999999999999999999999999999999
Q ss_pred EcCCCc--EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 205 LDKNRT--VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRK-CDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 205 i~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
++.++. ++|+|||++...... .......+++.|+|||++.+..++.+ +||||||+++|+|++|+.||.+.+..+
T Consensus 149 l~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (361)
T 3uc3_A 149 LDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225 (361)
T ss_dssp ECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC
T ss_pred EcCCCCceEEEeecCcccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH
Confidence 987665 999999998643222 22334578999999999988877655 899999999999999999998765533
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.86 Aligned_cols=219 Identities=32% Similarity=0.543 Sum_probs=183.9
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...|.+..++|++.+.||+|+||.||+|.+.+ ..||||+++..... .+.+.+|+.++++++||||++++
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hp~iv~~~ 245 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQLY 245 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 45688888999999999999999999998764 67999998754321 23478899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+ +.. +++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||
T Consensus 246 ~~~~~-~~~----------------~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 308 (452)
T 1fmk_A 246 AVVSE-EPI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308 (452)
T ss_dssp EEECS-SSC----------------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEcC-Cce----------------EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 98765 222 8999999999999999765556799999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 309 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp GGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997654321 12223446788999999998899999999999999999999 99999999999
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
++...+.++
T Consensus 389 ~~~~~i~~~ 397 (452)
T 1fmk_A 389 EVLDQVERG 397 (452)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHcC
Confidence 998888765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.77 Aligned_cols=220 Identities=31% Similarity=0.464 Sum_probs=183.1
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
.++..++|++.+.||+|+||.||+|.+ +++.||||+++... .. .....+.+|+.++++++||||+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~hpnIv 137 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SE----QDELDFLMEALIISKFNHQNIV 137 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC----CH----HHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc----Ch----hhHHHHHHHHHHHHhCCCCCCC
Confidence 455668999999999999999999974 35689999985321 11 1123477899999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHhCC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLHSQK 192 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~ 192 (292)
++++++.+.... ++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|
T Consensus 138 ~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 201 (367)
T 3l9p_A 138 RCIGVSLQSLPR----------------FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201 (367)
T ss_dssp CEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEecCCCC----------------EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 999998876655 899999999999999976432 35889999999999999999999999
Q ss_pred ccccCCCCCCeeEcCCC---cEEEeecCcceeccCC--CCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 193 IVHRDVKTENMLLDKNR---TVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 193 i~h~di~p~Nili~~~~---~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
++||||||+|||++.++ .++|+|||.+...... ........+++.|+|||.+.+..++.++|||||||++|+|++
T Consensus 202 ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999998554 5999999998643221 122233557889999999988899999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHHhh
Q 022794 268 -CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|..||...+..++...+.++.
T Consensus 282 ~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 282 LGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTC
T ss_pred CCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999999988887653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=289.17 Aligned_cols=215 Identities=24% Similarity=0.370 Sum_probs=176.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++++.||+|+||.||+|.+ +|+.||||++..... . ....+++.+|+.++++++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---S----ELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---S----HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc---C----HHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 47899999999999999999976 589999999854321 1 12345578999999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....+++|||+ +++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 97 ~~~~----------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 97 ETLD----------DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp SSTT----------TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred Cccc----------cCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence 4321 122348999999 8899999854 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||+++.... ......+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+..+.+..|.
T Consensus 163 ~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 163 EDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp TTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999986543 2344678999999999877 678999999999999999999999999999988888876
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 240 ~~ 241 (367)
T 1cm8_A 240 KV 241 (367)
T ss_dssp HH
T ss_pred Hh
Confidence 53
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=295.80 Aligned_cols=221 Identities=33% Similarity=0.568 Sum_probs=187.0
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
...|.+..++|.+.+.||+|+||.||+|.+ +++.||||+++.... ......+.+|+.++++++||||+++
T Consensus 106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~ 177 (377)
T 3cbl_A 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--------PDLKAKFLQEARILKQYSHPNIVRL 177 (377)
T ss_dssp CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--------HHHHTTTTHHHHHHTTCCCTTBCCE
T ss_pred ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--------HHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 456788889999999999999999999987 588999999863311 1223457889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++...+.. +++|||+++++|.+++... ...+++..++.++.|++.||+|||++|++|||||
T Consensus 178 ~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 240 (377)
T 3cbl_A 178 IGVCTQKQPI----------------YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLA 240 (377)
T ss_dssp EEEECSSSSC----------------EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEecCCCc----------------EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccC
Confidence 9998776554 8999999999999999753 3468999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCCC--CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~ 276 (292)
|+|||++.++.++|+|||++.......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+
T Consensus 241 p~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 241 ARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred HHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999987543321111 11234678999999988889999999999999999998 999999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
..++...+.++
T Consensus 321 ~~~~~~~~~~~ 331 (377)
T 3cbl_A 321 NQQTREFVEKG 331 (377)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHcC
Confidence 98888777655
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.48 Aligned_cols=201 Identities=26% Similarity=0.432 Sum_probs=159.9
Q ss_pred CceeEe-eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh-CCCCcccceeceecC
Q 022794 50 SKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK-LDHPNVTKFIGATMG 125 (292)
Q Consensus 50 ~~~~~~-~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 125 (292)
++|.+. +.||+|+||.||+|.+ +|+.||||+++.. ..+.+|+.++.+ .+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 567776 7899999999999976 5889999998521 125567887744 489999999998854
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... ....+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 127 ~~~------------~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill 194 (400)
T 1nxk_A 127 LYA------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 194 (400)
T ss_dssp EET------------TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred ccc------------CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEE
Confidence 110 11233899999999999999976555679999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 206 ~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
+. ++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 195 ~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 195 TSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp SSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ecCCCCccEEEEecccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 87 788999999999764432 233446789999999999999999999999999999999999999976543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=281.37 Aligned_cols=220 Identities=29% Similarity=0.562 Sum_probs=173.7
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
..++++..++|++.+.||+|+||.||+|.+. +..||+|+.+.... ....+.+.+|+.++++++||||
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i 78 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHI 78 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--------HHHHHHHHHHHHHHHhCCCCcc
Confidence 3557788899999999999999999999763 45699998753211 1234568899999999999999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++++++.+. . .+++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++||
T Consensus 79 v~~~~~~~~~-~----------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 140 (281)
T 1mp8_A 79 VKLIGVITEN-P----------------VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHR 140 (281)
T ss_dssp CCEEEEECSS-S----------------CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ceEEEEEccC-c----------------cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 9999987432 2 28999999999999999653 3468999999999999999999999999999
Q ss_pred CCCCCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 022794 197 DVKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (292)
Q Consensus 197 di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~ 274 (292)
||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp CCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 9999999999999999999999876543221 1223446778999999998889999999999999999996 9999999
Q ss_pred CCHHHHHHHHHHh
Q 022794 275 LSFSEVTSAVVRQ 287 (292)
Q Consensus 275 ~~~~~~~~~i~~~ 287 (292)
.+..++...+.++
T Consensus 221 ~~~~~~~~~i~~~ 233 (281)
T 1mp8_A 221 VKNNDVIGRIENG 233 (281)
T ss_dssp CCGGGHHHHHHTT
T ss_pred CCHHHHHHHHHcC
Confidence 9888888777654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=278.02 Aligned_cols=215 Identities=22% Similarity=0.314 Sum_probs=185.6
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||+|+||.||+|.+. ++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC------HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 468999999999999999999774 7899999986443221 12244578899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 88 ~~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 149 (294)
T 2rku_A 88 DFV----------------FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149 (294)
T ss_dssp SEE----------------EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CEE----------------EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc
Confidence 554 8999999999999988543 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 229 (294)
T 2rku_A 150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 229 (294)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence 99999999999998765444444556789999999999998899999999999999999999999999888887777665
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 230 ~ 230 (294)
T 2rku_A 230 N 230 (294)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=276.93 Aligned_cols=217 Identities=32% Similarity=0.648 Sum_probs=186.1
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
+|.+..++|++.+.||+|+||.||+|.+ +++.||+|++...... .+.+.+|+.++++++||||++++++
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~ 71 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGV 71 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4677788999999999999999999977 6778999999654321 1347789999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+.+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+|
T Consensus 72 ~~~~~~~----------------~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 134 (267)
T 3t9t_A 72 CLEQAPI----------------CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 134 (267)
T ss_dssp ECSSSSC----------------EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred EccCCCe----------------EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence 8876554 8999999999999999653 3468999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEV 280 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~ 280 (292)
|+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..++
T Consensus 135 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (267)
T 3t9t_A 135 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214 (267)
T ss_dssp EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH
Confidence 999999999999999987543211 12233456788999999988889999999999999999999 8999999999998
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 215 ~~~i~~~ 221 (267)
T 3t9t_A 215 VEDISTG 221 (267)
T ss_dssp HHHHHTT
T ss_pred HHHHhcC
Confidence 8888765
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=299.46 Aligned_cols=212 Identities=30% Similarity=0.454 Sum_probs=177.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ ++..||+|+++........ ...+.+|+.++++++||||+++++++.+..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-------NSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT-------THHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH-------HHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 5799999999999999999977 5889999998754322221 234778999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus 110 ~~----------------~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 110 NY----------------YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp EE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred EE----------------EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 55 8999999999999988643 56999999999999999999999999999999999999965
Q ss_pred C---CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 N---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
. +.++|+|||++...... .......+++.|+|||++.+ .++.++||||+|+++|+|++|.+||.+.+..+++..+
T Consensus 172 ~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 249 (494)
T 3lij_A 172 KEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249 (494)
T ss_dssp SSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4 55999999999765433 33344679999999999874 5899999999999999999999999999999999988
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 250 ~~~~ 253 (494)
T 3lij_A 250 EKGK 253 (494)
T ss_dssp HHTC
T ss_pred HhCC
Confidence 8763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=289.96 Aligned_cols=211 Identities=24% Similarity=0.387 Sum_probs=181.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +|+.||+|++.... .. ....+.+|+.++++++||||+++++++.+..
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~----~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PL----DKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HH----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hh----hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 5899999999999999999976 58899999986432 11 1235788999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus 122 ~~----------------~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 122 EM----------------VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp EE----------------EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence 55 8999999999999988542 346899999999999999999999999999999999999974
Q ss_pred --CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 --NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 --~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.+.++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.
T Consensus 185 ~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~ 263 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263 (387)
T ss_dssp TTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 477999999999865432 22233568999999999999999999999999999999999999999999888888776
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 264 ~~ 265 (387)
T 1kob_A 264 RC 265 (387)
T ss_dssp HC
T ss_pred hC
Confidence 64
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=278.57 Aligned_cols=214 Identities=29% Similarity=0.469 Sum_probs=180.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+. ++.||+|++... ..........+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA------QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecc------ccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 3478999999999999999999764 678999998521 11222234568889999999999999999999977
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 81 ~~~~----------------~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili 142 (279)
T 3fdn_A 81 ATRV----------------YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142 (279)
T ss_dssp SSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE
T ss_pred CCEE----------------EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE
Confidence 6654 8999999999999998653 468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++.++|+|||.+..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 143 GSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp CTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEEeccccccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 9999999999998854332 22334578999999999999999999999999999999999999999999988888776
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 221 ~~ 222 (279)
T 3fdn_A 221 RV 222 (279)
T ss_dssp HT
T ss_pred hC
Confidence 54
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=287.66 Aligned_cols=212 Identities=28% Similarity=0.453 Sum_probs=173.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +++.||+|+++....... ...+.+|+.++++++||||+++++++.+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--------PCTAIREVSLLKDLKHANIVTLHDIIHTEK 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--------chhHHHHHHHHHhcCCCCCCeeeeEEeeCC
Confidence 5899999999999999999976 588999999864332111 112446999999999999999999987766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||++ ++|.+++... ...+++..++.++.|++.||.+||+.|++||||||+||+++.
T Consensus 74 ~~----------------~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 74 SL----------------TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135 (324)
T ss_dssp CE----------------EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred EE----------------EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence 54 89999996 5999988654 446899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+.+..+.+
T Consensus 136 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 136 RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp TCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999765544444455678999999999877 5689999999999999999999999999999999888876
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 216 ~ 216 (324)
T 3mtl_A 216 I 216 (324)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.30 Aligned_cols=208 Identities=24% Similarity=0.453 Sum_probs=176.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||+|++...... ..+|+.++.++ +||||+++++++.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------------PTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------------CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------------hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 46899999999999999999976 5889999999754322 23577777777 89999999999987
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 88 ~~~~----------------~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~ 149 (342)
T 2qr7_A 88 GKYV----------------YVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149 (342)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCEE----------------EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEE
Confidence 6655 899999999999999864 3569999999999999999999999999999999999998
Q ss_pred cCC----CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC---CCHH
Q 022794 206 DKN----RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD---LSFS 278 (292)
Q Consensus 206 ~~~----~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~---~~~~ 278 (292)
.+. +.++|+|||.+..............+++.|+|||++.+..++.++|+||||+++|+|++|..||.+ .+..
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 229 (342)
T 2qr7_A 150 VDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE 229 (342)
T ss_dssp SSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH
T ss_pred ecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH
Confidence 543 359999999998765544444556789999999999887789999999999999999999999985 4667
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
++...+.++
T Consensus 230 ~~~~~i~~~ 238 (342)
T 2qr7_A 230 EILARIGSG 238 (342)
T ss_dssp HHHHHHHHC
T ss_pred HHHHHHccC
Confidence 777777654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=285.79 Aligned_cols=233 Identities=28% Similarity=0.499 Sum_probs=173.8
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEEC--Cc---eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GH---DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~---~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 112 (292)
......++.+..++|++.+.||+|+||.||+|.+. +. .||+|+++...... ...+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~ 83 (323)
T 3qup_A 11 LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-------SDIEEFLREAACMKEFD 83 (323)
T ss_dssp -----CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-------HHHHHHHHHHHHHTTCC
T ss_pred HHHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-------HHHHHHHHHHHHHHHCC
Confidence 34455667778899999999999999999999653 22 79999986432111 12345889999999999
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc----cccCHHHHHHHHHHHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----RKLAFKVVVQLALDLARGLSYL 188 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~l 188 (292)
||||+++++++....... ....++++|||+++++|.+++..... ..+++..++.++.|++.||.||
T Consensus 84 h~~iv~~~~~~~~~~~~~----------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L 153 (323)
T 3qup_A 84 HPHVAKLVGVSLRSRAKG----------RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL 153 (323)
T ss_dssp CTTBCCCCEEEECC-----------------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCceehhhceeecccccc----------CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH
Confidence 999999999987654331 11234899999999999999965321 2589999999999999999999
Q ss_pred HhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 022794 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 189 H~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~ 266 (292)
|+.|++||||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 154 H~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 233 (323)
T 3qup_A 154 SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233 (323)
T ss_dssp HHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHH
Confidence 999999999999999999999999999999975433221 122344677899999999989999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHHHh
Q 022794 267 C-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 267 ~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
+ |..||.+.+..++...+..+
T Consensus 234 ~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 234 TRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTT
T ss_pred hCCCCCccccChHHHHHHHhcC
Confidence 9 99999999988888877765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=283.16 Aligned_cols=225 Identities=26% Similarity=0.405 Sum_probs=178.8
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccc
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTK 118 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 118 (292)
...+....++|++.+.||+|+||.||+|.+ +|+.||||++...... ...+.+|+.+++++ +||||++
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~~h~~i~~ 85 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINMLKKYSHHRNIAT 85 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----------THHHHHHHHHHHHHCCSTTBCC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----------HHHHHHHHHHHHhccCCCCeee
Confidence 334445678999999999999999999987 7899999998654321 12367899999999 8999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++....... .....+++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||
T Consensus 86 ~~~~~~~~~~~~----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 155 (326)
T 2x7f_A 86 YYGAFIKKNPPG----------MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 155 (326)
T ss_dssp EEEEEEECC--C----------CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred eeeEEeeccCcc----------ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 999987643110 1234489999999999999998766677999999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
+|+||+++.++.++|+|||.+..............+++.|+|||.+. +..++.++|+||||+++|+|++|..||.
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 235 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999876544333344467899999999987 4568899999999999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 022794 274 DLSFSEVTSAVVR 286 (292)
Q Consensus 274 ~~~~~~~~~~i~~ 286 (292)
..+..+....+.+
T Consensus 236 ~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 236 DMHPMRALFLIPR 248 (326)
T ss_dssp TSCHHHHHHHHHH
T ss_pred CCcHHHHHHHhhc
Confidence 8887776665544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=286.63 Aligned_cols=223 Identities=34% Similarity=0.577 Sum_probs=186.8
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEE---------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY---------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 111 (292)
....|++..++|++.+.||+|+||.||+|.+ ++..||+|+++... .. .....+.+|+.+++++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l 97 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TE----KDLSDLVSEMEMMKMI 97 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CH----HHHHHHHHHHHHHHHH
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cH----HHHHHHHHHHHHHHHh
Confidence 4455778889999999999999999999975 35679999986432 11 1234578899999999
Q ss_pred -CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHH
Q 022794 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQ 176 (292)
Q Consensus 112 -~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~ 176 (292)
+||||+++++++...+.. +++|||+++++|.+++.... ...+++..++.
T Consensus 98 ~~hp~iv~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (334)
T 2pvf_A 98 GKHKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161 (334)
T ss_dssp CCCTTBCCEEEEECSSSCC----------------EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHH
T ss_pred hcCCCEeeEEEEEccCCce----------------EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHH
Confidence 999999999998776554 89999999999999997543 13488999999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhh
Q 022794 177 LALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCD 254 (292)
Q Consensus 177 i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 254 (292)
++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|
T Consensus 162 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence 999999999999999999999999999999999999999999976543322 122345678899999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 255 VYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 255 iwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|||||+++|+|++ |..||.+.+..++...+.++
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 275 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC
Confidence 9999999999999 99999999999888877665
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=280.31 Aligned_cols=217 Identities=22% Similarity=0.394 Sum_probs=184.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||+|+++......... ......+.+|+.+++++.||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR---GVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc---chhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 36799999999999999999976 58899999997544322110 00123477899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 88 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~ 149 (321)
T 2a2a_A 88 TDV----------------VLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (321)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred CEE----------------EEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe
Confidence 554 899999999999999964 35689999999999999999999999999999999999998
Q ss_pred CCC----cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++ .++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+...
T Consensus 150 ~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 228 (321)
T 2a2a_A 150 DKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228 (321)
T ss_dssp CTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred cCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 887 7999999999765443 23344678999999999999999999999999999999999999999999888888
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.+.
T Consensus 229 ~i~~~ 233 (321)
T 2a2a_A 229 NITSV 233 (321)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 77654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=283.51 Aligned_cols=222 Identities=29% Similarity=0.517 Sum_probs=185.3
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CC
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DH 113 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 113 (292)
...|++..++|.+.+.||+|+||.||+|.+ +++.||+|+++.... . ...+.+.+|+.+++++ +|
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~~h 86 (313)
T 1t46_A 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----L----TEREALMSELKVLSYLGNH 86 (313)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHHHCCC
T ss_pred ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh----H----HHHHHHHHHHHHHhhcccC
Confidence 455778889999999999999999999974 467899999964321 1 1235588999999999 99
Q ss_pred CcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc----------------cccCHHHHHHH
Q 022794 114 PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR----------------RKLAFKVVVQL 177 (292)
Q Consensus 114 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~i 177 (292)
|||+++++++.+.+.. +++|||+++++|.+++..... ..+++..++.+
T Consensus 87 ~~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (313)
T 1t46_A 87 MNIVNLLGACTIGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (313)
T ss_dssp TTBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred CCeeeEEEEEecCCCc----------------EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence 9999999999876654 899999999999999976432 24899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhH
Q 022794 178 ALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDV 255 (292)
Q Consensus 178 ~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di 255 (292)
+.|++.||.+||++|++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+
T Consensus 151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 230 (313)
T 1t46_A 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (313)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence 999999999999999999999999999999999999999998765433221 223446778999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 256 YSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 256 wslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
||||+++|+|++ |..||.+.+..+....+.+.
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 263 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc
Confidence 999999999999 99999987766655555443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=280.10 Aligned_cols=218 Identities=35% Similarity=0.647 Sum_probs=169.2
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
...+++..++|++.+.||+|+||.||+|.+.+ .||+|+++..... . ...+.+.+|+.++++++||||+++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~---~----~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPT---P----QQLQAFKNEVGVLRKTRHVNILLFMG 87 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCC---H----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCC---H----HHHHHHHHHHHHHHhCCCCcEEEEEe
Confidence 45567788999999999999999999998766 4999998654332 1 12345788999999999999999998
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
+.... . .+++|||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|+||||+
T Consensus 88 ~~~~~-~----------------~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~ 149 (289)
T 3og7_A 88 YSTAP-Q----------------LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149 (289)
T ss_dssp EECSS-S----------------CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eccCC-c----------------cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 65432 2 28999999999999998543 456999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCC--CCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASN--PNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||+++.++.++|+|||.+...... ........+++.|+|||.+. +..++.++||||||+++|+|++|..||.+.+
T Consensus 150 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp GEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred eEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 999999999999999998754321 22233456899999999987 5668889999999999999999999998766
Q ss_pred HHHHHHHHH
Q 022794 277 FSEVTSAVV 285 (292)
Q Consensus 277 ~~~~~~~i~ 285 (292)
..+.+..++
T Consensus 230 ~~~~~~~~~ 238 (289)
T 3og7_A 230 NRDQIIEMV 238 (289)
T ss_dssp CHHHHHHHH
T ss_pred hHHHHHHHh
Confidence 555544443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=287.60 Aligned_cols=204 Identities=30% Similarity=0.456 Sum_probs=171.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--------CPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--------hHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 47899999999999999999976 58899999986433211 123477899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++
T Consensus 78 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 139 (323)
T 3tki_A 78 NIQ----------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (323)
T ss_dssp SEE----------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CeE----------------EEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence 655 899999999999998843 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
.++.++|+|||.+....... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 99999999999997543221 22334678999999999987765 77899999999999999999999866553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=296.87 Aligned_cols=207 Identities=28% Similarity=0.391 Sum_probs=157.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+++.||+|+||.||+|.+ +|+.||||++..... . ....+++.+|+.++++++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~---~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---D----LIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS---S----HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc---C----HHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence 47899999999999999999965 588999999853321 1 12234578899999999999999999998654
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
..- ....+|++|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 125 ~~~-----------~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 125 DVE-----------KFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190 (458)
T ss_dssp CTT-----------TCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred Ccc-----------cCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC
Confidence 311 123459999998 6799998854 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC---------------------------CCCCCCCcccccCCccc-CCCCCCchhhHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN---------------------------DMTGETGTLGYMAPEVL-NGNPYNRKCDVYSF 258 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~---------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Diwsl 258 (292)
.++.++|+|||+++....... ......+|+.|+|||++ .+..++.++|||||
T Consensus 191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 999999999999976542211 12335679999999986 45679999999999
Q ss_pred HHHHHHHHh-----------CCCCCCCCC
Q 022794 259 GICLWEIYC-----------CDMPYPDLS 276 (292)
Q Consensus 259 g~il~~l~~-----------g~~pf~~~~ 276 (292)
||++|+|++ |.+||.+.+
T Consensus 271 G~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 271 GCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp HHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred HHHHHHHHHhccccccccccccccCCCCc
Confidence 999999999 788887755
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=292.24 Aligned_cols=214 Identities=21% Similarity=0.323 Sum_probs=170.1
Q ss_pred ecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHH----HHHHHHHHHHHHhCCCCc
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAAL----RSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~ 115 (292)
+..++|++.+.||+|+||.||+|.+. ++.||||++..... ....+...+ ...+..|+..++.+.|||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG--PLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH--HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch--hHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 45579999999999999999999763 47899999865432 111111111 123445677788889999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
|+++++++.....- ..+.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|
T Consensus 110 iv~~~~~~~~~~~~------------~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH 175 (364)
T 3op5_A 110 VPKYWGSGLHDKNG------------KSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVH 175 (364)
T ss_dssp SCCEEEEEEEEETT------------EEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCeEEeeeeeccCC------------cceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEE
Confidence 99999998764220 12348999999 99999998653 456999999999999999999999999999
Q ss_pred cCCCCCCeeEc--CCCcEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 022794 196 RDVKTENMLLD--KNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 196 ~di~p~Nili~--~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~ 266 (292)
|||||+|||++ .++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999998 889999999999976432211 112345899999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 022794 267 CCDMPYPDLS 276 (292)
Q Consensus 267 ~g~~pf~~~~ 276 (292)
+|..||.+..
T Consensus 256 ~g~~Pf~~~~ 265 (364)
T 3op5_A 256 TGHLPWEDNL 265 (364)
T ss_dssp HSCCTTGGGT
T ss_pred hCCCCccccc
Confidence 9999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=276.21 Aligned_cols=214 Identities=19% Similarity=0.316 Sum_probs=178.8
Q ss_pred ceecCCceeEeeeeccCcceEEEEEE--ECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGL--YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 121 (292)
..+..++|++.+.||+|+||.||+|. .+|+.||+|++....... .+.+|+.+++++ +|++++++++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~e~~~~~~l~~~~~i~~~~~ 73 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----------QLRDEYRTYKLLAGCTGIPNVYY 73 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-----------CHHHHHHHHHHTTTCTTCCCEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH-----------HHHHHHHHHHHHhcCCCCCeEEe
Confidence 34567899999999999999999997 479999999986543322 266799999999 8999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...... +++|||+ +++|.+++... ...+++..++.++.|++.||.+||++|++||||||+
T Consensus 74 ~~~~~~~~----------------~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~ 135 (298)
T 1csn_A 74 FGQEGLHN----------------VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 135 (298)
T ss_dssp EEEETTEE----------------EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred ecCCCcee----------------EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 88665544 8999999 99999999653 346999999999999999999999999999999999
Q ss_pred CeeEcCCCc-----EEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 022794 202 NMLLDKNRT-----VKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 202 Nili~~~~~-----~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~ 269 (292)
||+++.++. ++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 136 NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 136 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp GEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence 999987765 99999999986544322 233456899999999999999999999999999999999999
Q ss_pred CCCCCC---CHHHHHHHHHHh
Q 022794 270 MPYPDL---SFSEVTSAVVRQ 287 (292)
Q Consensus 270 ~pf~~~---~~~~~~~~i~~~ 287 (292)
.||.+. +..+.+..+...
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 216 LPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp CTTSSCCSCCHHHHHHHHHHH
T ss_pred CCcchhhccccHHHHHHHHhh
Confidence 999874 445555555443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=275.14 Aligned_cols=221 Identities=25% Similarity=0.410 Sum_probs=190.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 124 (292)
..++|.+.+.||+|++|.||+|.+ +|+.||||+++..........+.....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999977 57899999997665444455566667778899999999995 999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+
T Consensus 95 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 156 (298)
T 1phk_A 95 TNTFF----------------FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL 156 (298)
T ss_dssp CSSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCCeE----------------EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence 66554 8999999999999999643 56899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN------GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
++.++.++|+|||.+...... .......+++.|+|||.+. ...++.++|+||||+++|+|++|..||...+..
T Consensus 157 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 157 LDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp ECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 999999999999999765432 2334467899999999984 456789999999999999999999999998888
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
+....+.++
T Consensus 236 ~~~~~~~~~ 244 (298)
T 1phk_A 236 LMLRMIMSG 244 (298)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHhcC
Confidence 888877765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=274.57 Aligned_cols=210 Identities=26% Similarity=0.448 Sum_probs=181.4
Q ss_pred CceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+. +..||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---------VDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 57999999999999999999774 6689999986543211 234778999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE--
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL-- 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili-- 205 (292)
.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||||+||++
T Consensus 80 ~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 80 DI----------------YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLT 141 (277)
T ss_dssp EE----------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred eE----------------EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEec
Confidence 55 8999999999999998653 568999999999999999999999999999999999999
Q ss_pred -cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 -DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++.++|+|||.+...... .......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+..++...+
T Consensus 142 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (277)
T 3f3z_A 142 DSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219 (277)
T ss_dssp SSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 77889999999999765433 333446789999999998765 899999999999999999999999999999988888
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 220 ~~~~ 223 (277)
T 3f3z_A 220 REGT 223 (277)
T ss_dssp HHCC
T ss_pred HhCC
Confidence 7653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=283.88 Aligned_cols=207 Identities=25% Similarity=0.459 Sum_probs=154.4
Q ss_pred CceeEe---eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceecee
Q 022794 50 SKLVIK---SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGAT 123 (292)
Q Consensus 50 ~~~~~~---~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 123 (292)
.+|.+. +.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++.+. ||||+++++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------------EANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------------HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------------hhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 346554 7899999999999976 48899999985321 233668999999996 99999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.... +++|||+++++|.+++... ..+++..++.++.|++.+|.|||++|++||||||+||
T Consensus 76 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 137 (325)
T 3kn6_A 76 HDQLHT----------------FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137 (325)
T ss_dssp ECSSEE----------------EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred EcCCEE----------------EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence 876655 8999999999999999653 5699999999999999999999999999999999999
Q ss_pred eEcCCC---cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---
Q 022794 204 LLDKNR---TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF--- 277 (292)
Q Consensus 204 li~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~--- 277 (292)
+++.++ .++|+|||.+..............+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.
T Consensus 138 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 217 (325)
T 3kn6_A 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217 (325)
T ss_dssp EEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------
T ss_pred EEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc
Confidence 997765 79999999998665544444556789999999999999999999999999999999999999986433
Q ss_pred ----HHHHHHHHH
Q 022794 278 ----SEVTSAVVR 286 (292)
Q Consensus 278 ----~~~~~~i~~ 286 (292)
.++...+.+
T Consensus 218 ~~~~~~~~~~i~~ 230 (325)
T 3kn6_A 218 CTSAVEIMKKIKK 230 (325)
T ss_dssp CCCHHHHHHHHTT
T ss_pred cccHHHHHHHHHc
Confidence 455555544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=292.28 Aligned_cols=217 Identities=30% Similarity=0.572 Sum_probs=173.0
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.+...+|.+.+.||+|+||.||+|.+ ++..||||+++... . ....+.+.+|+.++++++||||++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----T----EKQRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----C----HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----C----HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 44557899999999999999999965 36789999986432 1 12245588999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++...+.. +++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 113 ~~~~~~~~~----------------~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 175 (373)
T 2qol_A 113 GVVTKSKPV----------------MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175 (373)
T ss_dssp EEECSSSSC----------------EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEeeCCce----------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc
Confidence 998776554 8999999999999999653 34689999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCC---CCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDM---TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~ 276 (292)
+||+++.++.++|+|||++.......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+
T Consensus 176 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp GGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999997654332211 12234678999999998899999999999999999998 999999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
..++...+.++
T Consensus 256 ~~~~~~~i~~~ 266 (373)
T 2qol_A 256 NQDVIKAVDEG 266 (373)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHcC
Confidence 99888877665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.94 Aligned_cols=212 Identities=32% Similarity=0.544 Sum_probs=180.4
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+++.||+|+||+||+|.+ +++.||||++......... ...+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 94 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDHPNIMKLFEILEDSS 94 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH-------HHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence 6899999999999999999976 5889999998633211111 234778999999999999999999988766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc-
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~- 206 (292)
.. +++|||+.+++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 95 ~~----------------~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 95 SF----------------YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp EE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred EE----------------EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 55 8999999999999988653 4699999999999999999999999999999999999994
Q ss_pred --CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 --KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 --~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.++.++|+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+++..+
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 234 (486)
T 3mwu_A 157 KEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234 (486)
T ss_dssp SSTTCCEEECSCSCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCCEEEEECCcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 4567999999998754432 23344679999999999986 4899999999999999999999999999999999988
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 235 ~~~~ 238 (486)
T 3mwu_A 235 ETGK 238 (486)
T ss_dssp HHTC
T ss_pred HhCC
Confidence 8763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=285.13 Aligned_cols=222 Identities=29% Similarity=0.509 Sum_probs=186.2
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 114 (292)
...|.+..++|++.+.||+|+||.||+|.+. ++.||+|++..... . .....+.+|+.++++++||
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~----~----~~~~~~~~E~~~l~~l~h~ 88 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS----M----RERIEFLNEASVMKEFNCH 88 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC----H----HHHHHHHHHHHHGGGCCCT
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC----H----HHHHHHHHHHHHHHhcCCC
Confidence 4567788899999999999999999999643 67899999863221 1 1234578899999999999
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--------cccCHHHHHHHHHHHHHHHH
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------RKLAFKVVVQLALDLARGLS 186 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~ 186 (292)
||+++++++.+.+.. +++|||+++++|.+++..... ..+++..++.++.|++.||.
T Consensus 89 ~i~~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 152 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152 (322)
T ss_dssp TBCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred CEeeeEEEEccCCcc----------------EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH
Confidence 999999998776554 899999999999999965332 35689999999999999999
Q ss_pred HHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHH
Q 022794 187 YLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWE 264 (292)
Q Consensus 187 ~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~ 264 (292)
+||++|++||||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+
T Consensus 153 ~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 232 (322)
T 1p4o_A 153 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232 (322)
T ss_dssp HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHH
Confidence 99999999999999999999999999999999875432211 1122345788999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 265 IYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 265 l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
|++ |..||.+.+..++...+.++
T Consensus 233 l~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 233 IATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp HHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred HHhcCCCccccCCHHHHHHHHHcC
Confidence 999 89999999998888877654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.29 Aligned_cols=213 Identities=27% Similarity=0.358 Sum_probs=174.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|.+.+.||+|+||.||+|.+ +|+.||||++...... ..+|+.++++++||||+++++++....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------------HHHHHHHHHHcCCCCccceeeEEeccC
Confidence 4799999999999999999977 5899999998643221 236999999999999999999885432
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. ....+.+++|||+++ +|.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 121 ~~----------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl 189 (420)
T 1j1b_A 121 EK----------KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189 (420)
T ss_dssp TT----------TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE
T ss_pred CC----------CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE
Confidence 11 012234799999965 77776643 234679999999999999999999999999999999999999
Q ss_pred cCC-CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 206 DKN-RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 206 ~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+.+ +.+||+|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.+
T Consensus 190 ~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~ 268 (420)
T 1j1b_A 190 DPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268 (420)
T ss_dssp ETTTTEEEECCCTTCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eCCCCeEEeccchhhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 855 678999999998654332 23346789999999999765 689999999999999999999999999998888887
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+++.
T Consensus 269 i~~~ 272 (420)
T 1j1b_A 269 IIKV 272 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=276.19 Aligned_cols=212 Identities=32% Similarity=0.507 Sum_probs=184.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.+.|.+.+.||+|+||.||+|.+ +++.||+|++........ .+.+.+|+.+++++.||||+++++++...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--------IEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTT--------HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHH--------HHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 36799999999999999999976 588999999975443211 33478899999999999999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 93 ~~~----------------~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 93 TKL----------------WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153 (303)
T ss_dssp TEE----------------EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CeE----------------EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence 554 899999999999999843 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 233 (303)
T 3a7i_A 154 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233 (303)
T ss_dssp TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc
Confidence 99999999999997665444444556789999999999999999999999999999999999999999888887776654
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
+
T Consensus 234 ~ 234 (303)
T 3a7i_A 234 N 234 (303)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=279.24 Aligned_cols=210 Identities=24% Similarity=0.412 Sum_probs=155.5
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +|+.||+|++.... .......+.+.+|+.++++++||||+++++++.+.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA------MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh------hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 36899999999999999999976 68999999985221 11112235688899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 84 ~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~ 146 (278)
T 3cok_A 84 NYV----------------YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146 (278)
T ss_dssp SEE----------------EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC
T ss_pred CeE----------------EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 554 8999999999999998643 35689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 221 (278)
T 3cok_A 147 RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221 (278)
T ss_dssp TTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence 999999999999976554433334466899999999999888999999999999999999999999876544433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=302.45 Aligned_cols=219 Identities=32% Similarity=0.543 Sum_probs=188.0
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEECC-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...|++..++|++.+.||+|+||.||+|.+.+ ..||||+++..... .+.+.+|+.++++++|+||++++
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~ 328 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQLY 328 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 46688888999999999999999999998764 67999999754321 23478899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+ ... ++||||+++++|.+++.......+++..++.++.||+.||.|||++|++||||||
T Consensus 329 ~~~~~-~~~----------------~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 391 (535)
T 2h8h_A 329 AVVSE-EPI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391 (535)
T ss_dssp EEECS-SSC----------------EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEee-ccc----------------eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence 98765 222 8999999999999999765556799999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+|||++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 392 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp GGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred hhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997543211 11223456788999999988889999999999999999999 99999999999
Q ss_pred HHHHHHHHh
Q 022794 279 EVTSAVVRQ 287 (292)
Q Consensus 279 ~~~~~i~~~ 287 (292)
+++..+.++
T Consensus 472 ~~~~~i~~~ 480 (535)
T 2h8h_A 472 EVLDQVERG 480 (535)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHcC
Confidence 998888765
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=275.83 Aligned_cols=215 Identities=26% Similarity=0.424 Sum_probs=183.5
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+..++|.+.+.||+|+||.||+|.+ +++.||+|++.... .........+.+|+.++++++||||+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ------LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc------cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 4457899999999999999999977 47789999985321 111122345788999999999999999999988
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus 85 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 85 DRKRI----------------YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp CSSEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred cCCEE----------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 76554 8999999999999999654 46899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++.++|+|||.+...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 224 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EcCCCCEEEecccccccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence 999999999999998654432 223457899999999999999999999999999999999999999998888887776
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.+.
T Consensus 225 ~~~ 227 (284)
T 2vgo_A 225 VNV 227 (284)
T ss_dssp HTT
T ss_pred hcc
Confidence 654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=281.07 Aligned_cols=238 Identities=26% Similarity=0.470 Sum_probs=180.9
Q ss_pred CccchhhhhhcccceecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHH
Q 022794 32 GKASNFLKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVA 106 (292)
Q Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~ 106 (292)
.....-+......+.+..++|.+.+.||+|+||.||+|.+ ++..||+|+++..... . ...+.+.+|+.
T Consensus 16 ~~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~---~----~~~~~~~~e~~ 88 (313)
T 3brb_A 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS---Q----REIEEFLSEAA 88 (313)
T ss_dssp --------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC---H----HHHHHHHHHHH
T ss_pred cCchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc---h----hHHHHHHHHHH
Confidence 3444446777778888889999999999999999999954 3457999998644322 1 12345788999
Q ss_pred HHHhCCCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh----cccccCHHHHHHHHHHHH
Q 022794 107 VWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN----RRRKLAFKVVVQLALDLA 182 (292)
Q Consensus 107 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~qi~ 182 (292)
++++++||||+++++++...+... ...++++|||+++++|.+++... ....+++..++.++.|++
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~-----------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~ 157 (313)
T 3brb_A 89 CMKDFSHPNVIRLLGVCIEMSSQG-----------IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157 (313)
T ss_dssp HHHTCCCTTBCCCCEEEEC------------------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHH
T ss_pred HHhcCCCCCeeeeeEEEeeccccC-----------CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHH
Confidence 999999999999999987654321 12348999999999999998542 335699999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHH
Q 022794 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (292)
Q Consensus 183 ~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~ 260 (292)
.||.+||+.|++||||||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+
T Consensus 158 ~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 237 (313)
T 3brb_A 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237 (313)
T ss_dssp HHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHH
Confidence 999999999999999999999999999999999999875433221 122345678899999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 261 CLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 261 il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
++|+|++ |..||...+..++...+.++
T Consensus 238 il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 238 TMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred HHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 9999999 99999999988888777665
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=286.84 Aligned_cols=227 Identities=22% Similarity=0.363 Sum_probs=178.2
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
+....+|++++.||+|+||.||+|.+ +|+.||||++...... ..+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------------~~~E~~il~~l~hpnIv~l~~~~ 69 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------------KNRELDIMKVLDHVNIIKLVDYF 69 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------------CCHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------------HHHHHHHHHHcCCCCccchhhee
Confidence 44568999999999999999999976 6899999998644322 23699999999999999999998
Q ss_pred cCCcccccc------------cccc----------cccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHH
Q 022794 124 MGSSELHIQ------------TENG----------QVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLAL 179 (292)
Q Consensus 124 ~~~~~~~~~------------~~~~----------~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ 179 (292)
......... .... .......+.+++|||++ ++|.+.+.. .....+++..++.++.
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~ 148 (383)
T 3eb0_A 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY 148 (383)
T ss_dssp EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence 654321000 0000 00012345689999997 588887754 2346799999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeeEc-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHH
Q 022794 180 DLARGLSYLHSQKIVHRDVKTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYS 257 (292)
Q Consensus 180 qi~~al~~lH~~~i~h~di~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws 257 (292)
||+.||.|||++|++||||||+||+++ .++.++|+|||.+...... .......+++.|+|||.+.+.. ++.++||||
T Consensus 149 qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 149 QLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 999999999999999999999999997 6899999999999865433 2334467899999999988754 899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 258 FGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 258 lg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+||++|+|++|+.||.+.+..+.+..+++.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~ 257 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQI 257 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999999999999999988888763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=299.19 Aligned_cols=215 Identities=30% Similarity=0.519 Sum_probs=184.1
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+ +|+.||||++.......... ...+.+|+.++++++||||+++++++.+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 97 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD------KESLLREVQLLKQLDHPNIMKLYEFFED 97 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH------HHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 346899999999999999999976 58899999986543322211 2347789999999999999999999987
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+.+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 98 ~~~~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 98 KGYF----------------YLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159 (484)
T ss_dssp SSEE----------------EEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCEE----------------EEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 6655 899999999999999854 3569999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 ---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.++.++|+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+++.
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 237 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK 237 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 56789999999998755433 22333568999999999976 68999999999999999999999999999999999
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.+.++.
T Consensus 238 ~i~~~~ 243 (484)
T 3nyv_A 238 KVEKGK 243 (484)
T ss_dssp HHHHCC
T ss_pred HHHcCC
Confidence 888763
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=274.53 Aligned_cols=212 Identities=29% Similarity=0.500 Sum_probs=175.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ ++..||+|++........ .+.+.+|+.++++++||||+++++++.+..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--------MEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--------HHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 6899999999999999999976 588999999875543222 234778999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. +++|||+++++|.+++... ....+++..++.++.|++.||.+||+.|++|+||||+||++
T Consensus 94 ~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~ 157 (285)
T 3is5_A 94 NM----------------YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF 157 (285)
T ss_dssp EE----------------EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred eE----------------EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEE
Confidence 54 8999999999999998643 34679999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 ---DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.++.++|+|||.+...... .......+++.|+|||.+. ..++.++|+||||+++|+|++|..||.+.+..++..
T Consensus 158 ~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 158 QDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp SSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 44578999999999754432 2334467899999999986 468899999999999999999999999988888777
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+...
T Consensus 236 ~~~~~ 240 (285)
T 3is5_A 236 KATYK 240 (285)
T ss_dssp HHHHC
T ss_pred hhccC
Confidence 66543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=282.23 Aligned_cols=218 Identities=28% Similarity=0.477 Sum_probs=186.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 126 (292)
++|.+.+.||+|++|.||+|.+ +|+.||||+++..... ..........+.+.+|+.+++++ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER-LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSC-CCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-cCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 5799999999999999999976 5899999999755432 23344455667788999999999 899999999998766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 173 ~~~----------------~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~ 234 (365)
T 2y7j_A 173 SFM----------------FLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234 (365)
T ss_dssp SEE----------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CEE----------------EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 554 8999999999999999643 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.++.++|+|||++...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+.
T Consensus 235 ~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 313 (365)
T 2y7j_A 235 DNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313 (365)
T ss_dssp TTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999998765433 23344678999999999853 3578899999999999999999999999888888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 314 ~~~i~~~ 320 (365)
T 2y7j_A 314 LRMIMEG 320 (365)
T ss_dssp HHHHHHT
T ss_pred HHHHHhC
Confidence 8777665
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=286.04 Aligned_cols=221 Identities=29% Similarity=0.447 Sum_probs=178.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+ +++.||+|++....... ......+.+.+|+.++++++||||+++++++.+
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ----INPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc----cCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 347899999999999999999976 57789999986321100 011224568899999999999999999999977
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--------------------------------------ccc
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------------------------------RRR 167 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------~~~ 167 (292)
.+.. +++|||+++++|.+++... ...
T Consensus 100 ~~~~----------------~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (345)
T 3hko_A 100 EQYI----------------CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDF 163 (345)
T ss_dssp SSEE----------------EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCH
T ss_pred CCeE----------------EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 6654 8999999999999988421 022
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC--cEEEeecCcceeccCCCC----CCCCCCCcccccCC
Q 022794 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR--TVKIADFGVARVEASNPN----DMTGETGTLGYMAP 241 (292)
Q Consensus 168 ~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aP 241 (292)
.+++..++.++.|++.||.+||+.|++||||||+||+++.++ .++|+|||.+........ ......+++.|+||
T Consensus 164 ~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 164 VQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 356788999999999999999999999999999999998776 899999999976433211 23346789999999
Q ss_pred cccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022794 242 EVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 242 E~~~~--~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.++.
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 292 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK 292 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc
Confidence 99976 578899999999999999999999999999999888887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=285.51 Aligned_cols=209 Identities=32% Similarity=0.518 Sum_probs=175.4
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
.++....++|.+.+.||+|+||.||+|.+ +|+.||+|++...... ..+.+.+|+.++++++||||+++++
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ---------GIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS---------HHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH---------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34444568999999999999999999976 4889999987643221 1334788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++...+.. +++|||+++++|.+++.... ...+++..++.++.|++.||.+||++|++|||||
T Consensus 103 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk 166 (321)
T 2qkw_B 103 FCDERNEM----------------ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166 (321)
T ss_dssp ECCCTTCC----------------EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred EEcCCCeE----------------EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCC
Confidence 98766554 89999999999999885432 2358999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 9999999999999999999975432211 2233457899999999988889999999999999999999999997544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=278.86 Aligned_cols=219 Identities=28% Similarity=0.485 Sum_probs=181.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... . ...+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---E----AEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC---H----HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC---H----HHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 46899999999999999999976 5889999999754322 1 1245688899999999999999999987543
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQK-----IVHRDVK 199 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-----i~h~di~ 199 (292)
... ..+++|||+++++|.+++.... ...+++..++.++.|++.||.+||+.| ++|+||+
T Consensus 78 ~~~--------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 78 TNT--------------TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp GGT--------------EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred CCc--------------eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 222 2389999999999999996532 345899999999999999999999999 9999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
|+||+++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 144 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 223 (279)
T 2w5a_A 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223 (279)
T ss_dssp GGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH
Confidence 99999999999999999998754433222223457889999999999899999999999999999999999999999888
Q ss_pred HHHHHHHhh
Q 022794 280 VTSAVVRQV 288 (292)
Q Consensus 280 ~~~~i~~~~ 288 (292)
+...+.++.
T Consensus 224 ~~~~i~~~~ 232 (279)
T 2w5a_A 224 LAGKIREGK 232 (279)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHhhcc
Confidence 888877653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=284.61 Aligned_cols=218 Identities=26% Similarity=0.367 Sum_probs=177.4
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+ +|+.||+|+++....... .....+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh----hhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 357899999999999999999976 588999999864322111 11122347789999999999999999999877
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++ +|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 84 ~~~~----------------~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 84 KSNI----------------SLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145 (346)
T ss_dssp TTCC----------------EEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred CCce----------------EEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
Confidence 6554 899999965 89888854 33468889999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+.++.++|+|||.+..............+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+.+..+
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i 225 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999998665544455556789999999999765 4889999999999999999999999999999988888
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.+.
T Consensus 226 ~~~ 228 (346)
T 1ua2_A 226 FET 228 (346)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.03 Aligned_cols=215 Identities=28% Similarity=0.546 Sum_probs=176.2
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCce----eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~----valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
+...+|++++.||+|+||.||+|.+ +++. |++|++........ ...+.+|+.++++++||||++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~ 81 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS--------FQAVTDHMLAIGSLDHAHIVRLL 81 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC--------BCSCCHHHHHHHTCCCTTBCCEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH--------HHHHHHHHHHHhcCCCCCcCeEE
Confidence 4567999999999999999999976 3444 77777653322111 11256799999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.... .+++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 82 ~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 82 GLCPGSS-----------------LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp EEECBSS-----------------EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred EEEcCCc-----------------cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 9875322 28999999999999998653 35689999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus 144 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp TTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred heEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 999999999999999999976543322 2233557779999999998899999999999999999999 9999999988
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 224 ~~~~~~~~~~ 233 (325)
T 3kex_A 224 AEVPDLLEKG 233 (325)
T ss_dssp THHHHHHHTT
T ss_pred HHHHHHHHcC
Confidence 8888777665
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=277.84 Aligned_cols=206 Identities=28% Similarity=0.527 Sum_probs=169.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
++..++|++++.||+|+||.||+|.+ +++.||+|++.... . ...+.+.+|+.++++++||||+++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~E~~~l~~l~h~~iv~~ 76 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-----E----EHLRDFEREIEILKSLQHDNIVKY 76 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-----H----HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-----H----HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 45668999999999999999999974 58899999986321 1 123457889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++...+.. ..+++|||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|||||
T Consensus 77 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 141 (295)
T 3ugc_A 77 KGVCYSAGRR--------------NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 141 (295)
T ss_dssp EEEECHHHHT--------------SCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCC--------------ceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 9988654332 128999999999999999764 3459999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp GGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred HhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 9999999999999999999976543321 122344677899999999889999999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=276.36 Aligned_cols=207 Identities=19% Similarity=0.331 Sum_probs=172.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATM 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 124 (292)
..++|++++.||+|+||.||+|.+ +++.||+|+++... ...+.+|+.+++++. ||||+++++++.
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------hHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 357899999999999999999965 68899999986321 234778999999996 999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.... ..+++|||+++++|.+++. .+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 102 ~~~~~--------------~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 162 (330)
T 3nsz_A 102 DPVSR--------------TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162 (330)
T ss_dssp CTTTC--------------CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred cCCCC--------------ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 64322 2389999999999998873 3889999999999999999999999999999999999
Q ss_pred EcCCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHH
Q 022794 205 LDKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYP-DLSFSEVT 281 (292)
Q Consensus 205 i~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~-~~~~~~~~ 281 (292)
++.++ .++|+|||.+...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. +.+..+.+
T Consensus 163 ~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l 241 (330)
T 3nsz_A 163 IDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241 (330)
T ss_dssp EETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred EcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHH
Confidence 99776 8999999999765433 23344678999999999987 568999999999999999999999994 44555555
Q ss_pred HHHHH
Q 022794 282 SAVVR 286 (292)
Q Consensus 282 ~~i~~ 286 (292)
..+.+
T Consensus 242 ~~~~~ 246 (330)
T 3nsz_A 242 VRIAK 246 (330)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 54443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=273.68 Aligned_cols=217 Identities=28% Similarity=0.522 Sum_probs=176.1
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
.+..++|++.+.||+|++|.||+|.+ +|+.||+|++.... .........+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK------IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc------ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 34457999999999999999999976 58999999985321 11112244578899999999999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||
T Consensus 81 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 142 (276)
T 2h6d_A 81 STPTDF----------------FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142 (276)
T ss_dssp ECSSEE----------------EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred ecCCeE----------------EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence 776554 8999999999999999653 4689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+++.++.++|+|||.+...... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..++..
T Consensus 143 l~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 221 (276)
T 2h6d_A 143 LLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221 (276)
T ss_dssp EECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 9999999999999998754432 22234568899999999988765 689999999999999999999999988888888
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.++
T Consensus 222 ~~~~~ 226 (276)
T 2h6d_A 222 KIRGG 226 (276)
T ss_dssp HHHHC
T ss_pred HhhcC
Confidence 77654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=281.12 Aligned_cols=218 Identities=31% Similarity=0.552 Sum_probs=178.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEEC------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYD------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
.++...+|.+.+.||+|+||.||+|.+. +..||+|+++... .. .....+.+|+.++++++||||++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~iv~ 110 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TE----KQRVDFLGEAGIMGQFSHHNIIR 110 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CH----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CH----HHHHHHHHHHHHHHhCCCCCCCc
Confidence 3567789999999999999999999653 2359999986432 11 12345788999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++...+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||
T Consensus 111 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 173 (333)
T 1mqb_A 111 LEGVISKYKPM----------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 173 (333)
T ss_dssp EEEEECSSSSE----------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCCc----------------EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 99998766554 8999999999999998653 356999999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~ 274 (292)
||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 174 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp CGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999998765432211 122345678999999998899999999999999999999 9999999
Q ss_pred CCHHHHHHHHHHh
Q 022794 275 LSFSEVTSAVVRQ 287 (292)
Q Consensus 275 ~~~~~~~~~i~~~ 287 (292)
.+..++...+.++
T Consensus 254 ~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 254 LSNHEVMKAINDG 266 (333)
T ss_dssp CCHHHHHHHHHTT
T ss_pred CCHHHHHHHHHCC
Confidence 9999888887765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.31 Aligned_cols=210 Identities=28% Similarity=0.416 Sum_probs=178.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|.+++.||+|+||.||+|.+ +|+.||||++...... .....+.+.+|+.++++++||||+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSC------HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccccc------chHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 4699999999999999999975 6899999998654321 1122345788999999999999999999987765
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+. |+|.+++... ...+++..++.++.|++.||.+||++|++||||||+||+++.
T Consensus 128 ~~----------------~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 189 (348)
T 1u5q_A 128 TA----------------WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 189 (348)
T ss_dssp EE----------------EEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred eE----------------EEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 54 89999996 6888887543 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.++|+|||++..... .....+++.|+|||++. +..++.++||||||+++|+|++|..||.+.+..+.+..+
T Consensus 190 ~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 265 (348)
T 1u5q_A 190 PGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265 (348)
T ss_dssp TTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999875432 23357899999999984 567899999999999999999999999988887777666
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.++
T Consensus 266 ~~~ 268 (348)
T 1u5q_A 266 AQN 268 (348)
T ss_dssp HHS
T ss_pred Hhc
Confidence 554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=280.82 Aligned_cols=222 Identities=26% Similarity=0.346 Sum_probs=180.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||+|++.......... ..+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-------ITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSC-------HHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccch-------HHHHHHHHHHHhccCCCcccHhheeecc
Confidence 36899999999999999999976 58899999986554333221 2366899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .......++||||+++ +|.+.+... ...+++..++.++.|++.||.+||++|++||||||+||+++
T Consensus 89 ~~~~--------~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 158 (351)
T 3mi9_A 89 ASPY--------NRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158 (351)
T ss_dssp ----------------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cccc--------ccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence 4211 0112345899999964 888777543 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCC----CCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 207 KNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
.++.++|+|||.+...... ........+++.|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+..
T Consensus 159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 238 (351)
T 3mi9_A 159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238 (351)
T ss_dssp TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999765422 2223445689999999999764 5799999999999999999999999999999888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.+.
T Consensus 239 ~~i~~~ 244 (351)
T 3mi9_A 239 ALISQL 244 (351)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=282.09 Aligned_cols=215 Identities=27% Similarity=0.561 Sum_probs=174.5
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCce----eEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHD----VAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~----valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
+...+|++.+.||+|+||.||+|.+ +++. |++|.++.... ....+.+.+|+.++++++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--------PKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC--------HHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 3457899999999999999999976 4544 57777643211 12234588899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.... . +++++++.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 84 ~~~~~~~-~----------------~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 84 GICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEEESSS-E----------------EEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEecCC-e----------------EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 9987643 2 7899999999999999753 35699999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
+||+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 9999999999999999999765433222 223446779999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 226 ~~~~~~~~~~ 235 (327)
T 3poz_A 226 SEISSILEKG 235 (327)
T ss_dssp GGHHHHHHTT
T ss_pred HHHHHHHHcC
Confidence 8887776654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=274.03 Aligned_cols=217 Identities=22% Similarity=0.422 Sum_probs=180.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||+|+++......... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR---GVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc---chHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 46799999999999999999977 48899999987543321110 00123477899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++
T Consensus 81 ~~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 142 (283)
T 3bhy_A 81 TDV----------------VLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142 (283)
T ss_dssp SEE----------------EEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred CeE----------------EEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe
Confidence 554 899999999999999964 34689999999999999999999999999999999999998
Q ss_pred CCC----cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++ .++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...
T Consensus 143 ~~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 221 (283)
T 3bhy_A 143 DKNVPNPRIKLIDFGIAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221 (283)
T ss_dssp CSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cCCCCCCceEEEecccceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 776 79999999997654322 2334568999999999999999999999999999999999999999988888877
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.+.
T Consensus 222 ~~~~~ 226 (283)
T 3bhy_A 222 NISAV 226 (283)
T ss_dssp HHHTT
T ss_pred HhHhc
Confidence 76554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=276.07 Aligned_cols=211 Identities=27% Similarity=0.449 Sum_probs=176.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|.+.+.||+|+||.||+|.+. |+.||+|++..... ...+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----------LQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----------CHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 4578999999999999999999774 88999999975432 1237789999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... +++|||+++++|.+++.. ....+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 96 ~~~~----------------~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 96 NTDL----------------WIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp TTEE----------------EEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCEE----------------EEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 6554 899999999999999864 34569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
+.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 238 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 99999999999999766544444455678999999999999899999999999999999999999999887766655544
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
.
T Consensus 239 ~ 239 (314)
T 3com_A 239 T 239 (314)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=287.40 Aligned_cols=211 Identities=24% Similarity=0.361 Sum_probs=180.6
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC------CCCcccc
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL------DHPNVTK 118 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~ 118 (292)
....+|++++.||+|+||.||+|.+ +++.||||+++.. . .....+.+|+.+++.+ +|+||++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~ 163 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------K----RFHRQAAEEIRILEHLRKQDKDNTMNVIH 163 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------c----chHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence 3457899999999999999999976 4789999998532 1 1223456677777776 6779999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++.+...... +++|||+. ++|.+++.......+++..++.++.||+.||.|||+.|++||||
T Consensus 164 ~~~~~~~~~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 226 (429)
T 3kvw_A 164 MLENFTFRNHI----------------CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDL 226 (429)
T ss_dssp EEEEEEETTEE----------------EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCC
T ss_pred EEeecccCCeE----------------EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 99998776554 89999995 69999998766667999999999999999999999999999999
Q ss_pred CCCCeeEcCCCc--EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 199 KTENMLLDKNRT--VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 199 ~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
||+|||++.++. ++|+|||+++..... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+
T Consensus 227 Kp~NILl~~~~~~~vkL~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 227 KPENILLKQQGRSGIKVIDFGSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHeEEccCCCcceEEeecccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999887 999999999754432 334678999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
..+.+..+.+.
T Consensus 304 ~~~~l~~i~~~ 314 (429)
T 3kvw_A 304 EGDQLACMIEL 314 (429)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99998888764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=280.80 Aligned_cols=216 Identities=25% Similarity=0.438 Sum_probs=180.9
Q ss_pred cCCceeEe-eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceecee
Q 022794 48 EPSKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (292)
Q Consensus 48 ~~~~~~~~-~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 123 (292)
..++|.+. +.||+|+||.||+|.+ +|+.||+|+++........ ...+.+|+.+++.+ .||||+++++++
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-------RAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC-------HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH-------HHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34678888 8999999999999976 4899999998754433222 23477899999999 679999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.+.. +++|||+++++|.+++.......+++..++.++.|++.||.+||++|++||||||+||
T Consensus 99 ~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NI 162 (327)
T 3lm5_A 99 ENTSEI----------------ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162 (327)
T ss_dssp ECSSEE----------------EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EeCCeE----------------EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHE
Confidence 876655 8999999999999998655557799999999999999999999999999999999999
Q ss_pred eEcC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 204 LLDK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+++. ++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 163 l~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 163 LLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp EESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEecCCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 9987 789999999999765433 223346789999999999999999999999999999999999999999998888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.+.
T Consensus 242 ~~~i~~~ 248 (327)
T 3lm5_A 242 YLNISQV 248 (327)
T ss_dssp HHHHHHT
T ss_pred HHHHHhc
Confidence 8777654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=275.33 Aligned_cols=219 Identities=27% Similarity=0.515 Sum_probs=179.5
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
..+.+..++|.+.+.||+|+||.||+|.+. +..||+|++..... . ...+.+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT----L----DNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC----H----HHHHHHHHHHHHHHHHCCTTBC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC----c----hHHHHHHHHHHHHHhCCCCCcc
Confidence 345667789999999999999999999753 23599999864321 1 1235588899999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
++++++.+.. .+++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+|
T Consensus 77 ~~~~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 138 (281)
T 3cc6_A 77 KLIGIIEEEP-----------------TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRD 138 (281)
T ss_dssp CEEEEECSSS-----------------CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred eEEEEEcCCC-----------------CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 9999875432 27999999999999999653 34589999999999999999999999999999
Q ss_pred CCCCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 198 VKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 198 i~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...
T Consensus 139 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 139 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp CSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 999999999999999999999875443221 2233456788999999988889999999999999999998 99999988
Q ss_pred CHHHHHHHHHHh
Q 022794 276 SFSEVTSAVVRQ 287 (292)
Q Consensus 276 ~~~~~~~~i~~~ 287 (292)
+..++...+.++
T Consensus 219 ~~~~~~~~~~~~ 230 (281)
T 3cc6_A 219 ENKDVIGVLEKG 230 (281)
T ss_dssp CGGGHHHHHHHT
T ss_pred ChHHHHHHHhcC
Confidence 887777766654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=283.10 Aligned_cols=216 Identities=24% Similarity=0.314 Sum_probs=172.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-------hHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 47899999999999999999976 5889999998643221 12234577899999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.... .....+++|||++ ++|.+++. ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 97 ~~~~----------~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 97 KSLE----------EFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp CSTT----------TCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cccc----------cccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 4321 1234589999996 58888874 3488999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.++|+|||.+...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+.+..+.+
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp TTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred CCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999999754432 223346789999999999999999999999999999999999999999999888888765
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 241 ~ 241 (371)
T 2xrw_A 241 Q 241 (371)
T ss_dssp -
T ss_pred H
Confidence 4
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=275.13 Aligned_cols=218 Identities=28% Similarity=0.556 Sum_probs=182.8
Q ss_pred cceecCCceeEee-eeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 44 DWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 44 ~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
.+.+..++|.+.+ .||+|+||.||+|.+ ++..||+|+++.... ....+.+.+|+.++++++||||++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~ 74 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KADTEEMMREAQIMHQLDNPYIVR 74 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--------hhHHHHHHHHHHHHHhCCCCCEeE
Confidence 4556678898888 999999999999965 577899999964321 122445788999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++... . .+++|||+++++|.+++.. ....+++..++.++.|++.||.+||+.|++|+||
T Consensus 75 ~~~~~~~~-~----------------~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 136 (287)
T 1u59_A 75 LIGVCQAE-A----------------LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136 (287)
T ss_dssp EEEEEESS-S----------------EEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEEEecCC-C----------------cEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCC
Confidence 99988432 2 2899999999999999864 3456999999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~ 274 (292)
+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 137 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999976543322 1223446789999999988889999999999999999998 9999999
Q ss_pred CCHHHHHHHHHHh
Q 022794 275 LSFSEVTSAVVRQ 287 (292)
Q Consensus 275 ~~~~~~~~~i~~~ 287 (292)
.+..++...+.++
T Consensus 217 ~~~~~~~~~i~~~ 229 (287)
T 1u59_A 217 MKGPEVMAFIEQG 229 (287)
T ss_dssp CCTHHHHHHHHTT
T ss_pred CCHHHHHHHHhcC
Confidence 9988888777665
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=279.40 Aligned_cols=216 Identities=25% Similarity=0.440 Sum_probs=170.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||||+++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--------LAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--------THHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 5799999999999999999977 5899999999754321 11345789999999999999999999986654
Q ss_pred cccccccc-----------------------------------------ccccCCCCceEEEEeecCCCCHHHHHHhhcc
Q 022794 128 ELHIQTEN-----------------------------------------GQVAMPSNICCVVVEYLPGGALKTYLIKNRR 166 (292)
Q Consensus 128 ~~~~~~~~-----------------------------------------~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 166 (292)
......+. ........+.+++|||+++++|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 31100000 0001123347999999999999999975432
Q ss_pred -cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCC------------CCCCCCC
Q 022794 167 -RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP------------NDMTGET 233 (292)
Q Consensus 167 -~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~------------~~~~~~~ 233 (292)
...++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....... .......
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 345667789999999999999999999999999999999999999999999998655432 1223356
Q ss_pred CcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 234 ~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 8999999999999999999999999999999999988763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=275.98 Aligned_cols=210 Identities=26% Similarity=0.454 Sum_probs=179.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||+|+++..... ....+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---------RDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---------chHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 36899999999999999999976 5899999999743221 123477899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE-
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL- 205 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili- 205 (292)
... +++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 79 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~ 140 (304)
T 2jam_A 79 THY----------------YLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140 (304)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEES
T ss_pred CEE----------------EEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 554 8999999999999998653 468999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 206 --DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 206 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+.++.++|+|||.+..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..++...
T Consensus 141 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 218 (304)
T 2jam_A 141 TPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218 (304)
T ss_dssp SSSTTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cCCCCCCEEEccCCcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 6788999999999864332 122334588999999999999999999999999999999999999999999888888
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.++
T Consensus 219 i~~~ 222 (304)
T 2jam_A 219 IKEG 222 (304)
T ss_dssp HHHC
T ss_pred HHcC
Confidence 7765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=279.21 Aligned_cols=215 Identities=27% Similarity=0.559 Sum_probs=173.5
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCcee----EEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDV----AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~v----alK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
+...+|++++.||+|+||.||+|.+ +++.+ ++|.+....... . ...+.+|+.++++++||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~-~-------~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-A-------NKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC-C-------HHHHHHHHHHHTTCCBTTBCCCC
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH-H-------HHHHHHHHHHHHhCCCCCeeEEE
Confidence 4568999999999999999999976 45554 666664332211 1 23477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.... . +++++++.+++|.+++... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 84 ~~~~~~~-~----------------~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 145 (327)
T 3lzb_A 84 GICLTST-V----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp EEEESSS-E----------------EEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEecCC-c----------------eEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCH
Confidence 9987654 2 7899999999999999754 34699999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 146 ~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred HHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 999999999999999999976533222 2223446778999999999999999999999999999999 9999999988
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++...+.++
T Consensus 226 ~~~~~~~~~~ 235 (327)
T 3lzb_A 226 SEISSILEKG 235 (327)
T ss_dssp GGHHHHHHTT
T ss_pred HHHHHHHHcC
Confidence 8887777655
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.88 Aligned_cols=221 Identities=29% Similarity=0.507 Sum_probs=183.6
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCC
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 114 (292)
..+.+..++|.+.+.||+|+||.||+|.+.+ ..||+|+++.... ......+.+|+.+++++ +||
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~ 110 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--------ADEKEALMSELKIMSHLGQHE 110 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--------HHHHHHHHHHHHHHHHHCCCT
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--------hHHHHHHHHHHHHHHhhcCCC
Confidence 4578888999999999999999999997642 4799999864321 11234578899999999 899
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc------------ccccCHHHHHHHHHHHH
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR------------RRKLAFKVVVQLALDLA 182 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~i~~qi~ 182 (292)
||+++++++...+.. +++|||+++++|.+++.... ...+++..++.++.|++
T Consensus 111 ~iv~~~~~~~~~~~~----------------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~ 174 (333)
T 2i1m_A 111 NIVNLLGACTHGGPV----------------LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174 (333)
T ss_dssp TBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHH
T ss_pred CeeeEEEEEecCCce----------------EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHH
Confidence 999999998876654 89999999999999996542 24579999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHH
Q 022794 183 RGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGI 260 (292)
Q Consensus 183 ~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~ 260 (292)
.||.+||+.|++|+||||+||+++.++.++|+|||++......... .....+++.|+|||.+.+..++.++||||||+
T Consensus 175 ~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 254 (333)
T 2i1m_A 175 QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254 (333)
T ss_dssp HHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHH
Confidence 9999999999999999999999999999999999999754433221 22344677899999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 261 CLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 261 il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
++|+|++ |..||.+....+....+.+.
T Consensus 255 il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 255 LLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp HHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred HHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 9999998 99999987766666555543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=287.19 Aligned_cols=213 Identities=21% Similarity=0.291 Sum_probs=173.2
Q ss_pred CCceeEeeeeccCcceEEEEEEEC----------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD----------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~----------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
.++|++.+.||+|+||.||+|.+. ++.||+|++... ..+.+|+.+++++.||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------STHHHHHHHHHHHCCHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------chHHHHHHHHHHhcccchhh
Confidence 579999999999999999999763 789999998643 12678999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++.+.......+....+.........+++|||+ +++|.+++.......+++..++.++.|++.||.|||++|++||||
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Di 185 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNV 185 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred hhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 7665544333222222222222345669999999 999999998665578999999999999999999999999999999
Q ss_pred CCCCeeEcCCC--cEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCC
Q 022794 199 KTENMLLDKNR--TVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 199 ~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~ 269 (292)
||+||+++.++ .++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|.
T Consensus 186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 265 (352)
T 2jii_A 186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265 (352)
T ss_dssp CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999988 899999999975432211 123347899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 022794 270 MPYPDLS 276 (292)
Q Consensus 270 ~pf~~~~ 276 (292)
.||....
T Consensus 266 ~pf~~~~ 272 (352)
T 2jii_A 266 LPWTNCL 272 (352)
T ss_dssp CTTGGGT
T ss_pred CCcccCC
Confidence 9998763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=284.18 Aligned_cols=218 Identities=28% Similarity=0.448 Sum_probs=165.9
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
|.+ .++|++++.||+|+||.||+|.+ +|+.||||++..... . ......+.+|+.+++.++||||++++++
T Consensus 25 ~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 96 (367)
T 2fst_X 25 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---S----IIHAKRTYRELRLLKHMKHENVIGLLDV 96 (367)
T ss_dssp EEE-ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS---S----HHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred cCC-CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc---C----HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 444 47899999999999999999965 688999999854321 1 1223457789999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+....... .....++++|++ +++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+|
T Consensus 97 ~~~~~~~~----------~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~N 162 (367)
T 2fst_X 97 FTPARSLE----------EFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 162 (367)
T ss_dssp ECSCSSGG----------GCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EecCCccc----------cCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhh
Confidence 87653221 123348999999 7899998843 469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
|+++.++.++|+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 163 Ill~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 239 (367)
T 2fst_X 163 LAVNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239 (367)
T ss_dssp EEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEECCCCCEEEeecccccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999754322 334578999999999987 67899999999999999999999999999998888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..|.+.
T Consensus 240 ~~i~~~ 245 (367)
T 2fst_X 240 KLILRL 245 (367)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=276.87 Aligned_cols=212 Identities=24% Similarity=0.343 Sum_probs=168.7
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +++.||+|++...... .....+.+.+|+.++++++||||+++++++...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS------DPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc------CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 47899999999999999999976 5889999998643211 123345688999999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. +++|||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus 107 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~ 168 (309)
T 2h34_A 107 GQL----------------YVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168 (309)
T ss_dssp TEE----------------EEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CeE----------------EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc
Confidence 554 8999999999999999653 4689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...+...+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247 (309)
T ss_dssp TTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence 99999999999987544322 2223456889999999999988999999999999999999999999987666444433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=274.30 Aligned_cols=215 Identities=28% Similarity=0.460 Sum_probs=166.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++.+.||+|+||.||+|.+ +|+.||+|+++...... ......+.+|+.++++++||||+++++++...
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD------AKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 36899999999999999999975 68999999986432211 12244578899999999999999999998876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.. +++|||+++++|.+++... ....+++..++.++.|++.||.+||+.|++|+||+|+||+
T Consensus 105 ~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl 168 (310)
T 2wqm_A 105 NEL----------------NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 168 (310)
T ss_dssp TEE----------------EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CcE----------------EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEE
Confidence 554 8999999999999998643 3456899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL--SFSEVTS 282 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~--~~~~~~~ 282 (292)
++.++.++|+|||.+..............+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+. ...++..
T Consensus 169 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 248 (310)
T 2wqm_A 169 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248 (310)
T ss_dssp ECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH
T ss_pred EcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH
Confidence 99999999999999876554444444467899999999999999999999999999999999999999753 3334444
Q ss_pred HHH
Q 022794 283 AVV 285 (292)
Q Consensus 283 ~i~ 285 (292)
.+.
T Consensus 249 ~~~ 251 (310)
T 2wqm_A 249 KIE 251 (310)
T ss_dssp HHH
T ss_pred Hhh
Confidence 443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=284.96 Aligned_cols=208 Identities=31% Similarity=0.508 Sum_probs=175.7
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+.+..++|.+.+.||+|+||.||+|.. +|+.||+|++........ ...+.+|+.++++++||||++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--------ELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--------CCHHHHHHHGGGTCCCTTBCCCC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--------HHHHHHHHHHHHhccCCCccceE
Confidence 345666778999999999999999999965 588999999864432211 11377899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--RRKLAFKVVVQLALDLARGLSYLHSQ---KIVH 195 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~h 195 (292)
+++...... +++|||+++++|.+++.... ...+++..++.++.|++.||.+||+. |++|
T Consensus 94 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 157 (326)
T 3uim_A 94 GFCMTPTER----------------LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 157 (326)
T ss_dssp EEECCSSCC----------------EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEEC
T ss_pred EEEecCCce----------------EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Confidence 998876655 89999999999999997543 23589999999999999999999999 9999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCC-CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPND-MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 158 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999999999999999999999865433222 233458999999999988889999999999999999999999995
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=277.02 Aligned_cols=202 Identities=31% Similarity=0.570 Sum_probs=166.1
Q ss_pred ecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh--CCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK--LDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~ 124 (292)
...++|++.+.||+|+||.||+|.++|+.||||++.... ...+..|.+++.. ++||||+++++++.
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------------EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 345799999999999999999999999999999985321 1224456666666 79999999999865
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--------hCCcccc
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH--------SQKIVHR 196 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH--------~~~i~h~ 196 (292)
..... ....+++|||+++++|.+++. ...+++..++.++.|++.||.||| +.|++||
T Consensus 73 ~~~~~------------~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 137 (301)
T 3q4u_A 73 TSRHS------------STQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHR 137 (301)
T ss_dssp EEETT------------EEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECS
T ss_pred cccCC------------CceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecC
Confidence 43221 223489999999999999994 346999999999999999999999 9999999
Q ss_pred CCCCCCeeEcCCCcEEEeecCcceeccCCCCC----CCCCCCcccccCCcccCCC------CCCchhhHHHHHHHHHHHH
Q 022794 197 DVKTENMLLDKNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIY 266 (292)
Q Consensus 197 di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~------~~~~~~Diwslg~il~~l~ 266 (292)
||||+||+++.++.++|+|||++......... .....+++.|+|||.+.+. .++.++||||||+++|+|+
T Consensus 138 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~ 217 (301)
T 3q4u_A 138 DLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217 (301)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999765433222 2234789999999999876 3457899999999999999
Q ss_pred hC----------CCCCCCC
Q 022794 267 CC----------DMPYPDL 275 (292)
Q Consensus 267 ~g----------~~pf~~~ 275 (292)
+| ..||...
T Consensus 218 tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 218 RRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TTBCBTTBCCCCCCTTTTT
T ss_pred hhhcCcccccccccccccc
Confidence 99 8899653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=290.34 Aligned_cols=219 Identities=22% Similarity=0.363 Sum_probs=177.6
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
....++|++.+.||+|+||.||+|.+. |+.||||+++....... .+.+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~~~~~~ 76 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--------VDVQMREFEVLKKLNHKNIVKLFAIE 76 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--------HHHHHHHHHHHHhcCCCCCCeEEEee
Confidence 345679999999999999999999774 88999999864322111 23467899999999999999999988
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
...... ..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++||||||+|
T Consensus 77 ~~~~~~--------------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 142 (396)
T 4eut_A 77 EETTTR--------------HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142 (396)
T ss_dssp ECTTTC--------------CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ccCCCC--------------eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHH
Confidence 765432 23899999999999999865332 239999999999999999999999999999999999
Q ss_pred eeE----cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC--------CCCCchhhHHHHHHHHHHHHhCCC
Q 022794 203 MLL----DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--------NPYNRKCDVYSFGICLWEIYCCDM 270 (292)
Q Consensus 203 ili----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diwslg~il~~l~~g~~ 270 (292)
|++ +.++.++|+|||.+...... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 143 Ill~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~ 221 (396)
T 4eut_A 143 IMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (396)
T ss_dssp EEEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999 67778999999999765433 23344678999999999864 456789999999999999999999
Q ss_pred CCCC----CCHHHHHHHHHHh
Q 022794 271 PYPD----LSFSEVTSAVVRQ 287 (292)
Q Consensus 271 pf~~----~~~~~~~~~i~~~ 287 (292)
||.. ....+++.++..+
T Consensus 222 Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 222 PFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp SEECTTCTTTCHHHHHHHHHS
T ss_pred CCCCCCcccchHHHHHHHhcC
Confidence 9974 3344555555544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=275.37 Aligned_cols=219 Identities=31% Similarity=0.535 Sum_probs=179.9
Q ss_pred ccceecCCceeEee-eeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 43 QDWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 43 ~~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
.++.+...+|.+.+ .||+|+||.||+|.+ .++.||||+++..... ....+.+.+|+.++++++||||+
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~ 81 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQLDNPYIV 81 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-------HHHHHHHHHHHHHHHhCCCCCEE
Confidence 45566678999999 999999999999954 3678999998643211 22345688999999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
++++++.. +. .+++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+|
T Consensus 82 ~~~~~~~~-~~----------------~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d 142 (291)
T 1xbb_A 82 RMIGICEA-ES----------------WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142 (291)
T ss_dssp CEEEEEES-SS----------------EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEEEEECC-CC----------------cEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCC
Confidence 99998832 22 28999999999999999653 4599999999999999999999999999999
Q ss_pred CCCCCeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 022794 198 VKTENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYP 273 (292)
Q Consensus 198 i~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~ 273 (292)
|||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus 143 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 222 (291)
T 1xbb_A 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 222 (291)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999765433221 122345688999999988888999999999999999999 999999
Q ss_pred CCCHHHHHHHHHHh
Q 022794 274 DLSFSEVTSAVVRQ 287 (292)
Q Consensus 274 ~~~~~~~~~~i~~~ 287 (292)
+.+..++...+.++
T Consensus 223 ~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 223 GMKGSEVTAMLEKG 236 (291)
T ss_dssp TCCHHHHHHHHHTT
T ss_pred CCCHHHHHHHHHcC
Confidence 99998888777654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.43 Aligned_cols=215 Identities=23% Similarity=0.360 Sum_probs=179.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++++.||+|+||.||+|.+ +++.||||++.... . ....+.+.+|+.++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE----H----QTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT----C----HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc----C----cHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 47899999999999999999976 58899999986321 1 12234578899999999999999999998764
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .....+++|||+. ++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 98 ~~~-----------~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~ 162 (364)
T 3qyz_A 98 TIE-----------QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162 (364)
T ss_dssp STT-----------TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred Ccc-----------ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC
Confidence 321 1223489999996 599998853 4599999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++.++|+|||.+........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.+.
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 242 (364)
T 3qyz_A 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242 (364)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence 999999999999976543221 1234578999999998654 458999999999999999999999999999988888
Q ss_pred HHHH
Q 022794 283 AVVR 286 (292)
Q Consensus 283 ~i~~ 286 (292)
.+.+
T Consensus 243 ~i~~ 246 (364)
T 3qyz_A 243 HILG 246 (364)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=287.00 Aligned_cols=205 Identities=24% Similarity=0.378 Sum_probs=167.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 121 (292)
..++|.+.+.||+|+||.||+|.+ +|+.||||+++........ .....+.+|+.+++++ +||||+++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh-----hHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 447999999999999999999976 6899999998542210000 0011255688999999 7999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...+.. +++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+
T Consensus 127 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~ 188 (355)
T 1vzo_A 127 AFQTETKL----------------HLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188 (355)
T ss_dssp EEEETTEE----------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred EEeeCceE----------------EEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 98776554 8999999999999999653 46999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
||+++.++.++|+|||++....... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...
T Consensus 189 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp GEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred HEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 9999999999999999987543221 122335689999999999863 4789999999999999999999999743
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=299.57 Aligned_cols=219 Identities=28% Similarity=0.549 Sum_probs=179.1
Q ss_pred cceecCCceeEee-eeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 44 DWEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 44 ~~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
.+.+...++.+.+ .||+|+||.||+|.+ ++..||||+++...... . .+.+.+|+.++++++||||++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~-------~~~~~~E~~il~~l~hpniv~ 400 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-D-------TEEMMREAQIMHQLDNPYIVR 400 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST-T-------HHHHHHHHHHHTTCCCTTBCC
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH-H-------HHHHHHHHHHHHhCCCCCEee
Confidence 3455566777777 899999999999965 45679999997542211 1 234788999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++... .. ++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||
T Consensus 401 l~~~~~~~-~~----------------~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDl 462 (613)
T 2ozo_A 401 LIGVCQAE-AL----------------MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462 (613)
T ss_dssp EEEEEESS-SE----------------EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEeccC-Ce----------------EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcC
Confidence 99998653 22 8999999999999998643 456999999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPD 274 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~ 274 (292)
||+|||++.++.++|+|||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+
T Consensus 463 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp SGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999754332211 112334578999999998899999999999999999998 9999999
Q ss_pred CCHHHHHHHHHHhh
Q 022794 275 LSFSEVTSAVVRQV 288 (292)
Q Consensus 275 ~~~~~~~~~i~~~~ 288 (292)
.+..++...+.++.
T Consensus 543 ~~~~~~~~~i~~~~ 556 (613)
T 2ozo_A 543 MKGPEVMAFIEQGK 556 (613)
T ss_dssp CCSHHHHHHHHTTC
T ss_pred CCHHHHHHHHHcCC
Confidence 99999998887764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=281.43 Aligned_cols=222 Identities=32% Similarity=0.548 Sum_probs=181.1
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 110 (292)
++.....|.+..++|++.+.||+|+||.||+|.+ +++.||+|+++.... . ...+.+.+|+.++++
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~~E~~~l~~ 86 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIH 86 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHH
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC----c----HHHHHHHHHHHHHHh
Confidence 3444556778889999999999999999999964 457899999864321 1 123457889999999
Q ss_pred C-CCCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--------------cccCHHHHH
Q 022794 111 L-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------------RKLAFKVVV 175 (292)
Q Consensus 111 l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~ 175 (292)
+ +||||+++++++...+. ..+++|||+++++|.+++..... ..+++..++
T Consensus 87 l~~hp~iv~~~~~~~~~~~---------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T 2xir_A 87 IGHHLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151 (316)
T ss_dssp HCCCTTBCCEEEEECCTTS---------------CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred cccCCCeeeEEEEEecCCC---------------ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence 9 79999999999876433 12899999999999999975432 128899999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchh
Q 022794 176 QLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKC 253 (292)
Q Consensus 176 ~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~ 253 (292)
.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++
T Consensus 152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 231 (316)
T 2xir_A 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231 (316)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence 99999999999999999999999999999999999999999999754432221 2234467789999999988899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022794 254 DVYSFGICLWEIYC-CDMPYPDLSFSEVTS 282 (292)
Q Consensus 254 Diwslg~il~~l~~-g~~pf~~~~~~~~~~ 282 (292)
|+||||+++|+|++ |..||.+.+..+.+.
T Consensus 232 Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 99999999999998 999998776544433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=281.92 Aligned_cols=212 Identities=23% Similarity=0.370 Sum_probs=166.2
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHH----HHHHHHHHHHHHhCCCCcc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAAL----RSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i 116 (292)
++..++|.+.+.||+|+||.||+|.+ ++..||+|+....... ...+...+ ...+.+|+..++.++||||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP--LFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CH--HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcc--hHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 34568999999999999999999977 5678999998754321 11222111 2346788999999999999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++++++..... .....+++|||+ +++|.+++... ..+++..++.++.|++.||.|||+.|++||
T Consensus 111 ~~~~~~~~~~~~------------~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 175 (345)
T 2v62_A 111 PLFYGSGLTEFK------------GRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHG 175 (345)
T ss_dssp CCEEEEEEEESS------------SCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred ceeecccccccC------------CCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 999999876210 122348999999 99999998543 379999999999999999999999999999
Q ss_pred CCCCCCeeEcCCC--cEEEeecCcceeccCCC-------CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 197 DVKTENMLLDKNR--TVKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 197 di~p~Nili~~~~--~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
||||+||+++.++ .++|+|||.+....... .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 176 Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp CCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999998877 99999999997643221 11134578999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 022794 268 CDMPYPD 274 (292)
Q Consensus 268 g~~pf~~ 274 (292)
|..||..
T Consensus 256 g~~pf~~ 262 (345)
T 2v62_A 256 GKLPWEQ 262 (345)
T ss_dssp SSCTTGG
T ss_pred CCCCccc
Confidence 9999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=282.27 Aligned_cols=218 Identities=28% Similarity=0.472 Sum_probs=183.4
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
.......++..++|++.+.||+|+||.||+|.+. ++.||+|++..... ....+.+.+|+.++++++||||
T Consensus 22 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i 93 (360)
T 3eqc_A 22 TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIRELQVLHECNSPYI 93 (360)
T ss_dssp HHHHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHGGGGGCCCTTB
T ss_pred hhhhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--------HHHHHHHHHHHHHHHHCCCCCE
Confidence 3334445667789999999999999999999875 88999999864321 1234558899999999999999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-Cccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVH 195 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h 195 (292)
+++++++...+.. +++|||+++++|.+++... ..+++..++.++.|++.+|.|||+. |++|
T Consensus 94 v~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H 155 (360)
T 3eqc_A 94 VGFYGAFYSDGEI----------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMH 155 (360)
T ss_dssp CCEEEEEEETTEE----------------EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred EEEeEEEEECCEE----------------EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence 9999998876554 8999999999999999653 4689999999999999999999996 9999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+||||+||+++.++.++|+|||.+...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998644322 223357899999999999999999999999999999999999999998
Q ss_pred CHHHHHHHH
Q 022794 276 SFSEVTSAV 284 (292)
Q Consensus 276 ~~~~~~~~i 284 (292)
+..++...+
T Consensus 234 ~~~~~~~~~ 242 (360)
T 3eqc_A 234 DAKELELMF 242 (360)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHh
Confidence 887765443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=271.07 Aligned_cols=210 Identities=31% Similarity=0.609 Sum_probs=173.6
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+..++|++.+.||+|+||.||+|.+ +++.||+|++......... ......+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET--EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCH--HHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccch--hHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 4568999999999999999999977 6889999998654432221 11111245789999999999999999999886
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCC
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTEN 202 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p~N 202 (292)
+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||++| ++|+||||+|
T Consensus 94 ~~~------------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 94 NPP------------------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp TTT------------------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred CCC------------------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 543 6899999999999988653 456999999999999999999999999 9999999999
Q ss_pred eeEcCCCc-----EEEeecCcceeccCCCCCCCCCCCcccccCCcccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 203 MLLDKNRT-----VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN--GNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 203 ili~~~~~-----~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
|+++.++. ++|+|||.+..... ......+++.|+|||.+. +..++.++|+||||+++|+|++|..||...
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EEEeccCCCCceeEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 99987776 99999999874332 233467899999999984 445789999999999999999999999876
Q ss_pred CHHHH
Q 022794 276 SFSEV 280 (292)
Q Consensus 276 ~~~~~ 280 (292)
+..+.
T Consensus 232 ~~~~~ 236 (287)
T 4f0f_A 232 SYGKI 236 (287)
T ss_dssp CCCHH
T ss_pred cccHH
Confidence 54443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.19 Aligned_cols=220 Identities=28% Similarity=0.393 Sum_probs=179.0
Q ss_pred cCCceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceec
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIG 121 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~ 121 (292)
..++|++.+.||+|+||.||+|.+ +|+.||+|+++......... ..+.+|+.+++.+ .||||+++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~h~~i~~~~~ 81 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-------LSTIREVAVLRHLETFEHPNVVRLFD 81 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB-------CTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC-------chhhHHHHHHHhhhccCCCCeEeeee
Confidence 347899999999999999999976 47889999987543222111 0134566665555 8999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...... .....+++|||++ ++|.+++.......+++..++.++.|++.||.+||+.|++|+||||+
T Consensus 82 ~~~~~~~~-----------~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~ 149 (326)
T 1blx_A 82 VCTVSRTD-----------RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQ 149 (326)
T ss_dssp EEEEEECS-----------SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeeecccC-----------CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHH
Confidence 88621100 1223389999996 69999997766666999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
||+++.++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (326)
T 1blx_A 150 NILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228 (326)
T ss_dssp GEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999999999999999998754322 2233466899999999999999999999999999999999999999999999888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.+.
T Consensus 229 ~~i~~~ 234 (326)
T 1blx_A 229 GKILDV 234 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=272.77 Aligned_cols=198 Identities=35% Similarity=0.681 Sum_probs=164.5
Q ss_pred ecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+..++|++.+.||+|+||.||+|.+.++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 73 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES-----------ERKAFIVELRQLSRVNHPNIVKLYGACLNP 73 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT-----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh-----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 345789999999999999999999999999999985221 134578899999999999999999987632
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-RKLAFKVVVQLALDLARGLSYLHS---QKIVHRDVKTEN 202 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~h~di~p~N 202 (292)
. +++|||+++++|.+++..... ..++...++.++.|++.||.+||+ +|++||||||+|
T Consensus 74 --~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 74 --V----------------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp --T----------------EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred --c----------------EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 2 899999999999999965332 347889999999999999999999 899999999999
Q ss_pred eeEcCCCc-EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 203 MLLDKNRT-VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 203 ili~~~~~-~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
|+++.++. ++|+|||.+...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 136 Ill~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 136 LLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp EEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred EEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 99988886 799999998754322 223468999999999999999999999999999999999999998543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=279.78 Aligned_cols=218 Identities=32% Similarity=0.492 Sum_probs=177.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
++..++|++.+.||+|+||.||+|.+ ++..||||++.... .. .....+.+|+.++++++||||++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SE----QDELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CH----HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----ch----hhHHHHHHHHHHHhhCCCCCCCe
Confidence 34568999999999999999999973 46689999985321 11 11234778999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHHhCCc
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLHSQKI 193 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i 193 (292)
+++++...... +++|||+++++|.+++..... ..+++..++.++.|++.||.+||+.|+
T Consensus 98 ~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 161 (327)
T 2yfx_A 98 CIGVSLQSLPR----------------FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161 (327)
T ss_dssp EEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEcCCCCc----------------EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe
Confidence 99998876554 899999999999999976432 348899999999999999999999999
Q ss_pred cccCCCCCCeeEcC---CCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-
Q 022794 194 VHRDVKTENMLLDK---NRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267 (292)
Q Consensus 194 ~h~di~p~Nili~~---~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~- 267 (292)
+||||||+||+++. +..++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999984 44699999999865432221 2223456889999999988889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHHh
Q 022794 268 CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 268 g~~pf~~~~~~~~~~~i~~~ 287 (292)
|..||...+..++...+.++
T Consensus 242 g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 242 GYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp SCCSSTTCCHHHHHHHHHTT
T ss_pred CCCCCCCcCHHHHHHHHhcC
Confidence 99999999988888877664
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=280.50 Aligned_cols=235 Identities=21% Similarity=0.317 Sum_probs=182.6
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCcc--HHHHHHHHHHHHHHHHHHHhCCCCc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRT--EAEIAALRSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~ 115 (292)
...........++|.+.+.||+|+||.||+|.+ +|+.||||++......... ........+.+.+|+.++++++|||
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 334445556678999999999999999999965 5889999998654332221 1122334466889999999999999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
|+++++++...... .....+++|||++ ++|.+++.. ....+++..++.++.|++.||.|||++|++|
T Consensus 91 iv~~~~~~~~~~~~-----------~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 157 (362)
T 3pg1_A 91 ILGLRDIFVHFEEP-----------AMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVH 157 (362)
T ss_dssp BCCCSEEEEECCTT-----------TCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccceeeeEEeccCC-----------CcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEe
Confidence 99999998543321 1234489999996 688888864 3446999999999999999999999999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+||||+||+++.++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+
T Consensus 158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 158 RDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCChHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999743332 23344568899999999887 6789999999999999999999999999
Q ss_pred CCHHHHHHHHHHh
Q 022794 275 LSFSEVTSAVVRQ 287 (292)
Q Consensus 275 ~~~~~~~~~i~~~ 287 (292)
.+..+.+..+.+.
T Consensus 237 ~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 237 STFYNQLNKIVEV 249 (362)
T ss_dssp SSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHH
Confidence 9999988888753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=276.33 Aligned_cols=214 Identities=25% Similarity=0.417 Sum_probs=181.2
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC------
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP------ 114 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------ 114 (292)
..++..++|++.+.||+|+||.||+|.+ +++.||+|+++.. . .....+.+|+.+++.++|+
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~ 77 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------D----RYCEAARSEIQVLEHLNTTDPNSTF 77 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------H----HHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------C----chhHHHHHHHHHHHHhhhcCCCCce
Confidence 3455678999999999999999999976 5789999998521 1 2234567888888888655
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 194 (292)
+++++++++...+.. +++|||+ +++|.+++.......+++..++.++.|++.||.|||++|++
T Consensus 78 ~i~~~~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 140 (339)
T 1z57_A 78 RCVQMLEWFEHHGHI----------------CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLT 140 (339)
T ss_dssp CBCCEEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eeEeeecccccCCcE----------------EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 489999988766554 8999999 88999999776656789999999999999999999999999
Q ss_pred ccCCCCCCeeEcC-------------------CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhH
Q 022794 195 HRDVKTENMLLDK-------------------NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDV 255 (292)
Q Consensus 195 h~di~p~Nili~~-------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 255 (292)
||||||+||+++. ++.++|+|||.+...... .....+++.|+|||.+.+..++.++|+
T Consensus 141 H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di 217 (339)
T 1z57_A 141 HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDV 217 (339)
T ss_dssp CCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHH
T ss_pred CCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhh
Confidence 9999999999987 667999999999764432 234578999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 256 YSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 256 wslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
||||+++|+|++|..||...+..+....+.+.
T Consensus 218 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp HHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999999999999999988877766543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=275.91 Aligned_cols=214 Identities=28% Similarity=0.481 Sum_probs=176.5
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++++.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---------ELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---------HHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 3478999999999999999999774 889999998643221 12347789999999999999999999877
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 88 ~~~~----------------~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (302)
T 2j7t_A 88 DGKL----------------WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150 (302)
T ss_dssp C-CE----------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred CCeE----------------EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence 6544 8999999999999988653 3569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+.++.++|+|||.+..............+++.|+|||.+ .+..++.++|+||||+++|+|++|..||...+..+.
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 230 (302)
T 2j7t_A 151 TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230 (302)
T ss_dssp CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 999999999999875332222222335689999999998 466789999999999999999999999999888887
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.+.
T Consensus 231 ~~~~~~~ 237 (302)
T 2j7t_A 231 LLKIAKS 237 (302)
T ss_dssp HHHHHHS
T ss_pred HHHHhcc
Confidence 7776654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=275.32 Aligned_cols=205 Identities=29% Similarity=0.483 Sum_probs=169.8
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.+...+|++++.||+|+||.||+|.+ +++.||+|+++...... ..+.+.+|+.++++++||||+++
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--------HIADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--------CHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--------hHHHHHHHHHHHHhCCCCCeeee
Confidence 34456799999999999999999973 68899999986433211 13447889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++...+.. ..+++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+|||
T Consensus 89 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 153 (302)
T 4e5w_A 89 KGICTEDGGN--------------GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLA 153 (302)
T ss_dssp EEEEEC---C--------------CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeEEecCCCc--------------eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCc
Confidence 9998765322 238999999999999999654 3469999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus 154 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 154 ARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred hheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 9999999999999999999976554332 2334567888999999988889999999999999999999998864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=282.15 Aligned_cols=216 Identities=23% Similarity=0.359 Sum_probs=175.7
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
....+|.+.+.||+|+||.||+|.+ .+..||+|.+...... ..+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------------~~~E~~il~~l~h~niv~l~~~~~~ 103 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------------KNRELQIMRIVKHPNVVDLKAFFYS 103 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------------CCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------------HHHHHHHHHhCCCCCcceEEEEEEe
Confidence 3446899999999999999999977 4566888887543321 2359999999999999999999865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.... ....+.+++|||+++ ++.+.+.. .....+++..++.++.|++.||.|||++|++||||||+||
T Consensus 104 ~~~~----------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Ni 172 (394)
T 4e7w_A 104 NGDK----------KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNL 172 (394)
T ss_dssp ESSS----------SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cCCC----------CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence 4321 012334899999976 44444432 2346799999999999999999999999999999999999
Q ss_pred eEc-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 204 LLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+++ .++.++|+|||++....... ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 173 ll~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l 251 (394)
T 4e7w_A 173 LLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251 (394)
T ss_dssp EEETTTTEEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEcCCCCcEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998 78999999999998654332 33346789999999999775 5899999999999999999999999999999888
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.+.
T Consensus 252 ~~i~~~ 257 (394)
T 4e7w_A 252 VEIIKV 257 (394)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=274.32 Aligned_cols=209 Identities=33% Similarity=0.507 Sum_probs=173.7
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELH 130 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 130 (292)
.|...+.||+|+||.||+|.++++.||+|++......... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 105 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE-----ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL- 105 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTT-----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC-
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchH-----HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce-
Confidence 3555689999999999999999999999998643321111 1234578899999999999999999998776654
Q ss_pred cccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCC
Q 022794 131 IQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR 209 (292)
Q Consensus 131 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~ 209 (292)
+++|||+++++|.+++.... ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++
T Consensus 106 ---------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~ 170 (307)
T 2nru_A 106 ---------------CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF 170 (307)
T ss_dssp ---------------EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred ---------------EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC
Confidence 89999999999999986432 34689999999999999999999999999999999999999999
Q ss_pred cEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 210 TVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 210 ~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
.++|+|||.+......... .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+..+.+
T Consensus 171 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred cEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 9999999998765432221 233568999999999875 4789999999999999999999999876554433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=283.34 Aligned_cols=199 Identities=25% Similarity=0.388 Sum_probs=162.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +|+.||||+++.... . ....+++.+|+.++++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE---D----LIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT---S----HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc---C----hHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 57999999999999999999976 578999999863321 1 12244578999999999999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... .....|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+|||++
T Consensus 98 ~~~-----------~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 98 DLL-----------KFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163 (432)
T ss_dssp CTT-----------TCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCC-----------cCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC
Confidence 321 1233499999995 699999854 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC----------------------CCCCCCCcccccCCccc-CCCCCCchhhHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN----------------------DMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLW 263 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~----------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Diwslg~il~ 263 (292)
.++.++|+|||+++....... ......+|+.|+|||++ .+..++.++|||||||++|
T Consensus 164 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ 243 (432)
T 3n9x_A 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243 (432)
T ss_dssp TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence 999999999999986543221 12456789999999986 5566999999999999999
Q ss_pred HHHhC
Q 022794 264 EIYCC 268 (292)
Q Consensus 264 ~l~~g 268 (292)
+|++|
T Consensus 244 ell~g 248 (432)
T 3n9x_A 244 ELLNM 248 (432)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=268.16 Aligned_cols=217 Identities=29% Similarity=0.514 Sum_probs=175.5
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
.......|.+.+.||+|+||.||+|.+ ++..|++|++...... . ...+.+.+|+.++++++||||++++++
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~---~----~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---K----SERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---H----HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC---H----HHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 344556799999999999999999976 5778999998644321 1 124557889999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKT 200 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p 200 (292)
+..... .....+++|||+++++|.+++... ..+++..++.++.|++.||.+||+.| ++|+||||
T Consensus 94 ~~~~~~------------~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp 159 (290)
T 1t4h_A 94 WESTVK------------GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp EEEESS------------SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred eccccC------------CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH
Confidence 764321 122348999999999999999653 56899999999999999999999999 99999999
Q ss_pred CCeeEc-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHH
Q 022794 201 ENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFS 278 (292)
Q Consensus 201 ~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~-~~~ 278 (292)
+||+++ .++.++|+|||.+..... .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +..
T Consensus 160 ~Nil~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 236 (290)
T 1t4h_A 160 DNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred HHEEEECCCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH
Confidence 999997 789999999999864332 22334568999999998875 5899999999999999999999999874 444
Q ss_pred HHHHHHH
Q 022794 279 EVTSAVV 285 (292)
Q Consensus 279 ~~~~~i~ 285 (292)
+....+.
T Consensus 237 ~~~~~~~ 243 (290)
T 1t4h_A 237 QIYRRVT 243 (290)
T ss_dssp HHHHHHT
T ss_pred HHHHHHh
Confidence 4444443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=278.17 Aligned_cols=214 Identities=32% Similarity=0.527 Sum_probs=176.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCcee--EEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceecee
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDV--AVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~v--alK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 123 (292)
.++|++.+.||+|+||.||+|.+ +|..+ ++|.++..... ...+.+.+|+.+++++ +||||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--------HHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 47899999999999999999964 56654 89988632211 1133478899999999 999999999998
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHHHHHHHHHHHHH
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
.+.+.. +++|||+++++|.+++.... ...+++..++.++.|++.||.+||
T Consensus 96 ~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 159 (327)
T 1fvr_A 96 EHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 159 (327)
T ss_dssp EETTEE----------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred eeCCce----------------EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 766554 89999999999999996542 246899999999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-C
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-C 268 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g 268 (292)
++|++||||||+||+++.++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 160 ~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 238 (327)
T 1fvr_A 160 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 238 (327)
T ss_dssp HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCC
Confidence 999999999999999999999999999998643221 12223456788999999988888999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHHh
Q 022794 269 DMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 269 ~~pf~~~~~~~~~~~i~~~ 287 (292)
..||.+.+..++...+.++
T Consensus 239 ~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 239 GTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp CCTTTTCCHHHHHHHGGGT
T ss_pred CCCCCCCcHHHHHHHhhcC
Confidence 9999999988888776654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=270.97 Aligned_cols=211 Identities=27% Similarity=0.447 Sum_probs=172.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|++++.||+|+||.||+|.+ +|+.||+|+++.... .+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------------KAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-------------GGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-------------HHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 35799999999999999999977 489999999974421 256799999999999999999987542
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
...................+++|||+++++|.+++.......+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 21100000001111133458999999999999999876667799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CCCCEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999999987654332 3344568999999999999899999999999999999999998885
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=277.92 Aligned_cols=218 Identities=25% Similarity=0.428 Sum_probs=178.9
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
.|++ ..+|.+.+.||+|+||.||+|.+ +|+.||||++...... ......+.+|+.+++.++||||+++++
T Consensus 37 ~~~l-~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~ 108 (371)
T 4exu_A 37 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENVIGLLD 108 (371)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred eecc-cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hhHHHHHHHHHHHHHhcCCCCchhhhh
Confidence 3444 47999999999999999999976 5899999998643221 123455788999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...+.... ....+++|||+. ++|.+++. ..+++..++.++.|++.||.|||+.|++||||||+
T Consensus 109 ~~~~~~~~~~----------~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 173 (371)
T 4exu_A 109 VFTPASSLRN----------FYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 173 (371)
T ss_dssp EECSCSSSTT----------CCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred heeccCCccc----------ceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHH
Confidence 9977654311 112389999996 68888762 34999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
||+++.++.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.
T Consensus 174 NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 250 (371)
T 4exu_A 174 NLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250 (371)
T ss_dssp GEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred HeEECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999999999754432 334568999999999987 6789999999999999999999999999999998
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+..+.+.
T Consensus 251 ~~~i~~~ 257 (371)
T 4exu_A 251 LTQILKV 257 (371)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.53 Aligned_cols=205 Identities=26% Similarity=0.421 Sum_probs=170.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+ +++.||||+++........... ......+.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE-DPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEE-ETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 6899999999999999999965 6889999999765322110000 000112567999999999999999999997766
Q ss_pred ccccccccccccCCCCceEEEEeecCCC-CHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. +++|||+.++ +|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 103 ~~----------------~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 164 (335)
T 3dls_A 103 FF----------------QLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA 164 (335)
T ss_dssp EE----------------EEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EE----------------EEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc
Confidence 55 8999998766 99999854 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
.++.++|+|||.+....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||..
T Consensus 165 ~~~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 165 EDFTIKLIDFGSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTSCEEECCCTTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCcEEEeecccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99999999999998654432 2334568999999999988876 7899999999999999999999965
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=269.50 Aligned_cols=215 Identities=24% Similarity=0.395 Sum_probs=164.0
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
+++..++|++++.||+|+||.||+|.+ +|+.||+|+++.... .....+.+.++...++.++||||++++++
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-------SQEQKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-------HHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-------cHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 456678999999999999999999987 789999999853321 11223335556666888899999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhC-CccccCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVK 199 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h~di~ 199 (292)
+.+.+.. +++|||++ ++|.+++... ....+++..++.++.|++.||.+||++ |++|||||
T Consensus 75 ~~~~~~~----------------~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk 137 (290)
T 3fme_A 75 LFREGDV----------------WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK 137 (290)
T ss_dssp EECSSSE----------------EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred eeccCCE----------------EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence 9876654 89999996 5998887542 345799999999999999999999998 99999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCC-
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL----NGNPYNRKCDVYSFGICLWEIYCCDMPYPD- 274 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Diwslg~il~~l~~g~~pf~~- 274 (292)
|+||+++.++.++|+|||.+....... ......+++.|+|||.+ .+..++.++|+||||+++|+|++|..||..
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 138 PSNVLINALGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp GGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred HHHEEECCCCCEEEeecCCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 999999999999999999987554332 22335689999999996 455789999999999999999999999985
Q ss_pred CCHHHHHHHH
Q 022794 275 LSFSEVTSAV 284 (292)
Q Consensus 275 ~~~~~~~~~i 284 (292)
....+....+
T Consensus 217 ~~~~~~~~~~ 226 (290)
T 3fme_A 217 GTPFQQLKQV 226 (290)
T ss_dssp SCHHHHHHHH
T ss_pred CchHHHHHHH
Confidence 3333333333
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=272.63 Aligned_cols=219 Identities=25% Similarity=0.380 Sum_probs=179.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +++.||+|+++.... .........+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL-----RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH-----HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc-----cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 47899999999999999999976 578999999853210 01012245688999999999999999999998543
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. ...+++|||++++ |.+++.......+++..++.++.|++.||.+||++|++|+||||+||+++
T Consensus 79 ~~--------------~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~ 143 (305)
T 2wtk_C 79 EK--------------QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143 (305)
T ss_dssp -----------------CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CC--------------CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc
Confidence 32 2238999999765 88888766667799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
.++.++|+|||.+....... .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+..++..
T Consensus 144 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (305)
T 2wtk_C 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223 (305)
T ss_dssp TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence 99999999999997654221 1223456899999999998754 3779999999999999999999999998888888
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.++
T Consensus 224 ~i~~~ 228 (305)
T 2wtk_C 224 NIGKG 228 (305)
T ss_dssp HHHHC
T ss_pred HHhcC
Confidence 77664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.96 Aligned_cols=206 Identities=21% Similarity=0.338 Sum_probs=167.0
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC--Cccccee
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PNVTKFI 120 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~ 120 (292)
.+.+...+|++++.||+|+||.||+|.+ +++.||+|++...... ....+.+.+|+.+++++.| +||++++
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 75 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLY 75 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-------hHHHHHHHHHHHHHHhhhhcCCceEEEe
Confidence 3566788999999999999999999965 5788999998754322 1123457889999999976 9999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++...... +++||+ .+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||
T Consensus 76 ~~~~~~~~~----------------~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp 136 (343)
T 3dbq_A 76 DYEITDQYI----------------YMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136 (343)
T ss_dssp EEEECSSEE----------------EEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeEeeCCEE----------------EEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 998876654 899995 48899999965 35689999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCC-----------CCCCchhhHHHHHHHHHHHHh
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-----------NPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Diwslg~il~~l~~ 267 (292)
+|||++ ++.++|+|||++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 137 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 999996 67899999999976543322 1234568999999999854 568899999999999999999
Q ss_pred CCCCCCCCC
Q 022794 268 CDMPYPDLS 276 (292)
Q Consensus 268 g~~pf~~~~ 276 (292)
|+.||....
T Consensus 216 g~~pf~~~~ 224 (343)
T 3dbq_A 216 GKTPFQQII 224 (343)
T ss_dssp SSCTTTTCC
T ss_pred CCCcchhhh
Confidence 999998643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=297.80 Aligned_cols=218 Identities=30% Similarity=0.523 Sum_probs=177.2
Q ss_pred ceecCCceeEee-eeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 45 WEIEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 45 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
+.+....+.+.+ .||+|+||.||+|.+ .++.||||+++....... ..+.+.+|+.++++++||||+++
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~~~E~~il~~l~hpnIv~l 435 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA-------LKDELLAEANVMQQLDNPYIVRM 435 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG-------GHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH-------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 344444555544 899999999999954 467899999965432221 23458899999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.... . ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 436 ~~~~~~~~-~----------------~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLk 496 (635)
T 4fl3_A 436 IGICEAES-W----------------MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 496 (635)
T ss_dssp EEEEESSS-E----------------EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCC-E----------------EEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCC
Confidence 99885432 2 799999999999999954 3568999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|+|||++.++.++|+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.
T Consensus 497 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 497 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp GGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred hHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999875543322 1222345678999999998899999999999999999998 99999999
Q ss_pred CHHHHHHHHHHhh
Q 022794 276 SFSEVTSAVVRQV 288 (292)
Q Consensus 276 ~~~~~~~~i~~~~ 288 (292)
+..++...+.++.
T Consensus 577 ~~~~~~~~i~~~~ 589 (635)
T 4fl3_A 577 KGSEVTAMLEKGE 589 (635)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHHcCC
Confidence 9999988887763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=280.24 Aligned_cols=215 Identities=20% Similarity=0.318 Sum_probs=171.6
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC--CCccccee
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HPNVTKFI 120 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~ 120 (292)
...+...+|.+.+.||+|+||.||+|.+ +++.||||++...... ....+.+.+|+.+++++. ||||++++
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~Ei~~l~~l~~~~~~iv~~~ 122 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSDKIIRLY 122 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-------HHHHHHHHHHHHHHHHcccCCCeEEEEE
Confidence 4556667899999999999999999965 4888999998754321 122345789999999995 59999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++...+.. +++||+ .+++|.+++... ..+++..++.++.||+.||.|||+.||+||||||
T Consensus 123 ~~~~~~~~~----------------~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp 183 (390)
T 2zmd_A 123 DYEITDQYI----------------YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183 (390)
T ss_dssp EEEECSSEE----------------EEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCG
T ss_pred EEEecCCEE----------------EEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCH
Confidence 998876654 899994 588999999653 4688999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCC-----------CCCCchhhHHHHHHHHHHHHh
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-----------NPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Diwslg~il~~l~~ 267 (292)
+|||++ ++.++|+|||++........ ......|++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 184 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~ 262 (390)
T 2zmd_A 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262 (390)
T ss_dssp GGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred HHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence 999995 58899999999976543221 2234579999999999865 368899999999999999999
Q ss_pred CCCCCCCCC-HHHHHHHHH
Q 022794 268 CDMPYPDLS-FSEVTSAVV 285 (292)
Q Consensus 268 g~~pf~~~~-~~~~~~~i~ 285 (292)
|..||.... ....+..+.
T Consensus 263 G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 263 GKTPFQQIINQISKLHAII 281 (390)
T ss_dssp SSCTTTTCCCHHHHHHHHH
T ss_pred CCCcchhhhHHHHHHHHHh
Confidence 999998653 334444444
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=273.31 Aligned_cols=209 Identities=25% Similarity=0.436 Sum_probs=172.2
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC--C-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD--G-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~-------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
.+..++|++.+.||+|+||.||+|.+. + ..||+|++..... ...+.+.+|+.++++++||||
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---------NYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---------GGHHHHHHHHHHHHTSCCTTB
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---------HHHHHHHHHHHHHHhCCCCCE
Confidence 345679999999999999999999653 3 4699999853221 123457889999999999999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++++++.+.+.. +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++||
T Consensus 75 v~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 137 (289)
T 4fvq_A 75 VLNYGVCVCGDEN----------------ILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHG 137 (289)
T ss_dssp CCEEEEECCTTCC----------------EEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eEEEEEEEeCCCC----------------EEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence 9999999876655 8999999999999999754 3459999999999999999999999999999
Q ss_pred CCCCCCeeEcCCCc--------EEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHh
Q 022794 197 DVKTENMLLDKNRT--------VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 197 di~p~Nili~~~~~--------~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~ 267 (292)
||||+||+++.++. ++|+|||.+...... ....+++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcCcceEEEecCCcccccccceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 99999999988877 999999988543211 22346788999999987 678999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHH
Q 022794 268 -CDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 268 -g~~pf~~~~~~~~~~~i 284 (292)
+.+||...+........
T Consensus 214 g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 214 GGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp TTCCTTTTSCHHHHHHHH
T ss_pred CCCCCccccchHHHHHHh
Confidence 56777776665554443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.31 Aligned_cols=214 Identities=33% Similarity=0.538 Sum_probs=166.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--C-C--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--D-G--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~-~--~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
..|.+.+.||+|+||.||+|.+ + + ..||+|.++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--------GEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--------HHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--------HHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 4588999999999999999965 2 2 35899988542211 12345788999999999999999999865
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+. ..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 161 ~~~~---------------~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 224 (373)
T 3c1x_A 161 RSEG---------------SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224 (373)
T ss_dssp CCSS---------------CCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred cCCC---------------CeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence 4322 22899999999999999964 3346889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 205 LDKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+
T Consensus 225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence 99999999999999975432211 1223456778999999998899999999999999999999 789999887777
Q ss_pred HHHHHHHh
Q 022794 280 VTSAVVRQ 287 (292)
Q Consensus 280 ~~~~i~~~ 287 (292)
+...+.++
T Consensus 305 ~~~~~~~~ 312 (373)
T 3c1x_A 305 ITVYLLQG 312 (373)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHcC
Confidence 77666554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=281.59 Aligned_cols=224 Identities=24% Similarity=0.420 Sum_probs=183.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccH--------HHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTE--------AEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
....++|.+.+.||+|+||.||+|.++|+.||+|++.......... .........+.+|+.++++++||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3445799999999999999999998899999999986432111000 00000114578899999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHH------HHhhcccccCHHHHHHHHHHHHHHHHHHHh-
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY------LIKNRRRKLAFKVVVQLALDLARGLSYLHS- 190 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~i~~qi~~al~~lH~- 190 (292)
++++++.+.+.. +++|||+++++|.++ +.......+++..++.++.|++.||.+||+
T Consensus 107 ~~~~~~~~~~~~----------------~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 170 (348)
T 2pml_X 107 TCEGIITNYDEV----------------YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170 (348)
T ss_dssp CCSEEEESSSEE----------------EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEeeCCeE----------------EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc
Confidence 999998876654 899999999999998 544335779999999999999999999999
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCc-hhhHHHHHHHHHHHHhC
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNR-KCDVYSFGICLWEIYCC 268 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Diwslg~il~~l~~g 268 (292)
.|++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||||+++|+|++|
T Consensus 171 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp SCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred CCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999765432 33446789999999999887 5665 99999999999999999
Q ss_pred CCCCCCCCH-HHHHHHHHHh
Q 022794 269 DMPYPDLSF-SEVTSAVVRQ 287 (292)
Q Consensus 269 ~~pf~~~~~-~~~~~~i~~~ 287 (292)
..||...+. .++...+.++
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSC
T ss_pred CCCCCCCCcHHHHHHHHhcc
Confidence 999998776 6666666543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=287.07 Aligned_cols=208 Identities=25% Similarity=0.412 Sum_probs=161.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.+ +++.||+|++.......... ........+.+|+.++++++||||+++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA-READPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC---------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccc-ccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46899999999999999999976 57899999987543211111 1111223477899999999999999999987543
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
. . +++|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++
T Consensus 213 ~-~----------------~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~ 273 (419)
T 3i6u_A 213 D-Y----------------YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 273 (419)
T ss_dssp E-E----------------EEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred c-e----------------EEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEe
Confidence 2 2 899999999999998843 45699999999999999999999999999999999999996
Q ss_pred CC---CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 207 KN---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 207 ~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
.+ +.++|+|||++...... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.....
T Consensus 274 ~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 274 SQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred cCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 54 45999999999765432 22334678999999999864 5678899999999999999999999986543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=276.92 Aligned_cols=203 Identities=29% Similarity=0.478 Sum_probs=169.9
Q ss_pred cCCce-eEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 48 EPSKL-VIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 48 ~~~~~-~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
...+| ++++.||+|+||.||++.+ +++.||||+++.... ....+.+.+|+.++++++||||++++
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--------PQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--------hHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 34555 9999999999999988754 688999999964321 12245578899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.+.. ..+++|||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||||
T Consensus 100 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp 162 (318)
T 3lxp_A 100 GCCEDAGAA--------------SLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAA 162 (318)
T ss_dssp EEEEETTTT--------------EEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEecCCCc--------------eEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCch
Confidence 998765322 23899999999999999854 3489999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 163 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp GGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred heEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 999999999999999999986544322 123345778899999999888999999999999999999999999764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=274.52 Aligned_cols=221 Identities=29% Similarity=0.421 Sum_probs=160.9
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccc
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTK 118 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~ 118 (292)
.+.+++...+|++.+.||+|+||.||+|.+ +|+.||+|++.... ....+.+.+|+.+++++. ||||++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---------EEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---------HHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---------hHHHHHHHHHHHHHHHhccCCChhh
Confidence 456788888999999999999999999987 78999999885331 112345778999999995 999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHhCC--ccc
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN-RRRKLAFKVVVQLALDLARGLSYLHSQK--IVH 195 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h 195 (292)
+++++...... .......++++|||+. |+|.+++... ....+++..++.++.|++.||.|||+.| ++|
T Consensus 91 ~~~~~~~~~~~--------~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH 161 (337)
T 3ll6_A 91 FCSAASIGKEE--------SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIH 161 (337)
T ss_dssp EEEEEEECTTT--------STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBC
T ss_pred ccccccccccc--------cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEE
Confidence 99988533221 0112334589999995 7999988652 3456999999999999999999999999 999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCC------------CCCCCCcccccCCccc---CCCCCCchhhHHHHHH
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPND------------MTGETGTLGYMAPEVL---NGNPYNRKCDVYSFGI 260 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~------------~~~~~~~~~y~aPE~~---~~~~~~~~~Diwslg~ 260 (292)
+||||+||+++.++.++|+|||.+......... .....+++.|+|||.+ .+..++.++||||||+
T Consensus 162 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~ 241 (337)
T 3ll6_A 162 RDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC 241 (337)
T ss_dssp CCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHH
T ss_pred ccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHH
Confidence 999999999999999999999999765432221 1134588999999998 5667889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHH
Q 022794 261 CLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 261 il~~l~~g~~pf~~~~~~~~ 280 (292)
++|+|++|..||......++
T Consensus 242 il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 242 ILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp HHHHHHHSSCCC--------
T ss_pred HHHHHHhCCCCCcchhHHHh
Confidence 99999999999987555443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=276.78 Aligned_cols=218 Identities=27% Similarity=0.447 Sum_probs=162.9
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
.+.+..++|.+.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.++++++||||+++++
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 80 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--------QTSMDELLKEIQAMSQCHHPNIVSYYT 80 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------------CCCCCCCTTBCCEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--------chhHHHHHHHHHHHhhcCCCCEeeEEE
Confidence 3567778999999999999999999965 689999998854321 112344778999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh------cccccCHHHHHHHHHHHHHHHHHHHhCCccc
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN------RRRKLAFKVVVQLALDLARGLSYLHSQKIVH 195 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h 195 (292)
++...+.. +++|||+++++|.+++... ....+++..++.++.|++.||.+||++|++|
T Consensus 81 ~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 144 (303)
T 2vwi_A 81 SFVVKDEL----------------WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144 (303)
T ss_dssp EEESSSCE----------------EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEeecCCc----------------EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 98876654 8999999999999998642 2345899999999999999999999999999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCC-----CCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNP-----NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~ 269 (292)
+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 224 (303)
T 2vwi_A 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224 (303)
T ss_dssp CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999886543221 11233568899999999875 46889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 022794 270 MPYPDLSFSEVTSAVV 285 (292)
Q Consensus 270 ~pf~~~~~~~~~~~i~ 285 (292)
.||...+..+......
T Consensus 225 ~pf~~~~~~~~~~~~~ 240 (303)
T 2vwi_A 225 APYHKYPPMKVLMLTL 240 (303)
T ss_dssp CTTTTSCGGGHHHHHH
T ss_pred CCCccCchhhHHHHHh
Confidence 9999877666554443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=271.24 Aligned_cols=217 Identities=32% Similarity=0.516 Sum_probs=175.2
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
...+|++.+.||+|+||.||+|.+. +..|++|.+.... .. ...+.+.+|+.++++++||||++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~----~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DI----GEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC----SH----HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC----CH----HHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 3457999999999999999999753 2358888885322 11 123457889999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...+. ..+++|||+++++|.+++.. ....+++..++.++.|++.||.+||++|++||||||+|
T Consensus 95 ~~~~~~---------------~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 95 CLRSEG---------------SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp ECCSSS---------------CCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEcCCC---------------ceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 654332 22899999999999999964 34568999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCC----CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
|+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.
T Consensus 159 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp EEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred EEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 999999999999999997543221 12233456788999999998899999999999999999999 7788988887
Q ss_pred HHHHHHHHHhh
Q 022794 278 SEVTSAVVRQV 288 (292)
Q Consensus 278 ~~~~~~i~~~~ 288 (292)
.+....+.++.
T Consensus 239 ~~~~~~~~~~~ 249 (298)
T 3f66_A 239 FDITVYLLQGR 249 (298)
T ss_dssp TTHHHHHHTTC
T ss_pred HHHHHHHhcCC
Confidence 77776666543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=274.14 Aligned_cols=201 Identities=26% Similarity=0.445 Sum_probs=164.4
Q ss_pred CCceeEe-eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceec
Q 022794 49 PSKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATM 124 (292)
Q Consensus 49 ~~~~~~~-~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 124 (292)
.++|.+. +.||+|+||.||+|.+ +++.||||++...... . ...+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--I-------RSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--C-------HHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--h-------HHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4678885 7899999999999965 6899999999754321 1 23477899999985 8999999999988
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.+.. +++|||+++++|.+++... ..+++..++.++.|++.||.+||++|++||||||+||+
T Consensus 82 ~~~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil 143 (316)
T 2ac3_A 82 EEDRF----------------YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143 (316)
T ss_dssp ETTEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred eCCEE----------------EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence 76654 8999999999999999653 46899999999999999999999999999999999999
Q ss_pred EcCCCc---EEEeecCcceeccCCC-------CCCCCCCCcccccCCcccCC-----CCCCchhhHHHHHHHHHHHHhCC
Q 022794 205 LDKNRT---VKIADFGVARVEASNP-------NDMTGETGTLGYMAPEVLNG-----NPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 205 i~~~~~---~~l~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diwslg~il~~l~~g~ 269 (292)
++.++. ++|+|||.+....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence 987765 9999999986543211 11223458999999999875 45788999999999999999999
Q ss_pred CCCCCCC
Q 022794 270 MPYPDLS 276 (292)
Q Consensus 270 ~pf~~~~ 276 (292)
.||.+.+
T Consensus 224 ~pf~~~~ 230 (316)
T 2ac3_A 224 PPFVGRC 230 (316)
T ss_dssp CSCCCCC
T ss_pred CCCcccc
Confidence 9998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=267.87 Aligned_cols=203 Identities=30% Similarity=0.461 Sum_probs=172.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+ +++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--------CPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--------HHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--------hhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 5799999999999999999976 58899999986543211 1345778999999999999999999987665
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 79 ~~----------------~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 79 IQ----------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp EE----------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred EE----------------EEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 54 899999999999998843 356899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 208 NRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
++.++|+|||.+....... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..
T Consensus 141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 9999999999987543221 12334568999999999988765 67899999999999999999999876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=279.05 Aligned_cols=205 Identities=27% Similarity=0.386 Sum_probs=170.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC--------CCc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--------HPN 115 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~ 115 (292)
++..++|++.+.||+|+||.||+|.+ +++.||||+++.. ......+.+|+.+++++. |+|
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 102 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----------EHYTETALDEIRLLKSVRNSDPNDPNREM 102 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----------HHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----------CcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence 34468999999999999999999965 5889999998522 122345778999998884 788
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-Ccc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIV 194 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~ 194 (292)
|+++++++..... .....+++|||+ +++|.+++.......+++..++.++.||+.||.|||++ |++
T Consensus 103 iv~~~~~~~~~~~------------~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~giv 169 (397)
T 1wak_A 103 VVQLLDDFKISGV------------NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII 169 (397)
T ss_dssp BCCEEEEEEEEET------------TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred eeeeecceeecCC------------CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 9999998863211 012338999999 67888888665556799999999999999999999998 999
Q ss_pred ccCCCCCCeeEcCCC-------------------------------------------------cEEEeecCcceeccCC
Q 022794 195 HRDVKTENMLLDKNR-------------------------------------------------TVKIADFGVARVEASN 225 (292)
Q Consensus 195 h~di~p~Nili~~~~-------------------------------------------------~~~l~Dfg~~~~~~~~ 225 (292)
||||||+|||++.++ .++|+|||.+......
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~ 249 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc
Confidence 999999999998765 7999999999865432
Q ss_pred CCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 226 PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 226 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 250 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 250 ---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp ---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 334578999999999999999999999999999999999999998665
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=278.34 Aligned_cols=223 Identities=27% Similarity=0.529 Sum_probs=181.7
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
....+.|.+..++|++.+.||+|+||.||+|.+.+ .+++|+++........ .+.+.+|+.++++++||||++
T Consensus 22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~ 93 (319)
T 2y4i_B 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ-------LKAFKREVMAYRQTRHENVVL 93 (319)
T ss_dssp CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC-------CCCCCTTGGGGTTCCCTTBCC
T ss_pred ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH-------HHHHHHHHHHHhcCCCCCEeE
Confidence 33556778888999999999999999999998876 5999998754332221 112567999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++.+.... +++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||
T Consensus 94 ~~~~~~~~~~~----------------~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 156 (319)
T 2y4i_B 94 FMGACMSPPHL----------------AIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156 (319)
T ss_dssp CCEEEECSSCE----------------EEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEecCCce----------------EEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 99998876654 8999999999999998543 346899999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccC-----CCCCCCCCCCcccccCCcccCC---------CCCCchhhHHHHHHHHHH
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEAS-----NPNDMTGETGTLGYMAPEVLNG---------NPYNRKCDVYSFGICLWE 264 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Diwslg~il~~ 264 (292)
||+||+++ ++.++|+|||.+..... .........+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 157 kp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 235 (319)
T 2y4i_B 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235 (319)
T ss_dssp CSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHH
T ss_pred ChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHH
Confidence 99999997 67999999998764321 1122233458899999999875 357889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHHh
Q 022794 265 IYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 265 l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|++|..||...+..++...+.++
T Consensus 236 l~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 236 LHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp HHHSSCSSSSCCHHHHHHHHHTT
T ss_pred HHhCCCCCCCCCHHHHHHHhccC
Confidence 99999999999998888877665
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=267.36 Aligned_cols=212 Identities=31% Similarity=0.541 Sum_probs=179.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|++|.||+|.+ +++.||+|++......... ...+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-------TSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH-------HHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 36899999999999999999977 5889999998754432222 23477899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... ++++||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 94 ~~~----------------~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 94 SSF----------------YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred CeE----------------EEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 554 8999999999999988643 4689999999999999999999999999999999999996
Q ss_pred CC---CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 207 KN---RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
.+ +.++|+|||.+...... .......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||.+.+..++...
T Consensus 156 ~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (287)
T 2wei_A 156 SKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233 (287)
T ss_dssp CSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 54 46999999998754332 222334578899999998764 88999999999999999999999999999888888
Q ss_pred HHHh
Q 022794 284 VVRQ 287 (292)
Q Consensus 284 i~~~ 287 (292)
+.++
T Consensus 234 ~~~~ 237 (287)
T 2wei_A 234 VETG 237 (287)
T ss_dssp HHHC
T ss_pred HHcC
Confidence 7765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=274.30 Aligned_cols=207 Identities=30% Similarity=0.518 Sum_probs=174.1
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
+..++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.++++++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---------PDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 4567999999999999999999974 57899999986331 11234578999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++...+.. ..+++|||+++++|.+++.... ..+++..++.++.|++.||.+||+.|++|+||||
T Consensus 91 ~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp 155 (327)
T 3lxl_A 91 GVSYGPGRQ--------------SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155 (327)
T ss_dssp EEEECSSSC--------------EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEecCCCc--------------eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCh
Confidence 988654332 2389999999999999997543 4699999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 156 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 999999999999999999986543322 22334577889999999988899999999999999999999999865443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=270.31 Aligned_cols=218 Identities=29% Similarity=0.524 Sum_probs=172.9
Q ss_pred eecCCceeEeeeeccCcceEEEEEEEC---Cc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYD---GH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~--~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.+..++|++.+.||+|+||.||+|.+. ++ .||+|+++..... .....+.+.+|+.++++++||||++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS------QPEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC------CHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 445579999999999999999999752 22 5899988643211 112345578999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.... . ++++||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||||
T Consensus 88 ~~~~~~~-~----------------~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp 149 (291)
T 1u46_A 88 GVVLTPP-M----------------KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA 149 (291)
T ss_dssp EEECSSS-C----------------EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEccCC-c----------------eeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCch
Confidence 9987653 2 7999999999999999754 35689999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~ 276 (292)
+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+
T Consensus 150 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 150 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 9999999999999999998765433221 223456778999999988888999999999999999999 999999999
Q ss_pred HHHHHHHHHHh
Q 022794 277 FSEVTSAVVRQ 287 (292)
Q Consensus 277 ~~~~~~~i~~~ 287 (292)
..++...+.+.
T Consensus 230 ~~~~~~~~~~~ 240 (291)
T 1u46_A 230 GSQILHKIDKE 240 (291)
T ss_dssp HHHHHHHHHTS
T ss_pred HHHHHHHHHcc
Confidence 98888887654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.48 Aligned_cols=224 Identities=31% Similarity=0.474 Sum_probs=179.8
Q ss_pred hhcccceecCC--ceeEeeeeccCcceEEEEEEE--CC---ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC
Q 022794 40 KQRQDWEIEPS--KLVIKSVIARGTFGTVHRGLY--DG---HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (292)
Q Consensus 40 ~~~~~~~~~~~--~~~~~~~lg~G~~g~V~~~~~--~~---~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 112 (292)
....++.+... .|.+.+.||+|+||.||+|.+ ++ ..||+|++..... ....+.+.+|+.++++++
T Consensus 9 ~~~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~~E~~~l~~l~ 80 (298)
T 3pls_A 9 AEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--------MQQVEAFLREGLLMRGLN 80 (298)
T ss_dssp HHTGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--------HHHHHHHHHHHHHHHTCC
T ss_pred hhhhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--------HHHHHHHHHHHHHHHhCC
Confidence 33444444333 567789999999999999965 33 2699999853221 112345788999999999
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK 192 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 192 (292)
||||+++++++.+.+.. .+++|||+.+++|.+++.. ....+++..++.++.|++.||.+||+.|
T Consensus 81 h~~iv~~~~~~~~~~~~---------------~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 81 HPNVLALIGIMLPPEGL---------------PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp CTTBCCCCEEECCSSSC---------------CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCeeeEEEEEecCCCC---------------cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999998765432 2789999999999999965 3456899999999999999999999999
Q ss_pred ccccCCCCCCeeEcCCCcEEEeecCcceeccCC----CCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-
Q 022794 193 IVHRDVKTENMLLDKNRTVKIADFGVARVEASN----PNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC- 267 (292)
Q Consensus 193 i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~- 267 (292)
++||||||+||+++.++.++|+|||.+...... ........+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 145 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 224 (298)
T 3pls_A 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224 (298)
T ss_dssp CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT
T ss_pred cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhC
Confidence 999999999999999999999999998754321 122333567889999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHh
Q 022794 268 CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 268 g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.+||...+..++...+.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 225 GAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp SCCTTTTSCGGGHHHHHHTT
T ss_pred CCCCCccCCHHHHHHHhhcC
Confidence 66778887877777766554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.77 Aligned_cols=217 Identities=25% Similarity=0.348 Sum_probs=166.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+ +|+.||||++........ ...+++..++.++||||+++++++....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----------RELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC----------HHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH----------HHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 6899999999999999999976 488999998865433221 2456778888899999999999986543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCCe
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLH--SQKIVHRDVKTENM 203 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH--~~~i~h~di~p~Ni 203 (292)
... ....+.+++|||+++ +|...+.. .....+++..++.++.|++.||.+|| +.|++||||||+||
T Consensus 93 ~~~---------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NI 162 (360)
T 3e3p_A 93 ERD---------RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNV 162 (360)
T ss_dssp SSC---------TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGE
T ss_pred ccc---------ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHE
Confidence 210 012234899999965 66655542 24456889999999999999999999 99999999999999
Q ss_pred eEcC-CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 204 LLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 204 li~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
+++. ++.++|+|||.+...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+.+
T Consensus 163 ll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 241 (360)
T 3e3p_A 163 LVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241 (360)
T ss_dssp EEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence 9986 899999999999765433 2334467899999999987654 899999999999999999999999999999999
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..+.+.
T Consensus 242 ~~~~~~ 247 (360)
T 3e3p_A 242 HEIVRV 247 (360)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.15 Aligned_cols=201 Identities=26% Similarity=0.361 Sum_probs=168.8
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+ +|+.||+|++....... .+.+|+.+++.+.|++++..+..+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----------QLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-----------HHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-----------HHHHHHHHHHHhhcCCCCCccccccC
Confidence 357899999999999999999974 68999999986544321 26789999999998887777665533
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.. ...+++|||+ +++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 76 ~~---------------~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 138 (296)
T 3uzp_A 76 EG---------------DYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138 (296)
T ss_dssp ET---------------TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CC---------------CceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEE
Confidence 22 2338999999 89999999643 3569999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 206 ---DKNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 206 ---~~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 139 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 4788999999999976544322 123457899999999999999999999999999999999999999864
Q ss_pred C
Q 022794 276 S 276 (292)
Q Consensus 276 ~ 276 (292)
+
T Consensus 219 ~ 219 (296)
T 3uzp_A 219 K 219 (296)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=269.61 Aligned_cols=201 Identities=26% Similarity=0.361 Sum_probs=165.5
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++.+.||+|+||.||+|.+ +++.||+|+........ .+.+|+.+++.+.|++++..+..+...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----------QLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-----------CHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-----------HHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 47899999999999999999974 68999999876543322 266799999999888887777665432
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE-
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL- 205 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili- 205 (292)
. ...+++|||+ +++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 77 ~---------------~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 77 G---------------DYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp T---------------TEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred C---------------CceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 2 2238999999 99999998643 3569999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 206 --DKNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 206 --~~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
+.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 7889999999999986543322 2234578999999999999999999999999999999999999998654
Q ss_pred H
Q 022794 277 F 277 (292)
Q Consensus 277 ~ 277 (292)
.
T Consensus 220 ~ 220 (296)
T 4hgt_A 220 A 220 (296)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=267.97 Aligned_cols=225 Identities=22% Similarity=0.315 Sum_probs=174.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++++.||+|+||.||+|.+. |+.||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---------PQSVKHALREIKIIRRLDHDNIVKVFEILGP 79 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---------hHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence 4589999999999999999999774 8999999986331 1223457789999999999999999998865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
...... ............+++|||++ ++|.+++. ...+++..++.++.|++.||++||++|++|+||||+||++
T Consensus 80 ~~~~~~--~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 153 (320)
T 2i6l_A 80 SGSQLT--DDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI 153 (320)
T ss_dssp TSCBCC--C----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred cccccc--cccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 432110 00111223456699999996 69999884 3468999999999999999999999999999999999999
Q ss_pred c-CCCcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 206 D-KNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 206 ~-~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+ +++.++|+|||.+....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+.
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 7 56799999999987543221 12233456889999998865 6789999999999999999999999999999888
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
+..+.+.
T Consensus 234 ~~~~~~~ 240 (320)
T 2i6l_A 234 MQLILES 240 (320)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 8887764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=265.48 Aligned_cols=199 Identities=25% Similarity=0.346 Sum_probs=166.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 126 (292)
++|++.+.||+|+||.||+|.+ +++.||+|+++........ ...+.+|+..+..+ +||||+++++++.+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-------EQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-------HHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-------HHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 6899999999999999999977 5899999998754332211 23467889999999 999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
+.. +++|||+++++|.+++..... ..+++..++.++.|++.||.+||++|++||||||+||+
T Consensus 84 ~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 147 (289)
T 1x8b_A 84 DHM----------------LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147 (289)
T ss_dssp TEE----------------EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CeE----------------EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEE
Confidence 654 899999999999999975432 56899999999999999999999999999999999999
Q ss_pred EcCC-------------------CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHH
Q 022794 205 LDKN-------------------RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWE 264 (292)
Q Consensus 205 i~~~-------------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~ 264 (292)
++.+ ..++|+|||.+....... ...+++.|+|||.+.+. .++.++||||||+++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp EC--------------------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred EcCCCCCcccccccccccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 9844 479999999987654322 24589999999999876 56689999999999999
Q ss_pred HHhCCCCCCCC
Q 022794 265 IYCCDMPYPDL 275 (292)
Q Consensus 265 l~~g~~pf~~~ 275 (292)
|++|.+|+...
T Consensus 224 l~~~~~~~~~~ 234 (289)
T 1x8b_A 224 AAGAEPLPRNG 234 (289)
T ss_dssp HTTCCCCCSSS
T ss_pred HhcCCCCCcch
Confidence 99999877543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.11 Aligned_cols=199 Identities=28% Similarity=0.315 Sum_probs=160.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh-CCCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK-LDHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 125 (292)
.++|++.+.||+|+||+||+|.+ +|+.||||++...... ... ......|+..+.+ ..||||+++++++.+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~----~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG---PKD----RARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS---HHH----HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC---hHH----HHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 36899999999999999999977 5899999987543321 111 1123344444444 499999999999977
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+ +++|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus 129 ~~~~----------------~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll 190 (311)
T 3p1a_A 129 GGIL----------------YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190 (311)
T ss_dssp TTEE----------------EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCEE----------------EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 6554 8999999 77999988654 3569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+.++.++|+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 191 GPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999998765433 23334568999999999886 689999999999999999999766544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.14 Aligned_cols=220 Identities=17% Similarity=0.231 Sum_probs=161.3
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHH---HHHHhCCCCcccceece
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV---AVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~~~ 122 (292)
...+|++.+.||+|+||.||+|.+ +|+.||||++......... ..+.+.+|+ .++++++||||+++++.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN------AIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTT------HHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchH------HHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 357899999999999999999974 5999999999754322221 134477899 55556689999999954
Q ss_pred ecCCcccccccccc---cccCC-----CCceEEEEeecCCCCHHHHHHhhcc-----cccCHHHHHHHHHHHHHHHHHHH
Q 022794 123 TMGSSELHIQTENG---QVAMP-----SNICCVVVEYLPGGALKTYLIKNRR-----RKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 123 ~~~~~~~~~~~~~~---~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH 189 (292)
+.......-..... ..... -...+++|||+ +|+|.+++..... ..+++..++.++.||+.||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 43322110000000 00000 01258999999 6799999975421 22335888899999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-----------CCCchhhHHHH
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-----------PYNRKCDVYSF 258 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Diwsl 258 (292)
++|++||||||+|||++.++.++|+|||++..... ......+ +.|+|||++.+. .++.++|||||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 99999999999999999999999999999975332 2233456 999999999877 79999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH
Q 022794 259 GICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 259 g~il~~l~~g~~pf~~~~~~ 278 (292)
|+++|+|++|+.||.+.+..
T Consensus 300 G~il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHHHHSSCCC------
T ss_pred HHHHHHHHHCCCCCcccccc
Confidence 99999999999999875543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=280.37 Aligned_cols=202 Identities=26% Similarity=0.395 Sum_probs=153.0
Q ss_pred CceeEe-eeeccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 50 SKLVIK-SVIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 50 ~~~~~~-~~lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+.|.+. ++||+|+||.||+|.+ +++.||||++...... ..+.+|+.++++++||||+++++++.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----------MSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----------HHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----------HHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 457774 4799999999999974 3788999998643221 13668999999999999999999985
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-------ccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
..... ..+++|||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+|||
T Consensus 89 ~~~~~--------------~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~D 153 (405)
T 3rgf_A 89 SHADR--------------KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153 (405)
T ss_dssp ETTTT--------------EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCCC--------------eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCC
Confidence 43222 2389999995 58888875332 12489999999999999999999999999999
Q ss_pred CCCCCeeE----cCCCcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCC
Q 022794 198 VKTENMLL----DKNRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 198 i~p~Nili----~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~ 269 (292)
|||+|||+ +.++.++|+|||+++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 154 lkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~ 233 (405)
T 3rgf_A 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233 (405)
T ss_dssp CCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC
Confidence 99999999 677899999999997654322 222345689999999999875 4899999999999999999999
Q ss_pred CCCCCCCH
Q 022794 270 MPYPDLSF 277 (292)
Q Consensus 270 ~pf~~~~~ 277 (292)
+||.+.+.
T Consensus 234 ~pf~~~~~ 241 (405)
T 3rgf_A 234 PIFHCRQE 241 (405)
T ss_dssp CTTCCCC-
T ss_pred CCCCCccc
Confidence 99987655
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=273.22 Aligned_cols=216 Identities=23% Similarity=0.357 Sum_probs=176.2
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+. |+.||||++.... . ......+.+|+.++++++||||+++++++..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----K----PLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----S----HHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----c----chHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 3579999999999999999999774 8999999985321 1 1223446789999999999999999998765
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... ......+++|||+. ++|.+++.. ..+++..++.++.|++.||.+||++|++||||||+||++
T Consensus 81 ~~~-----------~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 81 DSF-----------ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI 145 (353)
T ss_dssp SCS-----------TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccc-----------CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 321 11234589999996 699998854 469999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC----------CCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 206 DKNRTVKIADFGVARVEASNPN----------DMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+.++.++|+|||.+........ ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999976543211 1223467999999998754 6789999999999999999999999999
Q ss_pred CCHHHHHHHHHH
Q 022794 275 LSFSEVTSAVVR 286 (292)
Q Consensus 275 ~~~~~~~~~i~~ 286 (292)
.+..+.+..+..
T Consensus 226 ~~~~~~~~~~~~ 237 (353)
T 2b9h_A 226 RDYRHQLLLIFG 237 (353)
T ss_dssp SSHHHHHHHHHH
T ss_pred CCcHHHHHHHHH
Confidence 988877766653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=272.83 Aligned_cols=212 Identities=26% Similarity=0.367 Sum_probs=178.3
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CC-----ccc
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HP-----NVT 117 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv 117 (292)
+...++|++.+.||+|+||.||+|.+ +++.||||+++.. . .....+..|+.+++.+. |+ +++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------K----AFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------H----HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------H----HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 33457999999999999999999976 5889999998521 1 12334667888888874 55 488
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--hCCccc
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH--SQKIVH 195 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~i~h 195 (292)
++++++...+.. ++||||+. ++|.+++.......+++..++.++.|++.||.+|| +.||+|
T Consensus 120 ~~~~~~~~~~~~----------------~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH 182 (382)
T 2vx3_A 120 HLKRHFMFRNHL----------------CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIH 182 (382)
T ss_dssp CEEEEEEETTEE----------------EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEEC
T ss_pred EeeeeeccCCce----------------EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEc
Confidence 888888766554 89999995 59999997765567999999999999999999999 579999
Q ss_pred cCCCCCCeeEc--CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 196 RDVKTENMLLD--KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 196 ~di~p~Nili~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|||||+|||++ .++.++|+|||+++..... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 183 rDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 183 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CCCSGGGEEESSTTSCCEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCcccEEEecCCCCcEEEEeccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999995 4678999999999865432 334678999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHh
Q 022794 274 DLSFSEVTSAVVRQ 287 (292)
Q Consensus 274 ~~~~~~~~~~i~~~ 287 (292)
+.+..+.+..+.+.
T Consensus 260 ~~~~~~~~~~i~~~ 273 (382)
T 2vx3_A 260 GANEVDQMNKIVEV 273 (382)
T ss_dssp CSSHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHH
Confidence 99999999888764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.38 Aligned_cols=219 Identities=29% Similarity=0.566 Sum_probs=181.0
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccc
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVT 117 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 117 (292)
..+.+..++|.+.+.||+|+||.||+|.+. +..||+|..+.... ....+.+.+|+.++++++||||+
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv 454 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIV 454 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 456667789999999999999999999763 45699998753221 12345688999999999999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
++++++.+. .. +++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++|||
T Consensus 455 ~l~~~~~~~-~~----------------~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD 516 (656)
T 2j0j_A 455 KLIGVITEN-PV----------------WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRD 516 (656)
T ss_dssp CEEEEECSS-SC----------------EEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eEEEEEecC-ce----------------EEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 999987432 22 8999999999999999653 34689999999999999999999999999999
Q ss_pred CCCCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 198 VKTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 198 i~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|||+|||++.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 517 ikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp CSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999976543222 1223446778999999988899999999999999999997 99999999
Q ss_pred CHHHHHHHHHHh
Q 022794 276 SFSEVTSAVVRQ 287 (292)
Q Consensus 276 ~~~~~~~~i~~~ 287 (292)
+..++...+.++
T Consensus 597 ~~~~~~~~i~~~ 608 (656)
T 2j0j_A 597 KNNDVIGRIENG 608 (656)
T ss_dssp CHHHHHHHHHHT
T ss_pred CHHHHHHHHHcC
Confidence 999998888765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=271.37 Aligned_cols=211 Identities=27% Similarity=0.389 Sum_probs=177.1
Q ss_pred ecCCceeEeeeeccCcceEEEEEEEC--C-ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc------cc
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYD--G-HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN------VT 117 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~-~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv 117 (292)
...++|++.+.||+|+||.||+|.+. + +.||+|+++.. . .....+.+|+.+++++.|++ ++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------G----KYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------c----cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 44689999999999999999999763 4 68999998521 1 12345677899998886655 78
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
.+++++...+.. +++|||+ +++|.+++.......+++..++.++.||+.||.|||++|++|||
T Consensus 86 ~~~~~~~~~~~~----------------~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~D 148 (355)
T 2eu9_A 86 LMSDWFNFHGHM----------------CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTD 148 (355)
T ss_dssp CEEEEEEETTEE----------------EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred EeeeeeeeCCeE----------------EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 888877665544 8999999 77888888766556799999999999999999999999999999
Q ss_pred CCCCCeeE-------------------cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHH
Q 022794 198 VKTENMLL-------------------DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSF 258 (292)
Q Consensus 198 i~p~Nili-------------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 258 (292)
|||+||++ +.++.++|+|||.+...... .....+++.|+|||++.+..++.++|+|||
T Consensus 149 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 225 (355)
T 2eu9_A 149 LKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSI 225 (355)
T ss_dssp CCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred CCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHH
Confidence 99999999 56788999999999764432 234578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 259 GICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 259 g~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
|+++|+|++|..||...+..+.+..+.+.
T Consensus 226 G~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (355)
T 2eu9_A 226 GCILFEYYRGFTLFQTHENREHLVMMEKI 254 (355)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999999999988877776654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=280.61 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=166.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee-c
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT-M 124 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 124 (292)
..++|++++.||+|+||.||+|.+ +++.||||++........ +.+|+.+++.+.|++.+..+..+ .
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~-----------~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCC-----------HHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHH-----------HHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 457899999999999999999975 589999999875543322 56799999999775544444433 3
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
... ..+++|||+ +++|.+++... ...+++..++.++.||+.+|.|||++||+||||||+|||
T Consensus 74 ~~~----------------~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NIL 135 (483)
T 3sv0_A 74 EGD----------------YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (483)
T ss_dssp ETT----------------EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred eCC----------------EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEE
Confidence 322 238999999 99999998643 456999999999999999999999999999999999999
Q ss_pred E---cCCCcEEEeecCcceeccCCCCC-------CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 205 L---DKNRTVKIADFGVARVEASNPND-------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 205 i---~~~~~~~l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
| +.++.++|+|||++......... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+
T Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred EecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 9 58899999999999865443221 2246789999999999999999999999999999999999999987
Q ss_pred CCH
Q 022794 275 LSF 277 (292)
Q Consensus 275 ~~~ 277 (292)
...
T Consensus 216 ~~~ 218 (483)
T 3sv0_A 216 LKA 218 (483)
T ss_dssp CCC
T ss_pred ccc
Confidence 554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.12 Aligned_cols=209 Identities=28% Similarity=0.490 Sum_probs=170.5
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
..+.....+|.....||+|+||.||+|.+ +++.||+|.+...... ..+.+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~ 85 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---------YSQPLHEEIALHKHLKHKNIVQYL 85 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH---------HHHHHHHHHHHHHhCCCCCEeeEe
Confidence 33444445566666999999999999976 5789999998654321 123477899999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
+++...+.. +++|||+++++|.+++.... ...+++..++.++.|++.||.+||+.|++|+||+
T Consensus 86 ~~~~~~~~~----------------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 149 (295)
T 2clq_A 86 GSFSENGFI----------------KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149 (295)
T ss_dssp EEEEETTEE----------------EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred eEEEeCCcE----------------EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC
Confidence 998766544 89999999999999997542 2356789999999999999999999999999999
Q ss_pred CCCeeEcC-CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 022794 200 TENMLLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLS 276 (292)
Q Consensus 200 p~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Diwslg~il~~l~~g~~pf~~~~ 276 (292)
|+||+++. ++.++|+|||.+..............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||....
T Consensus 150 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp GGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred hhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 99999987 89999999999986554433344567899999999987643 7899999999999999999999997543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=273.75 Aligned_cols=202 Identities=32% Similarity=0.563 Sum_probs=159.3
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHH--HHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ--EVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~--e~~~l~~l~h~~iv~~~~~ 122 (292)
..+..++|++.+.||+|+||.||+|.++++.||||++.... ...+.. ++..+..++||||+++++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------------RQNFINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------------hhhHHHHHHHHHHHhccCcchhhheec
Confidence 34566899999999999999999999999999999986321 111233 3444455799999999975
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC---------Cc
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------KI 193 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---------~i 193 (292)
+..... .....++++|||+++++|.+++... ..++..++.++.|++.||.|||+. |+
T Consensus 76 ~~~~~~-----------~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i 141 (336)
T 3g2f_A 76 DERVTA-----------DGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141 (336)
T ss_dssp EEEECT-----------TSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE
T ss_pred cccccc-----------CCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccce
Confidence 432111 0122348999999999999999543 458889999999999999999999 99
Q ss_pred cccCCCCCCeeEcCCCcEEEeecCcceeccCCC--------CCCCCCCCcccccCCcccCC-------CCCCchhhHHHH
Q 022794 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNP--------NDMTGETGTLGYMAPEVLNG-------NPYNRKCDVYSF 258 (292)
Q Consensus 194 ~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Diwsl 258 (292)
+||||||+|||++.++.++|+|||++....... .......+++.|+|||++.+ ..++.++|||||
T Consensus 142 vH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp ECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred eecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 999999999999999999999999997654321 12223568999999999987 345678999999
Q ss_pred HHHHHHHHhCCCCC
Q 022794 259 GICLWEIYCCDMPY 272 (292)
Q Consensus 259 g~il~~l~~g~~pf 272 (292)
|+++|+|++|..||
T Consensus 222 G~il~ell~g~~p~ 235 (336)
T 3g2f_A 222 GLIYWEIFMRCTDL 235 (336)
T ss_dssp HHHHHHHHTTBGGG
T ss_pred HHHHHHHHhcCCcC
Confidence 99999999996655
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.11 Aligned_cols=213 Identities=22% Similarity=0.345 Sum_probs=171.3
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
..+.+.+..++|++.+.||+|+||.||+|.+ +|+.||+|++.... . ...+.+.+|+.++++++||||++
T Consensus 20 ~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~----~~~~~~~~E~~~l~~l~h~~iv~ 90 (317)
T 2buj_A 20 QGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----Q----QDREEAQREADMHRLFNHPNILR 90 (317)
T ss_dssp EEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-----H----HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-----H----HHHHHHHHHHHHHhhcCCCCeee
Confidence 3345667788999999999999999999975 68999999885421 1 22345788999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQKIVHR 196 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~ 196 (292)
+++++...... ....+++|||+++++|.+++... ....+++..++.++.|++.||.+||+.|++|+
T Consensus 91 ~~~~~~~~~~~------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 158 (317)
T 2buj_A 91 LVAYCLRERGA------------KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHR 158 (317)
T ss_dssp CCEEEEEEETT------------EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EEEEEEeccCC------------CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99988632211 12338999999999999998653 34569999999999999999999999999999
Q ss_pred CCCCCCeeEcCCCcEEEeecCcceeccCCCCC---------CCCCCCcccccCCcccCCCC---CCchhhHHHHHHHHHH
Q 022794 197 DVKTENMLLDKNRTVKIADFGVARVEASNPND---------MTGETGTLGYMAPEVLNGNP---YNRKCDVYSFGICLWE 264 (292)
Q Consensus 197 di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~---~~~~~Diwslg~il~~ 264 (292)
||||+||+++.++.++|+|||.+......... .....+++.|+|||.+.+.. ++.++||||||+++|+
T Consensus 159 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 238 (317)
T 2buj_A 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238 (317)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999988643211110 01134688999999997654 6889999999999999
Q ss_pred HHhCCCCCCC
Q 022794 265 IYCCDMPYPD 274 (292)
Q Consensus 265 l~~g~~pf~~ 274 (292)
|++|..||..
T Consensus 239 l~~g~~p~~~ 248 (317)
T 2buj_A 239 MMFGEGPYDM 248 (317)
T ss_dssp HHHSSCTTHH
T ss_pred HHhCCCChhh
Confidence 9999999953
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=272.18 Aligned_cols=213 Identities=25% Similarity=0.411 Sum_probs=176.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
..+|.+.+.||+|+||.||+|.+ +|+.||||++...... ......+.+|+.++++++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-------EIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 47899999999999999999976 5899999998643211 12344578899999999999999999998776
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
..... ....+++|||+. ++|.+++. ..+++..++.++.|++.||.+||++|++||||||+||+++
T Consensus 96 ~~~~~----------~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~ 160 (353)
T 3coi_A 96 SSLRN----------FYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160 (353)
T ss_dssp SSGGG----------CCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred ccccc----------ceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC
Confidence 54311 122389999996 58887662 3489999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 161 EDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp TTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred CCCcEEEeecccccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998754322 234568999999999887 678999999999999999999999999999888888776
Q ss_pred H
Q 022794 286 R 286 (292)
Q Consensus 286 ~ 286 (292)
+
T Consensus 238 ~ 238 (353)
T 3coi_A 238 K 238 (353)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=269.87 Aligned_cols=199 Identities=34% Similarity=0.574 Sum_probs=161.8
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC--CCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.++|+.||||++.... ......|..++..+ +||||+++++++....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 689999999999999999999999999999985321 11233455555544 9999999999887653
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC--------CccccCCC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ--------KIVHRDVK 199 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--------~i~h~di~ 199 (292)
.. ....+++|||+++++|.+++.. ..+++..++.++.|++.||.|||+. |++|||||
T Consensus 105 ~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 105 GS------------WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp GG------------GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred CC------------CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 21 1234899999999999999954 3699999999999999999999999 99999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCC----CCCCCCcccccCCcccCCCCCCch------hhHHHHHHHHHHHHhC-
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNGNPYNRK------CDVYSFGICLWEIYCC- 268 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~------~Diwslg~il~~l~~g- 268 (292)
|+||+++.++.++|+|||.+......... .....+++.|+|||.+.+...+.. +||||||+++|+|++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 99999999999999999999755433222 124578999999999988766554 9999999999999999
Q ss_pred ---------CCCCCCC
Q 022794 269 ---------DMPYPDL 275 (292)
Q Consensus 269 ---------~~pf~~~ 275 (292)
..||...
T Consensus 250 ~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CBTTBCCCCCCTTTTT
T ss_pred CcccccccccccHhhh
Confidence 7888653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=272.87 Aligned_cols=207 Identities=26% Similarity=0.420 Sum_probs=164.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|.+.+.||+|+||.||+|.+ +++.||||++.......... ........+.+|+.++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSA-READPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC----------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccc-ccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 5899999999999999999976 57899999986432211100 11112334778999999999999999999876543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
. +++|||+++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||||+||+++.
T Consensus 89 -~----------------~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 149 (322)
T 2ycf_A 89 -Y----------------YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 149 (322)
T ss_dssp -E----------------EEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESS
T ss_pred -e----------------EEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEec
Confidence 2 899999999999998853 456999999999999999999999999999999999999987
Q ss_pred CCc---EEEeecCcceeccCCCCCCCCCCCcccccCCcccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 208 NRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN---GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 208 ~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
++. ++|+|||.+...... .......+++.|+|||.+. ...++.++|+||||+++|+|++|..||.....
T Consensus 150 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 150 QEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp SSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred CCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 654 999999999765322 1112245789999999973 56788999999999999999999999976543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=267.18 Aligned_cols=223 Identities=24% Similarity=0.432 Sum_probs=164.1
Q ss_pred hhhcccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc
Q 022794 39 KKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
....+.+....++|.+++.||+|+||.||+|.+ +|+.||||++..... . ....+.+.++..+++.++||||
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~---~~~~~~~~~~~~~~~~~~h~~i 86 (318)
T 2dyl_A 14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN----K---EENKRILMDLDVVLKSHDCPYI 86 (318)
T ss_dssp EESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC----H---HHHHHHHHHHHHHHHTTTCTTB
T ss_pred EecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc----c---hHHHHHHHHHHHHHHhcCCCce
Confidence 334456667778999999999999999999977 589999999964431 1 1122335556667888899999
Q ss_pred cceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-Cccc
Q 022794 117 TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVH 195 (292)
Q Consensus 117 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~h 195 (292)
+++++++...+.. +++|||+ ++.+..+.. .....+++..++.++.|++.||.+||+. |++|
T Consensus 87 ~~~~~~~~~~~~~----------------~lv~e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H 148 (318)
T 2dyl_A 87 VQCFGTFITNTDV----------------FIAMELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148 (318)
T ss_dssp CCEEEEEECSSEE----------------EEEECCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred eeEEEEEecCCcE----------------EEEEecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEe
Confidence 9999999876654 8999999 556655543 3356799999999999999999999995 9999
Q ss_pred cCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCC
Q 022794 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDM 270 (292)
Q Consensus 196 ~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~ 270 (292)
+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+. +..++.++||||||+++|+|++|..
T Consensus 149 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 149 RDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 999999999999999999999998654432 2233356899999999995 4568899999999999999999999
Q ss_pred CCCC-CCHHHHHHHHHHh
Q 022794 271 PYPD-LSFSEVTSAVVRQ 287 (292)
Q Consensus 271 pf~~-~~~~~~~~~i~~~ 287 (292)
||.. .+..+....+.++
T Consensus 228 pf~~~~~~~~~~~~~~~~ 245 (318)
T 2dyl_A 228 PYKNCKTDFEVLTKVLQE 245 (318)
T ss_dssp TTTTCCSHHHHHHHHHHS
T ss_pred CCCCCCccHHHHHHHhcc
Confidence 9986 4555666665554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=271.36 Aligned_cols=205 Identities=24% Similarity=0.425 Sum_probs=145.0
Q ss_pred CCceeEee-eeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 49 PSKLVIKS-VIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~-~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
.++|.+.+ .||+|+||.||+|.+. |+.||||++... .. ...+....++.+.||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK-------ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH-------HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH-------HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 36899965 6999999999999774 899999998532 11 11223334566799999999999865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
...- ....+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 94 ~~~~------------~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll 161 (336)
T 3fhr_A 94 MHHG------------KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLY 161 (336)
T ss_dssp EETT------------EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCC------------CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 2210 1223899999999999999987655679999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 206 ~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+. ++.++|+|||.+..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+....
T Consensus 162 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 162 TSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp SCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 76 45599999999975442 223345679999999999888899999999999999999999999987665544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.93 Aligned_cols=205 Identities=28% Similarity=0.534 Sum_probs=171.1
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
.+...+|++++.||+|+||.||+|.+ +|+.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~~ 107 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---------EHLRDFEREIEILKSLQHDNIVKY 107 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---------HHHHHHHHHHHHHHhCCCCCeeeE
Confidence 44567899999999999999999974 588999999864321 123457889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++...+.. ..+++|||+++++|.+++... ...+++..++.++.|++.||.+||+.|++|+|||
T Consensus 108 ~~~~~~~~~~--------------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik 172 (326)
T 2w1i_A 108 KGVCYSAGRR--------------NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172 (326)
T ss_dssp EEEECC------------------CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred EEEEEecCCC--------------ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence 9988765422 238999999999999999754 3458999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|+||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 173 p~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 173 TRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999865433221 2234567789999999888899999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=268.63 Aligned_cols=200 Identities=35% Similarity=0.593 Sum_probs=167.8
Q ss_pred CCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh--CCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK--LDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~ 126 (292)
.++|.+.+.||+|+||.||+|.++|+.||||++.... ...+.+|.++++. ++||||+++++++...
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------------ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG------------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh------------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 3689999999999999999999999999999985321 1235678888887 6999999999998765
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--------hCCccccCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH--------SQKIVHRDV 198 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH--------~~~i~h~di 198 (292)
... ....+++|||+++++|.+++.. ..+++..++.++.|++.||.+|| +.|++|+||
T Consensus 109 ~~~------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dl 173 (342)
T 1b6c_B 109 NGT------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173 (342)
T ss_dssp CSS------------CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCC
T ss_pred CCc------------cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCC
Confidence 421 1134899999999999999954 35899999999999999999999 899999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCCCC------CCchhhHHHHHHHHHHHHhC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~------~~~~~Diwslg~il~~l~~g 268 (292)
||+||+++.++.++|+|||.+........ ......+++.|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99999999999999999999976544332 223457899999999998752 33689999999999999999
Q ss_pred ----------CCCCCCC
Q 022794 269 ----------DMPYPDL 275 (292)
Q Consensus 269 ----------~~pf~~~ 275 (292)
..||...
T Consensus 254 ~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp BCBTTBCCCCCCTTTTT
T ss_pred cCcCCcccccccCcccc
Confidence 8899764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=276.60 Aligned_cols=216 Identities=15% Similarity=0.197 Sum_probs=152.4
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC--CCCcccceeceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL--DHPNVTKFIGATM 124 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~ 124 (292)
..+|.+.+.||+|+||.||+|.+ +|+.||||++...... .....+.+.+|+.+++.+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN------SRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT------HHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc------cccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 34699999999999999999975 5889999999754321 112233466775444444 7999888664443
Q ss_pred CCcccccccc--------cccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHH------HHHHHHHHHHHHHHHh
Q 022794 125 GSSELHIQTE--------NGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV------VQLALDLARGLSYLHS 190 (292)
Q Consensus 125 ~~~~~~~~~~--------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------~~i~~qi~~al~~lH~ 190 (292)
.......... .+.........++||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||+
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 1111100000 0000001134699999997 89999997642 33455555 6778999999999999
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhC
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g 268 (292)
+|++||||||+|||++.++.++|+|||++....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998654221 13456699999999987 6799999999999999999999
Q ss_pred CCCCCCC
Q 022794 269 DMPYPDL 275 (292)
Q Consensus 269 ~~pf~~~ 275 (292)
+.||.+.
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=271.58 Aligned_cols=205 Identities=24% Similarity=0.377 Sum_probs=168.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-----------
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD----------- 112 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----------- 112 (292)
.+...+|++.+.||+|+||.||+|.+ +++.||||++... . .....+.+|+.+++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 84 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------K----VYTEAAEDEIKLLQRVNDADNTKEDSMG 84 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------H----HHHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------c----cchhhhhHHHHHHHHhhcccccchhccc
Confidence 34568999999999999999999975 6899999998521 1 12344677888888875
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC-
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ- 191 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~- 191 (292)
|+||+++++++...... ....+++||++ +++|.+++.......+++..++.++.||+.||.+||++
T Consensus 85 ~~~i~~~~~~~~~~~~~------------~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ 151 (373)
T 1q8y_A 85 ANHILKLLDHFNHKGPN------------GVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC 151 (373)
T ss_dssp HTTBCCCCEEEEEEETT------------EEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cchHHHHHHHhhccCCC------------CceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 88999999998754311 11338999999 88999999876666799999999999999999999998
Q ss_pred CccccCCCCCCeeEc------CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHH
Q 022794 192 KIVHRDVKTENMLLD------KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 192 ~i~h~di~p~Nili~------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l 265 (292)
|++||||||+||+++ ..+.++|+|||.+...... .....+++.|+|||++.+..++.++||||||+++|+|
T Consensus 152 ~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 228 (373)
T 1q8y_A 152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 228 (373)
T ss_dssp CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHH
T ss_pred CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHH
Confidence 999999999999994 3347999999999765432 3345789999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 022794 266 YCCDMPYPDLS 276 (292)
Q Consensus 266 ~~g~~pf~~~~ 276 (292)
++|..||...+
T Consensus 229 ~~g~~pf~~~~ 239 (373)
T 1q8y_A 229 ITGDFLFEPDE 239 (373)
T ss_dssp HHSSCCC----
T ss_pred HhCCCCCCCCc
Confidence 99999998655
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=267.60 Aligned_cols=209 Identities=27% Similarity=0.504 Sum_probs=153.5
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHH-HHHhCCCCccc
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVA-VWHKLDHPNVT 117 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv 117 (292)
..+.|.+..++|++.+.||+|+||.||+|.+. |+.||||+++.... ... ...+..|.. +++.++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~----~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKE----QKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHH----HHHHHHHHHHHHSSCCCTTBC
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chH----HHHHHHHHHHHHHcCCCCcEe
Confidence 34667788899999999999999999999774 89999999964321 111 122334444 77778999999
Q ss_pred ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 022794 118 KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK---NRRRKLAFKVVVQLALDLARGLSYLHSQ-KI 193 (292)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~-~i 193 (292)
++++++...+.. +++|||+++ +|.+++.. .....+++..++.++.|++.||.+||+. |+
T Consensus 85 ~~~~~~~~~~~~----------------~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i 147 (327)
T 3aln_A 85 QFYGALFREGDC----------------WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147 (327)
T ss_dssp CEEEEEECSSEE----------------EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred eeeeEEEeCCce----------------EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCE
Confidence 999998876554 899999964 88887753 2256789999999999999999999999 99
Q ss_pred cccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCccc----CCCCCCchhhHHHHHHHHHHHHhCC
Q 022794 194 VHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL----NGNPYNRKCDVYSFGICLWEIYCCD 269 (292)
Q Consensus 194 ~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Diwslg~il~~l~~g~ 269 (292)
+|+||||+||+++.++.++|+|||.+....... ......+++.|+|||.+ .+..++.++|+||||+++|+|++|.
T Consensus 148 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (327)
T 3aln_A 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226 (327)
T ss_dssp CCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSC
T ss_pred eECCCCHHHEEEcCCCCEEEccCCCceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999999999987554322 22334688999999998 4566899999999999999999999
Q ss_pred CCCCCC
Q 022794 270 MPYPDL 275 (292)
Q Consensus 270 ~pf~~~ 275 (292)
.||...
T Consensus 227 ~pf~~~ 232 (327)
T 3aln_A 227 FPYPKW 232 (327)
T ss_dssp CCSSCC
T ss_pred CCCCCc
Confidence 999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=262.58 Aligned_cols=212 Identities=21% Similarity=0.321 Sum_probs=168.4
Q ss_pred hhhhcccceecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC--CC
Q 022794 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HP 114 (292)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~ 114 (292)
.....+.+.+...+|.+.+.||+|+||.||+|.+ +++.||+|++...... ....+.+.+|+.+++++. |+
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~~~~~ 88 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-------NQTLDSYRNEIAYLNKLQQHSD 88 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-------HHHHHHHHHHHHHHHHHGGGCT
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-------ccchHHHHHHHHHHHhccccCC
Confidence 3445566788889999999999999999999966 4788999999754322 112345788999999996 59
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 194 (292)
||+++++++...+.. +++||+ .+++|.+++... ..+++..++.++.|++.||.+||+.|++
T Consensus 89 ~iv~~~~~~~~~~~~----------------~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~iv 149 (313)
T 3cek_A 89 KIIRLYDYEITDQYI----------------YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIV 149 (313)
T ss_dssp TBCCEEEEEECSSEE----------------EEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ceEEEEEEeecCCEE----------------EEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 999999998776554 899994 488999999653 4689999999999999999999999999
Q ss_pred ccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCC-----------CCCCchhhHHHHHHH
Q 022794 195 HRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNG-----------NPYNRKCDVYSFGIC 261 (292)
Q Consensus 195 h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Diwslg~i 261 (292)
|+||||+||+++ ++.++|+|||.+........ ......+++.|+|||.+.+ ..++.++||||||++
T Consensus 150 H~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~i 228 (313)
T 3cek_A 150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228 (313)
T ss_dssp CCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHH
T ss_pred ecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHH
Confidence 999999999996 48999999999875433222 1233568999999999876 468889999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 022794 262 LWEIYCCDMPYPDLS 276 (292)
Q Consensus 262 l~~l~~g~~pf~~~~ 276 (292)
+|+|++|..||....
T Consensus 229 l~el~~g~~pf~~~~ 243 (313)
T 3cek_A 229 LYYMTYGKTPFQQII 243 (313)
T ss_dssp HHHHHHSSCTTTTCC
T ss_pred HHHHHhCCCchhhHH
Confidence 999999999998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.07 Aligned_cols=207 Identities=27% Similarity=0.414 Sum_probs=162.1
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC----CCCcccc
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL----DHPNVTK 118 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----~h~~iv~ 118 (292)
.+...++|++.+.||+|+||.||+|.+ +++.||+|++......... .......+.+|+.+++++ +|+||++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS---PLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC-----------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc---cchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 444568899999999999999999976 6889999998654322111 011122355688888888 8999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEee-cCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEY-LPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRD 197 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~d 197 (292)
+++++...+.. ++++|+ +.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+|
T Consensus 103 ~~~~~~~~~~~----------------~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 164 (312)
T 2iwi_A 103 LLDWFETQEGF----------------MLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRD 164 (312)
T ss_dssp EEEEC-----C----------------EEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCC
T ss_pred EEEEEecCCeE----------------EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 99998776554 889999 7889999999653 4699999999999999999999999999999
Q ss_pred CCCCCeeEc-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 022794 198 VKTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 198 i~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|||+||+++ .++.++|+|||.+...... ......++..|+|||.+.+..+. .++|+||||+++|+|++|+.||..
T Consensus 165 lkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 165 IKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp CSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998 8899999999999765432 23445689999999998776654 589999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=263.38 Aligned_cols=208 Identities=24% Similarity=0.392 Sum_probs=169.7
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC--CCcccce
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HPNVTKF 119 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~ 119 (292)
..+...++|++.+.||+|+||.||+|.+ +++.||||++........... .....+.+|+.+++++. |+||+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL---PNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC---TTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh---hhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3455678999999999999999999976 688999999975432211000 00112556899999995 5999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCC-CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
++++...+.. ++++|++.+ ++|.+++.. ...+++..++.++.|++.||.+||+.|++||||
T Consensus 114 ~~~~~~~~~~----------------~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 175 (320)
T 3a99_A 114 LDWFERPDSF----------------VLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDI 175 (320)
T ss_dssp EEEEECSSEE----------------EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEEEecCCcE----------------EEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCC
Confidence 9999876654 899999976 899999965 356899999999999999999999999999999
Q ss_pred CCCCeeEc-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 199 KTENMLLD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 199 ~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
||+||+++ +++.++|+|||.+...... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..
T Consensus 176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 176 KDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99999998 7899999999999765432 2334568999999999877665 6789999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=257.08 Aligned_cols=207 Identities=30% Similarity=0.477 Sum_probs=161.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||+|++... . ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT------E----EKLSTILSEVMLLASLNHQYVVRYYAAWLERR 75 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE------H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc------H----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence 5799999999999999999976 6899999998531 1 12345788999999999999999999886543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
..... ..........+++|||+++++|.+++... ...+++..++.++.|++.||.+||++|++|+||||+||+++.
T Consensus 76 ~~~~~---~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 76 NFVKP---MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCC---------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred chhhh---hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC
Confidence 21100 00111234558999999999999999753 456888999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCC--------------CCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCC
Q 022794 208 NRTVKIADFGVARVEASN--------------PNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPY 272 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf 272 (292)
++.++|+|||.+...... ........+++.|+|||.+.+. .++.++|+||||+++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 999999999998754321 1122345688999999999865 68999999999999999998 55
Q ss_pred C
Q 022794 273 P 273 (292)
Q Consensus 273 ~ 273 (292)
.
T Consensus 229 ~ 229 (303)
T 1zy4_A 229 S 229 (303)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=271.08 Aligned_cols=207 Identities=26% Similarity=0.374 Sum_probs=161.4
Q ss_pred ccceecCCceeEeeeeccCcceEE-EEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCccccee
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTV-HRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFI 120 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V-~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 120 (292)
..+.+...+|.+.+.||+|+||+| +.+..+|+.||||++...... .+.+|+.+++++ +||||++++
T Consensus 17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------------~~~~E~~~l~~l~~HpnIv~l~ 84 (432)
T 3p23_A 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------------FADREVQLLRESDEHPNVIRYF 84 (432)
T ss_dssp -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------------ECHHHHHHHHHSCCCTTBCCEE
T ss_pred CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------------HHHHHHHHHHhccCCCCcCeEE
Confidence 446666778999999999999985 555788999999998542211 145799999999 899999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+.... +++|||+. ++|.+++.... ....+..++.++.||+.||.|||++||+||||||
T Consensus 85 ~~~~~~~~~----------------~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp 146 (432)
T 3p23_A 85 CTEKDRQFQ----------------YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP 146 (432)
T ss_dssp EEEEETTEE----------------EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCST
T ss_pred EEEecCCEE----------------EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCH
Confidence 988766554 89999995 69999996543 3344556778999999999999999999999999
Q ss_pred CCeeEcC---C--CcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHHHHHh-C
Q 022794 201 ENMLLDK---N--RTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYC-C 268 (292)
Q Consensus 201 ~Nili~~---~--~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~~l~~-g 268 (292)
+||+++. + ..++|+|||++....... .......|++.|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 147 ~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g 226 (432)
T 3p23_A 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG 226 (432)
T ss_dssp TSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTS
T ss_pred HHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCC
Confidence 9999953 2 357899999997654322 22334568999999999974 567889999999999999999 9
Q ss_pred CCCCCCCCHHH
Q 022794 269 DMPYPDLSFSE 279 (292)
Q Consensus 269 ~~pf~~~~~~~ 279 (292)
..||......+
T Consensus 227 ~~pf~~~~~~~ 237 (432)
T 3p23_A 227 SHPFGKSLQRQ 237 (432)
T ss_dssp CBTTBSTTTHH
T ss_pred CCCcchhhHHH
Confidence 99997654443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=253.35 Aligned_cols=178 Identities=15% Similarity=0.142 Sum_probs=150.3
Q ss_pred ecCCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
+..++|++.+.||+|+||.||+|.+. |+.||||+++...... ....+.+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP------DDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 55689999999999999999999875 8999999997543321 123455788999999999999999999987
Q ss_pred CCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCee
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENML 204 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nil 204 (292)
..+.. |++|||+++++|.+++.. . .....+..++.|++.||.|||++|++||||||+||+
T Consensus 102 ~~~~~----------------~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIl 161 (286)
T 3uqc_A 102 TRAGG----------------LVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVR 161 (286)
T ss_dssp ETTEE----------------EEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred ECCcE----------------EEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEE
Confidence 76554 899999999999999843 2 355678899999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 205 LDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 205 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
++.++.++|++++. ++ .++.++||||||+++|+|++|+.||.+.+.
T Consensus 162 l~~~g~~kl~~~~~--------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 162 VSIDGDVVLAYPAT--------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp EETTSCEEECSCCC--------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred EcCCCCEEEEeccc--------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 99999999985432 22 268899999999999999999999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=270.26 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=155.1
Q ss_pred CCceeEeeeeccCcceEEEEE-EECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~-~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 126 (292)
.+.|.+.+.||+|+||+||.+ ..+|+.||||++.... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------------CDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 456777899999999999755 6689999999985321 12356799999876 899999999988766
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccc-----cCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK-----LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
+.. +++|||+. ++|.+++....... .++..++.++.||+.||.|||++|++||||||+
T Consensus 82 ~~~----------------~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 82 RFL----------------YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp SEE----------------EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CeE----------------EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 554 89999995 69999996532211 123345789999999999999999999999999
Q ss_pred CeeEcCC-------------CcEEEeecCcceeccCCCCC----CCCCCCcccccCCcccCC-------CCCCchhhHHH
Q 022794 202 NMLLDKN-------------RTVKIADFGVARVEASNPND----MTGETGTLGYMAPEVLNG-------NPYNRKCDVYS 257 (292)
Q Consensus 202 Nili~~~-------------~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-------~~~~~~~Diws 257 (292)
||+++.+ +.++|+|||++......... .....+++.|+|||++.+ ..++.++||||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999754 47999999999865543221 223568999999999976 56899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHH
Q 022794 258 FGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 258 lg~il~~l~~-g~~pf~~~~~~ 278 (292)
|||++|+|++ |..||......
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTH
T ss_pred HHHHHHHHHhCCCCCCCCchhh
Confidence 9999999999 99999865443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=287.85 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=165.1
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE---CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY---DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
++..++|++.+.||+|+||.||+|.+ +|+.||||++..... ......+.+|+.++++++||||++++++
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 147 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--------AEAQAMAMAERQFLAEVVHPSIVQIFNF 147 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--------HHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--------HHHHHHHHHHHHHHHhcCCCCcCeEeee
Confidence 45568999999999999999999976 578999998864221 1223457889999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...+.. .....|+||||+++++|.+++.. .+++..++.++.||+.+|.|||++||+||||||+|
T Consensus 148 ~~~~~~~-----------~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~N 212 (681)
T 2pzi_A 148 VEHTDRH-----------GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212 (681)
T ss_dssp EEEECTT-----------SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EeecCCC-----------CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHH
Confidence 8765431 01123899999999999987632 69999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
|+++.+ .++|+|||.+...... ....|++.|+|||++.+. ++.++||||||+++|+|++|..||.+
T Consensus 213 Ill~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 213 IMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp EEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred eEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 999875 8999999999765432 345689999999998765 48899999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.66 Aligned_cols=213 Identities=18% Similarity=0.205 Sum_probs=158.5
Q ss_pred CCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---------CCcccce
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---------HPNVTKF 119 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---------h~~iv~~ 119 (292)
.++|++.+.||+|+||.||+|.++|+.||||+++......... ......+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNG-SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTT-BCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCcccccc-ccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4689999999999999999999999999999997654211000 00001233667888887775 5555555
Q ss_pred ece-----------------ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHH
Q 022794 120 IGA-----------------TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLA 182 (292)
Q Consensus 120 ~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~ 182 (292)
.+. +.+..... ............++||||+++|++.+.+.+ ..+++..++.++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~---~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSA---NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCS---SCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhcccc---ccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHH
Confidence 544 33210000 000001123456999999999976666632 5689999999999999
Q ss_pred HHHHHHH-hCCccccCCCCCCeeEcCCC--------------------cEEEeecCcceeccCCCCCCCCCCCcccccCC
Q 022794 183 RGLSYLH-SQKIVHRDVKTENMLLDKNR--------------------TVKIADFGVARVEASNPNDMTGETGTLGYMAP 241 (292)
Q Consensus 183 ~al~~lH-~~~i~h~di~p~Nili~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 241 (292)
.||.||| ++||+||||||+|||++.++ .++|+|||+++..... ...||+.|+||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 9999999 99999999999999999887 8999999999865432 24689999999
Q ss_pred cccCCCCCCchhhHHHHHHH-HHHHHhCCCCCCC
Q 022794 242 EVLNGNPYNRKCDVYSFGIC-LWEIYCCDMPYPD 274 (292)
Q Consensus 242 E~~~~~~~~~~~Diwslg~i-l~~l~~g~~pf~~ 274 (292)
|++.+.. +.++||||++++ .+++++|..||.+
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9998776 889999998766 7788999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=280.27 Aligned_cols=207 Identities=31% Similarity=0.455 Sum_probs=170.2
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||.||+|.+ +|+.||||+++... . ......+.+|+.++++++||||+++++++....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~----~----~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL----S----PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC----C----HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC----C----HHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 7899999999999999999965 68999999985431 1 122445788999999999999999999876532
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR-RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. ......+++|||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++||||+|+||+++
T Consensus 86 ~~----------~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~ 155 (676)
T 3qa8_A 86 KL----------APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155 (676)
T ss_dssp CC----------CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEE
T ss_pred cc----------cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEee
Confidence 21 11334489999999999999996532 23588999999999999999999999999999999999998
Q ss_pred CCCc---EEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 207 KNRT---VKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 207 ~~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
.++. ++|+|||.+...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 156 ~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 156 PGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 7765 899999999765433 2334467899999999999999999999999999999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.61 Aligned_cols=221 Identities=18% Similarity=0.222 Sum_probs=158.5
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC-Ccccceece---
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIGA--- 122 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~--- 122 (292)
...|.+.+.||+|+||.||+|.+. |+.||||+++....... ...+.+.+|+.+++.+.| ++.......
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~------~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH------HHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 346889999999999999999875 99999999874433221 112347789999999976 333222221
Q ss_pred ------ecCCccccccc-ccccccCCCCceEEEEeecCCCCHHHHHHh-----hcccccCHHHHHHHHHHHHHHHHHHHh
Q 022794 123 ------TMGSSELHIQT-ENGQVAMPSNICCVVVEYLPGGALKTYLIK-----NRRRKLAFKVVVQLALDLARGLSYLHS 190 (292)
Q Consensus 123 ------~~~~~~~~~~~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~i~~qi~~al~~lH~ 190 (292)
........+.. ..+.........+++|+.. +++|.+++.. .....+++..++.++.|++.||.|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11100000000 0000000122346777776 7899998852 234568888999999999999999999
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCccc----------CCCCCCchhhHHHHHH
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVL----------NGNPYNRKCDVYSFGI 260 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Diwslg~ 260 (292)
+||+||||||+|||++.++.++|+|||+++..... .....+ +.|+|||++ .+..++.++|||||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 99999999999999999999999999998765433 333456 999999999 5566889999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHH
Q 022794 261 CLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 261 il~~l~~g~~pf~~~~~~~~ 280 (292)
++|+|++|+.||...+..+.
T Consensus 306 il~elltg~~Pf~~~~~~~~ 325 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG 325 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC
T ss_pred HHHHHHHCCCCCCCcchhhh
Confidence 99999999999987655433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=247.71 Aligned_cols=181 Identities=24% Similarity=0.425 Sum_probs=148.6
Q ss_pred CceeEe-eeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH-HhCCCCcccceeceecC
Q 022794 50 SKLVIK-SVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW-HKLDHPNVTKFIGATMG 125 (292)
Q Consensus 50 ~~~~~~-~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~ 125 (292)
++|.+. +.||+|+||.||+|.+ +++.||+|+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 567777 7899999999999976 6889999998521 1255688887 55699999999998865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... .....+++|||+++++|.+++.......+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus 83 ~~~------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 150 (299)
T 3m2w_A 83 LYA------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 150 (299)
T ss_dssp EET------------TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred hcC------------CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 110 01223899999999999999987666679999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Q 022794 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278 (292)
Q Consensus 206 ~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~ 278 (292)
+. ++.++|+|||.+.... +..++.++|+||||+++|+|++|..||...+..
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 204 (299)
T 3m2w_A 151 TSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204 (299)
T ss_dssp SSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred ecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence 87 7889999999886432 234678999999999999999999999765443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=257.19 Aligned_cols=190 Identities=17% Similarity=0.154 Sum_probs=134.0
Q ss_pred eeccCcceEEEEE--EECCceeEEEEeecCCCC-CccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcccccc
Q 022794 57 VIARGTFGTVHRG--LYDGHDVAVKLLDWGEEG-HRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 57 ~lg~G~~g~V~~~--~~~~~~valK~~~~~~~~-~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 132 (292)
..+.|+.|.+..+ .+.|+.|++|++...... .....+.+...+.+.+|+.+|+++ .|+||+++++++.+....
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~--- 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG--- 317 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE---
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE---
Confidence 3456666666655 357999999999765432 234455556677899999999999 799999999999887776
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
||||||++|++|.+++.+. .++++. +|+.||+.||.|+|++||+||||||+|||++.+|.+|
T Consensus 318 -------------yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 318 -------------WLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp -------------EEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEE
T ss_pred -------------EEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEE
Confidence 9999999999999999653 456654 4789999999999999999999999999999999999
Q ss_pred EeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC
Q 022794 213 IADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g 268 (292)
|+|||+++.............||+.|+|||++.+. +..++|+|++|++++.++++
T Consensus 380 L~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 380 LIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp ECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred EeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 99999998665544444556799999999999864 56778999999987776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=234.21 Aligned_cols=192 Identities=16% Similarity=0.210 Sum_probs=145.9
Q ss_pred eEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcccccc
Q 022794 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQ 132 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 132 (292)
...+.||+|+||.||+|...++.+++|....... ...........+++.+|+.++++++||||+++..++...+..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~--- 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGY-RDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK--- 414 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTT-SCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT---
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccc-cchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc---
Confidence 4466899999999999998999999998754222 222333344466789999999999999999554444433333
Q ss_pred cccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEE
Q 022794 133 TENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVK 212 (292)
Q Consensus 133 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~ 212 (292)
+++|||+++++|.+++.. +..++.|++.+|.|||++||+||||||+|||++. .++
T Consensus 415 -------------~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~k 469 (540)
T 3en9_A 415 -------------RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLY 469 (540)
T ss_dssp -------------EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEE
T ss_pred -------------EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEE
Confidence 899999999999999843 5679999999999999999999999999999988 999
Q ss_pred EeecCcceeccCCCCC-------CCCCCCcccccCCcccCC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 213 IADFGVARVEASNPND-------MTGETGTLGYMAPEVLNG--NPYNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 213 l~Dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
|+|||+++........ .....+|+.|+|||++.. ..|+...|+|+..+-..+...++.+|.
T Consensus 470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999865432111 123568999999999976 567788899999888888888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-26 Score=187.97 Aligned_cols=152 Identities=15% Similarity=0.088 Sum_probs=112.8
Q ss_pred ceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccH---------HHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTE---------AEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.|.+.+.||+|+||.||+|.+ +|+.||||+++......... .........+.+|+.++++++ | +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 445669999999999999987 58899999996433211100 011123456889999999998 4 5666
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.. +. ++++|||+++++|.+ +. . .....++.|++.+|.+||++|++||||||
T Consensus 168 ~~~~~-~~----------------~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp 221 (282)
T 1zar_A 168 KVYAW-EG----------------NAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQ 221 (282)
T ss_dssp CEEEE-ET----------------TEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCST
T ss_pred eEEec-cc----------------eEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCH
Confidence 54432 22 289999999999987 41 1 12456999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN 245 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 245 (292)
+||+++ ++.++|+|||.+... ..+.|||.+.
T Consensus 222 ~NILl~-~~~vkl~DFG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 222 YNVLVS-EEGIWIIDFPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp TSEEEE-TTEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred HHEEEE-CCcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence 999999 999999999998632 2356778763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8e-22 Score=161.65 Aligned_cols=145 Identities=17% Similarity=0.136 Sum_probs=106.0
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCce--eEEEEeecCCCCCccH---------------HHHHHHHHHHHHHHHHHHhC
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHD--VAVKLLDWGEEGHRTE---------------AEIAALRSAFTQEVAVWHKL 111 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~--valK~~~~~~~~~~~~---------------~~~~~~~~~~~~e~~~l~~l 111 (292)
-|.+.+.||+|+||.||+|.+ +|+. ||||+++......... .........+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999976 8999 9999976432111100 00112234578899999999
Q ss_pred CCCcc--cceeceecCCcccccccccccccCCCCceEEEEeecCC-C----CHHHHHHhhcccccCHHHHHHHHHHHHHH
Q 022794 112 DHPNV--TKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG-G----ALKTYLIKNRRRKLAFKVVVQLALDLARG 184 (292)
Q Consensus 112 ~h~~i--v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~i~~qi~~a 184 (292)
.|+++ +.+++. .. .++||||+.+ | +|.++... .++..+..++.|++.+
T Consensus 128 ~~~~i~~p~~~~~----~~----------------~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MK----------------NVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HHTTCCCCCEEEE----ET----------------TEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHH
T ss_pred HhCCCCCCeEEEc----CC----------------CEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHH
Confidence 87754 333321 11 2899999942 3 77765422 2345678899999999
Q ss_pred HHHHH-hCCccccCCCCCCeeEcCCCcEEEeecCcceec
Q 022794 185 LSYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222 (292)
Q Consensus 185 l~~lH-~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~ 222 (292)
|.+|| +.|++||||||.|||+++ .++|+|||.+...
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999 999999999999999988 8999999999643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-19 Score=151.51 Aligned_cols=142 Identities=18% Similarity=0.170 Sum_probs=98.0
Q ss_pred ceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCC------------ccHHH-HHHHHHHHHHHHHHHHhCCCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGH------------RTEAE-IAALRSAFTQEVAVWHKLDHPNV 116 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~------------~~~~~-~~~~~~~~~~e~~~l~~l~h~~i 116 (292)
=|.+.+.||+|++|.||+|.+ +|+.||||+++...... ..... ....+.....|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999975 68999999986432111 11111 11112223356666666644333
Q ss_pred c--ceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCcc
Q 022794 117 T--KFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIV 194 (292)
Q Consensus 117 v--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~ 194 (292)
. .+++. . ..+|||||++|++|.+.. .......++.|++.+|.+||+.|++
T Consensus 176 ~vp~p~~~----~----------------~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 176 PVPEPIAQ----S----------------RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp SCCCEEEE----E----------------TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCeeeec----c----------------CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCc
Confidence 2 11111 0 117999999988886532 1123456889999999999999999
Q ss_pred ccCCCCCCeeEcCCC----------cEEEeecCcce
Q 022794 195 HRDVKTENMLLDKNR----------TVKIADFGVAR 220 (292)
Q Consensus 195 h~di~p~Nili~~~~----------~~~l~Dfg~~~ 220 (292)
||||||.|||+++++ .+.++||+-+.
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 999999999998776 38999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=8.7e-14 Score=113.97 Aligned_cols=140 Identities=13% Similarity=0.065 Sum_probs=105.6
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecCCcc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSE 128 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 128 (292)
..|.+...++.|+.+.||++...+..+++|+......... ..+.+|+.+++.+ .+..+.+++++....+.
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~---------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT---------YDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST---------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH---------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 3588889999999999999988889999999864221111 1266789999888 45667788877654433
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh------------------
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS------------------ 190 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~------------------ 190 (292)
.|++||+++|.+|.+.+. +......++.++.++|+.||+
T Consensus 85 ----------------~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 85 ----------------SNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp ----------------EEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred ----------------eEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 289999999999987531 112234678899999999998
Q ss_pred -----------------------------------------CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 -----------------------------------------QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 -----------------------------------------~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
..++|+|++|.||++++++.+.|+||+.+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 3489999999999998765567999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=2e-11 Score=99.52 Aligned_cols=133 Identities=17% Similarity=0.126 Sum_probs=90.6
Q ss_pred ceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc--ccceeceecCCc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSS 127 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~ 127 (292)
.+.+....+.|..+.||++.. +|..+++|+..... . ..+.+|+.+++.+.+.+ +.+++.+....+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~--~----------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--L----------NELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT--T----------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc--c----------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 455544444566699999865 46789999975431 0 12567888888884434 455776655433
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC---------------
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--------------- 192 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--------------- 192 (292)
. .+++|||++|.+|. .. . .+ ...++.+++.+|+.||+..
T Consensus 89 ~----------------~~~v~e~i~G~~l~--~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~ 142 (264)
T 1nd4_A 89 R----------------DWLLLGEVPGQDLL--SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIE 142 (264)
T ss_dssp C----------------EEEEEECCSSEETT--TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHH
T ss_pred C----------------CEEEEEecCCcccC--cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 2 38999999998884 21 0 11 1245667777777777643
Q ss_pred -------------------------------------------ccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 193 -------------------------------------------IVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 193 -------------------------------------------i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
++|+|++|.||++++++.+.|+||+.+..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 143 RARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766667999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=3.7e-11 Score=102.88 Aligned_cols=145 Identities=14% Similarity=0.169 Sum_probs=103.5
Q ss_pred eeEeeeeccCcceEEEEEEECCceeEEEEee--cCCCCCccHHHHHHHHHHHHHHHHHHHhCCC--CcccceeceecCCc
Q 022794 52 LVIKSVIARGTFGTVHRGLYDGHDVAVKLLD--WGEEGHRTEAEIAALRSAFTQEVAVWHKLDH--PNVTKFIGATMGSS 127 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~~~~~valK~~~--~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~ 127 (292)
...++.|+.|.++.||++...+..+++|+.. ..... .....+.+|+.+++.+.. ..+.+++..+.+.+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~--------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~ 111 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL--------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDES 111 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSSCEEEEECCCC------------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT
T ss_pred CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC--------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC
Confidence 3446778999999999998888899999874 22110 011236779999998863 44677777665442
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-----------------
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS----------------- 190 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~----------------- 190 (292)
. ....|++|||++|.++.+.. -..++......++.+++.+|+.||+
T Consensus 112 ~-------------~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~ 174 (359)
T 3dxp_A 112 V-------------IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY 174 (359)
T ss_dssp T-------------TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred c-------------cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence 1 12238999999988775421 1236777888899999999999997
Q ss_pred -----------------------------------------CCccccCCCCCCeeEcCCCc--EEEeecCccee
Q 022794 191 -----------------------------------------QKIVHRDVKTENMLLDKNRT--VKIADFGVARV 221 (292)
Q Consensus 191 -----------------------------------------~~i~h~di~p~Nili~~~~~--~~l~Dfg~~~~ 221 (292)
..++|+|++|.||++++++. +.|+||+.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=1.1e-10 Score=97.56 Aligned_cols=187 Identities=21% Similarity=0.232 Sum_probs=116.7
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcc--cceeceecCCccccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNV--TKFIGATMGSSELHI 131 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i--v~~~~~~~~~~~~~~ 131 (292)
++.++.|....||++. ..+++|+.... .....+.+|..+++.+ .+..+ .+++........
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~-----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~--- 87 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPKHS-----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSET--- 87 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEESSH-----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSS---
T ss_pred eEecCCCCcceEEEEC---CEEEEEecCCc-----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCC---
Confidence 3458999999999864 67999986311 1234477899999887 33332 333332211110
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh---------------------
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS--------------------- 190 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~--------------------- 190 (292)
....|+||++++|.+|.+... ..++......++.+++..++.||+
T Consensus 88 ----------~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~ 153 (304)
T 3sg8_A 88 ----------YQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINED 153 (304)
T ss_dssp ----------CSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHH
T ss_pred ----------CCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHH
Confidence 112378999999988875432 236677777788888888888885
Q ss_pred -------------------------------------CCccccCCCCCCeeEcC--CCcEEEeecCcceeccCCCCCCCC
Q 022794 191 -------------------------------------QKIVHRDVKTENMLLDK--NRTVKIADFGVARVEASNPNDMTG 231 (292)
Q Consensus 191 -------------------------------------~~i~h~di~p~Nili~~--~~~~~l~Dfg~~~~~~~~~~~~~~ 231 (292)
..++|+|++|.||++++ ++.+.++||+.+.... +......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl~~ 232 (304)
T 3sg8_A 154 NKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDFIS 232 (304)
T ss_dssp HHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHHHT
T ss_pred HHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHHHH
Confidence 13699999999999988 4567899999886532 1111000
Q ss_pred CCCcccccCCcccC------CCC--------CCchhhHHHHHHHHHHHHhCCCCCC
Q 022794 232 ETGTLGYMAPEVLN------GNP--------YNRKCDVYSFGICLWEIYCCDMPYP 273 (292)
Q Consensus 232 ~~~~~~y~aPE~~~------~~~--------~~~~~Diwslg~il~~l~~g~~pf~ 273 (292)
......-.+|+... +.. .....++|+++.+++.+.+|..+|-
T Consensus 233 ~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 233 LMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00000001222111 000 0122589999999999999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.72 E-value=2.2e-07 Score=77.56 Aligned_cols=134 Identities=18% Similarity=0.166 Sum_probs=85.7
Q ss_pred eeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCC---cccceeceecCCccccc
Q 022794 55 KSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP---NVTKFIGATMGSSELHI 131 (292)
Q Consensus 55 ~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~ 131 (292)
++.++.|....||+. |..+++|+... . .....+.+|..+++.+.+. .+.+++.+....
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~-------~----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----- 84 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS-------Q----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----- 84 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS-------H----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-----
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC-------c----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-----
Confidence 455788888899987 78899998521 1 1234578899999999542 234444433211
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC--------------------
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ-------------------- 191 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-------------------- 191 (292)
....+++|++++|.++.+.... .++......++.++...|+.||+.
T Consensus 85 ----------~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 85 ----------DGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp ----------TSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred ----------CCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 1233899999999888763211 123333334444444444444432
Q ss_pred ----------------------------------------CccccCCCCCCeeEcC---CCc-EEEeecCccee
Q 022794 192 ----------------------------------------KIVHRDVKTENMLLDK---NRT-VKIADFGVARV 221 (292)
Q Consensus 192 ----------------------------------------~i~h~di~p~Nili~~---~~~-~~l~Dfg~~~~ 221 (292)
.++|+|++|.||++++ ++. +.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4699999999999987 455 48999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.6e-06 Score=70.71 Aligned_cols=130 Identities=18% Similarity=0.161 Sum_probs=85.3
Q ss_pred eccCcce-EEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCCccccccc
Q 022794 58 IARGTFG-TVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSELHIQT 133 (292)
Q Consensus 58 lg~G~~g-~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 133 (292)
+..|..+ .||+... .+..+++|+.... . ...+.+|..+|+.+. +--+.+++.+..+.+..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--------~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~---- 95 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--------V----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA---- 95 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--------H----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE----
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--------C----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE----
Confidence 3445444 6887644 4668999987421 1 223667888888773 22355666665544333
Q ss_pred ccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhC----------------------
Q 022794 134 ENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQ---------------------- 191 (292)
Q Consensus 134 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---------------------- 191 (292)
+++|++++|.++.+...... .....+..++...|+.||..
T Consensus 96 ------------~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~ 157 (272)
T 4gkh_A 96 ------------WLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRM 157 (272)
T ss_dssp ------------EEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHH
T ss_pred ------------EEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHH
Confidence 89999999988877653211 11234555666666666631
Q ss_pred ------------------------------------CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 ------------------------------------KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ------------------------------------~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 158 NNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999998877778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=7.7e-07 Score=75.79 Aligned_cols=32 Identities=16% Similarity=0.327 Sum_probs=26.6
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
...++|+|+.+.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34699999999999998655578999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.2e-05 Score=67.75 Aligned_cols=31 Identities=26% Similarity=0.437 Sum_probs=27.8
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.+++|+|+++.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998788899999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.3e-05 Score=69.26 Aligned_cols=31 Identities=19% Similarity=0.366 Sum_probs=26.0
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
...++|||+.|.||++++++ +.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 35799999999999997654 89999987753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.04 E-value=4.2e-05 Score=63.68 Aligned_cols=77 Identities=19% Similarity=0.127 Sum_probs=54.8
Q ss_pred eEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC---CCcccceeceecCCccc
Q 022794 53 VIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD---HPNVTKFIGATMGSSEL 129 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~ 129 (292)
.-.+.|+.|....+|+...++..+++|+..... ...+..|+..|+.+. ...+++++.+....+.
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~- 105 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERSY------------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH- 105 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG------------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE-
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCccc------------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc-
Confidence 445678999999999998788899999875320 233677888887772 3456677666543322
Q ss_pred ccccccccccCCCCceEEEEeecCCCCH
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGAL 157 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L 157 (292)
.+++||++++.++
T Consensus 106 ---------------~~lvme~l~G~~~ 118 (312)
T 3jr1_A 106 ---------------SFLLLEALNKSKN 118 (312)
T ss_dssp ---------------EEEEEECCCCCCC
T ss_pred ---------------eEEEEEeccCCCC
Confidence 3899999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.03 E-value=4.4e-05 Score=62.84 Aligned_cols=56 Identities=16% Similarity=0.017 Sum_probs=40.7
Q ss_pred cCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 112 (292)
...+..-++.+|.|..+.||+... +|+.|++|+.......... .+..|+..|+.+.
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~---------~~~~Ea~~L~~L~ 69 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDG---------LFRAEALGLDWLG 69 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTT---------HHHHHHHHHHHHT
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhh---------HHHHHHHHHHHHH
Confidence 345677788999999999999964 6899999986543322111 2567888888874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.00 E-value=9.1e-05 Score=61.36 Aligned_cols=29 Identities=28% Similarity=0.365 Sum_probs=24.8
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667789999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00022 Score=59.86 Aligned_cols=31 Identities=32% Similarity=0.483 Sum_probs=26.9
Q ss_pred CCccccCCCCCCeeEcCC----CcEEEeecCccee
Q 022794 191 QKIVHRDVKTENMLLDKN----RTVKIADFGVARV 221 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~----~~~~l~Dfg~~~~ 221 (292)
..++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6799999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.0002 Score=62.30 Aligned_cols=32 Identities=16% Similarity=0.367 Sum_probs=28.0
Q ss_pred HhCCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 189 H~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
+...++|+|++|.||++++++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998776 99999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00022 Score=59.48 Aligned_cols=150 Identities=16% Similarity=0.128 Sum_probs=76.9
Q ss_pred ceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc--ccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN--VTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~ 128 (292)
...-++.|+.|....+|+...++..+++|+...... . ..+..|..+++.+...+ +.+++... ++..
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~--~---------~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~ 90 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE--K---------NDLPFFLGLMQHLAAKGLSCPLPLPRK-DGEL 90 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-----C---------CHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCS
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCCC--H---------HHHHHHHHHHHHHHHCCCCCCcccCCC-CCCE
Confidence 444566788888899999977767899999864211 1 11345666666663222 23333211 1111
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHH-----------HHHH---hh-cc--cc----cCHHHHHH-----------
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALK-----------TYLI---KN-RR--RK----LAFKVVVQ----------- 176 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~-----------~~l~---~~-~~--~~----~~~~~~~~----------- 176 (292)
+ . .. ....++++++++|.++. +.+. .. .. .+ ........
T Consensus 91 ~-~-~~-------~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 91 L-G-EL-------SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp C-E-EE-------TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred E-E-EE-------CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 0 0 00 12347899999875431 1110 00 00 00 01000000
Q ss_pred ----HHHHHHHHHHHHHh-------CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 177 ----LALDLARGLSYLHS-------QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 177 ----i~~qi~~al~~lH~-------~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
+...+...+..+.. .+++|+|+.+.||++++++.+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113334444442 3699999999999998776568999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00047 Score=58.75 Aligned_cols=29 Identities=17% Similarity=0.419 Sum_probs=24.2
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++|+|+.+.||++++++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999997655 89999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0004 Score=60.55 Aligned_cols=60 Identities=18% Similarity=0.167 Sum_probs=36.7
Q ss_pred eEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc-cceece
Q 022794 53 VIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TKFIGA 122 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~ 122 (292)
.-++.|+.|....+|++... +..+++|+.... ... ..+.+|..+++.+...++ .++++.
T Consensus 76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~-------~~li~E~~~l~~L~~~g~~P~l~~~ 144 (429)
T 1nw1_A 76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-------SHLVAESVIFTLLSERHLGPKLYGI 144 (429)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-------HHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcH-------HHHHHHHHHHHHHHhCCCCCcEEEE
Confidence 34567788888999998653 478999998421 110 113357777777733333 455544
Q ss_pred e
Q 022794 123 T 123 (292)
Q Consensus 123 ~ 123 (292)
+
T Consensus 145 ~ 145 (429)
T 1nw1_A 145 F 145 (429)
T ss_dssp E
T ss_pred e
Confidence 3
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0021 Score=56.40 Aligned_cols=60 Identities=12% Similarity=-0.027 Sum_probs=36.8
Q ss_pred EeeeeccCcceEEEEEEECC--ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcc-cceecee
Q 022794 54 IKSVIARGTFGTVHRGLYDG--HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNV-TKFIGAT 123 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~~~--~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~ 123 (292)
-++.|+.|-...+|++...+ ..+++|+.......... ..+|..+++.+...++ .++++.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id----------R~~E~~vl~~L~~~gl~P~ll~~~ 174 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN----------REREKKISCILYNKNIAKKIYVFF 174 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC----------HHHHHHHHHHHTTSSSBCCEEEEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC----------HHHHHHHHHHHHhcCCCCCEEEEe
Confidence 35577888889999998766 88999987432211111 1368888888854444 4555544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0035 Score=52.24 Aligned_cols=29 Identities=24% Similarity=0.266 Sum_probs=25.1
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0022 Score=49.77 Aligned_cols=102 Identities=12% Similarity=0.080 Sum_probs=67.8
Q ss_pred CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCC
Q 022794 155 GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET 233 (292)
Q Consensus 155 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 233 (292)
.+|.+.+.. .+.++++.++|.++.|.+.+|..+- +..-..+=+.|..|++..+|.|.+.+ +.+. .
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~ 98 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------A 98 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------c
Confidence 489998865 5678999999999999999988862 22222344456889999999887663 1110 1
Q ss_pred CcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 022794 234 GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (292)
Q Consensus 234 ~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~p 271 (292)
....+.|||... ...+.+.=|||||+++|..+-..+|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 123566787753 3346778899999999999886655
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0016 Score=55.60 Aligned_cols=30 Identities=23% Similarity=0.439 Sum_probs=26.6
Q ss_pred CccccCCCCCCeeEcCC----CcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKN----RTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~----~~~~l~Dfg~~~~ 221 (292)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 59999999999999876 7899999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0025 Score=53.60 Aligned_cols=31 Identities=19% Similarity=0.425 Sum_probs=27.5
Q ss_pred CCccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 QKIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 ~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999998888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0097 Score=51.58 Aligned_cols=29 Identities=17% Similarity=0.536 Sum_probs=25.9
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++|+|+.+.||+ .+++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7788899999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.003 Score=54.49 Aligned_cols=29 Identities=24% Similarity=0.495 Sum_probs=25.0
Q ss_pred ccccCCCCCCeeE------cCCCcEEEeecCccee
Q 022794 193 IVHRDVKTENMLL------DKNRTVKIADFGVARV 221 (292)
Q Consensus 193 i~h~di~p~Nili------~~~~~~~l~Dfg~~~~ 221 (292)
++|+|+.+.||++ +++..+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.10 E-value=1.2 Score=34.33 Aligned_cols=82 Identities=5% Similarity=0.076 Sum_probs=56.6
Q ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC
Q 022794 167 RKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG 246 (292)
Q Consensus 167 ~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 246 (292)
+..+....++++.+|+....+++ .-+|--++|+|++++.++.+++.-.|+-.. ++|..
T Consensus 76 k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~~p~i~~RGik~~-----------------l~P~~--- 133 (215)
T 4ann_A 76 KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDGLPIAKTRGLQNV-----------------VDPLP--- 133 (215)
T ss_dssp GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTSCEEESCCEETTT-----------------BSCCC---
T ss_pred HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCCCEEEEEccCccC-----------------CCCCC---
Confidence 34778889999999988874443 336778999999999999999986664321 22221
Q ss_pred CCCCchhhHH-HHHHHHHHHHhCCCCCC
Q 022794 247 NPYNRKCDVY-SFGICLWEIYCCDMPYP 273 (292)
Q Consensus 247 ~~~~~~~Diw-slg~il~~l~~g~~pf~ 273 (292)
.+. .|.| .+=|++..+++++..|.
T Consensus 134 --~~e-e~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 134 --VSE-AEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp --CCH-HHHHHHHHHHHHHHHCTTCCHH
T ss_pred --CCH-HHHHHHHHHHHHHHHcCCCCHH
Confidence 222 3443 36677888888877764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.75 E-value=4.3 Score=31.40 Aligned_cols=49 Identities=16% Similarity=0.170 Sum_probs=39.7
Q ss_pred ccCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCCeeEcCCCcEEEeecCc
Q 022794 168 KLAFKVVVQLALDLARGLS-YLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218 (292)
Q Consensus 168 ~~~~~~~~~i~~qi~~al~-~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~ 218 (292)
.++....++++.+|+.... ++ ..-+|--++|+|++++.++.+++.-.|+
T Consensus 81 ~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 81 KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEE
T ss_pred hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCC
Confidence 4778888999999888766 44 4457788999999999999999997664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 292 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-49 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 4e-64
Identities = 77/249 (30%), Positives = 126/249 (50%), Gaps = 31/249 (12%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
DWEI ++ + I G+FGTV++G + G DVAVK+L A AF
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML-------NVTAPTPQQLQAFKN 53
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
EV V K H N+ F+G + +V ++ G +L +L
Sbjct: 54 EVGVLRKTRHVNILLFMGYSTA-----------------PQLAIVTQWCEGSSLYHHL-H 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV-- 221
K ++ +A A+G+ YLH++ I+HRD+K+ N+ L ++ TVKI DFG+A V
Sbjct: 96 IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 222 EASNPNDMTGETGTLGYMAPEVL---NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
S + +G++ +MAPEV+ + NPY+ + DVY+FGI L+E+ +PY +++
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 279 EVTSAVVRQ 287
+ +V +
Sbjct: 216 DQIIFMVGR 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-60
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 30/243 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQE 104
W + +L + I +G FG V G Y G+ VAVK + AE + +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMT------ 55
Query: 105 VAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN 164
+L H N+ + +G + +V EY+ G+L YL
Sbjct: 56 -----QLRHSNLVQLLGVIV---------------EEKGGLYIVTEYMAKGSLVDYLRSR 95
Query: 165 RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
R L +++ +LD+ + YL VHRD+ N+L+ ++ K++DFG+ +
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---E 152
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFSEVTSA 283
+ + + APE L ++ K DV+SFGI LWEIY +PYP + +V
Sbjct: 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212
Query: 284 VVR 286
V +
Sbjct: 213 VEK 215
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-56
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 30/248 (12%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
+WE+ L + + G FG V G Y VAVK L G A
Sbjct: 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----------A 54
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F E + +L H + + + T+ ++ EY+ G+L +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYA---------VVTQEP--------IYIITEYMENGSLVDF 97
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L KL ++ +A +A G++++ + +HRD++ N+L+ + KIADFG+AR
Sbjct: 98 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 221 -VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFS 278
+E + G + + APE +N + K DV+SFGI L EI +PYP ++
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 279 EVTSAVVR 286
EV + R
Sbjct: 218 EVIQNLER 225
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-55
Identities = 62/247 (25%), Positives = 113/247 (45%), Gaps = 31/247 (12%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
E++ S + G G V + + G +A KL+ + A+R+ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--------PAIRNQIIR 53
Query: 104 EVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK 163
E+ V H+ + P + F GA E+ I +E++ GG+L L
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEISI----------------CMEHMDGGSLDQVL-- 95
Query: 164 NRRRKLAFKVVVQLALDLARGLSYLHSQ-KIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ ++ +++ ++++ + +GL+YL + KI+HRDVK N+L++ +K+ DFGV+
Sbjct: 96 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-- 153
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
+ GT YM+PE L G Y+ + D++S G+ L E+ P P E+
Sbjct: 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
Query: 283 AVVRQVQ 289
QV+
Sbjct: 214 MFGCQVE 220
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-55
Identities = 57/242 (23%), Positives = 102/242 (42%), Gaps = 30/242 (12%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G++G + DG + K L + A + EV + +L
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKEL-------DYGSMTEAEKQMLVSEVNLLREL 60
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ ++ + + + +V+EY GG L + + K + +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTL--------------YIVMEYCEGGDLASVITKGTKERQYL 106
Query: 172 --KVVVQLALDLARGLSYLHSQ-----KIVHRDVKTENMLLDKNRTVKIADFGVARVEAS 224
+ V+++ L L H + ++HRD+K N+ LD + VK+ DFG+AR+
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
+ + GT YM+PE +N YN K D++S G L+E+ P+ S E+ +
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226
Query: 285 VR 286
Sbjct: 227 RE 228
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-55
Identities = 69/248 (27%), Positives = 105/248 (42%), Gaps = 30/248 (12%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
+ WEI L ++ + +G FG V G + VA+K L G A
Sbjct: 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----------A 58
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
F QE V KL H + + +V EY+ G+L +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEP-----------------IYIVTEYMSKGSLLDF 101
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L + L +V +A +A G++Y+ VHRD++ N+L+ +N K+ADFG+AR
Sbjct: 102 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 161
Query: 221 -VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSFS 278
+E + G + + APE + K DV+SFGI L E+ +PYP +
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 279 EVTSAVVR 286
EV V R
Sbjct: 222 EVLDQVER 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-54
Identities = 62/244 (25%), Positives = 110/244 (45%), Gaps = 30/244 (12%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
W +E I + +G FG V+ +A+K+L + + E A +
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVL------FKAQLEKAGVEHQLR 54
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+EV + L HPN+ + G ++ +++ ++EY P G + L
Sbjct: 55 REVEIQSHLRHPNILRLYGYFHDATRVYL----------------ILEYAPLGTVYREL- 97
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ K + +LA LSY HS++++HRD+K EN+LL +KIADFG +
Sbjct: 98 -QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-- 154
Query: 223 ASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
+ + T GTL Y+ PE++ G ++ K D++S G+ +E P+ ++ E
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 283 AVVR 286
+ R
Sbjct: 215 RISR 218
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-54
Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 33/246 (13%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G FG V++ A K++D E + + E+ +
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED---------YMVEIDILASC 66
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
DHPN+ K + A + L I ++E+ GGA+ +++ R L
Sbjct: 67 DHPNIVKLLDAFYYENNLWI----------------LIEFCAGGAVDAVMLE-LERPLTE 109
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ + L+YLH KI+HRD+K N+L + +K+ADFGV+
Sbjct: 110 SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
Query: 232 ETGTLGYMAPEVL-----NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
GT +MAPEV+ PY+ K DV+S GI L E+ + P+ +L+ V + +
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
Query: 287 QVQYLL 292
L
Sbjct: 230 SEPPTL 235
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 7e-52
Identities = 68/250 (27%), Positives = 117/250 (46%), Gaps = 30/250 (12%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALR 98
WE+E + + +K + G +G V+ G++ VAVK L E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----------EDTMEV 57
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F +E AV ++ HPN+ + +G +I TE ++ G L
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE----------------FMTYGNLL 101
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
YL + R++++ V++ +A ++ + YL + +HRD+ N L+ +N VK+ADFG+
Sbjct: 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161
Query: 219 AR-VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDM-PYPDLS 276
+R + G + + APE L N ++ K DV++FG+ LWEI M PYP +
Sbjct: 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221
Query: 277 FSEVTSAVVR 286
S+V + +
Sbjct: 222 LSQVYELLEK 231
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-51
Identities = 63/253 (24%), Positives = 116/253 (45%), Gaps = 35/253 (13%)
Query: 43 QDWEIEPSKLVIKSV-IARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAAL 97
+ ++ L+I + + G FG+V +G+Y DVA+K+L G E A
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------KAD 52
Query: 98 RSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157
+E + H+LD+P + + IG + +V+E GG L
Sbjct: 53 TEEMMREAQIMHQLDNPYIVRLIGVCQAEA-----------------LMLVMEMAGGGPL 95
Query: 158 KTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFG 217
+L+ +R ++ V +L ++ G+ YL + VHRD+ N+LL KI+DFG
Sbjct: 96 HKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154
Query: 218 VARVEASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYP 273
+++ ++ + T + L + APE +N ++ + DV+S+G+ +WE PY
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214
Query: 274 DLSFSEVTSAVVR 286
+ EV + + +
Sbjct: 215 KMKGPEVMAFIEQ 227
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-51
Identities = 71/275 (25%), Positives = 109/275 (39%), Gaps = 56/275 (20%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAAL 97
WE L V+ G FG V VAVK+L E ++
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--------EKADSSE 83
Query: 98 RSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R A E+ + +L H N+ +GA S +++ + EY G
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYL----------------IFEYCCYGD 127
Query: 157 LKTYLIKNRRR---------------------KLAFKVVVQLALDLARGLSYLHSQKIVH 195
L YL R + L F+ ++ A +A+G+ +L + VH
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187
Query: 196 RDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKC 253
RD+ N+L+ + VKI DFG+AR S+ N + + +MAPE L Y K
Sbjct: 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKS 247
Query: 254 DVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQ 287
DV+S+GI LWEI+ PYP + +++
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN 282
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-51
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 30/243 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+P L + G FG V G + +DVA+K++ G F +E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----------FIEEA 50
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V L H + + G + I + EY+ G L YL
Sbjct: 51 KVMMNLSHEKLVQLYGVCTKQRPIFI----------------ITEYMANGCLLNYLR-EM 93
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR-VEAS 224
R + + ++++ D+ + YL S++ +HRD+ N L++ VK++DFG++R V
Sbjct: 94 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSA 283
G + + PEVL + ++ K D+++FG+ +WEIY MPY + SE
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
Query: 284 VVR 286
+ +
Sbjct: 214 IAQ 216
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-51
Identities = 70/249 (28%), Positives = 115/249 (46%), Gaps = 35/249 (14%)
Query: 47 IEPSKLVIKS-VIARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
++ L ++ + G FGTV +G Y VAVK+L + EA AL+
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------KNEANDPALKDEL 55
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
E V +LD+P + + IG S +V+E G L YL
Sbjct: 56 LAEANVMQQLDNPYIVRMIGICEAES-----------------WMLVMEMAELGPLNKYL 98
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+NR + K +++L ++ G+ YL VHRD+ N+LL KI+DFG+++
Sbjct: 99 QQNRH--VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156
Query: 222 EASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
++ N +T + + APE +N ++ K DV+SFG+ +WE + PY +
Sbjct: 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216
Query: 278 SEVTSAVVR 286
SEVT+ + +
Sbjct: 217 SEVTAMLEK 225
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 1e-50
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 34/248 (13%)
Query: 45 WEIEPSKL-VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAF 101
++ +P KL I G+FG V+ + + VA+K + + +
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM------SYSGKQSNEKWQDI 62
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+EV KL HPN ++ G + + V+EY G A
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWL----------------VMEYCLGSASDLLE 106
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ ++ L + + +GL+YLHS ++HRDVK N+LL + VK+ DFG A +
Sbjct: 107 V--HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 222 EASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
GT +MAPEV+ Y+ K DV+S GI E+ P +++
Sbjct: 165 M----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 279 EVTSAVVR 286
+ +
Sbjct: 221 SALYHIAQ 228
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-50
Identities = 55/244 (22%), Positives = 106/244 (43%), Gaps = 30/244 (12%)
Query: 51 KLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K I +G GTV+ + G +VA++ ++ ++ + E+ V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---------IINEILVM 71
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
+ +PN+ ++ + + EL + V+EYL GG+L + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWV----------------VMEYLAGGSLTDVVTETCMDE 115
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND 228
+ + + + L +LHS +++HRD+K++N+LL + +VK+ DFG +
Sbjct: 116 ---GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQV 288
+ GT +MAPEV+ Y K D++S GI E+ + PY + + +
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 289 QYLL 292
L
Sbjct: 233 TPEL 236
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 3e-49
Identities = 66/243 (27%), Positives = 114/243 (46%), Gaps = 30/243 (12%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEV 105
I+PS+L I G FG VH G + + VA+K + G F +E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----------FIEEA 51
Query: 106 AVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
V KL HP + + G + + + + V E++ G L YL R
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICL----------------VFEFMEHGCLSDYLRTQR 95
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASN 225
A + ++ + LD+ G++YL ++HRD+ N L+ +N+ +K++DFG+ R +
Sbjct: 96 GLFAA-ETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154
Query: 226 PNDMT-GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283
+ G + + +PEV + + Y+ K DV+SFG+ +WE++ +PY + S SEV
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214
Query: 284 VVR 286
+
Sbjct: 215 IST 217
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-49
Identities = 52/248 (20%), Positives = 97/248 (39%), Gaps = 28/248 (11%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
Q + P ++ G+F TV L + A+K+L+ +
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP------Y 54
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
T+E V +LDHP K +L+ + Y G L Y
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYF----------------GLSYAKNGELLKY 98
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ K ++ L YLH + I+HRD+K EN+LL+++ ++I DFG A+
Sbjct: 99 IRKIGS--FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156
Query: 221 VEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
V + GT Y++PE+L + D+++ G ++++ P+ +
Sbjct: 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216
Query: 279 EVTSAVVR 286
+ +++
Sbjct: 217 LIFQKIIK 224
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-49
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 29/239 (12%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I RG+F TV++GL +VA L + + R F +E + L
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCEL-------QDRKLTKSERQRFKEEAEMLKGL 65
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ +F + + + +V E + G LKTYL R + +
Sbjct: 66 QHPNIVRFYDSWESTVK------------GKKCIVLVTELMTSGTLKTYL--KRFKVMKI 111
Query: 172 KVVVQLALDLARGLSYLHSQK--IVHRDVKTENMLL-DKNRTVKIADFGVARVEASNPND 228
KV+ + +GL +LH++ I+HRD+K +N+ + +VKI D G+A + +
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASF 169
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
GT +MAPE+ Y+ DVY+FG+C+ E+ + PY + + V
Sbjct: 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-49
Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 31/244 (12%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ + G +G V VAVK++D E +E+ + L
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--------IKKEICINKML 60
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+H NV KF G + ++ +EY GG L + + +
Sbjct: 61 NHENVVKFYGHRREGNIQYL----------------FLEYCSGGELFDRIEPDIG--MPE 102
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--M 229
+ L G+ YLH I HRD+K EN+LLD+ +KI+DFG+A V N + +
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
Query: 230 TGETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQV 288
GTL Y+APE+L ++ DV+S GI L + ++P+ S S + ++
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 222
Query: 289 QYLL 292
+ L
Sbjct: 223 KTYL 226
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-48
Identities = 66/250 (26%), Positives = 115/250 (46%), Gaps = 33/250 (13%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALR 98
D+EI+ ++ + I G FG VH+G+Y VA+K ++R
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK--------NCTSDSVR 52
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F QE + DHP++ K IG + N +++E G L+
Sbjct: 53 EKFLQEALTMRQFDHPHIVKLIGV-----------------ITENPVWIIMELCTLGELR 95
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++ ++ R+ L ++ A L+ L+YL S++ VHRD+ N+L+ N VK+ DFG+
Sbjct: 96 SF-LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154
Query: 219 AR-VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCD-MPYPDLS 276
+R +E S + + +MAPE +N + DV+ FG+C+WEI P+ +
Sbjct: 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 277 FSEVTSAVVR 286
++V +
Sbjct: 215 NNDVIGRIEN 224
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (412), Expect = 1e-48
Identities = 54/258 (20%), Positives = 97/258 (37%), Gaps = 35/258 (13%)
Query: 37 FLKKQRQDWEIEPSKL----VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRT 90
+ + Q EI+ + I + G FG VHR G++ A K + E +
Sbjct: 9 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK- 67
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
+E+ L HP + A +E+ + + E
Sbjct: 68 --------ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM----------------IYE 103
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL--DKN 208
++ GG L + K++ V+ + +GL ++H VH D+K EN++ ++
Sbjct: 104 FMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS 162
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
+K+ DFG+ + TGT + APEV G P D++S G+ + +
Sbjct: 163 NELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 269 DMPYPDLSFSEVTSAVVR 286
P+ + E V
Sbjct: 222 LSPFGGENDDETLRNVKS 239
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 3e-48
Identities = 69/282 (24%), Positives = 113/282 (40%), Gaps = 56/282 (19%)
Query: 38 LKKQRQDWEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRT 90
L + E + + I G FG V + VAVK+L
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-------- 52
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
E A +++ F +E A+ + D+PN+ K +G + C++ E
Sbjct: 53 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM----------------CLLFE 96
Query: 151 YLPGGALKTYLIKNRRR----------------------KLAFKVVVQLALDLARGLSYL 188
Y+ G L +L L+ + +A +A G++YL
Sbjct: 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156
Query: 189 HSQKIVHRDVKTENMLLDKNRTVKIADFGVARV--EASNPNDMTGETGTLGYMAPEVLNG 246
+K VHRD+ T N L+ +N VKIADFG++R A + + +M PE +
Sbjct: 157 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216
Query: 247 NPYNRKCDVYSFGICLWEIYCCDM-PYPDLSFSEVTSAVVRQ 287
N Y + DV+++G+ LWEI+ + PY ++ EV V
Sbjct: 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (409), Expect = 5e-48
Identities = 52/237 (21%), Positives = 93/237 (39%), Gaps = 31/237 (13%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G FG VHR + G K ++ + E+++ ++L
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---------VKNEISIMNQL 83
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP + A E+ + ++E+L GG L I K++
Sbjct: 84 HHPKLINLHDAFEDKYEMVL----------------ILEFLSGGELFDR-IAAEDYKMSE 126
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR--TVKIADFGVARVEASNPNDM 229
V+ GL ++H IVH D+K EN++ + + +VKI DFG+A + +
Sbjct: 127 AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIV 185
Query: 230 TGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
T T + APE+++ P D+++ G+ + + P+ E V R
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-47
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 33/250 (13%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRTEAEIAALRSAF 101
I L + + G+FG V RG +D VAVK L + F
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD------DF 58
Query: 102 TQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL 161
+EV H LDH N+ + G + + +V E P G+L L
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVL-----------------TPPMKMVTELAPLGSLLDRL 101
Query: 162 IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV 221
K++ + + A+ +A G+ YL S++ +HRD+ N+LL VKI DFG+ R
Sbjct: 102 RKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160
Query: 222 EASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
N + + + APE L ++ D + FG+ LWE++ P+ L+
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 278 SEVTSAVVRQ 287
S++ + ++
Sbjct: 221 SQILHKIDKE 230
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 4e-47
Identities = 56/243 (23%), Positives = 102/243 (41%), Gaps = 28/243 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
K ++ RG V R + AVK++D G + E+ LR A +EV + K+
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 112 -DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
HPN+ + ++ + V + + G L YL + L+
Sbjct: 67 SGHPNIIQLKDTYETNTFFFL----------------VFDLMKKGELFDYL--TEKVTLS 108
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
K ++ L + LH IVHRD+K EN+LLD + +K+ DFG + + +
Sbjct: 109 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLR 167
Query: 231 GETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
GT Y+APE++ + Y ++ D++S G+ ++ + P+ + +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 285 VRQ 287
+
Sbjct: 228 MSG 230
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 5e-47
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 36/254 (14%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALR 98
EI+ S + I+ VI G FG V G VA+K L R
Sbjct: 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK--------SGYTEKQR 71
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E ++ + DHPNV G S+ + I + E++ G+L
Sbjct: 72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI----------------ITEFMENGSLD 115
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++L +N + +V + +A G+ YL VHRD+ N+L++ N K++DFG+
Sbjct: 116 SFLRQNDGQF-TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 219 ARVEASNPNDMT-----GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPY 272
+R + +D T G + + APE + + DV+S+GI +WE+ + PY
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 273 PDLSFSEVTSAVVR 286
D++ +V +A+ +
Sbjct: 235 WDMTNQDVINAIEQ 248
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 5e-47
Identities = 78/261 (29%), Positives = 120/261 (45%), Gaps = 36/261 (13%)
Query: 38 LKKQRQDWEIEPSKLVI--KSVIARGTFGTVHRGLYDGHD-----VAVKLLDWGEEGHRT 90
L + Q I PS L++ VI RG FG V+ G +D AVK L+
Sbjct: 13 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------- 64
Query: 91 EAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVE 150
S F E + HPNV +G + VV+
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL---------------RSEGSPLVVLP 109
Query: 151 YLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRT 210
Y+ G L+ + I+N K ++ L +A+G+ +L S+K VHRD+ N +LD+ T
Sbjct: 110 YMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 168
Query: 211 VKIADFGVARV----EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
VK+ADFG+AR E + ++ TG + +MA E L + K DV+SFG+ LWE+
Sbjct: 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 228
Query: 267 C-CDMPYPDLSFSEVTSAVVR 286
PYPD++ ++T +++
Sbjct: 229 TRGAPPYPDVNTFDITVYLLQ 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-47
Identities = 52/242 (21%), Positives = 95/242 (39%), Gaps = 31/242 (12%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
V V+ G G V + A+K+L + + E+ A
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRA---------- 61
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
P++ + + +V+E L GG L + + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGR------------KCLLIVMECLDGGELFSRIQDRGDQAFT 109
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK---NRTVKIADFGVARVEASNPN 227
+ ++ + + YLHS I HRDVK EN+L N +K+ DFG A+ S+ +
Sbjct: 110 EREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
T T Y+APEVL Y++ CD++S G+ ++ + C P+ ++ + +
Sbjct: 170 LTTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 288 VQ 289
++
Sbjct: 229 IR 230
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 7e-47
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 42/261 (16%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAA 96
+WE+ K+ + + +G+FG V+ G+ VA+K ++ EA
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--------EAASMR 65
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R F E +V + + +V + +G + ++E + G
Sbjct: 66 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV----------------IMELMTRGD 109
Query: 157 LKTYLIKNRRR--------KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
LK+YL R + ++Q+A ++A G++YL++ K VHRD+ N ++ ++
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169
Query: 209 RTVKIADFGVARV--EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIY 266
TVKI DFG+ R E + +M+PE L + DV+SFG+ LWEI
Sbjct: 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 267 CC-DMPYPDLSFSEVTSAVVR 286
+ PY LS +V V+
Sbjct: 230 TLAEQPYQGLSNEQVLRFVME 250
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 7e-47
Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 25/230 (10%)
Query: 53 VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
++ ++ +G+FG V + A+K L + E ++ +
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-----CTMVEKRVLSLA 59
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+HP +T L E YL GG L ++ K
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVME----------------YLNGGDLMYHI--QSCHKFD 101
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
A ++ GL +LHS+ IV+RD+K +N+LLDK+ +KIADFG+ +
Sbjct: 102 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161
Query: 231 GETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
GT Y+APE+L G YN D +SFG+ L+E+ P+ E+
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 1e-46
Identities = 63/248 (25%), Positives = 104/248 (41%), Gaps = 29/248 (11%)
Query: 49 PSKL----VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFT 102
PS L + ++ G VH L DVAVK+L A + F
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL------RADLARDPSFYLRFR 55
Query: 103 QEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
+E L+HP + + + +V+EY+ G L+ +
Sbjct: 56 REAQNAAALNHPAIVAVYDTGEAETPAG------------PLPYIVMEYVDGVTLRDIV- 102
Query: 163 KNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVE 222
+ + K +++ D + L++ H I+HRDVK N+++ VK+ DFG+AR
Sbjct: 103 -HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161
Query: 223 ASNPNDMTGET---GTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
A + N +T GT Y++PE G+ + + DVYS G L+E+ + P+ S
Sbjct: 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 280 VTSAVVRQ 287
V VR+
Sbjct: 222 VAYQHVRE 229
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-46
Identities = 72/241 (29%), Positives = 107/241 (44%), Gaps = 45/241 (18%)
Query: 51 KLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGH-RTEAEIAALRSAFTQEVAVWH 109
+V++ I +G FG V RG + G +VAVK+ EE EAEI
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTV----------- 52
Query: 110 KLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKL 169
L H N+ FI A + Q +V +Y G+L YL R +
Sbjct: 53 MLRHENILGFIAADNKDNGTWTQ------------LWLVSDYHEHGSLFDYL---NRYTV 97
Query: 170 AFKVVVQLALDLARGLSYLHSQ--------KIVHRDVKTENMLLDKNRTVKIADFGVARV 221
+ +++LAL A GL++LH + I HRD+K++N+L+ KN T IAD G+A
Sbjct: 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 222 EASNPNDM----TGETGTLGYMAPEVLNGN------PYNRKCDVYSFGICLWEIYCCDMP 271
S + + GT YMAPEVL+ + ++ D+Y+ G+ WEI
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
Query: 272 Y 272
Sbjct: 218 G 218
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-45
Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 35/255 (13%)
Query: 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALR 98
EI PS + + VI G FG V++G+ VA+K L R
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--------AGYTEKQR 53
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
F E + + H N+ + G + I + EY+ G
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI----------------ITEYMENG-AL 96
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
++ + + + +V + +A G+ YL + VHRD+ N+L++ N K++DFG+
Sbjct: 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156
Query: 219 ARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYP-D 274
+RV +P +G + + APE ++ + DV+SFGI +WE+ +
Sbjct: 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216
Query: 275 LSFSEVTSAVVRQVQ 289
LS EV A+ +
Sbjct: 217 LSNHEVMKAINDGFR 231
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 66/259 (25%), Positives = 112/259 (43%), Gaps = 41/259 (15%)
Query: 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQ 103
++ + + + VI G FG V + DG + + E + + F
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR------DFAG 59
Query: 104 EVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLI 162
E+ V KL HPN+ +GA L++ +EY P G L +L
Sbjct: 60 ELEVLCKLGHHPNIINLLGACEHRGYLYL----------------AIEYAPHGNLLDFLR 103
Query: 163 KN--------------RRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208
K+ L+ + ++ A D+ARG+ YL ++ +HRD+ N+L+ +N
Sbjct: 104 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163
Query: 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC 268
KIADFG++R + G + +MA E LN + Y DV+S+G+ LWEI
Sbjct: 164 YVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222
Query: 269 DM-PYPDLSFSEVTSAVVR 286
PY ++ +E+ + +
Sbjct: 223 GGTPYCGMTCAELYEKLPQ 241
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 5e-45
Identities = 65/272 (23%), Positives = 107/272 (39%), Gaps = 51/272 (18%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIA 95
WE ++L + G FG V VAVK+L H TE
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTE---- 69
Query: 96 ALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPG 154
R A E+ V L +H N+ +GA + + EY
Sbjct: 70 --REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV----------------ITEYCCY 111
Query: 155 GALKTYLIKNR----------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198
G L +L + R L + ++ + +A+G+++L S+ +HRD+
Sbjct: 112 GDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171
Query: 199 KTENMLLDKNRTVKIADFGVARVEASNPNDM--TGETGTLGYMAPEVLNGNPYNRKCDVY 256
N+LL R KI DFG+AR ++ N + + +MAPE + Y + DV+
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 257 SFGICLWEIYCCDMP-YPDLSFSEVTSAVVRQ 287
S+GI LWE++ YP + ++++
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 8e-45
Identities = 45/241 (18%), Positives = 89/241 (36%), Gaps = 32/241 (13%)
Query: 51 KLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
K +I + RG FG VHR K + +E+++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----------LVKKEISIL 55
Query: 109 HKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRK 168
+ H N+ + EL + + E++ G + I +
Sbjct: 56 NIARHRNILHLHESFESMEELVM----------------IFEFISGLDIFER-INTSAFE 98
Query: 169 LAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD--KNRTVKIADFGVARVEASNP 226
L + +V + L +LHS I H D++ EN++ ++ T+KI +FG AR +
Sbjct: 99 LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPG 157
Query: 227 NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
++ Y APEV + + D++S G ++ + P+ + ++ ++
Sbjct: 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 287 Q 287
Sbjct: 218 A 218
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-44
Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 51/270 (18%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDGHD---------VAVKLLDWGEEGHRTEAEI 94
WE+ +LV+ + G FG V G D VAVK+L
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--------SDAT 58
Query: 95 AALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLP 153
S E+ + + H N+ +GA L++ +VEY
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV----------------IVEYAS 102
Query: 154 GGALKTYL--------------IKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199
G L+ YL N +L+ K +V A +ARG+ YL S+K +HRD+
Sbjct: 103 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162
Query: 200 TENMLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYS 257
N+L+ ++ +KIADFG+AR + +MAPE L Y + DV+S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 258 FGICLWEIYCC-DMPYPDLSFSEVTSAVVR 286
FG+ LWEI+ PYP + E+ +
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 1e-44
Identities = 55/239 (23%), Positives = 106/239 (44%), Gaps = 32/239 (13%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ V+ G F V VA+K + + + + E+AV HK+
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--------KKALEGKEGSMENEIAVLHKI 64
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPN+ L++ +++ + GG L +++
Sbjct: 65 KHPNIVALDDIYESGGHLYL----------------IMQLVSGGELFDRIVEKGF--YTE 106
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL---DKNRTVKIADFGVARVEASNPND 228
+ +L + + YLH IVHRD+K EN+L D++ + I+DFG++++E +
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SV 165
Query: 229 MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
++ GT GY+APEVL PY++ D +S G+ + + C P+ D + +++ +++
Sbjct: 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-44
Identities = 71/268 (26%), Positives = 112/268 (41%), Gaps = 46/268 (17%)
Query: 44 DWEIEPSKLVIKSVIARGTFGTVHRG-------LYDGHDVAVKLLDWGEEGHRTEAEIAA 96
WE +L + + RG FG V VAVK+L + A +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------KEGATHSE 59
Query: 97 LRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGA 156
R+ ++ + H H NV +GA P V+VE+ G
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGA---------------CTKPGGPLMVIVEFCKFGN 104
Query: 157 LKTYLIKNR--------------RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202
L TYL R + L + ++ + +A+G+ +L S+K +HRD+ N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164
Query: 203 MLLDKNRTVKIADFGVARVEASNPNDMTGET--GTLGYMAPEVLNGNPYNRKCDVYSFGI 260
+LL + VKI DFG+AR +P+ + L +MAPE + Y + DV+SFG+
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 261 CLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287
LWEI+ PYP + E +++
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCRRLKE 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 1e-43
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 29/236 (12%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I + G+FG VH ++G A+K+L + E + +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVL------KKEIVVRLKQVEHTNDERLMLSIV 61
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP + + G + ++ ++++Y+ GG L + L K++R
Sbjct: 62 THPFIIRMWGTFQDAQQI----------------FMIMDYIEGGELFSLLRKSQRFP--N 103
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
V A ++ L YLHS+ I++RD+K EN+LLDKN +KI DFG A+ P+
Sbjct: 104 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYT 160
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
GT Y+APEV++ PYN+ D +SFGI ++E+ P+ D + + ++
Sbjct: 161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (371), Expect = 2e-42
Identities = 56/230 (24%), Positives = 98/230 (42%), Gaps = 26/230 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ +I RG FG V+ G A+K LD + + E AL +++
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALN--ERIMLSLVSTG 64
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
D P + A +L +++ + GG L +L ++
Sbjct: 65 DCPFIVCMSYAFHTPDKLSF----------------ILDLMNGGDLHYHLSQHGVFSE-- 106
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ A ++ GL ++H++ +V+RD+K N+LLD++ V+I+D G+A +
Sbjct: 107 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHA 164
Query: 232 ETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
GT GYMAPEVL G Y+ D +S G L+++ P+ +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-42
Identities = 50/239 (20%), Positives = 94/239 (39%), Gaps = 28/239 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ G F V + G A K + + + R +EV++ ++
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIK---KRRTKSSRRGVSREDIEREVSILKEI 70
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HPNV +++ + ++E + GG L + + L
Sbjct: 71 QHPNVITLHEVYENKTDVIL----------------ILELVAGGELFDF--LAEKESLTE 112
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN----RTVKIADFGVARVEASNPN 227
+ + + G+ YLHS +I H D+K EN++L +KI DFG+A + N
Sbjct: 113 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGN 171
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
+ GT ++APE++N P + D++S G+ + + P+ + E + V
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-42
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 25/233 (10%)
Query: 57 VIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
+ G F TV++ VA+K + GHR+EA+ R+ +E+ + +L HP
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRT-ALREIKLLQELSHP 60
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVV 174
N+ + A S + + V +++ +IK+ L +
Sbjct: 61 NIIGLLDAFGHKSNISL----------------VFDFMETDLE--VIIKDNSLVLTPSHI 102
Query: 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETG 234
L +GL YLH I+HRD+K N+LLD+N +K+ADFG+A+ S T +
Sbjct: 103 KAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162
Query: 235 TLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
T Y APE+L G Y D+++ G L E+ P S + + +
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 55/250 (22%), Positives = 100/250 (40%), Gaps = 30/250 (12%)
Query: 43 QDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSA 100
Q +++ P + S I G +G V + VA+K + E
Sbjct: 2 QVFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--------PFEHQTYCQR 52
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
+E+ + + H N+ + ++ +V +L G L
Sbjct: 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMK------------DVYLVTHLMGADLYKL 100
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
L + + L+ + + RGL Y+HS ++HRD+K N+LL+ +KI DFG+AR
Sbjct: 101 L---KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157
Query: 221 VEASNPNDMTGET---GTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLS 276
V + + T T Y APE++ N Y + D++S G L E+ +P
Sbjct: 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217
Query: 277 FSEVTSAVVR 286
+ + + ++
Sbjct: 218 YLDQLNHILG 227
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-41
Identities = 58/249 (23%), Positives = 116/249 (46%), Gaps = 35/249 (14%)
Query: 47 IEPSKLVIKSVIARGTFGTVHRGLYDGHD------VAVKLLDWGEEGHRTEAEIAALRSA 100
++ ++ V+ G FGTV++GL+ VA+K L EA
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--------EATSPKANKE 57
Query: 101 FTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTY 160
E V +D+P+V + +G + S+ ++ + +P G L Y
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTV-----------------QLITQLMPFGCLLDY 100
Query: 161 LIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVAR 220
+ +++ + ++ + +A+G++YL +++VHRD+ N+L+ + VKI DFG+A+
Sbjct: 101 VREHKDNI-GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159
Query: 221 VEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277
+ + + G + +MA E + Y + DV+S+G+ +WE+ PY +
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219
Query: 278 SEVTSAVVR 286
SE++S + +
Sbjct: 220 SEISSILEK 228
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-41
Identities = 49/231 (21%), Positives = 93/231 (40%), Gaps = 28/231 (12%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
S+ + ++ G FG+V+ G+ D VA+K ++ + ++ + EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVL 60
Query: 108 WHKLD--HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR 165
K+ V + + + +++E I
Sbjct: 61 LKKVSSGFSGVIRLLD----------------WFERPDSFVLILERPEPVQDLFDFIT-E 103
Query: 166 RRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNR-TVKIADFGVARVEAS 224
R L ++ + + + H+ ++HRD+K EN+L+D NR +K+ DFG +
Sbjct: 104 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--L 161
Query: 225 NPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPD 274
T GT Y PE + + Y R V+S GI L+++ C D+P+
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-41
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 27/236 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I GT+G V++ G VA+K + R + E + S +E+++ +L
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKEL 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+HPN+ K + ++L++ V LK ++ + +
Sbjct: 59 NHPNIVKLLDVIHTENKLYL-----------------VFEFLHQDLKKFMDASALTGIPL 101
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
++ L +GL++ HS +++HRD+K +N+L++ +K+ADFG+AR T
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 232 ETGTLGYMAPEVLNGNPYN-RKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
E TL Y APE+L G Y D++S G E+ +P S + + R
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-41
Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 26/236 (11%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
++ +GTFG V G A+K+L + E E V
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA------HTVTESRVLQNT 62
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
HP +T A L E Y GG L +L +R R
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVME----------------YANGGELFFHL--SRERVFTE 104
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
+ ++ L YLHS+ +V+RD+K EN++LDK+ +KI DFG+ + S+ M
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
GT Y+APEVL N Y R D + G+ ++E+ C +P+ + + ++ +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 57/244 (23%), Positives = 97/244 (39%), Gaps = 24/244 (9%)
Query: 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
SK + I +GTFG V + + G VA+K + E E +E+ +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-------LMENEKEGFPITALREIKI 62
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L H NV I + + + + +V ++ N
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGS--------IYLVFDFCEHDLAGLLS--NVLV 112
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARV----EA 223
K + ++ L GL Y+H KI+HRD+K N+L+ ++ +K+ADFG+AR +
Sbjct: 113 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172
Query: 224 SNPNDMTGETGTLGYMAPEVL-NGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282
S PN T TL Y PE+L Y D++ G + E++ + +
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
Query: 283 AVVR 286
+ +
Sbjct: 233 LISQ 236
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-40
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 26/241 (10%)
Query: 54 IKSVIARGTFGTVHRG---LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK 110
+ I G +G V + G VA+K + R + + + +EVAV
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRH 63
Query: 111 L---DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
L +HPNV + S +V E++ TYL K
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRE-----------TKLTLVFEHVDQDLT-TYLDKVPEP 111
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+ + + + L RGL +LHS ++VHRD+K +N+L+ + +K+ADFG+AR+ S
Sbjct: 112 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQM 170
Query: 228 DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287
+T TL Y APEVL + Y D++S G E++ + S + ++
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 288 V 288
+
Sbjct: 231 I 231
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 4e-39
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 27/235 (11%)
Query: 54 IKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD 112
I GT+G V++ G A+K + R E E + S +E+++ +L
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELK 58
Query: 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFK 172
H N+ K L +V E+L L+ L
Sbjct: 59 HSNIVKLYDVIHTKKRL----------------VLVFEHLDQDLK--KLLDVCEGGLESV 100
Query: 173 VVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGE 232
L L G++Y H ++++HRD+K +N+L+++ +KIADFG+AR T E
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 233 TGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
TL Y AP+VL G+ Y+ D++S G E+ +P +S ++ + R
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 3e-38
Identities = 52/249 (20%), Positives = 86/249 (34%), Gaps = 40/249 (16%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G+FG ++ G + G +VA+KL + + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYK-----------MM 59
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
I + ++ +V+E L L RK +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNV---------------MVMELLGPSLE--DLFNFCSRKFSL 102
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENML---LDKNRTVKIADFGVARVEASNPND 228
K V+ LA + + Y+HS+ +HRDVK +N L K V I DFG+A+
Sbjct: 103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 229 -------MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281
TGT Y + G +R+ D+ S G L +P+ L +
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 282 SAVVRQVQY 290
R +
Sbjct: 223 QKYERISEK 231
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-38
Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 27/234 (11%)
Query: 57 VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHP 114
VI G+FG V++ G VA+K + + +E+ + KLDH
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------------FKNRELQIMRKLDHC 73
Query: 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYL-IKNRRRKLAFKV 173
N+ + S E +V++Y+P + ++ L
Sbjct: 74 NIVRLRYFFYSSGEK----------KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN-RTVKIADFGVARVEASNPNDMTGE 232
V L R L+Y+HS I HRD+K +N+LLD + +K+ DFG A+ +++
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 233 TGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286
+ Y DV+S G L E+ +P S + +++
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (329), Expect = 5e-37
Identities = 41/247 (16%), Positives = 81/247 (32%), Gaps = 42/247 (17%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
+ I G+FG + G L + VA+K + + E + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEY--------RTYKLLAGC 60
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+ G +V++ L G L+ RK +
Sbjct: 61 TGIPNVYYFGQE------------------GLHNVLVIDLL--GPSLEDLLDLCGRKFSV 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK-----NRTVKIADFGVARV----- 221
K V A + + +H + +V+RD+K +N L+ + + + DFG+ +
Sbjct: 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 222 --EASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279
+ + +GT YM+ G +R+ D+ + G +P+ L +
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 280 VTSAVVR 286
R
Sbjct: 221 NKQKYER 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 6e-37
Identities = 56/273 (20%), Positives = 107/273 (39%), Gaps = 43/273 (15%)
Query: 24 ANATATPIGKASN----FLKKQRQD----WEIEPSKLV------IKSVIARGTFGTVHRG 69
NA A G FL K ++D WE + G+FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 70 LY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127
+ G+ A+K+LD + + E E + ++ P + K +
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIE------HTLNEKRILQAVNFPFLVKLEFSFK--- 111
Query: 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSY 187
++ +V+EY+ GG + ++L R + + A + Y
Sbjct: 112 -------------DNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN 247
LHS +++RD+K EN+L+D+ +++ DFG A+ + G +APE++
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILSK 213
Query: 248 PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
YN+ D ++ G+ ++E+ P+ ++
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-37
Identities = 55/249 (22%), Positives = 101/249 (40%), Gaps = 28/249 (11%)
Query: 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALR 98
+ WE+ + + G +G V G VA+K L +
Sbjct: 10 TKTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFA 61
Query: 99 SAFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALK 158
+E+ + + H NV + L T+ +V+ ++ G
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD----------FYLVMPFM--GTDL 109
Query: 159 TYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGV 218
L+K+ + L + L + +GL Y+H+ I+HRD+K N+ ++++ +KI DFG+
Sbjct: 110 GKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167
Query: 219 ARVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277
AR ++MTG T Y APEV LN Y + D++S G + E+ +
Sbjct: 168 AR---QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 278 SEVTSAVVR 286
+ +++
Sbjct: 225 LDQLKEIMK 233
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 4e-34
Identities = 53/237 (22%), Positives = 96/237 (40%), Gaps = 29/237 (12%)
Query: 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I GT+GTV + VA+K + R + + + S+ +E+ + +L
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKEL 58
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
H N+ + +L + E + L
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS------------------CNGDLDP 100
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
++V L +GL + HS+ ++HRD+K +N+L+++N +K+A+FG+AR +
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 232 ETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVVR 286
E TL Y P+VL G Y+ D++S G E+ P +P + + R
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-34
Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 28/248 (11%)
Query: 42 RQDWEIEPSKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRS 99
+ WE+ P + S + G +G+V G VAVK L +
Sbjct: 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-------SRPFQSIIHAK 62
Query: 100 AFTQEVAVWHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKT 159
+E+ + + H NV + + L +V +L G L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN-----------DVYLVTHLMGADLNN 111
Query: 160 YLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVA 219
+ +KL V L + RGL Y+HS I+HRD+K N+ ++++ +KI DFG+A
Sbjct: 112 I---VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 220 RVEASNPNDMTGETGTLGYMAPEV-LNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFS 278
R ++MTG T Y APE+ LN YN+ D++S G + E+ +P
Sbjct: 169 R---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 279 EVTSAVVR 286
+ ++R
Sbjct: 226 DQLKLILR 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (304), Expect = 6e-33
Identities = 43/247 (17%), Positives = 86/247 (34%), Gaps = 45/247 (18%)
Query: 39 KKQRQDWEIEPSKL--------VIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGH 88
+ R+ W+ E + + + RG + V + + V VK+L
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------ 69
Query: 89 RTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCV 147
+ +E+ + L PN+ +
Sbjct: 70 ------PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP--------------AL 109
Query: 148 VVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206
V E++ K + L + ++ + L Y HS I+HRDVK N+++D
Sbjct: 110 VFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 164
Query: 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEI 265
++R +++ D+G+A + + + PE+L Y+ D++S G L +
Sbjct: 165 EHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223
Query: 266 YCCDMPY 272
P+
Sbjct: 224 IFRKEPF 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-31
Identities = 54/244 (22%), Positives = 103/244 (42%), Gaps = 32/244 (13%)
Query: 54 IKSVIARGTFGTVHRGL-----YDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW 108
+ V+ G +G V G A+K+L T + A E V
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-----KATIVQKAKTTEHTRTERQVL 82
Query: 109 HKLDH-PNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+ P + A ++LH+ ++Y+ GG L T+L ++R
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLI----------------LDYINGGELFTHL--SQRE 124
Query: 168 KLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN 227
+ V ++ L +LH I++RD+K EN+LLD N V + DFG+++ ++
Sbjct: 125 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 228 DMT-GETGTLGYMAPEVLNGNP--YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284
+ GT+ YMAP+++ G +++ D +S G+ ++E+ P+ + +
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
Query: 285 VRQV 288
R++
Sbjct: 245 SRRI 248
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 25/237 (10%)
Query: 54 IKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL 111
I G G V +VA+K L + +E+ + +
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCV 73
Query: 112 DHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAF 171
+H N+ + L + +V+E + + ++ ++++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQD----------VYLVMELMDANLCQVIQMELDHERMSY 123
Query: 172 KVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTG 231
L + G+ +LHS I+HRD+K N+++ + T+KI DFG+AR MT
Sbjct: 124 -----LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTP 177
Query: 232 ETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQV 288
T Y APEV+ G Y D++S G + E+ + +P + + + V+ Q+
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 1e-28
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 24/242 (9%)
Query: 50 SKLVIKSVIARGTFGTVHRG--LYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAV 107
++ ++ + G F TV + + VA+K++ + A E+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKL 62
Query: 108 WHKLDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRR 167
+++ + TK MG++ + ++ P+ + V+V + G L + K R
Sbjct: 63 LQRVNDADNTKEDS--MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 168 KLAFKVVVQLALDLARGLSYLH-SQKIVHRDVKTENMLLDKNRT------VKIADFGVAR 220
+ V Q++ L GL Y+H I+H D+K EN+L++ + +KIAD G A
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 221 VEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280
+ + T Y +PEVL G P+ D++S ++E+ D +
Sbjct: 181 WYDEHYTNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 281 TS 282
T
Sbjct: 238 TK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 6e-19
Identities = 28/212 (13%), Positives = 59/212 (27%), Gaps = 37/212 (17%)
Query: 53 VIKSVIARGTFGTVHRG-LYDGHDVAVKLLDWGEEGHRTEAEIAALRSA-FTQEVAVWHK 110
I ++ G V + VK G + E F+ +
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 111 LDHPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLA 170
+ + K G + V + L + ++
Sbjct: 63 NEFRALQKLQGL--------------------AVPKVY-AWEGNAVLMELIDAKELYRVR 101
Query: 171 FKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMT 230
+ ++ + ++ + + IVH D+ N+L+ + + I DF + VE
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS-VEVGEEGWRE 159
Query: 231 GETGTLGYMAPEVLN-----GNPYNRKCDVYS 257
+ +V N Y + D+ S
Sbjct: 160 -------ILERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 292 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.12 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=343.20 Aligned_cols=210 Identities=26% Similarity=0.466 Sum_probs=187.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||||+++...... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---------KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---------HHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 5799999999999999999975 59999999987543221 234788999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. |+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 91 ~~----------------~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 91 EL----------------WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp EE----------------EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EE----------------EEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 65 899999999999998743 46999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++++||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.++
T Consensus 152 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 231 (293)
T d1yhwa1 152 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (293)
T ss_dssp TCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred CCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 99999999999987665555556678999999999999999999999999999999999999999999988888777665
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=338.03 Aligned_cols=213 Identities=29% Similarity=0.470 Sum_probs=186.5
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++.+.||+|+||+||+|.+ +|+.||+|++... ..........+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA------QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchH------HccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 6899999999999999999976 5889999998522 1112223456889999999999999999999998776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++|++||||||+|||++.
T Consensus 80 ~~----------------~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~ 141 (263)
T d2j4za1 80 RV----------------YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS 141 (263)
T ss_dssp EE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred EE----------------EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC
Confidence 65 8999999999999999643 56999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.++.+.
T Consensus 142 ~~~~kl~DFG~a~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 142 AGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219 (263)
T ss_dssp TSCEEECCCCSCSCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred CCCEeecccceeeecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 999999999999754432 234467999999999999999999999999999999999999999999999999888765
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 220 ~ 220 (263)
T d2j4za1 220 E 220 (263)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=339.45 Aligned_cols=218 Identities=28% Similarity=0.491 Sum_probs=176.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||+|+++..... .. ..+.+.+|+.++++++||||+++++++.+..
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EA----EKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HH----HHHHHHHHHHHTTSCCCTTBCCEEEEEEC--
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HH----HHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC
Confidence 6899999999999999999976 5889999998654321 11 2345789999999999999999999987543
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--cccccCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--RRRKLAFKVVVQLALDLARGLSYLHSQK-----IVHRDVKT 200 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~-----i~h~di~p 200 (292)
.. .+|++|||+++|+|.+++.+. ....+++..++.++.|++.||.|||+.| |+||||||
T Consensus 77 ~~--------------~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp 142 (269)
T d2java1 77 NT--------------TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 142 (269)
T ss_dssp ----------------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCG
T ss_pred CC--------------EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCch
Confidence 22 238999999999999998653 3457999999999999999999999876 99999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+|||++.++.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++
T Consensus 143 ~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~ 222 (269)
T d2java1 143 ANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222 (269)
T ss_dssp GGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred hhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH
Confidence 99999999999999999998765444444557799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhh
Q 022794 281 TSAVVRQV 288 (292)
Q Consensus 281 ~~~i~~~~ 288 (292)
..+|.++.
T Consensus 223 ~~~i~~~~ 230 (269)
T d2java1 223 AGKIREGK 230 (269)
T ss_dssp HHHHHHTC
T ss_pred HHHHHcCC
Confidence 99887764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=340.59 Aligned_cols=216 Identities=23% Similarity=0.385 Sum_probs=185.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
+++|++++.||+|+||+||+|.+ +|+.||||+++... .......+.+.+|+.++++++||||+++++++.+.
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH------IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH------ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 36899999999999999999976 58899999985321 11112235588999999999999999999999877
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ |+||||+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 81 ~~~----------------~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 81 EKL----------------YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp SEE----------------EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CEE----------------EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 665 8999999999999988643 5699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
+++.++|+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++.+|
T Consensus 143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i 222 (288)
T d1uu3a_ 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI 222 (288)
T ss_dssp TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH
Confidence 99999999999998654322 2233457999999999999999999999999999999999999999999999999998
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 223 ~~~~ 226 (288)
T d1uu3a_ 223 IKLE 226 (288)
T ss_dssp HTTC
T ss_pred HcCC
Confidence 8763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=342.60 Aligned_cols=216 Identities=29% Similarity=0.447 Sum_probs=189.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+++.||+|+||.||+|.+ +|+.||||+++... .........+.+|+.++++++||||+++++++.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~------~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV------IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhh------ccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence 36899999999999999999975 68999999986321 11111234578899999999999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ |+||||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 78 ~~~----------------~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~ 139 (337)
T d1o6la_ 78 DRL----------------CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp SEE----------------EEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred ccc----------------ccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec
Confidence 766 899999999999999865 35699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.+|.++|+|||+++.............||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..++.+.+.+
T Consensus 140 ~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~ 219 (337)
T d1o6la_ 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc
Confidence 99999999999998665544555567899999999999999999999999999999999999999999999999988876
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
+.
T Consensus 220 ~~ 221 (337)
T d1o6la_ 220 EE 221 (337)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-51 Score=337.55 Aligned_cols=212 Identities=29% Similarity=0.458 Sum_probs=183.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
+.|++++.||+|+||.||+|.+ +|+.||+|+++...... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---------LEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---------GGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 4699999999999999999976 58899999987543221 234778999999999999999999998776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. ++||||+++|+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~----------------~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~ 145 (288)
T d2jfla1 83 NL----------------WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL 145 (288)
T ss_dssp EE----------------EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred eE----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC
Confidence 65 8999999999999987653 356999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLN-----GNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++.+||+|||++..............||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+++.
T Consensus 146 ~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~ 225 (288)
T d2jfla1 146 DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225 (288)
T ss_dssp TSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH
T ss_pred CCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 99999999999876543323334467999999999984 4457899999999999999999999999999999988
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
++.++
T Consensus 226 ~i~~~ 230 (288)
T d2jfla1 226 KIAKS 230 (288)
T ss_dssp HHHHS
T ss_pred HHHcC
Confidence 88875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=332.49 Aligned_cols=218 Identities=34% Similarity=0.628 Sum_probs=179.0
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
++|++..++|++.+.||+|+||.||+|+..+ .||||+++........ .+.+.+|+.++++++||||++++++
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ-------LQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH-------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH-------HHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 4688899999999999999999999998765 5999998754433221 3458899999999999999999998
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+... .. +++|||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|
T Consensus 73 ~~~~-~~----------------~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~N 134 (276)
T d1uwha_ 73 STAP-QL----------------AIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN 134 (276)
T ss_dssp ECSS-SC----------------EEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred Eecc-EE----------------EEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHH
Confidence 6543 22 8999999999999999653 3469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGN---PYNRKCDVYSFGICLWEIYCCDMPYPDLSF 277 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~---~~~~~~Diwslg~il~~l~~g~~pf~~~~~ 277 (292)
||++.++.+||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 135 iLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp EEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999997654322 223345789999999998653 478999999999999999999999998776
Q ss_pred HHHHHHHHH
Q 022794 278 SEVTSAVVR 286 (292)
Q Consensus 278 ~~~~~~i~~ 286 (292)
.+.+..++.
T Consensus 215 ~~~~~~~~~ 223 (276)
T d1uwha_ 215 RDQIIFMVG 223 (276)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHh
Confidence 655554443
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=335.02 Aligned_cols=205 Identities=30% Similarity=0.448 Sum_probs=173.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||||+++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--------DCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--------hHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 36899999999999999999976 5889999998643221 1123478899999999999999999999877
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. |+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~~~----------------~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 76 NIQ----------------YLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp TEE----------------EEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cee----------------EEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 655 899999999999999843 45799999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 207 KNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
+++.+||+|||++....... .......||+.|+|||++.+..+ +.++|||||||++|+|++|++||...+...
T Consensus 138 ~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 99999999999998654322 22344679999999999988776 578999999999999999999998655443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-50 Score=332.57 Aligned_cols=220 Identities=29% Similarity=0.570 Sum_probs=188.7
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
-+.|++..++|++.+.||+|+||+||+|.+ +|+.||||+++..... .+.+.+|+.++++++||||+++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~il~~l~HpnIv~~ 78 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----------VEEFLKEAAVMKEIKHPNLVQL 78 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----------HHHHHHHHHHHHhCCCCCEecC
Confidence 356888889999999999999999999976 4889999998643321 2347889999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+.+.. +++|||+++|+|.+++.......+++..++.++.|++.||.|||++||+|||||
T Consensus 79 ~~~~~~~~~~----------------~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlK 142 (287)
T d1opja_ 79 LGVCTREPPF----------------YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 142 (287)
T ss_dssp EEEECSSSSC----------------EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CccEeeCCee----------------EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccc
Confidence 9999877665 899999999999999987667789999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC-DMPYPDLSF 277 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g-~~pf~~~~~ 277 (292)
|+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|++| .+||.+.+.
T Consensus 143 p~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 143 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp GGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH
Confidence 9999999999999999999976543322 22334578899999999999999999999999999999995 556677788
Q ss_pred HHHHHHHHHh
Q 022794 278 SEVTSAVVRQ 287 (292)
Q Consensus 278 ~~~~~~i~~~ 287 (292)
.++.+.+.++
T Consensus 223 ~~~~~~i~~~ 232 (287)
T d1opja_ 223 SQVYELLEKD 232 (287)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHhcC
Confidence 8777766554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.4e-50 Score=334.60 Aligned_cols=212 Identities=29% Similarity=0.468 Sum_probs=186.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++... .......+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI------VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 5799999999999999999976 58999999985321 111122456889999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. |+||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 ~~----------------~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~ 139 (316)
T d1fota_ 78 QI----------------FMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK 139 (316)
T ss_dssp EE----------------EEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT
T ss_pred ee----------------eeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC
Confidence 65 899999999999998854 356889999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.++.++
T Consensus 140 ~g~vkL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 216 (316)
T d1fota_ 140 NGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216 (316)
T ss_dssp TSCEEECCCSSCEECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred CCCEEEecCccceEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC
Confidence 999999999999875533 23467999999999999999999999999999999999999999999999999998876
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 217 ~ 217 (316)
T d1fota_ 217 E 217 (316)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-50 Score=334.62 Aligned_cols=213 Identities=25% Similarity=0.458 Sum_probs=171.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||+||+|.+ +|+.||||++....... ....+.+|+.++++++||||+++++++.+.
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--------KEGSMENEIAVLHKIKHPNIVALDDIYESG 79 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 35799999999999999999976 58899999986433211 123477899999999999999999999877
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. |++|||++||+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||++.
T Consensus 80 ~~~----------------~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~ 141 (307)
T d1a06a_ 80 GHL----------------YLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141 (307)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred CEE----------------EEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeec
Confidence 665 899999999999999964 45799999999999999999999999999999999999994
Q ss_pred ---CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 207 ---KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 207 ---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
+++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...
T Consensus 142 ~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 220 (307)
T d1a06a_ 142 SLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220 (307)
T ss_dssp SSSTTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCceEEEeccceeEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5789999999999755433 233446799999999999999999999999999999999999999999999999988
Q ss_pred HHHhh
Q 022794 284 VVRQV 288 (292)
Q Consensus 284 i~~~~ 288 (292)
+.++.
T Consensus 221 i~~~~ 225 (307)
T d1a06a_ 221 ILKAE 225 (307)
T ss_dssp HHTTC
T ss_pred HhccC
Confidence 88753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=327.25 Aligned_cols=221 Identities=29% Similarity=0.545 Sum_probs=190.5
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
..++|++..++|++.+.||+|+||.||+|.++ ++.||||+++..... .+.+.+|+.++++++||||+++
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~ 73 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----------PDAFLAEANLMKQLQHQRLVRL 73 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----------HHHHHHHHHHHHhCCCCCEeEE
Confidence 45678898899999999999999999999875 578999998643321 2347899999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+. .. ++||||+++|+|.+++.......+++..++.++.||+.||.|||++|++|||||
T Consensus 74 ~g~~~~~-~~----------------~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK 136 (272)
T d1qpca_ 74 YAVVTQE-PI----------------YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136 (272)
T ss_dssp EEEECSS-SC----------------EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EeeeccC-Ce----------------EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc
Confidence 9987543 22 899999999999998866555679999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
|+|||+++++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|+| |.+||...+.
T Consensus 137 p~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~ 216 (272)
T d1qpca_ 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (272)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999987654322 2334568899999999998889999999999999999999 5778888899
Q ss_pred HHHHHHHHHhh
Q 022794 278 SEVTSAVVRQV 288 (292)
Q Consensus 278 ~~~~~~i~~~~ 288 (292)
.++...+.++.
T Consensus 217 ~~~~~~i~~~~ 227 (272)
T d1qpca_ 217 PEVIQNLERGY 227 (272)
T ss_dssp HHHHHHHHTTC
T ss_pred HHHHHHHHhcC
Confidence 99888887763
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-48 Score=321.46 Aligned_cols=221 Identities=25% Similarity=0.409 Sum_probs=195.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 125 (292)
.++|++.+.||+|+||+||+|++ +|+.||||+++................+.+.+|+.+++++. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999976 68999999998766655566666777788999999999996 9999999999988
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. |++|||+++|+|.+++..+ ..+++..++.++.||+.||+|||++|++||||||+||++
T Consensus 82 ~~~~----------------~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill 143 (277)
T d1phka_ 82 NTFF----------------FLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL 143 (277)
T ss_dssp SSEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred Ccce----------------EEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE
Confidence 7766 8999999999999999653 469999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG------NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSE 279 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~ 279 (292)
+.++.+||+|||.++...... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp CTTCCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCCCCeEEccchheeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 999999999999998765433 3445779999999999853 346889999999999999999999999999999
Q ss_pred HHHHHHHhh
Q 022794 280 VTSAVVRQV 288 (292)
Q Consensus 280 ~~~~i~~~~ 288 (292)
+...+.++.
T Consensus 223 ~~~~i~~~~ 231 (277)
T d1phka_ 223 MLRMIMSGN 231 (277)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHhCC
Confidence 998888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=338.73 Aligned_cols=207 Identities=29% Similarity=0.499 Sum_probs=178.0
Q ss_pred eecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT 123 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 123 (292)
++..++|++++.||+|+||+||+|.+ +|+.||+|+++..... .....+.+|+.++++++||||++++++|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--------AIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--------THHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34567999999999999999999976 5899999998754321 1134578899999999999999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCC
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKIVHRDVKTEN 202 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~h~di~p~N 202 (292)
.+.+.+ ++||||+++|+|.+++.+. ..+++..++.++.|++.||.|||+ +||+||||||+|
T Consensus 74 ~~~~~~----------------~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N 135 (322)
T d1s9ja_ 74 YSDGEI----------------SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135 (322)
T ss_dssp ECSSEE----------------EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred EECCEE----------------EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence 887665 8999999999999999653 469999999999999999999997 599999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
||++.++.+||+|||+|...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+.
T Consensus 136 ILl~~~~~vkl~DFGla~~~~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 136 ILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred eeECCCCCEEEeeCCCccccCCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99999999999999999754322 23346899999999999999999999999999999999999999987665543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=321.09 Aligned_cols=215 Identities=32% Similarity=0.632 Sum_probs=177.2
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
+.+++|++++.||+|+||.||+|.+ +++.||||+++..... .+.+.+|+.++++++||||+++++++..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----------HHHHHHHHHHHHhcCCCCcccccceecc
Confidence 4567899999999999999999977 5778999998643321 1347889999999999999999999987
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. +++|||+++|+|.+++... ...+++..++.++.|++.||.|||+++++||||||+||++
T Consensus 72 ~~~~----------------~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 72 QAPI----------------CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134 (263)
T ss_dssp SSSC----------------EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred CCce----------------EEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence 7665 8999999999999998653 4568899999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSA 283 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~ 283 (292)
+.++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||+| |.+||...+..+++..
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~ 214 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 214 (263)
T ss_dssp CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH
T ss_pred cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 9999999999999976543322 2233568899999999999999999999999999999999 6888999999999988
Q ss_pred HHHhh
Q 022794 284 VVRQV 288 (292)
Q Consensus 284 i~~~~ 288 (292)
+.++.
T Consensus 215 i~~~~ 219 (263)
T d1sm2a_ 215 ISTGF 219 (263)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 87763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-49 Score=334.19 Aligned_cols=212 Identities=24% Similarity=0.399 Sum_probs=184.9
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||||++.... .. ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ES----DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HH----HHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hh----hHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 5899999999999999999976 58999999985321 11 1345788999999999999999999998776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. |+||||+++|+|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.
T Consensus 97 ~~----------------~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 97 EM----------------VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp EE----------------EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 65 8999999999999998543 346999999999999999999999999999999999999964
Q ss_pred --CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 208 --NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 208 --~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|.
T Consensus 160 ~~~~~vkL~DFG~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp TTSCCEEECCCTTCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCeEEEeecchheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 578999999999865433 33344678999999999999999999999999999999999999999999999999888
Q ss_pred Hhh
Q 022794 286 RQV 288 (292)
Q Consensus 286 ~~~ 288 (292)
+..
T Consensus 239 ~~~ 241 (350)
T d1koaa2 239 SCD 241 (350)
T ss_dssp HTC
T ss_pred hCC
Confidence 753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-49 Score=333.96 Aligned_cols=212 Identities=25% Similarity=0.395 Sum_probs=185.0
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||.||+|.+ +|+.||||+++... ..+ ...+.+|+.++++++||||++++++|.+.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLD----KYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHH----HHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4799999999999999999976 58999999986432 111 345778999999999999999999998776
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc-
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD- 206 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~- 206 (292)
.+ |+||||+++|+|.+++.. ...++++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~----------------~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 100 EM----------------VLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp EE----------------EEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EE----------------EEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence 65 899999999999987754 334699999999999999999999999999999999999997
Q ss_pred -CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 -KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++|+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++..|.
T Consensus 163 ~~~~~vkL~DFGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 163 KKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp TTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred cCCCeEEEeecccceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5689999999999865533 23344678999999999999999999999999999999999999999999999999888
Q ss_pred Hhh
Q 022794 286 RQV 288 (292)
Q Consensus 286 ~~~ 288 (292)
++.
T Consensus 242 ~~~ 244 (352)
T d1koba_ 242 RCD 244 (352)
T ss_dssp HCC
T ss_pred hCC
Confidence 753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-49 Score=329.28 Aligned_cols=211 Identities=28% Similarity=0.416 Sum_probs=181.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
..|++++.||+|+||.||+|.+ +|+.||||+++..... . ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ---S---NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC---H---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc---C---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence 3599999999999999999975 5889999998644321 1 122345788999999999999999999998766
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 ~~----------------~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 150 (309)
T d1u5ra_ 89 TA----------------WLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (309)
T ss_dssp EE----------------EEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred EE----------------EEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC
Confidence 55 899999999998776643 357999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG---NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
++.+||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 151 ~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i 226 (309)
T d1u5ra_ 151 PGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (309)
T ss_dssp TTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999975432 234679999999999865 35889999999999999999999999999998888887
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 227 ~~~~ 230 (309)
T d1u5ra_ 227 AQNE 230 (309)
T ss_dssp HHSC
T ss_pred HhCC
Confidence 7653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-49 Score=334.46 Aligned_cols=213 Identities=23% Similarity=0.332 Sum_probs=187.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||.||+|.+ +|+.||||++.... .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK------VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH------HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH------ccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc
Confidence 36899999999999999999976 58999999985211 11112234578999999999999999999999877
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
... +++|||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 114 ~~~----------------~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~ 175 (350)
T d1rdqe_ 114 SNL----------------YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp SEE----------------EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred ccc----------------ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC
Confidence 665 8999999999999999654 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+++.+|.+
T Consensus 176 ~~g~ikL~DFG~a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 176 QQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp TTSCEEECCCTTCEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEeeeceeeeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence 9999999999999876532 2346799999999999999999999999999999999999999999999999999887
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
+.
T Consensus 253 ~~ 254 (350)
T d1rdqe_ 253 GK 254 (350)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=325.45 Aligned_cols=217 Identities=24% Similarity=0.393 Sum_probs=186.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++......... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR---GVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS---SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh---hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 6799999999999999999976 58899999986543221110 011345788999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.+ |+||||+++|+|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 87 ~~----------------~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~ 148 (293)
T d1jksa_ 87 DV----------------ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD 148 (293)
T ss_dssp EE----------------EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred EE----------------EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec
Confidence 65 8999999999999999653 46999999999999999999999999999999999999987
Q ss_pred CC----cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 208 NR----TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 208 ~~----~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++ .++|+|||++...... .......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+++..
T Consensus 149 ~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 227 (293)
T d1jksa_ 149 RNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227 (293)
T ss_dssp SSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 66 5999999999865433 334456789999999999999999999999999999999999999999999999988
Q ss_pred HHHhh
Q 022794 284 VVRQV 288 (292)
Q Consensus 284 i~~~~ 288 (292)
+.++.
T Consensus 228 i~~~~ 232 (293)
T d1jksa_ 228 VSAVN 232 (293)
T ss_dssp HHTTC
T ss_pred HHhcC
Confidence 87753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=328.38 Aligned_cols=215 Identities=28% Similarity=0.450 Sum_probs=185.3
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHH-HhCCCCcccceeceecCC
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVW-HKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~ 126 (292)
++|.+++.||+|+||+||+|.+ +|+.||||+++... .......+.+..|..++ +.++||||+++++++.+.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~------~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV------VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH------HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh------ccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence 5799999999999999999977 68999999995321 01111122345566655 468999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. |+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++
T Consensus 76 ~~~----------------yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~ 137 (320)
T d1xjda_ 76 ENL----------------FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 137 (320)
T ss_dssp SEE----------------EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred Cce----------------eEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec
Confidence 766 8999999999999999643 5689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
.+++++|+|||.++.............||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..++..++.+
T Consensus 138 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217 (320)
T ss_dssp TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99999999999998665555555667899999999999999999999999999999999999999999999999998876
Q ss_pred hh
Q 022794 287 QV 288 (292)
Q Consensus 287 ~~ 288 (292)
+.
T Consensus 218 ~~ 219 (320)
T d1xjda_ 218 DN 219 (320)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=318.21 Aligned_cols=214 Identities=29% Similarity=0.526 Sum_probs=174.6
Q ss_pred Cce-eEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 50 SKL-VIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 50 ~~~-~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
++| ++.+.||+|+||+||+|.+ +++.||+|++...... . ...+.+.+|++++++++||||+++++++.+.
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~---~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT---K----SERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC---H----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC---H----HHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 455 7788999999999999977 4778999998654321 1 1234588999999999999999999998642
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCCee
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQK--IVHRDVKTENML 204 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~h~di~p~Nil 204 (292)
..- ....+++|||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 81 ~~~------------~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NIL 146 (270)
T d1t4ha_ 81 VKG------------KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146 (270)
T ss_dssp SSS------------CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEE
T ss_pred ccc------------CCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhce
Confidence 110 12338999999999999999653 56999999999999999999999998 999999999999
Q ss_pred Ec-CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Q 022794 205 LD-KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTS 282 (292)
Q Consensus 205 i~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~-~~~~~~~ 282 (292)
++ +++.+||+|||++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+. +..++.+
T Consensus 147 l~~~~~~~Kl~DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~ 223 (270)
T d1t4ha_ 147 ITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 223 (270)
T ss_dssp ESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred eeCCCCCEEEeecCcceeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH
Confidence 96 578999999999975332 23345679999999999876 5999999999999999999999999765 4555555
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.++
T Consensus 224 ~i~~~ 228 (270)
T d1t4ha_ 224 RVTSG 228 (270)
T ss_dssp HHTTT
T ss_pred HHHcC
Confidence 55544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-48 Score=324.44 Aligned_cols=217 Identities=31% Similarity=0.568 Sum_probs=174.1
Q ss_pred ecCCceeEeeeeccCcceEEEEEEEC--Cc---eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYD--GH---DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~---~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+...+|++.+.||+|+||.||+|.+. |+ .||||.+.... .. ...+.+.+|+.++++++||||+++++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~----~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----TE----KQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC----CH----HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc----CH----HHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 44578999999999999999999763 33 47888774322 11 22345889999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++...+.. +++|||+++|+|.+++... ...+++..++.++.|++.||.|||++|++||||||+
T Consensus 95 ~~~~~~~~----------------~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~ 157 (299)
T d1jpaa_ 95 VVTKSTPV----------------MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR 157 (299)
T ss_dssp EECSSSSC----------------EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEeeCCEE----------------EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccc
Confidence 99877665 8999999999999988653 346899999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCC-----CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPND-----MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||+| |..||.+.
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 999999999999999999765432221 122457889999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHHHhh
Q 022794 276 SFSEVTSAVVRQV 288 (292)
Q Consensus 276 ~~~~~~~~i~~~~ 288 (292)
+..+++..+.++.
T Consensus 238 ~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 238 TNQDVINAIEQDY 250 (299)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHHcCC
Confidence 9999998887653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-48 Score=320.51 Aligned_cols=220 Identities=26% Similarity=0.422 Sum_probs=180.2
Q ss_pred cCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMG 125 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 125 (292)
..++|++.+.||+|+||.||+|.+ +|+.||||+++..... . ......+.+|+.++++++||||+++++++..
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~----~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR--D----PSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT--C----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc--C----HHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence 357899999999999999999976 5999999999643321 1 2234568899999999999999999999876
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+.. ...+|+||||++|++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 79 ~~~~------------~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll 144 (277)
T d1o6ya_ 79 ETPA------------GPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144 (277)
T ss_dssp ECSS------------SEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ccCC------------CceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc
Confidence 5431 12348999999999999988543 569999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 DKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+.++..+++|||.+........ ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++..
T Consensus 145 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 224 (277)
T d1o6ya_ 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224 (277)
T ss_dssp ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH
Confidence 9999999999998865433222 2334568999999999999999999999999999999999999999999999888
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
++.++
T Consensus 225 ~~~~~ 229 (277)
T d1o6ya_ 225 QHVRE 229 (277)
T ss_dssp HHHHC
T ss_pred HHHhc
Confidence 87765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=314.25 Aligned_cols=213 Identities=27% Similarity=0.569 Sum_probs=185.9
Q ss_pred cCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 48 EPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 48 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.+++|++++.||+|+||+||+|++. ++.||||+++..... .+.+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----------HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----------HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 4578999999999999999999875 668999999754322 12478899999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.. ++||||+++|+|..++... ...+++..++.++.|++.||+|||+.|++||||||+||+++
T Consensus 72 ~~~----------------~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~ 134 (258)
T d1k2pa_ 72 RPI----------------FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134 (258)
T ss_dssp SSE----------------EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC
T ss_pred Cce----------------EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc
Confidence 665 8999999999999987643 45688999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i 284 (292)
.++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.+.+..++...+
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i 214 (258)
T d1k2pa_ 135 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214 (258)
T ss_dssp TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999999975443322 2334668899999999999999999999999999999998 89999999999999988
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.++
T Consensus 215 ~~~ 217 (258)
T d1k2pa_ 215 AQG 217 (258)
T ss_dssp HTT
T ss_pred HhC
Confidence 775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=329.75 Aligned_cols=221 Identities=32% Similarity=0.532 Sum_probs=183.1
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEECC-------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYDG-------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPN 115 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 115 (292)
.|++..++|++.+.||+|+||+||+|.+.+ ..||+|.+...... .....+.+|+.+++++ +|||
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~~Hpn 102 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--------SEREALMSELKMMTQLGSHEN 102 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTT
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--------HHHHHHHHHHHHHHHhcCCCc
Confidence 477788899999999999999999997632 26899988533221 1234578899999998 8999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc---------------------ccccCHHHH
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR---------------------RRKLAFKVV 174 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~ 174 (292)
|+++++++.+.+.. ++||||+++|+|.+++.... ...+++..+
T Consensus 103 Iv~l~~~~~~~~~~----------------~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 166 (325)
T d1rjba_ 103 IVNLLGACTLSGPI----------------YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 166 (325)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred EeEEEEEEeeCCeE----------------EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHH
Confidence 99999999887665 89999999999999996542 135889999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCch
Q 022794 175 VQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRK 252 (292)
Q Consensus 175 ~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 252 (292)
+.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........ .....+|+.|+|||++.+..++.+
T Consensus 167 ~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 246 (325)
T d1rjba_ 167 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK 246 (325)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc
Confidence 999999999999999999999999999999999999999999999765443322 223457899999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022794 253 CDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 253 ~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
+|||||||++|+|++ |.+||.+.+..+.+.+++++.
T Consensus 247 ~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~ 283 (325)
T d1rjba_ 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG 283 (325)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred eeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 999999999999998 899999888877777776653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=320.19 Aligned_cols=218 Identities=29% Similarity=0.571 Sum_probs=183.0
Q ss_pred ceecCCceeEeee-eccCcceEEEEEEE----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 45 WEIEPSKLVIKSV-IARGTFGTVHRGLY----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 45 ~~~~~~~~~~~~~-lg~G~~g~V~~~~~----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
+-+..++|.+.+. ||+|+||.||+|.+ ++..||||+++.... . ...+.+.+|+.++++++||||+++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~----~----~~~~~~~~E~~il~~l~HpnIv~l 74 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----K----ADTEEMMREAQIMHQLDNPYIVRL 74 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC----H----HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC----H----HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3345577888885 99999999999965 345799999864321 1 123458899999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+. .. ++||||+++|+|.+++.. .+..+++..++.++.|++.||+|||++|++|||||
T Consensus 75 ~g~~~~~-~~----------------~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK 136 (285)
T d1u59a_ 75 IGVCQAE-AL----------------MLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 136 (285)
T ss_dssp EEEEESS-SE----------------EEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred eeeeccC-eE----------------EEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCc
Confidence 9988543 22 899999999999998754 33569999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.
T Consensus 137 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 137 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred hhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986544322 2223457889999999998899999999999999999998 99999999
Q ss_pred CHHHHHHHHHHhh
Q 022794 276 SFSEVTSAVVRQV 288 (292)
Q Consensus 276 ~~~~~~~~i~~~~ 288 (292)
+..++...|.++.
T Consensus 217 ~~~~~~~~i~~~~ 229 (285)
T d1u59a_ 217 KGPEVMAFIEQGK 229 (285)
T ss_dssp CTHHHHHHHHTTC
T ss_pred CHHHHHHHHHcCC
Confidence 9999998887764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=317.88 Aligned_cols=220 Identities=31% Similarity=0.527 Sum_probs=183.1
Q ss_pred cccceecCCceeEeeeeccCcceEEEEEEEC-CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCccccee
Q 022794 42 RQDWEIEPSKLVIKSVIARGTFGTVHRGLYD-GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFI 120 (292)
Q Consensus 42 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 120 (292)
.++|++..++|++.+.||+|+||.||+|.++ ++.||||+++..... .+.+.+|+.++++++||||++++
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----------~~~~~~E~~~l~~l~h~nIv~~~ 78 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----------PEAFLQEAQVMKKLRHEKLVQLY 78 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----------HHHHHHHHHHHHhcccCCEeEEE
Confidence 4567888899999999999999999999774 568999998644321 23478999999999999999999
Q ss_pred ceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 022794 121 GATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKT 200 (292)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p 200 (292)
+++.+. .. ++||||+++|+|..++.......+++..++.++.||+.||+|||++|++||||||
T Consensus 79 g~~~~~-~~----------------~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp 141 (285)
T d1fmka3 79 AVVSEE-PI----------------YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 141 (285)
T ss_dssp EEECSS-SC----------------EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecC-Ce----------------EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccc
Confidence 988543 33 8999999999999998766666799999999999999999999999999999999
Q ss_pred CCeeEcCCCcEEEeecCcceeccCCC-CCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022794 201 ENMLLDKNRTVKIADFGVARVEASNP-NDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFS 278 (292)
Q Consensus 201 ~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~ 278 (292)
+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 142 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~ 221 (285)
T d1fmka3 142 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221 (285)
T ss_dssp GGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred eEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997653322 22333568999999999999999999999999999999999 56777888888
Q ss_pred HHHHHHHHhh
Q 022794 279 EVTSAVVRQV 288 (292)
Q Consensus 279 ~~~~~i~~~~ 288 (292)
+++..+.++.
T Consensus 222 ~~~~~i~~~~ 231 (285)
T d1fmka3 222 EVLDQVERGY 231 (285)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHHHhcC
Confidence 8888887653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=324.18 Aligned_cols=212 Identities=21% Similarity=0.345 Sum_probs=184.0
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
-++|++++.||+|+||+||+|.+ +|+.||+|+++... . + ...+.+|+.+|++++||||++++++|.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~-~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----T-D----QVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----H-H----HHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----c-c----HHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 36899999999999999999976 58899999996432 1 1 23467899999999999999999999877
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ |+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 74 ~~~----------------~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 74 EEL----------------VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp TEE----------------EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CEE----------------EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeec
Confidence 665 8999999999999998543 34699999999999999999999999999999999999997
Q ss_pred CC--CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KN--RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.+ ..++|+|||.+...... .......+++.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+++.+|
T Consensus 137 ~~~~~~ikl~DFG~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i 215 (321)
T d1tkia_ 137 TRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CCCceEEEEcccchhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54 57999999999765432 2233356889999999999999999999999999999999999999999999999998
Q ss_pred HHhh
Q 022794 285 VRQV 288 (292)
Q Consensus 285 ~~~~ 288 (292)
.++.
T Consensus 216 ~~~~ 219 (321)
T d1tkia_ 216 MNAE 219 (321)
T ss_dssp HHTC
T ss_pred HhCC
Confidence 8763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=316.63 Aligned_cols=214 Identities=32% Similarity=0.617 Sum_probs=182.2
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceec
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATM 124 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 124 (292)
|++..++|++.+.||+|+||.||+|.++|+.||||+++.... .+.+.+|+.++++++||||+++++++.
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~-----------~~~~~~E~~~l~~l~HpnIv~~~g~~~ 70 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT-----------AQAFLAEASVMTQLRHSNLVQLLGVIV 70 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 677778999999999999999999999999999999864321 234788999999999999999999886
Q ss_pred CCc-ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 125 GSS-ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 125 ~~~-~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
+.+ .+ ++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+++||||||+||
T Consensus 71 ~~~~~~----------------~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Ni 134 (262)
T d1byga_ 71 EEKGGL----------------YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 134 (262)
T ss_dssp CC--CC----------------EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCcE----------------EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhh
Confidence 542 23 8999999999999999766666799999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTS 282 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~ 282 (292)
+++.++.++|+|||.++..... .....+++.|+|||++.+..++.++||||||+++|||++ |++||...+..+++.
T Consensus 135 l~~~~~~~kl~dfg~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~ 211 (262)
T d1byga_ 135 LVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 211 (262)
T ss_dssp EECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH
T ss_pred eecCCCCEeecccccceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 9999999999999999754322 233467889999999998899999999999999999998 799999999999999
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.+.++.
T Consensus 212 ~i~~~~ 217 (262)
T d1byga_ 212 RVEKGY 217 (262)
T ss_dssp HHTTTC
T ss_pred HHHcCC
Confidence 887653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=317.06 Aligned_cols=214 Identities=28% Similarity=0.466 Sum_probs=183.1
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++...... .....+.+|++++++++||||+++++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-------GVPSTAIREISLLKELNHPNIVKLLDVIHTEN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-------HHHHHHHHHHHHHHhCCCCcEEEecccccccc
Confidence 5899999999999999999976 48999999986433211 12345788999999999999999999998876
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++|||+. +.+..++.......+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 75 ~~----------------~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~ 137 (298)
T d1gz8a_ 75 KL----------------YLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137 (298)
T ss_dssp EE----------------EEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred ce----------------eEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc
Confidence 65 89999995 56666665555677999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~ 286 (292)
++.++|+|||.+..............+++.|+|||.+.... ++.++|+||+||++|+|++|+.||.+.+..+.+.++.+
T Consensus 138 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999987665555566678999999999987765 57899999999999999999999999999888888765
Q ss_pred h
Q 022794 287 Q 287 (292)
Q Consensus 287 ~ 287 (292)
.
T Consensus 218 ~ 218 (298)
T d1gz8a_ 218 T 218 (298)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=315.91 Aligned_cols=207 Identities=32% Similarity=0.551 Sum_probs=173.1
Q ss_pred eeeccCcceEEEEEEEC----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccc
Q 022794 56 SVIARGTFGTVHRGLYD----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 56 ~~lg~G~~g~V~~~~~~----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
+.||+|+||.||+|.+. ++.||||+++..... ....+.+.+|+.++++++||||+++++++.... .
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-~-- 82 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------PALKDELLAEANVMQQLDNPYIVRMIGICEAES-W-- 82 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-E--
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-------HHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-E--
Confidence 46999999999999652 467999998543221 223456889999999999999999999885432 2
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcE
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~ 211 (292)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 83 --------------~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~ 146 (277)
T d1xbba_ 83 --------------MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 146 (277)
T ss_dssp --------------EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred --------------EEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcc
Confidence 799999999999999864 3569999999999999999999999999999999999999999999
Q ss_pred EEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022794 212 KIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 212 ~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 287 (292)
+|+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|||++ |++||.+.+..++...+.++
T Consensus 147 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999865433222 223468899999999998899999999999999999998 89999999999998888775
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 227 ~ 227 (277)
T d1xbba_ 227 E 227 (277)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-47 Score=324.04 Aligned_cols=209 Identities=25% Similarity=0.349 Sum_probs=172.8
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|.+++.||+|+||.||+|.+ +|+.||||++..... .............+++.+++.++||||+++++++.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI---KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc---chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC
Confidence 46899999999999999999976 589999999852210 0000111122234457778888999999999999887
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.+ |+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+|||++
T Consensus 80 ~~~----------------~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~ 141 (364)
T d1omwa3 80 DKL----------------SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 141 (364)
T ss_dssp SEE----------------EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CEE----------------EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc
Confidence 665 8999999999999999653 5689999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
.+|.+||+|||+++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 142 ~~g~iKl~DFGla~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 214 (364)
T d1omwa3 142 EHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 214 (364)
T ss_dssp SSSCEEECCCTTCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred CCCcEEEeeeceeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999865433 2344679999999999965 5689999999999999999999999987655443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=313.89 Aligned_cols=219 Identities=29% Similarity=0.562 Sum_probs=175.7
Q ss_pred cceecCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccc
Q 022794 44 DWEIEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTK 118 (292)
Q Consensus 44 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 118 (292)
+|++..++|++.+.||+|+||.||+|.+. +..||||.++.... ......+.+|+.++++++||||++
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~~E~~~l~~l~HpnIv~ 72 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------DSVREKFLQEALTMRQFDHPHIVK 72 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 47788889999999999999999999763 34588887743221 122456889999999999999999
Q ss_pred eeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 022794 119 FIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDV 198 (292)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di 198 (292)
+++++.+. .. +++|||+++|+|.+++... ...+++..++.++.||+.||.|||++|++||||
T Consensus 73 l~~~~~~~-~~----------------~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDl 134 (273)
T d1mp8a_ 73 LIGVITEN-PV----------------WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134 (273)
T ss_dssp EEEEECSS-SC----------------EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecC-eE----------------EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeecccc
Confidence 99988542 22 8999999999999987643 456899999999999999999999999999999
Q ss_pred CCCCeeEcCCCcEEEeecCcceeccCCCC-CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 022794 199 KTENMLLDKNRTVKIADFGVARVEASNPN-DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLS 276 (292)
Q Consensus 199 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~ 276 (292)
||+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+
T Consensus 135 Kp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 135 AARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp SGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred chhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999976543222 2233567889999999999999999999999999999998 899999999
Q ss_pred HHHHHHHHHHhh
Q 022794 277 FSEVTSAVVRQV 288 (292)
Q Consensus 277 ~~~~~~~i~~~~ 288 (292)
..+++..+.++.
T Consensus 215 ~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 215 NNDVIGRIENGE 226 (273)
T ss_dssp GGGHHHHHHTTC
T ss_pred HHHHHHHHHcCC
Confidence 999999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=318.00 Aligned_cols=212 Identities=26% Similarity=0.355 Sum_probs=176.3
Q ss_pred EeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccccc
Q 022794 54 IKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSELHI 131 (292)
Q Consensus 54 ~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 131 (292)
.+++||+|+||+||+|.+ +|+.||||+++....... .....+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~-- 75 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI-- 75 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC----------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC--
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh----hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce--
Confidence 467899999999999975 588999999864332111 112234578899999999999999999999887765
Q ss_pred ccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcE
Q 022794 132 QTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTV 211 (292)
Q Consensus 132 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~ 211 (292)
++||||+.++++.... ..+..+++..+..++.||+.||+|||++|++||||||+|||++.++.+
T Consensus 76 --------------~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~ 139 (299)
T d1ua2a_ 76 --------------SLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 139 (299)
T ss_dssp --------------EEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred --------------eehhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCcc
Confidence 8999999877666544 345679999999999999999999999999999999999999999999
Q ss_pred EEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 212 KIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 212 ~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
||+|||.+..............+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+.+|.+.
T Consensus 140 KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 140 KLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp EECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 999999997665555555556799999999998755 5799999999999999999999999999999998888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=323.68 Aligned_cols=208 Identities=25% Similarity=0.428 Sum_probs=170.5
Q ss_pred CceeEee-eeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHh-CCCCcccceeceecC
Q 022794 50 SKLVIKS-VIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHK-LDHPNVTKFIGATMG 125 (292)
Q Consensus 50 ~~~~~~~-~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 125 (292)
++|.+.+ .||+|+||.||+|.+ +|+.||||+++.. ..+.+|+.++.+ ++||||++++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 5898876 599999999999975 5899999998521 125678888655 489999999999865
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
... ....+|++||||+||+|.+++.......+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus 77 ~~~------------~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll 144 (335)
T d2ozaa1 77 LYA------------GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144 (335)
T ss_dssp EET------------TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ccc------------CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccc
Confidence 211 01234999999999999999976555679999999999999999999999999999999999999
Q ss_pred cC---CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 206 DK---NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 206 ~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
+. .+.++|+|||+++..... .......|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+...
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~ 223 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----
T ss_pred ccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH
Confidence 75 467999999999865543 33445679999999999999999999999999999999999999998776555544
Q ss_pred HH
Q 022794 283 AV 284 (292)
Q Consensus 283 ~i 284 (292)
.+
T Consensus 224 ~~ 225 (335)
T d2ozaa1 224 GM 225 (335)
T ss_dssp --
T ss_pred HH
Confidence 43
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=311.10 Aligned_cols=218 Identities=31% Similarity=0.553 Sum_probs=176.7
Q ss_pred eecCCceeEeeeeccCcceEEEEEEECC------ceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccce
Q 022794 46 EIEPSKLVIKSVIARGTFGTVHRGLYDG------HDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKF 119 (292)
Q Consensus 46 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 119 (292)
++.+++|.+.++||+|+||.||+|.+.+ ..||||.++.... . .....+.+|+.++++++||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~----~----~~~~~~~~E~~il~~l~H~nIv~~ 74 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT----E----KQRVDFLGEAGIMGQFSHHNIIRL 74 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC----h----HHHHHHHHHHHHHHhcCCCCEeee
Confidence 4566789999999999999999996532 3699999853321 1 123457899999999999999999
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVK 199 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~ 199 (292)
++++.+.+.. +++|||+.++++.+++... ...+++..++.++.|++.||+|||+++|+|||||
T Consensus 75 ~g~~~~~~~~----------------~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlK 137 (283)
T d1mqba_ 75 EGVISKYKPM----------------MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137 (283)
T ss_dssp EEEECSSSSE----------------EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eEEEecCCce----------------EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccc
Confidence 9999876665 8999999999999987643 4569999999999999999999999999999999
Q ss_pred CCCeeEcCCCcEEEeecCcceeccCCCC---CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 022794 200 TENMLLDKNRTVKIADFGVARVEASNPN---DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDL 275 (292)
Q Consensus 200 p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~ 275 (292)
|+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...
T Consensus 138 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~ 217 (283)
T d1mqba_ 138 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217 (283)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence 9999999999999999999976543322 2223457899999999999999999999999999999999 56677788
Q ss_pred CHHHHHHHHHHhh
Q 022794 276 SFSEVTSAVVRQV 288 (292)
Q Consensus 276 ~~~~~~~~i~~~~ 288 (292)
+..+++..+.++.
T Consensus 218 ~~~~~~~~i~~~~ 230 (283)
T d1mqba_ 218 SNHEVMKAINDGF 230 (283)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHhccC
Confidence 8888888877653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=314.21 Aligned_cols=214 Identities=27% Similarity=0.534 Sum_probs=177.0
Q ss_pred CCceeEeeeeccCcceEEEEEEEC--Cc----eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD--GH----DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~--~~----~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
..+|++++.||+|+||+||+|.+. |+ +||+|.++..... ...+.+.+|+.++++++||||++++++
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~g~ 79 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--------KANKEILDEAYVMASVDNPHVCRLLGI 79 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------------CTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 457999999999999999999763 43 5888877532211 123458899999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+.+... +++++++.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 80 ~~~~~~-----------------~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~N 141 (317)
T d1xkka_ 80 CLTSTV-----------------QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 141 (317)
T ss_dssp EESSSE-----------------EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EecCCe-----------------eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhc
Confidence 876532 6889999999999988653 4579999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSFSE 279 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~~~ 279 (292)
|+++.++.+||+|||+++........ .....+|+.|+|||.+.++.++.++||||||+++|+|+| |.+||.+.+..+
T Consensus 142 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp EEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 99999999999999999865433222 223457899999999999999999999999999999998 899999999999
Q ss_pred HHHHHHHhh
Q 022794 280 VTSAVVRQV 288 (292)
Q Consensus 280 ~~~~i~~~~ 288 (292)
+...+.++.
T Consensus 222 ~~~~i~~~~ 230 (317)
T d1xkka_ 222 ISSILEKGE 230 (317)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHcCC
Confidence 888877653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=308.83 Aligned_cols=218 Identities=29% Similarity=0.510 Sum_probs=174.6
Q ss_pred ecCCceeEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+..++|++.+.||+|+||.||+|.+. +..||||+++...... ....+.+.+|+.++++++||||+++++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~~~g 78 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------PEAMDDFIREVNAMHSLDHRNLIRLYG 78 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC------HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 44578999999999999999999653 2368999885433211 123345889999999999999999999
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
++.+. .. +++|||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+
T Consensus 79 ~~~~~-~~----------------~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~ 140 (273)
T d1u46a_ 79 VVLTP-PM----------------KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAAR 140 (273)
T ss_dssp EECSS-SC----------------EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEeec-ch----------------heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHH
Confidence 98654 22 7999999999999988654 456999999999999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCC---CCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPND---MTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC-CDMPYPDLSF 277 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~-g~~pf~~~~~ 277 (292)
||+++.++.++|+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++ |.+||.+.+.
T Consensus 141 NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 141 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred HhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 999999999999999999865433221 222456789999999999999999999999999999998 8999999999
Q ss_pred HHHHHHHHHhh
Q 022794 278 SEVTSAVVRQV 288 (292)
Q Consensus 278 ~~~~~~i~~~~ 288 (292)
.+++..+.++.
T Consensus 221 ~~~~~~i~~~~ 231 (273)
T d1u46a_ 221 SQILHKIDKEG 231 (273)
T ss_dssp HHHHHHHHTSC
T ss_pred HHHHHHHHhCC
Confidence 99999987763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-46 Score=308.96 Aligned_cols=213 Identities=28% Similarity=0.406 Sum_probs=177.6
Q ss_pred CceeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++........ ...+.+|+.++++++||||+++++++...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~-------~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-------PSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC-------CHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHH-------HHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 5899999999999999999976 5799999999654322221 2347889999999999999999999988776
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCC
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKN 208 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~ 208 (292)
. +++++++.++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 75 ~----------------~i~~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~ 136 (286)
T d1ob3a_ 75 L----------------VLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (286)
T ss_dssp E----------------EEEEECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred e----------------eEEEEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC
Confidence 6 88999997766655542 34679999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 209 RTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 209 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
+.++|+|||.+..............+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+.++.+.
T Consensus 137 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~ 216 (286)
T d1ob3a_ 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (286)
T ss_dssp SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 999999999997665544445556789999999998765 4689999999999999999999999999999988887653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-46 Score=310.63 Aligned_cols=222 Identities=30% Similarity=0.494 Sum_probs=186.5
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 115 (292)
..+++..++|++.+.||+|+||+||+|.+. ++.||||+++.... ....+.+.+|+.++++++|||
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~E~~il~~l~h~n 77 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------ADMQADFQREAALMAEFDNPN 77 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------HHHHHHHHHHHHHHHTCCCTT
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--------hHHHHHHHHHHHHHHhcCCCC
Confidence 446777789999999999999999999764 46899999853221 122456889999999999999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----------------------ccccCHHH
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------------RRKLAFKV 173 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~ 173 (292)
|+++++++...... +++|||+++|+|.+++.... ...+++..
T Consensus 78 iv~~~~~~~~~~~~----------------~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 141 (301)
T d1lufa_ 78 IVKLLGVCAVGKPM----------------CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141 (301)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred cccceeeeccCCce----------------EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHH
Confidence 99999999876655 89999999999999986422 23478899
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCC--CCCCCCCCcccccCCcccCCCCCCc
Q 022794 174 VVQLALDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNP--NDMTGETGTLGYMAPEVLNGNPYNR 251 (292)
Q Consensus 174 ~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 251 (292)
++.++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.
T Consensus 142 ~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 99999999999999999999999999999999999999999999987543222 2223456889999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHhh
Q 022794 252 KCDVYSFGICLWEIYCCD-MPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 252 ~~Diwslg~il~~l~~g~-~pf~~~~~~~~~~~i~~~~ 288 (292)
++||||||+++|||++|. +||.+.+..++...+.++.
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~ 259 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN 259 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999999999985 7899999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=308.81 Aligned_cols=223 Identities=31% Similarity=0.554 Sum_probs=172.1
Q ss_pred hcccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 41 QRQDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 41 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
....|++..++|++.+.||+|+||.||+|.+ +++.||||+++.... . ...+.+.+|..++.++ +
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----~----~~~~~~~~e~~~l~~~~~ 75 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT----H----SEHRALMSELKILIHIGH 75 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C----H----HHHHHHHHHHHHHHHHCC
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC----c----HHHHHHHHHHHHHHhhcC
Confidence 3456788888999999999999999999975 246799999853221 1 1133466677777776 7
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
|+||+.+++++...+. .++++|||+++|+|.+++.... ...+++..++.++
T Consensus 76 h~~iv~~~~~~~~~~~---------------~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (299)
T d1ywna1 76 HLNVVNLLGACTKPGG---------------PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140 (299)
T ss_dssp CTTBCCEEEEECSTTS---------------CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred CCeEEEeeeeeccCCC---------------eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence 8999999988765432 2289999999999999996543 2358899999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||
T Consensus 141 ~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 141 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccccee
Confidence 9999999999999999999999999999999999999999975443322 22345689999999999999999999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHH
Q 022794 257 SFGICLWEIYCC-DMPYPDLSFSEVTSAVVR 286 (292)
Q Consensus 257 slg~il~~l~~g-~~pf~~~~~~~~~~~i~~ 286 (292)
|+||++|+|++| .+||.+.+..+.+..+++
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~ 251 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999986 578987766555544443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=307.13 Aligned_cols=222 Identities=33% Similarity=0.546 Sum_probs=182.8
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-C
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-D 112 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 112 (292)
++|++..++|.+++.||+|+||.||+|... +..||||+++.... . .....+.+|...+.++ +
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~----~----~~~~~~~~e~~~l~~~~~ 77 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT----E----KDLSDLISEMEMMKMIGK 77 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC----H----HHHHHHHHHHHHHHHHCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC----h----HHHHHHHHHHHHHHHhcC
Confidence 458888999999999999999999999642 24699999864321 1 1134477788888888 8
Q ss_pred CCcccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc--------------ccccCHHHHHHHH
Q 022794 113 HPNVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR--------------RRKLAFKVVVQLA 178 (292)
Q Consensus 113 h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~ 178 (292)
||||+++++++.+.+.. +++|||+++|+|.+++.... ...+++..++.++
T Consensus 78 HpnIv~~~~~~~~~~~~----------------~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 141 (299)
T d1fgka_ 78 HKNIINLLGACTQDGPL----------------YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141 (299)
T ss_dssp CTTBCCEEEEECSSSSC----------------EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHH
T ss_pred CCeEEecccccccCCeE----------------EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHH
Confidence 99999999999876655 89999999999999996542 2458999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.||+.||+|||+.|++||||||+|||++.++.+||+|||.+........ ......+++.|+|||.+.++.++.++|||
T Consensus 142 ~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Diw 221 (299)
T d1fgka_ 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 221 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhH
Confidence 9999999999999999999999999999999999999999976543322 22335688899999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|||+++|+|++ |.+||.+.+..++...+.++.
T Consensus 222 S~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~ 254 (299)
T d1fgka_ 222 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 254 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred HhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998 799999999999988877653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=307.34 Aligned_cols=219 Identities=26% Similarity=0.360 Sum_probs=176.3
Q ss_pred CCceeEeeeeccCcceEEEEEEEC---CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC---CCCcccceece
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLYD---GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL---DHPNVTKFIGA 122 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~ 122 (292)
.++|++++.||+|+||+||+|.+. ++.||||+++......... ..+.+|+.+++.+ +||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~-------~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-------LSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB-------CTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH-------HHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 368999999999999999999863 5679999986543222211 1134566665554 89999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
|.....- .....+++||+++++.+.. ........+++..++.++.|++.||+|||++||+||||||+|
T Consensus 79 ~~~~~~~-----------~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N 146 (305)
T d1blxa_ 79 CTVSRTD-----------RETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN 146 (305)
T ss_dssp EEEEECS-----------SEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred ecccccc-----------cCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence 8543211 1223489999997765554 434455679999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
||++..+.++|+|||.+..... ........||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+..+.+.
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEEcCCCCeeecchhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999999875432 233445789999999999999999999999999999999999999999999999988
Q ss_pred HHHHh
Q 022794 283 AVVRQ 287 (292)
Q Consensus 283 ~i~~~ 287 (292)
.+.+.
T Consensus 226 ~i~~~ 230 (305)
T d1blxa_ 226 KILDV 230 (305)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 88764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=306.84 Aligned_cols=222 Identities=29% Similarity=0.505 Sum_probs=188.7
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEEC-------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLYD-------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN 115 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 115 (292)
++|++..++|++.+.||+|+||.||+|.+. ++.||||+++... ... ....+.+|+.++++++|||
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~----~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMR----ERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHH----HHHHHHHHHHHGGGCCCTT
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChH----HHHHHHHHHHHHHHcCCCC
Confidence 358888999999999999999999999653 4689999986322 111 2345789999999999999
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcc--------cccCHHHHHHHHHHHHHHHHH
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRR--------RKLAFKVVVQLALDLARGLSY 187 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~ 187 (292)
|+++++++...... +++|||+++|+|.+++..... ..+++..+..++.|++.||.|
T Consensus 85 Iv~~~~~~~~~~~~----------------~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~ 148 (308)
T d1p4oa_ 85 VVRLLGVVSQGQPT----------------LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 148 (308)
T ss_dssp BCCEEEEECSSSSC----------------EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred EeeeeeEEecCCce----------------eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999999776655 899999999999999864321 346888999999999999999
Q ss_pred HHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCC--CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHH
Q 022794 188 LHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPN--DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 265 (292)
Q Consensus 188 lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l 265 (292)
||.++++||||||+|||++.++.+||+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|||
T Consensus 149 LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El 228 (308)
T d1p4oa_ 149 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228 (308)
T ss_dssp HHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHH
Confidence 9999999999999999999999999999999975543322 12334578999999999999999999999999999999
Q ss_pred HhC-CCCCCCCCHHHHHHHHHHhh
Q 022794 266 YCC-DMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 266 ~~g-~~pf~~~~~~~~~~~i~~~~ 288 (292)
++| .+||.+.+..+++..+.++.
T Consensus 229 ~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 229 ATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp HHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhCC
Confidence 998 68999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-45 Score=304.34 Aligned_cols=222 Identities=29% Similarity=0.513 Sum_probs=187.0
Q ss_pred ccceecCCceeEeeeeccCcceEEEEEEE-------CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCC
Q 022794 43 QDWEIEPSKLVIKSVIARGTFGTVHRGLY-------DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHP 114 (292)
Q Consensus 43 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-------~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 114 (292)
..|++..++|++.+.||+|+||.||+|.+ +++.||||+++.... . .....+.+|+.+++++ +||
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~----~----~~~~~~~~E~~~~~~l~~Hp 87 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH----L----TEREALMSELKVLSYLGNHM 87 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC----H----HHHHHHHHHHHHHHHHCCCT
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC----H----HHHHHHHHHHHHHHhccCCC
Confidence 36788889999999999999999999965 356899999864321 1 1234578899999999 799
Q ss_pred cccceeceecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhc----------------ccccCHHHHHHHH
Q 022794 115 NVTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNR----------------RRKLAFKVVVQLA 178 (292)
Q Consensus 115 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~i~ 178 (292)
||+++++++.+.+.. +++|||+++|+|.+++.+.. ...+++..+..++
T Consensus 88 nIv~~~g~~~~~~~~----------------~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 151 (311)
T d1t46a_ 88 NIVNLLGACTIGGPT----------------LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151 (311)
T ss_dssp TBCCEEEEECSSSSC----------------EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHH
T ss_pred CEEEEEEEEeeCCEE----------------EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHH
Confidence 999999999877665 89999999999999996542 2358899999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCC--CCCCCCcccccCCcccCCCCCCchhhHH
Q 022794 179 LDLARGLSYLHSQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPND--MTGETGTLGYMAPEVLNGNPYNRKCDVY 256 (292)
Q Consensus 179 ~qi~~al~~lH~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diw 256 (292)
.||+.||+|||++|++||||||+||+++.++.++++|||.++........ .....+++.|+|||.+.+..++.++|||
T Consensus 152 ~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIw 231 (311)
T d1t46a_ 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231 (311)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCccccc
Confidence 99999999999999999999999999999999999999999865443322 2234678999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022794 257 SFGICLWEIYC-CDMPYPDLSFSEVTSAVVRQV 288 (292)
Q Consensus 257 slg~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 288 (292)
|||+++|+|++ |.+||...+..+.+.+++++.
T Consensus 232 S~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~ 264 (311)
T d1t46a_ 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (311)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred chHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999998 778888888877777776653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=303.76 Aligned_cols=203 Identities=24% Similarity=0.400 Sum_probs=167.2
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC--CCcccceeceec
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD--HPNVTKFIGATM 124 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~ 124 (292)
.++|++.+.||+|+||+||+|.+ +|+.||||+++........... ...++.+|+.++++++ ||||+++++++.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP---NGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT---TCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh---HHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 46899999999999999999976 5899999998643321110000 0112457999999985 899999999998
Q ss_pred CCcccccccccccccCCCCceEEEEeecCC-CCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 125 GSSELHIQTENGQVAMPSNICCVVVEYLPG-GALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
+.+.. +++|||+.+ +++.+++.. ...+++..++.++.||+.||+|||++|++||||||+||
T Consensus 80 ~~~~~----------------~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 141 (273)
T d1xwsa_ 80 RPDSF----------------VLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 141 (273)
T ss_dssp CSSEE----------------EEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred eCCeE----------------EEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccce
Confidence 87665 899999976 578888754 35699999999999999999999999999999999999
Q ss_pred eEcC-CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 022794 204 LLDK-NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPY-NRKCDVYSFGICLWEIYCCDMPYPD 274 (292)
Q Consensus 204 li~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diwslg~il~~l~~g~~pf~~ 274 (292)
+++. ++.++|+|||++..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..
T Consensus 142 ll~~~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 142 LIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp EEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEecCCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 9985 57999999999976443 23345679999999999987765 5778999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.8e-44 Score=296.05 Aligned_cols=201 Identities=20% Similarity=0.340 Sum_probs=169.3
Q ss_pred ecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC-Ccccceecee
Q 022794 47 IEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIGAT 123 (292)
Q Consensus 47 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~ 123 (292)
+..++|++++.||+|+||+||+|++ +|+.||||+......... +.+|++.++.+.| +|++.+++++
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~-----------~~~e~~~~~~l~~~~~i~~~~~~~ 70 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----------LRDEYRTYKLLAGCTGIPNVYYFG 70 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCC-----------HHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHH-----------HHHHHHHHHHhcCCCCCCEEEEEe
Confidence 4568999999999999999999976 588999999865433221 5678899999954 8999999888
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
...... +++|||+ +++|.+++.. ....++...+..++.|++.+|.+||+.|++||||||+||
T Consensus 71 ~~~~~~----------------~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Ni 132 (293)
T d1csna_ 71 QEGLHN----------------VLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132 (293)
T ss_dssp EETTEE----------------EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred ecCCcc----------------EEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Confidence 765554 8999999 7899998864 345699999999999999999999999999999999999
Q ss_pred eEcC-----CCcEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 022794 204 LLDK-----NRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMP 271 (292)
Q Consensus 204 li~~-----~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~p 271 (292)
+++. ++.++|+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..|
T Consensus 133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCc
Confidence 9964 57899999999986543211 22345699999999999999999999999999999999999999
Q ss_pred CCCCC
Q 022794 272 YPDLS 276 (292)
Q Consensus 272 f~~~~ 276 (292)
|.+.+
T Consensus 213 f~~~~ 217 (293)
T d1csna_ 213 WQGLK 217 (293)
T ss_dssp TSSCC
T ss_pred CCCcc
Confidence 97543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=304.50 Aligned_cols=212 Identities=27% Similarity=0.364 Sum_probs=174.2
Q ss_pred ceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCcc
Q 022794 51 KLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSE 128 (292)
Q Consensus 51 ~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 128 (292)
+|..+++||+|+||+||+|++ +|+.||||+++..... ..+|+.++++++||||++++++|.....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------------~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------------KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------------CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------------HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 799999999999999999987 5899999999754322 2369999999999999999999865432
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIK--NRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
.. ...+.+++|||++++ +.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 88 ~~----------~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~ 156 (350)
T d1q5ka_ 88 KK----------DEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD 156 (350)
T ss_dssp CC----------SCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred cC----------CceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe
Confidence 10 123448999999764 4444432 2445799999999999999999999999999999999999998
Q ss_pred CCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022794 207 KNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAV 284 (292)
Q Consensus 207 ~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i 284 (292)
.++ .+||+|||++...... .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||...+..+.+..|
T Consensus 157 ~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i 235 (350)
T d1q5ka_ 157 PDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235 (350)
T ss_dssp TTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred cCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH
Confidence 765 8999999999765433 334446789999999998764 6899999999999999999999999999999988888
Q ss_pred HHh
Q 022794 285 VRQ 287 (292)
Q Consensus 285 ~~~ 287 (292)
.+.
T Consensus 236 ~~~ 238 (350)
T d1q5ka_ 236 IKV 238 (350)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=304.15 Aligned_cols=215 Identities=24% Similarity=0.368 Sum_probs=175.5
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGS 126 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 126 (292)
.++|++++.||+|+||+||+|.+ +|+.||||+++.... .. ...+.+.+|+.+|++++||||++++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~----~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ---SE----LFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS---SH----HHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc---Ch----HHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 57999999999999999999976 489999999864322 11 2244578899999999999999999999876
Q ss_pred cccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEc
Q 022794 127 SELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLD 206 (292)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~ 206 (292)
+.... ...+|++|||+ +.+|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~~~~----------~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~ 155 (346)
T d1cm8a_ 90 ETLDD----------FTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 155 (346)
T ss_dssp SSTTT----------CCCCEEEEECC-SEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred ccccc----------cceEEEEEecc-cccHHHHHH---hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc
Confidence 54322 22348999999 668887764 34699999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022794 207 KNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVV 285 (292)
Q Consensus 207 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~ 285 (292)
.++.++++|||.+..... ......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.
T Consensus 156 ~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 156 EDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp TTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH
Confidence 999999999999986543 33456799999999998764 56899999999999999999999999999888877766
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
+.
T Consensus 233 ~~ 234 (346)
T d1cm8a_ 233 KV 234 (346)
T ss_dssp HH
T ss_pred hc
Confidence 53
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=304.04 Aligned_cols=214 Identities=32% Similarity=0.525 Sum_probs=177.6
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCc--eeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceecee
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGH--DVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGAT 123 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~--~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 123 (292)
.++|++.+.||+|+||.||+|.+ +|. .||||.++..... ...+.+.+|+++++++ +||||+++++++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--------DDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--------HHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 36899999999999999999965 444 4677776432211 1134488999999999 799999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhh--------------cccccCHHHHHHHHHHHHHHHHHHH
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKN--------------RRRKLAFKVVVQLALDLARGLSYLH 189 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~lH 189 (292)
.+.+.. ++||||+++|+|.+++... ....+++..++.++.||+.||.|||
T Consensus 81 ~~~~~~----------------~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH 144 (309)
T d1fvra_ 81 EHRGYL----------------YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 144 (309)
T ss_dssp EETTEE----------------EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCee----------------EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh
Confidence 877665 8999999999999999643 2356899999999999999999999
Q ss_pred hCCccccCCCCCCeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhC-
Q 022794 190 SQKIVHRDVKTENMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCC- 268 (292)
Q Consensus 190 ~~~i~h~di~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g- 268 (292)
+.|++||||||+|||++.++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 145 ~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~ 223 (309)
T d1fvra_ 145 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223 (309)
T ss_dssp HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred cCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcC
Confidence 999999999999999999999999999998754322 222345688999999999999999999999999999999996
Q ss_pred CCCCCCCCHHHHHHHHHHh
Q 022794 269 DMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 269 ~~pf~~~~~~~~~~~i~~~ 287 (292)
.+||.+.+..+++..+.++
T Consensus 224 ~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 224 GTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp CCTTTTCCHHHHHHHGGGT
T ss_pred CCCCCCCCHHHHHHHHHhc
Confidence 5789999999999888765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=302.15 Aligned_cols=214 Identities=24% Similarity=0.365 Sum_probs=172.6
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+|++++.||+|+||+||+|.+ +|+.||||+++.... ....+.+.+|+.+|++++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--------QTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--------HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--------hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 6799999999999999999976 599999999853221 122345788999999999999999999986654
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. .... +++++++.+++|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 80 ~~-----------~~~~-~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 80 IE-----------QMKD-VYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp TT-----------TCCC-EEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred cc-----------ccce-EEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 32 1112 344556669999999854 36999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC---CCCCCCCCcccccCCcccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNP---NDMTGETGTLGYMAPEVLNG-NPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSA 283 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~ 283 (292)
++.++|+|||.+....... .......+++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+....
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~ 224 (345)
T d1pmea_ 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224 (345)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999987543221 12344568999999999854 4678999999999999999999999999888887776
Q ss_pred HHH
Q 022794 284 VVR 286 (292)
Q Consensus 284 i~~ 286 (292)
+..
T Consensus 225 ~~~ 227 (345)
T d1pmea_ 225 ILG 227 (345)
T ss_dssp HHH
T ss_pred Hhh
Confidence 654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=293.66 Aligned_cols=213 Identities=26% Similarity=0.419 Sum_probs=182.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++....... ...++.+|+.++++++||||+++++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-------VPSSALREICLLKELKHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTT-------HHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChH-------HHHHHHHHHHHHHhcCcCCEEeecccccccc
Confidence 5899999999999999999976 588999999975543222 2345788999999999999999999998877
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
.. +++++++.+++|..++. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 75 ~~----------------~iv~~~~~~~~l~~~~~--~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~ 136 (292)
T d1unla_ 75 KL----------------TLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136 (292)
T ss_dssp EE----------------EEEEECCSEEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred ce----------------eEEeeeccccccccccc--cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc
Confidence 66 88999998888887764 3457899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMP-YPDLSFSEVTSAVV 285 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~p-f~~~~~~~~~~~i~ 285 (292)
++.++|+|||.+..............+++.|+|||.+.+.. ++.++||||+||++|+|++|+.| |.+.+..+.+.++.
T Consensus 137 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp TCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999987766555556667888999999988765 68999999999999999999887 56777777777765
Q ss_pred Hh
Q 022794 286 RQ 287 (292)
Q Consensus 286 ~~ 287 (292)
..
T Consensus 217 ~~ 218 (292)
T d1unla_ 217 RL 218 (292)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=297.78 Aligned_cols=222 Identities=25% Similarity=0.325 Sum_probs=175.8
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|++ +|+.||||++......... ...+.+|+.++++++|||++++++++....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-------~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-------PITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS-------CHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH-------HHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 7999999999999999999976 5899999998654332222 233678999999999999999999987654
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
..... .....+++|||++++.+..+. .....+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~--------~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~ 152 (318)
T d3blha1 83 SPYNR--------CKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 152 (318)
T ss_dssp ----------------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred ccccc--------cCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC
Confidence 32211 123458999999766555433 34457899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCC----CCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNP----NDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTS 282 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~ 282 (292)
++.++++|||++....... .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+...
T Consensus 153 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 232 (318)
T d3blha1 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232 (318)
T ss_dssp TSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH
Confidence 9999999999997543221 122335689999999998765 68999999999999999999999999999988888
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.+.+..
T Consensus 233 ~i~~~~ 238 (318)
T d3blha1 233 LISQLC 238 (318)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 877653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=299.61 Aligned_cols=218 Identities=28% Similarity=0.424 Sum_probs=177.3
Q ss_pred ceecCCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceece
Q 022794 45 WEIEPSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGA 122 (292)
Q Consensus 45 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 122 (292)
|++ +++|++++.||+|+||+||+|.+ +|+.||||+++..... . ...+++.+|+.++++++|||+++++++
T Consensus 14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~----~~~~~~~~Ei~il~~l~h~~iv~~~~~ 85 (348)
T d2gfsa1 14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS---I----IHAKRTYRELRLLKHMKHENVIGLLDV 85 (348)
T ss_dssp EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS---H----HHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC---h----HHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 444 47899999999999999999976 5899999998643321 1 123457789999999999999999999
Q ss_pred ecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCC
Q 022794 123 TMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTEN 202 (292)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~N 202 (292)
+...... +....+++++++.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 86 ~~~~~~~-----------~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~N 151 (348)
T d2gfsa1 86 FTPARSL-----------EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 151 (348)
T ss_dssp ECSCSST-----------TTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred Eeecccc-----------ccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcc
Confidence 8755432 11112456677779999998843 469999999999999999999999999999999999
Q ss_pred eeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022794 203 MLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNP-YNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVT 281 (292)
Q Consensus 203 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~ 281 (292)
||++.++.++++|||.+.... .......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+.....
T Consensus 152 ILi~~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~ 228 (348)
T d2gfsa1 152 LAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228 (348)
T ss_dssp EEECTTCCEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999986543 2334467899999999977754 688999999999999999999999999999988
Q ss_pred HHHHHh
Q 022794 282 SAVVRQ 287 (292)
Q Consensus 282 ~~i~~~ 287 (292)
..|.+.
T Consensus 229 ~~i~~~ 234 (348)
T d2gfsa1 229 KLILRL 234 (348)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 888765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-42 Score=289.15 Aligned_cols=208 Identities=25% Similarity=0.340 Sum_probs=164.1
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceecee-cC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGAT-MG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~ 125 (292)
+++|++++.||+|+||.||+|++ +|+.||||+......... +..|+++++++.|++++..+..+ .+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~-----------~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----------LHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCC-----------HHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHH-----------HHHHHHHHHHccCCCcccEEEEEEec
Confidence 36899999999999999999976 488999999875443222 56799999999777655554443 43
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.+. .+++|||+ +++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 75 ~~~----------------~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~ 136 (299)
T d1ckia_ 75 GDY----------------NVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 136 (299)
T ss_dssp TTE----------------EEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCE----------------EEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccc
Confidence 333 38899999 6677776654 34579999999999999999999999999999999999998
Q ss_pred c---CCCcEEEeecCcceeccCCCC-------CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 022794 206 D---KNRTVKIADFGVARVEASNPN-------DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDL 275 (292)
Q Consensus 206 ~---~~~~~~l~Dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~ 275 (292)
+ .+..++|+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 137 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp CCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence 5 345799999999986543322 223457999999999999999999999999999999999999999887
Q ss_pred CHHHHHHHHH
Q 022794 276 SFSEVTSAVV 285 (292)
Q Consensus 276 ~~~~~~~~i~ 285 (292)
...+....+.
T Consensus 217 ~~~~~~~~~~ 226 (299)
T d1ckia_ 217 KAATKRQKYE 226 (299)
T ss_dssp C-------HH
T ss_pred chHHHHHHHH
Confidence 7666555443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=297.46 Aligned_cols=216 Identities=24% Similarity=0.331 Sum_probs=171.7
Q ss_pred CceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
++|++++.||+|+||+||+|.+ +|+.||||+++..... .....++.+|+.++++++||||++++++|....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~ 89 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-------QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-------HHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence 6799999999999999999987 4899999999654321 112345789999999999999999999987653
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
... ....+|++|||+.+ ++.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 90 ~~~----------~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 90 TLE----------EFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154 (355)
T ss_dssp STT----------TCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred ccc----------cCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc
Confidence 321 13456999999965 5544442 35899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022794 208 NRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEVTSAVVRQ 287 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~~~~i~~~ 287 (292)
++.++++|||.++.... ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......++.+.
T Consensus 155 ~~~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~ 233 (355)
T d2b1pa1 155 DCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_dssp TCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccceeeechhhhhcccc-ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999998875433 23344467899999999999999999999999999999999999999999999988888765
Q ss_pred h
Q 022794 288 V 288 (292)
Q Consensus 288 ~ 288 (292)
.
T Consensus 234 ~ 234 (355)
T d2b1pa1 234 L 234 (355)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=300.85 Aligned_cols=215 Identities=23% Similarity=0.376 Sum_probs=176.0
Q ss_pred CceeEeeeeccCcceEEEEEEE-----CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCC-Ccccceecee
Q 022794 50 SKLVIKSVIARGTFGTVHRGLY-----DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDH-PNVTKFIGAT 123 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~ 123 (292)
++|++++.||+|+||.||+|.+ +|+.||||+++........ ...+.+.+|+.++++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~-----~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-----KTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-----SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch-----HHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 6799999999999999999965 4789999998532210000 001236679999999965 8999999999
Q ss_pred cCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 022794 124 MGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENM 203 (292)
Q Consensus 124 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Ni 203 (292)
.+.... +++|||+.+++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||
T Consensus 99 ~~~~~~----------------~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Ni 160 (322)
T d1vzoa_ 99 QTETKL----------------HLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160 (322)
T ss_dssp EETTEE----------------EEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred ccCCce----------------eeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccce
Confidence 887665 8999999999999998654 4578999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeecCcceeccCC-CCCCCCCCCcccccCCcccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022794 204 LLDKNRTVKIADFGVARVEASN-PNDMTGETGTLGYMAPEVLNGN--PYNRKCDVYSFGICLWEIYCCDMPYPDLSFSEV 280 (292)
Q Consensus 204 li~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Diwslg~il~~l~~g~~pf~~~~~~~~ 280 (292)
+++.++.++|+|||++...... ........+++.|++||.+.+. .++.++|||||||++|+|++|..||.+.+..+.
T Consensus 161 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 161 LLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp EECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred eecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999765432 2233446789999999999765 467899999999999999999999988776666
Q ss_pred HHHHHHh
Q 022794 281 TSAVVRQ 287 (292)
Q Consensus 281 ~~~i~~~ 287 (292)
...+.++
T Consensus 241 ~~~i~~~ 247 (322)
T d1vzoa_ 241 QAEISRR 247 (322)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 6666554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=294.58 Aligned_cols=199 Identities=34% Similarity=0.483 Sum_probs=161.6
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCccc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSSEL 129 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 129 (292)
.+|.+.+.||+|+||.||+|+++|+.||||+++... .. ......|+..+++++||||+++++++.+.+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~-------~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-------ER---SWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG-------HH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc-------hh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence 578999999999999999999999999999985321 11 11123466666778999999999998765421
Q ss_pred ccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCC
Q 022794 130 HIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS--------QKIVHRDVKTE 201 (292)
Q Consensus 130 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~--------~~i~h~di~p~ 201 (292)
....++||||+++|+|.+++.+ ..+++..++.++.|++.+|.++|. +||+||||||+
T Consensus 73 ------------~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 73 ------------WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp ------------SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred ------------ceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 1234899999999999999964 358899999999999999999996 59999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCCCC------CCchhhHHHHHHHHHHHHhCCCC
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNP------YNRKCDVYSFGICLWEIYCCDMP 271 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~------~~~~~Diwslg~il~~l~~g~~p 271 (292)
|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 138 NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~ 217 (303)
T d1vjya_ 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred ceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCC
Confidence 99999999999999999986544322 233467999999999987642 56789999999999999999887
Q ss_pred CC
Q 022794 272 YP 273 (292)
Q Consensus 272 f~ 273 (292)
|.
T Consensus 218 ~~ 219 (303)
T d1vjya_ 218 GG 219 (303)
T ss_dssp TT
T ss_pred CC
Confidence 64
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-42 Score=292.22 Aligned_cols=204 Identities=19% Similarity=0.329 Sum_probs=168.9
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhC-CCCcccceeceecC
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKL-DHPNVTKFIGATMG 125 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 125 (292)
.++|++++.||+|+||+||+|++ +|+.||||+++... .+.+.+|+.+|+++ .||||++++++|..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------------HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 46799999999999999999976 58999999985321 23477899999999 59999999999875
Q ss_pred CcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeE
Q 022794 126 SSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 205 (292)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili 205 (292)
.... ..+++|||+.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~--------------~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi 162 (328)
T d3bqca1 102 PVSR--------------TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162 (328)
T ss_dssp TTTC--------------SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred cCCC--------------ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence 4332 238999999999987653 459999999999999999999999999999999999999
Q ss_pred cCCC-cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Q 022794 206 DKNR-TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGN-PYNRKCDVYSFGICLWEIYCCDMPYPDL-SFSEVTS 282 (292)
Q Consensus 206 ~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwslg~il~~l~~g~~pf~~~-~~~~~~~ 282 (292)
+.++ .++|+|||.+...... .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|..||... +..+...
T Consensus 163 ~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~ 241 (328)
T d3bqca1 163 DHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241 (328)
T ss_dssp ETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred cCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence 8654 6999999999765433 334456789999999998775 4799999999999999999999999754 3444444
Q ss_pred HH
Q 022794 283 AV 284 (292)
Q Consensus 283 ~i 284 (292)
.+
T Consensus 242 ~i 243 (328)
T d3bqca1 242 RI 243 (328)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=290.01 Aligned_cols=212 Identities=32% Similarity=0.506 Sum_probs=166.9
Q ss_pred eEeeeeccCcceEEEEEEEC-----CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCcccceeceecCCc
Q 022794 53 VIKSVIARGTFGTVHRGLYD-----GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPNVTKFIGATMGSS 127 (292)
Q Consensus 53 ~~~~~lg~G~~g~V~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 127 (292)
.+.++||+|+||+||+|.+. ...||||.++... .. .....+.+|++++++++||||+++++++.+.+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~----~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC----CH----HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc----CH----HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence 34678999999999999763 2358999885321 11 22455889999999999999999999876532
Q ss_pred ccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeeEcC
Q 022794 128 ELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTENMLLDK 207 (292)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~Nili~~ 207 (292)
. ..++||||+++++|.+++.. .....++..++.++.|++.||.|||+.+++||||||+|||+++
T Consensus 102 ~---------------~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~ 165 (311)
T d1r0pa_ 102 G---------------SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165 (311)
T ss_dssp T---------------EEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred C---------------ceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC
Confidence 2 22899999999999998864 3456778889999999999999999999999999999999999
Q ss_pred CCcEEEeecCcceeccCCCC----CCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHH
Q 022794 208 NRTVKIADFGVARVEASNPN----DMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYCCDMPY-PDLSFSEVTS 282 (292)
Q Consensus 208 ~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~g~~pf-~~~~~~~~~~ 282 (292)
++.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..|| ...+..++..
T Consensus 166 ~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp TCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred CCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 99999999999976543322 222346889999999999999999999999999999999966555 4556666666
Q ss_pred HHHHhh
Q 022794 283 AVVRQV 288 (292)
Q Consensus 283 ~i~~~~ 288 (292)
.+.++.
T Consensus 246 ~i~~g~ 251 (311)
T d1r0pa_ 246 YLLQGR 251 (311)
T ss_dssp HHHTTC
T ss_pred HHHcCC
Confidence 666553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-36 Score=258.78 Aligned_cols=201 Identities=24% Similarity=0.370 Sum_probs=157.3
Q ss_pred CCceeEeeeeccCcceEEEEEEE--CCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-----------CCc
Q 022794 49 PSKLVIKSVIARGTFGTVHRGLY--DGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-----------HPN 115 (292)
Q Consensus 49 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~ 115 (292)
.++|++++.||+|+||+||+|++ +|+.||||+++... ...+.+.+|+.+++.+. |+|
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----------cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 46799999999999999999976 68999999996321 11234667888887774 578
Q ss_pred ccceeceecCCcccccccccccccCCCCceEEEEeecCCC-CHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh-CCc
Q 022794 116 VTKFIGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGG-ALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS-QKI 193 (292)
Q Consensus 116 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i 193 (292)
|+++++++........ ++++.++..+ .............+++..++.++.|++.||.+||+ .||
T Consensus 82 iv~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~I 147 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGV--------------HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 147 (362)
T ss_dssp BCCCCEEEEEEETTEE--------------EEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred eEEEEEEeeeccccce--------------eeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCc
Confidence 8888888765432211 5566655444 44444445556779999999999999999999997 899
Q ss_pred cccCCCCCCeeEcCCC------cEEEeecCcceeccCCCCCCCCCCCcccccCCcccCCCCCCchhhHHHHHHHHHHHHh
Q 022794 194 VHRDVKTENMLLDKNR------TVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEIYC 267 (292)
Q Consensus 194 ~h~di~p~Nili~~~~------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwslg~il~~l~~ 267 (292)
+||||||+|||++.++ .++++|||.+..... ......+++.|+|||.+.+..++.++|+||+||++++|++
T Consensus 148 vHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 224 (362)
T d1q8ya_ 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224 (362)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHH
Confidence 9999999999997654 399999999875543 2344679999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 022794 268 CDMPYPDLS 276 (292)
Q Consensus 268 g~~pf~~~~ 276 (292)
|+.||...+
T Consensus 225 g~~pF~~~~ 233 (362)
T d1q8ya_ 225 GDFLFEPDE 233 (362)
T ss_dssp SSCCC----
T ss_pred CCCCCCCCc
Confidence 999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.3e-26 Score=179.82 Aligned_cols=171 Identities=15% Similarity=0.099 Sum_probs=119.1
Q ss_pred eeEeeeeccCcceEEEEEEE-CCceeEEEEeecCCCCCc---------cHHHHHHHHHHHHHHHHHHHhCCCCcccceec
Q 022794 52 LVIKSVIARGTFGTVHRGLY-DGHDVAVKLLDWGEEGHR---------TEAEIAALRSAFTQEVAVWHKLDHPNVTKFIG 121 (292)
Q Consensus 52 ~~~~~~lg~G~~g~V~~~~~-~~~~valK~~~~~~~~~~---------~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 121 (292)
+.+.+.||+|+||+||+|.+ +|+.||||+++....... ..............|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999975 689999999764321100 00111222344567899999999999988775
Q ss_pred eecCCcccccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 022794 122 ATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHSQKIVHRDVKTE 201 (292)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~h~di~p~ 201 (292)
... . +++|||+++..+.+ ++...+..++.|++.+|.+||++|++||||||+
T Consensus 82 ~~~----~----------------~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~ 132 (191)
T d1zara2 82 WEG----N----------------AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQY 132 (191)
T ss_dssp EET----T----------------EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred ecC----C----------------EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChh
Confidence 421 1 78999998755432 444556789999999999999999999999999
Q ss_pred CeeEcCCCcEEEeecCcceeccCCCCCCCCCCCcccccCC------cccCCCCCCchhhHHHHHHH
Q 022794 202 NMLLDKNRTVKIADFGVARVEASNPNDMTGETGTLGYMAP------EVLNGNPYNRKCDVYSFGIC 261 (292)
Q Consensus 202 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~Diwslg~i 261 (292)
|||+++++ ++|+|||.+.....+.. ..|... +.+ ...|+.++|+||+.--
T Consensus 133 NILv~~~~-~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 133 NVLVSEEG-IWIIDFPQSVEVGEEGW--------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp SEEEETTE-EEECCCTTCEETTSTTH--------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred heeeeCCC-EEEEECCCcccCCCCCc--------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99998654 89999999865432111 111111 111 2456788899997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=2.3e-08 Score=79.49 Aligned_cols=140 Identities=13% Similarity=0.090 Sum_probs=87.8
Q ss_pred CceeEeeeeccCcceEEEEEEECCceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCC-CCcccceeceecCCcc
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYDGHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLD-HPNVTKFIGATMGSSE 128 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 128 (292)
+.|++++..+.++.+.||+...++..++||........... .+.+|...+..+. +--+.+++.+....+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~---------~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTY---------DVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTT---------CHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchh---------hHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 45677776555566789998888888999987544322221 1456777777663 2224555555443332
Q ss_pred cccccccccccCCCCceEEEEeecCCCCHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHh------------------
Q 022794 129 LHIQTENGQVAMPSNICCVVVEYLPGGALKTYLIKNRRRKLAFKVVVQLALDLARGLSYLHS------------------ 190 (292)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~------------------ 190 (292)
.+++|++++|.++.+..... .. ...++.++...++.||+
T Consensus 85 ----------------~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~ 141 (263)
T d1j7la_ 85 ----------------SNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp ----------------EEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHH
T ss_pred ----------------eEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhh
Confidence 38999999988876543110 11 11223334444444442
Q ss_pred -----------------------------------C------CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 191 -----------------------------------Q------KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 191 -----------------------------------~------~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
. .++|+|+.|.||++++++.+.|+||+.+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 278999999999998776677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=1.6e-05 Score=62.12 Aligned_cols=29 Identities=24% Similarity=0.385 Sum_probs=25.5
Q ss_pred ccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 193 IVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 193 i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
++|+|+.|.||+++++..+.|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999998877678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=0.00014 Score=60.66 Aligned_cols=29 Identities=21% Similarity=0.359 Sum_probs=25.2
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
.++|||+.|.||++++++ ++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998765 89999988764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.66 E-value=0.0003 Score=56.60 Aligned_cols=30 Identities=20% Similarity=0.309 Sum_probs=27.0
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
|+||+|+.+.|++++.+...-++||+.++.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 799999999999999887778999998763
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.58 E-value=0.00012 Score=59.32 Aligned_cols=28 Identities=25% Similarity=0.274 Sum_probs=23.3
Q ss_pred CccccCCCCCCeeEcCCCcEEEeecCccee
Q 022794 192 KIVHRDVKTENMLLDKNRTVKIADFGVARV 221 (292)
Q Consensus 192 ~i~h~di~p~Nili~~~~~~~l~Dfg~~~~ 221 (292)
++||+|+.+.||++++ + ..++||+.++.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 6899999999999964 3 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.12 E-value=0.00083 Score=55.79 Aligned_cols=76 Identities=22% Similarity=0.273 Sum_probs=45.0
Q ss_pred CceeEeeeeccCcceEEEEEEEC---------CceeEEEEeecCCCCCccHHHHHHHHHHHHHHHHHHHhCCCCc-ccce
Q 022794 50 SKLVIKSVIARGTFGTVHRGLYD---------GHDVAVKLLDWGEEGHRTEAEIAALRSAFTQEVAVWHKLDHPN-VTKF 119 (292)
Q Consensus 50 ~~~~~~~~lg~G~~g~V~~~~~~---------~~~valK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~ 119 (292)
+.+++ +.|+.|-.-.+|++... ++.|++++.-. . ..... ..+|..+++.+...+ ..++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~id-------r~~E~~i~~~ls~~gl~Pkl 110 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESH-------LVAESVIFTLLSERHLGPKL 110 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHH-------HHHHHHHHHHHHHTTSSSCE
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhH-------HHHHHHHHHHHHhCCCCCeE
Confidence 34444 56787888899998643 35688887631 1 11111 335778887773233 3466
Q ss_pred eceecCCcccccccccccccCCCCceEEEEeecCCCCH
Q 022794 120 IGATMGSSELHIQTENGQVAMPSNICCVVVEYLPGGAL 157 (292)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 157 (292)
++++.. ++|++|++|.+|
T Consensus 111 l~~~~~--------------------g~I~efi~g~~l 128 (395)
T d1nw1a_ 111 YGIFSG--------------------GRLEEYIPSRPL 128 (395)
T ss_dssp EEEETT--------------------EEEECCCCEEEC
T ss_pred EEEcCC--------------------ceEEEEeccccC
Confidence 665532 568888876444
|